<?xml version="1.0"?>

<!--
-
- Sequel Pro XML dump
- Version 4541
-
- http://www.sequelpro.com/
- https://github.com/sequelpro/sequelpro
-
- Host: 127.0.0.1 (MySQL 5.1.73-log)
- Database: lmdb
- Generation Time Time: 2019-11-27 15:54:51 +0000
-
-->

<lmdb>

	<custom>
	<row>
		<id>1</id>
		<lmdb_id>LMDB00001</lmdb_id>
		<created_at>2016-07-13 19:22:06</created_at>
		<updated_at>2016-08-02 20:14:58</updated_at>
		<export>1</export>
		<name>1-Methylhistidine</name>
		<description>One-methylhistidine (1-MHis) is derived mainly from the anserine of dietary flesh sources, especially poultry. The enzyme, carnosinase, splits anserine into b-alanine and 1-MHis. High levels of 1-MHis tend to inhibit the enzyme carnosinase and increase anserine levels. Conversely, genetic variants with deficient carnosinase activity in plasma show increased 1-MHis excretions when they consume a high meat diet. Reduced serum carnosinase activity is also found in patients with Parkinson's disease and multiple sclerosis and patients following a cerebrovascular accident. Vitamin E deficiency can lead to 1-methylhistidinuria from increased oxidative effects in skeletal muscle.</description>
		<cas>332-80-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN1C=NC(C[C@H](N)C(O)=O)=C1</moldb_smiles>
		<moldb_formula>C7H11N3O2</moldb_formula>
		<moldb_inchi>InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1</moldb_inchi>
		<moldb_inchikey>BRMWTNUJHUMWMS-LURJTMIESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>169.1811</moldb_average_mass>
		<moldb_mono_mass>169.085126611</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>2</id>
		<lmdb_id>LMDB00002</lmdb_id>
		<created_at>2016-07-13 19:22:07</created_at>
		<updated_at>2016-07-20 20:54:11</updated_at>
		<export>1</export>
		<name>1,3-Diaminopropane</name>
		<description>1,3-Diaminopropane is a stable, flammable and highly hydroscopic fluid. It is a polyamine that is normally quite toxic if swallowed, inhaled or absorbed through the skin. It is a catabolic byproduct of spermidine. It is also a precursor in the enzymatic synthesis of beta-alanine. 1, 3-Diaminopropane is involved in the arginine/proline metabolic pathways and the beta-alanine metabolic pathway.</description>
		<cas>109-76-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCCN</moldb_smiles>
		<moldb_formula>C3H10N2</moldb_formula>
		<moldb_inchi>InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2</moldb_inchi>
		<moldb_inchikey>XFNJVJPLKCPIBV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>74.1249</moldb_average_mass>
		<moldb_mono_mass>74.084398330</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>3</id>
		<lmdb_id>LMDB00003</lmdb_id>
		<created_at>2016-07-13 19:22:08</created_at>
		<updated_at>2016-07-20 20:48:18</updated_at>
		<export>1</export>
		<name>2-Hydroxybutyric acid</name>
		<description>2-Hydroxybutyric acid (alpha-hydroxybutyrate) is an organic acid derived from alpha-ketobutyrate. Alpha-ketobutyrate is produced by amino acid catabolism (threonine and methionine) and glutathione anabolism (cysteine formation pathway) and is metabolized to propionyl-CoA and carbon dioxide (PMID: 20526369). 2-Hydroxybutyric acid is formed as a by-product during the formation of Alpha-ketobutyrate via a reaction catalyzed by lactate dehydrogenase (LDH) or alphañhydroxybutyrate dehydrogenase (alphañHBDH). Alpha-hydroxybutyric acid is primarily produced in mammalian hepatic tissues that catabolize L-threonine or synthesize glutathione. Oxidative stress or detoxification of xenobiotics in the liver can dramatically increase the rate of hepatic glutathione synthesis. Under such metabolic stress conditions, supplies of L-cysteine for glutathione synthesis become limiting, so homocysteine is diverted from the transmethylation pathway (which forms methionine) into the transsulfuration pathway (which forms cystathionine). 2-Hydroxybutyrate is released as a byproduct when cystathionine is cleaved to cysteine that is incorporated into glutathione. Chronic shifts in the rate of glutathione synthesis may be reflected by urinary excretion of 2-hydroxybutyrate. 2-hydroxybutyrate is an early marker for both insulin resistance and impaired glucose regulation that appears to arise due to increased lipid oxidation and oxidative stress (PMID: 20526369). 2-Hydroxybutyric acid is often found in the urine of patients suffering from lactic acidosis and ketoacidosis. 2-Hydroxybutyric acid generally appears at high concentrations in situations related to deficient energy metabolism (e.g., birth asphyxia) and also in inherited metabolic diseases affecting the central nervous system during neonatal development, such as &quot;cerebral&quot; lactic acidosis, glutaric aciduria type II, dihydrolipoyl dehydrogenase (E3) deficiency, and propionic acidemia. More recently it has been noted that elevated levels of alpha-hydroxybutyrate in the plasma is a good marker for early stage type II diabetes (PMID:19166731). It was concluded from studies done in the mid 1970's that an increased NADH2/NAD ratio was the most important factor for the production of 2-hydorxybutyric acid (PMID:168632).</description>
		<cas>600-15-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC(O)C(O)=O</moldb_smiles>
		<moldb_formula>C4H8O3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(H,6,7)</moldb_inchi>
		<moldb_inchikey>AFENDNXGAFYKQO-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>104.1045</moldb_average_mass>
		<moldb_mono_mass>104.047344122</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>4</id>
		<lmdb_id>LMDB00004</lmdb_id>
		<created_at>2016-07-13 19:22:10</created_at>
		<updated_at>2016-07-20 20:54:12</updated_at>
		<export>1</export>
		<name>Deoxyuridine</name>
		<description>2'-Deoxyuridine is a naturally occurring nucleoside. It is similar in chemical structure to uridine, but without the 2'-hydroxyl group. It is considered to be an antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemia due to vitamin B12 and folate deficiencies.</description>
		<cas>951-78-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)NC1=O</moldb_smiles>
		<moldb_formula>C9H12N2O5</moldb_formula>
		<moldb_inchi>InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1</moldb_inchi>
		<moldb_inchikey>MXHRCPNRJAMMIM-SHYZEUOFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>228.2020</moldb_average_mass>
		<moldb_mono_mass>228.074621504</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>5</id>
		<lmdb_id>LMDB00005</lmdb_id>
		<created_at>2016-07-13 19:22:11</created_at>
		<updated_at>2016-07-20 20:54:13</updated_at>
		<export>1</export>
		<name>Cortexolone</name>
		<description>Cortexolone is the precursor of cortisol. Accumulation of Cortexolone can happen in a defect known as congenital adrenal hyperplasia, which is due to 11-beta-hydroxylase deficiency, resulting in androgen excess, virilization, and hypertension. (PMID: 2022736) A 17-hydroxycorticosteroid with glucocorticoid and anti-inflammatory activities. (PubChem).</description>
		<cas>152-58-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]C12CC[C@](O)(C(=O)CO)[C@@]1(C)CCC1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C21H30O4</moldb_formula>
		<moldb_inchi>InChI=1S/C21H30O4/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22/h11,15-17,22,25H,3-10,12H2,1-2H3/t15-,16?,17?,19+,20+,21+/m1/s1</moldb_inchi>
		<moldb_inchikey>WHBHBVVOGNECLV-HMGFGKNBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>346.4605</moldb_average_mass>
		<moldb_mono_mass>346.214409448</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>6</id>
		<lmdb_id>LMDB00006</lmdb_id>
		<created_at>2016-07-13 19:22:12</created_at>
		<updated_at>2016-08-02 20:40:49</updated_at>
		<export>1</export>
		<name>Alpha-ketoisovaleric acid</name>
		<description>Alpha-ketoisovaleric acid is a branched chain organic acid which is a precursor to leucine and valine synthesis. It is also a degradation product from valine. The enzyme dihydroxy-acid dehydratase catalyzes the fourth step in the biosynthesis of isoleucine and valine, through the dehydration of 2, 3-dihydroxy-isovaleic acid into alpha-ketoisovaleric acid.</description>
		<cas>759-05-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)C(=O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H8O3</moldb_formula>
		<moldb_inchi>InChI=1S/C5H8O3/c1-3(2)4(6)5(7)8/h3H,1-2H3,(H,7,8)</moldb_inchi>
		<moldb_inchikey>QHKABHOOEWYVLI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>116.1152</moldb_average_mass>
		<moldb_mono_mass>116.047344122</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>7</id>
		<lmdb_id>LMDB00007</lmdb_id>
		<created_at>2016-07-13 19:22:14</created_at>
		<updated_at>2016-07-20 21:02:58</updated_at>
		<export>1</export>
		<name>p-Hydroxyphenylacetic acid</name>
		<description>p-Hydroxyphenylacetic acid is an oxidative deaminated metabolite of p-tyramine. Also a metabolite of tyrosine via enteric bacteria. The bacterial origin of this compound was confirmed by the finding that this compound in urine decreased significantly after the use of the antibiotic neomycin.</description>
		<cas>156-38-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CC1=CC=C(O)C=C1</moldb_smiles>
		<moldb_formula>C8H8O3</moldb_formula>
		<moldb_inchi>InChI=1S/C8H8O3/c9-7-3-1-6(2-4-7)5-8(10)11/h1-4,9H,5H2,(H,10,11)</moldb_inchi>
		<moldb_inchikey>XQXPVVBIMDBYFF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>152.1473</moldb_average_mass>
		<moldb_mono_mass>152.047344122</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>8</id>
		<lmdb_id>LMDB00008</lmdb_id>
		<created_at>2016-07-13 19:22:15</created_at>
		<updated_at>2016-07-20 20:48:21</updated_at>
		<export>1</export>
		<name>Ureidopropionic acid</name>
		<description>Ureidopropionic acid is an intermediate in the metabolism of uracil. More specifically it is a breakdown product of dihydrouracil and is produced by the enzyme dihydropyrimidase. It is further decomposed to beta-alanine via the enzyme beta-ureidopropionase. Ureidopropionic acid is essentially a urea derivative of beta-alanine. High levels of Ureidopropionic acid are found in individuals with beta-ureidopropionase (UP) deficiency [PMID: 11675655]. Enzyme deficiencies in pyrimidine metabolism are associated with a risk for severe toxicity against the antineoplastic agent 5-fluorouracil.</description>
		<cas>462-88-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(=O)NCCC(O)=O</moldb_smiles>
		<moldb_formula>C4H8N2O3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8N2O3/c5-4(9)6-2-1-3(7)8/h1-2H2,(H,7,8)(H3,5,6,9)</moldb_inchi>
		<moldb_inchikey>JSJWCHRYRHKBBW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>132.1179</moldb_average_mass>
		<moldb_mono_mass>132.053492132</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>9</id>
		<lmdb_id>LMDB00009</lmdb_id>
		<created_at>2016-07-13 19:22:16</created_at>
		<updated_at>2016-09-23 18:44:27</updated_at>
		<export>1</export>
		<name>Biotin</name>
		<description>Biotin is an enzyme co-factor present in minute amounts in every living cell. Biotin is also known as vitamin H or B7 or coenzyme R. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk. Biotin has been recognized as an essential nutrient. Our biotin requirement is fulfilled in part through diet, through endogenous reutilization of biotin and perhaps through capture of biotin generated in the intestinal flora. The utilization of biotin for covalent attachment to carboxylases and its reutilization through the release of carboxylase biotin after proteolytic degradation constitutes the 'biotin cycle'. Biotin deficiency is associated with neurological manifestations, skin rash, hair loss and metabolic disturbances that are thought to relate to the various carboxylase deficiencies (metabolic ketoacidosis with lactic acidosis). It has also been suggested that biotin deficiency is associated with protein malnutrition, and that marginal biotin deficiency in pregnant women may be teratogenic. Biotin acts as a carboxyl carrier in carboxylation reactions. There are four biotin-dependent carboxylases in mammals: those of propionyl-CoA (PCC), 3-methylcrotonyl-CoA (MCC), pyruvate (PC) and acetyl-CoA carboxylases (isoforms ACC-1 and ACC-2). All but ACC-2 are mitochondrial enzymes. The biotin moiety is covalently bound to the epsilon amino group of a Lysine residue in each of these carboxylases in a domain 60-80 amino acids long. The domain is structurally similar among carboxylases from bacteria to mammals. There are four biotin-dependent carboxylases in mammals: those of propionyl-CoA (PCC), 3-methylcrotonyl-CoA (MCC), pyruvate (PC) and acetyl-CoA carboxylases (isoforms ACC-1 and ACC-2). All but ACC-2 are mitochondrial enzymes. The biotin moiety is covalently bound to the epsilon amino group of a Lys residue in each of these carboxylases in a domain 60-80 amino acids long. The domain is structurally similar among carboxylases from bacteria to mammals. Evidence is emerging that biotin participates in processes other than classical carboxylation reactions. Specifically, novel roles for biotin in cell signaling, gene expression, and chromatin structure have been identified in recent years. Human cells accumulate biotin by using both the sodium-dependent multivitamin transporter and monocarboxylate transporter 1. These transporters and other biotin-binding proteins partition biotin to compartments involved in biotin signaling: cytoplasm, mitochondria, and nuclei. The activity of cell signals such as biotinyl-AMP, Sp1 and Sp3, nuclear factor (NF)-kappaB, and receptor tyrosine kinases depends on biotin supply. Consistent with a role for biotin and its catabolites in modulating these cell signals, greater than 2000 biotin-dependent genes have been identified in various animal tissues. Many biotin-dependent gene products play roles in signal transduction and localize to the cell nucleus, consistent with a role for biotin in cell signaling. Posttranscriptional events related to ribosomal activity and protein folding may further contribute to effects of biotin on gene expression. Finally, research has shown that biotinidase and holocarboxylase synthetase mediate covalent binding of biotin to histones (DNA-binding proteins), affecting chromatin structure; at least seven biotinylation sites have been identified in animal histones. Biotinylation of histones appears to play a role in cell proliferation, gene silencing, and the cellular response to DNA repair. Roles for biotin in cell signaling and chromatin structure are consistent with the notion that biotin has a unique significance in cell biology. (PMID: 15992684, 16011464).</description>
		<cas>58-85-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2</moldb_smiles>
		<moldb_formula>C10H16N2O3S</moldb_formula>
		<moldb_inchi>InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1</moldb_inchi>
		<moldb_inchikey>YBJHBAHKTGYVGT-ZKWXMUAHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>244.3110</moldb_average_mass>
		<moldb_mono_mass>244.088163078</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>10</id>
		<lmdb_id>LMDB00010</lmdb_id>
		<created_at>2016-07-13 19:40:23</created_at>
		<updated_at>2016-07-20 20:48:22</updated_at>
		<export>1</export>
		<name>Carnosine</name>
		<description>Carnosine (beta-alanyl-L-histidine) is found exclusively in animal tissues. It is a dipeptide of the amino acids beta-alanine and histidine. Carnosine has the potential to suppress many of the biochemical changes (e.g., protein oxidation, glycation, AGE formation, and cross-linking) that accompany aging and associated pathologies (PMID 16804013). It is highly concentrated in muscle and brain tissues. Some autistics patients take it as a dietary supplement, and attribute an improvement in their condition to it. Supplemental carnosine may increase corticosterone levels. This may explain the &quot;hyperactivity&quot; seen in autistic subjects at higher doses. Carnosine also exhibits some antioxidant effects. The antioxidant mechanism of carnosine is attributed to its chelating effect against metal ions, superoxide dismutase (SOD)-like activity, ROS and free radicals scavenging ability (PMID 16406688).</description>
		<cas>305-84-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCC(=O)N[C@@H](CC1=CN=CN1)C(O)=O</moldb_smiles>
		<moldb_formula>C9H14N4O3</moldb_formula>
		<moldb_inchi>InChI=1S/C9H14N4O3/c10-2-1-8(14)13-7(9(15)16)3-6-4-11-5-12-6/h4-5,7H,1-3,10H2,(H,11,12)(H,13,14)(H,15,16)/t7-/m0/s1</moldb_inchi>
		<moldb_inchikey>CQOVPNPJLQNMDC-ZETCQYMHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>226.2325</moldb_average_mass>
		<moldb_mono_mass>226.106590334</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>11</id>
		<lmdb_id>LMDB00011</lmdb_id>
		<created_at>2016-07-13 19:40:25</created_at>
		<updated_at>2016-07-20 21:02:59</updated_at>
		<export>1</export>
		<name>Adenine</name>
		<description>Adenine is a purine base. Adenine is found in both DNA and RNA. Adenine is a fundamental component of adenine nucleotides. Adenine forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose; it forms adenosine triphosphate (ATP), a nucleotide, when three phosphate groups are added to adenosine. Adenosine triphosphate is used in cellular metabolism as one of the basic methods of transferring chemical energy between chemical reactions. Purine inborn errors of metabolism (IEM) are serious hereditary disorders, which should be suspected in any case of neonatal fitting, failure to thrive, recurrent infections, neurological deficit, renal disease, self-mutilation and other manifestations. Investigation usually starts with uric acid (UA) determination in urine and plasma. (OMIM 300322, 229600, 603027, 232400, 232600, 232800, 201450, 220150, 232200, 162000, 164050, 278300). (PMID: 17052198, 17520339).</description>
		<cas>73-24-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1=C2NC=NC2=NC=N1</moldb_smiles>
		<moldb_formula>C5H5N5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10)</moldb_inchi>
		<moldb_inchikey>GFFGJBXGBJISGV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>135.1267</moldb_average_mass>
		<moldb_mono_mass>135.054495185</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>12</id>
		<lmdb_id>LMDB00012</lmdb_id>
		<created_at>2016-07-13 19:40:26</created_at>
		<updated_at>2016-07-20 21:03:00</updated_at>
		<export>1</export>
		<name>Taurocholic acid</name>
		<description>Taurocholic acid is a bile acid and is the product of conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487 , 16037564 , 12576301 , 11907135 ) Taurocholic acid, as with all bile acids, acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and cholerectic (a bile purging agent). Hydrolysis of taurocholic acid yields taurine, a nonessential amino acid. Taurocholic acid is one of the main components of urinary nonsulfated bile acids in biliary atresia. Raised levels of the bile acid taurocholate in the fetal serum in obstetric cholestasis may result in the development of a fetal dysrhythmia and in sudden intra-uterine death. (PMID: 3944741 , 11256973 ).</description>
		<cas>81-24-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12C[C@H](O)CCC1(C)C1C[C@H](O)C3(C)C(CCC3C1[C@H](O)C2)C(C)CCC(=O)NCCS(O)(=O)=O</moldb_smiles>
		<moldb_formula>C26H45NO7S</moldb_formula>
		<moldb_inchi>InChI=1S/C26H45NO7S/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34)/t15?,16-,17+,18?,19?,20?,21+,22-,24?,25?,26?/m0/s1</moldb_inchi>
		<moldb_inchikey>WBWWGRHZICKQGZ-BKXUXKPJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>515.7030</moldb_average_mass>
		<moldb_mono_mass>515.291673489</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>13</id>
		<lmdb_id>LMDB00013</lmdb_id>
		<created_at>2016-07-13 19:40:27</created_at>
		<updated_at>2016-09-23 18:44:28</updated_at>
		<export>1</export>
		<name>Butyric acid</name>
		<description>Butyric acid, a four-carbon fatty acid, is formed in the animal colon by bacterial fermentation of carbohydrates (including dietary fiber), and putatively suppresses colorectal cancer (CRC). Butyrate has diverse and apparently paradoxical effects on cellular proliferation, apoptosis and differentiation that may be either pro-neoplastic or anti-neoplastic, depending upon factors such as the level of exposure, availability of other metabolic substrate and the intracellular milieu. In animals, the relationship between luminal butyrate exposure and CRC has been examined only indirectly in case-control studies, by measuring fecal butyrate concentrations, although this may not accurately reflect effective butyrate exposure during carcinogenesis. Perhaps not surprisingly, results of these investigations have been mutually contradictory. The direct effect of butyrate on tumorigenesis has been assessed in a no. of in vivo animal models, which have also yielded conflicting results. In part, this may be explained by methodology: differences in the amount and route of butyrate administration, which are likely to significantly influence delivery of butyrate to the distal colon. (PMID: 16460475) Butyric acid is a carboxylic acid found in rancid butter, parmesan cheese, and vomit, and has an unpleasant odor and acrid taste, with a sweetish aftertaste (similar to ether). Butyric acid is a fatty acid occurring in the form of esters in animal fats and plant oils. Interestingly, low-molecular-weight esters of butyric acid, such as methyl butyrate, have mostly pleasant aromas or tastes. As a consequence, they find use as food and perfume additives. Butyrate is produced as end-product of a fermentation process solely performed by obligate anaerobic bacteria.</description>
		<cas>107-92-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCC(O)=O</moldb_smiles>
		<moldb_formula>C4H8O2</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6)</moldb_inchi>
		<moldb_inchikey>FERIUCNNQQJTOY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>88.1051</moldb_average_mass>
		<moldb_mono_mass>88.052429500</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>14</id>
		<lmdb_id>LMDB00014</lmdb_id>
		<created_at>2016-07-13 19:40:29</created_at>
		<updated_at>2016-09-23 18:44:28</updated_at>
		<export>1</export>
		<name>Acetic acid</name>
		<description>Acetic acid is one of the simplest carboxylic acids. It is an important chemical reagent and industrial chemical that is used in the production of plastic soft drink bottles, photographic film; and polyvinyl acetate for wood glue, as well as many synthetic fibres and fabrics. In households diluted acetic acid is often used as a cleaning agent. In the food industry acetic acid is used as an acidity regulator. The acetyl group, derived from acetic acid, is fundamental to the biochemistry of virtually all forms of life. When bound to coenzyme A it is central to the metabolism of carbohydrates and fats. However, the concentration of free acetic acid in cells is kept at a low level to avoid disrupting the control of the pH of the cell contents. Acetic acid is produced and excreted by certain bacteria, notably the Acetobacter genus and Clostridium acetobutylicum. These bacteria are found universally in foodstuffs, water, and soil, and acetic acid is produced naturally as fruits and some other foods spoil. Acetic acid is also a component of the vaginal lubrication of animals and other primates, where it appears to serve as a mild antibacterial agent.</description>
		<cas>64-19-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(O)=O</moldb_smiles>
		<moldb_formula>C2H4O2</moldb_formula>
		<moldb_inchi>InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)</moldb_inchi>
		<moldb_inchikey>QTBSBXVTEAMEQO-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>60.0520</moldb_average_mass>
		<moldb_mono_mass>60.021129372</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>15</id>
		<lmdb_id>LMDB00015</lmdb_id>
		<created_at>2016-07-13 19:40:30</created_at>
		<updated_at>2016-07-20 20:48:38</updated_at>
		<export>1</export>
		<name>Betaine</name>
		<description>Betaine, (or N,N,N-trimethylglycine) was named after its discovery in sugar beet (Beta vulgaris) in the 19th century. It is a small N-trimethylated amino acid, existing in zwitterionic form at neutral pH. It is now often called glycine betaine to distinguish it from other betaines that are widely distributed in microorganisms, plants and animals.  Many naturally occurring betaines serve as organic osmolytes, substances synthesized or taken up from the environment by cells for protection against osmotic stress, drought, high salinity or high temperature. Intracellular accumulation of betaines permits water retention in cells, thus protecting from the effects of dehydration (Wikipedia). Betaine functions as a methyl donor in that it carries and donates methyl functional groups to facilitate necessary chemical processes. In particular it methylates homocysteine to methionine, also producing N,N-dimethylglycine. The donation of methyl groups is important to proper liver function, cellular replication, and detoxification reactions. Betaine also plays a role in the manufacture of carnitine and serves to protect the kidneys from damage. Betaine comes from either the diet or by the oxidation of choline. Betaine insufficiency is associated with the metabolic syndrome, lipid disorders and diabetes, and may have a role in vascular and other diseases (PMID: 20346934). Betaine is important in development, from the pre-implantation embryo to infancy. Betaine is also widely regarded as an anti-oxidant.  Betaine has been shown to have an inhibitory effect on NO release in activated microglial cells and may be an effective therapeutic component to control neurological disorders (PMID: 22801281).  As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. (From Martindale, The Extra Pharmacopoeia, 30th Ed, p1341).</description>
		<cas>107-43-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+](C)(C)CC([O-])=O</moldb_smiles>
		<moldb_formula>C5H11NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3</moldb_inchi>
		<moldb_inchikey>KWIUHFFTVRNATP-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>117.1463</moldb_average_mass>
		<moldb_mono_mass>117.078978601</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>16</id>
		<lmdb_id>LMDB00016</lmdb_id>
		<created_at>2016-07-13 19:40:32</created_at>
		<updated_at>2016-09-23 18:44:28</updated_at>
		<export>1</export>
		<name>Ascorbic acid</name>
		<description>Ascorbic acid is found naturally in citrus fruits and many vegetables and is an essential nutrient in animal diets. It is necessary to maintain connective tissue and bone. The biologically active form of ascorbic acid is vitamin C. Vitamin C is a water soluble vitamin. Primates (including animals) and a few other species in all divisions of the animal kingdom, notably the guinea pig, have lost the ability to synthesize ascorbic acid and must obtain it in their food. Vitamin C functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant. [PubChem] Ascorbic acid is an electron donor for enzymes involved in collagen hydroxylation, biosynthesis of carnitine and norepinephrine, tyrosine metabolism, and amidation of peptide hormones. Ascrobic acid (vitamin C) deficiency causes scurvy. The amount of vitamin C necessary to prevent scurvy may not be adequate to maintain optimal health. The ability of vitamin C to donate electrons also makes it a potent water-soluble antioxidant that readily scavenges free radicals such as molecular oxygen, superoxide, hydroxyl radical, and hypochlorous acid. In this setting, several mechanisms could account for a link between vitamin C and heart disease. One is the relation between LDL oxidation and vitamins C and E. Vitamin C in vitro can recycle vitamin E, which can donate electrons to prevent LDL oxidation in vitro. As the lipid-phase vitamin E is oxidized, it can be regenerated by aqueous vitamin C. Other possibilities are that vitamin C could decrease cholesterol by mechanisms not well characterized, or could improve vasodilatation and vascular reactivity, perhaps by decreasing the interactions of nitric oxide with oxidants. (PMID: 10799361).</description>
		<cas>50-81-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO</moldb_smiles>
		<moldb_formula>C6H8O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1</moldb_inchi>
		<moldb_inchikey>CIWBSHSKHKDKBQ-JLAZNSOCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>176.1241</moldb_average_mass>
		<moldb_mono_mass>176.032087988</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>17</id>
		<lmdb_id>LMDB00017</lmdb_id>
		<created_at>2016-07-13 19:40:33</created_at>
		<updated_at>2016-08-02 20:14:59</updated_at>
		<export>1</export>
		<name>Adenosine monophosphate</name>
		<description>Adenosine monophosphate, also known as 5'-adenylic acid and abbreviated AMP, is a nucleotide that is found in RNA. It is an ester of phosphoric acid with the nucleoside adenosine. AMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase adenine. AMP can be produced during ATP synthesis by the enzyme adenylate kinase. AMP has recently been approved as a 'Bitter Blocker' additive to foodstuffs. When AMP is added to bitter foods or foods with a bitter aftertaste it makes them seem 'sweeter'. This potentially makes lower calorie food products more palatable.</description>
		<cas>61-19-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1</moldb_smiles>
		<moldb_formula>C10H14N5O7P</moldb_formula>
		<moldb_inchi>InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1</moldb_inchi>
		<moldb_inchikey>UDMBCSSLTHHNCD-KQYNXXCUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>347.2212</moldb_average_mass>
		<moldb_mono_mass>347.063084339</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>18</id>
		<lmdb_id>LMDB00018</lmdb_id>
		<created_at>2016-07-13 19:40:34</created_at>
		<updated_at>2016-09-23 18:44:29</updated_at>
		<export>1</export>
		<name>Melibiose</name>
		<description>Melibiose is disaccharide consisting of one galactose and one glucose moiety in an alpha (1-6) glycosidic linkage. This sugar is produced and metabolized only by enteric and lactic acid bacteria and other microbes. It is not an endogenous metabolite but may be obtained from the consumption of partially fermented molasses, brown sugar or honey. Antibodies to melibiose will appear in individuals affected by Chagas' disease (Trypanosoma cruzi infection). Melibiose is not metabolized by animals, but can be broken down by gut microflora, such as E. coli. In fact, E. coli is able to utilize melibiose as a sole source of carbon. Melibiose is first imported by the melibiose permease, MelB and then converted to &amp;#946;-D-glucose and &amp;#946;-D-galactose by the &amp;#945;-galactosidase encoded by melA. Because of its poor digestability Melibiose (along with rhamnose) can be used together for noninvasive intestinal mucosa barrier testing. This test can be used to assess malabsorption or impairment of intestinal permeability. Recent studies with dietary melibiose have shown that can strongly affected the Th cell responses to an ingested antigen. It has been suggested that melibiose could be used to enhance the induction of oral tolerance. (PMID 17986780).</description>
		<cas>585-99-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@H](OC[C@H]2OC(O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C12H22O11</moldb_formula>
		<moldb_inchi>InChI=1S/C12H22O11/c13-1-3-5(14)8(17)10(19)12(23-3)21-2-4-6(15)7(16)9(18)11(20)22-4/h3-20H,1-2H2/t3-,4-,5+,6-,7+,8+,9-,10-,11?,12+/m1/s1</moldb_inchi>
		<moldb_inchikey>DLRVVLDZNNYCBX-ABXHMFFYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>342.2965</moldb_average_mass>
		<moldb_mono_mass>342.116211546</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>19</id>
		<lmdb_id>LMDB00019</lmdb_id>
		<created_at>2016-07-13 19:40:35</created_at>
		<updated_at>2016-07-20 21:03:03</updated_at>
		<export>1</export>
		<name>Adenosine</name>
		<description>Adenosine is a nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. For instance, adenosine plays an important role in energy transfer - as adenosine triphosphate (ATP) and adenosine diphosphate (ADP). It also plays a role in signal transduction as cyclic adenosine monophosphate, cAMP. Adenosine itself is both a neurotransmitter and potent vasodilator. When administered intravenously, adenosine causes transient heart block in the AV node. Because of the effects of adenosine on AV node-dependent supraventricular tachycardia, adenosine is considered a class V antiarrhythmic agent.</description>
		<cas>58-61-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1</moldb_smiles>
		<moldb_formula>C10H13N5O4</moldb_formula>
		<moldb_inchi>InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1</moldb_inchi>
		<moldb_inchikey>OIRDTQYFTABQOQ-KQYNXXCUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>267.2413</moldb_average_mass>
		<moldb_mono_mass>267.096753929</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>20</id>
		<lmdb_id>LMDB00020</lmdb_id>
		<created_at>2016-07-13 19:40:37</created_at>
		<updated_at>2016-07-19 23:17:49</updated_at>
		<export>1</export>
		<name>Ammonia</name>
		<description>Ammonia is a colorless alkaline gas with a characteristic sharp smell. Ammonia is one of the most abundant nitrogen-containing compounds in the atmosphere. It is an irritant with a characteristic pungent odor, which is widely used in industry. Inasmuch as ammonia is highly soluble in water and, upon inhalation, is deposited in the upper airways, occupational exposures to ammonia have commonly been associated with sinusitis, upper airway irritation, and eye irritation. Acute exposures to high levels of ammonia have also been associated with diseases of the lower airways and interstitial lung. Ammonia has been shown to be a neurotoxin that predominantly affects astrocytes. Disturbed mitochondrial function and oxidative stress, factors implicated in the induction of the mitochondrial permeability transition, appear to be involved in the mechanism of ammonia neurotoxicity. Ammonia is formed in nearly all tissues and organs of the vertebrate organism; it is the most common endogenous neurotoxic compounds. Ammonia can affect the glutamatergic and GABAergic neuronal systems, the two prevailing neuronal systems of the cortical structures. Ammonia is well recognized to be central in the pathogenesis of hepatic encephalopathy and has been of importance to generations dating back to the early Egyptians. The gut produces ammonia which is metabolized in the liver and almost all organ systems are involved in ammonia metabolism. Colonic bacteria produce ammonia by splitting urea and other amino acids, however this does not explain hyperammonemia and hepatic encephalopathy. The alternative explanation is that hyperammonemia is the result of intestinal breakdown of amino acids, especially glutamine. The intestines have significant glutaminase activity, predominantly located in the enterocytes. On the other hand, this organ has only a little glutamine synthetase activity, making it a major glutamine-consuming organ. In addition to the intestine, the kidney is an important source of blood ammonia in patients with liver disease. Ammonia is also taken up by the muscle and brain in hepatic coma, and there is confirmation that ammonia is metabolized in muscle. The excessive formation of ammonia in the brains of Alzheimer's disease patients has been demonstrated, and it has been shown that some Alzheimer's disease patients exhibit elevated blood ammonia concentrations. Ammonia is the most important natural modulator of lysosomal protein processing: there is evidence for the involvement of aberrant lysosomal processing of beta-amyloid precursor protein (beta-APP) in the formation of amyloid deposits. Inflammatory processes and activation of microglia are widely believed to be implicated in the pathology of Alzheimer's disease. Ammonia is able to affect the characteristic functions of microglia, such as endocytosis, and cytokine production. Based on these facts, an ammonia-based hypothesis for Alzheimer's disease has been suggested. (PMID: 17006913, 16167195, 15377862, 15369278, 12020619).</description>
		<cas>7664-41-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N</moldb_smiles>
		<moldb_formula>H3N</moldb_formula>
		<moldb_inchi>InChI=1S/H3N/h1H3</moldb_inchi>
		<moldb_inchikey>QGZKDVFQNNGYKY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>17.0305</moldb_average_mass>
		<moldb_mono_mass>17.026549101</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>21</id>
		<lmdb_id>LMDB00021</lmdb_id>
		<created_at>2016-07-13 19:40:38</created_at>
		<updated_at>2016-07-19 23:06:50</updated_at>
		<export>1</export>
		<name>Androstenedione</name>
		<description>Androstenedione is a delta-4 19-carbon steroid that is produced not only in the testis, but also in the ovary and the adrenal cortex. Depending on the tissue type, androstenedione can serve as a precursor to testosterone as well as estrone and estradiol. It is the common precursor of male and female sex hormones. Some androstenedione is also secreted into the plasma, and may be converted in peripheral tissues to testosterone and estrogens. Androstenedione originates either from the conversion of dehydroepiandrosterone or from 17-hydroxyprogesterone. It is further converted to either testosterone or estrone. The production of adrenal androstenedione is governed by ACTH, while production of gonadal androstenedione is under control by gonadotropins.</description>
		<cas>63-05-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C19H26O2</moldb_formula>
		<moldb_inchi>InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1</moldb_inchi>
		<moldb_inchikey>AEMFNILZOJDQLW-QAGGRKNESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>286.4085</moldb_average_mass>
		<moldb_mono_mass>286.193280076</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>22</id>
		<lmdb_id>LMDB00022</lmdb_id>
		<created_at>2016-07-13 19:40:39</created_at>
		<updated_at>2016-07-20 20:11:42</updated_at>
		<export>1</export>
		<name>Bilirubin</name>
		<description>Bilirubin is a bile pigment that is a degradation product of heme. In particular, bilirubin is a yellow breakdown product of normal heme catabolism. Its levels are elevated in certain diseases and it is responsible for the yellow color of bruises. Bilirubin is an excretion product, and the body does not control levels. Bilirubin levels reflect the balance between production and excretion. Thus, there is no &quot;normal&quot; level of bilirubin. Bilirubin consists of an open chain of four pyrroles (tetrapyrrole); by contrast, the heme molecule is a closed ring of four pyrroles, called porphyrin. -- Wikipedia.</description>
		<cas>635-65-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=C(C=C)\C(NC1=O)=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(CCC(O)=O)C(C)=C(N2)\C=C2/NC(=O)C(C=C)=C2C)N1</moldb_smiles>
		<moldb_formula>C33H36N4O6</moldb_formula>
		<moldb_inchi>InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-</moldb_inchi>
		<moldb_inchikey>BPYKTIZUTYGOLE-IFADSCNNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>584.6621</moldb_average_mass>
		<moldb_mono_mass>584.263484904</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>23</id>
		<lmdb_id>LMDB00023</lmdb_id>
		<created_at>2016-07-13 19:40:41</created_at>
		<updated_at>2016-07-20 20:54:28</updated_at>
		<export>1</export>
		<name>Cellobiose</name>
		<description>Cellobiose is a disaccharide consisting of two glucose units in a beta (1-4) glycosidic linkage. Obtained from the partial hydrolysis of cellulose, cellobiose is commonly used as an indicator carbohydrate for intestinal permeability in Crohn's disease and malabsorption syndrome. This carbohydrate is exogenous and is a microbial breakdown product from plant material (cellulose). It is not produced by the body nor is it readily metabolized by the body, but may be found in some food products (vegetables, fruits, corn syrups, etc.). Recent studies have shown that cellobiose can be processed or metabolized by endogenous beta glycosidases in the mammalian small intestine (PMID 18752931).</description>
		<cas>528-50-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C12H22O11</moldb_formula>
		<moldb_inchi>InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5-,6+,7-,8-,9-,10-,11-,12+/m1/s1</moldb_inchi>
		<moldb_inchikey>GUBGYTABKSRVRQ-QRZGKKJRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>342.2965</moldb_average_mass>
		<moldb_mono_mass>342.116211546</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>24</id>
		<lmdb_id>LMDB00024</lmdb_id>
		<created_at>2016-07-13 19:40:42</created_at>
		<updated_at>2016-07-20 20:48:41</updated_at>
		<export>1</export>
		<name>Beta-Alanine</name>
		<description>Beta-alanine is the only naturally occurring beta-amino acid - the amino group is at the &amp;#946;-position from the carboxylate group. It is formed in vivo by the degradation of dihydrouracil and carnosine. It is a component of the naturally occurring peptides carnosine and anserine and also of pantothenic acid (Vitamin B-5) which itself is a component of coenzyme A. Under normal conditions, beta-alanine is metabolized into acetic acid. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing gamma-aminobutyric acid. A rare genetic disorder, hyper-beta-alaninemia, has been reported.</description>
		<cas>107-95-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCC(O)=O</moldb_smiles>
		<moldb_formula>C3H7NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6)</moldb_inchi>
		<moldb_inchikey>UCMIRNVEIXFBKS-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>89.0932</moldb_average_mass>
		<moldb_mono_mass>89.047678473</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>25</id>
		<lmdb_id>LMDB00025</lmdb_id>
		<created_at>2016-07-13 19:40:43</created_at>
		<updated_at>2016-07-19 23:37:36</updated_at>
		<export>1</export>
		<name>Cyclic AMP</name>
		<description>Cyclic AMP is an adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. cAMP is synthesized from ATP by adenylate cyclase. Adenylate cyclase is located at the cell membranes. Adenylate cyclase is activated by the hormones glucagon and adrenaline and by G protein. Liver adenylate cyclase responds more strongly to glucagon, and muscle adenylate cyclase responds more strongly to adrenaline. cAMP decomposition into AMP is catalyzed by the enzyme phosphodiesterase.</description>
		<cas>60-92-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O</moldb_smiles>
		<moldb_formula>C10H12N5O6P</moldb_formula>
		<moldb_inchi>InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6-,7-,10-/m1/s1</moldb_inchi>
		<moldb_inchikey>IVOMOUWHDPKRLL-KQYNXXCUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>329.2059</moldb_average_mass>
		<moldb_mono_mass>329.052519653</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>26</id>
		<lmdb_id>LMDB00026</lmdb_id>
		<created_at>2016-07-13 19:40:45</created_at>
		<updated_at>2016-09-23 18:44:29</updated_at>
		<export>1</export>
		<name>Acetoacetic acid</name>
		<description>It is a weak organic acid and can be produced in the animal liver under certain conditions of poor metabolism leading to excessive fatty acid breakdown (diabetes mellitus leading to diabetic ketoacidosis), it is then partially converted to acetone by decarboxylation and excreted either in urine or through respiration. Persistent mild hyperketonemia is a common finding in newborns. These compounds serve as an indispensable source of energy for extrahepatic tissues, especially the brain and lung of developing rats. Another important function of ketone bodies is to provide acetoacetyl-CoA and acetyl-CoA for synthesis of cholesterol, fatty acids, and complex lipids. During the early postnatal period, acetoacetate (AcAc) and beta-hydroxybutyrate are preferred over glucose as substrates for synthesis of phospholipids and sphingolipids in accord with requirements for brain growth and myelination. Thus, during the first 2 wk of postnatal development, when the accumulation of cholesterol and phospholipids accelerates, the proportion of ketone bodies incorporated into these lipids increases. On the other hand, an increased proportion of ketone bodies are utilized for cerebroside synthesis during the period of active myelination. In the lung, AcAc serves better than glucose as a precursor for the synthesis of lung phospholipids. The synthesized lipids, particularly dipalmityl phosphatidylcholine, are incorporated into surfactant, and thus have a potential role in supplying adequate surfactant lipids to maintain lung function during the early days of life. (PMID 3884391) The acid is also present in the metabolism of those undergoing starvation or prolonged physical exertion as part of gluconeogenesis. When ketone bodies are measured by way of urine concentration, acetoacetic acid, along with beta-hydroxybutyric acid or acetone, is what is detected.</description>
		<cas>541-50-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)CC(O)=O</moldb_smiles>
		<moldb_formula>C4H6O3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H6O3/c1-3(5)2-4(6)7/h2H2,1H3,(H,6,7)</moldb_inchi>
		<moldb_inchikey>WDJHALXBUFZDSR-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>102.0886</moldb_average_mass>
		<moldb_mono_mass>102.031694058</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>27</id>
		<lmdb_id>LMDB00027</lmdb_id>
		<created_at>2016-07-13 19:40:46</created_at>
		<updated_at>2016-09-23 18:44:29</updated_at>
		<export>1</export>
		<name>L-Carnitine</name>
		<description>Carnitine is not an essential amino acid; it can be synthesized in the body. However, it is so important in providing energy to muscles including the heart-that some researchers are now recommending carnitine supplements in the diet, particularly for people who do not consume much red meat, the main food source for carnitine. Carnitine has been described as a vitamin, an amino acid, or a metabimin, i.e., an essential metabolite. Like the B vitamins, carnitine contains nitrogen and is very soluble in water, and to some researchers carnitine is a vitamin (Liebovitz 1984). It was found that an animal (yellow mealworm) could not grow without carnitine in its diet. However, as it turned out, almost all other animals, including animals, do make their own carnitine; thus, it is no longer considered a vitamin. Nevertheless, in certain circumstances-such as deficiencies of methionine, lysine or vitamin C or kidney dialysis--carnitine shortages develop. Under these conditions, carnitine must be absorbed from food, and for this reason it is sometimes referred to as a &quot;metabimin&quot; or a conditionally essential metabolite. Like the other amino acids used or manufactured by the body, carnitine is an amine. But like choline, which is sometimes considered to be a B vitamin, carnitine is also an alcohol (specifically, a trimethylated carboxy-alcohol). Thus, carnitine is an unusual amino acid and has different functions than most other amino acids, which are most usually employed by the body in the construction of protein. Carnitine is an essential factor in fatty acid metabolism in mammals. It's most important known metabolic function is to transport fat into the mitochondria of muscle cells, including those in the heart, for oxidation. This is how the heart gets most of its energy. In animals, about 25% of carnitine is synthesized in the liver, kidney and brain from the amino acids lysine and methionine. Most of the carnitine in the body comes from dietary sources such as red meat and dairy products. Inborn errors of carnitine metabolism can lead to brain deterioration like that of Reye's syndrome, gradually worsening muscle weakness, Duchenne-like muscular dystrophy and extreme muscle weakness with fat accumulation in muscles. Borurn et al. (1979) describe carnitine as an essential nutrient for pre-term babies, certain types (non-ketotic) of hypoglycemics, kidney dialysis patients, cirrhosis, and in kwashiorkor, type IV hyperlipidemia, heart muscle disease (cardiomyopathy), and propionic or organic aciduria (acid urine resulting from genetic or other anomalies). In all these conditions and the inborn errors of carnitine metabolism, carnitine is essential to life and carnitine supplements are valuable. carnitine therapy may also be useful in a wide variety of clinical conditions. carnitine supplementation has improved some patients who have angina secondary to coronary artery disease. It may be worth a trial in any form of hyperlipidemia or muscle weakness. carnitine supplements may be useful in many forms of toxic or metabolic liver disease and in cases of heart muscle disease. Hearts undergoing severe arrhythmia quickly deplete their stores of carnitine. Athletes, particularly in Europe, have used carnitine supplements for improved endurance. carnitine may improve muscle building by improving fat utilization and may even be useful in treating obesity. carnitine joins a long list of nutrients which may be of value in treating pregnant women, hypothyroid individuals, and male infertility due to low motility of sperm. Even the Physician's Desk Reference gives indication for carnitine supplements as &quot;improving the tolerance of ischemic heart disease, myocardial insufficiencies, and type IV hyperlipoproteinemia. carnitine deficiency is noted in abnormal liver function, renal dialysis patients, and severe to moderate muscular weakness with associated anorexia.&quot; (http://www.dcnutrition.com).</description>
		<cas>541-15-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+](C)(C)C[C@H](O)CC([O-])=O</moldb_smiles>
		<moldb_formula>C7H15NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m1/s1</moldb_inchi>
		<moldb_inchikey>PHIQHXFUZVPYII-ZCFIWIBFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>161.1989</moldb_average_mass>
		<moldb_mono_mass>161.105193351</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>28</id>
		<lmdb_id>LMDB00028</lmdb_id>
		<created_at>2016-07-13 19:40:47</created_at>
		<updated_at>2016-07-19 23:08:56</updated_at>
		<export>1</export>
		<name>Cortisol</name>
		<description>Cortisol is a corticosteroid hormone produced by the adrenal cortex that is involved in the response to stress; The main glucocorticoid secreted by the adrenal cortex. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. As an oral or injectable drug, cortisol is also known as hydrocortisone. It is used as an immunosuppressive drug, given by injection in the treatment of severe allergic reactions such as anaphylaxis and angioedema, in place of prednisolone in patients who need steroid treatment but cannot take oral medication, and peri-operatively in patients on long-term steroid treatment to prevent an Addisonian crisis. Cortisol or Hydrocortisone is a corticosteroid hormone produced by the adrenal cortex that is involved in the response to stress. It increases blood pressure, blood sugar levels, may cause infertility in women, and suppresses the immune system. Its synthetic counterpart (hydrocortisone) is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortisol is synthesized from pregnenolone. The amount of cortisol present in the serum undergoes diurnal variation, with the highest levels present in the early morning, and lower levels in the evening, several hours after the onset of sleep. Cortisol is a corticosteroid hormone produced by the adrenal cortex that is involved in the response to stress; it increases blood pressure, blood sugar levels, may cause infertility in women, and suppresses the immune system. Synthetic cortisol, also known as hydrocortisone, is used as a drug mainly to fight allergies and inflammation; it increases blood pressure, blood sugar levels, may cause infertility in women, and suppresses the immune system. Synthetic cortisol, also known as hydrocortisone, is used as a drug mainly to fight allergies and inflammation.</description>
		<cas>50-23-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C21H30O5</moldb_formula>
		<moldb_inchi>InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21+/m0/s1</moldb_inchi>
		<moldb_inchikey>JYGXADMDTFJGBT-CZFMHFDVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>362.4599</moldb_average_mass>
		<moldb_mono_mass>362.209324070</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>29</id>
		<lmdb_id>LMDB00029</lmdb_id>
		<created_at>2016-07-13 19:40:49</created_at>
		<updated_at>2016-09-23 18:44:30</updated_at>
		<export>1</export>
		<name>Creatine</name>
		<description>Creatine is an amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as creatinine in the urine. Creatine functions as part of the cell's energy shuttle. The high energy phosphate group of ATP is transferred to creatine to form phosphocreatine in the following reaction: Cr + ATP &lt;-&gt; PCr + ADP. This reaction is reversibly catalyzed by creatine kinase. In the animal body creatine is synthesized mainly in the liver by the use of parts from three different amino acids - arginine, glycine, and methionine. 95% of it is later stored in the skeletal muscles, with the rest in the brain, heart, testes.</description>
		<cas>57-00-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN(CC(O)=O)C(N)=N</moldb_smiles>
		<moldb_formula>C4H9N3O2</moldb_formula>
		<moldb_inchi>InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)</moldb_inchi>
		<moldb_inchikey>CVSVTCORWBXHQV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>131.1332</moldb_average_mass>
		<moldb_mono_mass>131.069476547</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>30</id>
		<lmdb_id>LMDB00030</lmdb_id>
		<created_at>2016-07-13 19:40:50</created_at>
		<updated_at>2016-07-20 20:48:52</updated_at>
		<export>1</export>
		<name>Cholesterol</name>
		<description>Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The name originates from the Greek chole- (bile) and stereos (solid), and the chemical suffix -ol for an alcohol, as researchers first identified cholesterol (C27H45OH) in solid form in gallstones in 1784. Cholesterol is transported throughout the body via lipoprotein particles. The largest lipoproteins, which primarily transport fats from the intestinal mucosa to the liver, are called chylomicrons. They carry mostly triglyceride fats and cholesterol (that are from food and especially internal cholesterol secreted by the liver into the bile). In the liver, chylomicron particles give up triglycerides and some cholesterol, and are converted into low-density lipoprotein (LDL) particles, which carry triglycerides and cholesterol on to other body cells. In healthy individuals the LDL particles are large and relatively few in number. In contrast, large numbers of small LDL particles are strongly associated with promoting atheromatous disease within the arteries. (Lack of information on LDL particle number and size is one of the major problems of conventional lipid tests.). In conditions with elevated concentrations of oxidized LDL particles, especially small LDL particles, cholesterol promotes atheroma plaque deposits in the walls of arteries, a condition known as atherosclerosis, which is a major contributor to coronary heart disease and other forms of cardiovascular disease. (In contrast, HDL particles have been the only identified mechanism by which cholesterol can be removed from atheroma. Increased concentrations of large HDL particles, not total HDL particles, correlate with lower rates of atheroma progressions, even regression.). There is a world-wide trend to believe that lower total cholesterol levels tend to correlate with lower atherosclerosis event rates (though many studies refute this idea). Due to this reason, cholesterol has become a very large focus for scientific researchers trying to determine the proper amount of cholesterol needed in a healthy diet. However, the primary association of atherosclerosis with cholesterol has always been specifically with cholesterol transport patterns, not total cholesterol per se. For example, total cholesterol can be low, yet made up primarily of small LDL and small HDL particles and atheroma growth rates are high. In contrast, however, if LDL particle number is low (mostly large particles) and a large percentage of the HDL particles are large (HDL is actively reverse transporting cholesterol), then atheroma growth rates are usually low, even negative, for any given total cholesterol concentration. These effects are further complicated by the relative concentration of asymmetric dimethylarginin (ADMA) in the endothelium, since ADMA down-regulates production of nitric oxide, a relaxant of the endothelium. Thus, high levels of ADMA, associated with high oxidized levels of LDL pose a heightened risk factor for vascular disease. -- Wikipedia.</description>
		<cas>57-88-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2CC(O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C27H46O</moldb_formula>
		<moldb_inchi>InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3/t19-,21?,22+,23-,24+,25+,26+,27-/m1/s1</moldb_inchi>
		<moldb_inchikey>HVYWMOMLDIMFJA-FNOPAARDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>386.6535</moldb_average_mass>
		<moldb_mono_mass>386.354866094</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>31</id>
		<lmdb_id>LMDB00031</lmdb_id>
		<created_at>2016-07-13 19:40:51</created_at>
		<updated_at>2016-09-23 18:44:30</updated_at>
		<export>1</export>
		<name>Pipecolic acid</name>
		<description>Pipecolic acid is a metabolite of lysine found in animal physiological fluids such as urine, plasma and CSF. However, it is uncertain if pipecolic acid originates directly from food intake or from mammalian or intestinal bacterial enzyme metabolism. Recent studies suggest that plasma pipecolic acid, particularly the D-isomer, originates mainly from the catabolism of dietary lysine by intestinal bacteria rather than by direct food intake. In classic Zellweger syndrome (a cerebro-hepato-renal genetic disorder, OMIM 214100) pipecolic acid accumulate in the plasma of the patients. It is known that plasma pipecolic acid levels are also elevated in patients with chronic liver diseases. Pipecolic acid is moderately elevated in patients with pyridoxine-dependent seizures and might therefore be a possible biochemical marker for selecting candidates for pyridoxine therapy (Plecko et al 2000). Pipecolic acid was also elevated in CSF in these vitamin B6-responsive patients. (PMID 12705501).</description>
		<cas>535-75-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C1CCCCN1</moldb_smiles>
		<moldb_formula>C6H11NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H11NO2/c8-6(9)5-3-1-2-4-7-5/h5,7H,1-4H2,(H,8,9)</moldb_inchi>
		<moldb_inchikey>HXEACLLIILLPRG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>129.1570</moldb_average_mass>
		<moldb_mono_mass>129.078978601</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>32</id>
		<lmdb_id>LMDB00032</lmdb_id>
		<created_at>2016-07-13 19:40:52</created_at>
		<updated_at>2016-07-20 20:48:53</updated_at>
		<export>1</export>
		<name>cis-Aconitic acid</name>
		<description>cis-Aconitic acid is an intermediate in the tricarboxylic acid cycle produced by the dehydration of citric acid. The enzyme aconitase (aconitate hydratase; EC 4.2.1.3) catalyses the stereo-specific isomerization of citrate to isocitrate via cis-aconitate in the tricarboxylic acid cycle.</description>
		<cas>585-84-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C\C(=C\C(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H6O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H6O6/c7-4(8)1-3(6(11)12)2-5(9)10/h1H,2H2,(H,7,8)(H,9,10)(H,11,12)/b3-1-</moldb_inchi>
		<moldb_inchikey>GTZCVFVGUGFEME-IWQZZHSRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>174.1082</moldb_average_mass>
		<moldb_mono_mass>174.016437924</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>33</id>
		<lmdb_id>LMDB00033</lmdb_id>
		<created_at>2016-07-13 19:40:54</created_at>
		<updated_at>2016-07-20 20:54:37</updated_at>
		<export>1</export>
		<name>Dihydrouracil</name>
		<description>Dihydrouracil is an intermediate breakdown product of uracil. Dihydropyrimidine dehydrogenase catalyzes the reduction of uracil to 5, 6-dihydrouracil then dihydropyrimidinase hydrolyzes 5, 6-dihydrouracil to N-carbamyl-b-alanine. Finally, beta-ureidopropionase catalyzes the conversion of N-carbamyl-b-alanine to beta-alanine. Patients with dihydropyrimidinase deficiency (DPYS; also called 5, 6-dihydropyrimidine amidohydrolase, or DHP; EC 3.5.2.2) exhibit highly increased concentrations of 5, 6-dihydrouracil in urine. The direct measurement of the activity of DHP in patients had been hampered by the fact that the enzyme is expressed almost exclusively in liver tissue. Various neurological abnormalities have been described in this group of patients. (OMIM 222748).</description>
		<cas>504-07-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O=C1CCNC(=O)N1</moldb_smiles>
		<moldb_formula>C4H6N2O2</moldb_formula>
		<moldb_inchi>InChI=1S/C4H6N2O2/c7-3-1-2-5-4(8)6-3/h1-2H2,(H2,5,6,7,8)</moldb_inchi>
		<moldb_inchikey>OIVLITBTBDPEFK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>114.1026</moldb_average_mass>
		<moldb_mono_mass>114.042927446</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>34</id>
		<lmdb_id>LMDB00034</lmdb_id>
		<created_at>2016-07-13 19:40:55</created_at>
		<updated_at>2016-09-23 18:44:30</updated_at>
		<export>1</export>
		<name>Dehydroepiandrosterone</name>
		<description>Dehydroepiandrosterone (DHEA) is a natural steroid hormone produced from cholesterol by the adrenal glands. DHEA is also produced in the gonads, adipose tissue and the brain. DHEA is structurally similar to, and is a precursor of, androstenedione, testosterone, estradiol, estrone and estrogen. It is the most abundant hormone in the animal body. Most of DHEA is sulfated (dehydroepiandrosterone sulfate- DEHAS) before secretion. DHEAS is the sulfated version of DHEA; - this conversion is reversibly catalyzed by sulfotransferase (SULT2A1) primarily in the adrenals, the liver, and small intestines. In blood, most DHEA is found as DHEAS with levels that are about 300 times higher than free DHEA. Blood measurements of DHEAS/DHEA are useful to detect excess adrenal activity as seen in adrenal cancer or hyperplasia, including certain forms of congenital adrenal hyperplasia. Women with polycystic ovary syndrome tend to have normal or mildly elevated levels of DHEAS.</description>
		<cas>53-43-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@]34C)C1CCC2=O</moldb_smiles>
		<moldb_formula>C19H28O2</moldb_formula>
		<moldb_inchi>InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14?,15?,16?,18-,19-/m0/s1</moldb_inchi>
		<moldb_inchikey>FMGSKLZLMKYGDP-INNQQZFDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>288.4244</moldb_average_mass>
		<moldb_mono_mass>288.208930140</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>35</id>
		<lmdb_id>LMDB00035</lmdb_id>
		<created_at>2016-07-13 19:40:56</created_at>
		<updated_at>2016-07-20 21:03:05</updated_at>
		<export>1</export>
		<name>Dihydrothymine</name>
		<description>Dihydrothymine is an intermediate breakdown product of thymine. Dihydropyrimidine dehydrogenase catalyzes the reduction of thymine to 5, 6-dihydrothymine then dihydropyrimidinase hydrolyzes 5, 6-dihydrothymine to N-carbamyl-b-alanine. Finally, beta-ureidopropionase catalyzes the conversion of N-carbamyl-b-alanine to beta-alanine. Patients with dihydropyrimidinase deficiency exhibit highly increased concentrations of 5, 6-dihydrouracil and 5, 6-dihydrothymine and moderately increased concentrations of uracil and thymine can be detected in urine.</description>
		<cas>696-04-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1CNC(=O)NC1=O</moldb_smiles>
		<moldb_formula>C5H8N2O2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H8N2O2/c1-3-2-6-5(9)7-4(3)8/h3H,2H2,1H3,(H2,6,7,8,9)</moldb_inchi>
		<moldb_inchikey>NBAKTGXDIBVZOO-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>128.1292</moldb_average_mass>
		<moldb_mono_mass>128.058577510</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>36</id>
		<lmdb_id>LMDB00036</lmdb_id>
		<created_at>2016-07-13 19:40:58</created_at>
		<updated_at>2016-07-20 20:48:55</updated_at>
		<export>1</export>
		<name>Glycerophosphocholine</name>
		<description>Glycerophosphorylcholine (GPC) is a choline derivative and one of the two major forms of choline storage (along with phosphocholine) in the cytosol. Glycerophosphorylcholine is also one of the four major organic osmolytes in renal medullary cells, changing their intracellular osmolyte concentration in parallel with extracellular tonicity during cellular osmoadaptation. As an osmolyte, Glycerophosphorylcholine counteracts the effects of urea on enzymes and other macromolecules. Kidneys (especially medullar cells), which are exposed under normal physiological conditions to widely fluctuating extracellular solute concentrations, respond to hypertonic stress by accumulating the organic osmolytes glycerophosphorylcholine (GPC), betaine, myo-inositol, sorbitol and free amino acids. Increased intracellular contents of these osmolytes are achieved by a combination of increased uptake (myo-inositol and betaine) and synthesis (sorbitol, GPC), decreased degradation (GPC) and reduced osmolyte release. GPC is formed in the breakdown of phosphatidylcholine (PtC). This pathway is active in many body tissues, including mammary tissue.</description>
		<cas>28319-77-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+](C)(C)CCOP([O-])(=O)OC[C@@H](O)CO</moldb_smiles>
		<moldb_formula>C8H20NO6P</moldb_formula>
		<moldb_inchi>InChI=1S/C8H20NO6P/c1-9(2,3)4-5-14-16(12,13)15-7-8(11)6-10/h8,10-11H,4-7H2,1-3H3/t8-/m0/s1</moldb_inchi>
		<moldb_inchikey>SUHOQUVVVLNYQR-QMMMGPOBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>257.2213</moldb_average_mass>
		<moldb_mono_mass>257.102823889</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>37</id>
		<lmdb_id>LMDB00037</lmdb_id>
		<created_at>2016-07-13 19:40:59</created_at>
		<updated_at>2016-09-23 18:44:31</updated_at>
		<export>1</export>
		<name>Dimethylamine</name>
		<description>Dimethylamine (DMA) is an organic secondary amine. It is a colorless, liquefied and flammable gas with an ammonia and fish-like odor. Dimethylamine is abundantly present in animal urine. Main sources of urinary DMA have been reported to include trimethylamine N-oxide, a common food component, and asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthesis. ADMA is excreted in the urine in part unmetabolized and in part after hydrolysis to DMA by dimethylarginine dimethylaminohydrolase (DDAH). Statistically significant increases in urinary DMA have been found in individuals after the consumption of fish and seafoods. The highest values were obtained for individuals that consumed coley, squid and whiting with cod, haddock, sardine, skate and swordfish (PMID: 18282650). As a pure chemical substance Dimethylamine is used as dehairing agent in tanning, in dyes, in rubber accelerators, in soaps and cleaning compounds and as an agricultural fungicide. In the body, DMA also undergoes nitrosation under weak acid conditions to give dimethlynitrosamine.</description>
		<cas>124-40-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CNC</moldb_smiles>
		<moldb_formula>C2H7N</moldb_formula>
		<moldb_inchi>InChI=1S/C2H7N/c1-3-2/h3H,1-2H3</moldb_inchi>
		<moldb_inchikey>ROSDSFDQCJNGOL-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>45.0837</moldb_average_mass>
		<moldb_mono_mass>45.057849229</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>38</id>
		<lmdb_id>LMDB00038</lmdb_id>
		<created_at>2016-07-13 19:41:00</created_at>
		<updated_at>2016-09-23 18:44:31</updated_at>
		<export>1</export>
		<name>Cytidine</name>
		<description>Cytidine is a nucleoside that is composed of the base cytosine linked to the five-carbon sugar D-ribose. Cytidine is a pyrimidine that besides being incorporated into nucleic acids, can serve as substrate for the salvage pathway of pyrimidine nucleotide synthesis; as precursor of the cytidine triphosphate (CTP) needed in the phosphatidylcholine (PC) and phosphatidylethanolamine (PE) biosynthetic pathway. These variations probably reflect the species differences in cytidine deaminase, the enzyme that converts cytidine to uridine in the body. The transports of cytidine into the brain's extracellular fluid, and then into neurons and glia, are essential prerequisites for cytidine to be utilized in brain. An efficient mechanism mediating the brain uptake of circulating cytidine has not yet been demonstrated. The biosynthesis of PC, the most abundant phosphatide in the brain, via the Kennedy pathway requires phosphocholine and cytidine triphosphate (CTP), a cytidine nucleotide, which is involved in the rate-limiting step. The enzyme that converts CTP to endogenous CDP-choline (CTP: phosphocholine cytidylyltransferase) is unsaturated at physiological brain CTP levels. APOBEC is a family of enzymes has been discovered with the ability to deaminate cytidines on RNA or DNA. The animal apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G (APOBEC3G, or hA3G) protein, provides cells with an intracellular antiretroviral activity that is associated with the hypermutation of viral DNA through cytidine deamination. Indeed, hA3G belongs to a family of vertebrate proteins that contain one or two copies of a signature sequence motif unique to cytidine deaminases (CTDAs). (PMID: 16769123, 15780864, 16720547).</description>
		<cas>65-46-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C9H13N3O5</moldb_formula>
		<moldb_inchi>InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7-,8-/m1/s1</moldb_inchi>
		<moldb_inchikey>UHDGCWIWMRVCDJ-XVFCMESISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>243.2166</moldb_average_mass>
		<moldb_mono_mass>243.085520541</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>39</id>
		<lmdb_id>LMDB00039</lmdb_id>
		<created_at>2016-07-13 19:41:02</created_at>
		<updated_at>2016-09-23 18:44:32</updated_at>
		<export>1</export>
		<name>Dimethylglycine</name>
		<description>Dimethylglycine (DMG) is an amino acid derivative found in the cells of all plants and animals and can be obtained in the diet in small amounts from grains and meat. The animal body produces DMG when metabolizing choline into Glycine. Dimethylglycine that is not metabolized in the liver is transported by the circulatory system to body tissue. Dimethylglycine was popular with Russian athletes and cosmonauts owing to its reputed ability to increase endurance and reduce fatigue. DMG is also a byproduct of homocysteine metabolism. Homocysteine and betaine are converted to methionine and N, N-dimethylglycine by betaine-homocysteine methyltransferase.</description>
		<cas>1118-68-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN(C)CC(O)=O</moldb_smiles>
		<moldb_formula>C4H9NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C4H9NO2/c1-5(2)3-4(6)7/h3H2,1-2H3,(H,6,7)</moldb_inchi>
		<moldb_inchikey>FFDGPVCHZBVARC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>103.1198</moldb_average_mass>
		<moldb_mono_mass>103.063328537</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>40</id>
		<lmdb_id>LMDB00040</lmdb_id>
		<created_at>2016-07-13 19:41:03</created_at>
		<updated_at>2016-09-23 18:44:32</updated_at>
		<export>1</export>
		<name>Citric acid</name>
		<description>Citric acid (citrate) is a weak acid that is formed in the tricarboxylic acid cycle or that may be introduced with diet. The evaluation of plasma citric acid is scarcely used in the diagnosis of animal diseases. On the contrary urinary citrate excretion is a common tool in the differential diagnosis of kidney stones, renal tubular acidosis and it plays also a role in bone diseases. The importance of hypocitraturia should be considered with regard to bone mass, urine crystallization and urolithiasis. (PMID 12957820) The secretory epithelial cells of the prostate gland of animals and other animals posses a unique citrate-related metabolic pathway regulated by testosterone and prolactin. This specialized hormone-regulated metabolic activity is responsible for the major prostate function of the production and secretion of extraordinarily high levels of citrate. The key regulatory enzymes directly associated with citrate production in the prostate cells are mitochondrial aspartate aminotransferase, pyruvate dehydrogenase, and mitochondrial aconitase. testosterone and prolactin are involved in the regulation of the corresponding genes associated with these enzymes. The regulatory regions of these genes contain the necessary response elements that confer the ability of both hormones to control gene transcription. Protein kinase c (PKC) is the signaling pathway for the prolactin regulation of the metabolic genes in prostate cells. testosterone and prolactin regulation of these metabolic genes (which are constitutively expressed in all mammalian cells) is specific for these citrate-producing cells. (PMID 12198595) Citric acid is found in citrus fruits, most concentrated in lemons and limes, where it can comprise as much as 8% of the dry weight of the fruit. Citric acid is a natural preservative and is also used to add an acidic (sour) taste to foods and soft drinks. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability. Intolerance to citric acid in the diet is known to exist. Little information is available as the condition appears to be rare, but like other types of food intolerance it is often described as a &quot;pseudo-allergic&quot; reaction.</description>
		<cas>77-92-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CC(O)(CC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H8O7</moldb_formula>
		<moldb_inchi>InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)</moldb_inchi>
		<moldb_inchikey>KRKNYBCHXYNGOX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>192.1235</moldb_average_mass>
		<moldb_mono_mass>192.027002610</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>41</id>
		<lmdb_id>LMDB00041</lmdb_id>
		<created_at>2016-07-13 19:41:04</created_at>
		<updated_at>2016-09-23 18:44:33</updated_at>
		<export>1</export>
		<name>Choline</name>
		<description>Choline is a basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. Choline is now considered to be an essential vitamin. While animals can synthesize small amounts (by converting phosphatidylethanolamine to phosphatidylcholine), it must be consumed in the diet to maintain health. Required levels are between 425 mg/day (female) and 550 mg/day (male). Milk, eggs, liver and peanuts are especially rich in choline. Most choline is found in phospholipids, namely phosphatidylcholine or lecithin. Choline can be oxidized to form betaine, which is a methyl source for many reactions (i.e. conversion of homocysteine e to methionine). Lack of sufficient amounts of choline in the diet can lead to a fatty liver condition and general liver damage. This arises from the lack of VLDL, which is necessary to transport fats away from the liver. Choline deficiency also leads to elevated serum levels of alanine amino transferase and is associated with increased incidence of liver cancer.</description>
		<cas>62-49-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+](C)(C)CCO</moldb_smiles>
		<moldb_formula>C5H14NO</moldb_formula>
		<moldb_inchi>InChI=1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+1</moldb_inchi>
		<moldb_inchikey>OEYIOHPDSNJKLS-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>104.1708</moldb_average_mass>
		<moldb_mono_mass>104.107539075</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>42</id>
		<lmdb_id>LMDB00042</lmdb_id>
		<created_at>2016-07-13 19:41:06</created_at>
		<updated_at>2016-09-23 18:44:33</updated_at>
		<export>1</export>
		<name>D-Xylose</name>
		<description>Xylose or wood sugar is an aldopentose - a monosaccharide containing five carbon atoms and an aldehyde functional group. It has chemical formula C5H10O5 and is 40% as sweet as sucrose. Xylose is found in the embryos of most edible plants. The polysaccharide xylan, which is closely associated with cellulose, consists practically entirely of d-xylose. Corncobs, cottonseed hulls, pecan shells, and straw contain considerable amounts of this sugar. Xylose is also found in mucopolysaccharides of connective tissue and sometimes in the urine. Xylose is the first sugar added to serine or threonine residues during proteoglycan type O-glycosylation. Therefore xylose is involved in the biosythetic pathways of most anionic polysaccharides such as heparan sulphate and chondroitin sulphate. In medicine, xylose is used to test for malabsorption by administering a xylose solution to the patient after fasting. If xylose is detected in the blood and/or urine within the next few hours, it has been absorbed by the intestines. Xylose is said to be one of eight sugars which are essential for animal nutrition, the others being galactose, glucose, mannose, N-acetylglucosamine, N-acetylgalactosamine, fucose, and sialic acid. (Wikipedia).</description>
		<cas>58-86-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@@H]1COC(O)[C@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C5H10O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O5/c6-2-1-10-5(9)4(8)3(2)7/h2-9H,1H2/t2-,3+,4-,5?/m1/s1</moldb_inchi>
		<moldb_inchikey>SRBFZHDQGSBBOR-IOVATXLUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>150.1299</moldb_average_mass>
		<moldb_mono_mass>150.052823430</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>43</id>
		<lmdb_id>LMDB00043</lmdb_id>
		<created_at>2016-07-13 19:41:07</created_at>
		<updated_at>2016-07-20 20:54:49</updated_at>
		<export>1</export>
		<name>Galactitol</name>
		<description>Galactitol is a naturally occurring product of plants obtained following reduction of galactose. It appears as a white crystalline powder with a slight sweet taste. It may form in excess in the lens of the eye in galactosemias a deficiency of galactokinase.</description>
		<cas>608-66-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO</moldb_smiles>
		<moldb_formula>C6H14O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4+,5+,6-</moldb_inchi>
		<moldb_inchikey>FBPFZTCFMRRESA-GUCUJZIJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>182.1718</moldb_average_mass>
		<moldb_mono_mass>182.079038180</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>44</id>
		<lmdb_id>LMDB00044</lmdb_id>
		<created_at>2016-07-13 19:41:08</created_at>
		<updated_at>2016-09-23 18:44:33</updated_at>
		<export>1</export>
		<name>Ethanol</name>
		<description>Ethanol is a clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in alcoholic beverages. Indeed, ethanol has widespread use as a solvent of substances intended for animal contact or consumption, including scents, flavorings, colorings, and medicines. Ethanol has a depressive effect on the central nervous system and because of its psychoactive effects, it is considered a drug. Ethanol has a complex mode of action and affects multiple systems in the brain, most notably it acts as an agonist to the GABA receptors. Death from ethanol consumption is possible when blood alcohol level reaches 0.4%. A blood level of 0.5% or more is commonly fatal. Levels of even less than 0.1% can cause intoxication, with unconsciousness often occurring at 0.3-0.4 %. Ethanol is metabolized by the body as an energy-providing carbohydrate nutrient, as it metabolizes into acetyl CoA, an intermediate common with glucose metabolism, that can be used for energy in the citric acid cycle or for biosynthesis. Ethanol within the animal body is converted into acetaldehyde by alcohol dehydrogenase and then into acetic acid by acetaldehyde dehydrogenase. The product of the first step of this breakdown, acetaldehyde, is more toxic than ethanol. Acetaldehyde is linked to most of the clinical effects of alcohol. It has been shown to increase the risk of developing cirrhosis of the liver,[77] multiple forms of cancer, and alcoholism. Industrially, ethanol is produced both as a petrochemical, through the hydration of ethylene, and biologically, by fermenting sugars with yeast. Small amounts of ethanol are endogenously produced by gut microflora through anaerobic fermentation. However most ethanol detected in biofluids and tissues likely comes from consumption of alcoholic beverages. Absolute ethanol or anhydrous alcohol generally refers to purified ethanol, containing no more than one percent water. Absolute alcohol is not intended for animal consumption. It often contains trace amounts of toxic benzene (used to remove water by azeotropic distillation). Consumption of this form of ethanol can be fatal over a short time period. Generally absolute or pure ethanol is used as a solvent for lab and industrial settings where water will disrupt a desired reaction. Pure ethanol is classed as 200 proof in the USA and Canada, equivalent to 175 degrees proof in the UK system.</description>
		<cas>64-17-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCO</moldb_smiles>
		<moldb_formula>C2H6O</moldb_formula>
		<moldb_inchi>InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3</moldb_inchi>
		<moldb_inchikey>LFQSCWFLJHTTHZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>46.0684</moldb_average_mass>
		<moldb_mono_mass>46.041864814</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>45</id>
		<lmdb_id>LMDB00045</lmdb_id>
		<created_at>2016-07-13 19:41:09</created_at>
		<updated_at>2016-09-23 18:44:33</updated_at>
		<export>1</export>
		<name>Gamma-Aminobutyric acid</name>
		<description>Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter found in the nervous systems of widely divergent species. It is the chief inhibitory neurotransmitter in the vertebrate central nervous system. In vertebrates, GABA acts at inhibitory synapses in the brain. GABA acts by binding to specific transmembrane receptors in the plasma membrane of both pre- and postsynaptic neurons. This binding causes the opening of ion channels to allow either the flow of negatively-charged chloride ions into the cell or positively-charged potassium ions out of the cell. This will typically result in a negative change in the transmembrane potential, usually causing hyperpolarization. Three general classes of GABA receptor are known. These include GABAA and GABAC ionotropic receptors, which are ion channels themselves, and GABAB metabotropic receptors, which are G protein-coupled receptors that open ion channels via intermediaries (G proteins). Neurons that produce GABA as their output are called GABAergic neurons, and have chiefly inhibitory action at receptors in the vertebrate. Medium Spiny Cells are a typical example of inhibitory CNS GABAergic cells. GABA exhibits excitatory actions in insects, mediating muscle activation at synapses between nerves and muscle cells and also the stimulation of certain glands. GABA has also been shown to have excitatory roles in the vertebrate, most notably in the developing cortex. Organisms synthesize GABA from glutamate using the enzyme L-glutamic acid decarboxylase and pyridoxal phosphate as a cofactor. It is worth noting that this involves converting the principal excitatory neurotransmitter (glutamate) into the principal inhibitory one (GABA). Drugs that act as agonists of GABA receptors (known as GABA analogues or GABAergic drugs) or increase the available amount of GABA typically have relaxing, anti-anxiety and anti-convulsive effects. (http://en.wikipedia.org/wiki/GABA) Doses of GABA 1 to 3 g orally also have been used effectively to raise the IQ of mentally retarded persons. GABA is found to be deficient in cerebrospinal fluid and brain in many studies of experimental and animal epilepsy. Benzodiazepines (such as Valium) are useful in status epilepticus because they act on GABA receptors. GABA increases in the brain after administration of many seizure medications. Hence, GABA is clearly an antiepileptic nutrient. Inhibitors of GAM metabolism can also produce convulsions. Spasticity and involuntary movement syndromes, e.g., Parkinson's, Friedreich's ataxia, tardive dyskinesia, and Huntington's chorea are all marked by low GABA when amino acid levels are studied. Trials of 2 to 3 g of GABA given orally have been effective in various epilepsy and spasticity syndromes. Agents that elevate GABA also are useful in lowering hypertension. Three grams orally have been effective in control of blood pressure. GABA is decreased in various encephalopathies. GABA can reduce appetite and is decreased in hypoglycemics. GABA reduces blood sugar in diabetics. Chronic brain syndromes can also be marked by deficiency of GABA; GABA has many promising uses in therapy. Cerebrospinal fluid levels of GABA may be useful in diagnosing very serious diseases. Vitamin B6, manganese, taurine and lysine can increase both GABA synthesis and effects, while aspartic acid and glutamic acid probably inhibit GABA effects. (http://www.dcnutrition.com/AminoAcids/Detail.CFM)The brain's principal inhibitory neurotransmitter, GABA, along with serotonin and norepinephrine, is one of several neurotransmitters that appear to be involved in the pathogenesis of anxiety and mood disorders. There are two principal subtypes of postsynaptic GABA receptor complexes, the GABA-A and GABA-B receptor complexes. Activation of the GABA-B receptor by GABA causes neuronal membrane hyperpolarization and a resultant inhibition of neurotransmitter release. In addition to binding sites for GABA, the GABA-A receptor has binding sites for benzodiazepines, barbiturates, and neurosteroids. GABA-A receptors are coupled to chloride ion channels; activation of the receptor induces increased inward chloride ion flux, resulting in membrane hyperpolarization and neuronal inhibition. After release into the synapse, free GABA that does not bind to either the GABA-A or GABA-B receptor complexes can be taken up by neurons and glial cells. Four different membrane transporter proteins, known as GAT-1, GAT-2, GAT-3, and BGT-1, which differ in their distribution in the CNS, are believed to mediate the uptake of synaptic GABA into neurons and glial cells. The GABA-A receptor subtype regulates neuronal excitability and rapid changes in fear arousal, such as anxiety, panic, and the acute stress response. Drugs that stimulate GABA-A receptors, such as the benzodiazepines and barbiturates, have anxiolytic and anti-seizure effects via GABA-A-mediated reduction of neuronal excitability, which effectively raises the seizure threshold. In support of the anticonvulsant and anxiolytic effects of the GABA-A receptor are findings that GABA-A antagonists produce convulsions in animals and the demonstration that there is decreased GABA-A receptor binding in a positron emission tomography (PET) study of patients with panic disorder. Low plasma GABA has been reported in some depressed patients and, in fact, may be a useful trait marker for mood disorders. (The Role Of GABA In The Pathogenesis And Treatment Of Anxiety And Other Neuropsychiatric Disorders: http://www.vcu-cme.org/gaba/overview.html).</description>
		<cas>56-12-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCCC(O)=O</moldb_smiles>
		<moldb_formula>C4H9NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C4H9NO2/c5-3-1-2-4(6)7/h1-3,5H2,(H,6,7)</moldb_inchi>
		<moldb_inchikey>BTCSSZJGUNDROE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>103.1198</moldb_average_mass>
		<moldb_mono_mass>103.063328537</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>46</id>
		<lmdb_id>LMDB00046</lmdb_id>
		<created_at>2016-07-13 19:41:11</created_at>
		<updated_at>2016-07-20 20:54:51</updated_at>
		<export>1</export>
		<name>Glycolic acid</name>
		<description>Glycolic acid (or hydroxyacetic acid) is the smallest alpha-hydroxy acid (AHA). In its pure form, glycolic acid is a colorless crystalline solid. Due to its excellent capability to penetrate skin, glycolic acid finds applications in skin care products, most often as a chemical peel. Glycolic acid is also used for tattoo removal.</description>
		<cas>79-14-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC(O)=O</moldb_smiles>
		<moldb_formula>C2H4O3</moldb_formula>
		<moldb_inchi>InChI=1S/C2H4O3/c3-1-2(4)5/h3H,1H2,(H,4,5)</moldb_inchi>
		<moldb_inchikey>AEMRFAOFKBGASW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>76.0514</moldb_average_mass>
		<moldb_mono_mass>76.016043994</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>47</id>
		<lmdb_id>LMDB00047</lmdb_id>
		<created_at>2016-07-13 19:41:12</created_at>
		<updated_at>2016-07-19 23:35:37</updated_at>
		<export>1</export>
		<name>Folic acid</name>
		<description>Folic acid is a member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (poaceae). Folic acid, being biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase. These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylated tRNA, and generate and use formate. Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia.</description>
		<cas>59-30-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1</moldb_smiles>
		<moldb_formula>C19H19N7O6</moldb_formula>
		<moldb_inchi>InChI=1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1</moldb_inchi>
		<moldb_inchikey>OVBPIULPVIDEAO-LBPRGKRZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>441.3975</moldb_average_mass>
		<moldb_mono_mass>441.139681375</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>48</id>
		<lmdb_id>LMDB00048</lmdb_id>
		<created_at>2016-07-13 19:41:14</created_at>
		<updated_at>2016-07-20 20:49:10</updated_at>
		<export>1</export>
		<name>D-Glucose</name>
		<description>Glucose is a monosaccharide containing six carbon atoms and an aldehyde group and is therefore referred to as an aldohexose. The glucose molecule can exist in an open-chain (acyclic) and ring (cyclic) form, the latter being the result of an intramolecular reaction between the aldehyde C atom and the C-5 hydroxyl group to form an intramolecular hemiacetal. In water solution both forms are in equilibrium and at pH 7 the cyclic one is the predominant. Glucose is a primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. In animals glucose arises from the breakdown of glycogen in a process known as glycogenolysis. Glucose is synthesized in the liver and kidneys from non-carbohydrate intermediates, such as pyruvate and glycerol, by a process known as gluconeogenesis.</description>
		<cas>50-99-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6?/m1/s1</moldb_inchi>
		<moldb_inchikey>WQZGKKKJIJFFOK-GASJEMHNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1559</moldb_average_mass>
		<moldb_mono_mass>180.063388116</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>49</id>
		<lmdb_id>LMDB00049</lmdb_id>
		<created_at>2016-07-13 19:41:15</created_at>
		<updated_at>2016-07-20 20:49:13</updated_at>
		<export>1</export>
		<name>Glycine</name>
		<description>Glycine is a simple, nonessential amino acid, although experimental animals show reduced growth on low-glycine diets. The average adult ingests 3 to 5 grams of glycine daily. Glycine is involved in the body's production of DNA, phospholipids and collagen, and in release of energy. Glycine levels are effectively measured in plasma in both normal patients and those with inborn errors of glycine metabolism. (http://www.dcnutrition.com/AminoAcids/) Nonketotic hyperglycinaemia (OMIM 606899) is an autosomal recessive condition caused by deficient enzyme activity of the glycine cleavage enzyme system (EC 2.1.1.10). The glycine cleavage enzyme system comprises four proteins: P-, T-, H- and L-proteins (EC 1.4.4.2, EC 2.1.2.10 and EC 1.8.1.4 for P-, T- and L-proteins). Mutations have been described in the GLDC (OMIM 238300), AMT (OMIM 238310), and GCSH (OMIM 238330) genes encoding the P-, T-, and H-proteins respectively. The glycine cleavage system catalyses the oxidative conversion of glycine into carbon dioxide and ammonia, with the remaining one-carbon unit transferred to folate as methylenetetrahydrofolate. It is the main catabolic pathway for glycine and it also contributes to one-carbon metabolism. Patients with a deficiency of this enzyme system have increased glycine in plasma, urine and cerebrospinal fluid (CSF) with an increased CSF: plasma glycine ratio. (PMID 16151895).</description>
		<cas>56-40-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCC(O)=O</moldb_smiles>
		<moldb_formula>C2H5NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)</moldb_inchi>
		<moldb_inchikey>DHMQDGOQFOQNFH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>75.0666</moldb_average_mass>
		<moldb_mono_mass>75.032028409</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>50</id>
		<lmdb_id>LMDB00050</lmdb_id>
		<created_at>2016-07-13 19:41:16</created_at>
		<updated_at>2016-07-20 20:55:03</updated_at>
		<export>1</export>
		<name>Fructose 6-phosphate</name>
		<description>Fructose 6-phosphate is an important intermediate in the Carbohydrates pathway. The interconversion of glucose-6-phosphate and fructose-6-phosphate, the second step of the Embden-Meyerhof glycolytic pathway, is catalyzed by the enzyme phosphoglucose isomerase (PGI). In gluconeogenesis, fructose-6-phosphate is the immediate precursor of glucose-6-phosphate (wikipedia).</description>
		<cas>643-13-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O</moldb_smiles>
		<moldb_formula>C6H13O9P</moldb_formula>
		<moldb_inchi>InChI=1S/C6H13O9P/c7-1-3(8)5(10)6(11)4(9)2-15-16(12,13)14/h4-7,9-11H,1-2H2,(H2,12,13,14)/t4-,5-,6-/m1/s1</moldb_inchi>
		<moldb_inchikey>GSXOAOHZAIYLCY-HSUXUTPPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>260.1358</moldb_average_mass>
		<moldb_mono_mass>260.029718526</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>51</id>
		<lmdb_id>LMDB00051</lmdb_id>
		<created_at>2016-07-13 19:41:18</created_at>
		<updated_at>2016-07-20 20:15:50</updated_at>
		<export>1</export>
		<name>Glutathione</name>
		<description>Glutathione is a compound synthesized from cysteine, perhaps the most important member of the body's toxic waste disposal team. Like cysteine, glutathione contains the crucial thiol (-SH) group that makes it an effective antioxidant. There are virtually no living organisms on this planet-animal or plant whose cells don't contain some glutathione. Scientists have speculated that glutathione was essential to the very development of life on earth. glutathione has many roles; in none does it act alone. It is a coenzyme in various enzymatic reactions. The most important of these are redox reactions, in which the thiol grouping on the cysteine portion of cell membranes protects against peroxidation; and conjugation reactions, in which glutathione (especially in the liver) binds with toxic chemicals in order to detoxify them. glutathione is also important in red and white blood cell formation and throughout the immune system. glutathione's clinical uses include the prevention of oxygen toxicity in hyperbaric oxygen therapy, treatment of lead and other heavy metal poisoning, lowering of the toxicity of chemotherapy and radiation in cancer treatments, and reversal of cataracts. (http://www.dcnutrition.com/AminoAcids/) glutathione participates in leukotriene synthesis and is a cofactor for the enzyme glutathione peroxidase. It is also important as a hydrophilic molecule that is added to lipophilic toxins and waste in the liver during biotransformation before they can become part of the bile. glutathione is also needed for the detoxification of methylglyoxal, a toxin produced as a by-product of metabolism. This detoxification reaction is carried out by the glyoxalase system. Glyoxalase I (EC 4.4.1.5) catalyzes the conversion of methylglyoxal and reduced glutathione to S-D-Lactoyl-glutathione. Glyoxalase II (EC 3.1.2.6) catalyzes the hydrolysis of S-D-Lactoyl-glutathione to glutathione and D-lactate. GSH is known as a substrate in both conjugation reactions and reduction reactions, catalyzed by glutathione S-transferase enzymes in cytosol, microsomes, and mitochondria. However, it is also capable of participating in non-enzymatic conjugation with some chemicals, as in the case of n-acetyl-p-benzoquinone imine (NAPQI), the reactive cytochrome P450-reactive metabolite formed by acetaminophen, that becomes toxic when GSH is depleted by an overdose (of acetaminophen). glutathione in this capacity binds to NAPQI as a suicide substrate and in the process detoxifies it, taking the place of cellular protein thiol groups which would otherwise be covalently modified; when all GSH has been spent, NAPQI begins to react with the cellular proteins, killing the cells in the process. The preferred treatment for an overdose of this painkiller is the administration (usually in atomized form) of N-acetylcysteine, which is used by cells to replace spent GSSG and renew the usable GSH pool. (http://en.wikipedia.org/wiki/glutathione).</description>
		<cas>70-18-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C10H17N3O6S</moldb_formula>
		<moldb_inchi>InChI=1S/C10H17N3O6S/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19)/t5-,6-/m0/s1</moldb_inchi>
		<moldb_inchikey>RWSXRVCMGQZWBV-WDSKDSINSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>307.3230</moldb_average_mass>
		<moldb_mono_mass>307.083805981</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>52</id>
		<lmdb_id>LMDB00052</lmdb_id>
		<created_at>2016-07-13 19:41:19</created_at>
		<updated_at>2016-07-20 21:03:09</updated_at>
		<export>1</export>
		<name>Glycerol 3-phosphate</name>
		<description>Glycerol 3-phosphate is a chemical intermediate in the glycolysis metabolic pathway. It is commonly confused with the similarly named glycerate 3-phosphate or glyceraldehyde 3-phosphate. Glycerol 3-phosphate is produced from glycerol, the triose sugar backbone of triglycerides and glycerophospholipids, by the enzyme glycerol kinase. Glycerol 3-phospate may then be converted by dehydrogenation to dihydroxyacetone phosphate (DHAP) by the enzyme glycerol-3-phosphate dehydrogenase. DHAP can then be rearranged into glyceraldehyde 3-phosphate (GA3P) by triose phosphate isomerase (TIM), and feed into glycolysis. The glycerol 3-phosphate shuttle is used to rapidly regenerate NAD+ in the brain and skeletal muscle cells of mammals (wikipedia).</description>
		<cas>57-03-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@@H](O)COP(O)(O)=O</moldb_smiles>
		<moldb_formula>C3H9O6P</moldb_formula>
		<moldb_inchi>InChI=1S/C3H9O6P/c4-1-3(5)2-9-10(6,7)8/h3-5H,1-2H2,(H2,6,7,8)/t3-/m1/s1</moldb_inchi>
		<moldb_inchikey>AWUCVROLDVIAJX-GSVOUGTGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>172.0737</moldb_average_mass>
		<moldb_mono_mass>172.013674532</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>53</id>
		<lmdb_id>LMDB00053</lmdb_id>
		<created_at>2016-07-13 19:41:20</created_at>
		<updated_at>2016-09-23 18:44:34</updated_at>
		<export>1</export>
		<name>D-Glucuronic acid</name>
		<description>Glucuronic acid is a carboxylic acid that has the structure of a glucose molecule that has had its sixth carbon atom (of six total) oxidized. The salts of glucuronic acid are known as glucuronates. Glucuronic acid is highly soluble in water. In animals, glucuronic acid is often linked to toxic or poisonous substances to allow for subsequent elimination, and to hormones to allow for easier transport. These linkages involve O-glycosidic bonds. The process is known as glucuronidation, and the resulting substances are known as glucuronides (or glucuronosides). Glucuronidation uses UDP-glucuronic acid (glucuronic acid linked via a glycosidic bond to uridine diphosphate) as an intermediate. UDP-glucuronic acid is formed in the liver of all animals.</description>
		<cas>6556-12-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H10O7</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O7/c7-1-2(8)4(5(10)11)13-6(12)3(1)9/h1-4,6-9,12H,(H,10,11)/t1-,2-,3+,4-,6-/m0/s1</moldb_inchi>
		<moldb_inchikey>AEMOLEFTQBMNLQ-WAXACMCWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>194.1394</moldb_average_mass>
		<moldb_mono_mass>194.042652674</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>54</id>
		<lmdb_id>LMDB00054</lmdb_id>
		<created_at>2016-07-13 19:41:22</created_at>
		<updated_at>2016-07-20 21:03:10</updated_at>
		<export>1</export>
		<name>Guanidoacetic acid</name>
		<description>Guanidoacetic acid is a metabolite in the Urea cycle and metabolism of amino groups, and in the metabolic pathways of several amino acids. This includes glycine, serine, threonine, arginine and proline metabolism. Guanidinoacetic acid is also a precursor of creatine, an essential substrate for muscle energy metabolism.</description>
		<cas>352-97-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(=N)NCC(O)=O</moldb_smiles>
		<moldb_formula>C3H7N3O2</moldb_formula>
		<moldb_inchi>InChI=1S/C3H7N3O2/c4-3(5)6-1-2(7)8/h1H2,(H,7,8)(H4,4,5,6)</moldb_inchi>
		<moldb_inchikey>BPMFZUMJYQTVII-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>117.1066</moldb_average_mass>
		<moldb_mono_mass>117.053826483</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>55</id>
		<lmdb_id>LMDB00055</lmdb_id>
		<created_at>2016-07-13 19:41:23</created_at>
		<updated_at>2016-07-20 20:49:18</updated_at>
		<export>1</export>
		<name>Glycerol</name>
		<description>Glycerol is an important component of triglycerides (i.e. fats and oils) and of phospholipids. glycerol is a three-carbon substance that forms the backbone of fatty acids in fats. When the body uses stored fat as a source of energy, glycerol and fatty acids are released into the bloodstream. The glycerol component can be converted to glucose by the liver and provides energy for cellular metabolism.</description>
		<cas>56-81-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC(O)CO</moldb_smiles>
		<moldb_formula>C3H8O3</moldb_formula>
		<moldb_inchi>InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2</moldb_inchi>
		<moldb_inchikey>PEDCQBHIVMGVHV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>92.0938</moldb_average_mass>
		<moldb_mono_mass>92.047344122</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>56</id>
		<lmdb_id>LMDB00056</lmdb_id>
		<created_at>2016-07-13 19:41:24</created_at>
		<updated_at>2016-07-20 20:55:09</updated_at>
		<export>1</export>
		<name>Guanine</name>
		<description>Guanine is one of the five main nucleobases found in the nucleic acids DNA and RNA. Guanine is a derivative of purine, consisting of a fused pyrimidine-imidazole ring system with conjugated double bonds. Being unsaturated, the bicyclic molecule is planar. The guanine nucleoside is called guanosine. The first isolation of guanine was reported in 1844 from the excreta of sea birds, known as guano, which was used as a source of fertilizer. High affinity binding of guanine nucleotides and the ability to hydrolyze bound GTP to GDP are characteristics of an extended family of intracellular proteins. Guanine nucleotide-binding regulatory proteins may be involved in the activation of phospholipases C and A2 by hormones and other ligands. The binding of hormones to receptors that activate phospholipase C is decreased by guanine nucleotides and these hormones also stimulate a high-affinity GTPase activity in cell membranes. Effects of hormones on phospholipase C activity in cell-free preparations are dependent on the presence of guanine nucleotides. Hypoxanthine-guanine phosphoribosyltransferase (HPRT, EC 2.4.2.8) is a purine salvage enzyme that catalyses the conversion of hypoxanthine and guanine to their respective mononucleotides. Partial deficiency of this enzyme can result in the overproduction of uric acid leading to a severe form of gout, whilst a virtual absence of HPRT activity causes the Lesch-Nyhan syndrome which is characterised by hyperuricaemia, mental retardation, choreoathetosis and compulsive self-mutilation. Peroxynitrite induces DNA base damage predominantly at guanine (G) and 8-oxoguanine (8-oxoG) nucleobases via oxidation reactions. G and 8-oxoG are the most reactive bases toward Peroxynitrite and possibly the major contributors to peroxynitrite-derived genotoxic and mutagenic lesions. The neutral G radical, reacts with NO2 to yield 8-nitroguanine and 5-nitro-4-guanidinohydantoin. (PMID: 16352449, 2435586, 2838362, 1487231).</description>
		<cas>73-40-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1=NC(=O)C2=C(N1)N=CN2</moldb_smiles>
		<moldb_formula>C5H5N5O</moldb_formula>
		<moldb_inchi>InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)</moldb_inchi>
		<moldb_inchikey>UYTPUPDQBNUYGX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>151.1261</moldb_average_mass>
		<moldb_mono_mass>151.049409807</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>57</id>
		<lmdb_id>LMDB00057</lmdb_id>
		<created_at>2016-07-13 19:41:26</created_at>
		<updated_at>2016-07-20 20:49:18</updated_at>
		<export>1</export>
		<name>Fumaric acid</name>
		<description>Fumaric acid is a dicarboxylic acid. It is a precursor to L-malate in the Krebs tricarboxylic acid (TCA) cycle. It is formed by the oxidation of succinic acid by succinate dehydrogenase. Fumarate is converted by the enzyme fumarase to malate. Fumaric acid has recently been identified as an oncometabolite or an endogenous, cancer causing metabolite. High levels of this organic acid can be found in tumors or biofluids surrounding tumors. Its oncogenic action appears to due to its ability to inhibit prolyl hydroxylase-containing enzymes. In many tumours, oxygen availability becomes limited (hypoxia) very quickly due to rapid cell proliferation and limited blood vessel growth. The major regulator of the response to hypoxia is the HIF transcription factor (HIF-alpha). Under normal oxygen levels, protein levels of HIF-alpha are very low due to constant degradation, mediated by a series of post-translational modification events catalyzed by the prolyl hydroxylase domain-containing enzymes PHD1, 2 and 3, (also known as EglN2, 1 and 3) that hydroxylate HIF-alpha and lead to its degradation. All three of the PHD enzymes are inhibited by fumarate.</description>
		<cas>110-17-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)\C=C\C(O)=O</moldb_smiles>
		<moldb_formula>C4H4O4</moldb_formula>
		<moldb_inchi>InChI=1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1+</moldb_inchi>
		<moldb_inchikey>VZCYOOQTPOCHFL-OWOJBTEDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>116.0722</moldb_average_mass>
		<moldb_mono_mass>116.010958616</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>58</id>
		<lmdb_id>LMDB00058</lmdb_id>
		<created_at>2016-07-13 19:41:27</created_at>
		<updated_at>2016-07-20 21:03:11</updated_at>
		<export>1</export>
		<name>Glycocholic acid</name>
		<description>Glycocholic acid is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895 ). More specifically, glycocholic acid or cholylglycine, is a crystalline bile acid involved in the emulsification of fats. It occurs as a sodium salt in the bile of mammals. Its anion is called glycocholate. As the glycine conjugate of cholic acid, this compound acts as a detergent to solubilize fats for absorption and is itself absorbed. (PubChem). Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487 , 16037564 , 12576301 , 11907135 ).</description>
		<cas>475-31-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H]([C@H](C)CCC(=O)NCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])[C@H](O)CC2C[C@H](O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C26H43NO6</moldb_formula>
		<moldb_inchi>InChI=1S/C26H43NO6/c1-14(4-7-22(31)27-13-23(32)33)17-5-6-18-24-19(12-21(30)26(17,18)3)25(2)9-8-16(28)10-15(25)11-20(24)29/h14-21,24,28-30H,4-13H2,1-3H3,(H,27,31)(H,32,33)/t14-,15?,16-,17-,18+,19+,20-,21+,24+,25+,26-/m1/s1</moldb_inchi>
		<moldb_inchikey>RFDAIACWWDREDC-MZMBZMQMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>465.6227</moldb_average_mass>
		<moldb_mono_mass>465.309038113</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>59</id>
		<lmdb_id>LMDB00059</lmdb_id>
		<created_at>2016-07-13 19:41:28</created_at>
		<updated_at>2016-09-23 18:44:34</updated_at>
		<export>1</export>
		<name>Glyceric acid</name>
		<description>Glyceric acid is a colorless syrupy acid, obtained from oxidation of glycerol. It is a compound that is secreted excessively in the urine by patients suffering from D-glyceric aciduria and D-glycerate anemia. Deficiency of animal glycerate kinase leads to D-glycerate acidemia/D-glyceric aciduria. Symptoms of the disease include progressive neurological impairment, hypotonia, seizures, failure to thrive and metabolic acidosis.</description>
		<cas>473-81-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@@H](O)C(O)=O</moldb_smiles>
		<moldb_formula>C3H6O4</moldb_formula>
		<moldb_inchi>InChI=1S/C3H6O4/c4-1-2(5)3(6)7/h2,4-5H,1H2,(H,6,7)/t2-/m1/s1</moldb_inchi>
		<moldb_inchikey>RBNPOMFGQQGHHO-UWTATZPHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>106.0773</moldb_average_mass>
		<moldb_mono_mass>106.026608680</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>60</id>
		<lmdb_id>LMDB00060</lmdb_id>
		<created_at>2016-07-13 19:41:30</created_at>
		<updated_at>2016-07-20 20:49:22</updated_at>
		<export>1</export>
		<name>Formic acid</name>
		<description>Formic acid is the simplest carboxylic acid. Formate is an intermediate in normal metabolism. It takes part in the metabolism of one-carbon compounds and its carbon may appear in methyl groups undergoing transmethylation. It is eventually oxidized to carbon dioxide. Formate is typically produced as a byproduct in the production of acetate. It is responsible for both metabolic acidosis and disrupting mitochondrial electron transport and energy production by inhibiting cytochrome oxidase activity, the terminal electron acceptor of the electron transport chain. Cell death from cytochrome oxidase inhibition by formate is believed to result partly from depletion of ATP, reducing energy concentrations so that essential cell functions cannot be maintained. Furthermore, inhibition of cytochrome oxidase by formate may also cause cell death by increased production of cytotoxic reactive oxygen species (ROS) secondary to the blockade of the electron transport chain. In nature, formic acid is found in the stings and bites of many insects of the order Hymenoptera, including bees and ants. The principal use of formic acid is as a preservative and antibacterial agent in livestock feed. When sprayed on fresh hay or other silage, it arrests certain decay processes and causes the feed to retain its nutritive value longer.</description>
		<cas>64-18-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC=O</moldb_smiles>
		<moldb_formula>CH2O2</moldb_formula>
		<moldb_inchi>InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)</moldb_inchi>
		<moldb_inchikey>BDAGIHXWWSANSR-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>46.0254</moldb_average_mass>
		<moldb_mono_mass>46.005479308</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>61</id>
		<lmdb_id>LMDB00061</lmdb_id>
		<created_at>2016-07-13 19:41:31</created_at>
		<updated_at>2016-07-20 20:49:23</updated_at>
		<export>1</export>
		<name>D-Galactose</name>
		<description>D-Galactose is an aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. D-Galactose is an energy-providing nutrient and also a necessary basic substrate for the biosynthesis of many macromolecules in the body. Metabolic pathways for D-Galactose are important not only for the provision of these pathways but also for the prevention of D-Galactose and D-Galactose metabolite accumulation. The main source of D-Galactose is lactose in the milk of mammals, but it can also be found in some fruits and vegetables. Utilization of D-Galactose in all living cells is initiated by the phosphorylation of the hexose by the enzyme galactokinase (E.C. 2.7.1.6) (GALK) to form D-Galactose-1-phosphate. In the presence of D-Galactose-1-phosphate uridyltransferase (E.C. 2.7.7.12) (GALT) D-Galactose-1-phosphate is exchanged with glucose-1-phosphate in UDP-glucose to form UDP-galactose. Glucose-1-phosphate will then enter the glycolytic pathway for energy production. Deficiency of the enzyme GALT in galactosemic patients leads to the accumulation of D-Galactose-1-phosphate. Classic galactosemia-a term that denotes the presence of D-Galactose in the blood is the rare inborn error of D-Galactose metabolism, diagnosed by the deficiency of the second enzyme of the D-Galactose assimilation pathway, GALT, which, in turn, is caused by mutations at the GALT gene. (PMID: 15256214, 11020650, 10408771).</description>
		<cas>59-23-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6+/m1/s1</moldb_inchi>
		<moldb_inchikey>WQZGKKKJIJFFOK-PHYPRBDBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1559</moldb_average_mass>
		<moldb_mono_mass>180.063388116</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>62</id>
		<lmdb_id>LMDB00062</lmdb_id>
		<created_at>2016-07-13 19:41:32</created_at>
		<updated_at>2016-09-23 18:44:34</updated_at>
		<export>1</export>
		<name>Estrone</name>
		<description>Estrone is a major mammalian estrogen. The conversion of the natural C19 steroids, testosterone and androstenedione into estrone is dependent on a complex key reaction catalyzed by the cytochrome P450 aromatase (EC 1.14.14.1, unspecific monooxygenase), which is expressed in many tissues of the adult animal (e.g. ovary, fat tissue), but not in the liver. The ovaries after menopause continue to produce androstenedione and testosterone in significant amounts and these androgens are converted in fat, muscle, and skin into estrone. When women between the ages of 45 and 64 years have prophylactic oophorectomy (when hysterectomy is performed for benign disease to prevent the development of ovarian cancer), evidence suggests that oophorectomy increases the subsequent risk of coronary heart disease (CHD) and osteoporosis. Whereas 14,000 women die of ovarian cancer every year nearly 490,000 women die of heart disease and 48,000 women die within 1 year after hip fracture. Therefore, the decision to perform prophylactic oophorectomy should be approached with great caution for the majority of women who are at low risk of developing ovarian cancer. Steroid sulfatase (EC 3.1.6.2, STS) hydrolyzes steroid sulfates, such as estrone sulfate to estrone which can be converted to steroids with potent estrogenic properties, that is, estradiol; STS activity is much higher in breast tumors and high levels of STS mRNA expression in tumors are associated with a poor prognosis. The biological roles of estrogens in tumorigenesis are certainly different between the endometrium and breast, although both are considered &quot;estrogen-dependent tissues&quot;. 17beta-hydroxysteroid dehydrogenases (EC 1.1.1.62, 17-HSDs) are enzymes involved in the formation of active sex steroids. estrone is interconverted by two enzymes 17-HSD types. Type 1 converts estrone to estradiol and Type 2 catalyzes the reverse reaction. (PMID: 17653961, 17513923, 17470679, 17464097).</description>
		<cas>53-16-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3</moldb_smiles>
		<moldb_formula>C18H22O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1</moldb_inchi>
		<moldb_inchikey>DNXHEGUUPJUMQT-CBZIJGRNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>270.3661</moldb_average_mass>
		<moldb_mono_mass>270.161979948</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>63</id>
		<lmdb_id>LMDB00063</lmdb_id>
		<created_at>2016-07-13 19:41:33</created_at>
		<updated_at>2016-09-23 18:44:35</updated_at>
		<export>1</export>
		<name>L-Glutamic acid</name>
		<description>Glutamic acid (Glu), also referred to as glutamate (the anion), is one of the 20 proteinogenic amino acids. It is not among the essential amino acids. Glutamate is a key molecule in cellular metabolism. In animals, dietary proteins are broken down by digestion into amino acids, which serves as metabolic fuel or other functional roles in the body. Glutamate is the most abundant fast excitatory neurotransmitter in the mammalian nervous system. At chemical synapses, glutamate is stored in vesicles. Nerve impulses trigger release of glutamate from the pre-synaptic cell. In the opposing post-synaptic cell, glutamate receptors, such as the NMDA receptor, bind glutamate and are activated. Because of its role in synaptic plasticity, it is believed that glutamic acid is involved in cognitive functions like learning and memory in the brain. Glutamate transporters are found in neuronal and glial membranes. They rapidly remove glutamate from the extracellular space. In brain injury or disease, they can work in reverse and excess glutamate can accumulate outside cells. This process causes calcium ions to enter cells via NMDA receptor channels, leading to neuronal damage and eventual cell death, and is called excitotoxicity. The mechanisms of cell death include: * Damage to mitochondria from excessively high intracellular Ca2+. * Glu/Ca2+-mediated promotion of transcription factors for pro-apoptotic genes, or downregulation of transcription factors for anti-apoptotic genes. Excitotoxicity due to glutamate occurs as part of the ischemic cascade and is associated with stroke and diseases like amyotrophic lateral sclerosis, lathyrism, and Alzheimer's disease. glutamic acid has been implicated in epileptic seizures. Microinjection of glutamic acid into neurons produces spontaneous depolarization around one second apart, and this firing pattern is similar to what is known as paroxysmal depolarizing shift in epileptic attacks. This change in the resting membrane potential at seizure foci could cause spontaneous opening of voltage activated calcium channels, leading to glutamic acid release and further depolarization. (http://en.wikipedia.org/wiki/Glutamic_acid).</description>
		<cas>56-86-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CCC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H9NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1</moldb_inchi>
		<moldb_inchikey>WHUUTDBJXJRKMK-VKHMYHEASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>147.1293</moldb_average_mass>
		<moldb_mono_mass>147.053157781</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>64</id>
		<lmdb_id>LMDB00064</lmdb_id>
		<created_at>2016-07-13 19:41:35</created_at>
		<updated_at>2016-07-20 20:49:28</updated_at>
		<export>1</export>
		<name>Ethanolamine</name>
		<description>Ethanolamine is a viscous, hygroscopic amino alcohol with an ammoniacal odor. It is widely distributed in biological tissue and is a component of lecithin. It is used as a surfactant, fluorometric reagent, and to remove CO2 and H2S from natural gas and other gases.</description>
		<cas>141-43-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCO</moldb_smiles>
		<moldb_formula>C2H7NO</moldb_formula>
		<moldb_inchi>InChI=1S/C2H7NO/c3-1-2-4/h4H,1-3H2</moldb_inchi>
		<moldb_inchikey>HZAXFHJVJLSVMW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>61.0831</moldb_average_mass>
		<moldb_mono_mass>61.052763851</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>65</id>
		<lmdb_id>LMDB00065</lmdb_id>
		<created_at>2016-07-13 19:41:36</created_at>
		<updated_at>2016-07-20 20:55:23</updated_at>
		<export>1</export>
		<name>Gluconolactone</name>
		<description>Gluconolactone is a lactone or oxidized derivative of glucose. Gluconolactone is a polyhydroxy acid (PHA) that is capable of chelating metals and may also function by scavenging free radicals, thereby protecting skin from some of the damaging effects of UV radiation. Also used as a pheromone by the oriental cockroach.</description>
		<cas>90-80-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C6H10O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-5,7-10H,1H2/t2-,3-,4+,5-/m1/s1</moldb_inchi>
		<moldb_inchikey>PHOQVHQSTUBQQK-SQOUGZDYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>178.1400</moldb_average_mass>
		<moldb_mono_mass>178.047738052</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>66</id>
		<lmdb_id>LMDB00066</lmdb_id>
		<created_at>2016-07-13 19:41:38</created_at>
		<updated_at>2016-07-20 20:55:24</updated_at>
		<export>1</export>
		<name>Gentisic acid</name>
		<description>Gentisic acid is a dihydroxybenzoic acid. It is a crystalline powder that forms monoclinic prism in water solution. Gentisic acid is an active metabolite of salicylic acid degradation. There is an increasing amount of evidence indicating that gentisic acid has a broad spectrum of biological activity, such as anti-inflammatory, antirheumatic and antioxidant properties. Gentisic acid is also a byproduct of tyrosine and benzoate metabolism.</description>
		<cas>490-79-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C1=C(O)C=CC(O)=C1</moldb_smiles>
		<moldb_formula>C7H6O4</moldb_formula>
		<moldb_inchi>InChI=1S/C7H6O4/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,8-9H,(H,10,11)</moldb_inchi>
		<moldb_inchikey>WXTMDXOMEHJXQO-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>154.1210</moldb_average_mass>
		<moldb_mono_mass>154.026608673</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>67</id>
		<lmdb_id>LMDB00067</lmdb_id>
		<created_at>2016-07-13 19:41:39</created_at>
		<updated_at>2016-07-20 20:49:29</updated_at>
		<export>1</export>
		<name>Hypoxanthine</name>
		<description>Hypoxanthine is a naturally occurring purine derivative and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway. Hypoxanthine is also a spontaneous deamination product of adenine. Lesch-Nyhan disease is caused by deficiency of the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase. (OMIN 308000).</description>
		<cas>68-94-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1=NC=NC2=C1NC=N2</moldb_smiles>
		<moldb_formula>C5H4N4O</moldb_formula>
		<moldb_inchi>InChI=1S/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)</moldb_inchi>
		<moldb_inchikey>FDGQSTZJBFJUBT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>136.1115</moldb_average_mass>
		<moldb_mono_mass>136.038510770</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>68</id>
		<lmdb_id>LMDB00068</lmdb_id>
		<created_at>2016-07-13 19:41:40</created_at>
		<updated_at>2016-09-23 18:44:35</updated_at>
		<export>1</export>
		<name>L-Tyrosine</name>
		<description>Tyrosine is an essential amino acid that readily passes the blood-brain barrier. Once in the brain, it is a precursor for the neurotransmitters dopamine, norepinephrine and epinephrine, better known as adrenalin. These neurotransmitters are an important part of the body's sympathetic nervous system, and their concentrations in the body and brain are directly dependent upon dietary tyrosine. Tyrosine is not found in large concentrations throughout the body, probably because it is rapidly metabolized. Folic acid, copper and vitamin C are cofactor nutrients of these reactions. Tyrosine is also the precursor for hormones, thyroid, catecholestrogens and the major animal pigment, melanin. Tyrosine is an important amino acid in many proteins, peptides and even enkephalins, the body's natural pain reliever. Valine and other branched amino acids, and possibly tryptophan and phenylalanine may reduce tyrosine absorption. A number of genetic errors of tyrosine metabolism occur. Most common is the increased amount of tyrosine in the blood of premature infants, which is marked by decreased motor activity, lethargy and poor feeding. Infection and intellectual deficits may occur. Vitamin C supplements reverse the disease. Some adults also develop elevated tyrosine in their blood. This indicates a need for more vitamin C. More tyrosine is needed under stress, and tyrosine supplements prevent the stress-induced depletion of norepinephrine and can cure biochemical depression. However, tyrosine may not be good for psychosis. Many antipsychotic medications apparently function by inhibiting tyrosine metabolism. L-dopa, which is directly used in Parkinson's, is made from tyrosine. Tyrosine, the nutrient, can be used as an adjunct in the treatment of Parkinson's. Peripheral metabolism of tyrosine necessitates large doses of tyrosine, however, compared to L-dopa. (http://www.dcnutrition.com).</description>
		<cas>60-18-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CC1=CC=C(O)C=C1)C(O)=O</moldb_smiles>
		<moldb_formula>C9H11NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1</moldb_inchi>
		<moldb_inchikey>OUYCCCASQSFEME-QMMMGPOBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>181.1885</moldb_average_mass>
		<moldb_mono_mass>181.073893223</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>69</id>
		<lmdb_id>LMDB00069</lmdb_id>
		<created_at>2016-07-13 19:41:41</created_at>
		<updated_at>2016-09-23 18:44:35</updated_at>
		<export>1</export>
		<name>L-Phenylalanine</name>
		<description>Phenylalanine is an essential amino acid and the precursor for the amino acid tyrosine. Like tyrosine, it is the precursor of catecholamines in the body (tyramine, dopamine, epinephrine and norepinephrine). The psychotropic drugs (mescaline, morphine, codeine, and papaverine) also have phenylalanine as a constituent. Phenylalanine is a precursor of the neurotransmitters called catecholamines, which are adrenalin-like substances. Phenylalanine is highly concentrated in the animal brain and plasma. Normal metabolism of phenylalanine requires biopterin, iron, niacin, vitamin B6, copper and vitamin C. An average adult ingests 5 g of phenylalanine per day and may optimally need up to 8 g daily. Phenylalanine is highly concentrated in high protein foods, such as meat, cottage cheese and wheat germ. A new dietary source of phenylalanine is artificial sweeteners containing aspartame. Aspartame appears to be nutritious except in hot beverages; however, it should be avoided by phenylketonurics and pregnant women. Phenylketonurics, who have a genetic error of phenylalanine metabolism, have elevated serum plasma levels of phenylalanine up to 400 times normal. Mild phenylketonuria can be an unsuspected cause of hyperactivity, learning problems, and other developmental problems in children. Phenylalanine can be an effective pain reliever. Its use in premenstrual syndrome and Parkinson's may enhance the effects of acupuncture and electric transcutaneous nerve stimulation (TENS). Phenylalanine and tyrosine, like L-dopa, produce a catecholamine effect. Phenylalanine is better absorbed than tyrosine and may cause fewer headaches. Low phenylalanine diets have been prescribed for certain cancers with mixed results. Some tumors use more phenylalanine (particularly melatonin-producing tumors called melanoma). One strategy is to exclude this amino acid from the diet, i.e., a Phenylketonuria (PKU) diet (compliance is a difficult issue; it is hard to quantify and is under-researched). The other strategy is just to increase phenylalanine's competing amino acids, i.e., tryptophan, valine, isoleucine and leucine, but not tyrosine. (http://www.dcnutrition.com).</description>
		<cas>63-91-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CC1=CC=CC=C1)C(O)=O</moldb_smiles>
		<moldb_formula>C9H11NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1</moldb_inchi>
		<moldb_inchikey>COLNVLDHVKWLRT-QMMMGPOBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>165.1891</moldb_average_mass>
		<moldb_mono_mass>165.078978601</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>70</id>
		<lmdb_id>LMDB00070</lmdb_id>
		<created_at>2016-07-13 19:41:43</created_at>
		<updated_at>2016-07-20 20:49:45</updated_at>
		<export>1</export>
		<name>L-Alanine</name>
		<description>Alanine is a nonessential amino acid made in the body from the conversion of the carbohydrate pyruvate or the breakdown of DNA and the dipeptides carnosine and anserine. It is highly concentrated in muscle and is one of the most important amino acids released by muscle, functioning as a major energy source. Plasma alanine is often decreased when the BCAA (Branched Chain Amino Acids) are deficient. This finding may relate to muscle metabolism. Alanine is highly concentrated in meat products and other high-protein foods like wheat germ and cottage cheese. Alanine is an important participant as well as regulator in glucose metabolism. Alanine levels parallel blood sugar levels in both diabetes and hypoglycemia, and alanine reduces both severe hypoglycemia and the ketosis of diabetes. It is an important amino acid for lymphocyte reproduction and immunity. Alanine therapy has helped dissolve kidney stones in experimental animals. Normal alanine metabolism, like that of other amino acids, is highly dependent upon enzymes that contain vitamin B6. Alanine, like GABA, taurine and glycine, is an inhibitory neurotransmitter in the brain. http://www.dcnutrition.com/AminoAcids/).</description>
		<cas>56-41-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[C@H](N)C(O)=O</moldb_smiles>
		<moldb_formula>C3H7NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1</moldb_inchi>
		<moldb_inchikey>QNAYBMKLOCPYGJ-REOHCLBHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>89.0932</moldb_average_mass>
		<moldb_mono_mass>89.047678473</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>71</id>
		<lmdb_id>LMDB00071</lmdb_id>
		<created_at>2016-07-13 19:41:44</created_at>
		<updated_at>2016-07-20 20:49:48</updated_at>
		<export>1</export>
		<name>L-Proline</name>
		<description>L-Proline is one of the twenty amino acids used in living organisms as the building blocks of proteins. Proline is sometimes called an imino acid, although the IUPAC definition of an imine requires a carbon-nitrogen double bond. Proline is a non-essential amino acid that is synthesized from glutamic acid. It is an essential component of collagen and is important for proper functioning of joints and tendons.</description>
		<cas>147-85-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)[C@@H]1CCCN1</moldb_smiles>
		<moldb_formula>C5H9NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m0/s1</moldb_inchi>
		<moldb_inchikey>ONIBWKKTOPOVIA-BYPYZUCNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>115.1305</moldb_average_mass>
		<moldb_mono_mass>115.063328537</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>72</id>
		<lmdb_id>LMDB00072</lmdb_id>
		<created_at>2016-07-13 19:41:45</created_at>
		<updated_at>2016-09-23 18:44:36</updated_at>
		<export>1</export>
		<name>D-Maltose</name>
		<description>Maltose, or malt sugar, is a primary disaccharide in the animal diet formed from two units of glucose joined with an alpha (1-&gt;4) linkage. It is the second member of an important biochemical series of glucose chains. The addition of another glucose unit yields maltotriose, Further additions will produce dextrins, also called maltodextrins, and eventually starch. Maltose can be broken down into two glucose molecules by hydrolysis in living organisms. At the surface of the small intestine, the brush border enzymes maltase, breaks down maltose. (PMID: 14522745).</description>
		<cas>69-79-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C12H22O11</moldb_formula>
		<moldb_inchi>InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5-,6+,7-,8+,9-,10-,11+,12-/m1/s1</moldb_inchi>
		<moldb_inchikey>GUBGYTABKSRVRQ-DKBJLJRDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>342.2965</moldb_average_mass>
		<moldb_mono_mass>342.116211546</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>73</id>
		<lmdb_id>LMDB00073</lmdb_id>
		<created_at>2016-07-13 19:41:47</created_at>
		<updated_at>2016-07-20 20:20:03</updated_at>
		<export>1</export>
		<name>Methylamine</name>
		<description>Methylamine occurs endogenously from amine catabolism and its tissue levels increase in some pathological conditions, including diabetes. Interestingly, methylamine and ammonia levels are reciprocally controlled by a semicarbazide-sensitive amine oxidase activity that deaminates methylamine to formaldehyde with the production of ammonia and hydrogen peroxide. Methylamine also targets the voltage-operated neuronal potassium channels, probably inducing release of neurotransmitter(s). Semicarbazide-sensitive amine oxidase (SSAO) catalyzes the deamination of primary amines. Such deamination has been shown capable of regulating glucose transport in adipose cells. It has been independently discovered that the primary structure of vascular adhesion protein-1 (VAP-1) is identical to SSAO. Increased serum SSAO activities have been found in patients with diabetic mellitus, vascular disorders and Alzheimer's disease. The SSAO-catalyzed deamination of endogenous substrates like methylamine led to production of toxic formaldehyde. Chronic elevated methylamine increases the excretion of malondialdehyde and microalbuminuria. Amine oxidase substrates such as methylamine have been shown to stimulate glucose uptake by increasing the recruitment of the glucose transporter GLUT4 from vesicles within the cell to the cell surface. Inhibition of this effect by the presence of semicarbazide and catalase led to the suggestion that the process is mediated by the H (2) O (2) produced in the oxidation of these amines. (PMID: 16049393, 12686132, 17406961).</description>
		<cas>74-89-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN</moldb_smiles>
		<moldb_formula>CH5N</moldb_formula>
		<moldb_inchi>InChI=1S/CH5N/c1-2/h2H2,1H3</moldb_inchi>
		<moldb_inchikey>BAVYZALUXZFZLV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>31.0571</moldb_average_mass>
		<moldb_mono_mass>31.042199165</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>74</id>
		<lmdb_id>LMDB00074</lmdb_id>
		<created_at>2016-07-13 19:41:48</created_at>
		<updated_at>2016-09-23 18:44:36</updated_at>
		<export>1</export>
		<name>L-Threonine</name>
		<description>Threonine is an essential amino acid in animals. It is abundant in animal plasma, particularly in newborns. Severe deficiency of threonine causes neurological dysfunction and lameness in experimental animals. Threonine is an immunostimulant which promotes the growth of thymus gland. It also can probably promote cell immune defense function. This amino acid has been useful in the treatment of genetic spasticity disorders and multiple sclerosis at a dose of 1 gram daily. It is highly concentrated in meat products, cottage cheese and wheat germ. (http://www.dcnutrition.com/AminoAcids/) The threonine content of most of the infant formulas currently on the market is approximately 20% higher than the threonine concentration in animal milk. Due to this high threonine content the plasma threonine concentrations are up to twice as high in premature infants fed these formulas than in infants fed animal milk. The whey proteins which are used for infant formulas are sweet whey proteins. Sweet whey results from cheese production. Threonine catabolism in mammals appears to be due primarily (70-80%) to the activity of threonine dehydrogenase (EC 1.1.1.103) that oxidizes threonine to 2-amino-3-oxobutyrate, which forms glycine and acetyl CoA, whereas threonine dehydratase (EC 4.2.1.16) that catabolizes threonine into 2-oxobutyrate and ammonia, is significantly less active. Increasing the threonine plasma concentrations leads to accumulation of threonine and glycine in the brain. Such accumulation affects the neurotransmitter balance which may have consequences for the brain development during early postnatal life. Thus, excessive threonine intake during infant feeding should be avoided. (PMID 9853925).</description>
		<cas>72-19-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[C@@H](O)[C@H](N)C(O)=O</moldb_smiles>
		<moldb_formula>C4H9NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1</moldb_inchi>
		<moldb_inchikey>AYFVYJQAPQTCCC-GBXIJSLDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>119.1192</moldb_average_mass>
		<moldb_mono_mass>119.058243159</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>75</id>
		<lmdb_id>LMDB00075</lmdb_id>
		<created_at>2016-07-13 19:41:49</created_at>
		<updated_at>2016-09-23 18:45:44</updated_at>
		<export>1</export>
		<name>L-Asparagine</name>
		<description>Asparagine (Asn) is one of the 20 most common natural amino acids on earth. It has carboxamide as the side chain's functional group. It is considered a non-essential amino acid. Asparagine is not an essential amino acid, which means that it can be synthesized from central metabolic pathway intermediates and is not required in the diet. The precursor to asparagine is oxaloacetate. Oxaloacetate is converted to aspartate using a transaminase enzyme. The enzyme transfers the amino group from glutamate to oxaloacetate producing alpha-ketoglutarate and aspartate. The enzyme asparagine synthetase produces asparagine, AMP, glutamate, and pyrophosphate from aspartate, glutamine, and ATP. In the asparagine synthetase reaction, ATP is used to activate aspartate, forming beta-aspartyl-AMP. glutamine donates an ammonium group which reacts with beta-aspartyl-AMP to form asparagine and free AMP. Since the asparagine side chain can make efficient hydrogen bond interactions with the peptide backbone, asparagines are often found near the beginning and end of alpha-helices, and in turn motifs in beta sheets. Its role can be thought as &quot;capping&quot; the hydrogen bond interactions which would otherwise need to be satisfied by the polypeptide backbone. Glutamines have an extra methylene group, have more conformational entropy and thus are less useful in this regard. Asparagine also provides key sites for N-linked glycosylation, modification of the protein chain with the addition of carbohydrate chains. A reaction between asparagine and reducing sugars or reactive carbonyls produces acrylamide (acrylic amide) in food when heated to sufficient temperature, i.e. baking. Asparagine was first isolated in 1806 from asparagus juice, in which it is abundant--hence its name--becoming the first amino acid to be isolated. The smell observed in the urine of some individuals after their consumption of asparagus is attributed to a byproduct of the metabolic breakdown of asparagine, asparagine-amino-succinic-acid monoamide. (However, some scientists disagree and implicate other substances in the smell, especially methanethiol). (http://en.wikipedia.org/wiki/Asparagine).</description>
		<cas>70-47-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CC(N)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C4H8N2O3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8N2O3/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H2,6,7)(H,8,9)/t2-/m0/s1</moldb_inchi>
		<moldb_inchikey>DCXYFEDJOCDNAF-REOHCLBHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>132.1179</moldb_average_mass>
		<moldb_mono_mass>132.053492132</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>76</id>
		<lmdb_id>LMDB00076</lmdb_id>
		<created_at>2016-07-13 19:41:50</created_at>
		<updated_at>2016-07-20 20:50:00</updated_at>
		<export>1</export>
		<name>D-Mannose</name>
		<description>D-Mannose is a carbohydrate. High-mannose-type oligosaccharides have been shown to play important roles in protein quality control. Several intracellular proteins, such as lectins, chaperones and glycan-processing enzymes, are involved in this process. These include calnexin/calreticulin, UDP-glucose:glycoprotein glucosyltransferase (UGGT), cargo receptors (such as VIP36 and ERGIC-53), mannosidase-like proteins (e.g. EDEM and Htm1p) and ubiquitin ligase (Fbs). They are thought to recognize high-mannose-type glycans with subtly different structures. Mannose-binding lectin (MBL) is an important constituent of the innate immune system. This protein binds through multiple lectin domains to the repeating sugar arrays that decorate many microbial surfaces, and is then able to activate the complement system through a specific protease called MBL-associated protease-2. The primary pathway for the formation of L-fucose in procaryotic and eucaryotic cells is from D-mannose via an internal oxidation reduction and then epimerization of GDP-D-mannose to produce GDP-L-fucose. (PMID: 9488699, 16154739, 11414367).</description>
		<cas>3458-28-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6?/m1/s1</moldb_inchi>
		<moldb_inchikey>WQZGKKKJIJFFOK-QTVWNMPRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1559</moldb_average_mass>
		<moldb_mono_mass>180.063388116</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>77</id>
		<lmdb_id>LMDB00077</lmdb_id>
		<created_at>2016-07-13 19:41:52</created_at>
		<updated_at>2016-09-23 18:44:37</updated_at>
		<export>1</export>
		<name>L-Isoleucine</name>
		<description>Branched chain amino acids (BCAA) are essential amino acids whose carbon structure is marked by a branch point. These three amino acids are critical to animal life and are particularly involved in stress, energy and muscle metabolism. BCAA supplementation as therapy, both oral and intravenous, in animal health and disease holds great promise. &quot;BCAA&quot; denotes valine, isoleucine and leucine which are branched chain essential amino acids. Despite their structural similarities, the branched amino acids have different metabolic routes, with valine going solely to carbohydrates, leucine solely to fats and isoleucine to both. The different metabolism accounts for different requirements for these essential amino acids in animals: 12 mg/kg, 14 mg/kg and 16 mg/kg of valine, leucine and isoleucine respectively. Furthermore, these amino acids have different deficiency symptoms. Valine deficiency is marked by neurological defects in the brain, while isoleucine deficiency is marked by muscle tremors. BCAA are decreased in patients with liver disease, such as hepatitis, hepatic coma, cirrhosis, extrahepatic biliary atresia or portacaval shunt; aromatic amino acids (AAA)-tyrosine, tryptophan and phenylalanine, as well as methionine-are increased in these conditions. Valine, in particular, has been established as a useful supplemental therapy to the ailing liver. All the BCAA probably compete with AAA for absorption into the brain. Supplemental BCAA with vitamin B6 and zinc help normalize the BCAA:AAA ratio. The BCAA are not without side effects. Leucine alone, for example, exacerbates pellagra and can cause psychosis in pellagra patients by increasing excretion of niacin in the urine. Leucine may lower brain serotonin and dopamine. A dose of 3 g of isoleucine added to the niacin regime has cleared leucine-aggravated psychosis in schizophrenic patients. Isoleucine may have potential as an antipsychotic treatment. Leucine is more highly concentrated in foods than other amino acids. A cup of milk contains 800 mg of leucine and only 500 mg of isoleucine and valine. A cup of wheat germ has about 1.6 g of leucine and 1 g of isoleucine and valine. The ratio evens out in eggs and cheese. One egg and an ounce of most cheeses each contain about 400 mg of leucine and 400 mg of valine and isoleucine. The ratio of leucine to other BCAA is greatest in pork, where leucine is 7 to 8 g and the other BCAA together are only 3 to 4 g. (http://www.dcnutrition.com).</description>
		<cas>73-32-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC[C@H](C)[C@H](N)C(O)=O</moldb_smiles>
		<moldb_formula>C6H13NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1</moldb_inchi>
		<moldb_inchikey>AGPKZVBTJJNPAG-WHFBIAKZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>131.1729</moldb_average_mass>
		<moldb_mono_mass>131.094628665</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>78</id>
		<lmdb_id>LMDB00078</lmdb_id>
		<created_at>2016-07-13 19:41:53</created_at>
		<updated_at>2016-07-20 20:56:06</updated_at>
		<export>1</export>
		<name>L-Fucose</name>
		<description>Fucose is a hexose deoxy sugar with the chemical formula C6H12O5. L-fucose (6-deoxy-L-galactose) is a monosaccharide that is a common component of many N- and O-linked glycans and glycolipids produced by mammalian cells. It is the fundamental sub-unit of the fucoidan polysaccharide. As a free sugar, L-fucose is normally found at very low levels in mammals. It is unique in that it is the only levorotatory sugar synthesized and utilized by mammals. Fucose polymers are synthesized by fucosyltransferases.  All fucosyltransferases utilize a nucleotide-activated form of fucose, GDP-fucose, as a fucose donor in the construction of fucosylated oligosaccharides. The ABO blood group antigens are among the most well known fucosylated glycans. The alpha-1-&gt;3 linked core fucose is a suspected carbohydrate antigen for IgE-mediated allergy. Two structural features distinguish fucose from other six-carbon sugars present in mammals: the lack of a hydroxyl group on the carbon at the 6-position (C-6) and the L-configuration. In fucose-containing glycan structures, fucosylated glycans, fucose can exist as a terminal modification or serve as an attachment point for adding other sugars. Fucose is metabolized by an enzyme called alpha-fucosidase. Fucose is secreted in urine when the liver is damaged.  Free L-fucose in serum and urine can be used as a marker for cancer, cirrhosis, alcoholic liver disease and gastric ulcers (PMID: 2311216) (PMID: 8488966). Elevated levels of serum fucose have been reported in breast cancer, ovarian cancer, lung cancer, liver cancer, diabetes and cardiovascular disease. It has been shown that feeding rats a diet high in L-fucose induces neuropathy similar to that seen in diabetics.</description>
		<cas>2438-80-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C6H12O5</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3+,4+,5-,6?/m0/s1</moldb_inchi>
		<moldb_inchikey>SHZGCJCMOBCMKK-DHVFOXMCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>164.1565</moldb_average_mass>
		<moldb_mono_mass>164.068473494</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>79</id>
		<lmdb_id>LMDB00079</lmdb_id>
		<created_at>2016-07-13 19:41:54</created_at>
		<updated_at>2016-07-20 20:56:07</updated_at>
		<export>1</export>
		<name>Maleic acid</name>
		<description>Maleic acid is an industrial raw material for the production of glyoxylic acid by ozonolysis. Maleic acid is an organic compound which is a dicarboxylic acid (molecule with two carboxyl groups). The molecule consists of an ethylene group flanked by two carboxylic acid groups. Maleic acid is the cis isomer of butenedioic acid, whereas fumaric acid is the trans isomer. The cis isomer is the less stable one of the two; the difference in heat of combustion is 22.7 kJ/mol. The physical properties of maleic acid are very different from that of fumaric acid. Maleic acid is soluble in water whereas fumaric acid is not and the melting point of maleic acid (130 - 131 degree centigrade) is also much lower than that of fumaric acid (287 degree centigrade). Both properties of maleic acid can be explained on account of the intramolecular hydrogen bonding that takes place at the expense of intermolecular interactions. Maleic acid is converted into maleic anhydride by dehydration, to malic acid by hydration, and to succinic acid by hydrogenation. It reacts with thionyl chloride or phosphorus pentachloride to give the maleic acid chloride (it is not possible to isolate the mono acid chloride). Maleic acid is a reactant in many Diels-Alder reactions.</description>
		<cas>110-16-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)\C=C/C(O)=O</moldb_smiles>
		<moldb_formula>C4H4O4</moldb_formula>
		<moldb_inchi>InChI=1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1-</moldb_inchi>
		<moldb_inchikey>VZCYOOQTPOCHFL-UPHRSURJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>116.0722</moldb_average_mass>
		<moldb_mono_mass>116.010958616</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>80</id>
		<lmdb_id>LMDB00080</lmdb_id>
		<created_at>2016-07-13 19:41:56</created_at>
		<updated_at>2016-09-23 18:44:37</updated_at>
		<export>1</export>
		<name>L-Histidine</name>
		<description>Histidine is an alpha-amino acid with an imidazole functional group. It is one of the 22 proteinogenic amino acids. Histidine was first isolated by German physician Albrecht Kossel in 1896. Histidine is an essential amino acid in animals and other mammals. It was initially thought that it was only essential for infants, but longer-term studies established that it is also essential for adults. Infants four to six months old require 33 mg/kg of histidine. It is not clear how adults make small amounts of histidine, and dietary sources probably account for most of the histidine in the body. Histidine is a precursor for histamine and carnosine biosynthesis. Inborn errors of histidine metabolism exist and are marked by increased histidine levels in the blood. Elevated blood histidine is accompanied by a wide range of symptoms, from mental and physical retardation to poor intellectual functioning, emotional instability, tremor, ataxia and psychosis. Histidine and other imidazole compounds have anti-oxidant, anti-inflammatory and anti-secretory properties (PMID: 9605177). The efficacy of L-histidine in protecting inflamed tissue is attributed to the capacity of the imidazole ring to scavenge reactive oxygen species (ROS) generated by cells during acute inflammatory response (PMID: 9605177). Histidine, when administered in therapeutic quantities is able to inhibit cytokines and growth factors involved in cell and tissue damage (US patent 6150392). Histidine in medical therapies has its most promising trials in rheumatoid arthritis where up to 4.5 g daily have been used effectively in severely affected patients. Arthritis patients have been found to have low serum histidine levels, apparently because of very rapid removal of histidine from their blood (PMID: 1079527). Other patients besides arthritis patients that have been found to be low in serum histidine are those with chronic renal failure. Urinary levels of histidine are reduced in pediatric patients with pneumonia. (PMID: 2084459). Asthma patients exhibit increased serum levels of histidine over normal controls (PMID: 23517038).  Serum histidine levels are lower and are negatively associated with inflammation and oxidative stress in obese women (PMID: 23361591).  Histidine supplementation has been shown to reduce insulin resistance, reduce BMI and fat mass and suppress inflammation and oxidative stress in obese women with metabolic syndrome.  Histidine appears to suppress pro-inflammatory cytokine expression, possibly via the NF-?B pathway, in adipocytes (PMID: 23361591). Low plasma concentrations of histidine are associated with protein-energy wasting, inflammation, oxidative stress, and greater mortality in chronic kidney disease patients (PMID: 18541578). Histidine may have many other possible functions because it is the precursor of the ubiquitous neurohormone-neurotransmitter histamine. Histidine increases histamine in the blood and probably in the brain. Low blood histamine with low serum histidine occurs in rheumatoid arthritis patients. Low blood histamine also occurs in some manic, schizophrenic, high copper and hyperactive groups of psychiatric patients. Histidine is a useful therapy in all patients with low histamine levels. (http://www.dcnutrition.com ).</description>
		<cas>71-00-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CC1=CN=CN1)C(O)=O</moldb_smiles>
		<moldb_formula>C6H9N3O2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1</moldb_inchi>
		<moldb_inchikey>HNDVDQJCIGZPNO-YFKPBYRVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>155.1546</moldb_average_mass>
		<moldb_mono_mass>155.069476547</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>81</id>
		<lmdb_id>LMDB00081</lmdb_id>
		<created_at>2016-07-13 19:41:57</created_at>
		<updated_at>2016-09-23 18:44:38</updated_at>
		<export>1</export>
		<name>L-Lysine</name>
		<description>L-lysine is an essential amino acid. Normal requirements for lysine have been found to be about 8 g per day or 12 mg/kg in adults. Children and infants need more- 44 mg/kg per day for an eleven to-twelve-year old, and 97 mg/kg per day for three-to six-month old. Lysine is highly concentrated in muscle compared to most other amino acids. Lysine is high in foods such as wheat germ, cottage cheese and chicken. Of meat products, wild game and pork have the highest concentration of lysine. Fruits and vegetables contain little lysine, except avocados. Normal lysine metabolism is dependent upon many nutrients including niacin, vitamin B6, riboflavin, vitamin C, glutamic acid and iron. Excess arginine antagonizes lysine. Several inborn errors of lysine metabolism are known. Most are marked by mental retardation with occasional diverse symptoms such as absence of secondary sex characteristics, undescended testes, abnormal facial structure, anemia, obesity, enlarged liver and spleen, and eye muscle imbalance. Lysine also may be a useful adjunct in the treatment of osteoporosis. Although high protein diets result in loss of large amounts of calcium in urine, so does lysine deficiency. Lysine may be an adjunct therapy because it reduces calcium losses in urine. Lysine deficiency also may result in immunodeficiency. Requirements for this amino acid are probably increased by stress. Lysine toxicity has not occurred with oral doses in animals. Lysine dosages are presently too small and may fail to reach the concentrations necessary to prove potential therapeutic applications. Lysine metabolites, amino caproic acid and carnitine have already shown their therapeutic potential. Thirty grams daily of amino caproic acid has been used as an initial daily dose in treating blood clotting disorders, indicating that the proper doses of lysine, its precursor, have yet to be used in medicine. Low lysine levels have been found in patients with Parkinson's, hypothyroidism, kidney disease, asthma and depression. The exact significance of these levels is unclear, yet lysine therapy can normalize the level and has been associated with improvement of some patients with these conditions. Abnormally elevated hydroxylysines have been found in virtually all chronic degenerative diseases and coumadin therapy. The levels of this stress marker may be improved by high doses of vitamin C. Lysine is particularly useful in therapy for marasmus (wasting) and herpes simplex. It stops the growth of herpes simplex in culture, and has helped to reduce the number and occurrence of cold sores in clinical studies. Dosing has not been adequately studied, but beneficial clinical effects occur in doses ranging from 100 mg to 4 g a day. Higher doses may also be useful, and toxicity has not been reported in doses as high as 8 g per day. Diets high in lysine and low in arginine can be useful in the prevention and treatment of herpes. Some researchers think herpes simplex virus is involved in many other diseases related to cranial nerves such as migraines, Bell's palsy and Meniere's disease. Herpes blister fluid will produce fatal encephalitis in the rabbit. (http://www.dcnutrition.com).</description>
		<cas>56-87-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCCC[C@H](N)C(O)=O</moldb_smiles>
		<moldb_formula>C6H14N2O2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/t5-/m0/s1</moldb_inchi>
		<moldb_inchikey>KDXKERNSBIXSRK-YFKPBYRVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>146.1876</moldb_average_mass>
		<moldb_mono_mass>146.105527702</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>82</id>
		<lmdb_id>LMDB00082</lmdb_id>
		<created_at>2016-07-13 19:41:58</created_at>
		<updated_at>2016-09-23 18:44:38</updated_at>
		<export>1</export>
		<name>Alpha-Lactose</name>
		<description>alpha-Lactose is the major sugar present in milk and the main source of energy supplied to the newborn mammalian in its mother's milk. Lactose is also an important osmotic regulator of lactation. It is digested by the intestinal lactase (EC 3.2.1.108), an enzyme expressed in newborns. Its activity declines following weaning. As a result, adult mammals are normally lactose-intolerant and more than 75% of the animal adult population suffers from lactase deficiency. Lactase deficiency is present in up to 80 percent of blacks and Latinos, and up to 100 percent of American Indians and Asians. Persons with lactose intolerance are unable to digest significant amounts of lactose. Common symptoms include abdominal pain and bloating, excessive flatus, and watery stool following the ingestion of foods containing lactose. A sizable number of adults believe they are lactose intolerant but do not actually have impaired lactose digestion, and some persons with lactase deficiency can tolerate moderate amounts of ingested lactose. A diagnosis of lactose intolerance can usually be made with a careful history supported by dietary manipulation. If necessary, diagnosis can be confirmed by using a breath hydrogen or lactose tolerance test. These mostly uncomfortable symptoms of lactose maldigestion are blamed for a variably dairy consumption. There is, however, emerging evidence that certain lactic acid-producing bacteria, which selectively consume prebiotics, may be beneficial against some lower intestinal diseases. Lactose maldigestion and lactose should perhaps be re-evaluated as a potential provider of such a prebiotic. Treatment consists primarily of avoiding lactose-containing foods. Lactase enzyme supplements may be helpful. The degree of lactose malabsorption varies greatly among patients with lactose intolerance, but most of them can ingest up to 350 mL of milk daily without symptoms. Lactose-intolerant patients must ensure adequate calcium intake. (PMID: 13130292, 12216958, 12197838, 12018807).</description>
		<cas>63-42-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C12H22O11</moldb_formula>
		<moldb_inchi>InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5+,6+,7-,8-,9-,10-,11+,12+/m1/s1</moldb_inchi>
		<moldb_inchikey>GUBGYTABKSRVRQ-XLOQQCSPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>342.2965</moldb_average_mass>
		<moldb_mono_mass>342.116211546</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>83</id>
		<lmdb_id>LMDB00083</lmdb_id>
		<created_at>2016-07-13 19:41:59</created_at>
		<updated_at>2016-09-23 18:44:39</updated_at>
		<export>1</export>
		<name>L-Serine</name>
		<description>Serine is a nonessential amino acid derived from glycine. Like all the amino acid building blocks of protein and peptides, serine can become essential under certain conditions, and is thus important in maintaining health and preventing disease. Low-average concentration of serine compared to other amino acids is found in muscle. Serine is highly concentrated in all cell membranes. (http://www.dcnutrition.com/AminoAcids/) L-Serine may be derived from four possible sources: dietary intake; biosynthesis from the glycolytic intermediate 3-phosphoglycerate; from glycine ; and by protein and phospholipid degradation. Little data is available on the relative contributions of each of these four sources of l-serine to serine homoeostasis. It is very likely that the predominant source of l-serine will be very different in different tissues and during different stages of animal development. In the biosynthetic pathway, the glycolytic intermediate 3-phosphoglycerate is converted into phosphohydroxypyruvate, in a reaction catalyzed by 3-phosphoglycerate dehydrogenase (3- PGDH; EC 1.1.1.95). Phosphohydroxypyruvate is metabolized to phosphoserine by phosphohydroxypyruvate aminotransferase (EC 2.6.1.52) and, finally, phosphoserine is converted into l-serine by phosphoserine phosphatase (PSP; EC 3.1.3.3). In liver tissue, the serine biosynthetic pathway is regulated in response to dietary and hormonal changes. Of the three synthetic enzymes, the properties of 3-PGDH and PSP are the best documented. Hormonal factors such as glucagon and corticosteroids also influence 3-PGDH and PSP activities in interactions dependent upon the diet. L-serine plays a central role in cellular proliferation. L-Serine is the predominant source of one-carbon groups for the de novo synthesis of purine nucleotides and deoxythymidine monophosphate. It has long been recognized that, in cell cultures, L-serine is a conditional essential amino acid, because it cannot be synthesized in sufficient quantities to meet the cellular demands for its utilization. In recent years, L-serine and the products of its metabolism have been recognized not only to be essential for cell proliferation, but also to be necessary for specific functions in the central nervous system. The findings of altered levels of serine and glycine in patients with psychiatric disorders and the severe neurological abnormalities in patients with defects of L-serine synthesis underscore the importance of L-serine in brain development and function. (PMID 12534373).</description>
		<cas>56-45-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CO)C(O)=O</moldb_smiles>
		<moldb_formula>C3H7NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m0/s1</moldb_inchi>
		<moldb_inchikey>MTCFGRXMJLQNBG-REOHCLBHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>105.0926</moldb_average_mass>
		<moldb_mono_mass>105.042593095</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>84</id>
		<lmdb_id>LMDB00084</lmdb_id>
		<created_at>2016-07-13 19:42:01</created_at>
		<updated_at>2016-08-01 19:10:33</updated_at>
		<export>1</export>
		<name>L-Lactic acid</name>
		<description>Lactic acid plays a role in several biochemical processes and is produced in the muscles during intense activity. Lactate measurement in the critically ill has been traditionally used to stratify patients with poor outcome. However, plasma lactate levels are the result of a finely tuned interplay of factors that affect the balance between its production and its clearance. When the oxygen supply does not match its consumption, organisms such as man who are forced to produce ATP for their integrity adapt in many different ways up to the point when energy failure occurs. Lactate, being part of the adaptive response, may then be used to assess the severity of the supply/demand imbalance. In such a scenario, the time to intervention becomes relevant: early and effective treatment may allow the cell to revert to a normal state, as long as the oxygen machinery (i.e. mitochondria) is intact. Conversely, once the mitochondria are deranged, energy failure occurs even in the presence of normoxia. The lactate increase in critically ill patients may therefore be viewed as an early marker of a potentially reversible state. (PMID 16356243) A number of studies have demonstrated that malignant transformation is associated with an increase in glycolytic flux and in anaerobic and aerobic cellular lactate excretion. Using quantitative bioluminescence imaging in various primary carcinomas in patients (uterine cervix, head and neck, colorectal region) at first diagnosis of the disease, lactate concentrations in tumors in vivo could be relatively low or extremely high (up to 40 micromol/g) in different individual tumors or within the same lesion. In all tumor entities investigated, high molar concentrations of lactate were correlated with a high incidence of distant metastasis already in an early stage of the disease. Low lactate tumors (&lt; median of approximately 8 micromol/g) were associated with both a longer overall and disease free survival compared to high lactate lesions (lactate &gt; approximately 8 micromol/g). Lactate dehydrogenase was found to be upregulated in most of these tumors compared to surrounding normal tissue. (PMID 15279558).</description>
		<cas>79-33-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[C@H](O)C(O)=O</moldb_smiles>
		<moldb_formula>C3H6O3</moldb_formula>
		<moldb_inchi>InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/t2-/m0/s1</moldb_inchi>
		<moldb_inchikey>JVTAAEKCZFNVCJ-REOHCLBHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>90.0779</moldb_average_mass>
		<moldb_mono_mass>90.031694058</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>85</id>
		<lmdb_id>LMDB00085</lmdb_id>
		<created_at>2016-07-13 19:42:02</created_at>
		<updated_at>2016-07-20 20:50:21</updated_at>
		<export>1</export>
		<name>L-Aspartic acid</name>
		<description>Aspartic acid (Asp, D), also known as aspartate, the name of its anion, is one of the 20 natural proteinogenic amino acids which are the building blocks of proteins. As its name indicates, aspartic acid is the carboxylic acid analog of asparagine. As a neurotransmitter, aspartic acid may provide resistance to fatigue and thus lead to endurance, although the evidence to support this idea is not strong. (http://en.wikipedia.org/wiki/Aspartic_acid) Aspartic acid is a nonessential amino acid which is made from glutamic acid by enzymes using vitamin B6. The amino acid has important roles in the urea cycle and DNA metabolism. Aspartic acid is a major excitatory neurotransmitter, which is sometimes found to be increased in epileptic and stroke patients. It is decreased in depressed patients and in patients with brain atrophy. Aspartic acid supplements are being evaluated. Five grams can raise blood levels. Magnesium and zinc may be natural inhibitors of some of the actions of aspartic acid. Aspartic acid, with the amino acid phenylalanine, is a part of a new natural sweetener, aspartame. This sweetener is an advance in artificial sweeteners, and is probably safe in normal doses to all except phenylketonurics. The jury is still out on the long term effects it has on many brain neurohormones. Aspartic acid may be a significant immunostimulant of the thymus and can protect against some of the damaging effects of radiation. Many claims have been made for the special value of administering aspartic acid in the form of potassium and magnesium salts. Since aspartic acid is relatively nontoxic, studies are now in progress to elucidate its pharmacological and therapeutic roles. (http://www.dcnutrition.com/AminoAcids).</description>
		<cas>56-84-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C4H7NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1</moldb_inchi>
		<moldb_inchikey>CKLJMWTZIZZHCS-REOHCLBHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>133.1027</moldb_average_mass>
		<moldb_mono_mass>133.037507717</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>86</id>
		<lmdb_id>LMDB00086</lmdb_id>
		<created_at>2016-07-13 19:42:03</created_at>
		<updated_at>2016-07-20 20:23:20</updated_at>
		<export>1</export>
		<name>L-Cystine</name>
		<description>Cystine is an oxidized dimeric form of cysteine. It is formed by linking two cysteine residues via a disulfide bond (cys-S-S-cys) between the -SH groups. Cystine is found in high concentrations in the cells of the immune system, skeletal and connective tissues, skin, digestive enzymes, and in hair. Hair and skin are 10-14% cystine. Cystine is the preferred form of cysteine for the synthesis of glutathione in cells involved in the immune function including macrophages and astrocytes. Lymphocytes and neurons prefer cysteine for glutathione production. Optimizing glutathione levels in macrophages and astrocytes with cystine allows these cells to provide cysteine to lymphocytes and neurons directly upon demand. (http://en.wikipedia.org/wiki/Cystine).</description>
		<cas>56-89-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H12N2O4S2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12N2O4S2/c7-3(5(9)10)1-13-14-2-4(8)6(11)12/h3-4H,1-2,7-8H2,(H,9,10)(H,11,12)/t3-,4-/m0/s1</moldb_inchi>
		<moldb_inchikey>LEVWYRKDKASIDU-IMJSIDKUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>240.3000</moldb_average_mass>
		<moldb_mono_mass>240.023848262</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>87</id>
		<lmdb_id>LMDB00087</lmdb_id>
		<created_at>2016-07-13 19:42:05</created_at>
		<updated_at>2016-07-20 20:56:23</updated_at>
		<export>1</export>
		<name>Isocitric acid</name>
		<description>The citrate oxidation to isocitrate is catalyzed by the enzyme aconitase. Human prostatic secretion is remarkably rich in citric acid and low aconitase activity will therefore play a significant role in enabling accumulation of high citrate levels (PubMed ID 8115279).</description>
		<cas>320-77-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(C(CC(O)=O)C(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H8O7</moldb_formula>
		<moldb_inchi>InChI=1S/C6H8O7/c7-3(8)1-2(5(10)11)4(9)6(12)13/h2,4,9H,1H2,(H,7,8)(H,10,11)(H,12,13)</moldb_inchi>
		<moldb_inchikey>ODBLHEXUDAPZAU-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>192.1235</moldb_average_mass>
		<moldb_mono_mass>192.027002610</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>88</id>
		<lmdb_id>LMDB00088</lmdb_id>
		<created_at>2016-07-13 19:42:06</created_at>
		<updated_at>2016-09-23 18:44:40</updated_at>
		<export>1</export>
		<name>Anserine</name>
		<description>This dipeptide is normally absent from animal tissues and body fluids, and its appearance there is an artifact of diet (Proc Soc Pediatr Res 134, 1967.) and serum carnosinase deficiency. (OMIM 212200) Anserine is present in the skeletal muscle of birds and certain species of mammals, notably the rabbit, rat, and whale, contains anserine. (Proc Soc Pediatr Res 134, 1967) The methyl group of anserine is added to carnosine by the enzyme S-adenosylmethionine: carnosine N-methyltransferase. (J Biol Chem 237:1207, 1962.).</description>
		<cas>584-85-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN1C=NC=C1C[C@H](NC(=O)CCN)C(O)=O</moldb_smiles>
		<moldb_formula>C10H16N4O3</moldb_formula>
		<moldb_inchi>InChI=1S/C10H16N4O3/c1-14-6-12-5-7(14)4-8(10(16)17)13-9(15)2-3-11/h5-6,8H,2-4,11H2,1H3,(H,13,15)(H,16,17)/t8-/m0/s1</moldb_inchi>
		<moldb_inchikey>MYYIAHXIVFADCU-QMMMGPOBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>240.2590</moldb_average_mass>
		<moldb_mono_mass>240.122240398</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>89</id>
		<lmdb_id>LMDB00089</lmdb_id>
		<created_at>2016-07-13 19:42:07</created_at>
		<updated_at>2016-07-20 20:50:22</updated_at>
		<export>1</export>
		<name>Inosine</name>
		<description>Inosine is a purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed).</description>
		<cas>58-63-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1NC=NC2=O</moldb_smiles>
		<moldb_formula>C10H12N4O5</moldb_formula>
		<moldb_inchi>InChI=1S/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s1</moldb_inchi>
		<moldb_inchikey>UGQMRVRMYYASKQ-KQYNXXCUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>268.2261</moldb_average_mass>
		<moldb_mono_mass>268.080769514</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>90</id>
		<lmdb_id>LMDB00090</lmdb_id>
		<created_at>2016-07-13 19:42:08</created_at>
		<updated_at>2016-09-23 18:44:40</updated_at>
		<export>1</export>
		<name>Indoleacetic acid</name>
		<description>Indoleacetic acid (IAA) is a breakdown product of tryptophan metabolism and is often produced by the action of bacteria in the mammalian gut. Some endogenous production of IAA in mammalian tissues also occurs. It may be produced by the decarboxylation of tryptamine or the oxidative deamination of tryptophan. IAA frequently occurs at low levels in urine and has been found in elevated levels in the urine of patients with phenylketonuria ((PMID: 13610897). Using material extracted from animal urine, it was discovered by Kogl in 1933 that Indoleacetic acid is also an important plant hormone (PMID: 13610897). Specifically IAA is a member of the group of phytohormones called auxins. IAA is generally considered to be the most important native auxin. Plant cells synthesize IAA from tryptophan. (wikipedia) IAA and some derivatives can be oxidised by horseradish peroxidase (HRP) to cytotoxic species. IAA is only toxic after oxidative decarboxylation; the effect of IAA/HRP is thought to be due in part to the formation of methylene-oxindole, which may conjugate with DNA bases and protein thiols. IAA/HRP could be used as the basis for targeted cancer, a potential new role for plant auxins in cancer therapy. (PMID: 11163327).</description>
		<cas>87-51-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CC1=CNC2=C1C=CC=C2</moldb_smiles>
		<moldb_formula>C10H9NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C10H9NO2/c12-10(13)5-7-6-11-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H,12,13)</moldb_inchi>
		<moldb_inchikey>SEOVTRFCIGRIMH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>175.1840</moldb_average_mass>
		<moldb_mono_mass>175.063328537</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>91</id>
		<lmdb_id>LMDB00091</lmdb_id>
		<created_at>2016-07-13 19:42:10</created_at>
		<updated_at>2016-08-01 19:10:35</updated_at>
		<export>1</export>
		<name>L-Acetylcarnitine</name>
		<description>L-Acetylcarnitine is an acetic acid ester of carnitine that facilitates movement of acetyl CoA into the matrices of mammalian mitochondria during the oxidation of fatty acids. In addition to his metabolic role, acetyl-L-carnitine (ALC) posses unique neuroprotective, neuromodulatory, and neurotrophic properties this may play an important role in counteracting various disease processes. (PubMed ID 15363640).</description>
		<cas>3040-38-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C9H17NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C9H17NO4/c1-7(11)14-8(5-9(12)13)6-10(2,3)4/h8H,5-6H2,1-4H3</moldb_inchi>
		<moldb_inchikey>RDHQFKQIGNGIED-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>203.2356</moldb_average_mass>
		<moldb_mono_mass>203.115758037</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>92</id>
		<lmdb_id>LMDB00092</lmdb_id>
		<created_at>2016-07-13 19:42:11</created_at>
		<updated_at>2016-07-20 20:56:25</updated_at>
		<export>1</export>
		<name>Methylmalonic acid</name>
		<description>Methylmalonic acid is a malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA.</description>
		<cas>516-05-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C4H6O4</moldb_formula>
		<moldb_inchi>InChI=1S/C4H6O4/c1-2(3(5)6)4(7)8/h2H,1H3,(H,5,6)(H,7,8)</moldb_inchi>
		<moldb_inchikey>ZIYVHBGGAOATLY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>118.0880</moldb_average_mass>
		<moldb_mono_mass>118.026608680</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>93</id>
		<lmdb_id>LMDB00093</lmdb_id>
		<created_at>2016-07-13 19:42:12</created_at>
		<updated_at>2016-07-20 20:50:30</updated_at>
		<export>1</export>
		<name>Oleic acid</name>
		<description>Oleic acid is an unsaturated fatty acid that is the most widely distributed and abundant fatty acid in nature. It is used commercially in the preparation of oleates and lotions, and as a pharmaceutical solvent. (Stedman, 26th ed) Biological Source: Major constituent of plant oils e.g. olive oil (about 80%), almond oil (about 80%) and many others, mainly as glyceride. Constituent of tall oil and present in fruits Use/Importance: Food additive. Oleic acid is used in manufacturing of surfactants, soaps, plasticizers. Emulsifying agent in foods and pharmaceuticals. Biological Use/Importance: Skin penetrant. Herbicide, insecticide, fungicide (Dictionary of Organic Compounds). Oleic acid is a fatty acid that occurs naturally in various animal and vegetable fats and oils. It is an odorless, colourless oil, although commercial samples may be yellowish. In chemical terms, oleic acid is classified as a monounsaturated omega-9 fatty acid. It has the formula CH3(CH2)7CH=CH(CH2)7COOH. The term &quot;oleic&quot; means related to, or derived from, oil or olive, the oil that is predominantly composed of oleic acid. (Wiki).</description>
		<cas>112-80-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/b10-9-</moldb_inchi>
		<moldb_inchikey>ZQPPMHVWECSIRJ-KTKRTIGZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4614</moldb_average_mass>
		<moldb_mono_mass>282.255880332</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>94</id>
		<lmdb_id>LMDB00094</lmdb_id>
		<created_at>2016-07-13 19:42:13</created_at>
		<updated_at>2016-08-02 20:38:59</updated_at>
		<export>1</export>
		<name>Oxoglutaric acid</name>
		<description>Alpha-ketoglutaric acid is an important biological compound and is a key intermediate in the Krebs cycle. Alpha-ketoglutaric acid occurs naturally within cells. One of its functions is to combine with ammonia to form glutamic acid and then glutamine. Another function is to combine with nitrogen released in the cell, therefore preventing nitrogen overload. (wikipedia).</description>
		<cas>328-50-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CCC(=O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H6O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H6O5/c6-3(5(9)10)1-2-4(7)8/h1-2H2,(H,7,8)(H,9,10)</moldb_inchi>
		<moldb_inchikey>KPGXRSRHYNQIFN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>146.0981</moldb_average_mass>
		<moldb_mono_mass>146.021523302</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>95</id>
		<lmdb_id>LMDB00095</lmdb_id>
		<created_at>2016-07-13 19:42:15</created_at>
		<updated_at>2016-07-20 20:50:31</updated_at>
		<export>1</export>
		<name>Phenylacetic acid</name>
		<description>Phenyl acetate (or phenylacetate) is a carboxylic acid ester that has been found in the biofluids of patients with nephritis and/or hepatitis as well as patients with phenylketonuria (PKU). Excess phenylalanine in the body can be disposed of through a transamination process leading to the production of phenylpyruvate. The phenylpyruvate can be further metabolized into a number of products. Decarboxylation of phenylpyruvate gives phenylacetate, while a reduction reaction gives phenyllactate. The phenylacetate can be further conjugated with glutamine to give phenylacetyl glutamine. All of these metabolites can be detected in serum and urine of PKU patients. Phenyl acetate is also produced endogenously as the metabolite of 2-Phenylethylamine, which is mainly metabolized by monoamine oxidase to form phenyl acetate. 2-phenylethylamine is an &quot;endogenous amphetamine&quot; which may modulate central adrenergic functions, and the urinary phenyl acetate levels have been postulated as a marker for depression. (PMID: 17978765, 476920, 6857245). Phenylacetate is also found in essential oils, e.g. neroli, rose oil, free and as esters' and in many fruits. As a result it is used as a perfumery and flavoring ingredient.</description>
		<cas>103-82-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CC1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C8H8O2</moldb_formula>
		<moldb_inchi>InChI=1S/C8H8O2/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)</moldb_inchi>
		<moldb_inchikey>WLJVXDMOQOGPHL-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>136.1479</moldb_average_mass>
		<moldb_mono_mass>136.052429500</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>96</id>
		<lmdb_id>LMDB00096</lmdb_id>
		<created_at>2016-07-13 19:42:16</created_at>
		<updated_at>2016-07-20 20:50:33</updated_at>
		<export>1</export>
		<name>Pantothenic acid</name>
		<description>Pantothenic acid, also called vitamin B5, is a water-soluble vitamin required to sustain life. Pantothenic acid is needed to form coenzyme-A (CoA), and is thus critical in the metabolism and synthesis of carbohydrates, proteins, and fats. Its name is derived from the Greek pantothen meaning &quot;from everywhere&quot; and small quantities of pantothenic acid are found in nearly every food, with high amounts in whole grain cereals, legumes, eggs, meat, and royal jelly.</description>
		<cas>79-83-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)(CO)C(O)C(=O)NCCC(O)=O</moldb_smiles>
		<moldb_formula>C9H17NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C9H17NO5/c1-9(2,5-11)7(14)8(15)10-4-3-6(12)13/h7,11,14H,3-5H2,1-2H3,(H,10,15)(H,12,13)</moldb_inchi>
		<moldb_inchikey>GHOKWGTUZJEAQD-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>219.2350</moldb_average_mass>
		<moldb_mono_mass>219.110672659</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>97</id>
		<lmdb_id>LMDB00097</lmdb_id>
		<created_at>2016-07-13 19:42:17</created_at>
		<updated_at>2016-08-01 19:10:38</updated_at>
		<export>1</export>
		<name>Myoinositol</name>
		<description>Inositol is a cyclic polyalcohol that plays an important role as a second messenger in a cell, in the form of inositol phosphates. It is found in many foods, particularly in cereals with high bran content. It is an isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed., p1379) Inositol phospholipids are important in signal transduction.</description>
		<cas>87-89-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H/t1-,2-,3-,4+,5-,6-</moldb_inchi>
		<moldb_inchikey>CDAISMWEOUEBRE-GPIVLXJGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1559</moldb_average_mass>
		<moldb_mono_mass>180.063388116</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>98</id>
		<lmdb_id>LMDB00098</lmdb_id>
		<created_at>2016-07-13 19:42:19</created_at>
		<updated_at>2016-07-20 20:56:29</updated_at>
		<export>1</export>
		<name>Myo-inositol 1-phosphate</name>
		<description>Myo-inositol 1-phosphate is a metabolite of the Inositol phosphate metabolism and the Phosphatidylinositol signaling system. Inositol phosphatases [EC:3.1.3.25] play a crucial role in the phosphatidylinositol signaling pathway; in brain, the expression is substantially higher in the subcortical regions, most prominently in the caudate. The phosphatidylinositol pathway is thought to be modified by lithium, a commonly prescribed medication in treating bipolar disorder. (OMIM 605922).</description>
		<cas>573-35-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@H]1[C@H](O)[C@H](O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C6H13O9P</moldb_formula>
		<moldb_inchi>InChI=1S/C6H13O9P/c7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h1-11H,(H2,12,13,14)/t1-,2-,3+,4-,5-,6-/m0/s1</moldb_inchi>
		<moldb_inchikey>INAPMGSXUVUWAF-PTQMNWPWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>260.1358</moldb_average_mass>
		<moldb_mono_mass>260.029718526</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>99</id>
		<lmdb_id>LMDB00099</lmdb_id>
		<created_at>2016-07-13 19:42:20</created_at>
		<updated_at>2016-08-04 22:05:33</updated_at>
		<export>1</export>
		<name>Ornithine</name>
		<description>Ornithine is an amino acid produced in the urea cycle by the splitting off of urea from arginine. It is a central part of the urea cycle, which allows for the disposal of excess nitrogen. L-Ornithine is also a precursor of citrulline and arginine. In order for ornithine produced in the cytosol to be converted to citrulline, it must first cross the inner mitochondrial membrane into the mitochondrial matrix where it is carbamylated by ornithine transcarbamylase. This transfer is mediated by the mitochondrial ornithine transporter (SLC25A15; AF112968; ORNT1). Mutations in the mitochondrial ornithine transporter result in hyperammonemia, hyperornithinemia, homocitrullinuria (HHH) syndrome, a disorder of the urea cycle. (PMID 16256388) The pathophysiology of the disease may involve diminished ornithine transport into mitochondria, resulting in ornithine accumulation in the cytoplasm and reduced ability to clear carbamoyl phosphate and ammonia loads. (OMIM 838970).</description>
		<cas>70-26-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCC[C@H](N)C(O)=O</moldb_smiles>
		<moldb_formula>C5H12N2O2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H12N2O2/c6-3-1-2-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/t4-/m0/s1</moldb_inchi>
		<moldb_inchikey>AHLPHDHHMVZTML-BYPYZUCNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>132.1610</moldb_average_mass>
		<moldb_mono_mass>132.089877638</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>100</id>
		<lmdb_id>LMDB00100</lmdb_id>
		<created_at>2016-07-13 19:42:22</created_at>
		<updated_at>2016-09-23 18:44:41</updated_at>
		<export>1</export>
		<name>N-Acetyl-D-glucosamine</name>
		<description>N-Acetyl-D-Glucosamine (N-acetlyglucosamine) is a monosaccharide derivative of glucose. Chemically it is an amide between glucosamine and acetic acid. A single N-acetlyglucosamine moiety linked to serine or threonine residues on nuclear and cytoplasmic proteins -O-GlcNAc, is an ubiquitous post-translational protein modification. O-GlcNAc modified proteins are involved in sensing the nutrient status of the surrounding cellular environment and adjusting the activity of cellular proteins accordingly. O-GlcNAc regulates cellular responses to hormones such as insulin, initiates a protective response to stress, modulates a cell's capacity to grow and divide, and regulates gene transcription. In animals, it exists in skin, cartilage and blood vessel as a component of hyaluronic acid, and bone tissue, cornea and aorta as a component of keratan sulfate. (PMID 16237703).</description>
		<cas>7512-17-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C8H15NO6</moldb_formula>
		<moldb_inchi>InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8?/m1/s1</moldb_inchi>
		<moldb_inchikey>OVRNDRQMDRJTHS-RTRLPJTCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>221.2078</moldb_average_mass>
		<moldb_mono_mass>221.089937217</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>101</id>
		<lmdb_id>LMDB00101</lmdb_id>
		<created_at>2016-07-13 19:42:23</created_at>
		<updated_at>2016-07-20 20:50:42</updated_at>
		<export>1</export>
		<name>Palmitic acid</name>
		<description>Palmitic acid, or hexadecanoic acid is one of the most common saturated fatty acids found in animals and plants, a saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.(wikipedia) Biological Source: Occurs in the form of esters (glycerides) in oils and fats of vegetable and animal origin. Usually obtained from palm oil. Widely distributed in plants Use/Importance:. Palmitic acid is used in determination of water hardness Biological Use/Importance: Active ingredient of *Levovist*TM, used in echo enhancement in sonographic Doppler B-mode imaging. Ultrasound contrast medium (Dictionary of Organic Compounds).</description>
		<cas>57-10-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C16H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C16H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H,17,18)</moldb_inchi>
		<moldb_inchikey>IPCSVZSSVZVIGE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>256.4241</moldb_average_mass>
		<moldb_mono_mass>256.240230268</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>102</id>
		<lmdb_id>LMDB00102</lmdb_id>
		<created_at>2016-07-13 19:42:24</created_at>
		<updated_at>2016-07-20 20:50:43</updated_at>
		<export>1</export>
		<name>L-Palmitoylcarnitine</name>
		<description>L-Palmitoylcarnitine is a long-chain acyl fatty acid derivative ester of carnitine which facilitates the transfer of long-chain fatty acids from cytoplasm into mitochondria during the oxidation of fatty acids. L-palmitoylcarnitine, due to its amphipatic character is, like detergents, a surface-active molecule and by changing the membrane fluidity and surface charge can change activity of several enzymes and transporters localized in the membrane. L-palmitoylcarnitine has been also reported to change the activity of certain proteins. On the contrary to carnitine, palmitoylcarnitine was shown to stimulate the activity of caspases 3, 7 and 8 and the level of this long-chain acylcarnitine increased during apoptosis. Palmitoylcarnitine was also reported to diminish completely binding of phorbol esters, the protein kinase C activators and to decrease the autophosphorylation of the enzyme. Apart from these isoform nonspecific phenomena, palmitoylcarnitine was also shown to be responsible for retardation in cytoplasm of protein kinase C isoforms &amp;#946; and &amp;#948; and, in the case of the latter one, to decrease its interaction with GAP-43. Some of the physico-chemical properties of palmitoylcarnitine may help to explain the need for coenzyme A-carnitine-coenzyme A acyl exchange during mitochondrial fatty acid import. The amphiphilic character of palmitoylcarnitine may also explain its proposed involvement in the pathogenesis of myocardial ischemia. L-Palmitoylcarnitine accumulates in ischemic myocardium and potentially contribute to myocardial damage through alterations in membrane molecular dynamics , one mechanism through which could play an important role in ischemic injury. Palmitoylcarnitine is characteristically elevated in carnitine palmitoyltransferase II deficiency, late-onset (OMIM 255110). (PMID 2540838, 15363641, 8706815).</description>
		<cas>2364-67-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C23H45NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C23H45NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(27)28-21(19-22(25)26)20-24(2,3)4/h21H,5-20H2,1-4H3/t21-/m1/s1</moldb_inchi>
		<moldb_inchikey>XOMRRQXKHMYMOC-OAQYLSRUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>399.6077</moldb_average_mass>
		<moldb_mono_mass>399.334858933</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>103</id>
		<lmdb_id>LMDB00103</lmdb_id>
		<created_at>2016-07-13 19:42:25</created_at>
		<updated_at>2016-07-20 20:25:05</updated_at>
		<export>1</export>
		<name>Oxalacetic acid</name>
		<description>Oxaloacetic acid, also known as oxosuccinic acid or oxalacetic acid, is a four-carbon dicarboxylic acid appearing as an intermediate of the citric acid cycle. In vivo, oxaloacetate (the ionized form of oxaloacetic acid) is formed by the oxidation of L-malate, catalyzed by malate dehydrogenase, and reacts with Acetyl-CoA to form citrate, catalyzed by citrate synthase.(wikipedia) A class of ketodicarboxylic acids derived from oxalic acid. Oxaloacetic acid is an intermediate in the citric acid cycle and is converted to aspartic acidD by a transamination reaction.</description>
		<cas>328-42-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CC(=O)C(O)=O</moldb_smiles>
		<moldb_formula>C4H4O5</moldb_formula>
		<moldb_inchi>InChI=1S/C4H4O5/c5-2(4(8)9)1-3(6)7/h1H2,(H,6,7)(H,8,9)</moldb_inchi>
		<moldb_inchikey>KHPXUQMNIQBQEV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>132.0716</moldb_average_mass>
		<moldb_mono_mass>132.005873238</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>104</id>
		<lmdb_id>LMDB00104</lmdb_id>
		<created_at>2016-07-13 19:42:27</created_at>
		<updated_at>2016-07-20 20:25:06</updated_at>
		<export>1</export>
		<name>O-Phosphoethanolamine</name>
		<description>Phosphoethanolamine (PE) is a phosphomonoester metabolite of the phospholipid metabolism. PE is a precursor of phospholipid synthesis and a product of phospholipid breakdown. Phosphomonoesters are present at much higher levels in brain than in other organs. In developing brain, phosphomonoesters are normally elevated during the period of neuritic proliferation. This also coincides with the occurrence of normal programmed cell death and synaptic pruning in developing brain. These findings are consistent with the role of phosphomonoesters in membrane biosynthesis. PE shows a strong structural similarity to the inhibitory neurotransmitter, GABA, and the GABAB receptor partial agonist, 3-amino-propylphosphonic acid. PE is a phosphomonoester which is decreased in post-mortem Alzheimer's disease (AD) brain. (PMID: 7791524, 8588821, 11566853).</description>
		<cas>1071-23-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCOP(O)(O)=O</moldb_smiles>
		<moldb_formula>C2H8NO4P</moldb_formula>
		<moldb_inchi>InChI=1S/C2H8NO4P/c3-1-2-7-8(4,5)6/h1-3H2,(H2,4,5,6)</moldb_inchi>
		<moldb_inchikey>SUHOOTKUPISOBE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>141.0630</moldb_average_mass>
		<moldb_mono_mass>141.019094261</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>105</id>
		<lmdb_id>LMDB00105</lmdb_id>
		<created_at>2016-07-13 19:42:28</created_at>
		<updated_at>2016-07-20 20:56:34</updated_at>
		<export>1</export>
		<name>Oxoadipic acid</name>
		<description>2-Oxoadipic acid is produced from lysine in the cytosol of cells via the saccharopine and the pipecolic acid pathways. Catabolites of hydroxylysine and tryptophan enter these pathways as 2-aminoadipic- -semialdehyde and 2-oxoadipate, respectively. In the matrix of mitochondria, 2-oxoadipate is decarboxylated to glutaryl-CoA by the 2-oxoadipate dehydrogenase complex and then converted to acetyl-CoA. 2-Oxoadipic aciduria is an in-born error of metabolism of lysine, tryptophan, and hydroxylysine, in which abnormal quantities of 2-aminoadipic acid are found in body fluids along with 2-oxoadipic acid. Patients with 2-Oxoadipic acidemias are mentally retarded with hypotonia or seizures. 2-Oxoadipic Aciduria can occur in patients with Kearns-Sayre Syndrome, a progressive disorder with onset prior to 20 years of age in which multiple organ systems are affected, including progressive external ophthalmoplegia, retinopathy, and the age of onset, and these are associated classically with abnormalities in cardiac conduction, cerebellar signs, and elevated cerebrospinal fluid protein. (PMID: 10655159, 16183823, 11083877).</description>
		<cas>3184-35-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CCCC(=O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H8O5</moldb_formula>
		<moldb_inchi>InChI=1S/C6H8O5/c7-4(6(10)11)2-1-3-5(8)9/h1-3H2,(H,8,9)(H,10,11)</moldb_inchi>
		<moldb_inchikey>FGSBNBBHOZHUBO-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>160.1247</moldb_average_mass>
		<moldb_mono_mass>160.037173366</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>106</id>
		<lmdb_id>LMDB00106</lmdb_id>
		<created_at>2016-07-13 19:42:29</created_at>
		<updated_at>2016-09-23 18:44:41</updated_at>
		<export>1</export>
		<name>Orotic acid</name>
		<description>Orotic acid is a minor dietary constituent. Indeed, until it was realized that it could be synthesized by animals, orotic acid was known as vitamin B-13. The richest dietary sources are cow's milk and other dairy products as well as root vegetables such as carrots and beets. Dietary intake probably contributes to a basal rate of orotic acid excretion in urine because fasting decreases excretion by ~50%. However, it is now apparent that most urinary orotic acid is synthesized in the body, where it arises as an intermediate in the pathway for the synthesis of pyrimidine nucleotides. Orotic acid is converted to UMP by UMP synthase, a multifunctional protein with both orotate phosphoribosyltransferase and orotidylate decarboxylase activity. The most frequently observed inborn error of pyrimidine nucleotide synthesis is a mutation of the multifunctional protein UMP synthase. This disorder prevents the conversion of orotic acid to UMP and thus to other pyrimidines. As a result, plasma orotic acid accumulates to high concentrations, and increased quantities appear in the urine. Indeed, urinary orotic acid is so markedly increased in individuals harboring a mutation in UMP synthase that orotic acid crystals can form in the urine. The urinary concentration of orotic acid in homozygotes can be of the order of millimoles per millimole creatinine. By comparison, the urinary level in unaffected individuals is ~ 1 umol/mmol creatinine. (PMID: 17513443).</description>
		<cas>65-86-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C1=CC(=O)NC(=O)N1</moldb_smiles>
		<moldb_formula>C5H4N2O4</moldb_formula>
		<moldb_inchi>InChI=1S/C5H4N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)</moldb_inchi>
		<moldb_inchikey>PXQPEWDEAKTCGB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>156.0963</moldb_average_mass>
		<moldb_mono_mass>156.017106626</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>107</id>
		<lmdb_id>LMDB00107</lmdb_id>
		<created_at>2016-07-13 19:42:31</created_at>
		<updated_at>2016-09-23 18:44:42</updated_at>
		<export>1</export>
		<name>N-Acetylneuraminic acid</name>
		<description>N-Acetylneuraminic acid (NeuAc) or sialic acid is an acetyl derivative of the amino sugar neuraminic acid. It occurs in many glycoproteins, glycolipids, and polysaccharides in both mammals and bacteria. The most abundant sialic acid, NeuAc, is synthesized in vivo from N-acetylated D-mannosamine (ManNAc) or D-glucosamine (GlcNAc). NeuAc and its activated form, CMP-NeuAc, are biosynthesized in five consecutive reactions: UDP-N-acetylglucosamine (UDP-GlcNAc) N-acetylmannosamine (ManNAc) ManNAc 6-phosphate NeuAc 9-phosphate NeuAc CMP-NeuAc. CMP-NeuAc is transported into the Golgi apparatus and, with the aid of specific sialyltransferases, added onto nonreducing positions on oligosaccharide chains of glycoproteins and glycolipids. NeuAc is widely distributed throughout animal tissues and found in several fluids, including serum, cerebrospinal fluid, saliva, urine, amniotic fluid, and breast milk. It is found in high levels in the brain, adrenal glands, and the heart. Serum and urine levels of the free acid are elevated in individuals suffering from renal failure. Serum and saliva Neu5Ac levels are also elevated in alcoholics. A disorder known as Salla disease or infantile NeuAc storage disease is also characterized by high serum and urine levels of this compound. The negative charge of is responsible for the slippery feel of saliva and mucins coating the body's organs. This particular sialic acid is known to act as a &quot;decoy&quot; for invading pathogens. Along with involvement in preventing infections (mucus associated with mucous membranes ó mouth, nose, GI, respiratory tract), Neu5Ac acts as a receptor for influenza viruses, allowing attachment to mucous cells via hemagglutinin (an early step in acquiring influenzavirus infection). NeuAc is also becoming known as an agent necessary for mediating ganglioside distribution and structures in the brain. Sialic acid (SA) is an N-acetylated derivative of neuraminic acid that is an abundant terminal monosaccharide of glycoconjugates. Normal animal serum SA is largely bound to glycoproteins or glycolipids (Total sialic acid, TSA, 1.5-2.5 mmol/L), with small amounts of free SA (1-3 umol/L). Negatively charged SA units stabilize glycoprotein conformation in cell surface receptors to increase cell rigidity. This enables signal recognition and adhesion to ligands, antibodies, enzymes and microbes. SA residues are antigenic determinant residues in carbohydrate chains of glycolipids and glycoproteins, chemical messengers in tissue and body fluids, and may regulate glomeruli basement membrane permeability. Sialic acids are structurally unique nine-carbon keto sugars occupying the interface between the host and commensal or pathogenic microorganisms. An important function of host sialic acid is to regulate innate immunity. Sialic acid is the moiety most actively recycled for metabolic purposes in the salvage pathways in glycosphingolipid metabolism. Sialic acid is indispensable for the neuritogenic activities of gangliosides constituents which are unique in that a sialic acid directly binds to the glucose of the cerebroside, they are mutually connected in tandem, and some are located in the internal parts of the sugar chain. Sialylation (sialic acid linked to galactose, N-acetylgalactosamine, or linked to another sialic acid) represents one of the most frequently occurring terminations of the oligosaccharide chains of glycoproteins and glycolipids. The biosynthesis of the various linkages is mediated by the different members of the sialyltransferase family. (PMID: 11425186 , 11287396 , 12770781 , 16624269 , 12510390 , 15007099 ).</description>
		<cas>131-48-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O</moldb_smiles>
		<moldb_formula>C11H19NO9</moldb_formula>
		<moldb_inchi>InChI=1S/C11H19NO9/c1-4(14)12-7-5(15)2-11(20,10(18)19)21-9(7)8(17)6(16)3-13/h5-9,13,15-17,20H,2-3H2,1H3,(H,12,14)(H,18,19)/t5-,6+,7+,8+,9+,11-/m0/s1</moldb_inchi>
		<moldb_inchikey>SQVRNKJHWKZAKO-PFQGKNLYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>309.2699</moldb_average_mass>
		<moldb_mono_mass>309.105981211</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>108</id>
		<lmdb_id>LMDB00108</lmdb_id>
		<created_at>2016-07-13 19:42:32</created_at>
		<updated_at>2016-09-23 18:44:42</updated_at>
		<export>1</export>
		<name>Testosterone</name>
		<description>Testosterone is the most important androgen in potency and quantity. Testosterone is synthesized and released by the Leydig cells that lie between the tubules and comprise less than 5% of the total testicular volume. testosterone diffuses into the seminiferous tubules where it is essential for maintaining spermatogenesis. Some binds to an androgen-binding protein (ABP) that is produced by the Sertoli cells and is homologous to the sex-hormone binding globulin that transports testosterone in the general circulation. The ABP carries testosterone in the testicular fluid where it maintains the activity of the accessory sex glands and may also help to retain testosterone within the tubule and bind excess free hormone. Some testosterone is converted to estradiol by Sertoli cell-derived aromatase enzyme. Leydig cell steroidogenesis is controlled primarily by luteinizing hormone with negative feedback of testosterone on the hypothalamic-pituitary axis. The requirement of spermatogenesis for high local concentrations of testosterone means that loss of androgen production is likely to be accompanied by loss of spermatogenesis. Indeed, if testicular androgen production is inhibited by the administration of exogenous androgens then spermatogenesis ceases. This is the basis of using exogenous testosterone as a male contraceptive. testosterone is converted to dihydrotestosterone by 5a-reductase type 2 (EC 1.3.1.22, SRD5A2), the androgen with the highest affinity for the androgen receptor. SRD5A2 deficiency illustrates the importance of dihydrotestosterone for external virilization, as individuals with this condition have normal male internal structures but their external genitalia are of female appearance. There is now clear evidence that the animal fetal testis and also the fetal adrenal gland is capable of testosterone biosynthesis during the first trimester. Regardless of the source of androgen production, the target tissue responds by male sexual differentiation of the external genitalia by the end of the first trimester. It is clear that testicular damage may result in loss of testosterone production or the loss of spermatogenesis or both. Loss of androgen production results in hypogonadism, the symptoms of which reflect the functions of testosterone. Male hypogonadism is defined as failure of the testes to produce normal amounts of testosterone, combined with signs and symptoms of androgen deficiency. Systemic testosterone levels fall by about 1% each year in men. Therefore, with increasing longevity and the aging of the population, the number of older men with testosterone deficiency will increase substantially over the next several decades. Serum testosterone levels decrease progressively in aging men, but the rate and magnitude of decrease vary considerably. Approximately 1% of healthy young men have total serum testosterone levels below normal; in contrast, approximately 20% of healthy men over age 60 years have serum testosterone levels below normal. (PMID: 17904450, 17875487).</description>
		<cas>58-22-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C19H28O2</moldb_formula>
		<moldb_inchi>InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1</moldb_inchi>
		<moldb_inchikey>MUMGGOZAMZWBJJ-DYKIIFRCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>288.4244</moldb_average_mass>
		<moldb_mono_mass>288.208930140</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>109</id>
		<lmdb_id>LMDB00109</lmdb_id>
		<created_at>2016-07-13 19:42:33</created_at>
		<updated_at>2016-07-19 23:35:51</updated_at>
		<export>1</export>
		<name>Thiamine</name>
		<description>Thiamine or thiamin, also known as vitamin B1, is a colorless compound with the chemical formula C12H17N4OS. It is soluble in water and insoluble in alcohol. Thiamine decomposes if heated. Thiamine was first discovered by Umetaro Suzuki in Japan when researching how rice bran cured patients of Beriberi. Thiamine plays a key role in intracellular glucose metabolism and it is thought that thiamine inhibits the effect of glucose and insulin on arterial smooth muscle cell proliferation. thiamine plays an important role in helping the body convert carbohydrates and fat into energy. It is essential for normal growth and development and helps to maintain proper functioning of the heart and the nervous and digestive systems. Thiamine cannot be stored in the body; however, once absorbed, the vitamin is concentrated in muscle tissue.</description>
		<cas>59-43-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N</moldb_smiles>
		<moldb_formula>C12H17N4OS</moldb_formula>
		<moldb_inchi>InChI=1S/C12H17N4OS/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15)/q+1</moldb_inchi>
		<moldb_inchikey>JZRWCGZRTZMZEH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>265.3550</moldb_average_mass>
		<moldb_mono_mass>265.112306876</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>110</id>
		<lmdb_id>LMDB00110</lmdb_id>
		<created_at>2016-07-13 19:42:35</created_at>
		<updated_at>2016-09-23 18:44:43</updated_at>
		<export>1</export>
		<name>Propionic acid</name>
		<description>Propionic acid (PA) is widely used as an antifungal agent in food. It is present naturally at low levels in dairy products and occurs ubiquitously, together with other short-chain fatty acids (SCFA), in the gastro-intestinal tract of animals and other mammals as an end-product of the microbial digestion of carbohydrates. It has significant physiological activity in animals. PA is irritant but produces no acute systemic effects and has no demonstrable genotoxic potential. (PMID 1628870) Propionic aciduria is one of the most frequent organic acidurias, a disease that comprise many various disorders. The outcome of patients born with Propionic aciduria is poor intellectual development patterns, with 60% having an IQ less than 75 and requiring special education. Successful liver and/or renal transplantations, in a few patients, have resulted in better quality of life but have not necessarily prevented neurological and various visceral complications. These results emphasize the need for permanent metabolic follow-up whatever the therapeutic strategy. (PMID 15868474) Decreased early mortality, less severe symptoms at diagnosis, and more favorable short-term neurodevelopmental outcome were recorded in patients identified through expanded newborn screening. (PMID 16763906).</description>
		<cas>79-09-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC(O)=O</moldb_smiles>
		<moldb_formula>C3H6O2</moldb_formula>
		<moldb_inchi>InChI=1S/C3H6O2/c1-2-3(4)5/h2H2,1H3,(H,4,5)</moldb_inchi>
		<moldb_inchikey>XBDQKXXYIPTUBI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>74.0785</moldb_average_mass>
		<moldb_mono_mass>74.036779436</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>111</id>
		<lmdb_id>LMDB00111</lmdb_id>
		<created_at>2016-07-13 19:42:36</created_at>
		<updated_at>2016-08-02 20:40:50</updated_at>
		<export>1</export>
		<name>Pyridoxine</name>
		<description>The 4-methanol form of vitamin B6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. Although pyridoxine and Vitamin B6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading (EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990). Pyridoxine is one of the compounds that can be called vitamin B6. Pyridoxine assists in the balancing of sodium and potassium as well as promoting red blood cell production. It is linked to cancer immunity and helps fight the formation of homocysteine. It has been suggested that Pyridoxine might help children with learning difficulties, and may also prevent dandruff, eczema, and psoriasis. In addition, pyridoxine can help balance hormonal changes in women and aid in immune system. Lack of pyridoxine may cause anemia, nerve damage, seizures, skin problems, and sores in the mouth. -- Wikipedia Deficiency, though rare because of widespread distribution in foods, leads to the development of peripheral neuritis in adults and affects the central nervous system in children (DOSE - 3rd edition).</description>
		<cas>65-23-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=C(O)C(CO)=C(CO)C=N1</moldb_smiles>
		<moldb_formula>C8H11NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3</moldb_inchi>
		<moldb_inchikey>LXNHXLLTXMVWPM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>169.1778</moldb_average_mass>
		<moldb_mono_mass>169.073893223</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>112</id>
		<lmdb_id>LMDB00112</lmdb_id>
		<created_at>2016-07-13 19:42:37</created_at>
		<updated_at>2016-07-20 20:50:48</updated_at>
		<export>1</export>
		<name>Pyruvic acid</name>
		<description>Pyruvic acid is an intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed.) Biological Source: Intermediate in primary metabolism including fermentation processes. Present in muscle in redox equilibrium with Lactic acid. A common constituent, as a chiral cyclic acetal linked to saccharide residues, of bacterial polysaccharides. Isolated from cane sugar fermentation broth and peppermint. Constituent of Bauhinia purpurea, Cicer arietinum (chickpea), Delonix regia, Pisum sativum (pea) and Trigonella caerulea (sweet trefoil) Use/Importance: Reagent for regeneration of carbonyl compdounds from semicarbazones, phenylhydrazones and oximes. Flavoring ingredient (Dictionary of Organic Compounds).</description>
		<cas>127-17-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)C(O)=O</moldb_smiles>
		<moldb_formula>C3H4O3</moldb_formula>
		<moldb_inchi>InChI=1S/C3H4O3/c1-2(4)3(5)6/h1H3,(H,5,6)</moldb_inchi>
		<moldb_inchikey>LCTONWCANYUPML-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>88.0621</moldb_average_mass>
		<moldb_mono_mass>88.016043994</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>113</id>
		<lmdb_id>LMDB00113</lmdb_id>
		<created_at>2016-07-13 19:42:39</created_at>
		<updated_at>2016-09-23 18:44:43</updated_at>
		<export>1</export>
		<name>Riboflavin</name>
		<description>Riboflavin or vitamin B2 is an easily absorbed, water-soluble micronutrient with a key role in maintaining animal health. Like the other B vitamins, it supports energy production by aiding in the metabolizing of fats, carbohydrates, and proteins. Vitamin B2 is also required for red blood cell formation and respiration, antibody production, and for regulating animal growth and reproduction. It is essential for healthy skin, nails, hair growth and general good health, including regulating thyroid activity. Riboflavin is found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables. Riboflavin is yellow or orange-yellow in color and in addition to being used as a food coloring it is also used to fortify some foods. It can be found in baby foods, breakfast cereals, sauces, processed cheese, fruit drinks and vitamin-enriched milk products. The richest natural source is yeast. It occurs in the free form only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as flavin mononucleotide and flavin adenine dinucleotide.</description>
		<cas>83-88-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=NC(=O)NC(=O)C3=NC2=C1</moldb_smiles>
		<moldb_formula>C17H20N4O6</moldb_formula>
		<moldb_inchi>InChI=1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1</moldb_inchi>
		<moldb_inchikey>AUNGANRZJHBGPY-SCRDCRAPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>376.3639</moldb_average_mass>
		<moldb_mono_mass>376.138284392</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>114</id>
		<lmdb_id>LMDB00114</lmdb_id>
		<created_at>2016-07-13 19:42:40</created_at>
		<updated_at>2016-07-19 23:09:42</updated_at>
		<export>1</export>
		<name>Thyroxine</name>
		<description>The thyronamines function via some unknown mechanism to inhibit neuronal activity; this plays an important role in the hibernation cycles of mammals. One effect of administering the thyronamines is a severe drop in body temperature. Iodide is actively absorbed from the bloodstream and concentrated in the thyroid follicles. (If there is a deficiency of dietary iodine, the thyroid enlarges in an attempt to trap more iodine, resulting in goitre.) Via a reaction with the enzyme thyroperoxidase, iodine is covalently bound to tyrosine residues in the thyroglobulin molecules, forming monoiodotyrosine (MIT) and diiodotyrosine (DIT). Linking two moieties of DIT produces thyroxine. Combining one particle of MIT and one particle of DIT produces triiodothyronine. Both T3 and T4 are used to treat thyroid hormone deficiency (hypothyroidism). They are both absorbed well by the gut, so can be given orally. Levothyroxine, the most commonly used synthetic thyroxine form, is a stereoisomer of physiological thyroxine, which is metabolized more slowly and hence usually only needs once-daily administration. Natural desiccated thyroid hormones, which are derived from pig thyroid glands, are a &quot;natural&quot; hypothyroid treatment containing 20% T3 and traces of T2, T1 and calcitonin. this plays an important role in the hibernation cycles of mammals. One effect of administering the thyronamines is a severe drop in body temperature. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (monoiodotyrosine) and the coupling of iodotyrosines (diiodotyrosine) in the thyroglobulin. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form triiodothyronine which exerts a broad spectrum of stimulatory effects on cell metabolism. The thyronamines function via some unknown mechanism to inhibit neuronal activity.</description>
		<cas>51-48-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O</moldb_smiles>
		<moldb_formula>C15H11I4NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1</moldb_inchi>
		<moldb_inchikey>XUIIKFGFIJCVMT-LBPRGKRZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>776.8700</moldb_average_mass>
		<moldb_mono_mass>776.686681525</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>115</id>
		<lmdb_id>LMDB00115</lmdb_id>
		<created_at>2016-07-13 19:42:41</created_at>
		<updated_at>2016-09-23 18:44:44</updated_at>
		<export>1</export>
		<name>Taurine</name>
		<description>Taurine is a sulfur amino acid like methionine, cystine, cysteine and homocysteine. It is a lesser-known amino acid because it is not incorporated into the structural building blocks of protein. Yet taurine is an essential amino acid in pre-term and newborn infants of animals and many other species. Adults can synthesize their own taurine, yet are probably dependent in part on dietary taurine. Taurine is abundant in the brain, heart, breast, gallbladder and kidney and has important roles in health and disease in these organs. Taurine has many diverse biological functions serving as a neurotransmitter in the brain, a stabilizer of cell membranes and a facilitator in the transport of ions such as sodium, potassium, calcium and magnesium. Taurine is highly concentrated in animal and fish protein, which are good sources of dietary taurine. It can be synthesized by the body from cysteine when vitamin B6 is present. Deficiency of taurine occurs in premature infants and neonates fed formula milk, and in various disease states. Inborn errors of taurine metabolism have been described. OMIM 168605, an unusual neuropsychiatric disorder inherited in an autosomal dominant fashion through 3 generations of a family. Symptoms began late in the fifth decade in 6 affected persons and death occurred after 4 to 6 years. The earliest and most prominent symptom was mental depression not responsive to antidepressant drugs or electroconvulsive therapy. Sleep disturbances, exhaustion and marked weight loss were features. Parkinsonism developed later, and respiratory failure occurred terminally. OMIM 145350 describes congestive cardiomyopathy and markedly elevated urinary taurine levels (about 5 times normal). Other family members had late or holosystolic mitral valve prolapse and elevated urinary taurine values (about 2.5 times normal). In 2 with mitral valve prolapse, congestive cardiomyopathy eventually developed while the amounts of urinary taurine doubled. Taurine, after GABA, is the second most important inhibitory neurotransmitter in the brain. Its inhibitory effect is one source of taurine's anticonvulsant and antianxiety properties. It also lowers glutamic acid in the brain, and preliminary clinical trials suggest taurine may be useful in some forms of epilepsy. Taurine in the brain is usually associated with zinc or manganese. The amino acids alanine and glutamic acid, as well as pantothenic acid, inhibit taurine metabolism while vitamins A and B6, zinc and manganese help build taurine. Cysteine and B6 are the nutrients most directly involved in taurine synthesis. Taurine levels have been found to decrease significantly in many depressed patients. One reason that the findings are not entirely clear is because taurine is often elevated in the blood of epileptics who need it. It is often difficult to distinguish compensatory changes in animal biochemistry from true metabolic or deficiency disease. Low levels of taurine are found in retinitis pigmentosa. Taurine deficiency in experimental animals produces degeneration of light-sensitive cells. Therapeutic applications of taurine to eye disease are likely to be forthcoming. Taurine has many important metabolic roles. Supplements can stimulate prolactin and insulin release. The parathyroid gland makes a peptide hormone called glutataurine (glutamic acid-taurine), which further demonstrates taurine's role in endocrinology. Taurine increases bilirubin and cholesterol excretion in bile, critical to normal gallbladder function. It seems to inhibit the effect of morphine and potentiates the effects of opiate antagonists. Low plasma taurine levels have been found in a variety of conditions, i.e., depression, hypertension, hypothyroidism, gout, institutionalized patients, infertility, obesity, kidney failure and others. (http://www.dcnutrition.com/AminoAcids/).</description>
		<cas>107-35-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCS(O)(=O)=O</moldb_smiles>
		<moldb_formula>C2H7NO3S</moldb_formula>
		<moldb_inchi>InChI=1S/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6)</moldb_inchi>
		<moldb_inchikey>XOAAWQZATWQOTB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>125.1470</moldb_average_mass>
		<moldb_mono_mass>125.014663785</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>116</id>
		<lmdb_id>LMDB00116</lmdb_id>
		<created_at>2016-07-13 19:42:42</created_at>
		<updated_at>2016-07-20 20:56:38</updated_at>
		<export>1</export>
		<name>Sphingosine</name>
		<description>Sphingosine is a 18-carbon amino alcohol with a long unsaturated hydrocarbon chain. Sphingosine and its derivative sphinganine are the major bases of the sphingolipids in mammals. (Dorland, 28th ed.). Sphingosine can be phosphorylated in vivo via two kinases, sphingosine kinase type 1 and sphingosine kinase type 2. This leads to the formation of sphingosine-1-phosphate, a potent signaling lipid.(Wikipedia).</description>
		<cas>123-78-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCC\C=C\C(O)C(N)CO</moldb_smiles>
		<moldb_formula>C18H37NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h14-15,17-18,20-21H,2-13,16,19H2,1H3/b15-14+</moldb_inchi>
		<moldb_inchikey>WWUZIQQURGPMPG-CCEZHUSRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>299.4919</moldb_average_mass>
		<moldb_mono_mass>299.282429433</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>117</id>
		<lmdb_id>LMDB00117</lmdb_id>
		<created_at>2016-07-13 19:42:44</created_at>
		<updated_at>2016-07-19 23:07:00</updated_at>
		<export>1</export>
		<name>Pregnenolone</name>
		<description>Pregnenolone is a derivative of cholesterol, the product of Cytochrome P450 side-chain cleavage (EC 1.14.15.6, CYP11A1); this reaction consists of three consecutive monooxygenations; a 22-hydroxylation, 20-hydroxylation and the cleavage of the C20-C22 bond, yielding pregnenolone. Pregnenolone is the precursor to gonadal steroid hormones and the adrenal corticosteroids. This reaction occurs in steroid hormone-producing tissues such as the adrenal cortex, corpus luteum and placenta. The most notable difference between the placenta and other steroidogenic tissues is that electron supply to CYP11A1 limits the rate at which cholesterol is converted to pregnenolone in the placenta. The limiting component for electron delivery to CYP11A1 is the concentration of adrenodoxin reductase in the mitochondrial matrix which is insufficient to maintain the adrenodoxin pool in a fully reduced state. Pregnenolone is also a neurosteroid, and is produced in the spinal cord; CYP11A1 is the key enzyme catalyzing the conversion of cholesterol into pregnenolone, the rate-limiting step in the biosynthesis of all classes of steroids, and has been localized in sensory networks of the spinal cord dorsal horn. In the adrenal glomerulosa cell angiotensin II, one of the major physiological regulators of mineralocorticoid synthesis, appears to affect most of the cholesterol transfer to the mitochondrial outer membrane and transport to the inner membrane steps and thus to exerts a powerful control over the use of cholesterol for aldosterone production. (PMID: 17222962, 15823613, 16632873, 15134809).</description>
		<cas>145-13-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])C2CC=C2C[C@H](O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C21H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16?,17-,18+,19+,20+,21-/m1/s1</moldb_inchi>
		<moldb_inchikey>ORNBQBCIOKFOEO-STZXPNGSSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>316.4776</moldb_average_mass>
		<moldb_mono_mass>316.240230268</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>118</id>
		<lmdb_id>LMDB00118</lmdb_id>
		<created_at>2016-07-13 19:42:45</created_at>
		<updated_at>2016-07-20 20:50:52</updated_at>
		<export>1</export>
		<name>Succinic acid</name>
		<description>Succinic acid is a dicarboxylic acid. The anion, succinate, is a component of the citric acid or TCA cycle and is capable of donating electrons to the electron transfer chain. Succinate dehydrogenase (SDH) plays an important role in mitochondrial function, being both part of the respiratory chain and the Krebs cycle. SDH with a covalently attached FAD prosthetic group, is able to bind several different enzyme substrates (succinate and fumarate) and physiological regulators (oxaloacetate and ATP). Oxidizing succinate links SDH to the fast-cycling Krebs cycle portion where it participates in the breakdown of acetyl-CoA throughout the entire Krebs cycle. Succinate can readily be imported into the mitochondrial matrix by the n-butylmalonate- (or phenylsuccinate-) sensitive dicarboxylate carrier in exchange with inorganic phosphate or another organic acid, e. g. malate. (PMID 16143825 ) Mutations in the four genes encoding the subunits of the mitochondrial succinate dehydrogenase are associated with a wide spectrum of clinical presentations (i.e.: Huntington's disease. (PMID 11803021 ). Succinic acid has recently been identified as an oncometabolite or an endogenous, cancer causing metabolite. High levels of this organic acid can be found in tumors or biofluids surrounding tumors. Its oncogenic action appears to due to its ability to inhibit prolyl hydroxylase-containing enzymes. In many tumours, oxygen availability becomes limited (hypoxia) very quickly due to rapid cell proliferation and limited blood vessel growth. The major regulator of the response to hypoxia is the HIF transcription factor (HIF-alpha). Under normal oxygen levels, protein levels of HIF-alpha are very low due to constant degradation, mediated by a series of post-translational modification events catalyzed by the prolyl hydroxylase domain-containing enzymes PHD1, 2 and 3, (also known as EglN2, 1 and 3) that hydroxylate HIF-alpha and lead to its degradation. All three of the PHD enzymes are inhibited by succinate.</description>
		<cas>110-15-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CCC(O)=O</moldb_smiles>
		<moldb_formula>C4H6O4</moldb_formula>
		<moldb_inchi>InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8)</moldb_inchi>
		<moldb_inchikey>KDYFGRWQOYBRFD-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>118.0880</moldb_average_mass>
		<moldb_mono_mass>118.026608680</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>119</id>
		<lmdb_id>LMDB00119</lmdb_id>
		<created_at>2016-07-13 19:42:46</created_at>
		<updated_at>2016-07-20 20:56:41</updated_at>
		<export>1</export>
		<name>Sucrose</name>
		<description>Sucrose is a nonreducing disaccharide composed of glucose and fructose linked via their anomeric carbons. It is obtained commercially from sugarcane, sugar beet (beta vulgaris), and other plants and used extensively as a food and a sweetener. Sucrose is derived by crushing and extraction of sugarcane (Saccharum officinarum) with water or extraction of the sugar beet (Beta vulgaris) with water, evaporating, and purifying with lime, carbon, and various liquids. Sucrose is also obtainable from sorghum. Sucrose occurs in low percentages in honey and maple syrup. Sucrose is used as a sweetener in foods and soft drinks, in the manufacture of syrups, in invert sugar, confectionery, preserves and jams, demulcent, pharmaceutical products, and caramel. Sucrose is also a chemical intermediate for detergents, emulsifying agents, and other sucrose derivatives. Sucrose is wiidespread in seeds, leaves, fruits, flowers and roots of plants, where it functions as an energy store for metabolism and as a carbon source for biosynthesis. The annual world production of sucrose is in excess of 90 million tons mainly from the juice of sugar cane (20%) and sugar beet (17%). In addition to its use as a sweetner, sucrose is used in food products as a preservative, antioxidant, moisture control agent, stabilizer and thickening agent.</description>
		<cas>57-50-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C12H22O11</moldb_formula>
		<moldb_inchi>InChI=1S/C12H22O11/c13-1-4-6(16)8(18)9(19)11(21-4)23-12(3-15)10(20)7(17)5(2-14)22-12/h4-11,13-20H,1-3H2/t4-,5-,6-,7-,8+,9-,10+,11-,12+/m1/s1</moldb_inchi>
		<moldb_inchikey>CZMRCDWAGMRECN-UGDNZRGBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>342.2965</moldb_average_mass>
		<moldb_mono_mass>342.116211546</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>120</id>
		<lmdb_id>LMDB00120</lmdb_id>
		<created_at>2016-07-13 19:42:48</created_at>
		<updated_at>2016-07-19 23:33:45</updated_at>
		<export>1</export>
		<name>Serotonin</name>
		<description>Serotonin is a biochemical messenger and regulator, synthesized from the essential amino acid L-Tryptophan. Serotonin in the nervous system acts as a local transmitter at synapses, and as a paracrine or hormonal modulator of circuits upon diffusion, allowing a wide variety of &quot;state-dependent&quot; behavioral responses to different stimuli. Serotonin is widely distributed in the nervous system of vertebrates and invertebrates and some of its behavioral effects have been preserved along evolution. Such is the case of aggressive behavior and rhythmic motor patterns , including those responsible for feeding. In vertebrates, which display a wider and much more sophisticated behavioral repertoire, serotonin also modulates sleep, the arousal state , sexual behavior, and others, and deficiencies of the serotonergic system causes disorders such as depression, obsessive-compulsive disorder, phobias, posttraumatic stress disorder, epilepsy, and generalized anxiety disorder. Serotonin has three different modes of action in the nervous system: as transmitter, acting locally at synaptic boutons; upon diffusion at a distance from its release sites, producing paracrine (also called volume) effects, and by circulating in the blood stream, producing hormonal effects. The three modes can affect a single neuronal circuit. (PMID: 16047543).</description>
		<cas>50-67-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCC1=CNC2=CC=C(O)C=C12</moldb_smiles>
		<moldb_formula>C10H12N2O</moldb_formula>
		<moldb_inchi>InChI=1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2</moldb_inchi>
		<moldb_inchikey>QZAYGJVTTNCVMB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>176.2151</moldb_average_mass>
		<moldb_mono_mass>176.094963016</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>121</id>
		<lmdb_id>LMDB00121</lmdb_id>
		<created_at>2016-07-13 19:42:49</created_at>
		<updated_at>2016-07-20 20:50:53</updated_at>
		<export>1</export>
		<name>Thymine</name>
		<description>One of the pyrimidine bases of living matter. Derivation: Hydrolysis of deoxyribonucleic acid, from methylcyanoacetylurea by catalytic reduction. Use: Biochemical research. (Hawley's Condensed Chemical Dictionary). Thymine is a pyrimidine nucleobase. As the name implies, thymine may be derived by methylation of uracil at the 5th carbon. Thymine is found in the nucleic acid DNA. In RNA thymine is replaced with uracil in most cases. In DNA, thymine binds to adenine via two hydrogen bonds to assist in stabilizing the nucleic acid structures.</description>
		<cas>65-71-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=CNC(=O)NC1=O</moldb_smiles>
		<moldb_formula>C5H6N2O2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H6N2O2/c1-3-2-6-5(9)7-4(3)8/h2H,1H3,(H2,6,7,8,9)</moldb_inchi>
		<moldb_inchikey>RWQNBRDOKXIBIV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>126.1133</moldb_average_mass>
		<moldb_mono_mass>126.042927446</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>122</id>
		<lmdb_id>LMDB00122</lmdb_id>
		<created_at>2016-07-13 19:42:50</created_at>
		<updated_at>2016-07-20 20:56:42</updated_at>
		<export>1</export>
		<name>Phosphoenolpyruvic acid</name>
		<description>Phosphoenolpyruvate (PEP) is an important chemical compound in biochemistry. It has a high energy phosphate bond, and is involved in glycolysis and gluconeogenesis. In glycolysis, PEP is formed by the action of the enzyme enolase on 2-phosphoglycerate. Metabolism of PEP to pyruvate by pyruvate kinase (PK) generates 1 molecule of adenosine triphosphate (ATP) via substrate-level phosphorylation. ATP is one of the major currencies of chemical energy within cells. In gluconeogenesis, PEP is formed from the decarboxylation of oxaloacetate and hydrolysis of 1 guanosine triphosphate molecule. This reaction is catalyzed by the enzyme phosphoenolpyruvate carboxykinase (PEPCK). This reaction is a rate-limiting step in gluconeogenesis. (wikipedia).</description>
		<cas>138-08-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C(=C)OP(O)(O)=O</moldb_smiles>
		<moldb_formula>C3H5O6P</moldb_formula>
		<moldb_inchi>InChI=1S/C3H5O6P/c1-2(3(4)5)9-10(6,7)8/h1H2,(H,4,5)(H2,6,7,8)</moldb_inchi>
		<moldb_inchikey>DTBNBXWJWCWCIK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>168.0420</moldb_average_mass>
		<moldb_mono_mass>167.982374404</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>123</id>
		<lmdb_id>LMDB00123</lmdb_id>
		<created_at>2016-07-13 19:42:51</created_at>
		<updated_at>2016-07-20 20:50:55</updated_at>
		<export>1</export>
		<name>Pyroglutamic acid</name>
		<description>Pyroglutamic acid is a cyclized derivative of L-glutamic acid. It is an uncommon amino acid derivative in which the free amino group of glutamic acid cyclizes to form a lactam. It is formed nonenzymatically from glutamate, glutamine, and gamma-glutamylated peptides, but it can also be produced by the action of gamma-glutamylcyclotransferase on an L-amino acid. Elevated blood levels may be associated with problems of glutamine or glutathione metabolism. This compound is found in substantial amounts in brain tissue and other tissue in bound form, especially skin. Also present in plant tissues. It is sold, over the counter, as a &quot;smart drug&quot; for improving blood circulation in the brain.</description>
		<cas>98-79-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)[C@@H]1CCC(=O)N1</moldb_smiles>
		<moldb_formula>C5H7NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C5H7NO3/c7-4-2-1-3(6-4)5(8)9/h3H,1-2H2,(H,6,7)(H,8,9)/t3-/m0/s1</moldb_inchi>
		<moldb_inchikey>ODHCTXKNWHHXJC-VKHMYHEASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>129.1140</moldb_average_mass>
		<moldb_mono_mass>129.042593095</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>124</id>
		<lmdb_id>LMDB00124</lmdb_id>
		<created_at>2016-07-13 19:42:53</created_at>
		<updated_at>2016-07-20 20:50:55</updated_at>
		<export>1</export>
		<name>Sarcosine</name>
		<description>Sarcosine is the N-methyl derivative of glycine. Sarcosine is metabolized to glycine by the enzyme sarcosine dehydrogenase, while glycine-N-methyl transferase generates sarcosine from glycine. Sarcosine is a natural amino acid found in muscles and other body tissues. In the laboratory it may be synthesized from chloroacetic acid and methylamine. Sarcosine is naturally found in the metabolism of choline to glycine. Sarcosine is sweet to the taste and dissolves in water. It is used in manufacturing biodegradable surfactants and toothpastes as well as in other applications. Sarcosine is ubiquitous in biological materials and is present in such foods as egg yolks, turkey, ham, vegetables, legumes, etc. Sarcosine is formed from dietary intake of choline and from the metabolism of methionine, and is rapidly degraded to glycine. Sarcosine has no known toxicity, as evidenced by the lack of phenotypic manifestations of sarcosinemia, an inborn error of sarcosine metabolism. Sarcosinemia can result from severe folate deficiency because of the folate requirement for the conversion of sarcosine to glycine (Wikipedia). Sarcosine has recently been identified as a biomarker for invasive prostate cancer. It was found to be greatly increased during prostate cancer progression to metastasis and could be detected in urine. Sarcosine levels were also increased in invasive prostate cancer cell lines relative to benign prostate epithelial cells.(PMID: 19212411).</description>
		<cas>107-97-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CNCC(O)=O</moldb_smiles>
		<moldb_formula>C3H7NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C3H7NO2/c1-4-2-3(5)6/h4H,2H2,1H3,(H,5,6)</moldb_inchi>
		<moldb_inchikey>FSYKKLYZXJSNPZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>89.0932</moldb_average_mass>
		<moldb_mono_mass>89.047678473</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>125</id>
		<lmdb_id>LMDB00125</lmdb_id>
		<created_at>2016-07-13 19:42:54</created_at>
		<updated_at>2016-09-23 18:44:44</updated_at>
		<export>1</export>
		<name>Phosphoserine</name>
		<description>The phosphoric acid ester of serine. As a constituent (residue) of proteins, its side chain can undergo O-linked glycosylation. This might be important in explaining some of the devastating consequences of diabetes. It is one of three amino acid residues that are commonly phosphorylated by kinases during cell signalling in eukaryotes. Phosphorylated serine residues are often referred to as phosphoserine. Serine proteases are a common type of protease. Serine, organic compound, one of the 20 amino acids commonly found in animal proteins. Only the L-stereoisomer appears in mammalian protein. It is not essential to the animal diet, since it can be synthesized in the body from other metabolites, including glycine. Serine was first obtained from silk protein, a particularly rich source, in 1865. Its name is derived from the Latin for silk, sericum. Serine's structure was established in 1902.</description>
		<cas>407-41-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](COP(O)(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C3H8NO6P</moldb_formula>
		<moldb_inchi>InChI=1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/t2-/m0/s1</moldb_inchi>
		<moldb_inchikey>BZQFBWGGLXLEPQ-REOHCLBHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>185.0725</moldb_average_mass>
		<moldb_mono_mass>185.008923505</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>126</id>
		<lmdb_id>LMDB00126</lmdb_id>
		<created_at>2016-07-13 19:42:56</created_at>
		<updated_at>2016-07-20 20:50:56</updated_at>
		<export>1</export>
		<name>D-Ribose</name>
		<description>D-ribose is commonly referred to simply as ribose, a five-carbon sugar found in all living cells. Ribose is not an essential nutrient because it can be synthesized by almost every tissue in the body from other substances, such as glucose. It is vital for life as a component of DNA, RNA, ATP, ADP, and AMP. In nature, small amounts of ribose can be found in ripe fruits and vegetables. Brewer's yeast, which has a high concentration of RNA, is another rich source of ribose. D-ribose is also a component of many so-called energy drinks and antiaging products available on the market today. Ribose is a structural component of ATP, which is the primary energy source for exercising muscle. The adenosine component is an adenine base attached to the five-carbon sugar ribose. ATP provides energy to working muscles by releasing a phosphate group, hence becoming ADP, which in turn may release a phosphate group, then becoming AMP. During intense muscular activity, the total amount of ATP available is quickly depleted. In an effort to correct this imbalance, AMP is broken down in the muscle and secreted from the cell. Once the breakdown products of AMP are released from the cell, the energy potential (TAN pool) of the muscle is reduced and ATP must then be reformed using ribose. Ribose helps restore the level of adenine nucleotides by bypassing the rate-limiting step in the de novo (oxidative pentose phosphate) pathway, which regenerates 5-phosphoribosyl-l-pyrophosphate (PRPP), the essential precursor for ATP. If ribose is not readily available to a cell, glucose may be converted to ribose. Ribose supplementation has been shown to increase the rate of ATP resynthesis following intense exercise. The use of ribose in men with severe coronary artery disease resulted in improved exercise tolerance. Hence, there is interest in the potential of ribose supplements to boost muscular performance in athletic activities. (PMID: 17618002, Curr Sports Med Rep. 2007 Jul;6(4):254-7.).</description>
		<cas>50-69-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1OC(O)[C@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C5H10O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O5/c6-1-2-3(7)4(8)5(9)10-2/h2-9H,1H2/t2-,3-,4-,5?/m1/s1</moldb_inchi>
		<moldb_inchikey>HMFHBZSHGGEWLO-SOOFDHNKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>150.1299</moldb_average_mass>
		<moldb_mono_mass>150.052823430</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>127</id>
		<lmdb_id>LMDB00127</lmdb_id>
		<created_at>2016-07-13 19:42:57</created_at>
		<updated_at>2016-07-20 20:56:43</updated_at>
		<export>1</export>
		<name>Uridine 5'-monophosphate</name>
		<description>5'-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position. Uridine 5'-monophosphate is a nucleotide that is found in RNA. It is an ester of phosphoric acid with the nucleoside uridine. UMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase uracil. (Wikipedia).</description>
		<cas>58-97-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O</moldb_smiles>
		<moldb_formula>C9H13N2O9P</moldb_formula>
		<moldb_inchi>InChI=1S/C9H13N2O9P/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1</moldb_inchi>
		<moldb_inchikey>DJJCXFVJDGTHFX-XVFCMESISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>324.1813</moldb_average_mass>
		<moldb_mono_mass>324.035866536</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>128</id>
		<lmdb_id>LMDB00128</lmdb_id>
		<created_at>2016-07-13 19:42:58</created_at>
		<updated_at>2016-09-23 18:44:44</updated_at>
		<export>1</export>
		<name>Uric acid</name>
		<description>Uric acid is a heterocyclic purine derivative that is the final oxidation product of purine metabolism. It is produced by the enzyme xanthine oxidase, which oxidizes oxypurines such as xanthine into uric acid. In most mammals, except animals and higher primates, the enzyme uricase further oxidizes uric acid to allantoin. Uric acid is also the end product of nitrogen metabolism in birds and reptiles. In such species, it is excreted in feces as a dry mass. Humans produce only small quantities of uric acid with excess accumulation leading to a type of arthritis known as gout. The loss of uricase in higher primates parallels the similar loss of the ability to synthesize ascorbic acid vitamin C. This may be because in higher primates uric acid partially replaces ascorbic acid.</description>
		<cas>69-93-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O=C1NC2=C(N1)C(=O)NC(=O)N2</moldb_smiles>
		<moldb_formula>C5H4N4O3</moldb_formula>
		<moldb_inchi>InChI=1S/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H4,6,7,8,9,10,11,12)</moldb_inchi>
		<moldb_inchikey>LEHOTFFKMJEONL-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>168.1103</moldb_average_mass>
		<moldb_mono_mass>168.028340014</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>129</id>
		<lmdb_id>LMDB00129</lmdb_id>
		<created_at>2016-07-13 19:43:00</created_at>
		<updated_at>2016-07-20 21:03:27</updated_at>
		<export>1</export>
		<name>Vanillylmandelic acid</name>
		<description>Vanillylmandelic acid is one of the products of the catabolism of catecholamines (epinephrine, norepinephrine and dopamine). High levels of vanillylmandelic acid can indicate an adrenal gland tumor (pheochromocytoma) or another type of tumor that produces catecholamines. (WebMD).</description>
		<cas>55-10-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>COC1=C(O)C=CC(=C1)[C@H](O)C(O)=O</moldb_smiles>
		<moldb_formula>C9H10O5</moldb_formula>
		<moldb_inchi>InChI=1S/C9H10O5/c1-14-7-4-5(2-3-6(7)10)8(11)9(12)13/h2-4,8,10-11H,1H3,(H,12,13)/t8-/m0/s1</moldb_inchi>
		<moldb_inchikey>CGQCWMIAEPEHNQ-QMMMGPOBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>198.1727</moldb_average_mass>
		<moldb_mono_mass>198.052823430</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>130</id>
		<lmdb_id>LMDB00130</lmdb_id>
		<created_at>2016-07-13 19:43:01</created_at>
		<updated_at>2016-07-20 20:51:00</updated_at>
		<export>1</export>
		<name>Xanthine</name>
		<description>Xanthine is a purine base found in most body tissues and fluids, certain plants, and some urinary calculi. It is an intermediate in the degradation of adenosine monophosphate to uric acid, being formed by oxidation of hypoxanthine. The methylated xanthine compounds caffeine, theobromine, and theophylline and their derivatives are used in medicine for their bronchodilator effects. (Dorland, 28th ed.).</description>
		<cas>69-89-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O=C1NC2=C(NC=N2)C(=O)N1</moldb_smiles>
		<moldb_formula>C5H4N4O2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H4N4O2/c10-4-2-3(7-1-6-2)8-5(11)9-4/h1H,(H3,6,7,8,9,10,11)</moldb_inchi>
		<moldb_inchikey>LRFVTYWOQMYALW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>152.1109</moldb_average_mass>
		<moldb_mono_mass>152.033425392</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>131</id>
		<lmdb_id>LMDB00131</lmdb_id>
		<created_at>2016-07-13 19:43:02</created_at>
		<updated_at>2016-09-23 18:44:44</updated_at>
		<export>1</export>
		<name>Urea</name>
		<description>Urea is a highly soluble organic compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Urea is formed in a cyclic pathway known simply as the urea cycle. In this cycle, amino groups donated by ammonia and L-aspartate are converted to urea. Urea is essentially a waste product; it has no physiological function. It is dissolved in blood (in animals in a concentration of 2.5 - 7.5 mmol/liter) and excreted by the kidney in the urine. In addition, a small amount of urea is excreted (along with sodium chloride and water) in animal sweat.</description>
		<cas>57-13-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(N)=O</moldb_smiles>
		<moldb_formula>CH4N2O</moldb_formula>
		<moldb_inchi>InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4)</moldb_inchi>
		<moldb_inchikey>XSQUKJJJFZCRTK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>60.0553</moldb_average_mass>
		<moldb_mono_mass>60.032362760</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>132</id>
		<lmdb_id>LMDB00132</lmdb_id>
		<created_at>2016-07-13 19:43:03</created_at>
		<updated_at>2016-07-20 21:03:28</updated_at>
		<export>1</export>
		<name>Uridine</name>
		<description>Uridine is a molecule (known as a nucleoside) that is formed when uracil is attached to a ribose ring (also known as a ribofuranose) via a b-N1-glycosidic bond. (Wikipedia).</description>
		<cas>58-96-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O</moldb_smiles>
		<moldb_formula>C9H12N2O6</moldb_formula>
		<moldb_inchi>InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7-,8-/m1/s1</moldb_inchi>
		<moldb_inchikey>DRTQHJPVMGBUCF-XVFCMESISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>244.2014</moldb_average_mass>
		<moldb_mono_mass>244.069536126</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>133</id>
		<lmdb_id>LMDB00133</lmdb_id>
		<created_at>2016-07-13 19:43:05</created_at>
		<updated_at>2016-08-01 19:10:41</updated_at>
		<export>1</export>
		<name>Uracil</name>
		<description>Uracil is a common naturally occurring pyrimidine found in RNA, it base pairs with adenine and is replaced by thymine in DNA. Methylation of uracil produces thymine. Uracil's use in the body is to help carry out the synthesis of many enzymes necessary for cell function through bonding with riboses and phosphates. Uracil serves as allosteric regulator and coenzyme for many important biochemical reactions. UDP and UTP regulate CPSase II activity in animals. UDP-glucose regulates the conversion of glucose to galactose in the liver and other tissues in the process of carbohydrate metabolism. Uracil is also involved in the biosynthesis of polysaccharides and the transportation of sugars containing aldehydes.</description>
		<cas>66-22-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O=C1NC=CC(=O)N1</moldb_smiles>
		<moldb_formula>C4H4N2O2</moldb_formula>
		<moldb_inchi>InChI=1S/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8)</moldb_inchi>
		<moldb_inchikey>ISAKRJDGNUQOIC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>112.0868</moldb_average_mass>
		<moldb_mono_mass>112.027277382</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>134</id>
		<lmdb_id>LMDB00134</lmdb_id>
		<created_at>2016-07-13 19:43:06</created_at>
		<updated_at>2016-07-19 23:17:01</updated_at>
		<export>1</export>
		<name>Tryptamine</name>
		<description>Tryptamine is a monoamine compound that is common precursor molecule to many hormones and neurotransmitters. Biosynthesis generally proceeds from the amino acid tryptophan, with tryptamine in turn acting as a precursor for other compounds. Substitutions to the tryptamine molecule give rise to a group of compounds collectively known as tryptamines. The most well-known tryptamines are serotonin, an important neurotransmitter, and melatonin, a hormone involved in regulating the sleep-wake cycle.</description>
		<cas>61-54-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCC1=CNC2=CC=CC=C12</moldb_smiles>
		<moldb_formula>C10H12N2</moldb_formula>
		<moldb_inchi>InChI=1S/C10H12N2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6,11H2</moldb_inchi>
		<moldb_inchikey>APJYDQYYACXCRM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>160.2157</moldb_average_mass>
		<moldb_mono_mass>160.100048394</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>135</id>
		<lmdb_id>LMDB00135</lmdb_id>
		<created_at>2016-07-13 19:43:07</created_at>
		<updated_at>2016-07-20 20:26:54</updated_at>
		<export>1</export>
		<name>Vitamin A</name>
		<description>Vitamin A (retinol) is a yellow fat-soluble, antioxidant vitamin important in vision and bone growth. It belongs to the family of chemical compounds known as retinoids. Retinol is ingested in a precursor form; animal sources (milk and eggs) contain retinyl esters, whereas plants (carrots, spinach) contain pro-vitamin A carotenoids. Hydrolysis of retinyl esters results in retinol while pro-vitamin A carotenoids can be cleaved to produce retinal. Retinal, also known as retinaldehyde, can be reversibly reduced to produce retinol or it can be irreversibly oxidized to produce retinoic acid. Retinol and derivatives of retinol that play an essential role in metabolic functioning of the retina, the growth of and differentiation of epithelial tissue, the growth of bone, reproduction, and the immune response. Dietary vitamin A is derived from a variety of carotenoids found in plants. It is enriched in the liver, egg yolks, and the fat component of dairy products.</description>
		<cas>68-26-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C</moldb_smiles>
		<moldb_formula>C20H30O</moldb_formula>
		<moldb_inchi>InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+</moldb_inchi>
		<moldb_inchikey>FPIPGXGPPPQFEQ-OVSJKPMPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>286.4516</moldb_average_mass>
		<moldb_mono_mass>286.229665582</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>136</id>
		<lmdb_id>LMDB00136</lmdb_id>
		<created_at>2016-07-13 19:43:09</created_at>
		<updated_at>2016-07-20 20:26:56</updated_at>
		<export>1</export>
		<name>Tyramine</name>
		<description>Tyramine is a monoamine compound derived from the amino acid tyrosine. Tyramine is metabolized by the enzyme monoamine oxidase. In foods, it is often produced by the decarboxylation of tyrosine during fermentation or decay. Foods containing considerable amounts of tyramine include fish, chocolate, alcoholic beverages, cheese, soy sauce, sauerkraut, and processed meat. A large dietary intake of tyramine can cause an increase in systolic blood pressure of 30 mmHg or more. Tyramine acts as a neurotransmitter via a G protein-coupled receptor with high affinity for tyramine called TA1. The TA1 receptor is found in the brain as well as peripheral tissues including the kidney. An indirect sympathomimetic, Tyramine can also serve as a substrate for adrenergic uptake systems and monoamine oxidase so it prolongs the actions of adrenergic transmitters. It also provokes transmitter release from adrenergic terminals.</description>
		<cas>51-67-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCC1=CC=C(O)C=C1</moldb_smiles>
		<moldb_formula>C8H11NO</moldb_formula>
		<moldb_inchi>InChI=1S/C8H11NO/c9-6-5-7-1-3-8(10)4-2-7/h1-4,10H,5-6,9H2</moldb_inchi>
		<moldb_inchikey>DZGWFCGJZKJUFP-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>137.1790</moldb_average_mass>
		<moldb_mono_mass>137.084063979</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>137</id>
		<lmdb_id>LMDB00137</lmdb_id>
		<created_at>2016-07-13 19:43:10</created_at>
		<updated_at>2016-07-20 20:56:51</updated_at>
		<export>1</export>
		<name>3-Amino-2-piperidone</name>
		<description>3-Amino-2-piperidone is a delta-lactam of ornithine. It is found in the urine of patients with hyperornithinemia (PMID 679477), due to Ornithine keto acid aminotransferase (EC 2.6.1.13) deficiency (OMIM 258870).</description>
		<cas>1892-22-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1CCCNC1=O</moldb_smiles>
		<moldb_formula>C5H10N2O</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10N2O/c6-4-2-1-3-7-5(4)8/h4H,1-3,6H2,(H,7,8)</moldb_inchi>
		<moldb_inchikey>YCCMTCQQDULIFE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>114.1457</moldb_average_mass>
		<moldb_mono_mass>114.079312952</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>138</id>
		<lmdb_id>LMDB00138</lmdb_id>
		<created_at>2016-07-13 19:43:11</created_at>
		<updated_at>2016-07-19 23:06:27</updated_at>
		<export>1</export>
		<name>16a-Hydroxyestrone</name>
		<description>Estrone (also oestrone) is an estrogenic hormone secreted by the ovary. Its molecular formula is C18H22O2. estrone has a melting point of 254.5 degrees Celsius. estrone is one of the three estrogens, which also include estriol and estradiol. estrone is the least prevalent of the three hormones, estradiol being prevalent almost always in a female body, estriol being prevalent primarily during pregnancy. estrone sulfate is relevant to health and disease due to its conversion to estrone sulfate, a long-lived derivative of estrone. estrone sulfate acts as a pool of estrone which can be converted as needed to the more active estradiol.</description>
		<cas>566-76-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12C[C@@H](O)C(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3</moldb_smiles>
		<moldb_formula>C18H22O3</moldb_formula>
		<moldb_inchi>InChI=1S/C18H22O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-16(20)17(18)21/h3,5,8,13-16,19-20H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,18+/m1/s1</moldb_inchi>
		<moldb_inchikey>WPOCIZJTELRQMF-QFXBJFAPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>286.3655</moldb_average_mass>
		<moldb_mono_mass>286.156894570</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>139</id>
		<lmdb_id>LMDB00139</lmdb_id>
		<created_at>2016-07-13 19:43:13</created_at>
		<updated_at>2016-09-23 18:44:45</updated_at>
		<export>1</export>
		<name>(S)-3,4-Dihydroxybutyric acid</name>
		<description>3,4-Dihydroxybutyric acid is a normal animal urinary metabolite that is excreted in increased concentration in patients with succinic semialdehyde dehydrogenase (SSADH) deficiency. (PMID 12127325) Normal adults excrete 0.37 +/- 0.15 (SD) mmoles of 3,4-dihydroxybutyrate per 24 hr. The compound is also detectable in blood. The renal clearance of this compound is roughly equal that of creatinine.</description>
		<cas>51267-44-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC(O)CC(O)=O</moldb_smiles>
		<moldb_formula>C4H8O4</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8O4/c5-2-3(6)1-4(7)8/h3,5-6H,1-2H2,(H,7,8)</moldb_inchi>
		<moldb_inchikey>DZAIOXUZHHTJKN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>120.1039</moldb_average_mass>
		<moldb_mono_mass>120.042258744</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>140</id>
		<lmdb_id>LMDB00140</lmdb_id>
		<created_at>2016-07-13 19:43:14</created_at>
		<updated_at>2016-07-19 23:06:37</updated_at>
		<export>1</export>
		<name>2-Hydroxyestrone</name>
		<description>Estrone (also oestrone) is an estrogenic hormone secreted by the ovary. Its molecular formula is C18H22O2. estrone has a melting point of 254.5 degrees Celsius. estrone is one of the three estrogens, which also include estriol and estradiol. estrone is the least prevalent of the three hormones, estradiol being prevalent almost always in a female body, estriol being prevalent primarily during pregnancy. estrone sulfate is relevant to health and disease due to its conversion to estrone sulfate, a long-lived derivative of estrone. estrone sulfate acts as a pool of estrone which can be converted as needed to the more active estradiol.</description>
		<cas>362-06-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(O)=C3</moldb_smiles>
		<moldb_formula>C18H22O3</moldb_formula>
		<moldb_inchi>InChI=1S/C18H22O3/c1-18-7-6-11-12(14(18)4-5-17(18)21)3-2-10-8-15(19)16(20)9-13(10)11/h8-9,11-12,14,19-20H,2-7H2,1H3/t11-,12+,14-,18-/m0/s1</moldb_inchi>
		<moldb_inchikey>SWINWPBPEKHUOD-JPVZDGGYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>286.3655</moldb_average_mass>
		<moldb_mono_mass>286.156894570</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>141</id>
		<lmdb_id>LMDB00141</lmdb_id>
		<created_at>2016-07-13 19:43:15</created_at>
		<updated_at>2016-07-20 20:56:53</updated_at>
		<export>1</export>
		<name>Erythrono-1,4-lactone</name>
		<description>Erythrono-1,4-lactone has been identified as a lactone of tetronic acid in the urine from normal adults and neonates. The formation of this compound may be a consequence of lactonization of erythronic acid during the extraction/isolation process. Lactonization is a potential problem when measuring acids that contain a hydroxyl group at the number 4 carbon, as lactones are formed under acidic conditions. Evidence indicates that most 4-hydroxy acids do not normally exist to any appreciable extent as lactones in urine. (PMID 1192581).</description>
		<cas>17675-99-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@@H]1COC(=O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C4H6O4</moldb_formula>
		<moldb_inchi>InChI=1S/C4H6O4/c5-2-1-8-4(7)3(2)6/h2-3,5-6H,1H2/t2-,3-/m1/s1</moldb_inchi>
		<moldb_inchikey>SGMJBNSHAZVGMC-PWNYCUMCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>118.0880</moldb_average_mass>
		<moldb_mono_mass>118.026608680</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>142</id>
		<lmdb_id>LMDB00142</lmdb_id>
		<created_at>2016-07-13 19:43:17</created_at>
		<updated_at>2016-07-20 20:56:53</updated_at>
		<export>1</export>
		<name>2-Methyl-3-hydroxybutyric acid</name>
		<description>3-Hydroxy-2-methyl-butanoic acid (HMBA) is a normal urinary metabolite involved in the isoleucine catabolism, as well as presumably beta-oxidation of fatty acids and ketogenesis, excreted in abnormally high amounts in beta-ketothiolase deficiency. Differences in the enantiomeric ratio of HMBA may originate from the enantioselectivity of different enzyme systems (PMID 10755375).</description>
		<cas>473-86-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(O)C(C)C(O)=O</moldb_smiles>
		<moldb_formula>C5H10O3</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O3/c1-3(4(2)6)5(7)8/h3-4,6H,1-2H3,(H,7,8)</moldb_inchi>
		<moldb_inchikey>VEXDRERIMPLZLU-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>118.1311</moldb_average_mass>
		<moldb_mono_mass>118.062994186</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>143</id>
		<lmdb_id>LMDB00143</lmdb_id>
		<created_at>2016-07-13 19:43:18</created_at>
		<updated_at>2016-08-06 20:09:00</updated_at>
		<export>1</export>
		<name>3-Hydroxymethylglutaric acid</name>
		<description>3-Hydroxymethylglutaric acid is a metabolite that accumulates in the urine of patients affected by 3-Hydroxy-3-methylglutaric aciduria, a rare inborn error of metabolism (OMIM 246450). 3-Hydroxy-3-methylglutaric aciduria is caused by reduced enzyme activity of the intramitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase (EC 4.1.3.4), the enzyme that catalyzes the final step of leucine degradation and plays a key role in ketone body formation. The profile of urinary organic acids is different from that of the other identified defects of leucine degradation--maple syrup urine disease (OMIM 248600), isovaleric acidemia (OMIM 243500), and methylcrotonylglycinemia (OMIM 210200). Clinical manifestations include hepatomegaly, lethargy or coma and apnoea. Biochemically there is a characteristic absence of ketosis with hypoglycemia, acidosis, hipertransaminasemia and variable hyperammoniemia. The urinary organic acid profile includes elevated concentrations of 3-hydroxy-3-isovaleric, 3-hydroxy-3-methylglutaric, 3-methylglutaconic and 3-methylglutaric acids. (PMID: 10916782, 9658458, 3063529).</description>
		<cas>503-49-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(O)(CC(O)=O)CC(O)=O</moldb_smiles>
		<moldb_formula>C6H10O5</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O5/c1-6(11,2-4(7)8)3-5(9)10/h11H,2-3H2,1H3,(H,7,8)(H,9,10)</moldb_inchi>
		<moldb_inchikey>NPOAOTPXWNWTSH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>162.1406</moldb_average_mass>
		<moldb_mono_mass>162.052823430</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>144</id>
		<lmdb_id>LMDB00144</lmdb_id>
		<created_at>2016-07-13 19:43:19</created_at>
		<updated_at>2016-09-23 18:44:45</updated_at>
		<export>1</export>
		<name>3-Hydroxybutyric acid</name>
		<description>3-Hydroxybutyric acid (or beta-hydroxybutyrate) is a ketone body. Like the other ketone bodies (acetoacetate and acetone), levels of 3-hydroxybutyrate in blood and urine are raised in ketosis. In animals, 3-hydroxybutyrate is synthesized in the liver from acetyl-CoA, and can be used as an energy source by the brain when blood glucose is low. Blood levels of 3-Hydroxybutyric acid levels may be monitored in diabetic patients to look for diabetic ketoacidosis. Persistent mild hyperketonemia is a common finding in newborns. Ketone bodies serve as an indispensable source of energy for extrahepatic tissues, especially the brain and lung of developing mammals. Another important function of ketone bodies is to provide acetoacetyl-CoA and acetyl-CoA for synthesis of cholesterol, fatty acids, and complex lipids. During the early postnatal period, acetoacetate (AcAc) and beta-hydroxybutyrate are preferred over glucose as substrates for synthesis of phospholipids and sphingolipids in accord with requirements for brain growth and myelination. Thus, during the first 2 weeks of postnatal development, when the accumulation of cholesterol and phospholipids accelerates, the proportion of ketone bodies incorporated into these lipids increases. On the other hand, an increased proportion of ketone bodies is utilized for cerebroside synthesis during the period of active myelination. In the lung, AcAc serves better than glucose as a precursor for the synthesis of lung phospholipids. The synthesized lipids, particularly dipalmityl phosphatidylcholine, are incorporated into surfactant, and thus have a potential role in supplying adequate surfactant lipids to maintain lung function during the early days of life. (PMID 3884391).</description>
		<cas>300-85-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(O)CC(O)=O</moldb_smiles>
		<moldb_formula>C4H8O3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)</moldb_inchi>
		<moldb_inchikey>WHBMMWSBFZVSSR-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>104.1045</moldb_average_mass>
		<moldb_mono_mass>104.047344122</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>145</id>
		<lmdb_id>LMDB00145</lmdb_id>
		<created_at>2016-07-13 19:43:20</created_at>
		<updated_at>2016-07-20 20:56:56</updated_at>
		<export>1</export>
		<name>2-Phosphoglyceric acid</name>
		<description>2-Phosphoglyceric acid (2PGA) is a glyceric acid which serves as the substrate in the ninth step of glycolysis. It is catalyzed by enolase into phosphoenolpyruvate (PEP), the penultimate step in the conversion of glucose to pyruvate. Enolase catalyzes the beta-elimination reaction in a stepwise manner wherein OH- is eliminated from C3 of a discrete carbanion (enolate) intermediate. This intermediate is created by removal of the proton from C2 of 2PGA by a base in the active site. (PMID: 8994873, Wikipedia).</description>
		<cas>2553-59-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC(OP(O)(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C3H7O7P</moldb_formula>
		<moldb_inchi>InChI=1S/C3H7O7P/c4-1-2(3(5)6)10-11(7,8)9/h2,4H,1H2,(H,5,6)(H2,7,8,9)</moldb_inchi>
		<moldb_inchikey>GXIURPTVHJPJLF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>186.0572</moldb_average_mass>
		<moldb_mono_mass>185.992939090</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>146</id>
		<lmdb_id>LMDB00146</lmdb_id>
		<created_at>2016-07-13 19:43:22</created_at>
		<updated_at>2016-07-19 23:06:30</updated_at>
		<export>1</export>
		<name>17a-Hydroxypregnenolone</name>
		<description>17a-Hydroxypregnenolone is a 21-carbon steroid that is converted from pregnenolone by cytochrome P450 17alpha hydroxylase/C17,20 lyase (CYP17, EC 1.14.99.9). 17a-Hydroxypregnenolone is an intermediate in the delta-5 pathway of biosynthesis of gonadal steroid hormones and the adrenal corticosteroids. The first, rate-limiting and hormonally regulated step in the biosynthesis of all steroid hormones is the conversion of cholesterol to pregnenolone. The conversion of cholesterol to pregnenolone is accomplished by the cleavage of the cholesterol side chain, catalyzed by a mitochondrial cytochrome P450 enzyme termed P450scc where scc designates Side Chain Cleavage. All steroid hormones are made from the pregnenolone produced by P450scc; thus, the presence or absence of each of the activities of CYP17 directs this pregnenolone towards its final metabolic pathway. While all cytochrome P450 enzymes can catalyze multiple reactions on a single active site, CYP17 is the only one described to date in which these multiple activities are differentially regulated by a physiologic process. 17a-Hydroxypregnenolone is converted to dehydroepiandrosterone by the 17,20 lyase activity of CYP17. The ratio of the 17,20 lyase to 17 alpha-hydroxylase activity of CYP17 determines the ratio of C21 to C19 steroids produced. This ratio is regulated post-translationally by at least three factors: the abundance of the electron-donating protein P450 oxidoreductase, the presence of cytochrome b5, and the serine phosphorylation of CYP17. (PMID: 12573809).</description>
		<cas>387-79-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C21H32O3</moldb_formula>
		<moldb_inchi>InChI=1S/C21H32O3/c1-13(22)21(24)11-8-18-16-5-4-14-12-15(23)6-9-19(14,2)17(16)7-10-20(18,21)3/h4,15-18,23-24H,5-12H2,1-3H3/t15-,16+,17-,18-,19-,20-,21-/m0/s1</moldb_inchi>
		<moldb_inchikey>JERGUCIJOXJXHF-TVWVXWENSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>332.4770</moldb_average_mass>
		<moldb_mono_mass>332.235144890</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>147</id>
		<lmdb_id>LMDB00147</lmdb_id>
		<created_at>2016-07-13 19:43:23</created_at>
		<updated_at>2016-07-19 23:06:32</updated_at>
		<export>1</export>
		<name>17-Hydroxyprogesterone</name>
		<description>It serves as an intermediate in the biosynthesis of hydrocortisone and gonadal steroid hormones. It is derived from progesterone via 17-hydroxylase, a P450c17 enzyme, or from 17-hydroxypregnenolone via 3&amp;#946;-hydroxysteroid dehydrogenase/&amp;#916;5-4 isomerase. 17-Hydroxyprogesterone is a natural progestin and in pregnancy increases in the third trimester primarily due to fetal adrenal production. This hormone is primarily produced in the adrenal glands and to some degree in the gonads, specifically the corpus luteum of the ovary. Normal levels are 3-90 ng/dl in children, and in women, 15-70 ng/dl prior to ovulation, and 35-290 ng/dl during the luteal phase. Measurements of levels of 17-hydroxyprogesterone are useful in the evaluation of patients with suspected congenital adrenal hyperplasia as the typical enzymes that are defective, namely 21-hydroxylase and 11&amp;#946;-hydroxylase, lead to a build-up of 17OHP. In contrast, the rare patient with 17&amp;#945;-hydroxylase deficiency will have very low or undetectable levels of 17OHP. 17OHP levels can also be used to measure contribution of progestational activity of the corpus luteum during pregnancy as progesterone but not 17OHP is also contributed by the placenta.</description>
		<cas>68-96-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C21H30O3</moldb_formula>
		<moldb_inchi>InChI=1S/C21H30O3/c1-13(22)21(24)11-8-18-16-5-4-14-12-15(23)6-9-19(14,2)17(16)7-10-20(18,21)3/h12,16-18,24H,4-11H2,1-3H3/t16-,17+,18+,19+,20+,21+/m1/s1</moldb_inchi>
		<moldb_inchikey>DBPWSSGDRRHUNT-CEGNMAFCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>330.4611</moldb_average_mass>
		<moldb_mono_mass>330.219494826</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>148</id>
		<lmdb_id>LMDB00148</lmdb_id>
		<created_at>2016-07-13 19:43:24</created_at>
		<updated_at>2016-07-20 20:56:57</updated_at>
		<export>1</export>
		<name>3-(3-Hydroxyphenyl)propanoic acid</name>
		<description>3-(3-Hydroxyphenyl)propanoic (hMPP) acid is one of the major metabolites of ingested caffeic acid (PMID 15479001) and of the phenolic degradation products of proanthocyanidins (the most abundant polyphenol present in chocolate) by the microflora in the colon (PMID 12663291). mHPP is suspected to have antioxidants properties and is actively absorbed by the monocarboxylic acid transporter (MCT) in intestinal Caco-2 cell monolayers (PMID 15479001, 12663291).</description>
		<cas>621-54-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CCC1=CC=CC(O)=C1</moldb_smiles>
		<moldb_formula>C9H10O3</moldb_formula>
		<moldb_inchi>InChI=1S/C9H10O3/c10-8-3-1-2-7(6-8)4-5-9(11)12/h1-3,6,10H,4-5H2,(H,11,12)</moldb_inchi>
		<moldb_inchikey>QVWAEZJXDYOKEH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>166.1739</moldb_average_mass>
		<moldb_mono_mass>166.062994186</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>149</id>
		<lmdb_id>LMDB00149</lmdb_id>
		<created_at>2016-07-13 19:43:26</created_at>
		<updated_at>2016-09-23 18:44:46</updated_at>
		<export>1</export>
		<name>2-Methylcitric acid</name>
		<description>Methylcitric acid (MCA) is elevated in body fluids of patients with propionic acidaemia (PA; OMIM 232000, 232050), methylmalonic aciduria (MMA; OMIM 251000, 251120) and multiple carboxylase deficiency (OMIM 253260, 253270). MCA is formed by condensation of accumulated propionyl- CoA and oxalacetate by the enzyme si-citrate synthase (EC 4.1.3.7). MCA molecule has two stereogenic centers so that it can occur in the form of four stereoisomers. Only two stereoisomers of MCA, (2S, 3S) and (2R, 3S), were found in animal urine. (PMID: 17295121).</description>
		<cas>6061-96-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C(O)=O)C(O)(CC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C7H10O7</moldb_formula>
		<moldb_inchi>InChI=1S/C7H10O7/c1-3(5(10)11)7(14,6(12)13)2-4(8)9/h3,14H,2H2,1H3,(H,8,9)(H,10,11)(H,12,13)</moldb_inchi>
		<moldb_inchikey>YNOXCRMFGMSKIJ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>206.1501</moldb_average_mass>
		<moldb_mono_mass>206.042652674</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>150</id>
		<lmdb_id>LMDB00150</lmdb_id>
		<created_at>2016-07-13 19:43:27</created_at>
		<updated_at>2016-09-23 18:44:46</updated_at>
		<export>1</export>
		<name>2-Pyrocatechuic acid</name>
		<description>2-Pyrocatechuic acid is a normal animal benzoic acid metabolite found in plasma (PMID 16351159), and is normally found with increased levels after consumption of many nutrients and drugs, i.e.: cranberry juice (PMID 14733499), aspirin ingestion. (PMID 3342084) It has been found associated with idiopathic oro-facial pain due to stress (oxidative stress might enhance the production of free radicals); it has been suggested that OH radicals are responsible for the production of many systemic and local tissue injury diseases which may initially manifest as pain syndrome, and 2-Pyrocatechuic acid is a biological marker for the detection and quantification of OH radicals, and patients had significantly increased circulating levels of 2-Pyrocatechuic acid after aspirin ingestion than control subjects. (PMID 7748148).</description>
		<cas>303-38-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C1=C(O)C(O)=CC=C1</moldb_smiles>
		<moldb_formula>C7H6O4</moldb_formula>
		<moldb_inchi>InChI=1S/C7H6O4/c8-5-3-1-2-4(6(5)9)7(10)11/h1-3,8-9H,(H,10,11)</moldb_inchi>
		<moldb_inchikey>GLDQAMYCGOIJDV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>154.1210</moldb_average_mass>
		<moldb_mono_mass>154.026608673</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>151</id>
		<lmdb_id>LMDB00151</lmdb_id>
		<created_at>2016-07-13 19:43:28</created_at>
		<updated_at>2016-07-20 21:03:29</updated_at>
		<export>1</export>
		<name>2-Hydroxy-3-methylbutyric acid</name>
		<description>2-Hydroxy-3-methylbutyric acid (also known as 2-Hydroxyisovaleric acid) is a metabolite found in the urine of patients with Phenylketonuria (PMID 7978272), Methylmalonic acidemia, Propionic acidemia, 3-Ketothiolase deficiency, Isovaleric acidemia, 3-Methylcrotonylglycemia, 3-Hydroxy-3-methylglutaric acidemia, Multiple carboxylase deficiency, Glutaric aciduria, Ornithine transcarbamylase deficiency, glyceroluria, Tyrosinemia type 1, Galactosemia, and Maple syrup urine disease (PMID 11048741). 2-hydroxyisovaleric acid has been identified in the urine of patients with lactic and ketoacidosis (PMID: 884872). It has also been identified in the urine of severely asphyxiated babies (PMID: 1610944). 2-hydroxyisovaleric acid originates mainly from ketogenesis and from the metabolism of valine, leucine and isoleucine (PMID: 6434570).</description>
		<cas>4026-18-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)C(O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H10O3</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O3/c1-3(2)4(6)5(7)8/h3-4,6H,1-2H3,(H,7,8)</moldb_inchi>
		<moldb_inchikey>NGEWQZIDQIYUNV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>118.1311</moldb_average_mass>
		<moldb_mono_mass>118.062994186</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>152</id>
		<lmdb_id>LMDB00152</lmdb_id>
		<created_at>2016-07-13 19:43:30</created_at>
		<updated_at>2016-09-23 18:44:47</updated_at>
		<export>1</export>
		<name>2-Methylglutaric acid</name>
		<description>2-Methylglutaric acid is an organic acid normally found in animal urine, in healthy adults and children. 2-Methylglutaric acid is a metabolite of succinic acid, a citric acid cycle intermediate. (PMID: 2925825, 8087979, 16379391, 1688138).</description>
		<cas>617-62-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(CCC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H10O4</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O4/c1-4(6(9)10)2-3-5(7)8/h4H,2-3H2,1H3,(H,7,8)(H,9,10)</moldb_inchi>
		<moldb_inchikey>AQYCMVICBNBXNA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>146.1412</moldb_average_mass>
		<moldb_mono_mass>146.057908808</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>153</id>
		<lmdb_id>LMDB00153</lmdb_id>
		<created_at>2016-07-13 19:43:31</created_at>
		<updated_at>2016-07-20 20:57:00</updated_at>
		<export>1</export>
		<name>Citramalic acid</name>
		<description>Citramalic acid is an analog of malic acid. The structure is citramalic acid is similar to the structure of malic acid except it has an extra CH3 group on it. It can inhibit the production of malic acid.</description>
		<cas>597-44-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(O)(CC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H8O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H8O5/c1-5(10,4(8)9)2-3(6)7/h10H,2H2,1H3,(H,6,7)(H,8,9)</moldb_inchi>
		<moldb_inchikey>XFTRTWQBIOMVPK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>148.1140</moldb_average_mass>
		<moldb_mono_mass>148.037173366</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>154</id>
		<lmdb_id>LMDB00154</lmdb_id>
		<created_at>2016-07-13 19:43:33</created_at>
		<updated_at>2016-09-23 18:44:48</updated_at>
		<export>1</export>
		<name>24,25-Dihydroxyvitamin D</name>
		<description>24,25-Dihydroxyvitamin D (24R,25(OH)2D3) circulates in blood at concentrations about 1000 times higher than 1alpha,25(OH)2D3. 24-Hydroxylase is present in the proximal convoluted tubule cells of the kidney and in virtual all target cells of 1alpha,25(OH)2D3. Interestingly, 1alpha,25(OH)2D3 is a very strong inducer of 24-hydroxylase activity and 24R,25(OH)2D3 formation. Also parathyroid hormone (PTH) regulates 24-hydroxylase activity but in a tissue specific manner, i.e. inhibitory in the kidney while a synergistic effect together with 1alpha,25(OH)2D3 is observed in osteoblasts. Generally, 24-hydroxylation has been considered the first step in the degradation pathway of 1alpha,25(OH)2D3 and 25-(OH)D3. However, through the past decades data have accumulated that 24R,25(OH)2D3 is not merely a degradation product but has effects on its own. Classic studies have demonstrated the significance of 24R,25(OH)2D3 for normal chicken egg hatchability and calcium and phosphorus homeostasis. More recently it became apparent that 24R,25(OH)2D3 also has distinct effects on cartilage in particular the resting zone cells. 24R,25(OH)2D3 stimulates osteocalcin synthesis in animal osteoblasts. 24R,25(OH)2D3 plays a role in bone metabolism but that it acts in concert with 1alpha,25(OH)2D3 to obtain an optimal effect. (PMID: 11179746 ).</description>
		<cas>40013-87-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[C@H](CCC(O)C(C)(C)O)[C@H]1CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@H](O)CCC1=C</moldb_smiles>
		<moldb_formula>C27H44O3</moldb_formula>
		<moldb_inchi>InChI=1S/C27H44O3/c1-18-8-12-22(28)17-21(18)11-10-20-7-6-16-27(5)23(13-14-24(20)27)19(2)9-15-25(29)26(3,4)30/h10-11,19,22-25,28-30H,1,6-9,12-17H2,2-5H3/b20-10+,21-11-/t19-,22-,23-,24+,25?,27-/m1/s1</moldb_inchi>
		<moldb_inchikey>FCKJYANJHNLEEP-OIMXRAFZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>416.6365</moldb_average_mass>
		<moldb_mono_mass>416.329045274</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>155</id>
		<lmdb_id>LMDB00155</lmdb_id>
		<created_at>2016-07-13 19:43:34</created_at>
		<updated_at>2018-04-30 21:14:37</updated_at>
		<export>1</export>
		<name>3-Hydroxyphenylacetic acid</name>
		<description>3-Hydroxyphenylacetic acid is a rutin metabolite and an antioxidant. It has a protective biological activity in animal. It is a substrate of enzyme 4-hydroxyphenylacetate 3-monooxygenase [EC 1.14.13.3] in the pathway tyrosine metabolism. (KEGG, PMID 155437).</description>
		<cas>621-37-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CC1=CC(O)=CC=C1</moldb_smiles>
		<moldb_formula>C8H8O3</moldb_formula>
		<moldb_inchi>InChI=1S/C8H8O3/c9-7-3-1-2-6(4-7)5-8(10)11/h1-4,9H,5H2,(H,10,11)</moldb_inchi>
		<moldb_inchikey>FVMDYYGIDFPZAX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>152.1473</moldb_average_mass>
		<moldb_mono_mass>152.047344122</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>156</id>
		<lmdb_id>LMDB00156</lmdb_id>
		<created_at>2016-07-13 19:43:35</created_at>
		<updated_at>2016-07-20 21:03:30</updated_at>
		<export>1</export>
		<name>Adipic acid</name>
		<description>Adipic acid is an important inudstrial dicarboxylic acid with about 2.5 billion kilograms produced per year. It is used mainly in the production of nylon. It occurs relatively rarely in nature. It has a tart taste and is also used as an additive and gelling agent in jello or gelatins. It is also used in some calcium carbonate antacids to make them tart. Adipic acid has also been incorporated into controlled-release formulation matrix tablets to obtain pH-independent release for both weakly basic and weakly acidic drugs. Adipic acid in the urine and in the blood is typically exogenous in origin and is a good biomarker of jello consumption. In fact, a condition known as adipic aciduria is actually an artifact of jello consumption (PMID: 1779643). However, certain disorders (such as diabetes and glutaric aciduria type I.) can lead to elevated levels of adipic acid snd other dicarboxcylic acids (such as suberic acid) in urine (PMID: 17520433; PMID: 6778884).</description>
		<cas>124-04-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CCCCC(O)=O</moldb_smiles>
		<moldb_formula>C6H10O4</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O4/c7-5(8)3-1-2-4-6(9)10/h1-4H2,(H,7,8)(H,9,10)</moldb_inchi>
		<moldb_inchikey>WNLRTRBMVRJNCN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>146.1412</moldb_average_mass>
		<moldb_mono_mass>146.057908808</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>157</id>
		<lmdb_id>LMDB00157</lmdb_id>
		<created_at>2016-07-13 19:43:37</created_at>
		<updated_at>2016-07-20 20:27:33</updated_at>
		<export>1</export>
		<name>L-Alpha-aminobutyric acid</name>
		<description>A-Aminobutyric acid is an isomer of the amino acid aminobutyric acid. It is a key intermediate in the biosynthesis of ophthalmic acid or ophthalmate.</description>
		<cas>1492-24-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC[C@H](N)C(O)=O</moldb_smiles>
		<moldb_formula>C4H9NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C4H9NO2/c1-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1</moldb_inchi>
		<moldb_inchikey>QWCKQJZIFLGMSD-VKHMYHEASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>103.1198</moldb_average_mass>
		<moldb_mono_mass>103.063328537</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>158</id>
		<lmdb_id>LMDB00158</lmdb_id>
		<created_at>2016-07-13 19:43:38</created_at>
		<updated_at>2016-09-23 18:44:48</updated_at>
		<export>1</export>
		<name>Allantoin</name>
		<description>Allantoin is a diureide of glyoxylic acid with the chemical formula C4H6N4O3. It is also called 5-ureidohydantoin, glyoxyldiureide, and 5-ureidohydantoin. It is a product of oxidation of uric acid. It is a product of purine metabolism in most mammals except higher apes, and it is present in their urine. In animals, uric acid is excreted instead of allantoin. The presence of allantoin in the urine can be an indication of microbial overgrowth or it can be created via non-enzymatic means through high levels of reactive oxygen species. In this regard Allantoin is sometimes used as a marker of oxidative stress. Allantoin can be isolated from cow urine or as a botanical extract of the comfrey plant. It has long been used for its healing, soothing, and anti-irritating properties. Allantoin helps to heal wounds and skin irritations and stimulates the growth of healthy tissue. Allantoin can be found in anti-acne products, sun care products, and clarifying lotions because of its ability to help heal minor wounds and promote healthy skin. Allantoin is frequently present in toothpaste, mouthwash, and other oral hygiene products as well as shampoos, lipsticks, various cosmetic lotions and creams and other cosmetic and pharmaceutical products.</description>
		<cas>97-59-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(=O)NC1NC(=O)NC1=O</moldb_smiles>
		<moldb_formula>C4H6N4O3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H6N4O3/c5-3(10)6-1-2(9)8-4(11)7-1/h1H,(H3,5,6,10)(H2,7,8,9,11)</moldb_inchi>
		<moldb_inchikey>POJWUDADGALRAB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>158.1154</moldb_average_mass>
		<moldb_mono_mass>158.043990078</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>159</id>
		<lmdb_id>LMDB00159</lmdb_id>
		<created_at>2016-07-13 19:43:39</created_at>
		<updated_at>2016-08-02 20:39:06</updated_at>
		<export>1</export>
		<name>Calcium</name>
		<description>Calcium is essential for the normal growth and maintenance of bones and teeth, and calcium requirements must be met throughout life. Requirements are greatest during periods of growth, such as childhood, during pregnancy and when breast-feeding. Long-term calcium deficiency can lead to osteoporosis, in which the bone deteriorates and there is an increased risk of fractures. Adults need between 1,000 and 1,300 mg of calcium in their daily diet. Calcium is essential for living organisms, particularly in cell physiology, and is the most common metal in many animals. Physiologically, it exists as an ion in the body. Calcium combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Calcium is an important component of a healthy diet. A deficit can affect bone and tooth formation, while overretention can cause kidney stones. Vitamin D is needed to absorb calcium. Dairy products, such as milk and cheese, are a well-known source of calcium. However, some individuals are allergic to dairy products and even more people, particularly those of non-European descent, are lactose-intolerant, leaving them unable to consume dairy products. Fortunately, many other good sources of calcium exist. These include: seaweeds such as kelp, wakame and hijiki; nuts and seeds (like almonds and sesame); beans; amaranth; collard greens; okra; rutabaga; broccoli; kale; and fortified products such as orange juice and soy milk. Calcium has also been found to assist in the production of lymphatic fluids.</description>
		<cas>7440-70-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Ca++]</moldb_smiles>
		<moldb_formula>Ca</moldb_formula>
		<moldb_inchi>InChI=1S/Ca/q+2</moldb_inchi>
		<moldb_inchikey>BHPQYMZQTOCNFJ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>40.0780</moldb_average_mass>
		<moldb_mono_mass>39.962591155</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>160</id>
		<lmdb_id>LMDB00160</lmdb_id>
		<created_at>2016-07-13 19:43:40</created_at>
		<updated_at>2016-07-20 20:57:05</updated_at>
		<export>1</export>
		<name>3-Methylindole</name>
		<description>3-Methylindole, or skatole, can be found as a white crystalline or fine powder solid, and it browns upon aging. It is nitrogenous and one of the rings is a pyrrole. This is probably the reason it's so foul smelling. It is soluble in alcohol and benzene and it gives violet color in potassium ferrocyanide (K4Fe(CN)6.3H2O) and sulfuric acid (H2SO4). Skatole has a double ring system which displays aromaticity that comes from the lone pair electrons on the nitrogen. It is continuous (all atoms in the ring are sp2 hybridized), planar, and follows the 4n+2 rule because it has 10 pi electrons. It can be synthesized through a Fischer indole synthesis which was developed by Emil Fischer.In a 1994 report released by five top cigarette companies, skatole was listed as one of the 599 additives to cigarettes. It is a flavoring ingredient. 3-Methylindole is a mildly toxic white crystalline organic compound with chemical formula C9H9N and CAS number 83-34-1. The compound belongs to the indole family and has a methyl substituent in position 3 of the indole ring. It occurs naturally in feces (it is produced from tryptophan in the mammalian digestive tract), beets, and coal tar, and has a strong fecal odor. In low concentrations it has a flowery smell and is found in several flowers and essential oils, including those of orange blossoms, jasmine, and Ziziphus mauritiana. It is used as a fragrance and fixative in many perfumes and as an aroma compound. Its name is derived from skato, the Greek word for dung.</description>
		<cas>83-34-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=CNC2=C1C=CC=C2</moldb_smiles>
		<moldb_formula>C9H9N</moldb_formula>
		<moldb_inchi>InChI=1S/C9H9N/c1-7-6-10-9-5-3-2-4-8(7)9/h2-6,10H,1H3</moldb_inchi>
		<moldb_inchikey>ZFRKQXVRDFCRJG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>131.1745</moldb_average_mass>
		<moldb_mono_mass>131.073499293</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>161</id>
		<lmdb_id>LMDB00161</lmdb_id>
		<created_at>2016-07-13 19:43:42</created_at>
		<updated_at>2016-07-20 20:57:06</updated_at>
		<export>1</export>
		<name>5-Hydroxy-L-tryptophan</name>
		<description>5-Hydroxy-L-tryptophan is an aromatic amino acid naturally produced by the body from the essential amino acid l-tryptophan. 5-Hydroxy-L-tryptophan is the immediate precursor of the neurotransmitter serotonin. The conversion to serotonin is catalyzed by the enzyme aromatic l-amino acid decarboxylase (EC 4.1.1.28, AADC1 also known as dopa decarboxylase), an essential enzyme in the metabolism of the monoamine neurotransmitters. An accumulation of 5-Hydroxy-L-tryptophan in cerebrospinal fluid occurs in Aromatic l-amino acid decarboxylase deficiency (OMIM 608643), accompanied by an increased excretion in the urine of the patients, which are indicative of the disorder but not specific 5-Hydroxy-L-tryptophan is also increased in other disorders such as in Parkinson's patients with severe postural instability and gait disorders. Confirmation of the diagnosis AADC deficiency is then required by enzyme activity measurement or genetic analysis. The amount of endogenous 5-Hydroxy-L-tryptophan available for serotonin synthesis depends on the availability of tryptophan and on the activity of various enzymes, especially tryptophan hydroxylase (EC 1.14.16.4), indoleamine 2,3-dioxygenase (EC 1.13.11.52), and tryptophan 2,3-dioxygenase. (EC 1.13.11.11, TDO). 5-Hydroxy-L-tryptophan has been used clinically for over 30 years. In addition to depression, the therapeutic administration of 5-Hydroxy-L-tryptophan has been shown to be effective in treating a wide variety of conditions, including fibromyalgia, insomnia, binge eating associated with obesity, cerebellar ataxia, and chronic headaches. 5-Hydroxy-L-tryptophan easily crosses the blood-brain barrier and effectively increases central nervous system (CNS) synthesis of serotonin. Supplementation with 5-Hydroxy-L-tryptophan is hypothesized to normalize serotonin synthesis, which is putatively related to its antidepressant properties. (PMID: 9295177, 17240182, 16023217).</description>
		<cas>4350-09-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(CC1=CNC2=C1C=C(O)C=C2)C(O)=O</moldb_smiles>
		<moldb_formula>C11H12N2O3</moldb_formula>
		<moldb_inchi>InChI=1S/C11H12N2O3/c12-9(11(15)16)3-6-5-13-10-2-1-7(14)4-8(6)10/h1-2,4-5,9,13-14H,3,12H2,(H,15,16)</moldb_inchi>
		<moldb_inchikey>LDCYZAJDBXYCGN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>220.2246</moldb_average_mass>
		<moldb_mono_mass>220.084792260</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>162</id>
		<lmdb_id>LMDB00162</lmdb_id>
		<created_at>2016-07-13 19:43:43</created_at>
		<updated_at>2016-07-20 20:57:06</updated_at>
		<export>1</export>
		<name>Butanone</name>
		<description>Butanone occurs as a natural product. It is made by some trees and found in some fruits and vegetables in small amounts. It is also released to the air from car and truck exhausts. The known health effects to people from exposure to butanone are irritation of the nose, throat, skin, and eyes. (wikipedia).</description>
		<cas>78-93-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC(C)=O</moldb_smiles>
		<moldb_formula>C4H8O</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8O/c1-3-4(2)5/h3H2,1-2H3</moldb_inchi>
		<moldb_inchikey>ZWEHNKRNPOVVGH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>72.1057</moldb_average_mass>
		<moldb_mono_mass>72.057514878</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>163</id>
		<lmdb_id>LMDB00163</lmdb_id>
		<created_at>2016-07-13 19:43:44</created_at>
		<updated_at>2016-07-20 20:27:44</updated_at>
		<export>1</export>
		<name>3-Methylhistidine</name>
		<description>3-Methylhistidine is a product of peptide bond synthesis and methylation of actin and myosin. The measurement of 3-Methylhistidine provides an index of the rate of muscle protein breakdown.</description>
		<cas>368-16-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN1C=NC=C1C[C@H](N)C(O)=O</moldb_smiles>
		<moldb_formula>C7H11N3O2</moldb_formula>
		<moldb_inchi>InChI=1S/C7H11N3O2/c1-10-4-9-3-5(10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1</moldb_inchi>
		<moldb_inchikey>JDHILDINMRGULE-LURJTMIESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>169.1811</moldb_average_mass>
		<moldb_mono_mass>169.085126611</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>164</id>
		<lmdb_id>LMDB00164</lmdb_id>
		<created_at>2016-07-13 19:43:46</created_at>
		<updated_at>2016-07-20 20:51:16</updated_at>
		<export>1</export>
		<name>Caprylic acid</name>
		<description>Caprylic acid is the common name for the eight-carbon straight chain fatty acid known by the systematic name octanoic acid. It is found naturally in coconuts and breast milk. It is an oily liquid with a slightly unpleasant rancid taste that is minimally soluble in water. Caprylic acid is used commercially in the production of esters used in perfumery and also in the manufacture of dyes. (wikipedia).</description>
		<cas>124-07-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C8H16O2</moldb_formula>
		<moldb_inchi>InChI=1S/C8H16O2/c1-2-3-4-5-6-7-8(9)10/h2-7H2,1H3,(H,9,10)</moldb_inchi>
		<moldb_inchikey>WWZKQHOCKIZLMA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>144.2114</moldb_average_mass>
		<moldb_mono_mass>144.115029756</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>165</id>
		<lmdb_id>LMDB00165</lmdb_id>
		<created_at>2016-07-13 19:43:47</created_at>
		<updated_at>2016-09-23 18:44:49</updated_at>
		<export>1</export>
		<name>Chloride ion</name>
		<description>Under standard conditions, chlorine exists as a diatomic molecule. Chlorine is a highly toxic, pale yellow-green gas that has a specific strong smell. In nature, chlorine is most abundant as a chloride ion. Physiologically, it exists as an ion in the body. The chloride ion is an essential anion that the body needs for many critical functions. It also helps keep the body's acid-base balance. The amount of chloride in the blood is carefully controlled by the kidneys. Chloride ions have important physiological roles. For instance, in the central nervous system, the inhibitory action of glycine and some of the action of GABA relies on the entry of Cl- into specific neurons. Also, the chloride-bicarbonate exchanger biological transport protein relies on the chloride ion to increase the blood's capacity of carbon dioxide, in the form of the bicarbonate ion. Chloride-transporting proteins (CLC) play fundamental roles in many tissues in the plasma membrane as well as in intracellular membranes. CLC proteins form a gene family that comprises nine members in mammals, at least four of which are involved in animal genetic diseases. GABA(A) receptors are pentameric complexes that function as ligand-gated chloride ion channels. WNK kinases are a family of serine-threonine kinases that have been shown to play an essential role in the regulation of electrolyte homeostasis, and they are found in diverse epithelia throughout the body that are involved in chloride ion flux. Cystic fibrosis (CF) is caused by alterations in the CF transmembrane conductance regulator (CFTCR) gene that result in deranged sodium and chloride ion transport channels. (PMID: 17539703, 17729441, 17562499, 15300163) (For a complete review see Evans, Richard B. Chlorine: state of the art. Lung (2005), 183(3), 151-167. PMID: 16078037).</description>
		<cas>16887-00-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Cl-]</moldb_smiles>
		<moldb_formula>Cl</moldb_formula>
		<moldb_inchi>InChI=1S/ClH/h1H/p-1</moldb_inchi>
		<moldb_inchikey>VEXZGXHMUGYJMC-UHFFFAOYSA-M</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>35.4530</moldb_average_mass>
		<moldb_mono_mass>34.968852707</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>166</id>
		<lmdb_id>LMDB00166</lmdb_id>
		<created_at>2016-07-13 19:43:48</created_at>
		<updated_at>2016-07-20 21:03:32</updated_at>
		<export>1</export>
		<name>4-Hydroxybenzoic acid</name>
		<description>4-Hydroxybenzoic acid, or p-hydroxybenzoic acid, is a phenolic derivative of benzoic acid. It a white crystalline solid that is slightly soluble in water and chloroform, but well soluble in alcohols, ether, and acetone.</description>
		<cas>99-96-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C1=CC=C(O)C=C1</moldb_smiles>
		<moldb_formula>C7H6O3</moldb_formula>
		<moldb_inchi>InChI=1S/C7H6O3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H,(H,9,10)</moldb_inchi>
		<moldb_inchikey>FJKROLUGYXJWQN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>138.1220</moldb_average_mass>
		<moldb_mono_mass>138.031694053</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>167</id>
		<lmdb_id>LMDB00167</lmdb_id>
		<created_at>2016-07-13 19:43:50</created_at>
		<updated_at>2016-09-23 18:44:49</updated_at>
		<export>1</export>
		<name>Ribitol</name>
		<description>Ribitol is a metabolic end product formed by the reduction of ribose in animal fibroblasts and erythrocytes (pentitol, sugar alcohol, polyol). Export of ribitol across the cell membrane indicates that can be cleared from the body without metabolic conversion. (PMID 15234337). Several inborn errors of metabolism with abnormal polyol concentrations in body fluids are known to date. Most of these defects can be diagnosed by the assessment of urinary concentrations of polyols. (PMID 16435188). Ribitol is normally absent in Breast milk. (PMID 16456418).</description>
		<cas>488-81-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H](O)[C@H](O)[C@H](O)CO</moldb_smiles>
		<moldb_formula>C5H12O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4+,5-</moldb_inchi>
		<moldb_inchikey>HEBKCHPVOIAQTA-ZXFHETKHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>152.1458</moldb_average_mass>
		<moldb_mono_mass>152.068473494</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>168</id>
		<lmdb_id>LMDB00168</lmdb_id>
		<created_at>2016-07-13 19:43:51</created_at>
		<updated_at>2016-09-23 18:44:50</updated_at>
		<export>1</export>
		<name>Aminoadipic acid</name>
		<description>Aminoadipic acid (2-aminoadipate) is a metabolite in the principal biochemical pathway of lysine. It is an intermediate in the metabolism (i.e. breakdown or degradation) of lysine and saccharopine.(Wikipedia).   It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-methyl-D-aspartate; (NMDA). Aminoadipic has also been shown to inhibit the production of kynurenic acid in brain tissue slices (PMID: 8566117). Kynurenic acid is a broad spectrum excitatory amino acid receptor antagonist. Recent studies have shown that aminoadipic acid is elevated in prostate biopsy tissues from prostate cancer patients (PMID: 23737455).  Mutations in DHTKD1 (dehydrogenase E1 and transketolase domain-containing protein 1) have been shown to cause animal 2-aminoadipic and 2-oxoadipic aciduria via impaired turnover of decarboxylation 2-oxoadipate to glutaryl-CoA, which is the last step in the lysine degradation pathway (PMID: 23141293).  Aging, diabetes, sepsis and renal failure are known to catalyze the oxidation of lysyl residues to 2-aminoadipic acid in animal skin collagen and potentially other tissues (PMID: 18448817).  Proteolytic breakdown of these tissues can lead to the release of free 2-aminoadipic acid.  Studies in rats indicate that aminoadipic acid (along with the 3 branched chain amino acid ñ Leu, Val and Ile) levels are elevated in the pre-diabetic phase and so aminoadipic acid may serve as a predictive biomarker for the development of diabetes. (PMID: 15389298). Long-term hyperglycemia of endothelial cells leads to elevated levels of aminoadipate which is though to be a sign of lysine breakdown through oxidative stress and reactive oxygen species (ROS) (PMID: 21961526).  2-aminoadipate is a potential small-molecule marker of oxidative stress (PMID: 21647514) </description>
		<cas>542-32-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(CCCC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H11NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C6H11NO4/c7-4(6(10)11)2-1-3-5(8)9/h4H,1-3,7H2,(H,8,9)(H,10,11)</moldb_inchi>
		<moldb_inchikey>OYIFNHCXNCRBQI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>161.1558</moldb_average_mass>
		<moldb_mono_mass>161.068807845</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>169</id>
		<lmdb_id>LMDB00169</lmdb_id>
		<created_at>2016-07-13 19:43:52</created_at>
		<updated_at>2016-07-20 20:51:25</updated_at>
		<export>1</export>
		<name>Capric acid</name>
		<description>Capric acid is a member of the series of fatty acids found in oils and animal fats. The names of Caproic, Caprylic, and Capric acids are all derived from the word caper (Latin: 'goat'). These are colorless light yellowish transparent oily liquids with unconfortable smells. These are used in organic synthesis, manufacture of perfume, medicine, lubricating grease, rubber and dye.(ChemicalLAND21).</description>
		<cas>334-48-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C10H20O2</moldb_formula>
		<moldb_inchi>InChI=1S/C10H20O2/c1-2-3-4-5-6-7-8-9-10(11)12/h2-9H2,1H3,(H,11,12)</moldb_inchi>
		<moldb_inchikey>GHVNFZFCNZKVNT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>172.2646</moldb_average_mass>
		<moldb_mono_mass>172.146329884</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>170</id>
		<lmdb_id>LMDB00170</lmdb_id>
		<created_at>2016-07-13 19:43:54</created_at>
		<updated_at>2016-08-01 19:10:43</updated_at>
		<export>1</export>
		<name>Beta-D-Glucose</name>
		<description>Beta-D-Glucose is a primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. A glucoside is a glycoside that is derived from glucose. Glucosides are common in plants, but rare in animals. Glucose is produced when a glucoside is hydrolysed by purely chemical means, or decomposed by fermentation or enzymes. This group contains a benzene and also an ethylene group, being derived from styrolene. Coniferin, C16H22O8, occurs in the cambium of conifer wood. Emulsin converts it into glucose and coniferyl alcohol, while oxidation gives glycovanillin, which yields with emulsin glucose and vanillin. Syringin, which occurs in the bark of Syringe vulgaris, is a methoxyconiferin. Phloridzus occurs in the root-bark of various fruit trees; it hydrolyses to glucose and phloretin, which is the phloroglucin ester of paraoxyhydratropic acid. It is related to the pentosides naringin, C21HEOi1, which hydrolyses to rhamnose and naringenin, the phioroglucin ester of para-oxycinnamic acid, and hesperidin, which hydrolyses to rhamnose and hesperetin, the phloroglucin ester of meta-oxy-para-methoxycinnamic acid or isoferulic acid, C10H10O4. Classification of the glucosides is a matter of some difficulty. One based on the chemical constitution of the non-glucose part of the molecules has been proposed that frames four groups: (I) ethylene derivatives, (2) benzene derivatives, (3) styrolene derivatives, (4) anthracene derivatives. A group may also be made to include the cyanogenetic glucosides, i.e. those containing prussic acid. Other classifications follow a botanical classification, which has several advantages; in particular, plants of allied genera contain similar compounds. In this article the chemical classification will be followed, and only the more important compounds will be discussed here.</description>
		<cas>492-61-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6-/m1/s1</moldb_inchi>
		<moldb_inchikey>WQZGKKKJIJFFOK-VFUOTHLCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1559</moldb_average_mass>
		<moldb_mono_mass>180.063388116</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>171</id>
		<lmdb_id>LMDB00171</lmdb_id>
		<created_at>2016-07-13 19:43:55</created_at>
		<updated_at>2016-07-20 20:51:27</updated_at>
		<export>1</export>
		<name>L-Arginine</name>
		<description>Arginine is an essential amino acid that is physiologically active in the L-form. In mammals, arginine is formally classified as a semiessential or conditionally essential amino acid, depending on the developmental stage and health status of the individual. Infants are unable to effectively synthesize arginine, making it nutritionally essential for infants. Adults, however, are able to synthesize arginine in the urea cycle. Arginine can be considered to be a basic amino acid as the part of the side chain nearest to the backbone is long, carbon-containing and hydrophobic, whereas the end of the side chain is a complex guanidinium group. With a pKa of 12.48, the guanidinium group is positively charged in neutral, acidic and even most basic environments. Because of the conjugation between the double bond and the nitrogen lone pairs, the positive charge is delocalized. This group is able to form multiple H-bonds. L-arginine is an amino acid that has numerous functions in the body. It helps dispose of ammonia, is used to make compounds such as nitric oxide, creatine, L-glutamate, L-proline, and it can be converted to glucose and glycogen if needed. In large doses, L-arginine also stimulates the release of hormones growth hormone and prolactin. Arginine is a known inducer of mTOR (mammalian target of rapamycin) and is responsible for inducing protein synthesis through the mTOR pathway. mTOR inhibition by rapamycin partially reduces arginine-induced protein synthesis PMID: 20841502. Catabolic disease states such as sepsis, injury, and cancer cause an increase in arginine utilization, which can exceed normal body production, leading to arginine depletion. Arginine also activates AMP kinase (AMPK) which then stimulates skeletal muscle fatty acid oxidation and muscle glucose uptake, thereby increasing insulin secretion by pancreatic beta-cells. PMID: 21311355 Arginine is found in plant and animal proteins, such as dairy products, meat, poultry, fish, and nuts. The ratio of L-arginine to lysine is also important - soy and other plant proteins have more L-arginine than animal sources of protein.</description>
		<cas>74-79-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CCCNC(N)=N)C(O)=O</moldb_smiles>
		<moldb_formula>C6H14N4O2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s1</moldb_inchi>
		<moldb_inchikey>ODKSFYDXXFIFQN-BYPYZUCNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>174.2010</moldb_average_mass>
		<moldb_mono_mass>174.111675712</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>172</id>
		<lmdb_id>LMDB00172</lmdb_id>
		<created_at>2016-07-13 19:43:56</created_at>
		<updated_at>2016-07-20 21:03:33</updated_at>
		<export>1</export>
		<name>Chenodeoxycholic acid</name>
		<description>Chenodeoxycholic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135). Usually conjugated with either glycine or taurine. It acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. It is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones.</description>
		<cas>474-25-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O</moldb_smiles>
		<moldb_formula>C24H40O4</moldb_formula>
		<moldb_inchi>InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20-,22+,23+,24-/m1/s1</moldb_inchi>
		<moldb_inchikey>RUDATBOHQWOJDD-BSWAIDMHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>392.5720</moldb_average_mass>
		<moldb_mono_mass>392.292659768</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>173</id>
		<lmdb_id>LMDB00173</lmdb_id>
		<created_at>2016-07-13 19:43:57</created_at>
		<updated_at>2016-07-20 21:03:34</updated_at>
		<export>1</export>
		<name>5-Dodecenoic acid</name>
		<description>5-Dodecenoic acid is an intermediate of unsaturated fatty acid oxidation. An increase of 5-dodecenoic acid in plasma is associated with acyl-CoA dehydrogenase deficiency disorders. (PMID 7586519).</description>
		<cas>2430-94-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCC(O)=O</moldb_smiles>
		<moldb_formula>C12H22O2</moldb_formula>
		<moldb_inchi>InChI=1S/C12H22O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h7-8H,2-6,9-11H2,1H3,(H,13,14)/b8-7-</moldb_inchi>
		<moldb_inchikey>IJBFSOLHRKELLR-FPLPWBNLSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>198.3019</moldb_average_mass>
		<moldb_mono_mass>198.161979948</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>174</id>
		<lmdb_id>LMDB00174</lmdb_id>
		<created_at>2016-07-13 19:43:59</created_at>
		<updated_at>2016-07-20 20:57:21</updated_at>
		<export>1</export>
		<name>3-Hydroxyvaleric acid</name>
		<description>3-Hydroxyvaleric acid may be products of the condensation of propionyl-CoA with acetyl-CoA catalyzed by 3-oxoacyl-CoA thiolases. An increase amount of 3-hydroxyvaleric acid can be found in methylmalonic acidemia and propionic acidemia. (PMID: 630060).</description>
		<cas>10237-77-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC(O)CC(O)=O</moldb_smiles>
		<moldb_formula>C5H10O3</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O3/c1-2-4(6)3-5(7)8/h4,6H,2-3H2,1H3,(H,7,8)</moldb_inchi>
		<moldb_inchikey>REKYPYSUBKSCAT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>118.1311</moldb_average_mass>
		<moldb_mono_mass>118.062994186</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>175</id>
		<lmdb_id>LMDB00175</lmdb_id>
		<created_at>2016-07-13 19:44:00</created_at>
		<updated_at>2016-07-19 23:16:13</updated_at>
		<export>1</export>
		<name>Acetylglycine</name>
		<description>N-Acetylglycine is used is in biological research of peptidomimetics. It is used as the blocking agent of the N-terminus to prepare unnatural and unusual amino acids and amino acid analogs as well as to modify peptides. N-Substituted glycine analogs are widely used in peptidomimetics and drug research. Excessive amounts N-acetyl amino acids including N-acetylglycine (as well as N-acetylserine, N-acetylglutamine, N-acetylglutamate, N-acetylalanine, Nacetylmethionine and smaller amounts of N-acetylthreonine, N-acetylleucine, N-acetylvaline and N-acetylisoleucine) can be detected in the urine with individuals with Acylase I defiency. This enzyme is involved in the degradation of N-acylated proteins. Individuals with this disorder will experience convulsions, hearing loss ond difficulty feeding.</description>
		<cas>543-24-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)NCC(O)=O</moldb_smiles>
		<moldb_formula>C4H7NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H7NO3/c1-3(6)5-2-4(7)8/h2H2,1H3,(H,5,6)(H,7,8)</moldb_inchi>
		<moldb_inchikey>OKJIRPAQVSHGFK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>117.1033</moldb_average_mass>
		<moldb_mono_mass>117.042593095</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>176</id>
		<lmdb_id>LMDB00176</lmdb_id>
		<created_at>2016-07-13 19:44:01</created_at>
		<updated_at>2016-09-23 18:44:51</updated_at>
		<export>1</export>
		<name>Caproic acid</name>
		<description>It is a colorless oily liquid smelling of cheese. It is a fatty acid found naturally in various animal fats and oils. Caproic acid is a medium chain triglycerides (MCT). MCTs are widely used for parenteral nutrition in individuals requiring supplemental nutrition and are being more widely used in foods, drugs and cosmetics; they are essentially non-toxic. It is safe for animal dietary consumption up to levels of 1g/kg. (PMID 10685018).</description>
		<cas>142-62-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C6H12O2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O2/c1-2-3-4-5-6(7)8/h2-5H2,1H3,(H,7,8)</moldb_inchi>
		<moldb_inchikey>FUZZWVXGSFPDMH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>116.1583</moldb_average_mass>
		<moldb_mono_mass>116.083729628</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>177</id>
		<lmdb_id>LMDB00177</lmdb_id>
		<created_at>2016-07-13 19:44:03</created_at>
		<updated_at>2016-09-23 18:44:52</updated_at>
		<export>1</export>
		<name>Adenosine triphosphate</name>
		<description>Adenosine triphosphate (ATP) is a nucleotide consisting of a purine base (adenine) attached to the first carbon atom of ribose (a pentose sugar). Three phosphate groups are esterified at the fifth carbon atom of the ribose. ATP is incorporated into nucleic acids by polymerases in the processes of DNA replication and transcription. ATP contributes to cellular energy charge and participates in overall energy balance, maintaining cellular homeostasis. ATP can act as an extracellular signaling molecule via interactions with specific purinergic receptors to mediate a wide variety of processes as diverse as neurotransmission, inflammation, apoptosis, and bone remodelling. Extracellular ATP and its metabolite adenosine have also been shown to exert a variety of effects on nearly every cell type in animal skin, and ATP seems to play a direct role in triggering skin inflammatory, regenerative, and fibrotic responses to mechanical injury, an indirect role in melanocyte proliferation and apoptosis, and a complex role in Langerhans cell-directed adaptive immunity. During exercise, intracellular homeostasis depends on the matching of adenosine triphosphate (ATP) supply and ATP demand. Metabolites play a useful role in communicating the extent of ATP demand to the metabolic supply pathways. Effects as different as proliferation or differentiation, chemotaxis, release of cytokines or lysosomal constituents, and generation of reactive oxygen or nitrogen species are elicited upon stimulation of blood cells with extracellular ATP. The increased concentration of adenosine triphosphate (ATP) in erythrocytes from patients with chronic renal failure (CRF) has been observed in many studies but the mechanism leading to these abnormalities still is controversial. (PMID: 15490415, 15129319, 14707763, 14696970, 11157473).</description>
		<cas>56-65-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C10H16N5O13P3</moldb_formula>
		<moldb_inchi>InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1</moldb_inchi>
		<moldb_inchikey>ZKHQWZAMYRWXGA-KQYNXXCUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>507.1810</moldb_average_mass>
		<moldb_mono_mass>506.995745159</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>178</id>
		<lmdb_id>LMDB00178</lmdb_id>
		<created_at>2016-07-13 19:44:04</created_at>
		<updated_at>2016-08-02 20:39:13</updated_at>
		<export>1</export>
		<name>Magnesium</name>
		<description>Magnesium salts are essential in nutrition, being required for the activity of many enzymes, especially those concerned with oxidative phosphorylation. Physiologically, it exists as an ion in the body. It is a component of both intra- and extracellular fluids and is excreted in the urine and feces. Deficiency causes irritability of the nervous system with tetany, vasodilatation, convulsions, tremors, depression, and psychotic behavior. Magnesium ion in large amounts is an ionic laxative, and magnesium sulfate (Epsom salts) is sometimes used for this purpose. So-called &quot;milk of magnesia&quot; is a water suspension of one of the few insoluble magnesium compounds, magnesium hydroxide; the undissolved particles give rise to its appearance and name. Milk of magnesia is a mild base, and is commonly used as an antacid.</description>
		<cas>7439-95-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Mg++]</moldb_smiles>
		<moldb_formula>Mg</moldb_formula>
		<moldb_inchi>InChI=1S/Mg/q+2</moldb_inchi>
		<moldb_inchikey>JLVVSXFLKOJNIY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>24.3050</moldb_average_mass>
		<moldb_mono_mass>23.985041898</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>179</id>
		<lmdb_id>LMDB00179</lmdb_id>
		<created_at>2016-07-13 19:44:06</created_at>
		<updated_at>2016-07-20 20:57:23</updated_at>
		<export>1</export>
		<name>B-Carotene</name>
		<description>B-Carotene is a carotenoid that is a precursor of vitamin A. It is administered to reduce the severity of photosensitivity reactions in patients with erythropoietic protoporphyria (porphyria, erythropoietic). (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Engewood, CO, 1995.) -- Pubchem; Carotene is an orange photosynthetic pigment important for photosynthesis. It is responsible for the orange colour of the carrot and many other fruits and vegetables. It contributes to photosynthesis by transmitting the light energy it absorbs to chlorophyll. Chemically, carotene is a terpene. It is the dimer of retinol (vitamin A) and comes in two primary forms: alpha- and beta-carotene. gamma-, delta- and epsilon-carotene also exist. Carotene can be stored in the liver and converted to vitamin A as needed. Beta-carotene is an anti-oxidant and such can be useful for curbing the excess of damaging free radicals in the body. However, the usefulness of beta-carotene as a dietary supplement (i.e. taken as a pill) is still subject to debate. Beta-carotene is fat-soluble, so a small amount of fat is needed to absorb it into the body. -- Wikipedia.</description>
		<cas>7235-40-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C\C(\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C</moldb_smiles>
		<moldb_formula>C40H56</moldb_formula>
		<moldb_inchi>InChI=1S/C40H56/c1-31(19-13-21-33(3)25-27-37-35(5)23-15-29-39(37,7)8)17-11-12-18-32(2)20-14-22-34(4)26-28-38-36(6)24-16-30-40(38,9)10/h11-14,17-22,25-28H,15-16,23-24,29-30H2,1-10H3/b12-11+,19-13+,20-14+,27-25+,28-26+,31-17+,32-18+,33-21+,34-22+</moldb_inchi>
		<moldb_inchikey>OENHQHLEOONYIE-JLTXGRSLSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>536.8880</moldb_average_mass>
		<moldb_mono_mass>536.438201803</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>180</id>
		<lmdb_id>LMDB00180</lmdb_id>
		<created_at>2016-07-13 19:44:07</created_at>
		<updated_at>2016-07-20 20:51:38</updated_at>
		<export>1</export>
		<name>Creatinine</name>
		<description>Creatinine or creatine anhydride, is a breakdown product of creatine phosphate in muscle. The loss of water molecule from creatine results in the formation of creatinine. Creatinine is transferred to the kidneys by blood plasma, whereupon it is eliminated from the body by glomerular filtration and partial tubular excretion. Creatinine is usually produced at a fairly constant rate by the body. Measuring serum creatinine is a simple test and it is the most commonly used indicator of renal function. A rise in blood creatinine levels is observed only with marked damage to functioning nephrons; therefore this test is not suitable for detecting early kidney disease. The typical reference range for women is considered about 45-90 umol/l, for men 60-110 umol/l. Creatine and creatinine are metabolized in the kidneys, muscle, liver and pancreas.</description>
		<cas>60-27-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN1CC(=O)NC1=N</moldb_smiles>
		<moldb_formula>C4H7N3O</moldb_formula>
		<moldb_inchi>InChI=1S/C4H7N3O/c1-7-2-3(8)6-4(7)5/h2H2,1H3,(H2,5,6,8)</moldb_inchi>
		<moldb_inchikey>DDRJAANPRJIHGJ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>113.1179</moldb_average_mass>
		<moldb_mono_mass>113.058911861</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>181</id>
		<lmdb_id>LMDB00181</lmdb_id>
		<created_at>2016-07-13 19:44:08</created_at>
		<updated_at>2016-09-23 18:44:52</updated_at>
		<export>1</export>
		<name>D-Arabitol</name>
		<description>D-Arabitol is a polyol. Polyols are sugar alcohols linked to the pentose phosphate pathway (PPP). They are classified on the basis of the number of carbon atoms. Polyols occur in body fluids. A patient with leukoencephalopathy and peripheral neuropathy has been identified as suffering from ribose-5-phosphate isomerase (RPI) deficiency, a defect in the PPP. In this disorder, highly elevated concentrations of the C5 polyols such as D-arabitol are found in body fluids. In addition, transaldolase deficiency, another defect in the PPP, has been diagnosed in a patient with mainly liver problems among others had increased concentrations of polyols, mainly D-arabitol. So far, the pathophysiological role of polyols is relatively unknown. It is thought that D-arabitol is a metabolic end-product in animals. The strong brain-CSF-plasma gradient of polyols in the patient with RPI deficiency suggested a primary metabolic disorder. The mechanisms of brain and neuronal damage in RPI deficiency remain to be elucidated. A neurotoxic effect due to accumulation of the polyols may play a role. D-Arabitol is a product of the enzyme D-arabinitol 4-dehydrogenase (EC 1.1.1.11) in the Pentose and glucuronate interconversion pathway. (PMID: 16435225, J Inherit Metab Dis. 2005;28(6):1181-3).</description>
		<cas>488-82-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC(O)C(O)C(O)CO</moldb_smiles>
		<moldb_formula>C5H12O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2</moldb_inchi>
		<moldb_inchikey>HEBKCHPVOIAQTA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>152.1458</moldb_average_mass>
		<moldb_mono_mass>152.068473494</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>182</id>
		<lmdb_id>LMDB00182</lmdb_id>
		<created_at>2016-07-13 19:44:09</created_at>
		<updated_at>2016-08-01 19:10:44</updated_at>
		<export>1</export>
		<name>Elaidic acid</name>
		<description>Elaidic acid is the major trans fat found in hydrogenated vegetable oils and occurs in small amounts in caprine and bovine milk (very roughly 0.1 % of the fatty acids) [1] and some meats. It is the trans isomer of oleic acid. The name of the elaidinization reaction comes from elaidic acid. Elaidic acid increases CETP activity, which in turn raises VLDL and lowers HDL cholesterol. (Wiki).</description>
		<cas>112-79-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C\CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/b10-9+</moldb_inchi>
		<moldb_inchikey>ZQPPMHVWECSIRJ-MDZDMXLPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4614</moldb_average_mass>
		<moldb_mono_mass>282.255880332</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>183</id>
		<lmdb_id>LMDB00183</lmdb_id>
		<created_at>2016-07-13 19:44:11</created_at>
		<updated_at>2016-09-23 18:44:53</updated_at>
		<export>1</export>
		<name>L-Cysteine</name>
		<description>Cysteine is a naturally occurring, sulfur-containing amino acid that is found in most proteins, although only in small quantities. Cysteine is unique amongst the twenty natural amino acids as it contains a thiol group. Thiol groups can undergo oxidation/reduction (redox) reactions; when cysteine is oxidized it can form cystine, which is two cysteine residues joined by a disulfide bond. This reaction is reversible: as reduction of this disulphide bond regenerates two cysteine molecules. The disulphide bonds of cystine are crucial to defining the structures of many proteins. Cysteine is often involved in electron-transfer reactions, and help the enzyme catalyze its reaction. Cysteine is also part of the antioxidant glutathione. N-acetyl-L-cysteine (NAC) is a form of cysteine where an acetyl group is attached to cysteine's nitrogen atom and is sold as a dietary supplement. Cysteine is named after cystine, which comes from the Greek word kustis meaning bladder - cystine was first isolated from kidney stones. As cysteine contains a sulphydryl group, it can undergo redox reactions. Oxidation of cysteine can produce a disulfide bond with another thiol, or further oxidation can produce sulphfinic or sulfonic acids. The cysteine thiol group is also a nucleophile and can undergo addition and substitution reactions. Thiol groups become much more reactive when they are ionized, and cysteine residues in proteins have pKa values close to neutrality, so are often in their reactive thiolate form in the cell. The thiol group also has a high affinity for heavy metals and proteins containing cysteine will bind metals such as mercury, lead and cadmium tightly. Due to this ability to undergo redox reactions, cysteine has antioxidant properties. Cysteine is an important source of sulfur in animal metabolism, and although it is classified as a non-essential amino acid, cysteine may be essential for infants, the elderly, and individuals with certain metabolic disease or who suffer from malabsorption syndromes. Cysteine may at some point be recognized as an essential or conditionally essential amino acid. (http://en.wikipedia.org/wiki/Cysteine). Cysteine is important in energy metabolism. As cystine, it is a structural component of many tissues and hormones. Cysteine has clinical uses ranging from baldness to psoriasis to preventing smoker's hack. In some cases, oral cysteine therapy has proved excellent for treatment of asthmatics, enabling them to stop theophylline and other medications. Cysteine also enhances the effect of topically applied silver, tin and zinc salts in preventing dental cavities. In the future, cysteine may play a role in the treatment of cobalt toxicity, diabetes, psychosis, cancer and seizures. (http://www.dcnutrition.com/AminoAcids/).</description>
		<cas>52-90-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CS)C(O)=O</moldb_smiles>
		<moldb_formula>C3H7NO2S</moldb_formula>
		<moldb_inchi>InChI=1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1</moldb_inchi>
		<moldb_inchikey>XUJNEKJLAYXESH-REOHCLBHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>121.1580</moldb_average_mass>
		<moldb_mono_mass>121.019749163</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>184</id>
		<lmdb_id>LMDB00184</lmdb_id>
		<created_at>2016-07-13 19:44:12</created_at>
		<updated_at>2016-07-20 20:57:29</updated_at>
		<export>1</export>
		<name>DL-Homocystine</name>
		<description>Homocystine is the double-bonded form of homocysteine, but it occurs only transiently before being converted to the harmless cystathionine via a vitamin B6-dependent enzyme. Homocystine and homocysteine-cysteine mixed disulfide account for &gt;98% of total homocysteine in plasma from healthy individuals. (PMID 11592966). Oxidation of low-density lipoprotein (LDL) is thought to be a major factor in the pathophysiology of atherosclerosis. Elevated plasma homocysteine is an accepted risk factor for atherosclerosis, and may act through LDL oxidation, although this is controversial. However, the major thiol in plasma is cysteine, which is present at concentrations approximately 10 times greater than homocysteine; therefore homocystine in plasma is insignificant, and consequently homocystine is unlikely to influence LDL oxidation in vivo. (PMID 14732479). Increasing evidence supports a role for an elevation of homocysteine in schizophrenia. It has been demonstrated that neural tube defects are related to a genetic defect in homocysteine metabolism. Sufficient intake of folic acid is believed to reduce this risk by enhancing methylation of homocysteine and its conversion to methionine, thereby compensating for this genetic defect. Plasma homocysteine levels are elevated when folate levels are in the lower half of the normal range. (PMID 16143442 ).</description>
		<cas>462-10-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(CCSSCCC(N)C(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C8H16N2O4S2</moldb_formula>
		<moldb_inchi>InChI=1S/C8H16N2O4S2/c9-5(7(11)12)1-3-15-16-4-2-6(10)8(13)14/h5-6H,1-4,9-10H2,(H,11,12)(H,13,14)</moldb_inchi>
		<moldb_inchikey>ZTVZLYBCZNMWCF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>268.3540</moldb_average_mass>
		<moldb_mono_mass>268.055148390</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>185</id>
		<lmdb_id>LMDB00185</lmdb_id>
		<created_at>2016-07-13 19:44:13</created_at>
		<updated_at>2016-07-19 23:39:13</updated_at>
		<export>1</export>
		<name>Potassium</name>
		<description>Potassium is an essential electrolyte. Potassium balance is crucial for regulating the excitability of nerves and muscles and so critical for regulating contractility of cardiac muscle. Although the most important changes seen in the presence of deranged potassium are cardiac, smooth muscle is also affected with increasing muscle weakness, a feature of both hyperkalaemia and hypokalaemia. Physiologically, it exists as an ion in the body. Potassium (K+) is a positively charged electrolyte, cation, which is present throughout the body in both intracellular and extracellular fluids. The majority of body potassium, &gt;90%, are intracellular. It moves freely from intracellular fluid (ICF) to extracellular fluid (ECF) and vice versa when adenosine triphosphate increases the permeability of the cell membrane. It is mainly replaced inside or outside the cells by another cation, sodium (Na+). The movement of potassium into or out of the cells is linked to certain body hormones and also to certain physiological states. Standard laboratory tests measure ECF potassium. Potassium enters the body rapidly during food ingestion. Insulin is produced when a meal is eaten; this causes the temporary movement of potassium from ECF to ICF. Over the ensuing hours, the kidneys excrete the ingested potassium and homeostasis is returned. In the critically ill patient, suffering from hyperkalaemia, this mechanism can be manipulated beneficially by administering high concentration (50%) intravenous glucose. Insulin can be added to the glucose, but glucose alone will stimulate insulin production and cause movement of potassium from ECF to ICF. The stimulation of alpha receptors causes increased movement of potassium from ICF to ECF. A noradrenaline infusion can elevate serum potassium levels. An adrenaline infusion, or elevated adrenaline levels, can lower serum potassium levels. Metabolic acidosis causes a rise in extracellular potassium levels. In this situation, excess of hydrogen ions (H+) are exchanged for intracellular potassium ions, probably as a result of the cellular response to a falling blood pH. Metabolic alkalosis causes the opposite effect, with potassium moving into the cells. (PMID: 17883675).</description>
		<cas>7440-09-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[K+]</moldb_smiles>
		<moldb_formula>K</moldb_formula>
		<moldb_inchi>InChI=1S/K/q+1</moldb_inchi>
		<moldb_inchikey>NPYPAHLBTDXSSS-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>39.0983</moldb_average_mass>
		<moldb_mono_mass>38.963706861</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>186</id>
		<lmdb_id>LMDB00186</lmdb_id>
		<created_at>2016-07-13 19:44:14</created_at>
		<updated_at>2016-09-23 18:44:53</updated_at>
		<export>1</export>
		<name>Sodium</name>
		<description>Sodium ions are necessary for regulation of blood and body fluids, transmission of nerve impulses, heart activity, and certain metabolic functions. Physiologically, it exists as an ion in the body. Sodium is needed by animals, which maintain high concentrations in their blood and extracellular fluids, but the ion is not needed by plants. The animal requirement for sodium in the diet is less than 500 mg per day, which is typically less than a tenth as much as many diets &quot;seasoned to taste.&quot; Most people consume far more sodium than is physiologically needed. For certain people with salt-sensitive blood pressure, this extra intake may cause a negative effect on health.</description>
		<cas>7440-23-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Na+]</moldb_smiles>
		<moldb_formula>Na</moldb_formula>
		<moldb_inchi>InChI=1S/Na/q+1</moldb_inchi>
		<moldb_inchikey>FKNQFGJONOIPTF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>22.9898</moldb_average_mass>
		<moldb_mono_mass>22.989769675</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>187</id>
		<lmdb_id>LMDB00187</lmdb_id>
		<created_at>2016-07-13 19:44:16</created_at>
		<updated_at>2016-07-19 23:35:50</updated_at>
		<export>1</export>
		<name>Sulfide</name>
		<description>A†sulfide†or sulphide (UK) is an†anion†of†sulfur†in its lowest oxidation state†of 2-.†Sulfide†is also a slightly archaic term for†thioethers, a common type oforganosulfur compound†that are well known for their bad odors. Sulfides are moderately strong reducing agents. They react with oxygen in the air in elevated temperatures to form higher-valence sulfur salts, such as†sulfates†and†sulfur dioxide. (Wikipedia). Sulfur (Greek is theion) is the chemical element in the periodic table that has the symbol S and atomic number 16. It is an abundant, tasteless, odorless, multivalent non-metal. Sulfur, in its native form, is a yellow crystalline solid. In nature, it can be found as the pure element or as sulfide and sulfate minerals. It is an essential element for life, and is widely used in biochemical processes. Sulfur is an important part of many enzymes and also in antioxidant molecules like glutathione and thioredoxin. The amino acids cysteine and methionine contain sulfur, as do all polypeptides, proteins, and enzymes which contain these amino acids. This makes sulfur a necessary component of all living cells. Disulfide bonds between polypeptides are very important in protein assembly and structure. They are largely responsible for the mechanical strength and insolubility of the protein keratin, found in outer skin, hair, and feathers, and the element contributes to their pungent odor when burned. (Wikipedia). Homocysteine and taurine are also sulfur containing amino acids but are not coded for by DNA nor are they part of the primary structure of proteins. Some forms of bacteria use hydrogen sulfide (H2S) in the place of water as the electron donor in a primitive photosynthesis-like process. Sulfur is absorbed by plants via the roots from soil as the sulfate ion and reduced to sulfide before it is incorporated into cysteine and other organic sulfur compounds (sulfur assimilation). Inorganic sulfur forms a part of iron-sulfur clusters, and sulfur is the bridging ligand in the CuA site of cytochrome c oxidase. Sulfur is an important component of coenzyme A. At room temperature, sulfur is a soft bright yellow solid. Although sulfur is blamed for the smell of rotten eggs elemental sulfur has only the faintest odor (the odor associated with rotten eggs is actually due to hydrogen sulfide and organic sulfur compounds). It burns with a blue flame that emits sulfur dioxide, notable for its peculiar suffocating odor. Sulfur is insoluble in water but soluble in carbon disulfide and to a lesser extent in other organic solvents such as benzene. Through its major derivative, sulfuric acid (H2SO4), sulfur ranks as one of the more important industrial raw materials. It is of prime importance to every sector of the world's economies. The Latin name of the element is sulfur with an F. Since it is an original Latin name and not a Classical Greek loan, the fricative phoneme is indeed denoted with f rather than ph. Its commercial uses are primarily in fertilizers, but it is also widely used in gunpowder, matches, insecticides and fungicides; A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed.) The burning of coal and petroleum by industry and power plants liberates huge amounts of sulfur dioxide (SO2) which reacts with atmospheric water and oxygen to produce sulfuric acid. This sulfuric acid is a component of acid rain, which lowers the pH of soil and freshwater bodies, resulting in substantial damage to the natural environment and chemical weathering of statues and architecture.</description>
		<cas>18496-25-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[S--]</moldb_smiles>
		<moldb_formula>S</moldb_formula>
		<moldb_inchi>InChI=1S/S/q-2</moldb_inchi>
		<moldb_inchikey>UCKMPCXJQFINFW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>32.0650</moldb_average_mass>
		<moldb_mono_mass>31.972070690</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>188</id>
		<lmdb_id>LMDB00188</lmdb_id>
		<created_at>2016-07-13 19:44:17</created_at>
		<updated_at>2016-09-23 18:44:53</updated_at>
		<export>1</export>
		<name>Chromium</name>
		<description>Chromium is a naturally occurring heavy metal found in the environment commonly in trivalent, Cr(III), and hexavalent, Cr(VI), forms. The reduction of Cr(VI) to Cr(III) results in the formation of reactive intermediates that contribute to the cytotoxicity, genotoxicity and carcinogenicity of Cr(VI)-containing compounds. The major non-occupational source of chromium for animals is food such as vegetables, meat, urban air, hip or knee prostheses and cigarettes. Cr(VI) is a widely used in industrial chemicals, extensively used in paints, metal finishes, steel including stainless steel manufacturing, alloy cast irons, chrome and wood treatment. On the contrary, Cr(III) salts such as chromium polynicotinate, chromium chloride and chromium picolinate (CrP) are used as micronutrients and nutritional supplements and have been demonstrated to exhibit a significant number of health benefits in animals and animals. Physiologically, it exists as an ion in the body. Chromium enters the body through the lungs, gastro-intestinal tract and to a lesser extent through skin. Inhalation is the most important route for occupational exposure, whereas non-occupational exposure occurs via ingestion of chromium-containing food and water. Regardless of route of exposure Cr(III) is poorly absorbed whereas Cr(VI) is more readily absorbed. Further, absorption of Cr(VI) is poorer by oral route, it is thus not very toxic when introduced by the oral route. But chromium is very toxic by dermal and inhalation routes and causes lung cancer, nasal irritation, nasal ulcer, hypersensitivity reactions and contact dermatitis. All the ingested Cr(VI) is reduced to Cr(III) before entering in the blood stream. The main routes for the excretion of chromium are via kidney/urine and the bile/feces. Cr(III) is unable to enter into the cells but Cr(VI) enters through membrane anionic transporters. Intracellular Cr(VI) is metabolically reduced to Cr(III). Cr(VI) does not react with macromolecules such as DNA, RNA, proteins and lipids. However, both Cr(III) and the reductional intermediate Cr(V) are capable of co-ordinate, covalent interactions with macromolecules. Chromium is an essential nutrient required by the animal body to promote the action of insulin for the utilization of sugars, proteins and fats. CrP has been used as nutritional supplement; it controls blood sugar in diabetes and may reduce cholesterol and blood pressure levels. Chromium increases insulin binding to cells, insulin receptor number and activates insulin receptor kinase leading to increased insulin sensitivity. But high doses of chromium and long term exposure of it can give rise to various, cytotoxic and genotoxic reactions that affect the immune system of the body. However, the mechanism of the Cr(VI)-induced cytotoxicity is not entirely understood. A series of in vitro and in vivo studies have demonstrated that Cr(VI) induces oxidative stress through enhanced production of reactive oxygen species (ROS) leading to genomic DNA damage and oxidative deterioration of lipids and proteins. A cascade of cellular events occur following Cr(VI)-induced oxidative stress including enhanced production of superoxide anion and hydroxyl radicals, increased lipid peroxidation and genomic DNA fragmentation, modulation of intracellular oxidized states, activation of protein kinase C, apoptotic cell death and altered gene expression. Some of the factors in determining the biological outcome of chromium exposure include the bioavailability, solubility of chromium compounds and chemical speciation, intracellular reduction and interaction with DNA. The chromium genotoxicity manifests as several types of DNA lesions, gene mutations and inhibition of macromolecular synthesis. Further, chromium exposure may lead to apoptosis, premature terminal growth arrest or neoplastic transformation. Chromium-induced tumor suppressor gene p53 and oxidative processes are some of the major factors that may determine the cellular outcome. Studies have utilized these approaches to understand the interrelationship between chromium-induced genotoxicity, apoptosis and effects on immune response. (PMID: 12208600).</description>
		<cas>7440-47-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Cr+3]</moldb_smiles>
		<moldb_formula>Cr</moldb_formula>
		<moldb_inchi>InChI=1S/Cr/q+3</moldb_inchi>
		<moldb_inchikey>BFGKITSFLPAWGI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>51.9961</moldb_average_mass>
		<moldb_mono_mass>51.940511904</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>189</id>
		<lmdb_id>LMDB00189</lmdb_id>
		<created_at>2016-07-13 19:44:18</created_at>
		<updated_at>2016-07-20 20:57:29</updated_at>
		<export>1</export>
		<name>D-2-Hydroxyglutaric acid</name>
		<description>D-2-Hydroxyglutaric acid is a biochemical hallmark of the inherited neurometabolic disorder D-2-hydroxyglutaric aciduria. D-2-hydroxyglutaric aciduria (caused by loss of D2HGDH or gain of function of IDH) is rare, with symptoms including cancer, macrocephaly, cardiomyopathy, mental retardation, hypotonia, and cortical blindness. An elevated urine level of D-2-hydroxyglutarate has been reported patient with spondyloenchondrodysplasia (OMIM 271550).  D-2-hydroxyglutarate can be converted to ?-ketoglutaric acid through the action of 2-hydroxyglutarate dehydrogenase (D2HGDH). Additionally, the enzyme D-3-phosphoglycerate dehydrogenase (PHGDH) can catalyze the NADH-dependent reduction of ?-ketoglutarate (AKG) to D-2-hydroxyglutarate (D-2HG). Nyhan et al. (1995) described 3 female patients, 2 of them sibs, who were found to have excess accumulation of D-2-hydroxyglutaric acid in the urine. The phenotype was quite variable, even among the sibs, but included mental retardation, macrocephaly with cerebral atrophy, hypotonia, seizures, and involuntary movements. One of the patients developed severe intermittent vomiting and was given a pyloromyotomy. The electroencephalogram demonstrated hypsarrhythmia. There was an increased concentration of protein in cerebrospinal fluid, an unusual finding in inborn errors of metabolism (OMIM 600721). D-2-Hydroxyglutaric acid is also considered to be an oncometabolite (or cancer-causing metabolite). It can be produced via gain-of-function mutations in the cytosolic and mitochondrial isoforms of isocitrate dehydrogenase (IDH). IDH is part of TCA cycle and this compound is generated in high abundance when IDH is mutated. D-2-hydroxyglutarate is sufficiently similar in structure to 2-oxogluratate (2OG) that it is able to inhibit a range of 2OG-dependent dioxygenases, including histone lysine demethylases (KDMs) and members of the ten-eleven translocation (TET) family of 5-methylcytosine (5mC) hydroxylases. This inhibitory effect leads to alterations in the hypoxia induced factor (HIF)-mediated hypoxic response and alterations in gene expression through global epigenetic remodeling. The net effect is that D-2-hydroxyglutarate causes a cascading effect that leads genetic perturbations and malignant transformation.</description>
		<cas>2889-31-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@H](CCC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H8O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H8O5/c6-3(5(9)10)1-2-4(7)8/h3,6H,1-2H2,(H,7,8)(H,9,10)/t3-/m1/s1</moldb_inchi>
		<moldb_inchikey>HWXBTNAVRSUOJR-GSVOUGTGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>148.1140</moldb_average_mass>
		<moldb_mono_mass>148.037173366</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>190</id>
		<lmdb_id>LMDB00190</lmdb_id>
		<created_at>2016-07-13 19:44:20</created_at>
		<updated_at>2016-07-19 23:35:14</updated_at>
		<export>1</export>
		<name>Cyanocobalamin</name>
		<description>Cyanocobalamin (commonly known as Vitamin B12) is the most chemically complex of all the vitamins. Cyanocobalamin's structure is based on a corrin ring, which, although similar to the porphyrin ring found in heme, chlorophyll, and cytochrome, has two of the pyrrole rings directly bonded. The central metal ion is Co (cobalt). Cyanocobalamin cannot be made by plants or by animals, as the only type of organisms that have the enzymes required for the synthesis of cyanocobalamin are bacteria and archaea. Higher plants do not concentrate cyanocobalamin from the soil and so are a poor source of the substance as compared with animal tissues. Cyanocobalamin is naturally found in foods including meat (especially liver and shellfish), eggs, and milk products.</description>
		<cas>68-19-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@@H]([C@H](O)[C@@H]1OP(O)(=O)O[C@]([H])(C)CNC(=O)CC[C@]1(C)[C@@H](CC(=O)N)[C@@]2([H])N([Co]C#N)\C1=C(C)/C1=N/C(=C\C3=N\C(=C(C)/C4=N[C@]2(C)[C@@](C)(CC(=O)N)[C@@H]4CCC(=O)N)\[C@@](C)(CC(=O)N)[C@@H]3CCC(=O)N)/C(C)(C)[C@@H]1CCC(=O)N)N1C=NC2=CC(C)=C(C)C=C12</moldb_smiles>
		<moldb_formula>C63H89CoN14O14P</moldb_formula>
		<moldb_inchi>InChI=1S/C62H90N13O14P.CN.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;1-2;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;/q;;+1/p-1/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;;/m1../s1</moldb_inchi>
		<moldb_inchikey>SEKGMJVHSBBHRD-WZHZPDAFSA-M</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>1356.3731</moldb_average_mass>
		<moldb_mono_mass>1355.575230332</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>191</id>
		<lmdb_id>LMDB00191</lmdb_id>
		<created_at>2016-07-13 19:44:21</created_at>
		<updated_at>2016-07-20 20:57:32</updated_at>
		<export>1</export>
		<name>Erythronic acid</name>
		<description>Erythronic acid is a sugar component of aqueous humour (eye). It may be derived from glycated proteins or from degradation of ascorbic acid. Erythronic acid is a normal organic acid present in a healthy adult and pediatric population. It has been found in urine, plasma, CSF and synovial fluid. (PMID: 14708889, 8087979, 8376520, 10420182). Erythronic acid is formed when N-Acetyl-D-glucosamine (GlcNAc) is oxidised. GlcNAc is a constituent of hyaluronic acid (HA), a polysaccharide consisting of alternating units of Glucuronic acid and GlcNAc, present as an aqueous solution in synovial fluid. In synovial fluid of patients suffering from rheumatoid arthritis, HA is thought to be degraded either by radicals generated by Fenton chemistry (Fe2+/H2O2) or by NaOCl generated by myeloperoxidase. (PMID: 10614067).</description>
		<cas>13752-84-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@@H](O)[C@@H](O)C(O)=O</moldb_smiles>
		<moldb_formula>C4H8O5</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8O5/c5-1-2(6)3(7)4(8)9/h2-3,5-7H,1H2,(H,8,9)/t2-,3-/m1/s1</moldb_inchi>
		<moldb_inchikey>JPIJQSOTBSSVTP-PWNYCUMCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>136.1033</moldb_average_mass>
		<moldb_mono_mass>136.037173366</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>192</id>
		<lmdb_id>LMDB00192</lmdb_id>
		<created_at>2016-07-13 19:44:22</created_at>
		<updated_at>2016-07-20 20:57:33</updated_at>
		<export>1</export>
		<name>D-Ribulose 5-phosphate</name>
		<description>D-Ribulose 5-phosphate is a metabolite in the Pentose phosphate pathway, Pentose and glucuronate interconversions, and in the Riboflavin metabolism (KEGG).</description>
		<cas>4151-19-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC(=O)[C@H](O)[C@H](O)COP(O)(O)=O</moldb_smiles>
		<moldb_formula>C5H11O8P</moldb_formula>
		<moldb_inchi>InChI=1S/C5H11O8P/c6-1-3(7)5(9)4(8)2-13-14(10,11)12/h4-6,8-9H,1-2H2,(H2,10,11,12)/t4-,5+/m1/s1</moldb_inchi>
		<moldb_inchikey>FNZLKVNUWIIPSJ-UHNVWZDZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>230.1098</moldb_average_mass>
		<moldb_mono_mass>230.019153840</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>193</id>
		<lmdb_id>LMDB00193</lmdb_id>
		<created_at>2016-07-13 19:44:24</created_at>
		<updated_at>2018-04-30 21:14:38</updated_at>
		<export>1</export>
		<name>Cholic acid</name>
		<description>Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).</description>
		<cas>81-25-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(O)=O</moldb_smiles>
		<moldb_formula>C24H40O5</moldb_formula>
		<moldb_inchi>InChI=1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/t13-,14+,15-,16-,17+,18+,19-,20+,22+,23+,24-/m1/s1</moldb_inchi>
		<moldb_inchikey>BHQCQFFYRZLCQQ-OELDTZBJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>408.5714</moldb_average_mass>
		<moldb_mono_mass>408.287574390</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>194</id>
		<lmdb_id>LMDB00194</lmdb_id>
		<created_at>2016-07-13 19:44:25</created_at>
		<updated_at>2016-07-20 20:57:36</updated_at>
		<export>1</export>
		<name>Gluconic acid</name>
		<description>Gluconic acid occurs naturally in fruit, honey and wine and is used as a food additive, an acidity regulator. It is also used in cleaning products where it helps cleaning up mineral deposits. It is a strong chelating agent, especially in alkaline solution. It chelates the anions of calcium, iron, aluminium, copper, and other heavy metals. Glucono delta lactone is a cyclic ester of D-gluconic acid.</description>
		<cas>526-95-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H12O7</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-5,7-11H,1H2,(H,12,13)/t2-,3-,4+,5-/m1/s1</moldb_inchi>
		<moldb_inchikey>RGHNJXZEOKUKBD-SQOUGZDYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>196.1553</moldb_average_mass>
		<moldb_mono_mass>196.058302738</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>195</id>
		<lmdb_id>LMDB00195</lmdb_id>
		<created_at>2016-07-13 19:44:26</created_at>
		<updated_at>2018-04-30 21:14:38</updated_at>
		<export>1</export>
		<name>Deoxycholic acid</name>
		<description>Deoxycholic acid is a bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).</description>
		<cas>83-44-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(O)=O</moldb_smiles>
		<moldb_formula>C24H40O4</moldb_formula>
		<moldb_inchi>InChI=1S/C24H40O4/c1-14(4-9-22(27)28)18-7-8-19-17-6-5-15-12-16(25)10-11-23(15,2)20(17)13-21(26)24(18,19)3/h14-21,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15-,16-,17+,18-,19+,20+,21+,23+,24-/m1/s1</moldb_inchi>
		<moldb_inchikey>KXGVEGMKQFWNSR-LLQZFEROSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>392.5720</moldb_average_mass>
		<moldb_mono_mass>392.292659768</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>196</id>
		<lmdb_id>LMDB00196</lmdb_id>
		<created_at>2016-07-13 19:44:28</created_at>
		<updated_at>2016-07-20 20:57:38</updated_at>
		<export>1</export>
		<name>Cytosine</name>
		<description>Cytosine is a pyrimidine base that is a fundamental unit of nucleic acids. The deamination of cytosine alone is apparent and the nucleotide of cytosine is the prime mutagenic nucleotide in leukaemia and cancer.</description>
		<cas>71-30-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1=CC=NC(=O)N1</moldb_smiles>
		<moldb_formula>C4H5N3O</moldb_formula>
		<moldb_inchi>InChI=1S/C4H5N3O/c5-3-1-2-6-4(8)7-3/h1-2H,(H3,5,6,7,8)</moldb_inchi>
		<moldb_inchikey>OPTASPLRGRRNAP-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>111.1020</moldb_average_mass>
		<moldb_mono_mass>111.043261797</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>197</id>
		<lmdb_id>LMDB00197</lmdb_id>
		<created_at>2016-07-13 19:44:30</created_at>
		<updated_at>2016-07-20 20:57:38</updated_at>
		<export>1</export>
		<name>Citraconic acid</name>
		<description>Mesaconic acid is one of several isomeric carboxylic acids obtained from citric acid. Is used as a fire retardant, recent studies revealed this acid is a competitive inhibitor of fumarate reduction.</description>
		<cas>498-23-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C\C(=C\C(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H6O4</moldb_formula>
		<moldb_inchi>InChI=1S/C5H6O4/c1-3(5(8)9)2-4(6)7/h2H,1H3,(H,6,7)(H,8,9)/b3-2-</moldb_inchi>
		<moldb_inchikey>HNEGQIOMVPPMNR-IHWYPQMZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>130.0987</moldb_average_mass>
		<moldb_mono_mass>130.026608680</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>198</id>
		<lmdb_id>LMDB00198</lmdb_id>
		<created_at>2016-07-13 19:44:31</created_at>
		<updated_at>2016-07-20 21:03:36</updated_at>
		<export>1</export>
		<name>Chenodeoxycholic acid glycine conjugate</name>
		<description>Chenodeoxycholic acid glycine conjugate is an acyl glycine and a bile acid-glycine conugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). This compound usually exists as the sodium salt and acts as a detergent to solubilize fats for absorption and is itself absorbed. It is a cholagogue and choleretic.</description>
		<cas>640-79-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12C[C@H](O)CC[C@]1(C)C1CC[C@]3(C)[C@H](CCC3C1[C@H](O)C2)[C@H](C)CCC(=O)NCC(O)=O</moldb_smiles>
		<moldb_formula>C26H43NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19?,20?,21-,24?,25+,26-/m1/s1</moldb_inchi>
		<moldb_inchikey>GHCZAUBVMUEKKP-AHBZRTSYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>449.6233</moldb_average_mass>
		<moldb_mono_mass>449.314123491</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>199</id>
		<lmdb_id>LMDB00199</lmdb_id>
		<created_at>2016-07-13 19:44:33</created_at>
		<updated_at>2016-07-20 20:51:46</updated_at>
		<export>1</export>
		<name>Dodecanoic acid</name>
		<description>Lauric acid, or dodecanoic acid is the main fatty acid in coconut oil and in palm kernel oil, and is believed to have antimicrobial properties. It is a white, powdery solid with a faint odor of bay oil. Lauric acid, although slightly irritating to mucous membranes, has a very low toxicity and so is used in many soaps and shampoos.</description>
		<cas>143-07-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C12H24O2</moldb_formula>
		<moldb_inchi>InChI=1S/C12H24O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2-11H2,1H3,(H,13,14)</moldb_inchi>
		<moldb_inchikey>POULHZVOKOAJMA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>200.3178</moldb_average_mass>
		<moldb_mono_mass>200.177630012</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>200</id>
		<lmdb_id>LMDB00200</lmdb_id>
		<created_at>2016-07-13 19:44:34</created_at>
		<updated_at>2016-07-20 20:57:43</updated_at>
		<export>1</export>
		<name>Galactaric acid</name>
		<description>Galactaric acid is the dicarboxylic sugar acid resulting from oxidation glactose with dilute nitric acid. It is a substrate of galactarate O-hydroxycinnamoyltransferase [EC 2.3.1.130]. (KEGG).</description>
		<cas>526-99-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@@H]([C@@H](O)[C@H](O)C(O)=O)[C@@H](O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H10O8</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O8/c7-1(3(9)5(11)12)2(8)4(10)6(13)14/h1-4,7-10H,(H,11,12)(H,13,14)/t1-,2+,3+,4-</moldb_inchi>
		<moldb_inchikey>DSLZVSRJTYRBFB-DUHBMQHGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>210.1388</moldb_average_mass>
		<moldb_mono_mass>210.037567296</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>201</id>
		<lmdb_id>LMDB00201</lmdb_id>
		<created_at>2016-07-13 19:44:35</created_at>
		<updated_at>2016-07-20 20:57:44</updated_at>
		<export>1</export>
		<name>Levoglucosan</name>
		<description>Levoglucosan is an anhydrohexose that is the 1,6-anhydro-derivative of beta-D-glucopyranose. It is formed from the pyrolysis of carbohydrates, such as starch and cellulose. As a result, levoglucosan is often used as a chemical tracer for biomass burning in atmospheric chemistry studies, particularly with respect to airborne particulate matter. Levoglucosan in urine has been shown to be highly correlated with regional fires and as a biomarker for wood smoke exposure (PMID: 19165390). This is because the gas emitted by the pyrolysis of wood (biomass) contains significant amounts of levoglucosan. The hydrolysis of levoglucosan generates the fermentable sugar glucose, and therefore lignocellulosic material exhibits great potential as a renewable feedstock for the production of bioethanol. Levoglucosan can also be utilized in the synthesis of chiral polymers such as unhydrolysable glucose polymers. Levoglucosan is also produced via caramelization of sugar. Consumption of caramel or caramel-containing sweets can lead to a short-term 5X increase in urinary levels of Levoglucosan (from 20 uM/mM creatinine to 100 uM/mM creatinine) (PMID: 19707249). Urinary levoglucosan levels increase within 2 h of caramel consumption and return to pre-exposure levels within 24 h. These data suggest that diet is a major factor in determining urinary Levoglucosan levels and that recent dietary history needs to be taken into account to use Levoglucosan as a marker for wood smoke exposure. Excretory levels of Levoglucosan vary widely from zero up to 5.3 mmol/l. (PMID: 3757263 , 16448658 , 16317539 ).</description>
		<cas>498-07-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12OC[C@@H](O1)[C@@H](O)[C@H](O)[C@H]2O</moldb_smiles>
		<moldb_formula>C6H10O5</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O5/c7-3-2-1-10-6(11-2)5(9)4(3)8/h2-9H,1H2/t2-,3-,4+,5-,6-/m1/s1</moldb_inchi>
		<moldb_inchikey>TWNIBLMWSKIRAT-VFUOTHLCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>162.1406</moldb_average_mass>
		<moldb_mono_mass>162.052823430</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>202</id>
		<lmdb_id>LMDB00202</lmdb_id>
		<created_at>2016-07-13 19:44:37</created_at>
		<updated_at>2016-09-23 18:44:54</updated_at>
		<export>1</export>
		<name>L-Glutamine</name>
		<description>Glutamine (Gln) is one of the 20 amino acids encoded by the standard genetic code. In animals it is considered a non-essential amino acid. Structurally, glutamine is similar to the amino acid glutamic acid. However, instead of having a terminal carboxylic acid, it has an amide. Enzymatically, glutamine is formed by replacing a side-chain hydroxyl of glutamic acid with an amine functional group. Glutamine is found in foods high in proteins, such as fish, red meat, beans, and dairy products. Glutamine is often used as a supplement in weightlifting, bodybuilding, endurance and other sports, as well as by those who suffer from muscular cramps or pain -- particularly elderly people. The main use of glutamine within the diet of either group is as a means of replenishing the body's stores of amino acids that have been used during exercise or everyday activities. Studies which have looked into problems with excessive consumption of glutamine thus far have proved inconclusive. However, normal supplementation is healthy mainly because glutamine is supposed to be supplemented after prolonged periods of exercise (for example, a workout or exercise in which amino acids are required for use) and replenishes amino acid stores. This is one of the main reasons glutamine is recommended during fasting or for people who suffer from physical trauma, immune deficiencies, or cancer. There is a significant body of evidence that links glutamine-enriched diets with positive intestinal effects. These include maintenance of gut barrier function, aiding intestinal cell proliferation and differentiation, as well as generally reducing septic morbidity and the symptoms of Irritable Bowel Syndrome (IBS). The reason for such &quot;cleansing&quot; properties is thought to stem from the fact that the intestinal extraction rate of glutamine is higher than that for other amino acids, and is therefore thought to be the most viable option when attempting to alleviate conditions relating to the gastrointestinal tract. These conditions were discovered after comparing plasma concentration within the gut between glutamine-enriched and non glutamine-enriched diets. However, even though glutamine is thought to have &quot;cleansing&quot; properties and effects, it is unknown to what extent glutamine has clinical benefits, due to the varied concentrations of glutamine in varieties of food. It is also known that glutamine has positive effects in reducing healing time after operations. Hospital waiting times after abdominal surgery are reduced by providing parenteral nutrition regimens containing amounts of glutamine to patients. Clinical trials have revealed that patients on supplementation regimes containing glutamine have improved nitrogen balances, generation of cysteinyl-leukotrienes from polymorphonuclear neutrophil granulocytes and improved lymphocyte recovery and intestinal permeability (in postoperative patients) - in comparison to those who had no glutamine within their dietary regime; all without any side-effects. (http://en.wikipedia.org/wiki/glutamine). Glutamine is now identified as an important fuel source for a number of cancers. In particular, the conversion of glutamine to lactate via a process called glutaminolysis is a mechanism that complements aerobic glycolysis (the conversion of glucose to lactate). Glutaminolysis incorporates parts of the citrate cycle and the malate-aspartate shuttle. The reaction steps of glutaminolysis take place in both the cytosol and mitochondria. Low serum levels of glutamine and high serum levels of lactate can be a potential indicator of cancer.</description>
		<cas>56-85-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CCC(N)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H10N2O3</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1</moldb_inchi>
		<moldb_inchikey>ZDXPYRJPNDTMRX-VKHMYHEASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>146.1445</moldb_average_mass>
		<moldb_mono_mass>146.069142196</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>203</id>
		<lmdb_id>LMDB00203</lmdb_id>
		<created_at>2016-07-13 19:44:38</created_at>
		<updated_at>2016-07-20 20:31:04</updated_at>
		<export>1</export>
		<name>Galactose 1-phosphate</name>
		<description>Galactose 1-phosphate is an intermediate in the Galactose metabolism. and Nucleotide sugars metabolism pathways (KEGG). Galactose-1-phosphate is an intermediate in the intraconversion of glucose and galactose. It is formed from galactose by galactokinase. (Wikipeida).</description>
		<cas>2255-14-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C6H13O9P</moldb_formula>
		<moldb_inchi>InChI=1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/t2-,3+,4+,5-,6-/m1/s1</moldb_inchi>
		<moldb_inchikey>HXXFSFRBOHSIMQ-FPRJBGLDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>260.1358</moldb_average_mass>
		<moldb_mono_mass>260.029718526</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>204</id>
		<lmdb_id>LMDB00204</lmdb_id>
		<created_at>2016-07-13 19:44:39</created_at>
		<updated_at>2016-09-23 18:44:54</updated_at>
		<export>1</export>
		<name>Copper</name>
		<description>Copper is an essential nutrient to all higher plants and animals. Physiologically, it exists as an ion in the body. In animals, it is found primarily in the bloodstream, as a cofactor in various enzymes, and in copper-based pigments. In the body, copper shifts between the cuprous (Cu1+) and cupric (Cu2+) forms, though the majority of the body's copper is in the Cu2+ form. The ability of copper to easily accept and donate electrons explains its important role in oxidation-reduction (redox) reactions and in scavenging free radicals. Copper is a critical functional component of a number of essential enzymes known as cuproenzymes. For instance, the copper-dependent enzyme, cytochrome c oxidase, plays a critical role in cellular energy production. By catalyzing the reduction of molecular oxygen (O2) to water (H2O), cytochrome c oxidase generates an electrical gradient used by the mitochondria to create the vital energy-storing molecule, ATP. Another cuproenzyme, lysyl oxidase, is required for the cross-linking of collagen and elastin, which are essential for the formation of strong and flexible connective tissue. Another cuproeznyme, Monoamine oxidase (MAO), plays a role in the metabolism of the neurotransmitters norepinephrine, epinephrine, and dopamine. MAO also functions in the degradation of the neurotransmitter serotonin, which is the basis for the use of MAO inhibitors as antidepressants. One of the most important cuproenzymes is Superoxide dismutase (SOD). SOD functions as an antioxidant by catalyzing the conversion of superoxide radicals (free radicals or ROS) to hydrogen peroxide, which can subsequently be reduced to water by other antioxidant enzymes. Two forms of SOD contain copper: 1) copper/zinc SOD is found within most cells of the body, including red blood cells, and 2) extracellular SOD is a copper-containing enzyme found at high levels in the lungs and low levels in blood plasma. In sufficient amounts, copper can be poisonous or even fatal to organisms. Copper is normally bound to cuproenzymes (such as SOD, MOA) and is thus only toxic when unsequestered and unmediated. It is believed that zinc and copper compete for absorption in the digestive tract so that a diet that is excessive in one of these minerals may result in a deficiency in the other. An imbalance of zinc and copper status might be involved in animal hypertension.</description>
		<cas>7440-50-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Cu++]</moldb_smiles>
		<moldb_formula>Cu</moldb_formula>
		<moldb_inchi>InChI=1S/Cu/q+2</moldb_inchi>
		<moldb_inchikey>JPVYNHNXODAKFH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>63.5460</moldb_average_mass>
		<moldb_mono_mass>62.929601079</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>205</id>
		<lmdb_id>LMDB00205</lmdb_id>
		<created_at>2016-07-13 19:44:41</created_at>
		<updated_at>2016-07-20 20:57:53</updated_at>
		<export>1</export>
		<name>D-Fructose</name>
		<description>Fructose, or levulose, is a levorotatory monosaccharide and an isomer of glucose (C6H12O6). The chemical composition of fructose is (C6H12O6). Pure fructose has a sweet taste similar to cane sugar, but with a &quot;fruity&quot; aroma. Although fructose is a hexose (6 carbon sugar), it generally exists as a 5-member hemiketal ring (a furanose). This structure is responsible for the long metabolic pathway and high reactivity compared to glucose. Fructose is found in many foods and is one of the three most important blood sugars along with glucose and galactose. Honey; tree fruits; berries; melons; and some root vegetables, such as beets, sweet potatoes, parsnips and onions, contain fructose, usually in combination with sucrose and glucose. Fructose is also derived from the digestion of sucrose, a disaccharide consisting of glucose and fructose that is broken down by enzymes during digestion. Fructose is the sweetest naturally occurring sugar, estimated to be twice as sweet as sucrose. It is used as a preservative and an intravenous infusion in parenteral feeding. Fructose is a reducing sugar, as are all monosaccharides. The spontaneous addition of single sugar molecules to proteins, known as glycation, is a significant cause of damage in diabetics. Fructose appears to be as dangerous as glucose in this regard and so does not seem to be the answer for diabetes (McPherson et al, 1988). This may be an important contribution to senescence and many age-related chronic diseases (Levi &amp; Werman 1998).</description>
		<cas>53188-23-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-3-4(9)5(10)6(11,2-8)12-3/h3-5,7-11H,1-2H2/t3-,4-,5+,6-/m1/s1</moldb_inchi>
		<moldb_inchikey>RFSUNEUAIZKAJO-ARQDHWQXSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1559</moldb_average_mass>
		<moldb_mono_mass>180.063388116</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>206</id>
		<lmdb_id>LMDB00206</lmdb_id>
		<created_at>2016-07-13 19:44:42</created_at>
		<updated_at>2016-07-20 20:57:55</updated_at>
		<export>1</export>
		<name>Glutaric acid</name>
		<description>Glutaric acid is a simple five-carbon linear dicarboxylic acid. The accumulation of glutaric acid ranging from slightly or intermittently elevated urinary glutaric acid to gross organic aciduria occurs in Glutaric aciduria. Glutaric aciduria type 1 is an autosomal-recessive disorder resulting from a deficiency of mitochondrial glutaryl-CoA dehydrogenase (EC 1.3.99.7, GCDH) which is involved in the metabolism of lysine, hydroxylysine, and tryptophan. Glutaric aciduria type I lead to nonspecific developmental delay, hypotonia, and macrocephaly with cerebral atrophy of prenatal onset. Treatment is mainly based on restriction of lysine intake, supplementation of carnitine, and an intensification of therapy during intercurrent illnesses. The major principle of dietary treatment is to reduce the production of glutaric acid and 3-hydroxyglutaric acid by restriction of natural protein in general and of lysine in particular. (PMID: 17465389, 15505398).</description>
		<cas>110-94-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CCCC(O)=O</moldb_smiles>
		<moldb_formula>C5H8O4</moldb_formula>
		<moldb_inchi>InChI=1S/C5H8O4/c6-4(7)2-1-3-5(8)9/h1-3H2,(H,6,7)(H,8,9)</moldb_inchi>
		<moldb_inchikey>JFCQEDHGNNZCLN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>132.1146</moldb_average_mass>
		<moldb_mono_mass>132.042258744</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>207</id>
		<lmdb_id>LMDB00207</lmdb_id>
		<created_at>2016-07-13 19:44:43</created_at>
		<updated_at>2016-07-20 20:57:56</updated_at>
		<export>1</export>
		<name>Heptanoic acid</name>
		<description>Heptanoic acid, also called enanthic acid, is an organic compound composed of a seven-carbon chain terminating in a carboxylic acid. It is an oily liquid with an unpleasant, rancid odor. It contributes to the odor of some rancid oils. It is slightly soluble in water, but well soluble in ethanol and ether.</description>
		<cas>111-14-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C7H14O2</moldb_formula>
		<moldb_inchi>InChI=1S/C7H14O2/c1-2-3-4-5-6-7(8)9/h2-6H2,1H3,(H,8,9)</moldb_inchi>
		<moldb_inchikey>MNWFXJYAOYHMED-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>130.1849</moldb_average_mass>
		<moldb_mono_mass>130.099379692</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>208</id>
		<lmdb_id>LMDB00208</lmdb_id>
		<created_at>2016-07-13 19:44:44</created_at>
		<updated_at>2016-09-23 18:44:54</updated_at>
		<export>1</export>
		<name>Indolelactic acid</name>
		<description>Indolelactic acid is a tryptophan metabolite found in animal plasma and serum and normal urine. Tryptophan is metabolized by two major pathways in animals, either through kynurenine or via a series of indoles, and some of its metabolites are known to be biologically active. Indolelactic acid is present in various amounts, significantly higher in umbilical foetal plasma than in maternal plasma in the protein-bound form. (PMID 2361979, 1400722, 3597614, 11060358, 1400722).</description>
		<cas>1821-52-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(CC1=CNC2=C1C=CC=C2)C(O)=O</moldb_smiles>
		<moldb_formula>C11H11NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C11H11NO3/c13-10(11(14)15)5-7-6-12-9-4-2-1-3-8(7)9/h1-4,6,10,12-13H,5H2,(H,14,15)</moldb_inchi>
		<moldb_inchikey>XGILAAMKEQUXLS-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>205.2099</moldb_average_mass>
		<moldb_mono_mass>205.073893223</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>209</id>
		<lmdb_id>LMDB00209</lmdb_id>
		<created_at>2016-07-13 19:44:46</created_at>
		<updated_at>2016-07-20 20:57:57</updated_at>
		<export>1</export>
		<name>Hexadecanedioic acid</name>
		<description>Hexadecanedioic acid is activated by mitochondrial and microsomal fractions in liver (PMID 4372285). It has an antitumor activity (PMID 14987827).</description>
		<cas>505-54-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C16H30O4</moldb_formula>
		<moldb_inchi>InChI=1S/C16H30O4/c17-15(18)13-11-9-7-5-3-1-2-4-6-8-10-12-14-16(19)20/h1-14H2,(H,17,18)(H,19,20)</moldb_inchi>
		<moldb_inchikey>QQHJDPROMQRDLA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>286.4070</moldb_average_mass>
		<moldb_mono_mass>286.214409448</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>210</id>
		<lmdb_id>LMDB00210</lmdb_id>
		<created_at>2016-07-13 19:44:47</created_at>
		<updated_at>2016-09-23 18:44:55</updated_at>
		<export>1</export>
		<name>Linoleic acid</name>
		<description>Linoleic acid is a doubly unsaturated fatty acid, also known as an omega-6 fatty acid, occurring widely in plant glycosides. In this particular polyunsaturated fatty acid (PUFA), the first double bond is located between the sixth and seventh carbon atom from the methyl end of the fatty acid (n-6). Linoleic acid is an essential fatty acid in animal nutrition because it cannot be synthesized by animals. It is used in the biosynthesis of prostaglandins (via arachidonic acid) and cell membranes. (From Stedman, 26th ed).</description>
		<cas>60-33-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-</moldb_inchi>
		<moldb_inchikey>OYHQOLUKZRVURQ-HZJYTTRNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>280.4455</moldb_average_mass>
		<moldb_mono_mass>280.240230268</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>211</id>
		<lmdb_id>LMDB00211</lmdb_id>
		<created_at>2016-07-13 19:44:48</created_at>
		<updated_at>2016-07-19 23:35:38</updated_at>
		<export>1</export>
		<name>Iodine</name>
		<description>Iodine is an essential trace element. Chemically, iodine is the least reactive of the halogens, and the most electropositive halogen after astatine. However, iodine does not occur in the free state in nature. As with all other halogens , when freed from its compounds iodine forms diatomic molecules (I2). Iodine and its compounds are primarily used in medicine, photography, and dyes. Iodine is required for the production of thyroid hormones, which are essential for normal brain development, and the fetus, newborn, and young child are particularly vulnerable to iodine deficiency. Physiologically, iodine exists as an ion in the body. The iodine requirement increases during pregnancy and recommended intakes are in the range of 220-250 microg/day. Monitoring iodine status during pregnancy is a challenge. New recommendations from World Health Organization suggest that a median urinary iodine concentration &gt;250 microg/L and &lt;500 microg/L indicates adequate iodine intake in pregnancy. Based on this range, it appears that many pregnant women in have inadequate intakes. Thyroid-stimulating hormone concentration in the newborn is a sensitive indicator of mild iodine deficiency in late pregnancy. The potential adverse effects of mild iodine deficiency during pregnancy are uncertain. Controlled trials of iodine supplementation in mildly iodine-deficient pregnant women suggest beneficial effects on maternal and newborn serum thyroglobulin and thyroid volume, but no effects on maternal and newborn total or free thyroid hormone concentrations. There are no long-term data on the effect of iodine supplementation on birth outcomes or infant development. New data from well-controlled studies indicate that iodine repletion in moderately iodine-deficient school-age children has clear benefits: it improves cognitive and motor function; it also increases concentrations of insulin-like growth factor 1 and insulin-like growth factor-binding protein 3, and improves somatic growth. (PMID: 17956157).</description>
		<cas>7553-56-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>II</moldb_smiles>
		<moldb_formula>I2</moldb_formula>
		<moldb_inchi>InChI=1S/I2/c1-2</moldb_inchi>
		<moldb_inchikey>PNDPGZBMCMUPRI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>253.8089</moldb_average_mass>
		<moldb_mono_mass>253.808936840</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>212</id>
		<lmdb_id>LMDB00212</lmdb_id>
		<created_at>2016-07-13 19:44:50</created_at>
		<updated_at>2016-07-20 20:58:02</updated_at>
		<export>1</export>
		<name>Isovalerylglycine</name>
		<description>Isovalerylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:. acyl-CoA + glycine &lt; -- &gt; CoA + N-acylglycine. Isovalerylglycine is a byproduct of the catabolism of the aminoacid leucine. Accumulation of isovalerylglycine occurs in Isovaleric Acidemia (IVA). IVA (OMIM/ McKusick 243500) is an autosomal recessive disorder caused by mutations in the isovaleryl-CoA dehydrogenase (EC 1.3.99.10) gene. The deficiency of this enzyme in the metabolism of leucine leads to the accumulation of a series of isovaleryl-CoA metabolites, such as isovalerylglycine (IVG). It is very important to caution for false positive results when screening for isovaleric acidemia by tandem mass spectrometry based on dried blood-spot levels of C5-acylcarnitines, including isovalerylcarnitine and its isomer, pivaloylcarnitine; pivaloylcarnitine is derived from pivalate-generating antibiotics, and has caused many false-positive results. (PMID: 17850781).</description>
		<cas>16284-60-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)CC(=O)NCC(O)=O</moldb_smiles>
		<moldb_formula>C7H13NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C7H13NO3/c1-5(2)3-6(9)8-4-7(10)11/h5H,3-4H2,1-2H3,(H,8,9)(H,10,11)</moldb_inchi>
		<moldb_inchikey>ZRQXMKMBBMNNQC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>159.1830</moldb_average_mass>
		<moldb_mono_mass>159.089543287</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>213</id>
		<lmdb_id>LMDB00213</lmdb_id>
		<created_at>2016-07-13 19:44:51</created_at>
		<updated_at>2016-07-20 21:03:39</updated_at>
		<export>1</export>
		<name>Indoxyl sulfate</name>
		<description>Indoxyl sulfate is a dietary protein metabolite, and also the metabolite of the common amino acid tryptophan. Indoxyl sulfate is a circulating uremic toxin stimulating glomerular sclerosis and interstitial fibrosis. Indoxyl sulfate is one of the well known substances of a group of protein-bound uremic retention solutes. Indoxyl sulfate increases the rate of progression of renal failure. In plasma, indoxyl sulfate is a protein-bound uremic solute that induces endothelial dysfunction by inhibiting endothelial proliferation and migration in vitro. Some studies suggest that indoxyl sulfate is also involved in oxidative stress. In hemodialyzed patients, serum levels of indoxyl sulfate are associated with levels of pentosidine, a marker of carbonyl and oxidative stress; in vitro, indoxyl sulfate increases reactive oxygen species (ROS) production in tubular cells, and increases NAD(P)H oxidase activity in endothelial cells. Indoxyl sulfate impairs osteoblst function and induces abnormalities of bone turnover. Indoxyl sulfate strongly decreases the levels of glutathione, one of the most active antioxidant systems of the cell. (PMID: 10681668, 14681860, 17471003, 17403109).</description>
		<cas>487-94-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OS(=O)(=O)OC1=CNC2=CC=CC=C12</moldb_smiles>
		<moldb_formula>C8H7NO4S</moldb_formula>
		<moldb_inchi>InChI=1S/C8H7NO4S/c10-14(11,12)13-8-5-9-7-4-2-1-3-6(7)8/h1-5,9H,(H,10,11,12)</moldb_inchi>
		<moldb_inchikey>BXFFHSIDQOFMLE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>213.2100</moldb_average_mass>
		<moldb_mono_mass>213.009578407</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>214</id>
		<lmdb_id>LMDB00214</lmdb_id>
		<created_at>2016-07-13 19:44:52</created_at>
		<updated_at>2016-07-20 20:31:48</updated_at>
		<export>1</export>
		<name>L-Kynurenine</name>
		<description>Kynurenine is a metabolite of the amino acid tryptophan used in the production of niacin. L-kynurenine is a central compound of the pathway of tryptophan metabolism pathway since it can change to the neuroprotective agent kynurenic acid or to the neurotoxic agent quinolinic acid. The break-up of these endogenous compounds' balance can be observable in many disorders. It can occur in neurodegenerative disorders, such as Parkinson's disease, Huntington's and Alzheimer's disease, in stroke, in epilepsy, in multiple sclerosis, in amyotrophic lateral sclerosis, and in mental failures, such as schizophrenia and depression.</description>
		<cas>343-65-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CC(=O)C1=CC=CC=C1N)C(O)=O</moldb_smiles>
		<moldb_formula>C10H12N2O3</moldb_formula>
		<moldb_inchi>InChI=1S/C10H12N2O3/c11-7-4-2-1-3-6(7)9(13)5-8(12)10(14)15/h1-4,8H,5,11-12H2,(H,14,15)/t8-/m0/s1</moldb_inchi>
		<moldb_inchikey>YGPSJZOEDVAXAB-QMMMGPOBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>208.2139</moldb_average_mass>
		<moldb_mono_mass>208.084792260</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>215</id>
		<lmdb_id>LMDB00215</lmdb_id>
		<created_at>2016-07-13 19:44:54</created_at>
		<updated_at>2016-09-23 18:44:55</updated_at>
		<export>1</export>
		<name>L-Leucine</name>
		<description>Branched chain amino acids (BCAA) are essential amino acids whose carbon structure is marked by a branch point. These three amino acids are critical to animal life and are particularly involved in stress, energy and muscle metabolism. BCAA supplementation as therapy, both oral and intravenous, in animal health and disease holds great promise. 'BCAA' denotes valine, isoleucine and leucine which are branched chain essential amino acids. Despite their structural similarities, the branched amino acids have different metabolic routes, with valine going solely to carbohydrates, leucine solely to fats and isoleucine to both. The different metabolism accounts for different requirements for these essential amino acids in animals: 12 mg/kg, 14 mg/kg and 16 mg/kg of valine, leucine and isoleucine respectively. Furthermore, these amino acids have different deficiency symptoms. Valine deficiency is marked by neurological defects in the brain, while isoleucine deficiency is marked by muscle tremors. Many types of inborn errors of BCAA metabolism exist, and are marked by various abnormalities. The most common form is the maple syrup urine disease, marked by a characteristic urinary odor. Other abnormalities are associated with a wide range of symptoms, such as mental retardation, ataxia, hypoglycemia, spinal muscle atrophy, rash, vomiting and excessive muscle movement. Most forms of BCAA metabolism errors are corrected by dietary restriction of BCAA and at least one form is correctable by supplementation with 10 mg of biotin daily. BCAA are useful because they are metabolized primarily by muscle. Stress state- e.g surgery, trauma, cirrhosis, infections, fever and starvation--require proportionately more BCAA than other amino acids and probably proportionately more leucine than either valine or isoleucine. BCAA and other amino acids are frequently fed intravenously (TPN) to malnourished surgical patients and in some cases of severe trauma. BCAA, particularly leucine, stimulate protein synthesis, increase reutilization of amino acids in many organs and reduce protein breakdown. Furthermore, leucine can be an important source of calories, and is superior as fuel to the ubiquitous intravenous glucose (dextrose). Leucine also stimulates insulin release, which in turn stimulates protein synthesis and inhibits protein breakdown. These effects are particularly useful in athletic training. BCAA should also replace the use of steroids as commonly used by weightlifters. Huntington's chorea and anorexic disorders both are characterized by low serum BCAA. These diseases, as well as forms of Parkinson's, may respond to BCAA therapy. BCAA, and particularly leucine, are among the amino acids most essential for muscle health. (http://www.dcnutrition.com).</description>
		<cas>61-90-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)C[C@H](N)C(O)=O</moldb_smiles>
		<moldb_formula>C6H13NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1</moldb_inchi>
		<moldb_inchikey>ROHFNLRQFUQHCH-YFKPBYRVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>131.1729</moldb_average_mass>
		<moldb_mono_mass>131.094628665</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>216</id>
		<lmdb_id>LMDB00216</lmdb_id>
		<created_at>2016-07-13 19:44:55</created_at>
		<updated_at>2016-09-23 18:44:56</updated_at>
		<export>1</export>
		<name>Isovalerylcarnitine</name>
		<description>Isovalerylcarnitine is the phenotypic abnormality in isovaleric acidemia (OMIM 243500) resulting from an accumulation of isovaleric acid, which is toxic to the central nervous system. Isovaleric acidemia is an autosomal recessive inborn error of leucine metabolism caused by a deficiency of the mitochondrial enzyme isovaleryl-CoA dehydrogenase (EC 1.3.99.10) resulting in the accumulation of derivatives of isovaleryl-CoA. It was the first organic acidemia recognized in animals and can cause significant morbidity and mortality. Early diagnosis and treatment with a protein restricted diet and supplementation with carnitine and glycine are effective in promoting normal development in severely affected individuals. An alternative pathway through glycine-N-acylase (EC 2.3.1.13) allows detoxification by producing isovalerylglycine, which is excreted. Thus, isovalerylcarnitine and isovalerylglycine are the hallmarks of this disorder in plasma and urine, respectively, and are elevated regardless of a patient's metabolic condition. (PMID: 16602101).</description>
		<cas>31023-24-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)CC(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C12H23NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C12H23NO4/c1-9(2)6-12(16)17-10(7-11(14)15)8-13(3,4)5/h9-10H,6-8H2,1-5H3</moldb_inchi>
		<moldb_inchikey>IGQBPDJNUXPEMT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>245.3153</moldb_average_mass>
		<moldb_mono_mass>245.162708229</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>217</id>
		<lmdb_id>LMDB00217</lmdb_id>
		<created_at>2016-07-13 19:44:56</created_at>
		<updated_at>2016-07-20 21:03:41</updated_at>
		<export>1</export>
		<name>Malonic acid</name>
		<description>Malonic acid (IUPAC systematic name: propanedioic acid) is a dicarboxylic acid with structure CH2(COOH)2. The ionised form of malonic acid, as well as its esters and salts, are known as malonates. For example, diethyl malonate is malonic acid's ethyl ester. The name originates from Latin malum, meaning apple. Malonic acid is the archetypal example of a competitive inhibitor: it acts against succinate dehydrogenase (complex II) in the respiratory electron transport chain.</description>
		<cas>141-82-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CC(O)=O</moldb_smiles>
		<moldb_formula>C3H4O4</moldb_formula>
		<moldb_inchi>InChI=1S/C3H4O4/c4-2(5)1-3(6)7/h1H2,(H,4,5)(H,6,7)</moldb_inchi>
		<moldb_inchikey>OFOBLEOULBTSOW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>104.0615</moldb_average_mass>
		<moldb_mono_mass>104.010958616</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>218</id>
		<lmdb_id>LMDB00218</lmdb_id>
		<created_at>2016-07-13 19:44:57</created_at>
		<updated_at>2016-07-20 20:58:13</updated_at>
		<export>1</export>
		<name>Fe2+</name>
		<description>Iron is a chemical element with the symbol Fe and atomic number 26. Iron makes up 5% of the Earth's crust and is second in abundance to aluminium among the metals and fourth in abundance among the elements. Physiologically, it. exists as an ion in the body. Iron (as Fe2+, ferrous ion) is a necessary trace element used by all known living organisms. Iron-containing enzymes, usually containing heme prosthetic groups, participate in catalysis of oxidation reactions in biology, and in transport of a number of soluble gases. Iron is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Inorganic iron involved in redox reactions is also found in the iron-sulfur clusters of many enzymes, such as nitrogenase (involved in the synthesis of ammonia from nitrogen and hydrogen) and hydrogenase. A class of non-heme iron proteins is responsible for a wide range of functions such as ribonucleotide reductase (reduces ribose to deoxyribose; DNA biosynthesis) and purple acid phosphatase (hydrolysis of phosphate esters). When the body is fighting a bacterial infection, the body sequesters iron inside of cells (mostly stored in the storage molecule ferritin) so that it cannot be used by bacteria. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia. Humans experience iron toxicity above 20 milligrams of iron for every kilogram of weight, and 60 milligrams per kilogram is a lethal dose. Over-consumption of iron, often the result of children eating large quantities of ferrous sulfate tablets intended for adult consumption, is the most common toxicological cause of death in children under six. The DRI lists the Tolerable Upper Intake Level (UL) for adults as 45 mg/day. For children under fourteen years old the UL is 40 mg/day. Iron is a metal extracted from iron ore, and is almost never found in the free elemental state.</description>
		<cas>15438-31-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Fe++]</moldb_smiles>
		<moldb_formula>Fe</moldb_formula>
		<moldb_inchi>InChI=1S/Fe/q+2</moldb_inchi>
		<moldb_inchikey>CWYNVVGOOAEACU-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>55.8450</moldb_average_mass>
		<moldb_mono_mass>55.934942133</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>219</id>
		<lmdb_id>LMDB00219</lmdb_id>
		<created_at>2016-07-13 19:44:59</created_at>
		<updated_at>2018-04-30 21:14:39</updated_at>
		<export>1</export>
		<name>L-2-Hydroxyglutaric acid</name>
		<description>L-2-Hydroxyglutaric acid is a metabolite that accumulates in L-2-hydroxyglutaric aciduria (a neurometabolic disorder, OMIM 236792 ), and has been reported in multiple patients who have a clinical phenotype of progressive neurodegeneration with extrapyramidal and cerebellar signs, seizures, and spongiform changes in the white matter (OMIM 600721 ). L-2-hydroxyglutarate can be converted to ?-ketoglutaric acid through the action of L-2-hydroxyglutarate dehydrogenase (L2HGDH). L-2-Hydroxyglutaric acid is also considered to be an oncometabolite (or cancer-causing metabolite). It can be produced via gain-of-function mutations in the cytosolic and mitochondrial isoforms of isocitrate dehydrogenase (IDH). IDH is part of TCA cycle and this compound is generated in high abundance when IDH is mutated. L-2-hydroxyglutarate is sufficiently similar in structure to 2-oxogluratate (2OG) that it is able to inhibit a range of 2OG-dependent dioxygenases, including histone lysine demethylases (KDMs) and members of the ten-eleven translocation (TET) family of 5-methylcytosine (5mC) hydroxylases. This inhibitory effect leads to alterations in the hypoxia induced factor (HIF)-mediated hypoxic response and alterations in gene expression through global epigenetic remodeling. The net effect is that L-2-hydroxyglutarate causes a cascading effect that leads genetic perturbations and malignant transformation.</description>
		<cas>13095-48-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@@H](CCC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H8O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H8O5/c6-3(5(9)10)1-2-4(7)8/h3,6H,1-2H2,(H,7,8)(H,9,10)/t3-/m0/s1</moldb_inchi>
		<moldb_inchikey>HWXBTNAVRSUOJR-VKHMYHEASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>148.1140</moldb_average_mass>
		<moldb_mono_mass>148.037173366</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>220</id>
		<lmdb_id>LMDB00220</lmdb_id>
		<created_at>2016-07-13 19:45:00</created_at>
		<updated_at>2016-07-20 20:58:15</updated_at>
		<export>1</export>
		<name>Ketoleucine</name>
		<description>Ketoleucine is a metabolite that accumulates in Maple Syrup Urine Disease (MSUD) and shown to compromise brain energy metabolism by blocking the respiratory chain; this is of relevance to the understanding of the pathophysiology of the neurological dysfunction of MSUD patients. (PMID 14636955).</description>
		<cas>816-66-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)CC(=O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H10O3</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O3/c1-4(2)3-5(7)6(8)9/h4H,3H2,1-2H3,(H,8,9)</moldb_inchi>
		<moldb_inchikey>BKAJNAXTPSGJCU-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>130.1418</moldb_average_mass>
		<moldb_mono_mass>130.062994186</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>221</id>
		<lmdb_id>LMDB00221</lmdb_id>
		<created_at>2016-07-13 19:45:02</created_at>
		<updated_at>2016-09-23 18:44:56</updated_at>
		<export>1</export>
		<name>L-Methionine</name>
		<description>Methionine is a dietary indispensable amino acid required for normal growth and development of animals, other mammals, and avian species. In addition to being a substrate for protein synthesis, it is an intermediate in transmethylation reactions, serving as the major methyl group donor in vivo, including the methyl groups for DNA and RNA intermediates. Methionine is a methyl acceptor for 5-methyltetrahydrofolate-homocysteine methyl transferase (methionine synthase), the only reaction that allows for the recycling of this form of folate, and is also a methyl acceptor for the catabolism of betaine. Methionine is also required for synthesis of cysteine. Methionine is accepted as the metabolic precursor for cysteine. Only the sulfur atom from methionine is transferred to cysteine; the carbon skeleton of cysteine is donated by serine. (PMID 16702340). The adequacy range of dietary requirements of specific amino acids in disease states is difficult to determine. Requirements may not be similar in disease with regard to protein synthesis. Requirements for this purpose can be assessed only when such a function can be measured and related to clinical outcome. There is apparent consensus concerning normal sulfur amino acid (SAA) requirements. WHO recommendations amount to 13 mg/kg per 24 h in healthy adults. This amount is roughly doubled in artificial nutrition regimens. In disease or after trauma, requirements may be altered for methionine, cysteine, and taurine. Although in specific cases of congenital enzyme deficiency, prematurity, or diminished liver function, hypermethionemia or hyperhomocysteinemia may occur, SAA supplementation can be considered safe in amounts exceeding 2-3 times the minimal recommended daily intake. Apart from some very specific indications (e.g., acetaminophen poisoning) the usefulness of SAA supplementation is not yet established.(PMID 16702341). Methionine is known to exacerbate psychopathological symptoms in schizophrenic patients, there is no evidence of similar effects in healthy subjects. The role of methionine as a precursor of homocysteine is the most notable cause for concern. A &quot;loading dose&quot; of methionine (0.1 g/kg) has been given, and the resultant acute increase in plasma homocysteine has been used as an index of the susceptibility to cardiovascular disease. Although this procedure results in vascular dysfunction, this is acute and unlikely to result in permanent damage. However, a 10-fold larger dose, given mistakenly, resulted in death. Longer-term studies in adults have indicated no adverse consequences of moderate fluctuations in dietary methionine intake, but intakes higher than 5 times normal resulted in elevated homocysteine levels. These effects of methionine on homocysteine and vascular function are moderated by supplements of vitamins B-6, B-12, C, and folic acid. In infants, methionine intakes of 2 to 5 times normal resulted in impaired growth and extremely high plasma methionine levels, but no adverse long-term consequences were observed. (PMID 16702346).</description>
		<cas>63-68-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CSCC[C@H](N)C(O)=O</moldb_smiles>
		<moldb_formula>C5H11NO2S</moldb_formula>
		<moldb_inchi>InChI=1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1</moldb_inchi>
		<moldb_inchikey>FFEARJCKVFRZRR-BYPYZUCNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>149.2110</moldb_average_mass>
		<moldb_mono_mass>149.051049291</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>222</id>
		<lmdb_id>LMDB00222</lmdb_id>
		<created_at>2016-07-13 19:45:03</created_at>
		<updated_at>2016-07-19 23:16:00</updated_at>
		<export>1</export>
		<name>1-Methylnicotinamide</name>
		<description>1-Methylnicotinamide is a metabolite of nicotinamide and is produced primarily in the liver. It has anti-inflammatory properties (PMID 16197374). It is a product of nicotinamide N-methyltransferase [EC 2.1.1.1] in the pathway of nicotinate and nicotinamide metabolism (KEGG). 1-Methylnicotinamide may be an endogenous activator of prostacyclin production and thus may regulate thrombotic as well as inflammatory processes in the cardiovascular system (PMID: 17641676).</description>
		<cas>3106-60-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+]1=CC=CC(=C1)C(N)=O</moldb_smiles>
		<moldb_formula>C7H9N2O</moldb_formula>
		<moldb_inchi>InChI=1S/C7H8N2O/c1-9-4-2-3-6(5-9)7(8)10/h2-5H,1H3,(H-,8,10)/p+1</moldb_inchi>
		<moldb_inchikey>LDHMAVIPBRSVRG-UHFFFAOYSA-O</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>137.1592</moldb_average_mass>
		<moldb_mono_mass>137.071487920</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>223</id>
		<lmdb_id>LMDB00223</lmdb_id>
		<created_at>2016-07-13 19:45:04</created_at>
		<updated_at>2016-07-20 20:58:20</updated_at>
		<export>1</export>
		<name>Hydroxypropionic acid</name>
		<description>3-Hydroxypropionic acid is a carboxylic acid. It is used in the production of various chemicals such as acrylates in industry. It can be produced by certain microbes. Its chemical structure is similar to L-serine.</description>
		<cas>503-66-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCCC(O)=O</moldb_smiles>
		<moldb_formula>C3H6O3</moldb_formula>
		<moldb_inchi>InChI=1S/C3H6O3/c4-2-1-3(5)6/h4H,1-2H2,(H,5,6)</moldb_inchi>
		<moldb_inchikey>ALRHLSYJTWAHJZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>90.0779</moldb_average_mass>
		<moldb_mono_mass>90.031694058</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>224</id>
		<lmdb_id>LMDB00224</lmdb_id>
		<created_at>2016-07-13 19:45:05</created_at>
		<updated_at>2016-07-20 20:58:20</updated_at>
		<export>1</export>
		<name>4-Hydroxyphenylpyruvic acid</name>
		<description>4-Hydroxyphenylpyruvic acid (4-HPPA) is a keto acid that is involved in the tyrosine catabolism pathway. It is a product of the enzyme (R)-4-hydroxyphenyllactate dehydrogenase [EC 1.1.1.222] and is formed during tyrosine metabolism. The conversion from tyrosine to 4-HPPA is catalyzed by tyrosine aminotransferase. Additionally, 4-HPPA can be converted to homogentisic acid which is one of the precursors to ochronotic pigment. The enzyme 4-hydroxyphenylpyruvic acid dioxygenase (HPD) catalyzes the reaction that converts 4-hydroxyphenylpyruvic acid to homogentisic acid. A deficiency in the catalytic activity of HPD is known to lead to tyrosinemia type III, an autosomal recessive disorder characterized by elevated levels of blood tyrosine and massive excretion of tyrosine derivatives into urine. It has been shown that hawkinsinuria, an autosomal dominant disorder characterized by the excretion of 'hawkinsin,' may also be a result of HPD deficiency (PMID: 11073718). There are two isomers of HPPA, specifically 4HPPA and 3HPPA, of which 4HPPA is the most common.</description>
		<cas>156-39-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C(=O)CC1=CC=C(O)C=C1</moldb_smiles>
		<moldb_formula>C9H8O4</moldb_formula>
		<moldb_inchi>InChI=1S/C9H8O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,10H,5H2,(H,12,13)</moldb_inchi>
		<moldb_inchikey>KKADPXVIOXHVKN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1574</moldb_average_mass>
		<moldb_mono_mass>180.042258744</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>225</id>
		<lmdb_id>LMDB00225</lmdb_id>
		<created_at>2016-07-13 19:45:07</created_at>
		<updated_at>2016-07-20 21:03:43</updated_at>
		<export>1</export>
		<name>Glycoursodeoxycholic acid</name>
		<description>Glycoursodeoxycholic acid is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).</description>
		<cas>64480-66-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(=O)NCC(O)=O</moldb_smiles>
		<moldb_formula>C26H43NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21+,24+,25+,26-/m1/s1</moldb_inchi>
		<moldb_inchikey>GHCZAUBVMUEKKP-XROMFQGDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>449.6233</moldb_average_mass>
		<moldb_mono_mass>449.314123491</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>226</id>
		<lmdb_id>LMDB00226</lmdb_id>
		<created_at>2016-07-13 19:45:08</created_at>
		<updated_at>2016-07-20 20:52:08</updated_at>
		<export>1</export>
		<name>4-Hydroxybutyric acid</name>
		<description>4-Hydroxybutyric acid (GHB) is a precursor and a metabolite of gamma-aminobutyric acid (GABA), it is anticipated that GHB acts as a central nervous. system (CNS)neuromodulator, mediating its effects through GABA and GHB-specific receptors, or by affecting dopamine transmission.(PMID: 16620539). Gamma-hydroxybutyric acid (GHB) occurs naturally in all. mammals, but its function remains unknown. GHB is labeled as an illegal drug in most countries,but also used as a legal drug (Xyrem) in patients with narcolepsy. In high doses, GHB inhibits the CNS, inducing sleep and inhibiting the respiratory drive. In lower doses, its euphoriant effect predominates (PMID: 17658710).</description>
		<cas>591-81-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCCCC(O)=O</moldb_smiles>
		<moldb_formula>C4H8O3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8O3/c5-3-1-2-4(6)7/h5H,1-3H2,(H,6,7)</moldb_inchi>
		<moldb_inchikey>SJZRECIVHVDYJC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>104.1045</moldb_average_mass>
		<moldb_mono_mass>104.047344122</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>227</id>
		<lmdb_id>LMDB00227</lmdb_id>
		<created_at>2016-07-13 19:45:09</created_at>
		<updated_at>2016-07-20 20:52:09</updated_at>
		<export>1</export>
		<name>Hippuric acid</name>
		<description>Hippuric acid is an acyl glycine formed by the conjugation of benzoic aicd with glycine. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine &lt; -- &gt; CoA + N-acylglycine. Hippuric acid is a normal component of urine and is typically increased with increased consumption of phenolic compounds (tea, wine, fruit juices). These phenols are converted to benzoic acid which is then converted to hippuric acid and excreted in the urine. Hippuric acid is the most frequently used biomarker in the biological monitoring of occupational exposure to toluene. This product of solvent biotransformation may be also found in the urine of individuals who have not been exposed to the solvent. A smaller fraction of the absorbed toluene is oxidized to aromatic compounds including ortho-cresol, which is not found significantly in the urine of nonexposed individuals. The concentration of hippuric acid in the urine of individuals exposed to a low toluene concentration does not differ from that of individuals not exposed to the solvent. This has led to the conclusion that hippuric acid should not be utilized in the biological monitoring of occupational exposure to low levels of toluene in the air. Protein-bound organic acids such as hippuric acid are markedly accumulated in uremic plasma and produce defective protein binding of drugs. (PMID: 9120876, 8734460).</description>
		<cas>495-69-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CNC(=O)C1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C9H9NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C9H9NO3/c11-8(12)6-10-9(13)7-4-2-1-3-5-7/h1-5H,6H2,(H,10,13)(H,11,12)</moldb_inchi>
		<moldb_inchikey>QIAFMBKCNZACKA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>179.1727</moldb_average_mass>
		<moldb_mono_mass>179.058243159</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>228</id>
		<lmdb_id>LMDB00228</lmdb_id>
		<created_at>2016-07-13 19:45:11</created_at>
		<updated_at>2016-09-23 18:44:57</updated_at>
		<export>1</export>
		<name>Isovaleric acid</name>
		<description>Isovaleric acid, is a natural fatty acid found in a wide variety of plants and essential oils. Isovaleric acid is clear colorless liquid that is sparingly soluble in water, but well soluble in most common organic solvents. It has been suggested that isovaleric acid from pilot whales, a species frequently consumed in the Faroe Islands, may be the unusual dietary factor in prolonged gestation in the population of the Faroe Islands. Previous studies suggested that was due to the high intake of n-3 polyunsaturated fatty acids has been, but fatty acid data for eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA) in blood lipids of Faroese and Norwegians was reviewed in terms of the type of fish eaten (mostly lean white fish with DHA much greater than EPA); the popular lean fish, thus, probably provides too little EPA to produce a marked effect on animal biochemistry. (PMID 2646392).</description>
		<cas>503-74-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)CC(O)=O</moldb_smiles>
		<moldb_formula>C5H10O2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O2/c1-4(2)3-5(6)7/h4H,3H2,1-2H3,(H,6,7)</moldb_inchi>
		<moldb_inchikey>GWYFCOCPABKNJV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>102.1317</moldb_average_mass>
		<moldb_mono_mass>102.068079564</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>229</id>
		<lmdb_id>LMDB00229</lmdb_id>
		<created_at>2016-07-13 19:45:12</created_at>
		<updated_at>2016-07-20 20:58:24</updated_at>
		<export>1</export>
		<name>L-Homoserine</name>
		<description>Homoserine is a more reactive variant of the amino acid serine. In this variant, the hydroxyl side chain contains an additional CH2 group which brings the hydroxyl group closer to its own carboxyl group, allowing it to chemically react to form a five-membered ring. This occurs at the point that amino acids normally join to their neighbours in a peptide bond. Homoserine is therefore unsuitable for forming proteins and has been eliminated from the repertoire of amino acids used by living things. Homoserine is the final product on the C-terminal end of the N-terminal fragment following a cyanogen bromide cleavage. (wikipedia).</description>
		<cas>672-15-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CCO)C(O)=O</moldb_smiles>
		<moldb_formula>C4H9NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H9NO3/c5-3(1-2-6)4(7)8/h3,6H,1-2,5H2,(H,7,8)/t3-/m0/s1</moldb_inchi>
		<moldb_inchikey>UKAUYVFTDYCKQA-VKHMYHEASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>119.1192</moldb_average_mass>
		<moldb_mono_mass>119.058243159</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>230</id>
		<lmdb_id>LMDB00230</lmdb_id>
		<created_at>2016-07-13 19:45:13</created_at>
		<updated_at>2016-08-04 22:05:59</updated_at>
		<export>1</export>
		<name>4-Hydroxyproline</name>
		<description>4-Hydroxyproline (or hydroxyproline or Hyp) is a major component of the protein collagen. Hydroxyproline is produced by hydroxylation of the amino acid proline and is, therefore, a post-translationally modified amino acid. Hydroxyproline and proline play key roles for collagen stability. In particular, they permit the sharp twisting of the collagen helix. Hydroxyproline is found in few proteins other than collagen. The only other mammalian protein which includes hydroxyproline is elastin. For this reason, hydroxyproline content has been used as an indicator to determine collagen and/or gelatin amount in tissue or biological samples.  Increased serum and urine levels of hydroxyproline have been found in Paget's disease (PMID: 436278). Hydroxyproline (Hyp) content in biological fluids is used as a parameter of collagen catabolism, especially bone resorption or tissue degradation. Bedridden and elderly individuals show significantly elevated serum levels of hydroxyproline in comparison to normal, active individuals (PMID: 10706420). Elevated levels of urinary hydroxyproline are also indicative of muscle damage (PMID: 21988268). Increased reactive oxygen species (ROS) are also known to accelerate collagen degradation. Hydroxyproline levels increase in cases of depression and stress (PMID: 21483218).</description>
		<cas>51-35-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@H]1CN[C@@H](C1)C(O)=O</moldb_smiles>
		<moldb_formula>C5H9NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4+/m1/s1</moldb_inchi>
		<moldb_inchikey>PMMYEEVYMWASQN-DMTCNVIQSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>131.1299</moldb_average_mass>
		<moldb_mono_mass>131.058243159</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>231</id>
		<lmdb_id>LMDB00231</lmdb_id>
		<created_at>2016-07-13 19:45:15</created_at>
		<updated_at>2016-07-20 21:03:44</updated_at>
		<export>1</export>
		<name>Alpha-Hydroxyisobutyric acid</name>
		<description>Alpha-Hydroxyisobutyric acid is a metabolite of methyl tert-butyl ether (MTBE). MTBE may be obtained through environmental exposure. MTBE is rapidly eliminated from the body, mainly through expired air as the unchanged compound. MTBE is to some extent metabolised to t-butyl alcohol (TBA) and formaldehyde and oxidised to 2-methyl-1,2-propanediol and a-hydroxy isobuturic acid. Alpha-Hydroxyisobutyric acid has been used as an arial bactericide.</description>
		<cas>594-61-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)(O)C(O)=O</moldb_smiles>
		<moldb_formula>C4H8O3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8O3/c1-4(2,7)3(5)6/h7H,1-2H3,(H,5,6)</moldb_inchi>
		<moldb_inchikey>BWLBGMIXKSTLSX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>104.1045</moldb_average_mass>
		<moldb_mono_mass>104.047344122</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>232</id>
		<lmdb_id>LMDB00232</lmdb_id>
		<created_at>2016-07-13 19:45:16</created_at>
		<updated_at>2016-07-20 20:58:26</updated_at>
		<export>1</export>
		<name>Hydroxykynurenine</name>
		<description>Hydroxykynurenine is a free radical generator and a bioprecursor quinolinic acid which is a endogenous excitotoxin (PMID 16697652). It is a product of enzyme kynurenine 3-monooxygenase in the tryptophan catabolism pathway (Reactome http://www.reactome.org).</description>
		<cas>484-78-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(CC(=O)C1=C(N)C(O)=CC=C1)C(O)=O</moldb_smiles>
		<moldb_formula>C10H12N2O4</moldb_formula>
		<moldb_inchi>InChI=1S/C10H12N2O4/c11-6(10(15)16)4-8(14)5-2-1-3-7(13)9(5)12/h1-3,6,13H,4,11-12H2,(H,15,16)</moldb_inchi>
		<moldb_inchikey>VCKPUUFAIGNJHC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>224.2133</moldb_average_mass>
		<moldb_mono_mass>224.079706882</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>233</id>
		<lmdb_id>LMDB00233</lmdb_id>
		<created_at>2016-07-13 19:45:17</created_at>
		<updated_at>2016-07-20 20:58:27</updated_at>
		<export>1</export>
		<name>Indoleacrylic acid</name>
		<description>Indoleacrylic acid is a natural auxin from lentil roots. Inhibits the growth of mycelia of Neurospora crassa and causes the cells to accumulate indoleglycerol phosphate.</description>
		<cas>1204-06-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)\C=C\C1=CC2=C(N1)C=CC=C2</moldb_smiles>
		<moldb_formula>C11H9NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C11H9NO2/c13-11(14)6-5-9-7-8-3-1-2-4-10(8)12-9/h1-7,12H,(H,13,14)/b6-5+</moldb_inchi>
		<moldb_inchikey>SXOUIMVOMIGLHO-AATRIKPKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>187.1947</moldb_average_mass>
		<moldb_mono_mass>187.063328537</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>234</id>
		<lmdb_id>LMDB00234</lmdb_id>
		<created_at>2016-07-13 19:45:19</created_at>
		<updated_at>2016-09-23 18:44:58</updated_at>
		<export>1</export>
		<name>Hydroxyphenylacetylglycine</name>
		<description>Hydroxyphenylacetylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:. acyl-CoA + glycine &lt; -- &gt; CoA + N-acylglycine. Hydroxyphenylacetylglycine is an endogenous animal metabolite. It can be originated from the metabolism of tyramine, itself is a monoamine compound derived from the amino acid tyrosine. Hydroxyphenylacetylglycine can also be derived from the metabolism of 3,4-dihydroxyphenylalanine (L-DOPA). In the metabolism of tyrosine, this compound is involved in the reaction Hydroxyphenylacetyl-CoA + Glycine &lt;=&gt; Hydroxyphenylacetylglycine + CoA, catalyzed by acyltransferase enzymes (EC 2.3.1.-). Hydroxyphenylacetylglycine has been identified in animal biofluids. (PMID: 14201174, 912020, 716472, 7096501, 7438429, 7438430).</description>
		<cas>28116-23-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CNC(=O)CC1=CC=C(O)C=C1</moldb_smiles>
		<moldb_formula>C10H11NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C10H11NO4/c12-8-3-1-7(2-4-8)5-9(13)11-6-10(14)15/h1-4,12H,5-6H2,(H,11,13)(H,14,15)</moldb_inchi>
		<moldb_inchikey>CPPDWYIPKSSNNM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>209.1986</moldb_average_mass>
		<moldb_mono_mass>209.068807845</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>235</id>
		<lmdb_id>LMDB00235</lmdb_id>
		<created_at>2016-07-13 19:45:20</created_at>
		<updated_at>2016-09-23 18:44:58</updated_at>
		<export>1</export>
		<name>Indole</name>
		<description>Indole is an aromatic heterocyclic organic compound. It has a bicyclic structure, consisting of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring. It can be produced by bacteria as a degradation product of the amino acid tryptophan. It occurs naturally in animal feces and has an intense fecal smell. At very low concentrations, however, it has a flowery smell, and is a constituent of many flower scents (such as orange blossoms) and perfumes. Natural jasmine oil, used in the perfume industry, contains around 2.5% of indole. Indole also occurs in coal tar. The participation of the nitrogen lone electron pair in the aromatic ring means that indole is not a base, and it does not behave like a simple amine.</description>
		<cas>120-72-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N1C=CC2=C1C=CC=C2</moldb_smiles>
		<moldb_formula>C8H7N</moldb_formula>
		<moldb_inchi>InChI=1S/C8H7N/c1-2-4-8-7(3-1)5-6-9-8/h1-6,9H</moldb_inchi>
		<moldb_inchikey>SIKJAQJRHWYJAI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>117.1479</moldb_average_mass>
		<moldb_mono_mass>117.057849229</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>236</id>
		<lmdb_id>LMDB00236</lmdb_id>
		<created_at>2016-07-13 19:45:21</created_at>
		<updated_at>2016-09-23 18:44:59</updated_at>
		<export>1</export>
		<name>Homocysteine</name>
		<description>Homocysteine is a sulfur-containing amino acid that arises during methionine metabolism. Although its concentration in plasma is only about 10 micromolar (uM), even moderate hyperhomocysteinemia is associated with increased incidence of cardiovascular disease and Alzheimer's disease. Elevations in plasma homocysteine are commonly found as a result of vitamin deficiencies, polymorphisms of enzymes of methionine metabolism, and renal disease. Pyridoxal, folic acid, riboflavin, and Vitamin B(12) are all required for methionine metabolism, and deficiency of each of these vitamins result in elevated plasma homocysteine. A polymorphism of methylenetetrahydrofolate reductase (C677T), which is quite common in most populations with a homozygosity rate of 10-15 %, is associated with moderate hyperhomocysteinemia, especially in the context of marginal folate intake. Plasma homocysteine is inversely related to plasma creatinine in patients with renal disease. This is due to an impairment in homocysteine removal in renal disease. The role of these factors, and of modifiable lifestyle factors, in affecting methionine metabolism and in determining plasma homocysteine levels is discussed. Homocysteine is an independent cardiovascular disease (CVD) risk factor modifiable by nutrition and possibly exercise. Homocysteine was first identified as an important biological compound in 1932 and linked with animal disease in 1962 when elevated urinary homocysteine levels were found in children with mental retardation. This condition, called homocysteinuria, was later associated with premature occlusive CVD, even in children. These observations led to research investigating the relationship of elevated homocysteine levels and CVD in a wide variety of populations including middle age and elderly men and women with and without traditional risk factors for CVD. (PMID 17136938, 15630149).</description>
		<cas>454-29-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(CCS)C(O)=O</moldb_smiles>
		<moldb_formula>C4H9NO2S</moldb_formula>
		<moldb_inchi>InChI=1S/C4H9NO2S/c5-3(1-2-8)4(6)7/h3,8H,1-2,5H2,(H,6,7)</moldb_inchi>
		<moldb_inchikey>FFFHZYDWPBMWHY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>135.1850</moldb_average_mass>
		<moldb_mono_mass>135.035399227</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>237</id>
		<lmdb_id>LMDB00237</lmdb_id>
		<created_at>2016-07-13 19:45:23</created_at>
		<updated_at>2016-08-02 20:40:28</updated_at>
		<export>1</export>
		<name>Malic acid</name>
		<description>Malic acid is a tart-tasting organic dicarboxylic acid that plays a role in many sour or tart foods. In its ionised form it is malate, an intermediate of the TCA cycle along with fumarate. It can also be formed from pyruvate as one of the anaplerotic reactions.</description>
		<cas>6915-15-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(CC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C4H6O5</moldb_formula>
		<moldb_inchi>InChI=1S/C4H6O5/c5-2(4(8)9)1-3(6)7/h2,5H,1H2,(H,6,7)(H,8,9)</moldb_inchi>
		<moldb_inchikey>BJEPYKJPYRNKOW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>134.0874</moldb_average_mass>
		<moldb_mono_mass>134.021523302</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>238</id>
		<lmdb_id>LMDB00238</lmdb_id>
		<created_at>2016-07-13 19:45:24</created_at>
		<updated_at>2016-09-23 18:44:59</updated_at>
		<export>1</export>
		<name>3-Hydroxyisovaleric acid</name>
		<description>3-Hydroxyisovaleric acid is a normal animal metabolite excreted in the urine. Elevated levels of this compound are found in several inherited disorders such as Dihydrolipoamide dehydrogenase Deficiency, 3-Methylcrotonyl-CoA carboxylase 1 deficiency, 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency (3-hydroxy-3-methylglutaryl -CoA lyase Deficiency, Biotinidase deficiency multiple carboxylase deficiency late-onset , Late onset multiple carboxylase deficiency, HolMcarboxylase synthetase deficiency, 3-Methylcrotonyl-CoA carboxylase 2 deficiency. 3-Hydroxyisovaleric acid is also elevated in smokers, in subjects undergoing long-term anticonvulsant therapy with carbamazepine and/or phenytoin. These levels are elevated due to impairment of renal reclamation of biotin. Levels may also be increased from prolonged consumption of raw egg-whites (PMID: 16895887, 9523856, 15447901, 9176832)(OMIM: 210210, 253270, 600529, 253260, 246450, 210200, 238331).</description>
		<cas>625-08-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)(O)CC(O)=O</moldb_smiles>
		<moldb_formula>C5H10O3</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O3/c1-5(2,8)3-4(6)7/h8H,3H2,1-2H3,(H,6,7)</moldb_inchi>
		<moldb_inchikey>AXFYFNCPONWUHW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>118.1311</moldb_average_mass>
		<moldb_mono_mass>118.062994186</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>239</id>
		<lmdb_id>LMDB00239</lmdb_id>
		<created_at>2016-07-13 19:45:25</created_at>
		<updated_at>2016-07-20 21:03:44</updated_at>
		<export>1</export>
		<name>Hydroxyphenyllactic acid</name>
		<description>Hydroxyphenyllactic acid or 4-hydroxyphenyllactate (the L-form) is a tyrosine metabolite. The level of L-hydroxyphenyllactic acid is elevated in patients with a deficiency of the enzyme p-hydroxyphenylpyruvate oxidase (EC 1.14.2.2). (PMID 4720815 ). L-hydroxyphenyllactate is present in relatively higher concentrations in the cerebrospinal fluid and urine of patients with phenylketonuria (PKU) and tyrosinemia. (PMID: 3126358).  However the D-form of hydroxyphneyllactate is of bacterial origin and is also found in individuals with bacterial overgrowth or unusual gut microflora (PMID: 3126358).  Microbial hydroxyphenyllactate is likely derived from phenolic or polyphenolic compounds in the diet.  Bifidobacteria and lactobacilli produced considerable amounts of phenyllactic and p-hydroxyphenyllactic acids (PMID: 23061754).  It has also been shown that hydroxyphenyllactate decreases ROS (reactive oxygen species) production in both mitochondria and neutrophils and so hydroxyphenyllactate may function as a natural anti-oxidant (PMID: 23061754).</description>
		<cas>306-23-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(CC1=CC=C(O)C=C1)C(O)=O</moldb_smiles>
		<moldb_formula>C9H10O4</moldb_formula>
		<moldb_inchi>InChI=1S/C9H10O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,8,10-11H,5H2,(H,12,13)</moldb_inchi>
		<moldb_inchikey>JVGVDSSUAVXRDY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>182.1733</moldb_average_mass>
		<moldb_mono_mass>182.057908808</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>240</id>
		<lmdb_id>LMDB00240</lmdb_id>
		<created_at>2016-07-13 19:45:27</created_at>
		<updated_at>2016-09-23 18:45:00</updated_at>
		<export>1</export>
		<name>Glycogen</name>
		<description>Glycogen is a highly-branched polymer of about 30,000 glucose residues and has a molecular weight between 106 and 107 daltons (4.8 million approx.). Most of Glc units are linked by alpha-1,4 glycosidic bonds, approximately 1 in 12 Glc residues also makes -1,6 glycosidic bond with a second Glc which results in the creation of a branch. Glycogen only has one reducing end and a large number of non-reducing ends with a free hydroxyl group at carbon 4. The glycogen granules contain both glycogen and the enzymes of glycogen synthesis (glycogenesis) and degradation (glycogenolysis). The enzymes are nested between the outer branches of the glycogen molecules and act on the non-reducing ends. Therefore, the many non-reducing end-branches of glycogen facilitate its rapid synthesis and breakdown. In hypoglycemia caused by excessive insulin, liver glycogen levels are high, but the high insulin level prevents the glycogenolysis necessary to maintain normal blood sugar levels. Glucagon is a common treatment for this type of hypoglycemia. Glycogen is a polysaccharide that is the principal storage form of glucose (Glc) in animal and animal cells. Glycogen is found in the form of granules in the cytosol in many cell types. Hepatocytes (liver cells) have the highest concentration of it - up to 8% of the fresh weight in well fed state, or 100 to 120 g in an adult - giving liver a distinctive, 'starchy taste'. In the muscles, glycogen is found in a much lower concentration (1% of the muscle mass), but the total amount exceeds that in liver. Small amounts of glycogen are found in the kidneys, and even smaller amounts in certain glial cells in the brain and white blood cells.</description>
		<cas>9005-79-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@H](OC[C@H]2O[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]3CO)[C@H](O)[C@@H](O)[C@@H]2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C24H42O21</moldb_formula>
		<moldb_inchi>InChI=1S/C24H42O21/c25-1-5-9(28)11(30)16(35)22(41-5)39-4-8-20(45-23-17(36)12(31)10(29)6(2-26)42-23)14(33)18(37)24(43-8)44-19-7(3-27)40-21(38)15(34)13(19)32/h5-38H,1-4H2/t5-,6-,7-,8-,9-,10-,11+,12+,13-,14-,15-,16-,17-,18-,19-,20-,21+,22+,23-,24-/m1/s1</moldb_inchi>
		<moldb_inchikey>BYSGBSNPRWKUQH-UJDJLXLFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>666.5777</moldb_average_mass>
		<moldb_mono_mass>666.221858406</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>241</id>
		<lmdb_id>LMDB00241</lmdb_id>
		<created_at>2016-07-13 19:45:28</created_at>
		<updated_at>2016-07-20 21:03:45</updated_at>
		<export>1</export>
		<name>Hyocholic acid</name>
		<description>Hyocholic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).</description>
		<cas>547-75-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CCC([C@H](C)CCC(O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H](O)[C@H](O)[C@]2([H])C[C@H](O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C24H40O5</moldb_formula>
		<moldb_inchi>InChI=1S/C24H40O5/c1-13(4-7-19(26)27)15-5-6-16-20-17(9-11-23(15,16)2)24(3)10-8-14(25)12-18(24)21(28)22(20)29/h13-18,20-22,25,28-29H,4-12H2,1-3H3,(H,26,27)/t13-,14-,15?,16+,17+,18+,20+,21-,22+,23-,24-/m1/s1</moldb_inchi>
		<moldb_inchikey>DKPMWHFRUGMUKF-NNFRHCBVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>408.5714</moldb_average_mass>
		<moldb_mono_mass>408.287574390</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>242</id>
		<lmdb_id>LMDB00242</lmdb_id>
		<created_at>2016-07-13 19:45:30</created_at>
		<updated_at>2016-07-20 20:33:46</updated_at>
		<export>1</export>
		<name>Hydrocinnamic acid</name>
		<description>Hydrocinnamic acid is an analogue of phenylalanine. It is a substrate of the enzyme oxidoreductases [EC 1.14.12.-] in the pathway phenylalanine metabolism (KEGG).</description>
		<cas>501-52-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CCC1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C9H10O2</moldb_formula>
		<moldb_inchi>InChI=1S/C9H10O2/c10-9(11)7-6-8-4-2-1-3-5-8/h1-5H,6-7H2,(H,10,11)</moldb_inchi>
		<moldb_inchikey>XMIIGOLPHOKFCH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>150.1745</moldb_average_mass>
		<moldb_mono_mass>150.068079564</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>243</id>
		<lmdb_id>LMDB00243</lmdb_id>
		<created_at>2016-07-13 19:45:31</created_at>
		<updated_at>2016-07-20 20:58:37</updated_at>
		<export>1</export>
		<name>Mannitol</name>
		<description>Mannitol is a diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity. Chemically, mannitol is an alcohol and a sugar, or a polyol; it is similar to xylitol or sorbitol. However, mannitol has a tendency to lose a hydrogen ion in aqueous solutions, which causes the solution to become acidic. For this, it is not uncommon to add a substance to adjust its pH, such as sodium bicarbonate. Mannitol is a non-permeating molecule i.e. it cannot cross biological membranes. Mannitol or hexan-1,2,3,4,5,6-hexol (C6H8(OH)6) is an osmotic diuretic agent and a weak renal vasodilator. It is a sorbitol isomer.</description>
		<cas>69-65-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO</moldb_smiles>
		<moldb_formula>C6H14O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4-,5-,6-/m1/s1</moldb_inchi>
		<moldb_inchikey>FBPFZTCFMRRESA-KVTDHHQDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>182.1718</moldb_average_mass>
		<moldb_mono_mass>182.079038180</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>244</id>
		<lmdb_id>LMDB00244</lmdb_id>
		<created_at>2016-07-13 19:45:33</created_at>
		<updated_at>2016-07-20 20:58:38</updated_at>
		<export>1</export>
		<name>Nonadecanoic acid</name>
		<description>Nonadecanoic acid is an odd-numbered long chain fatty acid, likely derived from bacterial or plant sources. Nonadecanoic acid has been found in ox fats and vegetable oils. It is also used by certain insects as a phermone.</description>
		<cas>646-30-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C19H38O2</moldb_formula>
		<moldb_inchi>InChI=1S/C19H38O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19(20)21/h2-18H2,1H3,(H,20,21)</moldb_inchi>
		<moldb_inchikey>ISYWECDDZWTKFF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>298.5038</moldb_average_mass>
		<moldb_mono_mass>298.287180460</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>245</id>
		<lmdb_id>LMDB00245</lmdb_id>
		<created_at>2016-07-13 19:45:34</created_at>
		<updated_at>2016-07-20 20:58:41</updated_at>
		<export>1</export>
		<name>Azelaic acid</name>
		<description>Azelaic acid (AZA) is a naturally occurring saturated nine-carbon dicarboxylic acid (COOH (CH2)7-COOH). It possesses a variety of biological actions both in vitro and in vivo. Interest in the biological activity of AZA arose originally out of studies of skin surface lipids and the pathogenesis of hypochromia in pityriasis versicolor infection. Later, it was shown that Pityrosporum can oxidize unsaturated fatty acids to C8-C12 dicarboxylic acids that are cornpetitive inhibitors of tyrosinase in vitro. Azelaic acid was chosen for further investigation and development of a new topical drug for treating hyperpigmentary disorders for the following reasons: it possesses a middle-range of antityrosinase activity, is inexpensive, and more soluble to be incorporated into a base cream than other dicarboxylic acids. Azelaic acid is another option for the topical treatment of mild to moderate inflammatory acne vulgaris. It offers effectiveness similar to that of other agents without the systemic side effects of oral antibiotics or the allergic sensitization of topical benzoyl peroxide and with less irritation than tretinoin. Azelaic acid is less expensive than certain other prescription acne preparations, but it is much more expensive than nonprescription benzoyl peroxide preparations. Whether it is safe and effective when used in combination with other agents is not known. (PMID: 7737781, 8961845).</description>
		<cas>123-99-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C9H16O4</moldb_formula>
		<moldb_inchi>InChI=1S/C9H16O4/c10-8(11)6-4-2-1-3-5-7-9(12)13/h1-7H2,(H,10,11)(H,12,13)</moldb_inchi>
		<moldb_inchikey>BDJRBEYXGGNYIS-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>188.2209</moldb_average_mass>
		<moldb_mono_mass>188.104859000</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>246</id>
		<lmdb_id>LMDB00246</lmdb_id>
		<created_at>2016-07-13 19:45:35</created_at>
		<updated_at>2016-07-20 21:03:46</updated_at>
		<export>1</export>
		<name>Sebacic acid</name>
		<description>Sebacic acid is a saturated, straight-chain naturally occurring dicarboxylic acid with 10 carbon atoms. Sebacic acid is a normal urinary acid. In patients with multiple acyl-CoA-dehydrogenase deficiency (MADD) or glutaric aciduria type II (GAII) are a group of metabolic disorders due to deficiency of either electron transfer flavoprotein or electron transfer flavoprotein ubiquinone oxidoreductase, biochemical data shows an increase in urine sebacic acid excretion. Sebacic acid is a white flake or powdered crystal slightly soluble in water that has been proposed as an alternative energy substrate in total parenteral nutrition. Sebacic Acid was named from the Latin sebaceus (tallow candle) or sebum (tallow) in reference to its use in the manufacture of candles. Sebacic Acid and its derivatives such as azelaic acid have a variety of industrial uses as plasticizers, lubricants, hydraulic fluids, cosmetics, candles, etc. It is used in the synthesis of polyamide and alkyd resins. It is also used as an intermediate for aromatics, antiseptics and painting materials. (PMID: 10556649, 1738216, 8442769, 12706375).</description>
		<cas>111-20-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C10H18O4</moldb_formula>
		<moldb_inchi>InChI=1S/C10H18O4/c11-9(12)7-5-3-1-2-4-6-8-10(13)14/h1-8H2,(H,11,12)(H,13,14)</moldb_inchi>
		<moldb_inchikey>CXMXRPHRNRROMY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>202.2475</moldb_average_mass>
		<moldb_mono_mass>202.120509064</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>247</id>
		<lmdb_id>LMDB00247</lmdb_id>
		<created_at>2016-07-13 19:45:37</created_at>
		<updated_at>2016-07-20 20:58:41</updated_at>
		<export>1</export>
		<name>Phytanic acid</name>
		<description>Phytanic acid is a 20-carbon branched chain fatty acid, Phytanic acid is present in animal (primarily herbivores or omnivores) tissues where it may be derived from the chlorophyll in consumed plant material. Phytanic acid derives from the corresponding alcohol, phytol, and is ultimately oxidized into pristanic acid. In phytanic acid storage disease (Refsum disease) this lipid may comprise as much as 30% of the total fatty acids in plasma. These high levels in Refsum disease (a neurological disorder) are due to a phytanic acid alpha-hydroxylase deficiency.</description>
		<cas>14721-66-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)CCCC(C)CCCC(C)CCCC(C)CC(O)=O</moldb_smiles>
		<moldb_formula>C20H40O2</moldb_formula>
		<moldb_inchi>InChI=1S/C20H40O2/c1-16(2)9-6-10-17(3)11-7-12-18(4)13-8-14-19(5)15-20(21)22/h16-19H,6-15H2,1-5H3,(H,21,22)</moldb_inchi>
		<moldb_inchikey>RLCKHJSFHOZMDR-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>312.5304</moldb_average_mass>
		<moldb_mono_mass>312.302830524</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>248</id>
		<lmdb_id>LMDB00248</lmdb_id>
		<created_at>2016-07-13 19:45:38</created_at>
		<updated_at>2016-07-20 20:52:18</updated_at>
		<export>1</export>
		<name>Myristic acid</name>
		<description>Myristic acid is a saturated 14-carbon fatty acid occurring in most animal and vegetable fats, particularly butterfat and coconut, palm, and nutmeg oils. It is used to synthesize flavor and as an ingredient in soaps and cosmetics. (From Dorland, 28th ed). Myristic acid is also commonly added to a penultimate nitrogen terminus glycine in receptor-associated kinases to confer the membrane localisation of the enzyme. this is achieved by the myristic acid having a high enough hydrophobicity to become incorporated into the fatty acyl core of the phospholipid bilayer of the plasma membrane of the eukaryotic cell.(wikipedia).</description>
		<cas>544-63-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C14H28O2</moldb_formula>
		<moldb_inchi>InChI=1S/C14H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2-13H2,1H3,(H,15,16)</moldb_inchi>
		<moldb_inchikey>TUNFSRHWOTWDNC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>228.3709</moldb_average_mass>
		<moldb_mono_mass>228.208930140</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>249</id>
		<lmdb_id>LMDB00249</lmdb_id>
		<created_at>2016-07-13 19:45:39</created_at>
		<updated_at>2016-07-20 20:58:42</updated_at>
		<export>1</export>
		<name>3-Phosphoglyceric acid</name>
		<description>3-phosphoglyceric acid (3PG) is a 3-carbon molecule that is a metabolic intermediate in both glycolysis and the Calvin cycle. This chemical is often termed PGA when referring to the Calvin cycle. In the Calvin cycle, two glycerate 3-phosphate molecules are reduced to form two molecules of glyceraldehyde 3-phosphate (GALP). (wikipedia).</description>
		<cas>820-11-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(COP(O)(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C3H7O7P</moldb_formula>
		<moldb_inchi>InChI=1S/C3H7O7P/c4-2(3(5)6)1-10-11(7,8)9/h2,4H,1H2,(H,5,6)(H2,7,8,9)</moldb_inchi>
		<moldb_inchikey>OSJPPGNTCRNQQC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>186.0572</moldb_average_mass>
		<moldb_mono_mass>185.992939090</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>250</id>
		<lmdb_id>LMDB00250</lmdb_id>
		<created_at>2016-07-13 19:45:40</created_at>
		<updated_at>2016-07-20 20:58:44</updated_at>
		<export>1</export>
		<name>N-Acetyl-L-aspartic acid</name>
		<description>N-Acetylaspartic acid is a derivative of aspartic acid. It is the second most concentrated molecule in the brain after the amino acid glutamate. It is synthesized in neurons from the amino acid aspartate and acetyl coenzyme A. The various functions served by N-acetylaspartic acid are still under investigation, but the primary proposed functions include:. 1) A neuronal osmolyte that is involved in fluid balance in the brain 2) A source of acetate for lipid and myelin synthesis in oligodendrocytes, the glial cells that myelinate neuronal axons 3) A precursor for the synthesis of the important neuronal dipeptide N-acetylaspartylglutamate 4)N-Acetylaspartic acid may also be involved in energy production from the amino acid glutamate in neuronal mitochondria.</description>
		<cas>997-55-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)N[C@@H](CC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H9NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C6H9NO5/c1-3(8)7-4(6(11)12)2-5(9)10/h4H,2H2,1H3,(H,7,8)(H,9,10)(H,11,12)/t4-/m0/s1</moldb_inchi>
		<moldb_inchikey>OTCCIMWXFLJLIA-BYPYZUCNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>175.1394</moldb_average_mass>
		<moldb_mono_mass>175.048072403</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>251</id>
		<lmdb_id>LMDB00251</lmdb_id>
		<created_at>2016-07-13 19:45:42</created_at>
		<updated_at>2016-07-20 20:58:45</updated_at>
		<export>1</export>
		<name>Propyl alcohol</name>
		<description>Propyl alcohol is a colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate. Propyl alcohol is a primary alcohol with the formula CH3CH2CH2OH. It is also known as propan-1-ol, 1-propanol, 1-propyl alcohol, n-propyl alcohol, or simply propanol. It is an isomer of propan-2-ol. It is used as a solvent in the pharmaceutical industry, and for resins and cellulose esters. It is formed naturally in small amounts during many fermentation processes and small amounts are produced by gut microflora.</description>
		<cas>71-23-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCO</moldb_smiles>
		<moldb_formula>C3H8O</moldb_formula>
		<moldb_inchi>InChI=1S/C3H8O/c1-2-3-4/h4H,2-3H2,1H3</moldb_inchi>
		<moldb_inchikey>BDERNNFJNOPAEC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>60.0950</moldb_average_mass>
		<moldb_mono_mass>60.057514878</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>252</id>
		<lmdb_id>LMDB00252</lmdb_id>
		<created_at>2016-07-13 19:45:43</created_at>
		<updated_at>2016-09-23 18:45:00</updated_at>
		<export>1</export>
		<name>Phenylacetylglycine</name>
		<description>Phenylacetylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:. acyl-CoA + glycine &lt; -- &gt; CoA + N-acylglycine. Phenylacetylglycine or PAG is a glycine conjugate of phenylacetic acid. Phenylacetic acid may arise from exposure to styrene (plastic) or through the consumption of fruits and vegetables. Phenylacetic acid is used in some perfumes, possessing a honey-like odour in low concentrations, and is also used in penicillin G production. PAG is a putative biomarker of phospholipidosis. Urinary PAG is elevated in animals exhibiting abnormal phospholipid accumulation in many tissues and may thus be useful as a surrogate biomarker for phospholipidosis. (PMID: 15764292) The presence of phenylacetylglycine in urine has been confirmed for dogs, rats and mice. However, the presence of this compound in animal urine is controversial. GC-MS studies have not found this compound (PMID: 7492634) while NMR studies claimed to have identified it (PMID: 21167146). It appears that phenylacetylglycine may sometimes be mistaken for phenylacetylglutamine via NMR.</description>
		<cas>500-98-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CNC(=O)CC1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C10H11NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C10H11NO3/c12-9(11-7-10(13)14)6-8-4-2-1-3-5-8/h1-5H,6-7H2,(H,11,12)(H,13,14)</moldb_inchi>
		<moldb_inchikey>UTYVDVLMYQPLQB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>193.1992</moldb_average_mass>
		<moldb_mono_mass>193.073893223</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>253</id>
		<lmdb_id>LMDB00253</lmdb_id>
		<created_at>2016-07-13 19:45:44</created_at>
		<updated_at>2016-07-20 20:52:22</updated_at>
		<export>1</export>
		<name>Propionylcarnitine</name>
		<description>Propionylcarnitine is present in high abundance in the urine of patients with Methylmalonyl-CoA mutase (MUT) deficiency, (together with Methylmalonic acid). MUT is a mitochondrial enzyme that catalyzes the isomerization of methylmalonyl-CoA to succinyl-CoA (OMIM 609058 ).</description>
		<cas>17298-37-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C10H19NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C10H19NO4/c1-5-10(14)15-8(6-9(12)13)7-11(2,3)4/h8H,5-7H2,1-4H3</moldb_inchi>
		<moldb_inchikey>UFAHZIUFPNSHSL-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>217.2622</moldb_average_mass>
		<moldb_mono_mass>217.131408101</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>254</id>
		<lmdb_id>LMDB00254</lmdb_id>
		<created_at>2016-07-13 19:45:45</created_at>
		<updated_at>2016-09-23 18:45:01</updated_at>
		<export>1</export>
		<name>3'-Sialyllactose</name>
		<description>Sialyllactose is an oligossaccharide found in both animal breast milk and cow's milk. It is the predominant sialylated component in milk. Sialyllactose has recently been shown to inhibit the infection of HIV-1 virus. Sialyllactose is also responsible for the inhibitory activity of milk on cholera toxin.</description>
		<cas>35890-38-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)[C@@H]1O)C(O)=O)[C@H](O)[C@H](O)CO</moldb_smiles>
		<moldb_formula>C23H39NO19</moldb_formula>
		<moldb_inchi>InChI=1S/C23H39NO19/c1-7(29)24-13-8(30)2-23(22(38)39,42-19(13)15(35)10(32)4-26)43-20-16(36)12(6-28)40-21(17(20)37)41-18(11(33)5-27)14(34)9(31)3-25/h3,8-21,26-28,30-37H,2,4-6H2,1H3,(H,24,29)(H,38,39)/t8-,9-,10+,11+,12+,13+,14+,15+,16-,17+,18+,19+,20-,21-,23-/m0/s1</moldb_inchi>
		<moldb_inchikey>OIZGSVFYNBZVIK-FHHHURIISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>633.5511</moldb_average_mass>
		<moldb_mono_mass>633.211628071</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>255</id>
		<lmdb_id>LMDB00255</lmdb_id>
		<created_at>2016-07-13 19:45:47</created_at>
		<updated_at>2016-09-23 18:45:01</updated_at>
		<export>1</export>
		<name>Pentadecanoic acid</name>
		<description>Pentadecanoic acid is a fatty acid of exogenous (primarily ruminant) origin. Many &quot;odd&quot; length long chain amino acids are derived from the consumption of dairy fats (milk and meat). Pentadecanoic acid constitutes 1.05% of milk fat and 0.43% of ruminant meat fat. The content of heptadecanoic acid in the subcutaneous adipose tissue of animals appears to be a good biological marker of long-term milk fat intake in free-living individuals in populations with high consumption of dairy products. (PMID 9701185; PMID 11238766).</description>
		<cas>1002-84-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C15H30O2</moldb_formula>
		<moldb_inchi>InChI=1S/C15H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15(16)17/h2-14H2,1H3,(H,16,17)</moldb_inchi>
		<moldb_inchikey>WQEPLUUGTLDZJY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>242.3975</moldb_average_mass>
		<moldb_mono_mass>242.224580204</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>256</id>
		<lmdb_id>LMDB00256</lmdb_id>
		<created_at>2016-07-13 19:45:48</created_at>
		<updated_at>2016-07-20 20:52:31</updated_at>
		<export>1</export>
		<name>Stearic acid</name>
		<description>Stearic acid, also called octadecanoic acid, is one of the useful types of saturated fatty acids that comes from many animal and vegetable fats and oils. It is a waxy solid, and its chemical formula is CH3(CH2)16COOH. Its name comes from the Greek word stear, which means tallow. Its IUPAC name is octadecanoic acid. -- Wikipedia.</description>
		<cas>57-11-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H36O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20)</moldb_inchi>
		<moldb_inchikey>QIQXTHQIDYTFRH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>284.4772</moldb_average_mass>
		<moldb_mono_mass>284.271530396</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>257</id>
		<lmdb_id>LMDB00257</lmdb_id>
		<created_at>2016-07-13 19:45:50</created_at>
		<updated_at>2016-07-20 20:58:52</updated_at>
		<export>1</export>
		<name>Ureidosuccinic acid</name>
		<description>Ureidosuccinic acid is an intermediary product in pyrimidine biosynthesis.</description>
		<cas>13184-27-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(=O)N[C@@H](CC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H8N2O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H8N2O5/c6-5(12)7-2(4(10)11)1-3(8)9/h2H,1H2,(H,8,9)(H,10,11)(H3,6,7,12)/t2-/m0/s1</moldb_inchi>
		<moldb_inchikey>HLKXYZVTANABHZ-REOHCLBHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>176.1274</moldb_average_mass>
		<moldb_mono_mass>176.043321376</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>258</id>
		<lmdb_id>LMDB00258</lmdb_id>
		<created_at>2016-07-13 19:45:51</created_at>
		<updated_at>2016-09-23 18:45:02</updated_at>
		<export>1</export>
		<name>Salicyluric acid</name>
		<description>Salicyluric acid is an aryl glycine conjugate formed by the body to eliminate excess salicylates, including aspirin. Aspirin is rapidly hydrolysed to salicylic acid which is further metabolized to various compounds, including salicyluric acid (SU) as well as various acyl and phenolic glucuronides, and hydroxylated metabolites. SU is the major metabolite of SA excreted in urine and it is present in the urine of people who have not taken salicylate drugs, although it has no anti-inflammatory effects in animals or in animals. More salicyluric acid (SU) is excreted in the urine of vegetarians than in non-vegetarians, primarily because fruits and vegetables are important sources of dietary salicylates. However, significantly less (10-15X) SU is excreted by vegetarians than individuals taking low-dose aspirin (PMID: 12944546). The induction of the salicyluric acid formation is one of the saturable pathways of salicylate elimination. The formation of the methyl ester of salicyluric acid is observed during the quantitation of salicyluric acid and other salicylate metabolites in urine by high-pressure liquid chromatography. This methyl ester formation causes artificially low values for salicyluric acid and high values for salicylic acid. (PMID: 6101164, 6857178).</description>
		<cas>487-54-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CNC(=O)C1=CC=CC=C1O</moldb_smiles>
		<moldb_formula>C9H9NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C9H9NO4/c11-7-4-2-1-3-6(7)9(14)10-5-8(12)13/h1-4,11H,5H2,(H,10,14)(H,12,13)</moldb_inchi>
		<moldb_inchikey>ONJSZLXSECQROL-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>195.1721</moldb_average_mass>
		<moldb_mono_mass>195.053157781</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>259</id>
		<lmdb_id>LMDB00259</lmdb_id>
		<created_at>2016-07-13 19:45:52</created_at>
		<updated_at>2016-07-20 20:58:56</updated_at>
		<export>1</export>
		<name>Pelargonic acid</name>
		<description>Pelargonic acid, or nonanoic acid, is a fatty acid which occurs naturally as esters is the oil of pelargonium. Synthetic esters, such as methyl nonanoate, are used as flavorings. Pelargonic acid is an organic compound composed of a nine-carbon chain terminating in a carboxylic acid. It is an oily liquid with an unpleasant, rancid odor. It is nearly insoluble in water, but well soluble in chloroform and ether. The derivative 4-nonanoylmorpholine is an ingredient in some pepper sprays.</description>
		<cas>112-05-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C9H18O2</moldb_formula>
		<moldb_inchi>InChI=1S/C9H18O2/c1-2-3-4-5-6-7-8-9(10)11/h2-8H2,1H3,(H,10,11)</moldb_inchi>
		<moldb_inchikey>FBUKVWPVBMHYJY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>158.2380</moldb_average_mass>
		<moldb_mono_mass>158.130679820</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>260</id>
		<lmdb_id>LMDB00260</lmdb_id>
		<created_at>2016-07-13 19:45:54</created_at>
		<updated_at>2016-07-20 20:58:57</updated_at>
		<export>1</export>
		<name>Stearoylcarnitine</name>
		<description>Stearoylcarnitine is found in significantly greater amounts of lpatients with carnitine palmitoyltransferase (CPT) II deficiency when compared to controls. ( PubMed ID 15653102 ). The carnitine palmitoyltransferase (CPT; EC 2.3.1.21) enzyme system, in conjunction with acyl-CoA synthetase and carnitine/acylcarnitine translocase (212138), provides the mechanism whereby long-chain fatty acids are transferred from the cytosol to the mitochondrial matrix to undergo beta-oxidation. (OMIM 600650 ).</description>
		<cas>1976-27-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C25H49NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C25H49NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(21-24(27)28)22-26(2,3)4/h23H,5-22H2,1-4H3</moldb_inchi>
		<moldb_inchikey>FNPHNLNTJNMAEE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>427.6609</moldb_average_mass>
		<moldb_mono_mass>427.366159061</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>261</id>
		<lmdb_id>LMDB00261</lmdb_id>
		<created_at>2016-07-13 19:45:55</created_at>
		<updated_at>2016-07-20 20:58:58</updated_at>
		<export>1</export>
		<name>Rhamnose</name>
		<description>Rhamnose (Rham) is a naturally occurring deoxy sugar. It can be classified as either a methyl-pentose or a 6-deoxy-hexose. Rhamnose occurs in nature in its L-form as L-rhamnose (6-deoxy-L-mannose). This is unusual, since most of the naturally occurring sugars are in D-form. Rhamnose is commonly bound to other sugars in nature. It is a common glycone component of glycosides from many plants. Rhamnose is also a component of the outer cell membrane of certain bacteria. L-rhamnose is metabolized to L-Lactaldehyde, which is a branching point in the metabolic pathway of L-fucose and L-rhamnose utilization. It exists in two anomeric forms, alpha-L-rhamnose and beta-L-rhamnose.</description>
		<cas>3615-41-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C6H12O5</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3-,4+,5+,6?/m0/s1</moldb_inchi>
		<moldb_inchikey>SHZGCJCMOBCMKK-JFNONXLTSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>164.1565</moldb_average_mass>
		<moldb_mono_mass>164.068473494</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>262</id>
		<lmdb_id>LMDB00262</lmdb_id>
		<created_at>2016-07-13 19:45:56</created_at>
		<updated_at>2016-07-20 20:58:58</updated_at>
		<export>1</export>
		<name>Beta-Sitosterol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CC[C@@H](CC)C(C)C</moldb_smiles>
		<moldb_formula>C29H50O</moldb_formula>
		<moldb_inchi>InChI=1S/C29H50O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h10,19-21,23-27,30H,7-9,11-18H2,1-6H3/t20-,21-,23+,24+,25-,26+,27+,28+,29-/m1/s1</moldb_inchi>
		<moldb_inchikey>KZJWDPNRJALLNS-VJSFXXLFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>414.7180</moldb_average_mass>
		<moldb_mono_mass>414.386166230</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>263</id>
		<lmdb_id>LMDB00263</lmdb_id>
		<created_at>2016-07-13 19:45:57</created_at>
		<updated_at>2016-09-23 18:45:02</updated_at>
		<export>1</export>
		<name>Nicotinamide riboside</name>
		<description>Nicotinamide riboside is involved in nicotinate and nicotinamide metabolism. Nicotinamide riboside was originally identified as a nutrient in milk. It is a useful compound for elevation of NAD+ levels in animals. Nicotinamide riboside has recently been discovered to be an NAD(+) precursor that is converted to nicotinamide mononucleotide by specific nicotinamide riboside kinases, Nrk1 and Nrk2. It has been shown that exogenous nicotinamide riboside promotes Sir2-dependent repression of recombination, improves gene silencing, and extends the lifespan of certain animal models without calorie restriction [PMID:17482543]. Supplementation in mammalian cells and mouse tissues increases NAD(+) levels and activates SIRT1 and SIRT3, culminating in enhanced oxidative metabolism and protection against high-fat diet-induced metabolic abnormalities. (PMID:22682224). Recent data suggest that nicotinamide riboside may be the only vitamin precursor that supports neuronal NAD+ synthesis (PMID: 18429699). Nicotinamide riboside kinase has an essential role for phosphorylation of nicotinamide riboside and the cancer drug tiazofurin (PMID 15137942).</description>
		<cas>1341-23-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C11H15N2O5</moldb_formula>
		<moldb_inchi>InChI=1S/C11H14N2O5/c12-10(17)6-2-1-3-13(4-6)11-9(16)8(15)7(5-14)18-11/h1-4,7-9,11,14-16H,5H2,(H-,12,17)/p+1/t7-,8-,9-,11-/m1/s1</moldb_inchi>
		<moldb_inchikey>JLEBZPBDRKPWTD-TURQNECASA-O</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>255.2472</moldb_average_mass>
		<moldb_mono_mass>255.098096600</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>264</id>
		<lmdb_id>LMDB00264</lmdb_id>
		<created_at>2016-07-13 19:45:59</created_at>
		<updated_at>2016-07-20 20:58:59</updated_at>
		<export>1</export>
		<name>Pimelic acid</name>
		<description>Pimelic acid is a group of compounds that are derivatives of heptanedioic acid with the general formula R-C7H11O4. Pimelic acid is the organic compound with the formula HO2C(CH2)5CO2H. Derivatives of pimelic acid are involved in the biosynthesis of the amino acid called lysine. Pimelic acid is one methylene longer than a related dicarboxylic acid, adipic acid, a precursor to many polyesters and polyamides. Pimelic acid has been synthesized from cyclohexanone and from salicylic acid.[1] In the former route, the additional carbon is suppled by dimethyloxalate, which reacts with the enolate. (Wikipedia).</description>
		<cas>111-16-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C7H12O4</moldb_formula>
		<moldb_inchi>InChI=1S/C7H12O4/c8-6(9)4-2-1-3-5-7(10)11/h1-5H2,(H,8,9)(H,10,11)</moldb_inchi>
		<moldb_inchikey>WLJVNTCWHIRURA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>160.1678</moldb_average_mass>
		<moldb_mono_mass>160.073558872</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>265</id>
		<lmdb_id>LMDB00265</lmdb_id>
		<created_at>2016-07-13 19:46:00</created_at>
		<updated_at>2016-07-20 20:58:59</updated_at>
		<export>1</export>
		<name>Methylhippuric acid</name>
		<description>Methylhippuric acid is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:. acyl-CoA + glycine &lt; -- &gt; CoA + N-acylglycine. Methylhippuric acid is a metabolite of xylene which is an aromatic hydrocarbon widely used as a solvant. It'e level can be measured in urine of workers exposed to xylene (PMID 8689499).</description>
		<cas>1205-08-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>COC(=O)CNC(=O)C1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C10H11NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C10H11NO3/c1-14-9(12)7-11-10(13)8-5-3-2-4-6-8/h2-6H,7H2,1H3,(H,11,13)</moldb_inchi>
		<moldb_inchikey>XTKVNQKOTKPCKM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>193.1992</moldb_average_mass>
		<moldb_mono_mass>193.073893223</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>266</id>
		<lmdb_id>LMDB00266</lmdb_id>
		<created_at>2016-07-13 19:46:01</created_at>
		<updated_at>2016-07-20 20:59:01</updated_at>
		<export>1</export>
		<name>Isopropyl alcohol</name>
		<description>Isopropyl alcohol or 2-propanol is an isomer of 1-propanol. It is a colorless liquid having disinfectant properties. It is used in the manufacture of acetone and its derivatives and as a solvent. Topically, it is used as an antiseptic. Small amounts of this alcohol are produced naturally by gut microbial flora.</description>
		<cas>67-63-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)O</moldb_smiles>
		<moldb_formula>C3H8O</moldb_formula>
		<moldb_inchi>InChI=1S/C3H8O/c1-3(2)4/h3-4H,1-2H3</moldb_inchi>
		<moldb_inchikey>KFZMGEQAYNKOFK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>60.0950</moldb_average_mass>
		<moldb_mono_mass>60.057514878</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>267</id>
		<lmdb_id>LMDB00267</lmdb_id>
		<created_at>2016-07-13 19:46:03</created_at>
		<updated_at>2016-07-20 20:59:02</updated_at>
		<export>1</export>
		<name>Ribonic acid</name>
		<description>Ribonic acid is a product of the enzyme ribose 1-dehydrogenase (NADP+) [EC 1.1.1.115] (KEGG).</description>
		<cas>17812-24-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@@H](O)[C@@H](O)[C@@H](O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H10O6</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O6/c6-1-2(7)3(8)4(9)5(10)11/h2-4,6-9H,1H2,(H,10,11)/t2-,3-,4-/m1/s1</moldb_inchi>
		<moldb_inchikey>QXKAIJAYHKCRRA-BXXZVTAOSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>166.1293</moldb_average_mass>
		<moldb_mono_mass>166.047738052</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>268</id>
		<lmdb_id>LMDB00268</lmdb_id>
		<created_at>2016-07-13 19:46:04</created_at>
		<updated_at>2016-07-19 23:25:14</updated_at>
		<export>1</export>
		<name>Histamine</name>
		<description>Histamine is an amine derived by enzymatic decarboxylation of histidine. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.</description>
		<cas>51-45-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCC1=CNC=N1</moldb_smiles>
		<moldb_formula>C5H9N3</moldb_formula>
		<moldb_inchi>InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)</moldb_inchi>
		<moldb_inchikey>NTYJJOPFIAHURM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>111.1451</moldb_average_mass>
		<moldb_mono_mass>111.079647303</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>269</id>
		<lmdb_id>LMDB00269</lmdb_id>
		<created_at>2016-07-13 19:46:05</created_at>
		<updated_at>2016-07-20 20:59:03</updated_at>
		<export>1</export>
		<name>Tauroursodeoxycholic acid</name>
		<description>Tauroursodeoxycholic acid is a bile acid also known as TUDCA formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. TUDCA is able to prevent apoptosis and protect mitochondria from cellular elements that would otherwise interfere with energy production. One of these elements is a protein called Bax. TUDCA plays an important role in preventing Bax from being transported to the mitochondria. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).</description>
		<cas>14605-22-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H]([C@H](C)CCC(=O)NCCS(O)(=O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)CC2C[C@H](O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C26H45NO6S</moldb_formula>
		<moldb_inchi>InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17?,18-,19-,20+,21+,22+,24+,25+,26-/m1/s1</moldb_inchi>
		<moldb_inchikey>BHTRKEVKTKCXOH-VSHSPWMTSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>499.7040</moldb_average_mass>
		<moldb_mono_mass>499.296758867</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>270</id>
		<lmdb_id>LMDB00270</lmdb_id>
		<created_at>2016-07-13 19:46:06</created_at>
		<updated_at>2018-04-30 21:14:41</updated_at>
		<export>1</export>
		<name>Trigonelline</name>
		<description>Trigonelline is an alkaloid. Trigonelline is a product of the metabolism of niacin (vitamin B3) which is excreted in the urine. Trigonelline occurs in many other plants, including fenugreek seeds, garden peas, hemp seed, oats and potatoes.</description>
		<cas>535-83-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+]1=CC=CC(=C1)C([O-])=O</moldb_smiles>
		<moldb_formula>C7H7NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C7H7NO2/c1-8-4-2-3-6(5-8)7(9)10/h2-5H,1H3</moldb_inchi>
		<moldb_inchikey>WWNNZCOKKKDOPX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>137.1360</moldb_average_mass>
		<moldb_mono_mass>137.047678473</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>271</id>
		<lmdb_id>LMDB00271</lmdb_id>
		<created_at>2016-07-13 19:46:08</created_at>
		<updated_at>2016-09-23 18:45:03</updated_at>
		<export>1</export>
		<name>L-Valine</name>
		<description>Valine (abbreviated as Val or V) is an -amino acid with the chemical formula HO2CCH(NH2)CH(CH3)2. It is named after the plant valerian. L-Valine is one of 20 proteinogenic amino acids. Its codons are GUU, GUC, GUA, and GUG. This essential amino acid is classified as nonpolar. Along with leucine and isoleucine, valine is a branched-chain amino acid. Branched chain amino acids (BCAA) are essential amino acids whose carbon structure is marked by a branch point. These three amino acids are critical to animal life and are particularly involved in stress, energy and muscle metabolism. BCAA supplementation as therapy, both oral and intravenous, in animal health and disease holds great promise. &quot;BCAA&quot; denotes valine, isoleucine and leucine which are branched chain essential amino acids. Despite their structural similarities, the branched amino acids have different metabolic routes, with valine going solely to carbohydrates, leucine solely to fats and isoleucine to both. The different metabolism accounts for different requirements for these essential amino acids in animals: 12 mg/kg, 14 mg/kg and 16 mg/kg of valine, leucine and isoleucine respectively. Furthermore, these amino acids have different deficiency symptoms. Valine deficiency is marked by neurological defects in the brain, while isoleucine deficiency is marked by muscle tremors. Many types of inborn errors of BCAA metabolism exist, and are marked by various abnormalities. The most common form is the maple syrup urine disease, marked by a characteristic urinary odor. Other abnormalities are associated with a wide range of symptoms, such as mental retardation, ataxia, hypoglycemia, spinal muscle atrophy, rash, vomiting and excessive muscle movement. Most forms of BCAA metabolism errors are corrected by dietary restriction of BCAA and at least one form is correctable by supplementation with 10 mg of biotin daily. BCAA are decreased in patients with liver disease, such as hepatitis, hepatic coma, cirrhosis, extrahepatic biliary atresia or portacaval shunt; aromatic amino acids (AAA)ótyrosine, tryptophan and phenylalanine, as well as methionineóare increased in these conditions. Valine in particular, has been established as a useful supplemental therapy to the ailing liver. All the BCAA probably compete with AAA for absorption into the brain. Supplemental BCAA with vitamin B6 and zinc help normalize the BCAA:AAA ratio. (http://www.dcnutrition.com). In sickle-cell disease, valine substitutes for the hydrophilic amino acid glutamic acid in hemoglobin. Because valine is hydrophobic, the hemoglobin does not fold correctly. Valine is an essential amino acid, hence it must be ingested, usually as a component of proteins.</description>
		<cas>72-18-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)[C@H](N)C(O)=O</moldb_smiles>
		<moldb_formula>C5H11NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8)/t4-/m0/s1</moldb_inchi>
		<moldb_inchikey>KZSNJWFQEVHDMF-BYPYZUCNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>117.1463</moldb_average_mass>
		<moldb_mono_mass>117.078978601</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>272</id>
		<lmdb_id>LMDB00272</lmdb_id>
		<created_at>2016-07-13 19:46:09</created_at>
		<updated_at>2016-07-20 20:52:40</updated_at>
		<export>1</export>
		<name>Valeric acid</name>
		<description>Valeric acid, or pentanoic acid, is a straight chain alkyl carboxylic acid with the chemical formula CH3(CH2)3COOH. Like other low molecular weight carboxylic acids, it has a very unpleasant odor. It is found naturally in the perennial flowering plant valerian (Valeriana officinalis), from which it gets its name. Its primary use is in the synthesis of its esters. Volatile esters of valeric acid tend to have pleasant odors and are used in perfumes and cosmetics. Ethyl valerate and pentyl valerate are used as food additives because of their fruity flavors.</description>
		<cas>109-52-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC(O)=O</moldb_smiles>
		<moldb_formula>C5H10O2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O2/c1-2-3-4-5(6)7/h2-4H2,1H3,(H,6,7)</moldb_inchi>
		<moldb_inchikey>NQPDZGIKBAWPEJ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>102.1317</moldb_average_mass>
		<moldb_mono_mass>102.068079564</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>273</id>
		<lmdb_id>LMDB00273</lmdb_id>
		<created_at>2016-07-13 19:46:10</created_at>
		<updated_at>2016-07-20 20:59:11</updated_at>
		<export>1</export>
		<name>Taurodeoxycholic acid</name>
		<description>Taurodeoxycholic acid is a bile salt formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).</description>
		<cas>516-50-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O</moldb_smiles>
		<moldb_formula>C26H45NO6S</moldb_formula>
		<moldb_inchi>InChI=1S/C26H45NO6S/c1-16(4-9-24(30)27-12-13-34(31,32)33)20-7-8-21-19-6-5-17-14-18(28)10-11-25(17,2)22(19)15-23(29)26(20,21)3/h16-23,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17-,18-,19+,20-,21+,22+,23+,25+,26-/m1/s1</moldb_inchi>
		<moldb_inchikey>AWDRATDZQPNJFN-VAYUFCLWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>499.7040</moldb_average_mass>
		<moldb_mono_mass>499.296758867</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>274</id>
		<lmdb_id>LMDB00274</lmdb_id>
		<created_at>2016-07-13 19:46:12</created_at>
		<updated_at>2016-07-20 20:52:41</updated_at>
		<export>1</export>
		<name>Citrulline</name>
		<description>Citrulline is an amino acid made from ornithine and carbamoyl phosphate in one of the central reactions in the urea cycle. It is also produced from arginine as a by-product of the reaction catalyzed by NOS family (NOS; EC 1.14.13.39). In this reaction arginine is first oxidized into N-hydroxyl-arginine, which is then further oxidized to citrulline concomitant with the release of nitric oxide. EC 1.14.13.39). Citrulline's name is derived from citrullus, the Latin word for watermelon, from which it was first isolated.</description>
		<cas>372-75-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CCCNC(N)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H13N3O3</moldb_formula>
		<moldb_inchi>InChI=1S/C6H13N3O3/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)/t4-/m0/s1</moldb_inchi>
		<moldb_inchikey>RHGKLRLOHDJJDR-BYPYZUCNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>175.1857</moldb_average_mass>
		<moldb_mono_mass>175.095691297</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>275</id>
		<lmdb_id>LMDB00275</lmdb_id>
		<created_at>2016-07-13 19:46:13</created_at>
		<updated_at>2016-07-20 21:03:51</updated_at>
		<export>1</export>
		<name>Trimethylamine</name>
		<description>Trimethylamine, also known as NMe3, N(CH3)3, and TMA, is a colorless, hygroscopic, and flammable simple amine with a typical fishy odor in low concentrations and an ammonia like odor in higher concentrations. Trimethylamine has a boiling point of 2.9 degree centigrade and is a gas at room temperature. Trimethylamine usually comes in pressurized gas cylinders or as a 40% solution in water. Trimethylamine is a nitrogenous base and its positively charged cation is called trimethylammonium cation. A common salt of trimethylamine is trimethylammonium chloride, a hygroscopic colorless solid. -- Wikipedia; Trimethylamine is a product of decomposition of plants and animals. It is the substance mainly responsible for the fishy odor often associated with fouling fish, bacterial vagina infections, and bad breath. It is also associated with taking large doses of choline. -- Wikipedia; Trimethylaminuria is a genetic disorder in which the body is unable to metabolize trimethylamine from food sources. Patients develop a characteristic fish odour of their sweat, urine, and breath after the consumption of choline-rich foods. Trimethylaminuria is an autosomal recessive disorder involving a trimethylamine oxidase deficiency. Trimethylaminuria has also been observed in a certain breed of Rhode Island Red chicken that produces eggs with a fishy smell. -- Wikipedia.</description>
		<cas>75-50-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN(C)C</moldb_smiles>
		<moldb_formula>C3H9N</moldb_formula>
		<moldb_inchi>InChI=1S/C3H9N/c1-4(2)3/h1-3H3</moldb_inchi>
		<moldb_inchikey>GETQZCLCWQTVFV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>59.1103</moldb_average_mass>
		<moldb_mono_mass>59.073499293</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>276</id>
		<lmdb_id>LMDB00276</lmdb_id>
		<created_at>2016-07-13 19:46:14</created_at>
		<updated_at>2016-07-20 21:03:51</updated_at>
		<export>1</export>
		<name>Tridecanoic acid</name>
		<description>Tridecanoic acid is a short-chain fatty acid.</description>
		<cas>638-53-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C13H26O2</moldb_formula>
		<moldb_inchi>InChI=1S/C13H26O2/c1-2-3-4-5-6-7-8-9-10-11-12-13(14)15/h2-12H2,1H3,(H,14,15)</moldb_inchi>
		<moldb_inchikey>SZHOJFHSIKHZHA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>214.3443</moldb_average_mass>
		<moldb_mono_mass>214.193280076</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>277</id>
		<lmdb_id>LMDB00277</lmdb_id>
		<created_at>2016-07-13 19:46:15</created_at>
		<updated_at>2016-07-20 20:59:20</updated_at>
		<export>1</export>
		<name>Cholestenone</name>
		<description>Cholestenone is a dehydrocholestanone. It is a product of cholesterol oxidase {EC 1.1.3.6] in the Bile acid biosynthesis pathway (KEGG).</description>
		<cas>601-57-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C27H44O</moldb_formula>
		<moldb_inchi>InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h17-19,22-25H,6-16H2,1-5H3/t19-,22+,23-,24+,25+,26+,27-/m1/s1</moldb_inchi>
		<moldb_inchikey>NYOXRYYXRWJDKP-GYKMGIIDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>384.6377</moldb_average_mass>
		<moldb_mono_mass>384.339216030</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>278</id>
		<lmdb_id>LMDB00278</lmdb_id>
		<created_at>2016-07-13 19:46:17</created_at>
		<updated_at>2016-09-23 18:45:03</updated_at>
		<export>1</export>
		<name>Trimethylamine N-oxide</name>
		<description>Trimethylamine N-oxide (TMAO) is an oxidation product of trimethylamine and a common metabolite in animals and animals. In particular, trimethylamine-N-oxide is biosynthesized endogenously from trimethylamine, which is derived from choline, which can be derived from dietary lecithin (phosphatidylcholines) or dietary carnitine. TMAO decomposes to trimethylamine (TMA), which is the main odorant that is characteristic of degrading seafood. TMAO is an osmolyte that the body will use to counteract the effects of increased concentrations of urea (due to kidney failure) and high levels can be used as a biomarker for kidney problems. Fish odor syndrome or trimethylaminuria is a defect in the production of the enzyme flavin containing monooxygenase 3 (FMO3) causing incomplete breakdown of trimethylamine from choline-containing food into trimethylamine oxide. Trimethylamine then builds up and is released in the person's sweat, urine, and breath, giving off a strong fishy odor. The concentration of TMAO in the blood increases after consuming foods containing carnitine or lecithin (phosphatidylcholines), if the bacteria that convert those substances to TMAO are present in the gut (PMID: 23614584). High concentrations of carnitine are found in red meat, some energy drinks, and certain dietary supplements; lecithin is found in eggs and is commonly used as an ingredient in processed food. High levels of TMAO are found in many seafoods.  Some types of normal gut bacteria (e.g. species of Acinetobacter) in the animal gut convert dietary carnitine and dietary lecithin to TMAO (PMID: 21475195). TMAO alters cholesterol metabolism in the intestines, in the liver and in arterial wall. When TMAO is present, cholesterol metabolism is altered and there is an increased deposition of cholesterol within, and decreased removal of cholesterol from, peripheral cells such as those in the artery wall (PMID: 23563705).</description>
		<cas>1184-78-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+](C)(C)[O-]</moldb_smiles>
		<moldb_formula>C3H9NO</moldb_formula>
		<moldb_inchi>InChI=1S/C3H9NO/c1-4(2,3)5/h1-3H3</moldb_inchi>
		<moldb_inchikey>UYPYRKYUKCHHIB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>75.1097</moldb_average_mass>
		<moldb_mono_mass>75.068413915</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>279</id>
		<lmdb_id>LMDB00279</lmdb_id>
		<created_at>2016-07-13 19:46:18</created_at>
		<updated_at>2018-04-30 21:14:42</updated_at>
		<export>1</export>
		<name>L-Tryptophan</name>
		<description>Tryptophan is an essential amino acid which is the precursor of serotonin. Serotonin is a brain neurotransmitter, platelet clotting factor and neurohormone found in organs throughout the body. Metabolism of tryptophan to serotonin requires nutrients such as vitamin B6, niacin and glutathione. Niacin is an important metabolite of tryptophan. High corn or other tryptophan-deficient diets can cause pellagra, which is a niacin-tryptophan deficiency disease with symptoms of dermatitis, diarrhea and dementia. Inborn errors of tryptophan metabolism exist where a tumor (carcinoid) makes excess serotonin. Hartnup's disease is a disease where tryptophan and other amino acids are not absorbed properly. Tryptophan supplements may be useful in each condition, in carcinoid replacing the over-metabolized nutrient and in Hartnup's supplementing a malabsorbed nutrient. Some disorders of excess tryptophan in the blood may contribute to mental retardation. Assessment of tryptophan deficiency is done through studying excretion of tryptophan metabolites in the urine or blood. Blood may be the most sensitive test because the amino acid tryptophan is transported in a unique way. Increased urination of tryptophan fragments correlates with increased tryptophan degradation, which occurs with oral contraception, depression, mental retardation, hypertension and anxiety states. The requirement for tryptophan and protein decreases with age. Adults' minimum daily requirement is 3 mg/kg/day or about 200 mg a day. This may be an underestimation, for there are 400 mg of tryptophan in just a cup of wheat germ. A cup of low fat cottage cheese contains 300 mg of tryptophan and chicken and turkey contain up to 600 mg per pound. (http://www.dcnutrition.com).</description>
		<cas>73-22-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O</moldb_smiles>
		<moldb_formula>C11H12N2O2</moldb_formula>
		<moldb_inchi>InChI=1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m0/s1</moldb_inchi>
		<moldb_inchikey>QIVBCDIJIAJPQS-VIFPVBQESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>204.2252</moldb_average_mass>
		<moldb_mono_mass>204.089877638</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>280</id>
		<lmdb_id>LMDB00280</lmdb_id>
		<created_at>2016-07-13 19:46:19</created_at>
		<updated_at>2016-07-20 20:59:24</updated_at>
		<export>1</export>
		<name>Threonolactone</name>
		<description>Threonolactone is an oxidation product of the autoxidation reaction of L-ascorbic acid.</description>
		<cas>21730-93-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@H]1COC(=O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C4H6O4</moldb_formula>
		<moldb_inchi>InChI=1S/C4H6O4/c5-2-1-8-4(7)3(2)6/h2-3,5-6H,1H2/t2-,3+/m0/s1</moldb_inchi>
		<moldb_inchikey>SGMJBNSHAZVGMC-STHAYSLISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>118.0880</moldb_average_mass>
		<moldb_mono_mass>118.026608680</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>281</id>
		<lmdb_id>LMDB00281</lmdb_id>
		<created_at>2016-07-13 19:46:21</created_at>
		<updated_at>2016-08-01 19:10:55</updated_at>
		<export>1</export>
		<name>Threonic acid</name>
		<description>Threonic acid is probably derived from glycated proteins or from degradation of ascorbic acid. It is a normal component is aqeous humour and blood (PMID 10420182). Threonic acid is a substrate of L-threonate 3-dehydrogenase [EC 1.1.1.129] in ascorbate and aldarate metabolism pathway (KEGG).</description>
		<cas>3909-12-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@@H](O)[C@H](O)C(O)=O</moldb_smiles>
		<moldb_formula>C4H8O5</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8O5/c5-1-2(6)3(7)4(8)9/h2-3,5-7H,1H2,(H,8,9)/t2-,3+/m1/s1</moldb_inchi>
		<moldb_inchikey>JPIJQSOTBSSVTP-GBXIJSLDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>136.1033</moldb_average_mass>
		<moldb_mono_mass>136.037173366</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>282</id>
		<lmdb_id>LMDB00282</lmdb_id>
		<created_at>2016-07-13 19:46:22</created_at>
		<updated_at>2016-07-20 20:37:21</updated_at>
		<export>1</export>
		<name>Behenic acid</name>
		<description>Behenic acid, also docosanoic acid, is a normal carboxylic acid, a fatty acid with formula C21H43COOH. -- Wikipedia; It is an important constituent of the behen oil extracted from the seeds of the Ben-oil tree, and it is so named from the Persian month Bahman when the roots of this tree were harvested. -- Wikipedia.</description>
		<cas>112-85-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C22H44O2</moldb_formula>
		<moldb_inchi>InChI=1S/C22H44O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h2-21H2,1H3,(H,23,24)</moldb_inchi>
		<moldb_inchikey>UKMSUNONTOPOIO-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>340.5836</moldb_average_mass>
		<moldb_mono_mass>340.334130652</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>283</id>
		<lmdb_id>LMDB00283</lmdb_id>
		<created_at>2016-07-13 19:46:23</created_at>
		<updated_at>2016-08-02 20:15:04</updated_at>
		<export>1</export>
		<name>Ursodeoxycholic acid</name>
		<description>Ursodeoxycholic acid is an epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic. [PubChem]</description>
		<cas>128-13-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O</moldb_smiles>
		<moldb_formula>C24H40O4</moldb_formula>
		<moldb_inchi>InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1</moldb_inchi>
		<moldb_inchikey>RUDATBOHQWOJDD-UZVSRGJWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>392.5720</moldb_average_mass>
		<moldb_mono_mass>392.292659768</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>284</id>
		<lmdb_id>LMDB00284</lmdb_id>
		<created_at>2016-07-13 19:46:25</created_at>
		<updated_at>2016-07-20 20:59:31</updated_at>
		<export>1</export>
		<name>Undecanoic acid</name>
		<description>Undecanoic acid is a medium chain length monocarboxylic acid that appears to be involved in the control of triacylglycerol synthesis.(PMID 1739406). It is found in breast milk produced by women in the United States (PMID 16332663), in infant formulas ( Mljekarstvo (2005), 55(2), 101-112.), in seminal plasma (PMID 736283), and other fluids (PMID 8548929).</description>
		<cas>112-37-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C11H22O2</moldb_formula>
		<moldb_inchi>InChI=1S/C11H22O2/c1-2-3-4-5-6-7-8-9-10-11(12)13/h2-10H2,1H3,(H,12,13)</moldb_inchi>
		<moldb_inchikey>ZDPHROOEEOARMN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>186.2912</moldb_average_mass>
		<moldb_mono_mass>186.161979948</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>285</id>
		<lmdb_id>LMDB00285</lmdb_id>
		<created_at>2016-07-13 19:46:26</created_at>
		<updated_at>2016-07-20 20:59:32</updated_at>
		<export>1</export>
		<name>Taurochenodesoxycholic acid</name>
		<description>Taurochenodesoxycholic acid is a bile acid formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).</description>
		<cas>516-35-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O</moldb_smiles>
		<moldb_formula>C26H45NO6S</moldb_formula>
		<moldb_inchi>InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22-,24+,25+,26-/m1/s1</moldb_inchi>
		<moldb_inchikey>BHTRKEVKTKCXOH-BJLOMENOSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>499.7040</moldb_average_mass>
		<moldb_mono_mass>499.296758867</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>286</id>
		<lmdb_id>LMDB00286</lmdb_id>
		<created_at>2016-07-13 19:46:27</created_at>
		<updated_at>2016-07-20 20:59:33</updated_at>
		<export>1</export>
		<name>Suberylglycine</name>
		<description>Suberylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:acyl-CoA + glycine &lt; -- &gt; CoA + N-acylglycineSuberylglycine is a dicarboxylic acid. It is formed by glycine-N-acylase catalyzed conjugation (PMID 947635). It can be used for the diagnosis of hereditary medium-chain acyl-CoA dehydrogenase deficiency (PMID 2775902).</description>
		<cas>60317-54-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CCCCCCC(=O)NCC(O)=O</moldb_smiles>
		<moldb_formula>C10H17NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C10H17NO5/c12-8(11-7-10(15)16)5-3-1-2-4-6-9(13)14/h1-7H2,(H,11,12)(H,13,14)(H,15,16)</moldb_inchi>
		<moldb_inchikey>HXATVKDSYDWTCX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>231.2457</moldb_average_mass>
		<moldb_mono_mass>231.110672659</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>287</id>
		<lmdb_id>LMDB00287</lmdb_id>
		<created_at>2016-07-13 19:46:30</created_at>
		<updated_at>2016-07-19 23:24:27</updated_at>
		<export>1</export>
		<name>trans-Ferulic acid</name>
		<description>trans-Ferulic acid is a highly abundant phenolic phytochemical which is present in plant cell walls. trans-Ferulic acid is a phenolic acid that can be absorbed by the small intestine and excreted through the urine. It is one of the most abundant phenolic acids in plants, varying from 5 g/Kg in wheat bran to 9 g/kg in sugar-beet pulp and 50 g/kg in corn kernel. It occurs primarily in seeds and leaves both in its free form (rarely) and covalently linked to lignin and other biopolymers. It is usually found as ester cross-links with polysaccharides in the cell wall, such as arabinoxylans in grasses, pectin in spinach and sugar beet and xyloglucans in bamboo. It also can cross-link with proteins. Due to its phenolic nucleus and an extended side chain conjugation (carbohydrates and proteins), it readily forms a resonance stabilized phenoxy radical which accounts for its potent antioxidant potential. Food supplementation with curcumin and ferulic acid is considered a nutritional approach to reduce oxidative damage and amyloid pathology in Alzheimer disease. (PMID: 17127365, 1398220, 15453708, 9878519).</description>
		<cas>537-98-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>COC1=C(O)C=CC(\C=C\C(O)=O)=C1</moldb_smiles>
		<moldb_formula>C10H10O4</moldb_formula>
		<moldb_inchi>InChI=1S/C10H10O4/c1-14-9-6-7(2-4-8(9)11)3-5-10(12)13/h2-6,11H,1H3,(H,12,13)/b5-3+</moldb_inchi>
		<moldb_inchikey>KSEBMYQBYZTDHS-HWKANZROSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>194.1840</moldb_average_mass>
		<moldb_mono_mass>194.057908808</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>288</id>
		<lmdb_id>LMDB00288</lmdb_id>
		<created_at>2016-07-13 19:46:31</created_at>
		<updated_at>2016-09-23 18:45:04</updated_at>
		<export>1</export>
		<name>Tartaric acid</name>
		<description>Tartaric acid is a white crystalline organic acid. It occurs naturally in many plants, particularly grapes and tamarinds, and is one of the main acids found in wine. It is added to other foods to give a sour taste, and is used as an antioxidant. Salts of tartaric acid are known as tartrates. It is a dihydroxy derivative of dicarboxylic acid. Tartaric acid is a muscle toxin, which works by inhibiting the production of malic acid, and in high doses causes paralysis and death. The minimum recorded fatal dose for a animal is about 12 grams. In spite of that, it is included in many foods, especially sour-tasting sweets. As a food additive, tartaric acid is used as an antioxidant with E number E334, tartrates are other additives serving as antioxidants or emulsifiers. Naturally-occurring tartaric acid is chiral, meaning that it has molecules that are non-superimposable on their mirror-images. It is a useful raw material in organic chemistry for the synthesis of other chiral molecules. The naturally occurring form of the acid is L-(+)-tartaric acid or dextrotartaric acid. The mirror-image (enantiomeric) form, levotartaric acid or D-(-)-tartaric acid, and the achiral form, mesotartaric acid, can be made artificially. Tartarate is believed to play a role in inhibiting kidney stone formation. Most tartarate that is consumed by animals is metabolized by bacteria in the gastrointestinal tract -- primarily in the large instestine. Only about 15-20% of consumed tartaric acid is secreted in the urine unchanged.</description>
		<cas>87-69-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@H]([C@@H](O)C(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C4H6O6</moldb_formula>
		<moldb_inchi>InChI=1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)/t1-,2-/m1/s1</moldb_inchi>
		<moldb_inchikey>FEWJPZIEWOKRBE-JCYAYHJZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>150.0868</moldb_average_mass>
		<moldb_mono_mass>150.016437924</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>289</id>
		<lmdb_id>LMDB00289</lmdb_id>
		<created_at>2016-07-13 19:46:33</created_at>
		<updated_at>2018-04-30 21:14:42</updated_at>
		<export>1</export>
		<name>Pyrocatechol</name>
		<description>Pyrocatechol, often known as catechol or benzene-1,2-diol, is a benzenediol, with formula C6H4(OH)2. It was first prepared in 1839 by H. Reinsch by distilling catechin (the juice of Mimosa catechu). This colourless compound occurs naturally, but about 20000 tons are manufactured each year, mainly as precursors to pesticides, flavors, and fragrances. Its sulfonic acid is often present in the urine of many mammals. Small amounts of catechol occur naturally in fruits and vegetables, along with the enzyme polyphenol oxidase. Upon mixing the enzyme with the substrate and exposure to oxygen (as when a potato or apple is cut), the colorless catechol oxidizes to reddish-brown benzoquinone derivatives. The enzyme is inactivated by adding an acid, such as lemon juice, or by refrigeration. Excluding oxygen also prevents the browning reaction. Catechol melts at 28 oC and boils at 250 oC. It is employed in medicine as an expectorant. The dimethyl ether or veratrol is also used in medicine. Many other pyrocatechin derivatives have been suggested for therapeutic application.</description>
		<cas>120-80-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]OC1=C([H])C([H])=C([H])C([H])=C1O[H]</moldb_smiles>
		<moldb_formula>C6H6O2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8H</moldb_inchi>
		<moldb_inchikey>YCIMNLLNPGFGHC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>110.1106</moldb_average_mass>
		<moldb_mono_mass>110.036779436</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>290</id>
		<lmdb_id>LMDB00290</lmdb_id>
		<created_at>2016-07-13 19:46:35</created_at>
		<updated_at>2016-09-23 18:45:04</updated_at>
		<export>1</export>
		<name>trans-Aconitic acid</name>
		<description>trans-Aconitic acid is normally present in normal animal urine, and it has been suggested that is present in larger amounts with Reye's syndrome and organic aciduria. trans-Aconitic acid is a substrate of enzyme trans-aconitate 2-methyltransferase (EC 2.1.1.144) (PMID: 7096501, 4019674, 2950263).</description>
		<cas>4023-65-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C\C(=C/C(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H6O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H6O6/c7-4(8)1-3(6(11)12)2-5(9)10/h1H,2H2,(H,7,8)(H,9,10)(H,11,12)/b3-1+</moldb_inchi>
		<moldb_inchikey>GTZCVFVGUGFEME-HNQUOIGGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>174.1082</moldb_average_mass>
		<moldb_mono_mass>174.016437924</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>291</id>
		<lmdb_id>LMDB00291</lmdb_id>
		<created_at>2016-07-13 19:46:36</created_at>
		<updated_at>2016-07-20 20:59:36</updated_at>
		<export>1</export>
		<name>Tiglylglycine</name>
		<description>Tiglylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:. acyl-CoA + glycine &lt; -- &gt; CoA + N-acylglycine. Tiglylglycine is an intermediate product of the catabolism of isoleucine. An elevated level of tiglylglycine is identified in urine of patients with beta-ketothiolase deficiency or with disorders of propionate metabolism (PMID 7923765).</description>
		<cas>35842-45-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C\C=C(/C)C(=O)NCC(O)=O</moldb_smiles>
		<moldb_formula>C7H11NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C7H11NO3/c1-3-5(2)7(11)8-4-6(9)10/h3H,4H2,1-2H3,(H,8,11)(H,9,10)/b5-3+</moldb_inchi>
		<moldb_inchikey>WRUSVQOKJIDBLP-HWKANZROSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>157.1671</moldb_average_mass>
		<moldb_mono_mass>157.073893223</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>292</id>
		<lmdb_id>LMDB00292</lmdb_id>
		<created_at>2016-07-13 19:46:37</created_at>
		<updated_at>2016-07-20 21:03:54</updated_at>
		<export>1</export>
		<name>Hypotaurine</name>
		<description>Hypotaurine is a product of enzyme cysteamine dioxygenase [EC 1.13.11.19] in taurine and hypotaurine metabolism pathway (KEGG). It may function as an antioxidant and a protective agent under physiological conditions (PMID 14992269).</description>
		<cas>300-84-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCS(O)=O</moldb_smiles>
		<moldb_formula>C2H7NO2S</moldb_formula>
		<moldb_inchi>InChI=1S/C2H7NO2S/c3-1-2-6(4)5/h1-3H2,(H,4,5)</moldb_inchi>
		<moldb_inchikey>VVIUBCNYACGLLV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>109.1470</moldb_average_mass>
		<moldb_mono_mass>109.019749163</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>293</id>
		<lmdb_id>LMDB00293</lmdb_id>
		<created_at>2016-07-13 19:46:39</created_at>
		<updated_at>2016-09-23 18:45:05</updated_at>
		<export>1</export>
		<name>Biliverdin</name>
		<description>Biliverdin is a green pigment formed as a byproduct of hemoglobin breakdown. It consists of four linearly connected pyrrole rings (a tetrapyrrole). Biliverdin is formed when the heme group in hemoglobin is cleaved at its alpha-methene bridge. The resulting biliverdin is then reduced to bilirubin, a yellow pigment, by the enzyme biliverdin reductase. The changing color of a bruise from deep purple to yellow over time is a graphical indicator of this reaction. Biosynthesized from hemoglobin as a precursor of bilirubin. Occurs in the bile of amphibia and of birds, but not in normal animal bile or serum.</description>
		<cas>114-25-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=C(C=C)\C(NC1=O)=C\C1=C(C)C(CCC(O)=O)=C(N1)\C=C1/N\C(=C\C2=NC(=O)C(C=C)=C2C)C(C)=C1CCC(O)=O</moldb_smiles>
		<moldb_formula>C33H34N4O6</moldb_formula>
		<moldb_inchi>InChI=1S/C33H34N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-15,34-35H,1-2,9-12H2,3-6H3,(H,37,42)(H,38,39)(H,40,41)/b24-13+,27-14-,28-15-</moldb_inchi>
		<moldb_inchikey>RCNSAJSGRJSBKK-YKSNQIBWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>582.6463</moldb_average_mass>
		<moldb_mono_mass>582.247834840</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>294</id>
		<lmdb_id>LMDB00294</lmdb_id>
		<created_at>2016-07-13 19:46:40</created_at>
		<updated_at>2016-09-23 18:45:05</updated_at>
		<export>1</export>
		<name>Arachidonic acid</name>
		<description>Arachidonic acid is a polyunsaturated, essential fatty acid. It is found in animal and animal fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid. Arachidonic acid mediates inflammation and the functioning of several organs and systems either directly or upon its conversion into eicosanoids. Arachidonic acid in cell membrane phospholipids is the substrate for the synthesis of a range of biologically active compounds (eicosanoids) including prostaglandins, thromboxanes, and leukotrienes. These compounds can act as mediators in their own right and can also act as regulators of other processes, such as platelet aggregation, blood clotting, smooth muscle contraction, leukocyte chemotaxis, inflammatory cytokine production, and immune function. Arachidonic acid can be metabolized by cytochrome p450 (CYP450) enzymes to 5,6-, 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acids (EETs), their corresponding dihydroxyeicosa-trienoic acids (DHETs), and 20-hydroxyeicosatetraenoic acid (20-HETE). The production of kidney CYP450 arachidonic acid metabolites is altered in diabetes, pregnancy, hepatorenal syndrome, and in various models of hypertension, and it is likely that changes in this system contribute to the abnormalities in renal function that are associated with many of these conditions. Phospholipase A2 (PLA2) catalyzes the hydrolysis of the sn-2 position of membrane glycerophospholipids to liberate arachidonic acid (PMID: 12736897, 12736897, 12700820, 12570747, 12432908).</description>
		<cas>506-32-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O</moldb_smiles>
		<moldb_formula>C20H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-</moldb_inchi>
		<moldb_inchikey>YZXBAPSDXZZRGB-DOFZRALJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>304.4669</moldb_average_mass>
		<moldb_mono_mass>304.240230268</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>295</id>
		<lmdb_id>LMDB00295</lmdb_id>
		<created_at>2016-07-13 19:46:41</created_at>
		<updated_at>2016-07-20 20:59:40</updated_at>
		<export>1</export>
		<name>2-Hydroxyphenethylamine</name>
		<description>Simple amine found in the brain. It may be modulator of sympathetic functions. Its derivatives are adrenergic agonists and antagonists. It is also used in chemical industry.</description>
		<cas>7568-93-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCC(O)C1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C8H11NO</moldb_formula>
		<moldb_inchi>InChI=1S/C8H11NO/c9-6-8(10)7-4-2-1-3-5-7/h1-5,8,10H,6,9H2</moldb_inchi>
		<moldb_inchikey>ULSIYEODSMZIPX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>137.1790</moldb_average_mass>
		<moldb_mono_mass>137.084063979</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>296</id>
		<lmdb_id>LMDB00296</lmdb_id>
		<created_at>2016-07-13 19:46:42</created_at>
		<updated_at>2016-07-20 20:59:40</updated_at>
		<export>1</export>
		<name>N-Acetylaspartylglutamic acid</name>
		<description>N-Acetylaspartylglutamate (NAAG) is a neuropeptide found in millimolar concentrations in brain that is localized to subpopulations of glutamatergic, cholinergic, GABAergic, and noradrenergic neuronal systems. NAAG is released upon depolarization by a Ca(2+)-dependent process and is an agonist at mGluR3 receptors and an antagonist at NMDA receptors. NAAG is catabolized to N-acetylaspartate and glutamate primarily by glutamate carboxypeptidase II, which is expressed on the extracellular surface of astrocytes. The levels of NAAG and the activity of carboxypeptidase II are altered in a regionally specific fashion in several neuropsychiatric disorders. (PMID 9361299). N-Acetylaspartylglutamic acid (NAAG) is a purported precursor of N-Acetylaspartic acid (NAA) and is present at about one-tenth of the concentration of NAA in the brain. NAAG has been reported to activate N-methyl- D-aspartic acid (NMDA) receptors in neurons. Previous immunohistochemical studies in the vertebrate central nervous system (CNS) have suggested that NAAG is exclusively localized to neurons. Recent evidence, however, indicates that NAAG might also be localized to nonneuronal cells within the CNS. Only traces of NAA and NAAG are detectable in other tissues. Some compounds can change levels of NAA and NAAG in the brain. For example, methylphenidante increases the levels of NAA and NAAG in the cerebral cortex; amphetamine also increases NAA concentration in a mature brain by 26%, raising the possibility that other neurochemical systems might be involved in the clinical effects of stimulants. (PMID: 10603234).</description>
		<cas>3106-85-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)NC(CC(O)=O)C(=O)NC(CCC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C11H16N2O8</moldb_formula>
		<moldb_inchi>InChI=1S/C11H16N2O8/c1-5(14)12-7(4-9(17)18)10(19)13-6(11(20)21)2-3-8(15)16/h6-7H,2-4H2,1H3,(H,12,14)(H,13,19)(H,15,16)(H,17,18)(H,20,21)</moldb_inchi>
		<moldb_inchikey>OPVPGKGADVGKTG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>304.2533</moldb_average_mass>
		<moldb_mono_mass>304.090665498</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>297</id>
		<lmdb_id>LMDB00297</lmdb_id>
		<created_at>2016-07-13 19:46:44</created_at>
		<updated_at>2016-09-23 18:45:06</updated_at>
		<export>1</export>
		<name>Coenzyme Q10</name>
		<description>Coenzyme Q10 (ubiquinone) is a naturally occurring compound widely distributed in animal organisms and in animals. The primary compounds involved in the biosynthesis of ubiquinone are 4-hydroxybenzoate and the polyprenyl chain. An essential role of coenzyme Q10 is as an electron carrier in the mitochondrial respiratory chain. Moreover, coenzyme Q10 is one of the most important lipophilic antioxidants, preventing the generation of free radicals as well as oxidative modifications of proteins, lipids, and DNA, it and can also regenerate the other powerful lipophilic antioxidant, alpha-tocopherol. Antioxidant action is a property of the reduced form of coenzyme Q10, ubiquinol (CoQ10H2), and the ubisemiquinone radical (CoQ10H*). Paradoxically, independently of the known antioxidant properties of coenzyme Q10, the ubisemiquinone radical anion (CoQ10-) possesses prooxidative properties. Decreased levels of coenzyme Q10 in animals are observed in many pathologies (e.g. cardiac disorders, neurodegenerative diseases, AIDS, cancer) associated with intensive generation of free radicals and their action on cells and tissues. In these cases, treatment involves pharmaceutical supplementation or increased consumption of coenzyme Q10 with meals as well as treatment with suitable chemical compounds (i.e. folic acid or B-group vitamins) which significantly increase ubiquinone biosynthesis in the organism. Estimation of coenzyme Q10 deficiency and efficiency of its supplementation requires a determination of ubiquinone levels in the organism. Therefore, highly selective and sensitive methods must be applied, such as HPLC with UV or coulometric detection. For a number of years, coenzyme Q (CoQ10 in animals) was known for its key role in mitochondrial bioenergetics; later studies demonstrated its presence in other subcellular fractions and in plasma, and extensively investigated its antioxidant role. These two functions constitute the basis on which research supporting the clinical use of CoQ10 is founded. Also at the inner mitochondrial membrane level, coenzyme Q is recognized as an obligatory co-factor for the function of uncoupling proteins and a modulator of the transition pore. Furthermore, recent data reveal that CoQ10 affects expression of genes involved in animal cell signalling, metabolism, and transport and some of the effects of exogenously administered CoQ10 may be due to this property. Coenzyme Q is the only lipid soluble antioxidant synthesized endogenously. In its reduced form, CoQH2, ubiquinol, inhibits protein and DNA oxidation but it is the effect on lipid peroxidation that has been most deeply studied. Ubiquinol inhibits the peroxidation of cell membrane lipids and also that of lipoprotein lipids present in the circulation. Dietary supplementation with CoQ10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of animal low-density lipoproteins to the initiation of lipid peroxidation. Moreover, CoQ10 has a direct anti-atherogenic effect, which has been demonstrated in apolipoprotein E-deficient mice fed with a high-fat diet. (PMID: 15928598, 17914161).</description>
		<cas>303-98-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O</moldb_smiles>
		<moldb_formula>C59H90O4</moldb_formula>
		<moldb_inchi>InChI=1S/C59H90O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61/h24,26,28,30,32,34,36,38,40,42H,15-23,25,27,29,31,33,35,37,39,41,43H2,1-14H3/b45-26+,46-28+,47-30+,48-32+,49-34+,50-36+,51-38+,52-40+,53-42+</moldb_inchi>
		<moldb_inchikey>ACTIUHUUMQJHFO-UPTCCGCDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>863.3435</moldb_average_mass>
		<moldb_mono_mass>862.683911368</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>298</id>
		<lmdb_id>LMDB00298</lmdb_id>
		<created_at>2016-07-13 19:46:45</created_at>
		<updated_at>2016-07-20 20:59:41</updated_at>
		<export>1</export>
		<name>Fructose 1-phosphate</name>
		<description>Fructose 1-phosphate is an intermediate metabolite in the Fructose and mannose metabolism pathway.</description>
		<cas>15978-08-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@](O)(COP(O)(O)=O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C6H13O9P</moldb_formula>
		<moldb_inchi>InChI=1S/C6H13O9P/c7-1-3-4(8)5(9)6(10,15-3)2-14-16(11,12)13/h3-5,7-10H,1-2H2,(H2,11,12,13)/t3-,4-,5+,6-/m1/s1</moldb_inchi>
		<moldb_inchikey>RHKKZBWRNHGJEZ-ARQDHWQXSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>260.1358</moldb_average_mass>
		<moldb_mono_mass>260.029718526</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>299</id>
		<lmdb_id>LMDB00299</lmdb_id>
		<created_at>2016-07-13 19:46:47</created_at>
		<updated_at>2016-07-20 20:59:41</updated_at>
		<export>1</export>
		<name>N-Acetylglutamic acid</name>
		<description>N-acetylglutamic acid is an acetylated amino acid. N-Acetylglutamic acid (abbreviated NAcGlu) is biosynthesized from glutamic acid and acetyl-CoA by the enzyme N-acetylglutamate synthase (NAGS). NAcGlu activates carbamoyl phosphate synthetase in the urea cycle. A deficiency in N-Acetyl Glutamate Synthase or a genetic mutation in the gene coding for the enzyme, will lead to urea cycle failure in which ammonia is not converted to urea, but rather accumulated in blood leading to the condition called Type I Hyperammonemia. This is a severe neonatal disorder with fatal consequences, if not detected immediately upon birth.</description>
		<cas>1188-37-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)NC(CCC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C7H11NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C7H11NO5/c1-4(9)8-5(7(12)13)2-3-6(10)11/h5H,2-3H2,1H3,(H,8,9)(H,10,11)(H,12,13)</moldb_inchi>
		<moldb_inchikey>RFMMMVDNIPUKGG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>189.1659</moldb_average_mass>
		<moldb_mono_mass>189.063722467</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>300</id>
		<lmdb_id>LMDB00300</lmdb_id>
		<created_at>2016-07-13 19:46:48</created_at>
		<updated_at>2016-07-20 20:59:42</updated_at>
		<export>1</export>
		<name>Octanal</name>
		<description>Octanal is a substrate for Fatty aldehyde dehydrogenase and Alcohol dehydrogenase.</description>
		<cas>124-13-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC=O</moldb_smiles>
		<moldb_formula>C8H16O</moldb_formula>
		<moldb_inchi>InChI=1S/C8H16O/c1-2-3-4-5-6-7-8-9/h8H,2-7H2,1H3</moldb_inchi>
		<moldb_inchikey>NUJGJRNETVAIRJ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>128.2120</moldb_average_mass>
		<moldb_mono_mass>128.120115134</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>301</id>
		<lmdb_id>LMDB00301</lmdb_id>
		<created_at>2016-07-13 19:46:49</created_at>
		<updated_at>2016-09-23 18:45:06</updated_at>
		<export>1</export>
		<name>Aminomalonic acid</name>
		<description>Aminomalonic acid (Ama) was first detected in alkaline hydrolysates of proteins in 1984. Ama has been isolated from proteins of Escherichia coli and animal atherosclerotic plaque. The presence of Ama has important biological implications because the malonic acid moiety potentially imparts calcium binding properties to protein. Ama is not formed from any of the 20 major amino acids during the hydrolysis procedure. Furthermore, the amount of Ama found does not depend on the presence of small amounts of O2 during the hydrolysis. No artifactual formation of ama has been demonstrated and may indeed be a constituent of proteins before the hydrolysis procedure. Possible origins of Ama include errors in protein synthesis and oxidative damage to amino acid residues in proteins. (PMID: 1621954, 6366787).</description>
		<cas>1068-84-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(C(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C3H5NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C3H5NO4/c4-1(2(5)6)3(7)8/h1H,4H2,(H,5,6)(H,7,8)</moldb_inchi>
		<moldb_inchikey>JINBYESILADKFW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>119.0761</moldb_average_mass>
		<moldb_mono_mass>119.021857653</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>302</id>
		<lmdb_id>LMDB00302</lmdb_id>
		<created_at>2016-07-13 19:46:50</created_at>
		<updated_at>2016-09-23 18:45:07</updated_at>
		<export>1</export>
		<name>Tricosanoic acid</name>
		<description>Tricosanoic acid is found in different plant oils and extracts such as the Brazilian peppertree, but it can also be produced in the animal body. It has shown to be a hair growth stimulant.</description>
		<cas>2433-96-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C23H46O2</moldb_formula>
		<moldb_inchi>InChI=1S/C23H46O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23(24)25/h2-22H2,1H3,(H,24,25)</moldb_inchi>
		<moldb_inchikey>XEZVDURJDFGERA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>354.6101</moldb_average_mass>
		<moldb_mono_mass>354.349780716</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>303</id>
		<lmdb_id>LMDB00303</lmdb_id>
		<created_at>2016-07-13 19:46:52</created_at>
		<updated_at>2016-07-20 20:52:54</updated_at>
		<export>1</export>
		<name>Lathosterol</name>
		<description>Lathosterol is a a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. It is used as an indicator of whole-body cholesterol synthesis (PMID 14511438). Plasma lathosterol levels are significantly elevated in patients with bile acid malabsorption (PMID: 8777839). Lathosterol oxidase (EC 1.14.21.6) is an enzyme that catalyzes the chemical reaction 5alpha-cholest-7-en-3beta-ol + NAD(P)H + H+ + O2 cholesta-5,7-dien-3beta-ol + NAD(P)+ + 2 H2O.</description>
		<cas>80-99-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CC[C@@]2([H])C3=CC[C@@]4([H])C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C</moldb_smiles>
		<moldb_formula>C27H46O</moldb_formula>
		<moldb_inchi>InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h10,18-21,23-25,28H,6-9,11-17H2,1-5H3/t19-,20+,21+,23-,24+,25+,26+,27-/m1/s1</moldb_inchi>
		<moldb_inchikey>IZVFFXVYBHFIHY-SKCNUYALSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>386.6535</moldb_average_mass>
		<moldb_mono_mass>386.354866094</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>304</id>
		<lmdb_id>LMDB00304</lmdb_id>
		<created_at>2016-07-13 19:46:53</created_at>
		<updated_at>2016-09-23 18:45:07</updated_at>
		<export>1</export>
		<name>5'-Methylthioadenosine</name>
		<description>5'-Methylthioadenosine (MTA) is a naturally occurring sulfur-containing nucleoside present in all mammalian tissues. It is produced from S-adenosylmethionine mainly through the polyamine biosynthetic pathway, where it behaves as a powerful inhibitory product. MTA is metabolized solely by MTA-phosphorylase, to yield 5-methylthioribose-1-phosphate and adenine, a crucial step in the methionine and purine salvage pathways, respectively. Evidence suggests that MTA can affect cellular processes in many ways. For instance, MTA has been shown to influence regulation of gene expression, proliferation, differentiation and apoptosis (PMID 15313459). 5-Methylthioadenosine can be found in animal urine. Elevated excretion appears in children with severe combined immunodeficiency syndrome (PMID 3987052).</description>
		<cas>2457-80-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N</moldb_smiles>
		<moldb_formula>C11H15N5O3S</moldb_formula>
		<moldb_inchi>InChI=1S/C11H15N5O3S/c1-20-2-5-7(17)8(18)11(19-5)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1</moldb_inchi>
		<moldb_inchikey>WUUGFSXJNOTRMR-IOSLPCCCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>297.3340</moldb_average_mass>
		<moldb_mono_mass>297.089560061</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>305</id>
		<lmdb_id>LMDB00305</lmdb_id>
		<created_at>2016-07-13 19:46:54</created_at>
		<updated_at>2016-09-23 18:45:08</updated_at>
		<export>1</export>
		<name>Octanol</name>
		<description>Octanol occurs naturally in the form of esters in some essential oils. Octanol and water are immiscible. The distribution of a compound between water and octanol is used to calculate the partition coefficient (logP) of that molecule. Water/octanol partitioning is a good approximation of the partitioning between the cytosol and lipid membranes of living systems.(wikipedia). A colorless, slightly viscous liquid used as a defoaming or wetting agent. It is also used as a solvent for protective coatings, waxes, and oils, and as a raw material for plasticizers. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed). It is also one of many compounds derived from tobacco and tobacco smoke and shown to increase the permeability of the membranes of animal lung fibroblasts (PMID 7466833).</description>
		<cas>111-87-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCO</moldb_smiles>
		<moldb_formula>C8H18O</moldb_formula>
		<moldb_inchi>InChI=1S/C8H18O/c1-2-3-4-5-6-7-8-9/h9H,2-8H2,1H3</moldb_inchi>
		<moldb_inchikey>KBPLFHHGFOOTCA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>130.2279</moldb_average_mass>
		<moldb_mono_mass>130.135765198</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>306</id>
		<lmdb_id>LMDB00306</lmdb_id>
		<created_at>2016-07-13 19:46:56</created_at>
		<updated_at>2016-09-23 18:45:08</updated_at>
		<export>1</export>
		<name>Allantoic acid</name>
		<description>Allantoic acid is the END product of Allantoicase [EC:3.5.3.4], an enzyme involved in uric acid degradation (Purine metabolism). Although it is commonly accepted that allantoicase is lost in mammals, it has been identified in mice and animals. (PMID 11852104). A crystalline, transparent, colorless substance found in the allantoic liquid of the fetal calf; -- formerly called allantoic acid and amniotic acid.</description>
		<cas>99-16-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(=O)NC(NC(N)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C4H8N4O4</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8N4O4/c5-3(11)7-1(2(9)10)8-4(6)12/h1H,(H,9,10)(H3,5,7,11)(H3,6,8,12)</moldb_inchi>
		<moldb_inchikey>NUCLJNSWZCHRKL-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>176.1307</moldb_average_mass>
		<moldb_mono_mass>176.054554764</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>307</id>
		<lmdb_id>LMDB00307</lmdb_id>
		<created_at>2016-07-13 19:46:57</created_at>
		<updated_at>2016-07-20 20:59:47</updated_at>
		<export>1</export>
		<name>Prostaglandin E2</name>
		<description>The naturally occurring prostaglandin E2 (PGE2) is known in medicine as dinoprostone. It has important effects in labour and also stimulates osteoblasts to release factors which stimulate bone resorption by osteoclasts (a type of bone cell that removes bone tissue by removing the bone's mineralized matrix). PGE2 is also the prostaglandin that ultimately induces fever. PGE2 has been shown to increase vasodilation and cAMP production, to enhance the effects of bradykinin and histamine, induction of uterine contractions and of platelet aggregation. PGE2 is also responsible for maintaining the open passageway of the fetal ductus arteriosus; decreasing T-cell proliferation and lymphocyte migration and activating the secretion of IL-1&amp;#945; and IL-2. PGE2 exhibits both pro- and anti-inflammatory effects, particularly on dendritic cells (DC). Depending on the nature of maturation signals, PGE2 has different and sometimes opposite effects on DC biology. PGE2 exerts an inhibitory action, reducing the maturation of DC and their ability to present antigen. PGE2 has also been shown to stimulate DC and promote IL-12 production when given in combination with TNF-alpha. PGE2 is an environmentally bioactive substance. Its action is prolonged and sustained by other factors especially IL-10. It modulates the activities of professional DC by acting on their differentiation, maturation and their ability to secrete cytokines. PGE2 is a potent inducer of IL-10 in bone marrow-derived DC (BM-DC), and PGE2-induced IL-10 is a key regulator of the BM-DC pro-inflammatory phenotype (PMID: 16978535). Dinoprostone is a naturally occurring prostaglandin E2 (PGE2) and the most common and most biologically active of the mammalian prostaglandins. It has important effects in labour and also stimulates osteoblasts to release factors which stimulate bone resorption by osteoclasts (a type of bone cell that removes bone tissue by removing the bone's mineralized matrix). PGE2 has been shown to increase vasodilation and cAMP production, to enhance the effects of bradykinin and histamine, to induce uterine contractions and to activate platelet aggregation. PGE2 is also responsible for maintaining the open passageway of the fetal ductus arteriosus; decreasing T-cell proliferation and lymphocyte migration and activating the secretion of IL-1alpha and IL-2. PGE2 exhibits both pro- and anti-inflammatory effects, particularly on dendritic cells (DC). Depending on the nature of maturation signals, PGE2 has different and sometimes opposite effects on DC biology. PGE2 exerts an inhibitory action, reducing the maturation of DC and their ability to present antigen. PGE2 has also been shown to stimulate DC and promote IL-12 production when given in combination with TNF-alpha. PGE2 is an environmentally bioactive substance. Its action is prolonged and sustained by other factors especially IL-10. It modulates the activities of professional DC by acting on their differentiation, maturation and their ability to secrete cytokines. PGE2 is a potent inducer of IL-10 in bone marrow-derived DC (BM-DC), and PGE2-induced IL-10 is a key regulator of the BM-DC pro-inflammatory phenotype (PMID: 16978535). Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.</description>
		<cas>363-24-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O</moldb_smiles>
		<moldb_formula>C20H32O5</moldb_formula>
		<moldb_inchi>InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1</moldb_inchi>
		<moldb_inchikey>XEYBRNLFEZDVAW-ARSRFYASSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>352.4651</moldb_average_mass>
		<moldb_mono_mass>352.224974134</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>308</id>
		<lmdb_id>LMDB00308</lmdb_id>
		<created_at>2016-07-13 19:46:58</created_at>
		<updated_at>2016-07-20 20:52:57</updated_at>
		<export>1</export>
		<name>Aluminum</name>
		<description>Aluminium is a soft, lightweight metal with appearance ranging from silvery to dull gray, depending on the surface roughness. Data indicate that aluminum contaminates much of the raw material used to manufacture solutions used for intravenous nutritional support of hospitalized and ambulatory patients, and that pharmaceutical manufacturers have only recently obtained the technology necessary to detect aluminum contamination of their products. As a result, aluminum bypassed normal barriers and entered the blood, accumulating in tissues such as bone, liver and the central nervous system with toxic consequences. Now that the FDA has finally issued a rule governing aluminum contamination in these solutions, manufacturers will need to develop methods to minimize such contamination; scientists should also realize that when data they obtain indicate a serious problem in the manufacturing sector they should be sure that the problem is properly addressed.Physiologically, this metal/element. exists as an ion in the body. (PMID: 16198633).</description>
		<cas>7429-90-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Al+3]</moldb_smiles>
		<moldb_formula>Al</moldb_formula>
		<moldb_inchi>InChI=1S/Al/q+3</moldb_inchi>
		<moldb_inchikey>REDXJYDRNCIFBQ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>26.9815</moldb_average_mass>
		<moldb_mono_mass>26.981538441</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>309</id>
		<lmdb_id>LMDB00309</lmdb_id>
		<created_at>2016-07-13 19:47:00</created_at>
		<updated_at>2016-07-20 20:52:58</updated_at>
		<export>1</export>
		<name>Lanosterin</name>
		<description>Lanosterol is a tetracyclic triterpenoid which is the compound from which all steroids are derived. Lanosterol is biochemically synthesized starting from acetyl-CoA by the HMG-CoA reductase pathway. The critical step is the enzymatic conversion of the acyclic terpene squalene to the polycylic lanosterol via 2,3-squalene oxide.(wikipedia).</description>
		<cas>79-63-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@]1([H])CC3)[C@H](C)CCC=C(C)C</moldb_smiles>
		<moldb_formula>C30H50O</moldb_formula>
		<moldb_inchi>InChI=1S/C30H50O/c1-20(2)10-9-11-21(3)22-14-18-30(8)24-12-13-25-27(4,5)26(31)16-17-28(25,6)23(24)15-19-29(22,30)7/h10,21-22,25-26,31H,9,11-19H2,1-8H3/t21-,22-,25+,26+,28-,29-,30+/m1/s1</moldb_inchi>
		<moldb_inchikey>CAHGCLMLTWQZNJ-BQNIITSRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>426.7174</moldb_average_mass>
		<moldb_mono_mass>426.386166222</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>310</id>
		<lmdb_id>LMDB00310</lmdb_id>
		<created_at>2016-07-13 19:47:01</created_at>
		<updated_at>2016-07-20 20:38:06</updated_at>
		<export>1</export>
		<name>Spermine</name>
		<description>Spermine is a biogenic polyamine formed from spermidine. It is found in a wide variety of organisms and tissues and is an essential growth factor in some bacteria. It is found as a polycation at all pH values. Spermine is associated with nucleic acids, particularly in viruses, and is thought to stabilize the helical structure.</description>
		<cas>71-44-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCCNCCCCNCCCN</moldb_smiles>
		<moldb_formula>C10H26N4</moldb_formula>
		<moldb_inchi>InChI=1S/C10H26N4/c11-5-3-9-13-7-1-2-8-14-10-4-6-12/h13-14H,1-12H2</moldb_inchi>
		<moldb_inchikey>PFNFFQXMRSDOHW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>202.3402</moldb_average_mass>
		<moldb_mono_mass>202.215746852</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>311</id>
		<lmdb_id>LMDB00311</lmdb_id>
		<created_at>2016-07-13 19:47:02</created_at>
		<updated_at>2016-07-20 20:38:08</updated_at>
		<export>1</export>
		<name>Spermidine</name>
		<description>Spermidine is a polyamine formed from putrescine. It is found in almost all tissues in association with nucleic acids. It is found as a cation at all pH values, and is thought to help stabilize some membranes and nucleic acid structures. It is a precursor of spermine.</description>
		<cas>124-20-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCCCNCCCN</moldb_smiles>
		<moldb_formula>C7H19N3</moldb_formula>
		<moldb_inchi>InChI=1S/C7H19N3/c8-4-1-2-6-10-7-3-5-9/h10H,1-9H2</moldb_inchi>
		<moldb_inchikey>ATHGHQPFGPMSJY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>145.2459</moldb_average_mass>
		<moldb_mono_mass>145.157897623</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>312</id>
		<lmdb_id>LMDB00312</lmdb_id>
		<created_at>2016-07-13 19:47:04</created_at>
		<updated_at>2016-07-20 20:59:48</updated_at>
		<export>1</export>
		<name>Succinic acid semialdehyde</name>
		<description>Succinic acid semialdehyde is an intermediate in the catabolism of gamma-aminobutyrate (PMID 16435183). Succinate semialdehyde dehydrogenase is an enzyme that catalyses the reaction of succinate semialdehyde and NAD+ to form succinate and NADH. Succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria) is a rare neurometabolic disorder of gamma-aminobutyric acid degradation. Symptoms include motor delay, hypotonia, speech delay, autistic features, seizures, and ataxia. Patients also exhibit behavioral problems, such as attention deficit, hyperactivity, anxiety, or aggression. (PMID: 18622364).</description>
		<cas>692-29-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CCC=O</moldb_smiles>
		<moldb_formula>C4H6O3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H6O3/c5-3-1-2-4(6)7/h3H,1-2H2,(H,6,7)</moldb_inchi>
		<moldb_inchikey>UIUJIQZEACWQSV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>102.0886</moldb_average_mass>
		<moldb_mono_mass>102.031694058</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>313</id>
		<lmdb_id>LMDB00313</lmdb_id>
		<created_at>2016-07-13 19:47:05</created_at>
		<updated_at>2016-09-23 18:45:08</updated_at>
		<export>1</export>
		<name>Maltotriose</name>
		<description>Maltotriose is a common oligosaccharide metabolite found in animal urine after maltose ingestion or infusion (PMID 6645121). Maltotriose is increased in Glycogen storage disease II (OMIM 232300) due to a mutation of the enzyme alpha-1,4-glucosidase (E.C. 3.2.1.20) (4286143).</description>
		<cas>1109-28-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)C(O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C18H32O16</moldb_formula>
		<moldb_inchi>InChI=1S/C18H32O16/c19-1-4-7(22)8(23)12(27)17(31-4)34-15-6(3-21)32-18(13(28)10(15)25)33-14-5(2-20)30-16(29)11(26)9(14)24/h4-29H,1-3H2/t4-,5-,6-,7-,8+,9-,10-,11-,12-,13-,14-,15-,16?,17-,18-/m1/s1</moldb_inchi>
		<moldb_inchikey>FYGDTMLNYKFZSV-DZOUCCHMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>504.4371</moldb_average_mass>
		<moldb_mono_mass>504.169034976</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>314</id>
		<lmdb_id>LMDB00314</lmdb_id>
		<created_at>2016-07-13 19:47:06</created_at>
		<updated_at>2016-08-01 19:10:56</updated_at>
		<export>1</export>
		<name>L-Sorbose</name>
		<description>Sorbose is a ketose belonging to the group of sugars known as monosaccharides. The commercial production of vitamin C (ascorbic acid) often begins with sorbose.</description>
		<cas>87-79-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@@]1(O)OC[C@H](O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-2-6(11)5(10)4(9)3(8)1-12-6/h3-5,7-11H,1-2H2/t3-,4+,5-,6+/m0/s1</moldb_inchi>
		<moldb_inchikey>LKDRXBCSQODPBY-BGPJRJDNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1559</moldb_average_mass>
		<moldb_mono_mass>180.063388116</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>315</id>
		<lmdb_id>LMDB00315</lmdb_id>
		<created_at>2016-07-13 19:47:08</created_at>
		<updated_at>2016-09-23 18:45:09</updated_at>
		<export>1</export>
		<name>Maltotetraose</name>
		<description>Maltotetraose is a normal animal oligo saccharide present in plasma, but is elevated in cases of Pompe disease (PMID 15886040).</description>
		<cas>34612-38-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)C(O)O[C@@H]4CO)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C24H42O21</moldb_formula>
		<moldb_inchi>InChI=1S/C24H42O21/c25-1-5-9(29)10(30)15(35)22(40-5)44-19-7(3-27)42-24(17(37)12(19)32)45-20-8(4-28)41-23(16(36)13(20)33)43-18-6(2-26)39-21(38)14(34)11(18)31/h5-38H,1-4H2/t5-,6-,7-,8-,9-,10+,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21?,22-,23-,24-/m1/s1</moldb_inchi>
		<moldb_inchikey>LUEWUZLMQUOBSB-AYQJAVFRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>666.5777</moldb_average_mass>
		<moldb_mono_mass>666.221858406</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>316</id>
		<lmdb_id>LMDB00316</lmdb_id>
		<created_at>2016-07-13 19:47:09</created_at>
		<updated_at>2016-07-20 20:38:11</updated_at>
		<export>1</export>
		<name>Molybdenum</name>
		<description>Molybdenum is a transition metal with the atomic symbol Mo, atomic number 42, and atomic weight 95.94. The pure metal is silvery white in color, fairly soft, and has one of the highest melting points of all pure elements. Physiologically, it exists as an ion in the body. It is an essential trace element, being a component of the enzymes xanthine oxidase, aldehyde oxidase, and nitrate reductase. There is a trace requirement for molybdenum in plants, and soils can be barren due to molybdenum deficiencies. Plants and animals generally have molybdenum present in amounts of a few parts per million. In animals molybdenum is a cofactor of the enzyme xanthine oxidase which is involved in the pathways of purine degradation and formation of uric acid. In some animals, adding a small amount of dietary molybdenum enhances growth. Francis Crick suggested that since molybdenum is an essential trace element that plays an important role in many enzymatic reactions, despite being less abundant than the more common elements, such as chromium and nickel, that perhaps this fact is indicative of &quot;Panspermia.&quot; Crick theorized that if it could be shown that the elements represented in terrestrial living organisms correlate closely with those that are abundant in some class of star - molybdenum stars, for example, that this would provide evidence of such Directed Panspermia. In small quantities, molybdenum is effective at hardening steel. Molybdenum is important in plant nutrition, and is found in certain enzymes, including xanthine oxidase. Molybdenum is used to this day in high-strength alloys and in high-temperature steels. Special molybdenum-containing alloys, such as the Hastelloys, are notably heat-resistant and corrosion-resistant. Molybdenum is used in oil pipelines, aircraft and missile parts, and in filaments. Molybdenum finds use as a catalyst in the petroleum industry, especially in catalysts for removing organic sulfurs from petroleum products. It is used to form the anode in some x-ray tubes, particularly in mammography applications. And is found in some electronic applications as the conductive metal layers in thin-film transistors (TFTs). Molybdenum disulfide is a good lubricant, especially at high temperatures. And Mo-99 is used in the nuclear isotope industry. Molybdenum pigments range from red-yellow to a bright red orange and are used in paints, inks, plastics, and rubber compounds.</description>
		<cas>7439-98-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Mo++]</moldb_smiles>
		<moldb_formula>Mo</moldb_formula>
		<moldb_inchi>InChI=1S/Mo/q+2</moldb_inchi>
		<moldb_inchikey>MMVYPOCJESWGTC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>95.9400</moldb_average_mass>
		<moldb_mono_mass>97.905407846</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>317</id>
		<lmdb_id>LMDB00317</lmdb_id>
		<created_at>2016-07-13 19:47:10</created_at>
		<updated_at>2016-08-02 20:39:21</updated_at>
		<export>1</export>
		<name>Phosphorus</name>
		<description>Phosphorus, in its common form, is a waxy white (or yellowish) solid that has a characteristic, disagreeable smell similar to that of garlic. Pure forms of the element are colorless and transparent. This nonmetal is not soluble in water, but is soluble in carbon disulfide. The white allotrope ignites spontaneously in air; however both white and red phosphorus burn in air to produce phosphorus pentoxide. Phosphorus is a key element in all known forms of life. Physiologically, it exists as an ion in the body. Inorganic phosphorus in the form of the phosphate PO43- plays a major role in biological molecules such as DNA and RNA where it forms part of the structural framework of these molecules. Living cells also utilize phosphate to transport cellular energy via adenosine triphosphate (ATP). Nearly every cellular process that uses energy gets it in the form of ATP. ATP is also important for phosphorylation, a key regulatory event in cells. Phospholipids are the main structural components of all cellular membranes. Calcium phosphate salts are used by animals to stiffen their bones. An average person contains a little less than 1 kg of phosphorus, about three quarters of which is present in bones and teeth in the form of apatite. A well-fed adult in the industrialized world consumes and excretes about 1-3 g of phosphorus per day in the form of phosphate. Phosphorus is an essential mineral macronutrient, which is studied extensively in soil conservation in order to understand plant uptake from soil systems. Due to its reactivity to air and many other oxygen containing substances, phosphorus is not found free in nature but it is widely distributed in many different minerals.</description>
		<cas>7723-14-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>P</moldb_smiles>
		<moldb_formula>H3P</moldb_formula>
		<moldb_inchi>InChI=1S/H3P/h1H3</moldb_inchi>
		<moldb_inchikey>XYFCBTPGUUZFHI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>33.9976</moldb_average_mass>
		<moldb_mono_mass>33.997236608</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>318</id>
		<lmdb_id>LMDB00318</lmdb_id>
		<created_at>2016-07-13 19:47:12</created_at>
		<updated_at>2016-07-20 20:59:50</updated_at>
		<export>1</export>
		<name>6-Phosphogluconic acid</name>
		<description>Intermediate in the Pentose phosphate pathway (KEGG).</description>
		<cas>921-62-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H13O10P</moldb_formula>
		<moldb_inchi>InChI=1S/C6H13O10P/c7-2(1-16-17(13,14)15)3(8)4(9)5(10)6(11)12/h2-5,7-10H,1H2,(H,11,12)(H2,13,14,15)/t2-,3-,4+,5-/m1/s1</moldb_inchi>
		<moldb_inchikey>BIRSGZKFKXLSJQ-SQOUGZDYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>276.1352</moldb_average_mass>
		<moldb_mono_mass>276.024633148</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>319</id>
		<lmdb_id>LMDB00319</lmdb_id>
		<created_at>2016-07-13 19:47:13</created_at>
		<updated_at>2016-07-20 20:59:51</updated_at>
		<export>1</export>
		<name>N6,N6,N6-Trimethyl-L-lysine</name>
		<description>N6,N6,N6-Trimethyl-L-lysine is a methylated derivative of the amino acid lysine. It is a component of histone proteins, a precursor of carnitine and a coenzyme of fatty acid oxidation. N6,N6,N6-Trimethyl-L-lysine residues are found in a number of proteins and are generated by the action of S-adenosyl-L-methionine on exposed lysine residues. When trimethyllysine is released from cognate proteins via proteolysis, it serves as a precursor for carnitine biosynthesis. Mitochondrial 6-N-trimethyllysine dioxygenase converts 6-N-trimethyllysine to 3-hydroxy-6-N-trimethyllysine as the first step for carnitine biosynthesis. Because the subsequent carnitine biosynthesis enzymes are cytosolic, 3-hydroxy-6-N-trimethyllysine must be transported out of the mitochondria by a putative mitochondrial 6-N-trimethyllysine/3-hydroxy-6-N-trimethyllysine transporter system. Plasma -N-trimethyllysine concentrations are significantly lower in systemic carnitine deficiency patients compared to normal individuals, but no significant difference in urinary -N-trimethyllysine excretion is seen between the two groups.</description>
		<cas>19253-88-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+](C)(C)CCCC[C@H](N)C([O-])=O</moldb_smiles>
		<moldb_formula>C9H20N2O2</moldb_formula>
		<moldb_inchi>InChI=1S/C9H20N2O2/c1-11(2,3)7-5-4-6-8(10)9(12)13/h8H,4-7,10H2,1-3H3/t8-/m0/s1</moldb_inchi>
		<moldb_inchikey>MXNRLFUSFKVQSK-QMMMGPOBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>188.2673</moldb_average_mass>
		<moldb_mono_mass>188.152477894</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>320</id>
		<lmdb_id>LMDB00320</lmdb_id>
		<created_at>2016-07-13 19:47:14</created_at>
		<updated_at>2016-09-23 18:45:09</updated_at>
		<export>1</export>
		<name>Rubidium</name>
		<description>Rubidium is a soft, silvery-white metallic element of the alkali metal group, present in traces amounts in animal tissues and fluids. Rb-87, a naturally occurring isotope, is (slightly) radioactive. Rubidium is very soft and highly reactive, with properties similar to other elements in group 1, like rapid oxidation in air. Rubidium, particularly 87Rb, in the form of vapor, is one of the most commonly-used atomic species employed for laser cooling and Bose-Einstein condensation. Its desirable features for this application include the ready availability of inexpensive diode laser light at the relevant wavelength, and the moderate temperatures required to obtain substantial vapor pressures. Physiologically, it exists as an ion in the body. It has been found slightly increased in neoplastic animal breast tissues obtained from patients at the time of mastectomy, compared to normal tissue. (PMID: 6488192, 15820728, 7324778, 9630429, 577330).</description>
		<cas>7440-17-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Rb+]</moldb_smiles>
		<moldb_formula>Rb</moldb_formula>
		<moldb_inchi>InChI=1S/Rb/q+1</moldb_inchi>
		<moldb_inchikey>NCCSSGKUIKYAJD-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>85.4678</moldb_average_mass>
		<moldb_mono_mass>84.911789341</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>321</id>
		<lmdb_id>LMDB00321</lmdb_id>
		<created_at>2016-07-13 19:47:15</created_at>
		<updated_at>2016-07-19 23:36:26</updated_at>
		<export>1</export>
		<name>Manganese</name>
		<description>Manganese is an essential trace nutrient in all forms of life. Physiologically, it. exists as an ion in the body. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver.</description>
		<cas>7439-96-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Mn++]</moldb_smiles>
		<moldb_formula>Mn</moldb_formula>
		<moldb_inchi>InChI=1S/Mn/q+2</moldb_inchi>
		<moldb_inchikey>WAEMQWOKJMHJLA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>54.9380</moldb_average_mass>
		<moldb_mono_mass>54.938049636</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>322</id>
		<lmdb_id>LMDB00322</lmdb_id>
		<created_at>2016-07-13 19:47:17</created_at>
		<updated_at>2016-07-20 21:03:56</updated_at>
		<export>1</export>
		<name>ADP</name>
		<description>Adenosine diphosphate, abbreviated ADP, is a nucleotide. It is an ester of pyrophosphoric acid with the nucleotide adenine. ADP consists of the pyrophosphate group, the pentose sugar ribose, and the nucleobase adenine. ADP is the product of ATP dephosphorylation by ATPases. ADP is converted back to ATP by ATP synthases.</description>
		<cas>58-64-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C10H15N5O10P2</moldb_formula>
		<moldb_inchi>InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1</moldb_inchi>
		<moldb_inchikey>XTWYTFMLZFPYCI-KQYNXXCUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>427.2011</moldb_average_mass>
		<moldb_mono_mass>427.029414749</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>323</id>
		<lmdb_id>LMDB00323</lmdb_id>
		<created_at>2016-07-13 19:47:18</created_at>
		<updated_at>2016-09-23 18:45:10</updated_at>
		<export>1</export>
		<name>Selenium</name>
		<description>Selenium-dependent enzymes and selenoprotein P regulate immune and endothelial cell function. (PMID: 16607122). Thyroid hormone synthesis, metabolism and action require adequate availability of the essential trace elements iodine and selenium, which affect homeostasis of thyroid hormone-dependent metabolic pathways. The three selenocysteine-containing iodothyronine deiodinases constitute a novel gene family. Selenium is retained and deiodinase expression is maintained at almost normal levels in the thyroid gland, the brain and several other endocrine tissues during selenium deficiency, thus guaranteeing adequate local and systemic levels of the active thyroid hormone T(3). (PMID: 16131327). The trace element nutrient selenium (Se) discharges its well-known nutritional antioxidant activity through the Se-dependent glutathione peroxidases. It also regulates nuclear factor activities by redox mechanisms through the selenoprotein thioredoxin reductases. Converging data from epidemiological, ecological, and clinical studies have shown that Se can decrease the risk for some types of animal cancers, especially those of the prostate, lung, and colon. Mechanistic studies have indicated that the methylselenol metabolite pool has many desirable attributes of chemoprevention, targeting both cancer cells and vascular endothelial cells, whereas the hydrogen selenide pool in excess of selenoprotein synthesis can lead to DNA single strand breaks, which may be mediated by some reactive oxygen species. (PMID: 16356132). SePP (selenoprotein P) is the major transporter of Se in the serum. Moreover, in the sanctuary area of the brain, SePP was shown to play a hitherto unexpected role as a local Se storage and recycling protein that directly maintains brain Se levels. Physiologically, it exists as an ion in the body. The function of Se is important in normal brain metabolism, redox regulation, antioxidant defenses, thyroid hormone metabolism and the development of neurodegenerative conditions. (PMID: 15720294). In areas where soils are low in bioavailable selenium (Se), potential Se deficiencies cause health risks for animals. (PMID: 16028492) Dietary selenium comes from cereals, meat, fish, and eggs. The recommended dietary allowance for adults is 55 micrograms per day.</description>
		<cas>7782-49-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Se++]</moldb_smiles>
		<moldb_formula>Se</moldb_formula>
		<moldb_inchi>InChI=1S/Se/q+2</moldb_inchi>
		<moldb_inchikey>MFSBVGSNNPNWMD-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>78.9600</moldb_average_mass>
		<moldb_mono_mass>79.916521828</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>324</id>
		<lmdb_id>LMDB00324</lmdb_id>
		<created_at>2016-07-13 19:47:19</created_at>
		<updated_at>2016-07-19 23:35:00</updated_at>
		<export>1</export>
		<name>Nitrogen</name>
		<description>Elemental nitrogen is a colorless, odorless, tasteless and mostly inert diatomic gas at standard conditions, constituting 78% by volume of Earth's atmosphere. Nitrogen occurs in all living organisms. It is a constituent element of amino acids and therefore of proteins and nucleic acids (DNA and RNA). Nitrogen is found in the chemical structure of almost all neurotransmitters and is a key component of alkaloids. Specific bacteria (e.g. Rhizobium trifolium) possess nitrogenase enzymes which can fix atmospheric nitrogen into a form (ammonium ion) which is chemically useful to higher organisms. Animals use nitrogen-containing amino acids from plant sources, as starting materials for all nitrogen-compound animal biochemistry, including the manufacture of proteins and nucleic acids. Animal metabolism of NO (nitric oxide) results in production of nitrite. Animal metabolism of nitrogen in proteins generally results in excretion of urea, while animal metabolism of nucleic acids results in excretion of urea and uric acid. The characteristic odor of animal flesh decay is caused by nitrogen-containing long-chain amines, such as putrescine and cadaverine. Decay of organisms and their waste products may produce small amounts of nitrate, but most decay eventually returns nitrogen content to the atmosphere, as molecular nitrogen. The circulation of nitrogen from the atmosphere through organics and then back to the atmosphere is commonly referred to as the nitrogen cycle.</description>
		<cas>7727-37-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N#N</moldb_smiles>
		<moldb_formula>N2</moldb_formula>
		<moldb_inchi>InChI=1S/N2/c1-2</moldb_inchi>
		<moldb_inchikey>IJGRMHOSHXDMSA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>28.0134</moldb_average_mass>
		<moldb_mono_mass>28.006148010</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>325</id>
		<lmdb_id>LMDB00325</lmdb_id>
		<created_at>2016-07-13 19:47:21</created_at>
		<updated_at>2016-07-20 20:59:52</updated_at>
		<export>1</export>
		<name>N-Methylphenylethanolamine</name>
		<description>N-Methylphenylethanolamine is an intermediate in the metabolism of Tyrosine. It is a substrate for Phenylethanolamine N-methyltransferase.</description>
		<cas>68579-60-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CNCC(O)C1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C9H13NO</moldb_formula>
		<moldb_inchi>InChI=1S/C9H13NO/c1-10-7-9(11)8-5-3-2-4-6-8/h2-6,9-11H,7H2,1H3</moldb_inchi>
		<moldb_inchikey>ZCTYHONEGJTYQV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>151.2056</moldb_average_mass>
		<moldb_mono_mass>151.099714043</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>326</id>
		<lmdb_id>LMDB00326</lmdb_id>
		<created_at>2016-07-13 19:47:22</created_at>
		<updated_at>2016-09-23 18:45:11</updated_at>
		<export>1</export>
		<name>Alpha-Linolenic acid</name>
		<description>Alpha-linolenic acid (ALA) is a polyunsaturated fatty acid (PUFA). It is a member of the group of essential fatty acids called omega-3 fatty acids. Alpha-linolenic acid, in particular, is not synthesized by mammals and therefore is an essential dietary requirement for all mammals. Certain nuts (English walnuts) and vegetable oils (canola, soybean, flaxseed/linseed, olive) are particularly rich in alpha-linolenic acid (ALA). Omega-3 fatty acids get their name based on the location of one of their first double bond. In all omega-3 fatty acids, the first double bond is located between the third and fourth carbon atom counting from the methyl end of the fatty acid (n-3). Although animals and other mammals can synthesize saturated and some monounsaturated fatty acids from carbon groups in carbohydrates and proteins, they lack the enzymes necessary to insert a cis double bond at the n-6 or the n-3 position of a fatty acid. Omega-3 fatty acids like a-linolenic acid are important structural components of cell membranes. When incorporated into phospholipids, they affect cell membrane properties such as fluidity, flexibility, permeability and the activity of membrane bound enzymes. Omega-3 fatty acids can modulate the expression of a number of genes, including those involved with fatty acid metabolism and inflammation. Alpha linolenic acid and other omega 3 fatty acids may regulate gene expression by interacting with specific transcription factors, including peroxisome proliferator activated receptors (PPARs) and liver X receptors (LXRs).</description>
		<cas>463-40-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H30O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-</moldb_inchi>
		<moldb_inchikey>DTOSIQBPPRVQHS-PDBXOOCHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>278.4296</moldb_average_mass>
		<moldb_mono_mass>278.224580204</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>327</id>
		<lmdb_id>LMDB00327</lmdb_id>
		<created_at>2016-07-13 19:47:23</created_at>
		<updated_at>2016-07-20 21:03:57</updated_at>
		<export>1</export>
		<name>Glucose 6-phosphate</name>
		<description>Glucose 6 phosphate (alpha-D-glucose 6 phosphate or G6P) is the alpha-anomer of glucose-6-phosphate. There are two anomers of glucose 6 phosphate, the alpha anomer and the beta anomer. Glucose 6 phosphate is an ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. It is a normal constituent of resting muscle and probably is in constant equilibrium with fructose-6-phosphate. (Stedman, 26th ed). Glucose-6-phosphate is a phosphorylated glucose molecule on carbon 6. When glucose enters a cell, it is immediately phosphorylated to G6P. This is catalyzed with hexokinase enzymes, thus consuming one ATP. A major reason for immediate phosphorylation of the glucose is so that it cannot diffuse out of the cell. The phosphorylation adds a charged group so the G6P cannot easily cross cell membranes. G6P can travel down two metabolic pathways, glycolysis and the pentose phosphate pathway. In addition to the metabolic pathways, G6P can also be stored as glycogen in the liver if blood glucose levels are high. If the body needs energy or carbon skeletons for syntheses, G6P can be isomerized to Fructose-6-phosphate and then phosphorylated to Fructose-1,6-bisphosphate. Note, the molecule now has 2 phosphoryl groups attached. The addition of the 2nd phosphoryl group is an irreversible step, so once this happens G6P will enter glycolysis and be turned into pyruvate (ATP production occurs). If blood glucose levels are high, the body needs a way to store the excess glucose. After being converted to G6P, phosphoglucose mutase (isomerase) can turn the molecule into glucose-1-phosphate. Glucose-1-phosphate can then be combined with uridine triphosphate (UTP) to form UDP-glucose. This reaction is driven by the hydrolysis of pyrophosphate that is released in the reaction. Now, the activated UDP-glucose can add to a growing glycogen molecule with the help of glycogen synthase. This is a very efficient storage mechanism for glucose since it costs the body only 1 ATP to store the 1 glucose molecule and virtually no energy to remove it from storage. It is important to note that glucose-6-phosphate is an allosteric activator of glycogen synthase, which makes sense because when the level of glucose is high the body should store the excess glucose as glycogen. On the other hand, glycogen synthase is inhibited when it is phosphorylated by protein kinase a during times of high stress or low blood glucose levels. -- Wikipedia.</description>
		<cas>56-73-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C6H13O9P</moldb_formula>
		<moldb_inchi>InChI=1S/C6H13O9P/c7-3-2(1-14-16(11,12)13)15-6(10)5(9)4(3)8/h2-10H,1H2,(H2,11,12,13)/t2-,3-,4+,5-,6?/m1/s1</moldb_inchi>
		<moldb_inchikey>NBSCHQHZLSJFNQ-GASJEMHNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>260.1358</moldb_average_mass>
		<moldb_mono_mass>260.029718526</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>328</id>
		<lmdb_id>LMDB00328</lmdb_id>
		<created_at>2016-07-13 19:47:25</created_at>
		<updated_at>2016-07-20 20:53:03</updated_at>
		<export>1</export>
		<name>Niacinamide</name>
		<description>Niacinamide or vitamin B3 is an important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and pellagra. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. Niacinamide is used to increase the effect of radiation therapy on tumor cells. Niacin (nicotinic acid) and niacinamide, while both labeled as vitamin B3 also have different applications. Niacinamide is useful in arthritis and early-onset type I diabetes while niacin is an effective reducer of high cholesterol levels.</description>
		<cas>98-92-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(=O)C1=CC=CN=C1</moldb_smiles>
		<moldb_formula>C6H6N2O</moldb_formula>
		<moldb_inchi>InChI=1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9)</moldb_inchi>
		<moldb_inchikey>DFPAKSUCGFBDDF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>122.1246</moldb_average_mass>
		<moldb_mono_mass>122.048012824</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>329</id>
		<lmdb_id>LMDB00329</lmdb_id>
		<created_at>2016-07-13 19:47:26</created_at>
		<updated_at>2016-07-20 20:53:04</updated_at>
		<export>1</export>
		<name>Putrescine</name>
		<description>Putrescine is a polyamine. Putrescine is related to cadaverine (another polyamine). Both are produced by the breakdown of amino acids in living and dead organisms and both are toxic in large doses. Putrescine and cadaverine are largely responsible for the foul odor of putrefying flesh, but also contribute to the odor of such processes as bad breath and bacterial vaginosis. Putrescine is also found in semen. Putrescine attacks s-adenosyl methionine and converts it to spermidine. Spermidine in turn attacks another s-adenosyl methionine and converts it to spermine. Putrescine is synthesized in small quantities by healthy living cells by the action of ornithine decarboxylase. The polyamines, of which putrescine is one of the simplest, appear to be growth factors necessary for cell division. Putrescine apparently has specific role in skin physiology and neuroprotection. (PMID: 15009201, 16364196). Pharmacological interventions have demonstrated convincingly that a steady supply of polyamines is a prerequisite for cell proliferation to occur. Genetic engineering of polyamine metabolism in transgenic rodents has shown that polyamines play a role in spermatogenesis, skin physiology, promotion of tumorigenesis and organ hypertrophy as well as neuronal protection. Transgenic activation of polyamine catabolism not only profoundly disturbs polyamine homeostasis in most tissues, but also creates a complex phenotype affecting skin, female fertility, fat depots, pancreatic integrity and regenerative growth. Transgenic expression of ornithine decarboxylase antizyme has suggested that this unique protein may act as a general tumor suppressor. Homozygous deficiency of the key biosynthetic enzymes of the polyamines, ornithine and S-adenosylmethionine decarboxylase is not compatible with murine embryogenesis.</description>
		<cas>110-60-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCCCN</moldb_smiles>
		<moldb_formula>C4H12N2</moldb_formula>
		<moldb_inchi>InChI=1S/C4H12N2/c5-3-1-2-4-6/h1-6H2</moldb_inchi>
		<moldb_inchikey>KIDHWZJUCRJVML-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>88.1515</moldb_average_mass>
		<moldb_mono_mass>88.100048394</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>330</id>
		<lmdb_id>LMDB00330</lmdb_id>
		<created_at>2016-07-13 19:47:28</created_at>
		<updated_at>2016-07-20 20:59:54</updated_at>
		<export>1</export>
		<name>24-Hydroxycholesterol</name>
		<description>24-Hydroxycholesterol (24OHC) is almost exclusively formed in the brain. The enzymatic conversion of CNS cholesterol to 24OHC, which readily crosses the blood-brain barrier, is the major pathway for brain cholesterol elimination and brain cholesterol homeostasis maintenance. The enzyme mediating this conversion has been characterized at the molecular level as cholesterol 24-hydroxylase (EC 1.14.13.98, CYP46) and is mainly located in neurons. Like other oxysterols, 24OHC is efficiently converted into normal bile acids or excreted in bile in its sulfated and glucuronidated form. Levels of 24OHC in the circulation decrease with age in infants and children. In adults, however, the levels appear to be stable. There is accumulating evidence pointing toward a potentially important link between cholesterol, beta-amyloid, and Alzheimer's disease. Patients with active demyelinating diseases had increased levels of 24OHC in cerebrospinal fluid (CSF). Patients with Alzheimer's disease have slightly increased levels of 24OHC in CSF. Patients with multiple sclerosis have a tendency to have higher levels of 24OHC during active periods. (PMID: 15061359, 14574622).</description>
		<cas>474-73-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CC[C@H](O)C(C)C</moldb_smiles>
		<moldb_formula>C27H46O2</moldb_formula>
		<moldb_inchi>InChI=1S/C27H46O2/c1-17(2)25(29)11-6-18(3)22-9-10-23-21-8-7-19-16-20(28)12-14-26(19,4)24(21)13-15-27(22,23)5/h7,17-18,20-25,28-29H,6,8-16H2,1-5H3/t18-,20+,21+,22-,23+,24+,25+,26+,27-/m1/s1</moldb_inchi>
		<moldb_inchikey>IOWMKBFJCNLRTC-XWXSNNQWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>402.6529</moldb_average_mass>
		<moldb_mono_mass>402.349780716</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>331</id>
		<lmdb_id>LMDB00331</lmdb_id>
		<created_at>2016-07-13 19:47:29</created_at>
		<updated_at>2016-09-23 18:45:11</updated_at>
		<export>1</export>
		<name>Phosphate</name>
		<description>Phosphate is a salt of phosphoric acid. In organic chemistry, a phosphate, or organophosphate, is an ester of phosphoric acid. Organic phosphates are important in biochemistry, biogeochemistry and ecology. Phosphate (Pi) is an essential component of life. In biological systems, phosphorus is found as a free phosphate ion in solution and is called inorganic phosphate, to distinguish it from phosphates bound in various phosphate esters. Inorganic phosphate is generally denoted Pi and at physiological (neutral) pH primarily consists of a mixture of HPO&lt;sup&gt;2-&lt;/sup&gt;&lt;sub&gt;4&lt;/sub&gt; and H&lt;sub&gt;2&lt;/sub&gt;PO&lt;sup&gt;-&lt;/sup&gt;&lt;sub&gt;4&lt;/sub&gt; ions. phosphates are most commonly found in the form of adenosine phosphates, (AMP, ADP and ATP) and in DNA and RNA and can be released by the hydrolysis of ATP or ADP. Similar reactions exist for the other nucleoside diphosphates and triphosphates. Phosphoanhydride bonds in ADP and ATP, or other nucleoside diphosphates and triphosphates, contain high amounts of energy which give them their vital role in all living organisms. Phosphate must be actively transported into cells against its electrochemical gradient. In vertebrates, two unrelated families of Na+-dependent Pi transporters carry out this task. Remarkably, the two families transport different Pi species: whereas type II Na+/Pi cotransporters (SCL34) prefer divalent HPO4(2), type III Na+/Pi cotransporters (SLC20) transport monovalent H2PO4. The SCL34 family comprises both electrogenic and electroneutral members that are expressed in various epithelia and other polarized cells. Through regulated activity in apical membranes of the gut and kidney, they maintain body Pi homeostasis, and in salivary and mammary glands, liver, and testes they play a role in modulating the Pi content of luminal fluids. Phosphate levels in the blood play an important role in hormone signaling and in bone homeostasis. In classical endocrine regulation, low serum phosphate induces the renal production of the seco-steroid hormone 1,25-dihydroxyvitamin D3 (1,25(OH)2D3).This active metabolite of vitamin D acts to restore circulating mineral (i.e. phosphate and calcium) levels by increasing absorption in the intestine, reabsorption in the kidney, and mobilization of calcium and phosphate from bone. Thus, chronic renal failure is associated with hyperparathyroidism, which in turn contributes to osteomalacia (softening of the bones). Another complication of chronic renal failure is hyperphosphatemia (low levels of phosphate in the blood). Hyperphosphatemia (excess levels of phosphate in the blood) is a prevalent condition in kidney dialysis patients and is associated with increased risk of mortality. Hypophosphatemia (hungry bone syndrome) has been associated to postoperative electrolyte aberrations and after parathyroidectomy. (PMID: 17581921, 11169009, 11039261, 9159312, 17625581)Fibroblast growth factor 23 (FGF-23) has recently been recognized as a key mediator of phosphate homeostasis, its most notable effect being promotion of phosphate excretion. FGF-23 was discovered to be involved in diseases such as autosomal dominant hypophosphatemic rickets, X-linked hypophosphatemia, and tumor-induced osteomalacia in which phosphate wasting was coupled to inappropriately low levels of 1,25(OH)2D3. FGF-23 is regulated by dietary phosphate in animals. In particular it was found that phosphate restriction decreased FGF-23, and phosphate loading increased FGF-23.</description>
		<cas>14265-44-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[O-]P([O-])([O-])=O</moldb_smiles>
		<moldb_formula>O4P</moldb_formula>
		<moldb_inchi>InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)/p-3</moldb_inchi>
		<moldb_inchikey>NBIIXXVUZAFLBC-UHFFFAOYSA-K</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>94.9714</moldb_average_mass>
		<moldb_mono_mass>94.953420000</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>332</id>
		<lmdb_id>LMDB00332</lmdb_id>
		<created_at>2016-07-13 19:47:30</created_at>
		<updated_at>2016-07-20 20:59:54</updated_at>
		<export>1</export>
		<name>Pyridoxamine</name>
		<description>The 4-aminomethyl form of vitamin B6. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate. -- Pubchem; Pyridoxamine is one of the compounds that can be called vitamin B6, along with Pyridoxal and Pyridoxine. -- Wikipedia.</description>
		<cas>85-87-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=C(O)C(CN)=C(CO)C=N1</moldb_smiles>
		<moldb_formula>C8H12N2O2</moldb_formula>
		<moldb_inchi>InChI=1S/C8H12N2O2/c1-5-8(12)7(2-9)6(4-11)3-10-5/h3,11-12H,2,4,9H2,1H3</moldb_inchi>
		<moldb_inchikey>NHZMQXZHNVQTQA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>168.1931</moldb_average_mass>
		<moldb_mono_mass>168.089877638</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>333</id>
		<lmdb_id>LMDB00333</lmdb_id>
		<created_at>2016-07-13 19:47:31</created_at>
		<updated_at>2018-04-30 21:14:44</updated_at>
		<export>1</export>
		<name>3-Methoxytyrosine</name>
		<description>3-Methoxytyrosine is one of the main biochemical markers for Aromatic L-amino acid decarboxylase (AADC, EC 4.1.1.28) deficiency, an inborn error of metabolism that affects serotonin and dopamine biosynthesis. Patients are usually detected in infancy due to developmental delay, hypotonia, and extrapyramidal movements. Diagnosis is based on an abnormal neurotransmitter metabolite profile in CSF and reduced AADC activity in plasma. 3-methoxytyrosine is elevated in CSF, plasma, and urine. (PMID 1357595, 1281049, 16288991).</description>
		<cas>7636-26-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>COC1=C(O)C=CC(CC(N)C(O)=O)=C1</moldb_smiles>
		<moldb_formula>C10H13NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C10H13NO4/c1-15-9-5-6(2-3-8(9)12)4-7(11)10(13)14/h2-3,5,7,12H,4,11H2,1H3,(H,13,14)</moldb_inchi>
		<moldb_inchikey>PFDUUKDQEHURQC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>211.2145</moldb_average_mass>
		<moldb_mono_mass>211.084457909</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>334</id>
		<lmdb_id>LMDB00334</lmdb_id>
		<created_at>2016-07-13 19:47:33</created_at>
		<updated_at>2016-09-23 18:45:12</updated_at>
		<export>1</export>
		<name>Zirconium</name>
		<description>The action of Zirconium (Zr) on biological systems presents an enigma. It is ubiquitous, being present in nature in amounts higher than most trace elements. It is taken up by plants from soil and water and accumulated in certain tissues. The entry into animal systems in vivo is related to the mode of exposure and the concentration in the surrounding environment. Retention is initially in soft tissues and then slowly in the bone. The metal is able to cross the blood brain-barrier and is deposited in the brain and the placental barrier to enter milk. Physiologically, it exists as an ion in the body. The daily animal uptake has been known to be as high as 125 mg. The level of toxicity has been found to be moderately low, both in histological and cytological studies. The toxic effects induced by very high concentrations are nonspecific in nature. Despite the presence and retention in relatively high quantities in biological systems, Zr has not yet been associated with any specific metabolic function. Very little information is available about its interaction with the compounds of the genetical systems, such as nucleic acids. Apparently, the metal is neither an essential nor toxic element in the conventional sense. However, the increasing exposure to this element through its increasing use in new materials and following radioactive fallout, has increased the importance of the study of its effects on living organisms. The tetravalent nature of the ionic state and the high stability of the compounds formed are important factors that need to be considered, as also the accumulation of this element in the brain, reminiscent of the relationship between Aluminum and Alzheimer's disease. Zirconium is a metallic element with the atomic number 40 and mol wt 91.99, and belongs to the group IVB and second transition series of the fifth period of Mendeleyev's periodic table. It was named from Arabic zargun, meaning gold color. Discovered in the semiprecious gem zircon, as orthosilicate, by Klaproth in 1789, Zr was isolated as an element by Berzelius in 1824. In its metal form, Zr is hard and resistant to corrosion, heat, and acid. Zirconium behaves like an essential trace metal in the biosphere, although the possibility that it is a natural contaminant with no considerable physiological effects must be considered (PMID: 1283692, Biol Trace Elem Res. 1992 Dec;35(3):247-71.).</description>
		<cas>7440-67-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Zr+4]</moldb_smiles>
		<moldb_formula>Zr</moldb_formula>
		<moldb_inchi>InChI=1S/Zr/q+4</moldb_inchi>
		<moldb_inchikey>GBNDTYKAOXLLID-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>91.2240</moldb_average_mass>
		<moldb_mono_mass>89.904703679</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>335</id>
		<lmdb_id>LMDB00335</lmdb_id>
		<created_at>2016-07-13 19:47:34</created_at>
		<updated_at>2016-07-19 23:24:46</updated_at>
		<export>1</export>
		<name>Gallium</name>
		<description>Discovered in 1875, gallium is a trivalent metal that shares certain chemical characteristics with Fe 3+, Al3+ and In3+. An important property of gallium is its high affinity binding to transferrin, the iron transport protein in the circulation. Approximately one third of transferrin in blood is occupied by iron, leaving the remainder free to bind and transport gallium to cells that display transferrin receptors. In support of this mechanism is the finding that during radiogallium tumor imaging (Ga-67 scanning) in patients, Ga-67 in the circulation is bound almost exclusively to transferrin. A recent study examining the distribution of nonradioactive gallium in the circulation after its gastrointestinal uptake from gallium maltolate (an oral formulation of gallium) has confirmed that it binds to transferrin. The cellular uptake of gallium (transferrin-gallium) is mediated primarily by cell surface transferrin receptors, although a small amount of gallium may also be incorporated into cells via transferrin dependent mechanisms. Transferrin receptors are normally present on erythroid progenitor cells in the marrow to facilitate cellular iron uptake for hemoglobin synthesis. However, transferrin receptors are also expressed in high density on proliferating cells, because iron is needed for the activity of ribonucleotide reductase, the enzyme responsible for deoxyribonucleotide synthesis. In particular, transferrin receptors are expressed on non Hodgkin lymphoma (NHL) and bladder cancer cells (but not on their normal counterparts), making them obvious targets for gallium. Although the transferrin mediated delivery of gallium to cancer cells appears to be an important initial step in its antineoplastic action, the downstream events leading to cell death are only partly understood. At the cell surface, transferrin gallium competes with transferrin iron for entry into the cell. Inside the cell, endosomal acidification, essential for the release of iron from transferrin, is perturbed by gallium. Hence, gallium disrupts cellular iron homeostasis. The gallium induced block in cellular iron uptake, coupled with a direct effect of intracellular gallium, leads to inhibition of the iron-dependent R2 subunit of ribonucleotide reductase and an arrest in DNA synthesis. The nature of gallium-induced cell death was first reported by Haq et al. who demonstrated the induction of DNA fragmentation and morphologic changes consistent with apoptosis in lymphoma cells exposed to gallium nitrate. More recently, gallium nitrate was shown to induce apoptosis through the intrinsic pathway involving Bax, mitochondrial release of cytochrome c, and caspase-3 activation. The molecular basis for tumor cell resistance to gallium is not understood. It is not the result of an increase in ribonucleotide reductase activity, but it may be related to decreased cellular gallium incorporation. A complementary DNA microarray analysis of gallium resistant and gallium sensitive lymphoma cell lines has suggested that gallium resistance may involve changes in proteins responsible for intracellular trafficking. The action of gallium extends to other pathologic conditions in which cellular transferrin receptors are increased. Mitogen activated T and B cells express transferrin receptors; the proliferation of these cells, along with immunoglobulin production by B cells, can be inhibited by gallium. Gallium nitrate has been shown to have immunosuppressive activity in animal models of graft-versus-host disease following bone marrow transplantation, adjuvant arthritis, cardiac transplant rejection, and allergic autoimmune encephalomyelitis. The trivalent gallium cation is capable of inhibiting tumor growth, mainly because of its resemblance to ferric iron. It affects cellular acquisition of iron by binding to transferrin, and it interacts with the iron-dependent enzyme ribonucleotide reductase, resulting in reduced dNTP pools and inhibition of DNA synthesis. The abundance of transferrin receptors and the up regulation of ribonucleotide reductase render tumor cells susceptible to the cytotoxicity of gallium. Remarkable clinical activity in lymphomas and bladder cancer has been documented in clinical studies employing intravenous gallium nitrate, which is currently being re-evaluated in non-Hodgkin's lymphoma. (PMID: 15579097, 15627016)</description>
		<cas>7440-55-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[GaH3]</moldb_smiles>
		<moldb_formula>GaH3</moldb_formula>
		<moldb_inchi>InChI=1S/Ga.3H</moldb_inchi>
		<moldb_inchikey>PHMDYZQXPPOZDG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>72.7470</moldb_average_mass>
		<moldb_mono_mass>71.949056008</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>336</id>
		<lmdb_id>LMDB00336</lmdb_id>
		<created_at>2016-07-13 19:47:35</created_at>
		<updated_at>2016-07-20 20:59:55</updated_at>
		<export>1</export>
		<name>Octane</name>
		<description>One of the isomers, 2,2,4-trimethylpentane or isooctane, is of major importance, as it has been selected as the 100 point on the octane rating scale, with n-heptane as the zero point. Octane ratings are ratings used to represent the anti-knock performance of petroleum-based fuels (octane is less likely to prematurely combust under pressure than heptane), given as the percentage of 2,2,4-trimethylpentane in an 2,2,4-trimethylpentane / n-heptane mixture that would have the same performance. It is an important constituent of gasoline. Octane is an alkane with the chemical formula C8H18. It has 18 isomers.</description>
		<cas>111-65-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC</moldb_smiles>
		<moldb_formula>C8H18</moldb_formula>
		<moldb_inchi>InChI=1S/C8H18/c1-3-5-7-8-6-4-2/h3-8H2,1-2H3</moldb_inchi>
		<moldb_inchikey>TVMXDCGIABBOFY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>114.2285</moldb_average_mass>
		<moldb_mono_mass>114.140850576</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>337</id>
		<lmdb_id>LMDB00337</lmdb_id>
		<created_at>2016-07-13 19:47:36</created_at>
		<updated_at>2016-07-20 20:53:04</updated_at>
		<export>1</export>
		<name>Nicotinic acid</name>
		<description>Nicotinic acid, also known as niacin or vitamin B3, is a water-soluble vitamin whose derivatives such as NADH, NAD, NAD+, and NADP play essential roles in energy metabolism in the living cell and DNA repair. The designation vitamin B3 also includes the amide form, nicotinamide or niacinamide. Severe lack of niacin causes the deficiency disease pellagra, whereas a mild deficiency slows down the metabolism decreasing cold tolerance. The recommended daily allowance of niacin is 2-12 mg a day for children, 14 mg a day for women, 16 mg a day for men, and 18 mg a day for pregnant or breast-feeding women. It is found in various animal and plant tissues and has pellagra-curative, vasodilating, and antilipemic properties. The liver can synthesize niacin from the essential amino acid tryptophan (see below), but the synthesis is extremely slow and requires vitamin B6; 60 mg of tryptophan are required to make one milligram of niacin. Bacteria in the gut may also perform the conversion but are inefficient.</description>
		<cas>59-67-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C1=CN=CC=C1</moldb_smiles>
		<moldb_formula>C6H5NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)</moldb_inchi>
		<moldb_inchikey>PVNIIMVLHYAWGP-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>123.1094</moldb_average_mass>
		<moldb_mono_mass>123.032028409</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>338</id>
		<lmdb_id>LMDB00338</lmdb_id>
		<created_at>2016-07-13 19:47:38</created_at>
		<updated_at>2016-07-20 20:59:56</updated_at>
		<export>1</export>
		<name>Gamma-Tocopherol</name>
		<description>Gamma-Tocopherol is a collective name for a group of closely related lipids that contain substitutions on the 2H-1-benzopyran-6-ol nucleus and a long hydrocarbon chain of isoprenoid units. They are antioxidants by virtue of the phenolic hydrogen. Tocopherols react with the most reactive form of oxygen and protect unsaturated fatty acids from oxidation.</description>
		<cas>1406-66-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)CCCC(C)CCCC(C)CCCC1(C)CCC2=CC(O)=C(C)C(C)=C2O1</moldb_smiles>
		<moldb_formula>C28H48O2</moldb_formula>
		<moldb_inchi>InChI=1S/C28H48O2/c1-20(2)11-8-12-21(3)13-9-14-22(4)15-10-17-28(7)18-16-25-19-26(29)23(5)24(6)27(25)30-28/h19-22,29H,8-18H2,1-7H3</moldb_inchi>
		<moldb_inchikey>QUEDXNHFTDJVIY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>416.6795</moldb_average_mass>
		<moldb_mono_mass>416.365430780</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>339</id>
		<lmdb_id>LMDB00339</lmdb_id>
		<created_at>2016-07-13 19:47:39</created_at>
		<updated_at>2016-07-20 20:59:57</updated_at>
		<export>1</export>
		<name>7a-Hydroxycholesterol</name>
		<description>7alpha-hydroxycholesterol is an oxysterol and can serve as a biomarker for lipid peroxidation. (PMID: 17386651) Products of cholesterol oxidation accumulate within atherosclerotic plaque and have been proposed to contribute to inflammatory signalling in the diseased artery. (PMID: 17364953). 7alpha-hydroxycholesterol is a cholesterol oxide that has been described as biomarker of oxidative stress in subjects with impaired glucose tolerance and diabetes. (PMID: 16634125).</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2C3[C@H](O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C</moldb_smiles>
		<moldb_formula>C27H46O2</moldb_formula>
		<moldb_inchi>InChI=1S/C27H46O2/c1-17(2)7-6-8-18(3)21-9-10-22-25-23(12-14-27(21,22)5)26(4)13-11-20(28)15-19(26)16-24(25)29/h16-18,20-25,28-29H,6-15H2,1-5H3/t18-,20+,21-,22-,23+,24-,25?,26+,27-/m1/s1</moldb_inchi>
		<moldb_inchikey>OYXZMSRRJOYLLO-AWBHSAGMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>402.6529</moldb_average_mass>
		<moldb_mono_mass>402.349780716</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>340</id>
		<lmdb_id>LMDB00340</lmdb_id>
		<created_at>2016-07-13 19:47:40</created_at>
		<updated_at>2016-07-20 20:59:58</updated_at>
		<export>1</export>
		<name>Phosphocreatine</name>
		<description>Phosphocreatine undergoes irreversible cyclization and dehydration to form creatinine at a fractional rate of 0.026 per day, thus forming approximately 2 g creatinine/day in an adult male. This is the amount of creatine that must be provided either from dietary sources or by endogenous synthesis to maintain the body pool of (creatine and) phosphocreatine. Creatine is an amino acid that plays a vital role as phosphocreatine in regenerating adenosine triphosphate in skeletal muscle to energize muscle contraction. Creatine is phosphorylated to phosphocreatine in muscle in a reaction that is catalyzed by the enzyme creatine kinase. This enzyme is in highest concentration in muscle and nerve. Oral administration increases muscle stores. During the past decade, creatine has assumed prominence as an ergogenic (and legal) aid for professional and elite athletes. Most (~ 95%) of the total body creatine-phosphocreatine pool is in muscle (more in skeletal muscle than in smooth muscle) and amounts to 120 g (or 925 mmol) in a 70 kg adult male. Approximately 60-67% of the content in resting muscle is in the phosphorylated form. This generates enough ATP at the myofibrillar apparatus to power about 4 seconds of muscle contraction in exercise. Phosphocreatine reacts with ADP to yield ATP and creatine; the reversible reaction is catalyzed by creatine kinase. phosphocreatine is the chief store of high-energy phosphates in muscle. Thus, this reaction, which permits the rephosphorylation of ADP to ATP, is the immediate source of energy in muscle contraction. During rest, metabolic processes regenerate phosphocreatine stores. In normal muscle, ATP that is broken down to ADP is immediately rephosphorylated to ATP. Thus, phosphocreatine serves as a reservoir of ATP-synthesizing potential. phosphocreatine is the only fuel available to precipitously regenerate ATP during episodes of rapid fluctuations in demand. The availability of phosphocreatine likely limits muscle performance during brief, high-power exercise, i.e., maximal exercise of short duration. With near maximal isometric contraction, the rate of utilization of phosphocreatine declines after 1-2 seconds of contraction, prior to the glycolysis peak at approximately 3 seconds. (PMID: 10079702, Nutr Rev. 1999 Feb;57(2):45-50.).</description>
		<cas>67-07-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN(CC(O)=O)C(=N)NP(O)(O)=O</moldb_smiles>
		<moldb_formula>C4H10N3O5P</moldb_formula>
		<moldb_inchi>InChI=1S/C4H10N3O5P/c1-7(2-3(8)9)4(5)6-13(10,11)12/h2H2,1H3,(H,8,9)(H4,5,6,10,11,12)</moldb_inchi>
		<moldb_inchikey>DRBBFCLWYRJSJZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>211.1131</moldb_average_mass>
		<moldb_mono_mass>211.035806957</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>341</id>
		<lmdb_id>LMDB00341</lmdb_id>
		<created_at>2016-07-13 19:47:42</created_at>
		<updated_at>2016-09-23 18:45:12</updated_at>
		<export>1</export>
		<name>Glucosamine</name>
		<description>In the United States, glucosamine is not approved by the Food and Drug Administration for medical use in animals. Since glucosamine is classified as a dietary supplement, evidence of safety and efficacy is not required as long as it is not advertised as a treatment for a medical condition. Nevertheless, glucosamine is a popular alternative medicine used by consumers for the treatment of osteoarthritis. Glucosamine is also extensively used in veterinary medicine as an unregulated but widely accepted supplement (Nolen RS, 2002). Treatment with oral glucosamine is commonly used for the treatment of osteoarthritis. Since glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage, supplemental glucosamine may help to rebuild cartilage and treat arthritis. However, there is little evidence that any clinical effect of glucosamine works this way (Laverty et al., 2005; Biggee et al., 2005). Its use as a therapy for osteoarthritis appears safe but there is conflicting evidence as to its effectiveness. Glucosamine (C6H14NO5) is an amino sugar that is an important precursor in the biochemical synthesis of glycosylated proteins and lipids.</description>
		<cas>3416-24-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C6H13NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6?/m1/s1</moldb_inchi>
		<moldb_inchikey>MSWZFWKMSRAUBD-IVMDWMLBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>179.1711</moldb_average_mass>
		<moldb_mono_mass>179.079372531</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>342</id>
		<lmdb_id>LMDB00342</lmdb_id>
		<created_at>2016-07-13 19:47:43</created_at>
		<updated_at>2016-07-20 21:03:57</updated_at>
		<export>1</export>
		<name>Methylguanidine</name>
		<description>Methylguanidine (MG) is a guanidine compound deriving from protein catabolism. It is also a product of putrefaction. Methylguanidine is a suspected uraemic toxin that accumulates in renal failure, however it also exhibits anti-inflammatory effects. Methylguanidine is synthesized from creatinine concomitant with the synthesis of hydrogen peroxide from endogenous substrates in peroxisomes. Recent evidence suggests that methylguanidine significantly inhibits iNOS activity and TNF- release. This means that methylguandine can attenuate the degree of inflammation and tissue damage associated with endotoxic shock.</description>
		<cas>471-29-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CNC(N)=N</moldb_smiles>
		<moldb_formula>C2H7N3</moldb_formula>
		<moldb_inchi>InChI=1S/C2H7N3/c1-5-2(3)4/h1H3,(H4,3,4,5)</moldb_inchi>
		<moldb_inchikey>CHJJGSNFBQVOTG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>73.0971</moldb_average_mass>
		<moldb_mono_mass>73.063997239</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>343</id>
		<lmdb_id>LMDB00343</lmdb_id>
		<created_at>2016-07-13 19:47:44</created_at>
		<updated_at>2016-07-20 21:03:58</updated_at>
		<export>1</export>
		<name>Imidazole</name>
		<description>Imidazole is a heterocyclic aromatic organic compound. It is further classified as an alkaloid. Imidazole refers to the parent compound C3H4N2, while imidazoles are a class of heterocycles with similar ring structure but varying substituents. This ring system is present in important biological building blocks such as histidine and histamine. Imidazole can act as a base and as a weak acid. Imidazole exists in two tautomeric forms with the hydrogen atom moving between the two nitrogens. Many drugs contain an imidazole ring, such as antifungal drugs and nitroimidazole. Imidazole is a 5 membered planar ring which is soluble in water and polar solvents. Imidazole is a base and an excellent nucleophile. It reacts at the NH nitrogen, attacking alkylating and acylating compounds. It is not particularly susceptible to electrophilic attacks at the carbon atoms, and most of these reactions are substitutions that keep the aromaticity intact. One can see from the resonance structure that the carbon-2 is the carbon most likely to have a nucleophile attack it, but in general nucleophilic substitutions are difficult with imidazole. Imidazole is incorporated into many important biological molecules. The most obvious is the amino acid histidine, which has an imidazole side chain. histidine is present in many proteins and enzymes and plays a vital part in the structure and binding functions of hemoglobin.</description>
		<cas>288-32-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N1C=CN=C1</moldb_smiles>
		<moldb_formula>C3H4N2</moldb_formula>
		<moldb_inchi>InChI=1S/C3H4N2/c1-2-5-3-4-1/h1-3H,(H,4,5)</moldb_inchi>
		<moldb_inchikey>RAXXELZNTBOGNW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>68.0773</moldb_average_mass>
		<moldb_mono_mass>68.037448138</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>344</id>
		<lmdb_id>LMDB00344</lmdb_id>
		<created_at>2016-07-13 19:47:45</created_at>
		<updated_at>2016-09-23 18:45:13</updated_at>
		<export>1</export>
		<name>Asymmetric dimethylarginine</name>
		<description>Asymmetric dimethylarginine (ADMA) is a naturally occurring chemical found in blood plasma. It is a metabolic by-product of continual protein modification processes in the cytoplasm of all animal cells. It is closely related to L-arginine, a conditionally-essential amino acid. ADMA interferes with L-arginine in the production of nitric oxide, a key chemical to endothelial and hence cardiovascular health. Asymmetric dimethylarginine is created in protein methylation, a common mechanism of post-translational protein modification. This reaction is catalyzed by an enzyme set called S-adenosylmethionine protein N-methyltransferases (protein methylases I and II). The methyl groups transferred to create ADMA are derived from the methyl group donor S-adenosylmethionine, an intermediate in the metabolism of homocysteine. (Homocysteine is an important blood chemical, because it is also a marker of cardiovascular disease). After synthesis, ADMA migrates into the extracellular space and thence into blood plasma. Asymmetric dimethylarginine is measured using high performance liquid chromatography.</description>
		<cas>30315-93-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CCC\N=C(/N)N(C)C)C(O)=O</moldb_smiles>
		<moldb_formula>C8H18N4O2</moldb_formula>
		<moldb_inchi>InChI=1S/C8H18N4O2/c1-12(2)8(10)11-5-3-4-6(9)7(13)14/h6H,3-5,9H2,1-2H3,(H2,10,11)(H,13,14)/t6-/m0/s1</moldb_inchi>
		<moldb_inchikey>YDGMGEXADBMOMJ-LURJTMIESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>202.2541</moldb_average_mass>
		<moldb_mono_mass>202.142975840</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>345</id>
		<lmdb_id>LMDB00345</lmdb_id>
		<created_at>2016-07-13 19:47:47</created_at>
		<updated_at>2016-07-20 21:03:58</updated_at>
		<export>1</export>
		<name>Pyridoxal</name>
		<description>The 4-carboxyaldehyde form of vitamin B6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid.</description>
		<cas>66-72-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=NC=C(CO)C(C=O)=C1O</moldb_smiles>
		<moldb_formula>C8H9NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C8H9NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,4,10,12H,3H2,1H3</moldb_inchi>
		<moldb_inchikey>RADKZDMFGJYCBB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>167.1620</moldb_average_mass>
		<moldb_mono_mass>167.058243159</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>346</id>
		<lmdb_id>LMDB00346</lmdb_id>
		<created_at>2016-07-13 19:47:48</created_at>
		<updated_at>2016-07-20 21:00:01</updated_at>
		<export>1</export>
		<name>CDP</name>
		<description>Cytidine 5'-(trihydrogen diphosphate). A cytosine nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: CRPP; cytidine pyrophosphate.</description>
		<cas>63-38-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C9H15N3O11P2</moldb_formula>
		<moldb_inchi>InChI=1S/C9H15N3O11P2/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1</moldb_inchi>
		<moldb_inchikey>ZWIADYZPOWUWEW-XVFCMESISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>403.1764</moldb_average_mass>
		<moldb_mono_mass>403.018181361</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>347</id>
		<lmdb_id>LMDB00347</lmdb_id>
		<created_at>2016-07-13 19:47:50</created_at>
		<updated_at>2016-07-20 21:00:01</updated_at>
		<export>1</export>
		<name>2-Oxo-4-methylthiobutanoic acid</name>
		<description>4-Methylthio-2-oxobutanoic acid is the direct precursor of methional, which is a potent inducer of apoptosis in a BAF3 murine lymphoid cell line which is interleukin-3 (IL3)-dependent. (PMID 7848263).</description>
		<cas>583-92-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CSCCC(=O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H8O3S</moldb_formula>
		<moldb_inchi>InChI=1S/C5H8O3S/c1-9-3-2-4(6)5(7)8/h2-3H2,1H3,(H,7,8)</moldb_inchi>
		<moldb_inchikey>SXFSQZDSUWACKX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>148.1800</moldb_average_mass>
		<moldb_mono_mass>148.019414812</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>348</id>
		<lmdb_id>LMDB00348</lmdb_id>
		<created_at>2016-07-13 19:47:51</created_at>
		<updated_at>2016-07-20 21:03:59</updated_at>
		<export>1</export>
		<name>1-Methylguanosine</name>
		<description>1-Methylguanosine is a methylated nucleoside. It is known that some modified, especially methylated, nucleosides originating from RNA degradation are excreted in abnormal levels in the urine of patients with malignant tumours and they have been proposed as tumour markers. Their. measurement could provide a non-invasive diagnostic method, be helpful in the identification of different cancers and in the monitoring of therapeutic effects. PMID: 9129323.</description>
		<cas>2140-65-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN1C(N)=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1=O</moldb_smiles>
		<moldb_formula>C11H15N5O5</moldb_formula>
		<moldb_inchi>InChI=1S/C11H15N5O5/c1-15-9(20)5-8(14-11(15)12)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14)/t4-,6-,7-,10-/m1/s1</moldb_inchi>
		<moldb_inchikey>UTAIYTHAJQNQDW-KQYNXXCUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>297.2673</moldb_average_mass>
		<moldb_mono_mass>297.107318615</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>349</id>
		<lmdb_id>LMDB00349</lmdb_id>
		<created_at>2016-07-13 19:47:52</created_at>
		<updated_at>2016-07-20 20:53:09</updated_at>
		<export>1</export>
		<name>Phosphorylcholine</name>
		<description>Phosphorylcholine is a small haptenic molecule, is found in a wide variety of organisms. Human hepatic tumors undergo an elevation in the concentration of phosphorylcholine as the principal metabolic change is observed (PMID: 11076016). Phosphorylcholine is the precursor metabolite of choline in the glycine, serine and threonine metabolism pathways (KEGG, map00260) and in intermediate between choline and cytidine-diphosphate choline in the glycerophospholipid metabolism pathway (KEGG, map00564).</description>
		<cas>3616-04-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+](C)(C)CCOP(O)(O)=O</moldb_smiles>
		<moldb_formula>C5H15NO4P</moldb_formula>
		<moldb_inchi>InChI=1S/C5H14NO4P/c1-6(2,3)4-5-10-11(7,8)9/h4-5H2,1-3H3,(H-,7,8,9)/p+1</moldb_inchi>
		<moldb_inchikey>YHHSONZFOIEMCP-UHFFFAOYSA-O</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>184.1507</moldb_average_mass>
		<moldb_mono_mass>184.073869485</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>350</id>
		<lmdb_id>LMDB00350</lmdb_id>
		<created_at>2016-07-13 19:47:54</created_at>
		<updated_at>2016-07-20 21:04:00</updated_at>
		<export>1</export>
		<name>Glucose 1-phosphate</name>
		<description>The direct product of the reaction in which glycogen phosphorylase cleaves off a molecule of glucose from a greater glycogen structure. It cannot travel down many metabolic pathways and must be interconverted by the enzyme phosphoglucomutase in order to become glucose 6-phosphate. Free glucose 1-phosphate can also react with UTP to form UDP-glucose. It can then return to the greater glycogen structure via glycogen synthase.</description>
		<cas>59-56-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1OC(OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C6H13O9P</moldb_formula>
		<moldb_inchi>InChI=1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/t2-,3-,4+,5-,6?/m1/s1</moldb_inchi>
		<moldb_inchikey>HXXFSFRBOHSIMQ-GASJEMHNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>260.1358</moldb_average_mass>
		<moldb_mono_mass>260.029718526</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>351</id>
		<lmdb_id>LMDB00351</lmdb_id>
		<created_at>2016-07-13 19:47:55</created_at>
		<updated_at>2016-07-20 21:00:04</updated_at>
		<export>1</export>
		<name>L-Norleucine</name>
		<description>L-Norleucine is an unnatural amino acid that is used experimentally to study protein structure and function. It is structurally similar to methionine, however it does not contain sulfur. Aminocaproic acid works as an antifibrinolytic. It is a derivative of the amino acid lysine. It binds reversibly to the kringle domain of plasminogen and blocks the binding of plasminogen to fibrin and its activation to plasmin.</description>
		<cas>327-57-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCC[C@H](N)C(O)=O</moldb_smiles>
		<moldb_formula>C6H13NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H13NO2/c1-2-3-4-5(7)6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m0/s1</moldb_inchi>
		<moldb_inchikey>LRQKBLKVPFOOQJ-YFKPBYRVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>131.1729</moldb_average_mass>
		<moldb_mono_mass>131.094628665</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>352</id>
		<lmdb_id>LMDB00352</lmdb_id>
		<created_at>2016-07-13 19:47:56</created_at>
		<updated_at>2016-07-20 20:39:12</updated_at>
		<export>1</export>
		<name>Acetone</name>
		<description>Acetone is one of the ketone bodies produced during ketoacidosis. Acetone is not regarded as a waste product of metabolism. However, its physiological role in biochemical machinery is not clear. A model for the role of acetone metabolism is presented that orders the events occurring in acetonemia in sequence: in diabetic ketosis or starvation, ketone body production (b-hydroxy-butyrate, acetoacetate) provides fuel for vital organs (heart, brain .) raising the chance of survival of the metabolic catastrophe. However, when ketone body production exceeds the degrading capacity, the accumulating acetoacetic acid presents a new challenge to the pH regulatory system. Acetone production and its further degradation to C3 fragments fulfill two purposes: the maintenance of pH buffering capacity and provision of fuel for peripheral tissues. Since ketosis develops under serious metabolic circumstances, all the mechanisms that balance or moderate the effects of ketosis enhance the chance for survival. From this point of view, the theory that transportable C3 fragments can serve as additional nutrients is a novel view of acetone metabolism which introduces a new approach to the study of acetone degradation, especially in understanding its physiological function and the interrelationship between liver and peripheral tissues. (PMID 10580530). Acetone is typically derived from acetoacetate through the action of microbial acetoacetate decarboxylases found in gut microflora. In chemistry, acetone is the simplest representative of the ketones. Acetone is a colorless, mobile, flammable liquid readily soluble in water, ethanol, ether, etc., and itself serves as an important solvent. Acetone is an irritant and inhalation may lead to hepatotoxic effects (causing liver damage).</description>
		<cas>67-64-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)=O</moldb_smiles>
		<moldb_formula>C3H6O</moldb_formula>
		<moldb_inchi>InChI=1S/C3H6O/c1-3(2)4/h1-2H3</moldb_inchi>
		<moldb_inchikey>CSCPPACGZOOCGX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>58.0791</moldb_average_mass>
		<moldb_mono_mass>58.041864814</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>353</id>
		<lmdb_id>LMDB00353</lmdb_id>
		<created_at>2016-07-13 19:47:57</created_at>
		<updated_at>2016-09-23 18:45:13</updated_at>
		<export>1</export>
		<name>Progesterone</name>
		<description>The major progestational steroid that is secreted primarily by the corpus luteum and the placenta. Progesterone acts on the uterus, the mammary glands and the brain. It is required in embryo implantation, pregnancy maintenance, and the development of mammary tissue for milk production. Progesterone, converted from pregnenolone, also serves as an intermediate in the biosynthesis of gonadal steroid hormones and adrenal corticosteroids. -- Pubchem; Progesterone is a C-21 steroid hormone involved in the female menstrual cycle, pregnancy (supports gestation) and embryogenesis of animals and other species. Progesterone belongs to a class of hormones called progestagens, and is the major naturally occurring animal progestagen. -- Wikipedia; During implantation and gestation, progesterone appears to decrease the maternal immune response to allow for the acceptance of the pregnancy. Progesterone decreases contractility of the uterine smooth muscle. The fetus metabolizes placental progesterone in the production of adrenal mineralo- and glucosteroids. A drop in progesterone levels is possibly one step that facilitates the onset of labor. In addition progesterone inhibits lactation during pregnancy. The fall in progesterone levels following delivery is one of the triggers for milk production. -- Wikipedia.</description>
		<cas>57-83-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C21H30O2</moldb_formula>
		<moldb_inchi>InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1</moldb_inchi>
		<moldb_inchikey>RJKFOVLPORLFTN-LEKSSAKUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>314.4617</moldb_average_mass>
		<moldb_mono_mass>314.224580204</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>354</id>
		<lmdb_id>LMDB00354</lmdb_id>
		<created_at>2016-07-13 19:47:59</created_at>
		<updated_at>2016-09-23 18:45:43</updated_at>
		<export>1</export>
		<name>Caffeine</name>
		<description>Caffeine is a member of the methylxanthine family of drugs. A number of in vitro and in vivo studies have demonstrated that caffeine modulates both innate and adaptive immune responses. For instance studies indicate that caffeine and its major metabolite paraxanthine suppress neutrophil and monocyte chemotaxis, and also suppress production of the pro-inflammatory cytokine tumor necrosis factor (TNF) alpha. Caffeine has also been reported to suppress lymphocyte function as indicated by reduced T-cell proliferation and impaired production of Th1 (interleukin [IL]-2 and interferon [IFN]-gamma), Th2 (IL-4, IL-5) and Th3 (IL-10) cytokines. Studies also indicate that caffeine suppresses antibody production. The evidence suggests that at least some of the immunomodulatory actions of caffeine are mediated via inhibition of cyclic adenosine monophosphate (cAMP)-phosphodiesterase (PDE), and consequential increase in intracellular cAMP concentrations. Overall, these studies indicate that caffeine, like other members of the methylxanthine family, is largely anti-inflammatory in nature (PMID 16540173 ). Whether caffeine consumption contribute to the development of cardiovascular disease (CVD) is unclear. The literature indicates a strong relationship between caffeine consumption and elevated cholesterol levels. Available studies are limited by small samples sizes (PMID: 16856769 ). There is extensive evidence that caffeine at dietary doses increases blood pressure (BP). When considered comprehensively, findings from experimental and epidemiologic studies converge to show that BP remains reactive to the pressor effects of caffeine in the diet (PMID: 14747639 ). Caffeine is a purine alkaloid. At intake levels, caffeine appears to exert most of its biological effects through the antagonism of the A1 and A2A subtypes of the adenosine receptor. Adenosine is an endogenous neuromodulator with mostly inhibitory effects, and adenosine antagonism by caffeine results in effects that are generally stimulatory. Some physiological effects associated with caffeine administration include central nervous system stimulation, acute elevation of blood pressure, increased metabolic rate, and diuresis. Caffeine is rapidly and almost completely absorbed in the digestive system and distributed to all tissues, including the brain. Caffeine metabolism occurs primarily in the liver, where the activity of the cytochrome P450 isoform CYP1A2 accounts for almost 95% of the primary metabolism of caffeine. CYP1A2-catalyzed 3-demethylation of caffeine results in the formation of 1,7-dimethylxanthine (paraxanthine). Paraxanthine may be demethylated by CYP1A2 to form 1-methylxanthine, which may be oxidized to 1-methyluric acid by xanthine oxidase. Paraxanthine may also be hydroxylated by CYP2A6 to form 1,7-dimethyluric acid, or acetylated by N-acetyltransferase 2 (NAT2) to form 5-acetylamino-6-formylamino-3-methyluracil, an unstable compound that may be deformylated nonenzymatically to form 5-acetylamino-6-amino-3-methyluracil (PMID 16507475 ).</description>
		<cas>58-08-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN1C=NC2=C1C(=O)N(C)C(=O)N2C</moldb_smiles>
		<moldb_formula>C8H10N4O2</moldb_formula>
		<moldb_inchi>InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3</moldb_inchi>
		<moldb_inchikey>RYYVLZVUVIJVGH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>194.1906</moldb_average_mass>
		<moldb_mono_mass>194.080375584</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>355</id>
		<lmdb_id>LMDB00355</lmdb_id>
		<created_at>2016-07-13 19:48:00</created_at>
		<updated_at>2016-07-20 21:00:06</updated_at>
		<export>1</export>
		<name>p-Cresol</name>
		<description>p-Cresol (4-methylphenol), a 108.1 Da volatile low-molecular-weight compound, is a phenol. It is a partially lipophilic moiety which strongly binds to plasma protein (close to 100%) under normal conditions. p-Cresol is metabolized through conjugation, mainly sulphation and glucuronization, but removal of the unconjugated p-cresol is, at least in part, via the urine. Therefore it is not surprising that this compound, together with several other phenoles, is retained when the kidneys fail. P-Cresol is an end-product of protein breakdown, and an increase of the nutritional protein load in healthy individuals results in enhanced generation and urinary excretion. The serum p-cresol concentration in uremic patients can be decreased by changing to a low-protein diet. p-Cresol is one of the metabolites of the amino acid tyrosine, and to a certain extent also of phenylalanine, which are converted to 4-hydroxyphenylacetic acid by intestinal bacteria, before being decarboxylated to p-cresol (putrefaction). The main contributing bacteria are aerobes (mainly enterobacteria), but to a certain extent also anaerobes play a role (mainly Clostridium perfringens). In uremia, modifications in the intestinal flora result in the specific overgrowth of bacteria that are specific p-cresol producers. The administration of antibiotics reduces urinary excretion of p-cresol, as a result of the liquidation of the producing bacteria. Environmental factors might also contribute. The liver cytochrome P450 metabolizes toluene to benzyl alcohol, but also to o-cresol and p-cresol. Toluene is not only used industrially, but it is also the most widely abusively inhaled solvent. Furthermore, p-cresol is a metabolite of menthofuran, one of the metabolites of R-(+)-pulegone, which is found in extracts from the plants Mentha pulegium and Hedeoma pulegioides, commonly known as pennyroyal oil and pennyroyal tea. These extracts are popular as unconventional herbal therapeutic agents and are applied as abortiva, diaphoretics, emmenagogues, and psychedelic drugs. Pennyroyal oil is extensively used for its pleasant mint-like smell in the flavoring industry. The toxicity of pennyroyal oil and menthofuran is well known. Another compound used in traditional medicine, especially in Japan, which is a precursor of p-cresol is wood tar creosote. p-Cresol has been reported to affect several biochemical, biological and physiological functions: (i) it diminishes the oxygen uptake of rat cerebral cortex slices; (ii) it increases the free active drug concentration of warfarin and diazepam; (iii) it has been related to growth retardation in the weanling pig; (iv) it alters cell membrane permeability, at least in bacteria; (v) it induces LDH leakage from rat liver slices; (vi) it induces susceptibility to auditive epileptic crises; and (vii) it blocks cell K+ channels. (PMID: 10570076). p-Cresol is a uremic toxin that is at least partially removed by peritoneal dialysis in haemodialysis patients, and has been involved in the progression of renal failure. (MID: 11169029). At concentrations encountered during uremia, p-cresol inhibits phagocyte function and decreases leukocyte adhesion to cytokine-stimulated endothelial cells. (PMID: 14681860).</description>
		<cas>106-44-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=CC=C(O)C=C1</moldb_smiles>
		<moldb_formula>C7H8O</moldb_formula>
		<moldb_inchi>InChI=1S/C7H8O/c1-6-2-4-7(8)5-3-6/h2-5,8H,1H3</moldb_inchi>
		<moldb_inchikey>IWDCLRJOBJJRNH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>108.1378</moldb_average_mass>
		<moldb_mono_mass>108.057514878</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>356</id>
		<lmdb_id>LMDB00356</lmdb_id>
		<created_at>2016-07-13 19:48:01</created_at>
		<updated_at>2016-07-20 20:39:18</updated_at>
		<export>1</export>
		<name>Benzoic acid</name>
		<description>Benzoic acid, C6H5COOH, is a colourless crystalline solid and the simplest aromatic carboxylic acid. Benzoic acid occurs naturally free and bound as benzoic acid esters in many plant and animal species. Appreciable amounts have been found in most berries (around 0.05%). Cranberries contain as much as 300-1300 mg free benzoic acid per kg fruit. Benzoic acid is a fungistatic compound that is widely used as a food preservative. It often is conjugated to glycine in the liver and excreted as hippuric acid. Benzoic acid is a byproduct of phenylalanine metabolism in bacteria. It is also produced when gut bacteria process polyphenols (from ingested fruits or beverages).</description>
		<cas>65-85-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C7H6O2</moldb_formula>
		<moldb_inchi>InChI=1S/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9)</moldb_inchi>
		<moldb_inchikey>WPYMKLBDIGXBTP-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>122.1230</moldb_average_mass>
		<moldb_mono_mass>122.036779433</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>357</id>
		<lmdb_id>LMDB00357</lmdb_id>
		<created_at>2016-07-13 19:48:02</created_at>
		<updated_at>2016-07-20 20:39:25</updated_at>
		<export>1</export>
		<name>Isobutyric acid</name>
		<description>Isobutyric acid is a carboxylic or short chain fatty acid with characteristic sweat-like smell. Small amount of isobutyrate is generated via microbial (gut) metabolism. Small amounts may also be found in certain foods or fermented beverages. There is anosmia (genetic inability to smell) for the odor of isobutyric acid with a frequency of about 2.5%. (OMIM 207000). Isobutyric acid is slightly soluble in water but much more soluble in ethanol, ether and organic solvents. Isobutyric acid can affect people if breathed in and may be absorbed through the skin. Contact can irritate and burn the skin and eyes. Breathing Isobutyric acid can irritate the nose, throat and lungs causing coughing, wheezing and/or shortness of breath.</description>
		<cas>79-31-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)C(O)=O</moldb_smiles>
		<moldb_formula>C4H8O2</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8O2/c1-3(2)4(5)6/h3H,1-2H3,(H,5,6)</moldb_inchi>
		<moldb_inchikey>KQNPFQTWMSNSAP-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>88.1051</moldb_average_mass>
		<moldb_mono_mass>88.052429500</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>358</id>
		<lmdb_id>LMDB00358</lmdb_id>
		<created_at>2016-07-13 19:48:04</created_at>
		<updated_at>2016-07-20 20:53:11</updated_at>
		<export>1</export>
		<name>Methanol</name>
		<description>It is the simplest alcohol, and is a light, volatile, colourless, flammable, poisonous liquid with a distinctive odor that is somewhat milder and sweeter than ethanol (Wikipedia). Methanol is responsible for accidental, suicidal, and epidemic poisonings, resulting in death or permanent sequelae. Toxicity is due to the metabolic products of alcohol dehydrogenase (ADH) and aldehyde dehydrogenase. (PMID 15627163). The rapid and accurate diagnosis of toxic alcohol poisoning due to methanol (methyl alcohol) is paramount in preventing serious adverse outcomes. The quantitative measurement of specific serum levels of methanol using gas chromatography is expensive, time consuming and generally only available at major tertiary-care facilities. (PMID 15862085).</description>
		<cas>67-56-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CO</moldb_smiles>
		<moldb_formula>CH4O</moldb_formula>
		<moldb_inchi>InChI=1S/CH4O/c1-2/h2H,1H3</moldb_inchi>
		<moldb_inchikey>OKKJLVBELUTLKV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>32.0419</moldb_average_mass>
		<moldb_mono_mass>32.026214750</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>359</id>
		<lmdb_id>LMDB00359</lmdb_id>
		<created_at>2016-07-13 19:48:05</created_at>
		<updated_at>2016-07-20 21:00:08</updated_at>
		<export>1</export>
		<name>Thymol</name>
		<description>Thymol is a phenol obtained from thyme oil or other volatile oils. It is used as a stabilizer in pharmaceutic preparations. It has been used for its antiseptic, antibacterial, and antifungal actions, and was formerly used as a vermifuge. (Dorland, 28th ed) -- Pubchem; Thymol is a monoterpene phenol derivative of cymene, C10H13OH, isomeric with carvacrol, found in oil of thyme, and extracted as a white crystalline substance of a pleasant aromatic odor and strong antiseptic properties. It is also called &quot;hydroxy cymene&quot;. (from Webster's 1913 dictionary) -- Wikipedia; In a 1994 report released by five top cigarette companies, thymol is one of the 599 additives to cigarettes. Its use or purpose, however, is unknown, like most cigarette additives. -- Wikipedia.</description>
		<cas>89-83-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)C1=C(O)C=C(C)C=C1</moldb_smiles>
		<moldb_formula>C10H14O</moldb_formula>
		<moldb_inchi>InChI=1S/C10H14O/c1-7(2)9-5-4-8(3)6-10(9)11/h4-7,11H,1-3H3</moldb_inchi>
		<moldb_inchikey>MGSRCZKZVOBKFT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>150.2210</moldb_average_mass>
		<moldb_mono_mass>150.104465071</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>360</id>
		<lmdb_id>LMDB00360</lmdb_id>
		<created_at>2016-07-13 19:48:06</created_at>
		<updated_at>2016-09-23 18:45:14</updated_at>
		<export>1</export>
		<name>Propylene glycol</name>
		<description>Propylene glycol (1,2-propanediol) is an organic compound (a diol alcohol), usually a tasteless, odorless, and colorless clear oily liquid that is hygroscopic and miscible with water, acetone, and chloroform. It is manufactured by the hydration of propylene oxide. Propylene glycol is used as a solvent for intravenous, oral, and topical pharmaceutical preparations It is generally considered safe. However in large doses it can be toxic, especially if given over a short period of time. Intravenous lorazepam contains the largest amount of propylene glycol of commonly used drugs. In adults with normal liver and kidney function, the terminal half-life of propylene glycol ranges from 1.4 to 3.3 hours. Propylene glycol is metabolized by the liver to form lactate, acetate, and pyruvate. The nonmetabolized drug is excreted in the urine mainly as the glucuronide conjugate, approximately 12 to 45 percent is excreted unchanged in urine. Renal clearance decreases as the dose administered increases (390 ml/minute/173 m2 at a dose of 5 g/day but only 144 ml/minute/173 m2 at a dose of 21 g/day). These data suggest that renal clearance declines at higher propylene glycol doses because of saturation of proximal tubular secretion of the drug. As an acceptable level of propylene glycol has not been defined, the clinical implication of a propylene glycol level is unclear. The World Health Organization (WHO) recommends a maximum consumption of 25 mg/kg/day (1.8 g/day for a 75 kg male) of propylene glycol when used as a food additive, but this limit does not address its use as a drug solvent. No maximum dose is recommended in the literature for intravenous therapy with propylene glycol. Intoxication occurs at much higher doses than the WHO dose limit and is exclusive to pharmacologic exposure. Propylene glycol toxicity includes development of serum hyperosmolality, lactic acidosis, and kidney failure. It has been suggested that proximal tubular necrosis is the cause of acute kidney injury from propylene glycol. Along these lines, proximal tubular cell injury occurs in cultured animal cells exposed to propylene glycol. Acute tubular necrosis was described with propylene glycol toxicity in a case of concomitant administration of intravenous lorazepam and trimethoprim sulfamethoxazole. Propylene glycol induced intoxication can also mimic sepsis or systemic inflammatory response syndrome (SIRS). Patients suspected of having sepsis with negative cultures should be evaluated for propylene glycol toxicity if they have been exposed to high dose lorazepam or other medications containing this solvent. (PMID: 17555487).</description>
		<cas>57-55-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(O)CO</moldb_smiles>
		<moldb_formula>C3H8O2</moldb_formula>
		<moldb_inchi>InChI=1S/C3H8O2/c1-3(5)2-4/h3-5H,2H2,1H3</moldb_inchi>
		<moldb_inchikey>DNIAPMSPPWPWGF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>76.0944</moldb_average_mass>
		<moldb_mono_mass>76.052429500</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>361</id>
		<lmdb_id>LMDB00361</lmdb_id>
		<created_at>2016-07-13 19:48:07</created_at>
		<updated_at>2016-07-20 20:39:34</updated_at>
		<export>1</export>
		<name>Dihydroxyacetone</name>
		<description>Dihydroxyacetone is a ketotriose compound. Its addition to blood preservation solutions results in better maintenance of 2,3-diphosphoglycerate levels during storage. It is readily phosphorylated to dihydroxyacetone phosphate by triokinase in erythrocytes. In combination with naphthoquinones it acts as a sunscreening agent. -- Pubchem; Dihydroxyacetone (also known as DHA) is a triose carbohydrate with chemical formula C3H6O3. It is the simplest of all ketoses and, having no chiral centre, is the only one that has no optical activity. -- Wikipedia; Dihydroxyacetone is a simple non-toxic sugar. It is often derived from plant sources such as sugar beets and sugar cane, by the fermentation of glycerin; it is a white crystalline powder which is water soluble. -- Wikipedia.</description>
		<cas>96-26-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC(=O)CO</moldb_smiles>
		<moldb_formula>C3H6O3</moldb_formula>
		<moldb_inchi>InChI=1S/C3H6O3/c4-1-3(6)2-5/h4-5H,1-2H2</moldb_inchi>
		<moldb_inchikey>RXKJFZQQPQGTFL-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>90.0779</moldb_average_mass>
		<moldb_mono_mass>90.031694058</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>362</id>
		<lmdb_id>LMDB00362</lmdb_id>
		<created_at>2016-07-13 19:48:09</created_at>
		<updated_at>2016-07-20 21:00:11</updated_at>
		<export>1</export>
		<name>3-Methylxanthine</name>
		<description>3-Methylxanthine is a caffeine and a theophylline metabolite. (PMID 16870158, 16678550). CYP1A2 probably plays a major role in theophylline 8-hydroxylation at a therapeutic concentration after the full development of CYP1A2 activity in children (after 3 years old). (PMID 9890610).</description>
		<cas>1076-22-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN1C2=C(NC=N2)C(=O)NC1=O</moldb_smiles>
		<moldb_formula>C6H6N4O2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H6N4O2/c1-10-4-3(7-2-8-4)5(11)9-6(10)12/h2H,1H3,(H,7,8)(H,9,11,12)</moldb_inchi>
		<moldb_inchikey>GMSNIKWWOQHZGF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>166.1374</moldb_average_mass>
		<moldb_mono_mass>166.049075456</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>363</id>
		<lmdb_id>LMDB00363</lmdb_id>
		<created_at>2016-07-13 19:48:10</created_at>
		<updated_at>2016-07-20 21:00:12</updated_at>
		<export>1</export>
		<name>Acetylcysteine</name>
		<description>Acetylcysteine is the N-acetyl derivative of the amino acid L-cysteine, and is a precursor in the formation of the antioxidant glutathione in the body. The thiol (sulfhydryl) group confers antioxidant effects and is able to reduce free radicals. wikipedia. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates. -- Pubchem. Acetylcysteine is a pharmacological agent used in the management of paracetamol overdose. For these indications, acetylcysteine is available under the trade names Mucomyst (Bristol-Myers Squibb) and Parvolex (GSK.-- Wikipedia.</description>
		<cas>616-91-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)N[C@@H](CS)C(O)=O</moldb_smiles>
		<moldb_formula>C5H9NO3S</moldb_formula>
		<moldb_inchi>InChI=1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1</moldb_inchi>
		<moldb_inchikey>PWKSKIMOESPYIA-BYPYZUCNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>163.1950</moldb_average_mass>
		<moldb_mono_mass>163.030313849</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>364</id>
		<lmdb_id>LMDB00364</lmdb_id>
		<created_at>2016-07-13 19:48:11</created_at>
		<updated_at>2018-04-30 21:14:45</updated_at>
		<export>1</export>
		<name>Alpha-Tocopherol</name>
		<description>Alpha-tocopherol is traditionally recognized as the most active form of vitamin E in animals, and is a powerful biological antioxidant. The measurement of &quot;vitamin E&quot; activity in international units (IU) was based on fertility enhancement by the prevention of spontaneous abortions in pregnant rats relative to alpha tocopherol. Natural vitamin E exists in eight different forms or isomers, four tocopherols and four tocotrienols. In foods, the most abundant sources of vitamin E are vegetable oils such as palm oil, sunflower, corn, soybean and olive oil. Nuts, sunflower seeds, and wheat germ are also good sources. --Wikipedia.</description>
		<cas>59-02-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(O)=C(C)C(C)=C2O1</moldb_smiles>
		<moldb_formula>C29H50O2</moldb_formula>
		<moldb_inchi>InChI=1S/C29H50O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h20-22,30H,9-19H2,1-8H3/t21-,22-,29-/m1/s1</moldb_inchi>
		<moldb_inchikey>GVJHHUAWPYXKBD-IEOSBIPESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>430.7061</moldb_average_mass>
		<moldb_mono_mass>430.381080844</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>365</id>
		<lmdb_id>LMDB00365</lmdb_id>
		<created_at>2016-07-13 19:48:13</created_at>
		<updated_at>2016-07-20 21:00:13</updated_at>
		<export>1</export>
		<name>Salicylic acid</name>
		<description>Salicylic acid is a colorless, crystalline organic carboxylic acid. Salicylic acid is toxic if ingested in large quantities, but in small quantities is used as a food preservative and antiseptic in toothpaste. It is also the key additive in many skin-care products for the treatment of acne, psoriasis, callouses, corns, keratosis pilaris and warts. The carboxyl group (COOH) can react with alcohols, forming several useful esters. The name derives from the latin word for the willow tree (Salix), from whose bark it can be obtained. --Wikipedia.</description>
		<cas>69-72-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C1=CC=CC=C1O</moldb_smiles>
		<moldb_formula>C7H6O3</moldb_formula>
		<moldb_inchi>InChI=1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10)</moldb_inchi>
		<moldb_inchikey>YGSDEFSMJLZEOE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>138.1220</moldb_average_mass>
		<moldb_mono_mass>138.031694053</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>366</id>
		<lmdb_id>LMDB00366</lmdb_id>
		<created_at>2016-07-13 19:48:14</created_at>
		<updated_at>2016-09-23 18:45:15</updated_at>
		<export>1</export>
		<name>17a-Ethynylestradiol</name>
		<description>Ethinyl estradiol. A semisynthetic alkylated estradiol with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in oral contraceptives. -- Pubchem; estradiol (17-beta estradiol) (also oestradiol) is a sex hormone. Labelled the &quot;female&quot; hormone but also present in males it represents the major estrogen in animals. Critical for sexual functioning, estradiol also supports bone growth. -- Wikipedia; One of the fascinating twists to mammalian sexual differentiation is that estradiol is one of the two active metabolites of testosterone in males (the other being dihydrotestosterone). estradiol cannot be transferred readily from the circulation into the brain. Since fetuses of both sexes are exposed to similarly high levels of maternal estradiol, it can play little role in prenatal sexual differentiation. However, testosterone enters the central nervous system more freely and significant amounts are aromatized to estradiol within the brain of most male mammals, including animals. There is now much evidence that the programming of adult male sexual behavior in &quot;lower mammals,&quot; (such as mounting rather than lordosis behavior), is largely dependent on estradiol produced in the central nervous system during prenatal life and early infancy from testosterone. We do not yet know whether this process plays a minimal or significant part in animal sexual behaviors. -- Wikipedia; A synthetic form of estradiol, called ethinyl estradiol is a major component of hormonal contraceptive devices. Combined oral contraceptives contain ethinyl estradiol and a progestin, which both contribute to the inhibition of GnRH, LH, and FSH. The inhibition of these hormones accounts for the ability of combined oral contraceptives or birth control pills to prevent ovulation and thus prevent pregnancy. Other types of hormonal birth control contain only progestins and no ethinyl estradiol. -- Wikipedia.</description>
		<cas>57-63-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3</moldb_smiles>
		<moldb_formula>C20H24O2</moldb_formula>
		<moldb_inchi>InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1</moldb_inchi>
		<moldb_inchikey>BFPYWIDHMRZLRN-SLHNCBLASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>296.4034</moldb_average_mass>
		<moldb_mono_mass>296.177630012</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>367</id>
		<lmdb_id>LMDB00367</lmdb_id>
		<created_at>2016-07-13 19:48:15</created_at>
		<updated_at>2016-09-23 18:45:43</updated_at>
		<export>1</export>
		<name>Caffeic acid</name>
		<description>Caffeic acid is a polyphenol present in normal urine positively correlated to caffeine consumption and influenced by the dietary intake of diverse types of feed. (PMID:16870009 ).</description>
		<cas>331-39-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)\C=C/C1=CC=C(O)C(O)=C1</moldb_smiles>
		<moldb_formula>C9H8O4</moldb_formula>
		<moldb_inchi>InChI=1S/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2-</moldb_inchi>
		<moldb_inchikey>QAIPRVGONGVQAS-RQOWECAXSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1574</moldb_average_mass>
		<moldb_mono_mass>180.042258744</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>368</id>
		<lmdb_id>LMDB00368</lmdb_id>
		<created_at>2016-07-13 19:48:16</created_at>
		<updated_at>2016-07-20 21:00:14</updated_at>
		<export>1</export>
		<name>Titanium</name>
		<description>Titanium is a light, strong, lustrous, corrosion-resistant (including resistance to sea water and chlorine) transition metal with a white-silvery-metallic color; in the periodic table it has the symbol Ti and atomic number 22. Titanium and its alloys are used for medical purpose like osteosynthesis, arthroplasty, pacemaker encasing, orthodontical wires, or in daily-use articles like spectacle frames. At a composition of 50% nickel and 50% titanium, the material nitinol can be folded but returns at given temperatures to its original form without damage. This shape memory effect is used for spectacle frames, flexible tubes, intravascular stents, or orthodontic wires. When exposing the latter to an acidic environment, a substantial nickel and titanium release can be observed. However, even 'pure' titanium materials used for implant alloys may contain nickel as result of the production process. Standard titanium alloys (TiAl6Nb7, TiAl6V4) and pure titanium discs supplied by five different titanium manufactures were shown to contain up to 0.034 wt % nickel, with iodide-titanium having the lowest percentage (0.002 wt %). Here, the nickel atoms are reported to be in solid solution in the titanium lattice. Suspected delayed-type hypersensitivity reactions to titanium were first reported as pacemaker dermatitis, but their existence is still put in question due to not always complete allergological work up and insufficient patch test preparations. In 1984, Peters et al. described a patient who had repeatedly cardiac pacemakers implanted and removed because pruritus, redness, and swelling of the skin overlying the pacemaker had developed within several weeks after insertion. These reactions were interpreted as contact sensitivity to the pure titanium encasing of the pacemaker, as there was a ++ patch test reaction to a thin square of metallic titanium applied with artificial sweat. Physiologically, it exists as an ion in the body. Humans exposed to titanium can develop pulmonary alveolar proteinosis (PAP, a disease of obscure cause that is characterized by the accumulation of a granular material that contains abundant lipid within the alveoli of lung.) with severe respiratory failure; analysis of particles found in lung tissues obtained by open lung biopsies demonstrated the presence of titanium. Salts of titanium are often considered to be relatively harmless but its chlorine compounds, such as TiCl2, TiCl3 and TiCl4, have unusual hazards. The dichloride takes the form of pyrophoric black crystals, and the tetrachloride is a volatile fuming liquid. All of titanium's chlorides are corrosive. (PMID: 7606971, 14756054, 16958916).</description>
		<cas>7440-32-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Ti+4]</moldb_smiles>
		<moldb_formula>Ti</moldb_formula>
		<moldb_inchi>InChI=1S/Ti/q+4</moldb_inchi>
		<moldb_inchikey>LCKIEQZJEYYRIY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>47.8670</moldb_average_mass>
		<moldb_mono_mass>47.947947053</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>369</id>
		<lmdb_id>LMDB00369</lmdb_id>
		<created_at>2016-07-13 19:48:18</created_at>
		<updated_at>2016-09-23 18:45:16</updated_at>
		<export>1</export>
		<name>Eicosapentaenoic acid</name>
		<description>Eicosapentaenoic acid (EPA or also icosapentaenoic acid) is an important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families. Eicosapentaenoic acid is an omega-3 fatty acid. In physiological literature, it is given the name 20:5(n-3). Its systematic chemical name is all-cis-5,8,11,14,17-icosapentaenoic acid. It also has the trivial name timnodonic acid. Chemically, EPA is a carboxylic acid with a 20-carbon chain and five cis double bonds; the first double bond is located at the third carbon from the omega end. Because of the presence of double bonds, EPS is a polyunsaturated fatty acid. Metabolically it acts as a precursor for prostaglandin-3 (which inhibits platelet aggregation), thromboxane-3 and leukotriene-5 groups. It is found in fish oils of cod liver, herring, mackerel, salmon, menhaden and sardine. It is also found in animal breast milk. -- Wikipedia.</description>
		<cas>10417-94-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O</moldb_smiles>
		<moldb_formula>C20H30O2</moldb_formula>
		<moldb_inchi>InChI=1S/C20H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-19H2,1H3,(H,21,22)/b4-3-,7-6-,10-9-,13-12-,16-15-</moldb_inchi>
		<moldb_inchikey>JAZBEHYOTPTENJ-JLNKQSITSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>302.4510</moldb_average_mass>
		<moldb_mono_mass>302.224580204</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>370</id>
		<lmdb_id>LMDB00370</lmdb_id>
		<created_at>2016-07-13 19:48:19</created_at>
		<updated_at>2016-09-23 18:45:16</updated_at>
		<export>1</export>
		<name>Myristoleic acid</name>
		<description>Myristoleic acid is a monounsaturated fatty acid that represent approximately 0.3 - 0.7% of the total fatty acid composition of adipose tissue triacylglycerol in animal. (PMID 10393134). It has been suggested that his cytotoxic and effective cell death inducer activity could be used for the treatment of prostate cancer. (PMID 11304730).</description>
		<cas>544-64-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCC\C=C/CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C14H26O2</moldb_formula>
		<moldb_inchi>InChI=1S/C14H26O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h5-6H,2-4,7-13H2,1H3,(H,15,16)/b6-5-</moldb_inchi>
		<moldb_inchikey>YWWVWXASSLXJHU-WAYWQWQTSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>226.3550</moldb_average_mass>
		<moldb_mono_mass>226.193280076</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>371</id>
		<lmdb_id>LMDB00371</lmdb_id>
		<created_at>2016-07-13 19:48:20</created_at>
		<updated_at>2016-09-23 18:45:17</updated_at>
		<export>1</export>
		<name>Dimethylmalonic acid</name>
		<description>Dimethylmalonic acid is a short-chain dicarboxylic acid occasionally found in animal serum (PMID 7762817). It is also a volatile organic compound detected in alveolar breath (PMID 1733607).</description>
		<cas>595-46-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)(C(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H8O4</moldb_formula>
		<moldb_inchi>InChI=1S/C5H8O4/c1-5(2,3(6)7)4(8)9/h1-2H3,(H,6,7)(H,8,9)</moldb_inchi>
		<moldb_inchikey>OREAFAJWWJHCOT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>132.1146</moldb_average_mass>
		<moldb_mono_mass>132.042258744</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>372</id>
		<lmdb_id>LMDB00372</lmdb_id>
		<created_at>2016-07-13 19:48:22</created_at>
		<updated_at>2016-07-20 21:00:18</updated_at>
		<export>1</export>
		<name>Tetracosanoic acid</name>
		<description>Lignoceric acid, also tetracosanoic acid, is a normal carboxylic acid, a very long chain fatty acid (VLCFA). Very long chain fatty acids (VLCFAs) are exclusively oxidized in peroxisomes and their levels are significantly increased in tissues of patients with peroxisomal disorders. (PMID 15565636).</description>
		<cas>557-59-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C24H48O2</moldb_formula>
		<moldb_inchi>InChI=1S/C24H48O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26/h2-23H2,1H3,(H,25,26)</moldb_inchi>
		<moldb_inchikey>QZZGJDVWLFXDLK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>368.6367</moldb_average_mass>
		<moldb_mono_mass>368.365430780</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>373</id>
		<lmdb_id>LMDB00373</lmdb_id>
		<created_at>2016-07-13 19:48:23</created_at>
		<updated_at>2016-07-19 23:30:46</updated_at>
		<export>1</export>
		<name>Methionine sulfoxide</name>
		<description>Methionine sulfoxide is an oxidation product of methionine with reactive oxygen species via 2-electron-dependent mechanism. Such oxidants can be generated from activated neutrophils; therefore, methionine sulfoxide can be regarded as a biomarker of oxidative stress in vivo. (PMID 12576054).</description>
		<cas>62697-73-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CS(=O)CCC(N)C(O)=O</moldb_smiles>
		<moldb_formula>C5H11NO3S</moldb_formula>
		<moldb_inchi>InChI=1S/C5H11NO3S/c1-10(9)3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)</moldb_inchi>
		<moldb_inchikey>QEFRNWWLZKMPFJ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>165.2110</moldb_average_mass>
		<moldb_mono_mass>165.045963913</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>374</id>
		<lmdb_id>LMDB00374</lmdb_id>
		<created_at>2016-07-13 19:48:25</created_at>
		<updated_at>2016-07-20 21:04:01</updated_at>
		<export>1</export>
		<name>Butyrylcarnitine</name>
		<description>Butyrylcarnitine is elevated in patients with acyl-coa dehydrogenase, short-chain (SCAD) deficiencyin; in infants with acute acidosis and generalized muscle weakness; and in middle-aged patients with chronic myopathy localized in muscle. (OMIM 201470).</description>
		<cas>25576-40-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCC(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C11H21NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C11H21NO4/c1-5-6-11(15)16-9(7-10(13)14)8-12(2,3)4/h9H,5-8H2,1-4H3</moldb_inchi>
		<moldb_inchikey>QWYFHHGCZUCMBN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>231.2887</moldb_average_mass>
		<moldb_mono_mass>231.147058165</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>375</id>
		<lmdb_id>LMDB00375</lmdb_id>
		<created_at>2016-07-13 19:48:26</created_at>
		<updated_at>2016-07-20 20:39:54</updated_at>
		<export>1</export>
		<name>cis-5-Tetradecenoylcarnitine</name>
		<description>Tetradecenoylcarnitine (C14:1) is the most characteristic metabolic marker of very long chain acyl-dehydrogenase (VLCAD) deficiency (PubMed ID 11433098 ); beta-Oxidation of long-chain fatty acids provides the major source of energy in the heart. Defects in enzymes of the beta-oxidation pathway cause sudden, unexplained death in childhood, acute hepatic encephalopathy or liver failure, skeletal myopathy, and cardiomyopathy. ( PubMed ID 7479827 ).</description>
		<cas>835598-21-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCC(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C21H39NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C21H39NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-21(25)26-19(17-20(23)24)18-22(2,3)4/h12-13,19H,5-11,14-18H2,1-4H3/b13-12-</moldb_inchi>
		<moldb_inchikey>NNCBVXBBLABOCB-SEYXRHQNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>369.5387</moldb_average_mass>
		<moldb_mono_mass>369.287908741</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>376</id>
		<lmdb_id>LMDB00376</lmdb_id>
		<created_at>2016-07-13 19:48:27</created_at>
		<updated_at>2016-07-19 23:37:05</updated_at>
		<export>1</export>
		<name>Fructosamine</name>
		<description>Fructosamine is a compound which can be considered as the result of a reaction between fructose and ammonia or an amine (with a molecule of water being released). A fructosamine is also formed when carbonyl group of glucose reacts with an amino group of a protein, as the double bond to oxygen moves from the end carbon atom to the next carbon atom and water is released. Fructosamines formed from blood proteins such as serum albumin are known as Glycated Serum Protein (GSP) or Glycated Albumin, and are used to identify the plasma glucose concentration over time and so assess diabetic control. (wikipedia). Glucose molecules are joined to protein molecules to form stable ketoamines, or fructosamines, through glycation, a nonenzymatic mechanism involving a labile Schiff base intermediate and the Amadori rearrangement. The amount of fructosamine in serum is increased in diabetes mellitus owing to the abnormally high concentration of sugar in blood. The concentration of fructosamine in serum thus reflects the degree of glycemic control attained by the diabetic patient and is useful in monitoring the effectiveness of therapy in diabetes over a period of several weeks, in a manner analogous to the determination of glycated hemoglobin. Of the analytical approaches used to measure fructosamine, affinity chromatography with m-aminophenylboronic acid and the nitroblue tetrazolium reduction method appear to be the most practical means for clinical chemists to assay fructosamine quickly, economically, and accurately. Fructosamine values can readily distinguish normal individuals and diabetic patients in good glycemic control from diabetics in poor control. Unlike glycated hemoglobin, which reflects the average blood sugar concentration over the past six to eight weeks, fructosamine reflects the average blood sugar concentration over the past two to three weeks. Thus a clinical advantage is that fructosamine responds more quickly to changes in therapy, thereby allowing for improved glycemic control. Fructosamine is used in conjunction with determinations of blood sugar and (or) of glycated hemoglobin, or by itself, the fructosamine assay can provide clinically useful information for the detection and control of diabetes. (PMID: 3319287).</description>
		<cas>4429-04-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC[C@@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C6H13NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C6H13NO5/c7-2-6(11)5(10)4(9)3(8)1-12-6/h3-5,8-11H,1-2,7H2/t3-,4-,5+,6-/m1/s1</moldb_inchi>
		<moldb_inchikey>IXZISFNWUWKBOM-ARQDHWQXSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>179.1711</moldb_average_mass>
		<moldb_mono_mass>179.079372531</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>377</id>
		<lmdb_id>LMDB00377</lmdb_id>
		<created_at>2016-07-13 19:48:29</created_at>
		<updated_at>2016-09-23 18:45:17</updated_at>
		<export>1</export>
		<name>N-Acetylputrescine</name>
		<description>N-Acetylputrescine is a polyamine commonly occurring excreted in normal animal urine (PMID 7775374). N-Acetylputrescine is the most abundant of all polyamines both in normal individuals and in patients with leukemia (PMID 9464484). N-Acetylputrescine is the N-acetylated form of the naturally occurring polyamine called putrescine. The N-acetylation is mediated by the enzyme diamine N-acetyltransferase. Putrescine is related to cadaverine (another polyamine). Both are produced by the breakdown of amino acids in living and dead organisms and both are toxic in large doses. Putrescine and cadaverine are largely responsible for the foul odor of putrefying flesh, but also contribute to the odor of such processes as bad breath and bacterial vaginosis. Putrescine is also found in semen. Putrescine attacks s-adenosyl methionine and converts it to spermidine. Spermidine in turn attacks another s-adenosyl methionine and converts it to spermine. Putrescine is synthesized in small quantities by healthy living cells by the action of ornithine decarboxylase.</description>
		<cas>18233-70-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)NCCCCN</moldb_smiles>
		<moldb_formula>C6H14N2O</moldb_formula>
		<moldb_inchi>InChI=1S/C6H14N2O/c1-6(9)8-5-3-2-4-7/h2-5,7H2,1H3,(H,8,9)</moldb_inchi>
		<moldb_inchikey>KLZGKIDSEJWEDW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>130.1882</moldb_average_mass>
		<moldb_mono_mass>130.110613080</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>378</id>
		<lmdb_id>LMDB00378</lmdb_id>
		<created_at>2016-07-13 19:48:30</created_at>
		<updated_at>2016-09-23 18:45:18</updated_at>
		<export>1</export>
		<name>Erucic acid</name>
		<description>Erucic acid is a monounsaturated omega-9 fatty acid found mainly in the Brassica family of plants such as canola, rapeseed, wallflower seed, mustard seed as well as Brussels spouts and broccoli. Some Brassica cultivars can have up to 40 to 50 percent of their oil recovered as erucic acid. Erucic acid is also known as cis-13-docosenoic acid. The trans isomer is known as brassidic acid. Erucic acid occurs in nature only along with bitter-tasting compounds. Erucic acid has many of the same uses as mineral oils but with the advantage that it is more readily bio-degradable. Its high tolerance to temperature makes it suitable for transmission oil. Its ability to polymerize and dry means it can be - and is - used as a binder for oil paints. Increased levels of eicosenoic acid (20:ln9) and erucic acid (22:1n9) have been found in the red blood cell membranes of autistic subjects with developmental regression (PMID: 16581239). Erucic acid is broken down long-chain acyl-coenzyme A (CoA) dehydrogenase, which is produced in the liver. This enzyme breaks this long chain fatty acid into shorter-chain fatty acids. animal infants have relatively low amounts of this enzyme and because of this, babies should not be given foods high in erucic acid.</description>
		<cas>112-86-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C22H42O2</moldb_formula>
		<moldb_inchi>InChI=1S/C22H42O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h9-10H,2-8,11-21H2,1H3,(H,23,24)/b10-9-</moldb_inchi>
		<moldb_inchikey>DPUOLQHDNGRHBS-KTKRTIGZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>338.5677</moldb_average_mass>
		<moldb_mono_mass>338.318480588</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>379</id>
		<lmdb_id>LMDB00379</lmdb_id>
		<created_at>2016-07-13 19:48:31</created_at>
		<updated_at>2016-07-20 21:00:21</updated_at>
		<export>1</export>
		<name>Itaconic acid</name>
		<description>Itaconic acid is an intermediate in the C5-Branched dibasic acid metabolism, a substrate for the enzyme Succinate-CoA ligase (ADP-forming) (EC:6.2.1.5)(Kegg).</description>
		<cas>97-65-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CC(=C)C(O)=O</moldb_smiles>
		<moldb_formula>C5H6O4</moldb_formula>
		<moldb_inchi>InChI=1S/C5H6O4/c1-3(5(8)9)2-4(6)7/h1-2H2,(H,6,7)(H,8,9)</moldb_inchi>
		<moldb_inchikey>LVHBHZANLOWSRM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>130.0987</moldb_average_mass>
		<moldb_mono_mass>130.026608680</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>380</id>
		<lmdb_id>LMDB00380</lmdb_id>
		<created_at>2016-07-13 19:48:33</created_at>
		<updated_at>2016-07-20 21:00:22</updated_at>
		<export>1</export>
		<name>Phosphoric acid</name>
		<description>Phosphoric acid, also known as orthophosphoric acid or phosphoric(V) acid, is a mineral acid with the chemical formula H3PO4. Alternatively, orthophosphoric acid molecules can combine with themselves to form a variety of compounds referred to as phosphoric acids in a more general way. For a discussion of these, see Phosphoric acids and Phosphates. Appears to exist only as a food additive and produced synthetically. --Wikipedia.</description>
		<cas>7664-38-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OP(O)(O)=O</moldb_smiles>
		<moldb_formula>H3O4P</moldb_formula>
		<moldb_inchi>InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)</moldb_inchi>
		<moldb_inchikey>NBIIXXVUZAFLBC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>97.9952</moldb_average_mass>
		<moldb_mono_mass>97.976895096</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>381</id>
		<lmdb_id>LMDB00381</lmdb_id>
		<created_at>2016-07-13 19:48:34</created_at>
		<updated_at>2016-07-19 23:35:52</updated_at>
		<export>1</export>
		<name>Cobalamin</name>
		<description>Cobalamin participates in two enzymatic processes in mammalian cells. In the methionine synthase (EC 2.1.1.13) reaction, homocysteine (HCys) is converted to methionine allowing for the &quot;recycling&quot; of 5-methyl-tetrahydrofolate (THF) to N5,10 methylene-THF which is needed for the de novo synthesis of thymidylic acid and ultimately, for DNA formation. Since conversion of N5,10-methylene-THF to N5-methyl-THF is irreversible, cobalamin deficiency &quot;traps&quot; folic acid as N5-methyl-THF. Concurrently, HCys accumulates while methionine decreases, leading to a decrease in S-adenosylmethionine which further limits N5,10-methylene-THF formation by decreasing the synthesis of formyl-THF (&quot;formate starvation&quot;). Decreased methionine and S-adenosylmethionine may limit many methylation reactions including those involving DNA and myelin basic protein. In the methylmalonyl CoA mutase (EC 5.1.99.1) reaction, methylmalonyl CoA, derived from propionic acid synthesized by intestinal bacteria, is converted to succinyl CoA, a precursor for fatty acid and heme synthesis Thus, cobalamin deficiency results in methylmalonic acid (MMA) accumulation. Cobalamin deficiency causes megaloblastic anemia and neurocognitive abnormalities but effects on immune function and bone formation have also been described. Low serum cobalamin levels increase the risk of osteoporosis. Tests for cobalamin deficiency include measurements of 1) total cobalamin; 2) MMA and HCys, as indices of functional cobalamin deficiency; and 3) holotranscobalamin as a measure of the metabolically active fraction of circulating cobalamin. Each approach has significant limitations. Moreover, since the pathogenesis of neurologic dysfunction in cobalamin deficiency remains unclear, these tests may not be reliable markers of neurocognitive impairment. Subtle cobalamin deficiency, defined as elevated metabolite levels usually in asymptomatic patients with low or normal serum cobalamin values, is prevalent in the elderly and has been associated with food cobalamin malabsorption, a disorder characterized by the inability to release vitamin B12 from food or from its binding proteins. Malabsorption is often unrecognized or not investigated. However, because of the potential seriousness of the complications, particularly neuropsychiatric and hematological investigation of all patients who present with vitamin or nutritional deficiency is required. Classic disorders, such as pernicious anemia, are the cause of cobalamin deficiency in only a limited proportion of elderly patients. Epidemiological studies have shown a prevalence of cobalamin deficiency of around 20% in the elderly population of industrialized countries (between 50% and 60%, depending on the definition of cobalamin deficiency used in the study). New routes of cobalamin administration (oral and nasal) are currently being developed, especially the use of oral cobalamin therapy to treat food-cobalamin malabsorption. (PMID: 16814909, 17822656).</description>
		<cas>13408-78-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Co+3].CC(CNC(=O)CCC1(C)C(CC(N)=O)C2[N-]\C1=C(C)/C1=N/C(=C\C3=N\C(=C(C)/C4=NC2(C)C(C)(CC(N)=O)C4CCC(N)=O)\C(C)(CC(N)=O)C3CCC(N)=O)/C(C)(C)C1CCC(N)=O)OP([O-])(=O)OC1C(CO)OC(C1O)N1C=NC2=C1C=C(C)C(C)=C2</moldb_smiles>
		<moldb_formula>C62H88CoN13O14P</moldb_formula>
		<moldb_inchi>InChI=1S/C62H90N13O14P.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);/q;+3/p-2</moldb_inchi>
		<moldb_inchikey>NSLAUEAQDBERRV-UHFFFAOYSA-L</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>1329.3478</moldb_average_mass>
		<moldb_mono_mass>1328.564331295</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>382</id>
		<lmdb_id>LMDB00382</lmdb_id>
		<created_at>2016-07-13 19:48:35</created_at>
		<updated_at>2016-09-23 18:45:18</updated_at>
		<export>1</export>
		<name>Docosahexaenoic acid</name>
		<description>Docosahexaenoic acid (DHA) is an omega-3 essential fatty acid. Chemically, DHA is a carboxylic acid with a 22-carbon chain and six cis double bonds with the first double bond is located at the third carbon from the omega end. DHA is most often found in fish oil. It is a major fatty acid in sperm and brain phospholipids, especially in the retina. Dietary DHA can reduce the level of blood triglycerides in animals, which may reduce the risk of heart disease. (wikipedia).</description>
		<cas>6217-54-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O</moldb_smiles>
		<moldb_formula>C22H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C22H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-</moldb_inchi>
		<moldb_inchikey>MBMBGCFOFBJSGT-KUBAVDMBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>328.4883</moldb_average_mass>
		<moldb_mono_mass>328.240230268</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>383</id>
		<lmdb_id>LMDB00383</lmdb_id>
		<created_at>2016-07-13 19:48:37</created_at>
		<updated_at>2016-09-23 18:45:18</updated_at>
		<export>1</export>
		<name>Desaminotyrosine</name>
		<description>Desaminotyrosine is a normal constituent of animal urine. A product of tyrosine metabolism; concentration in urine increases in patients with gastrointestinal diseases. (Dictionary of Organic Compounds). It is considered also that may result from metabolism to phenolic acids by colonic bacteria. (PMID 15315398).</description>
		<cas>501-97-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CCC1=CC=C(O)C=C1</moldb_smiles>
		<moldb_formula>C9H10O3</moldb_formula>
		<moldb_inchi>InChI=1S/C9H10O3/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-2,4-5,10H,3,6H2,(H,11,12)</moldb_inchi>
		<moldb_inchikey>NMHMNPHRMNGLLB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>166.1739</moldb_average_mass>
		<moldb_mono_mass>166.062994186</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>384</id>
		<lmdb_id>LMDB00384</lmdb_id>
		<created_at>2016-07-13 19:48:38</created_at>
		<updated_at>2016-07-20 20:53:20</updated_at>
		<export>1</export>
		<name>Arachidic acid</name>
		<description>Arachidic acid also called eicosanoic acid is a saturated fatty acid found in peanut oil. It can be formed by the hydrogenation of arachidonic acid. It is practically insoluble in water and stable under ordinary conditions -- Wikipedia.</description>
		<cas>506-30-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C20H40O2</moldb_formula>
		<moldb_inchi>InChI=1S/C20H40O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h2-19H2,1H3,(H,21,22)</moldb_inchi>
		<moldb_inchikey>VKOBVWXKNCXXDE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>312.5304</moldb_average_mass>
		<moldb_mono_mass>312.302830524</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>385</id>
		<lmdb_id>LMDB00385</lmdb_id>
		<created_at>2016-07-13 19:48:39</created_at>
		<updated_at>2016-07-20 21:00:26</updated_at>
		<export>1</export>
		<name>Adrenic acid</name>
		<description>Adrenic acid, which is a prostacyclin inhibitor, appears to be potential prothrombotic agent. (PMID 1642692).</description>
		<cas>2091-25-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C22H36O2</moldb_formula>
		<moldb_inchi>InChI=1S/C22H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-21H2,1H3,(H,23,24)/b7-6-,10-9-,13-12-,16-15-</moldb_inchi>
		<moldb_inchikey>TWSWSIQAPQLDBP-DOFZRALJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>332.5200</moldb_average_mass>
		<moldb_mono_mass>332.271530396</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>386</id>
		<lmdb_id>LMDB00386</lmdb_id>
		<created_at>2016-07-13 19:48:41</created_at>
		<updated_at>2016-07-20 21:04:02</updated_at>
		<export>1</export>
		<name>Eicosenoic acid</name>
		<description>Eicosenoic acid is an monounsaturated omega-9 fatty acid found in a variety of plant oils. It is also found in the red cell membrane with increased concentrations in children with regressive autism (16581239).</description>
		<cas>26764-41-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C20H38O2</moldb_formula>
		<moldb_inchi>InChI=1S/C20H38O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h9-10H,2-8,11-19H2,1H3,(H,21,22)/b10-9-</moldb_inchi>
		<moldb_inchikey>BITHHVVYSMSWAG-KTKRTIGZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>310.5145</moldb_average_mass>
		<moldb_mono_mass>310.287180460</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>387</id>
		<lmdb_id>LMDB00387</lmdb_id>
		<created_at>2016-07-13 19:48:42</created_at>
		<updated_at>2016-07-20 21:00:29</updated_at>
		<export>1</export>
		<name>Picolinic acid</name>
		<description>Picolinic acid is a metabolite of the tryptophan catabolism. Picolinic acid is produced under inflammatory conditions and a costimulus with interferon-gamma (IFNgamma) of macrophage (Mphi) effector functions, is a selective inducer of the Mphi inflammatory protein-1alpha (MIP-1alpha) and -1beta (MIPs), two chemokines/cytokines involved in the elicitation of the inflammatory reactions and in the development of the Th1 responses. IFNgamma and picolinic acid have reciprocal effects on the production of MIPs chemokines and the expression of their receptor. The concerted action of IFNgamma and picolinic acid on MIP-1alpha/beta chemokine/receptor system is likely to be of pathophysiological significance and to represent an important regulatory mechanism for leukocyte recruitment and distribution into damaged tissues during inflammatory responses. Picolinic acid has an effect on the production of L-arginine-derived reactive nitrogen intermediates in macrophages, by augmenting IFN-gamma-induced NO2- production, and acts synergistically with IFN-gamma in activating macrophages. Children with acrodermatitis enteropathica (AE) are treated with oral zinc dipicolinate (zinc-PA). The concentration of picolinic acid in the plasma of asymptomatic children with AE was significantly less than that of normal children. However, oral treatment with PA alone is ineffective. The results support the hypothesis that the genetic defect in AE is in the tryptophan pathway, although the role of PA in zinc metabolism remains to be defined. (PMID: 15206716, 8473748, 1701787, 6694049).</description>
		<cas>98-98-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C1=CC=CC=N1</moldb_smiles>
		<moldb_formula>C6H5NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H5NO2/c8-6(9)5-3-1-2-4-7-5/h1-4H,(H,8,9)</moldb_inchi>
		<moldb_inchikey>SIOXPEMLGUPBBT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>123.1094</moldb_average_mass>
		<moldb_mono_mass>123.032028409</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>388</id>
		<lmdb_id>LMDB00388</lmdb_id>
		<created_at>2016-07-13 19:48:43</created_at>
		<updated_at>2016-09-23 18:45:19</updated_at>
		<export>1</export>
		<name>Heptadecanoic acid</name>
		<description>Heptadecanoic acid is a fatty acid of exogenous (primarily ruminant) origin. Many &quot;odd&quot; length long chain amino acids are derived from the consumption of dairy fats (milk and meat). Heptadecanoic acid constitutes 0.61% of milk fat and 0.83% of ruminant meat fat. The content of heptadecanoic acid in the subcutaneous adipose tissue of animals appears to be a good biological marker of long-term milk fat intake in free-living individuals in populations with high consumption of dairy products. (PMID 9701185).</description>
		<cas>506-12-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C17H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C17H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17(18)19/h2-16H2,1H3,(H,18,19)</moldb_inchi>
		<moldb_inchikey>KEMQGTRYUADPNZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>270.4507</moldb_average_mass>
		<moldb_mono_mass>270.255880332</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>389</id>
		<lmdb_id>LMDB00389</lmdb_id>
		<created_at>2016-07-13 19:48:45</created_at>
		<updated_at>2016-07-20 21:00:30</updated_at>
		<export>1</export>
		<name>2-Indolecarboxylic acid</name>
		<description>2-Indolecarboxylic acid is a strong inhibitor of lipid peroxidation, similar to melatonin and some structurally related indole compounds. Lipid peroxidation with tert-butyl hydroperoxide is a source of free radicals (PMID 12236544). 2-Indolecarboxylic acid is a phenolic components known to exist in Korean ginseng (Koryo Insam Hakhoechi (1996), 20(3), 284-290) and brown rice (Han'guk Nonghwa Hakhoechi (1995), 38(5), 478-83).</description>
		<cas>1477-50-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C1=CC2=C(N1)C=CC=C2</moldb_smiles>
		<moldb_formula>C9H7NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C9H7NO2/c11-9(12)8-5-6-3-1-2-4-7(6)10-8/h1-5,10H,(H,11,12)</moldb_inchi>
		<moldb_inchikey>HCUARRIEZVDMPT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>161.1574</moldb_average_mass>
		<moldb_mono_mass>161.047678473</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>390</id>
		<lmdb_id>LMDB00390</lmdb_id>
		<created_at>2016-07-13 19:48:46</created_at>
		<updated_at>2016-07-20 20:40:38</updated_at>
		<export>1</export>
		<name>Cadaverine</name>
		<description>Cadaverine is a foul-smelling diamine formed by bacterial decarboxylation of lysine that occurs during protein hydrolysis during putrefaction of animal tissue. However, this diamine is not purely associated with putrefaction. It is also produced in small quantities by mammals. In particular, it is partially responsible for the distinctive smell of urine and semen. Elevated levels of cadaverine have been found in the urine of some patients with defects in lysine metabolism. Cadaverine is toxic in large doses. In rats it had a low acute oral toxicity of more than 2000 mg/kg body weight (Wikipedia).</description>
		<cas>462-94-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCCCCN</moldb_smiles>
		<moldb_formula>C5H14N2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H14N2/c6-4-2-1-3-5-7/h1-7H2</moldb_inchi>
		<moldb_inchikey>VHRGRCVQAFMJIZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>102.1781</moldb_average_mass>
		<moldb_mono_mass>102.115698458</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>391</id>
		<lmdb_id>LMDB00391</lmdb_id>
		<created_at>2016-07-13 19:48:47</created_at>
		<updated_at>2016-07-20 21:00:31</updated_at>
		<export>1</export>
		<name>Oxalic acid</name>
		<description>Oxalic acid is a strong dicarboxylic acid occurring in many plants and vegetables. It is produced in the body by metabolism of glyoxylic acid or ascorbic acid. It is not metabolized but excreted in the urine. It is used as an analytical reagent and general reducing agent. -- Pubchem; Oxalic acid (IUPAC name: ethanedioic acid, formula H2C2O4) is a dicarboxylic acid with structure (HOOC)-(COOH). Because of the joining of two carboxyl groups, this is one of the strongest organic acids. It is also a reducing agent. The anions of oxalic acid as well as its salts and esters are known as oxalates. -- Wikipedia; Bodily oxalic acid may also be synthesized via the metabolism of either glyoxylic acid or unused ascorbic acid (vitamin C), which is a serious health consideration for long term megadosers of vitamin C supplements. 80% of kidney stones are formed from calcium oxalate. Some Aspergillus species produce oxalic acid, which reacts with blood or tissue calcium to precipitate calcium oxalate. There is some preliminary evidence that the administration of probiotics can affect oxalic acid excretion rates (and presumably oxalic acid levels as well.) -- Wikipedia.</description>
		<cas>144-62-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C(O)=O</moldb_smiles>
		<moldb_formula>C2H2O4</moldb_formula>
		<moldb_inchi>InChI=1S/C2H2O4/c3-1(4)2(5)6/h(H,3,4)(H,5,6)</moldb_inchi>
		<moldb_inchikey>MUBZPKHOEPUJKR-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>90.0349</moldb_average_mass>
		<moldb_mono_mass>89.995308552</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>392</id>
		<lmdb_id>LMDB00392</lmdb_id>
		<created_at>2016-07-13 19:48:49</created_at>
		<updated_at>2016-09-23 18:45:20</updated_at>
		<export>1</export>
		<name>Heneicosanoic acid</name>
		<description>Heneicosanoic acid (HEA) is a fatty acid found in animal milk fat (PMID: 16332663, 16512938). HEA is also a part of the phospholipids of the articular cartilage boundary lubricant (PMID: 11518278). HEA is a constituent of red blood cell fatty acids. (PMID: 9972864).</description>
		<cas>2363-71-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C21H42O2</moldb_formula>
		<moldb_inchi>InChI=1S/C21H42O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21(22)23/h2-20H2,1H3,(H,22,23)</moldb_inchi>
		<moldb_inchikey>CKDDRHZIAZRDBW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>326.5570</moldb_average_mass>
		<moldb_mono_mass>326.318480588</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>393</id>
		<lmdb_id>LMDB00393</lmdb_id>
		<created_at>2016-07-13 19:48:51</created_at>
		<updated_at>2016-09-23 18:45:20</updated_at>
		<export>1</export>
		<name>Octacosanoic acid</name>
		<description>Octacosanoic acid is a very-long-chain fatty acid found in animal brain and visceral organs (PMID: 2474624). Octacosanoic acid is a higher aliphatic primary acids purified from sugar-cane (Saccharum officinarum L.) wax that has been shown to inhibit platelet aggregation induced ex vivo by addition of agonists to platelet-rich plasma (PRP) of rats, guinea pigs, and healthy animal volunteers. (PMID: 5099499). Octacosanoic acid is formed from octacosanol via beta-oxidation. (PMID: 15847942).</description>
		<cas>506-48-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C28H56O2</moldb_formula>
		<moldb_inchi>InChI=1S/C28H56O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27-28(29)30/h2-27H2,1H3,(H,29,30)</moldb_inchi>
		<moldb_inchikey>UTOPWMOLSKOLTQ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>424.7430</moldb_average_mass>
		<moldb_mono_mass>424.428031036</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>394</id>
		<lmdb_id>LMDB00394</lmdb_id>
		<created_at>2016-07-13 19:48:52</created_at>
		<updated_at>2016-07-20 21:04:04</updated_at>
		<export>1</export>
		<name>Hexacosanoic acid</name>
		<description>X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder biochemically characterized by the accumulation of very long chain fatty acids (VLCFA), particularly hexacosanoic acid (C(26:0)) and tetracosanoic acid (C(24:0)), in tissues and biological fluids. (PMID 16750542).</description>
		<cas>506-46-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C26H52O2</moldb_formula>
		<moldb_inchi>InChI=1S/C26H52O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26(27)28/h2-25H2,1H3,(H,27,28)</moldb_inchi>
		<moldb_inchikey>XMHIUKTWLZUKEX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>396.6899</moldb_average_mass>
		<moldb_mono_mass>396.396730908</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>395</id>
		<lmdb_id>LMDB00395</lmdb_id>
		<created_at>2016-07-13 19:48:54</created_at>
		<updated_at>2016-07-20 21:04:04</updated_at>
		<export>1</export>
		<name>Phenylpropiolic acid</name>
		<description>Phenylpropiolic acid is one of a number of phenylpropanoid, natural products occurring in plants pathways involved in plant resistance providing building units of physical barriers against pathogen invasion, synthesizing an array of antibiotic compounds, and producing signals implicated in the mounting of plant resistance. (PMID 15199968). Phenylpropiolic acid is a cis-pyrrolidinone that has been tested as an inhibitors of type II 17beta-hydroxysteroid dehydrogenase for the treatment of osteoporosis. (PMID 16806919).</description>
		<cas>637-44-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C#CC1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C9H6O2</moldb_formula>
		<moldb_inchi>InChI=1S/C9H6O2/c10-9(11)7-6-8-4-2-1-3-5-8/h1-5H,(H,10,11)</moldb_inchi>
		<moldb_inchikey>XNERWVPQCYSMLC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>146.1427</moldb_average_mass>
		<moldb_mono_mass>146.036779436</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>396</id>
		<lmdb_id>LMDB00396</lmdb_id>
		<created_at>2016-07-13 19:48:55</created_at>
		<updated_at>2016-09-23 18:45:21</updated_at>
		<export>1</export>
		<name>2,4-Diaminobutyric acid</name>
		<description>2,4-Diaminobutyric acid is a non-physiological, cationic amino acid analogue that is transported into cells by System A with potent antitumoral activity in vitro against animal glioma cells, the result of the pronounced concentrated uptake of DAB in glioma cells to the extent that a cellular lysis could occur due to osmotic reasons. (PMID: 1561943).</description>
		<cas>305-62-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCC(N)C(O)=O</moldb_smiles>
		<moldb_formula>C4H10N2O2</moldb_formula>
		<moldb_inchi>InChI=1S/C4H10N2O2/c5-2-1-3(6)4(7)8/h3H,1-2,5-6H2,(H,7,8)</moldb_inchi>
		<moldb_inchikey>OGNSCSPNOLGXSM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>118.1344</moldb_average_mass>
		<moldb_mono_mass>118.074227574</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>397</id>
		<lmdb_id>LMDB00397</lmdb_id>
		<created_at>2016-07-13 19:48:56</created_at>
		<updated_at>2016-08-01 19:11:01</updated_at>
		<export>1</export>
		<name>Tiglylcarnitine</name>
		<description>Tiglylcarnitine is detected in the urinary organic acid and blood spot acylcarnitine profiles in patients with mitochondrial acetoacetyl-CoA thiolase (T2) deficiency -- an inborn error of metabolism affecting isoleucine and ketone bodies in the catabolic process. (PubMed ID 14518824 ).</description>
		<cas>64191-86-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C\C=C(/C)C(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C12H21NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C12H21NO4/c1-6-9(2)12(16)17-10(7-11(14)15)8-13(3,4)5/h6,10H,7-8H2,1-5H3/b9-6+</moldb_inchi>
		<moldb_inchikey>WURBQCVBQNMUQT-RMKNXTFCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>243.2994</moldb_average_mass>
		<moldb_mono_mass>243.147058165</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>398</id>
		<lmdb_id>LMDB00398</lmdb_id>
		<created_at>2016-07-13 19:48:57</created_at>
		<updated_at>2016-09-23 18:45:21</updated_at>
		<export>1</export>
		<name>Boron</name>
		<description>Boron may be an essential nutrient for animals and animals. Physiologically, this metal/element exists as an ion in the body. Dietary boron influences the activity of many metabolic enzymes, as well as the metabolism of steroid hormones and several micronutrients, including calcium, magnesium, and vitamin D. Boron may also play a role in improving arthritis, plasma lipid profiles, and brain function.</description>
		<cas>7440-42-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[B+3]</moldb_smiles>
		<moldb_formula>B</moldb_formula>
		<moldb_inchi>InChI=1S/B/q+3</moldb_inchi>
		<moldb_inchikey>FRWDHMWMHYXNLW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>10.8110</moldb_average_mass>
		<moldb_mono_mass>11.009305466</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>399</id>
		<lmdb_id>LMDB00399</lmdb_id>
		<created_at>2016-07-13 19:48:59</created_at>
		<updated_at>2016-07-20 20:53:29</updated_at>
		<export>1</export>
		<name>Beryllium</name>
		<description>Beryllium is a light-weight metallic element, which was first recognized as a lung hazard in Europe in the 1930s, shortly after its first production in modern industry. People exposed to beryllium compounds are at increased risk of developing beryllium sensitization and chronic beryllium disease (CBD). The chronic lung disease was first described among workers exposed to beryllium-containing materials used in the manufacture of fluorescent lamps. In primary production of beryllium metal, which was used in nuclear weapons components, physicians recognized severe dermatitis, reversible pneumonitis, and chronic granulomatous lung disease. Physiologically, this metal/element exists as an ion in the body. It is now recognized that the physicochemical properties of beryllium compounds may account for the differing clinical presentations in different industries. In primary production of beryllium metal, soluble salts are present and cause rashes in approximately one fourth of exposed workers and reversible acute pneumonitis in a smaller portion of the workforce. After heavy inhalation exposures, radiographic abnormalities evolve at approximately three weeks; resolution of symptoms and radiologic abnormalities away from exposure occur only after months, but symptoms recur immediately upon reexposure. The granulomatous nature of chronic beryllium disease is now known to be caused by cell-mediated sensitization to beryllium. Chronic beryllium disease (CBD) is a granulomatous lung disorder characterized by the accumulation of beryllium-specific CD4(+) T cells. Depending on genetic susceptibility and the nature of the exposure, CBD occurs in up to 20% of exposed workers. Genetic susceptibility has been associated with particular HLA-DP alleles, especially those possessing a negatively charged glutamic acid residue at the 69th position of the beta-chain. The mechanism for this association lies in the ability of these HLA-DP molecules to bind and present beryllium to pathogenic CD4(+) T cells. Large numbers of effector memory, beryllium-specific CD4(+) T cells are recruited to the lung of these subjects and secrete Th1-type cytokines upon beryllium recognition. The presence of circulating beryllium-specific CD4(+) T cells directly correlates with the severity of lymphocytic alveolitis. Since 1987, this biomarker of sensitization has enabled medical surveillance of beryllium-exposed workforces. Beryllium lymphocyte proliferation tests have been used to screen workers to detect sensitization, to characterize epidemiologically workplace risks for beryllium sensitization, and to evaluate the effectiveness of interventions intended to prevent sensitization. The most compelling real-world example of genetic testing for susceptibility to a workplace exposure involves those industries that process or fabricate beryllium. Under reasonable assumptions, the longitudinal positive predictive value of the HLA-DPB1-Glu69 marker of susceptibility to beryllium disease is 12%. Interpretive challenges further limit the utility of the test and may inadvertently suggest a false sense of safety among workers. Reduction in inhalation exposure to beryllium has not resulted in a concomitant reduction in the occurrence of beryllium sensitization or CBD, suggesting that continued prevalence may be due, in part, to unchecked skin exposure to beryllium-containing particles. (PMID: 17094767, 16697706, 16231190).</description>
		<cas>7440-41-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Be++]</moldb_smiles>
		<moldb_formula>Be</moldb_formula>
		<moldb_inchi>InChI=1S/Be/q+2</moldb_inchi>
		<moldb_inchikey>PWOSZCQLSAMRQW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>9.0122</moldb_average_mass>
		<moldb_mono_mass>9.012182135</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>400</id>
		<lmdb_id>LMDB00400</lmdb_id>
		<created_at>2016-07-13 19:49:00</created_at>
		<updated_at>2016-07-20 21:00:33</updated_at>
		<export>1</export>
		<name>Terephthalic acid</name>
		<description>Terephthalic acid is one isomer of the three phthalic acids. It finds important use as a commodity chemical, principally as a starting compound for the manufacture of polyester (specifically PET), used in clothing and to make plastic bottles. It is also known as 1,4-benzenedicarboxylic acid, and it has the chemical formula C6H4(COOH)2. -- Wikipedia.</description>
		<cas>100-21-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C1=CC=C(C=C1)C(O)=O</moldb_smiles>
		<moldb_formula>C8H6O4</moldb_formula>
		<moldb_inchi>InChI=1S/C8H6O4/c9-7(10)5-1-2-6(4-3-5)8(11)12/h1-4H,(H,9,10)(H,11,12)</moldb_inchi>
		<moldb_inchikey>KKEYFWRCBNTPAC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>166.1308</moldb_average_mass>
		<moldb_mono_mass>166.026608680</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>401</id>
		<lmdb_id>LMDB00401</lmdb_id>
		<created_at>2016-07-13 19:49:02</created_at>
		<updated_at>2016-07-20 21:04:05</updated_at>
		<export>1</export>
		<name>Hydroquinone</name>
		<description>Hydroquinone, also benzene-1,4-diol, is an aromatic organic compound which is a type of phenol, having the chemical formula C6H4(OH)2. Its chemical structure has two hydroxyl groups bonded to a benzene ring in a para position. Hydroquinone is commonly used as a biomarker for benzene exposure. The presence of hydroquinone in normal individuals stems mainly from direct dietary ingestion, catabolism of tyrosine and other substrates by gut bacteria, ingestion of arbutin containing foods, cigarette smoking, and the use of some over-the-counter medicines. Hydroquinone is a white granular solid at room temperature and pressure. The hydroxyl groups of hydroquinone are quite weakly acidic. Hydroquinone can lose an H+ from one of the hydroxyls to form a monophenolate ion or lose an H+ from both to form a diphenolate ion. Hydroquinone has a variety of uses principally associated with its action as a reducing agent which is soluble in water. It is a major component in most photographic developers where, with the compound Metol, it reduces silver halides to elemental silver.</description>
		<cas>123-31-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1=CC=C(O)C=C1</moldb_smiles>
		<moldb_formula>C6H6O2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H6O2/c7-5-1-2-6(8)4-3-5/h1-4,7-8H</moldb_inchi>
		<moldb_inchikey>QIGBRXMKCJKVMJ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>110.1106</moldb_average_mass>
		<moldb_mono_mass>110.036779436</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>402</id>
		<lmdb_id>LMDB00402</lmdb_id>
		<created_at>2016-07-13 19:49:03</created_at>
		<updated_at>2016-07-19 23:26:32</updated_at>
		<export>1</export>
		<name>Nickel</name>
		<description>Nickel is a solid, silver-white, hard, malleable transition metal with an atomic number of 28. It resists corrosion even at high temperatures. It is present in many alloys in widespread use, including stainless steels. It may also be present as an impurity in any alloy. Nickel is used in the production of coins, jewellery, and nickel-cadmium batteries, and as a catalyst for the hydrogenation of liquid oils to solid fats such as oleomargarine and vegetable shortening. Nickel-containing dental alloys continue to be used successfully in the provision of various forms of dental care. Many of these alloys have applications in the construction of restorations designed to remain in clinical service for many years, including crowns, fixed bridgework, and removable partial dentures. Furthermore, nickel containing alloys find extensive application in orthodontics, including metallic brackets, arch wires, bands, springs and ligature wires. Many instruments and devises, for example, endodontic instruments also contain nickel. Allergic responses are mediated through the immune system. In a sensitized individual, allergic responses can be initiated by relatively small amounts of the allergen; for example, if nickel ions are released from a nickel plated material following direct and prolonged contact with the skin. Individuals are first sensitized to the allergen. Subsequent exposures, if sufficiently high, may then result in an allergic reaction. A number of allergens are used in the clinical practice of dentistry, notably eugenol, mercury, nickel, chromium, cobalt, components of resin-based materials and a host of other chemical agents. The majority of dental allergies, including allergic responses to nickel-containing dental alloys, comprise Type IV hypersensitivity reactions, cell-mediated by T-lymphocytes. Physiologically, it exists as an ion in the body.(PMID: 17243350, 16405986).</description>
		<cas>7440-02-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Ni++]</moldb_smiles>
		<moldb_formula>Ni</moldb_formula>
		<moldb_inchi>InChI=1S/Ni/q+2</moldb_inchi>
		<moldb_inchikey>VEQPNABPJHWNSG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>58.6934</moldb_average_mass>
		<moldb_mono_mass>57.935347922</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>403</id>
		<lmdb_id>LMDB00403</lmdb_id>
		<created_at>2016-07-13 19:49:04</created_at>
		<updated_at>2016-09-23 18:45:21</updated_at>
		<export>1</export>
		<name>Vanadium</name>
		<description>Vanadium is a steel-grey, corrosion-resistant metal, which exists in oxidation states ranging from -1 to +5. Metallic vanadium does not occur in nature, and the most common valence states are +3, +4, and +5. The pentavalent form (VO3-) predominates in extracellular body fluids whereas the quadrivalent form (VO+2) is the most common intracellular form. Because of its hardness and its ability to form alloys, vanadium (i.e., ferrovanadium) is a common component of hard steel alloys used in machines and tools. Although most foods contain low concentrations of vanadium (&lt; 1 ng/g), food is the major source of exposure to vanadium for the general population. High air concentrations of vanadium occur in the occupation setting during boiler-cleaning operations as a result of the presence of vanadium oxides in the dust. The lungs absorb soluble vanadium compounds (V2O5) well, but the absorption of vanadium salts from the gastrointestinal tract is poor. The excretion of vanadium by the kidneys is rapid with a biological half-life of 20-40 hours in the urine. Physiologically, it exists as an ion in the body. Vanadium is probably an essential trace element, but a vanadium-deficiency disease has not been identified in animals. The estimated daily intake of the US population ranges from 10-60 micrograms V. Vanadyl sulfate is a common supplement used to enhance weight training in athletes at doses up to 60 mg/d. In vitro and animal studies indicate that vanadate and other vanadium compounds increase glucose transport activity and improve glucose metabolism. In general, the toxicity of vanadium compounds is low. Pentavalent compounds are the most toxic and the toxicity of vanadium compounds usually increases as the valence increases. Most of the toxic effects of vanadium compounds result from local irritation of the eyes and upper respiratory tract rather than systemic toxicity. The only clearly documented effect of exposure to vanadium dust is upper respiratory tract irritation characterized by rhinitis, wheezing, nasal hemorrhage, conjunctivitis, cough, sore throat, and chest pain. Case studies have described the onset of asthma after heavy exposure to vanadium compounds, but clinical studies to date have not detected an increased prevalence of asthma in workers exposed to vanadium. Vanadium is a trace element present in practically all cells in plants and animals. It exerts interesting actions in living systems. At pharmacological doses, vanadium compounds display relevant biological actions such as mimicking insulin and growth factors as well as having osteogenic activity. Some vanadium compounds also show antitumoral properties. The importance of vanadium in bone arises from the studies developed to establish the essentiality of this element in animals and animals. Bone tissue, where the element seems to play an important role, accumulates great amounts of vanadium. Among several metals, vanadium has emerged as an extremely potent agent with insulin-like properties. These insulin-like properties have been demonstrated in isolated cells, tissues, different animal models of type I and type II diabetes as well as a limited number of animal subjects. Vanadium treatment has been found to improve abnormalities of carbohydrate and lipid metabolism and of gene expression in rodent models of diabetes. In isolated cells, it enhances glucose transport, glycogen and lipid synthesis, and inhibits gluconeogenesis and lipolysis. The molecular mechanism responsible for the insulin-like effects of vanadium compounds have been shown to involve the activation of several key components of insulin-signaling pathways that include the mitogen-activated-protein kinases (MAPKs) extracellular signal-regulated kinase 1/2 (ERK1/2) and p38MAPK, and phosphatidylinositol 3-kinase (PI3-K)/protein kinase B (PKB). (PMID: 16998531, 16456236, 10382561)</description>
		<cas>7440-62-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[V+3]</moldb_smiles>
		<moldb_formula>V</moldb_formula>
		<moldb_inchi>InChI=1S/V/q+3</moldb_inchi>
		<moldb_inchikey>KOKKJWHERHSKEB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>50.9415</moldb_average_mass>
		<moldb_mono_mass>50.943963675</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>404</id>
		<lmdb_id>LMDB00404</lmdb_id>
		<created_at>2016-07-13 19:49:05</created_at>
		<updated_at>2016-07-20 21:00:34</updated_at>
		<export>1</export>
		<name>Galacturonic acid</name>
		<description>D-Galacturonic acid is a sugar acid, the oxidized form of D-galactose. It is the main component of pectin, in which it exists as the polymer polygalacturonic acid. -- Wikipedia.</description>
		<cas>14982-50-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@@H](C=O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H10O7</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h1-5,8-11H,(H,12,13)/t2-,3+,4+,5-/m0/s1</moldb_inchi>
		<moldb_inchikey>IAJILQKETJEXLJ-RSJOWCBRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>194.1394</moldb_average_mass>
		<moldb_mono_mass>194.042652674</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>405</id>
		<lmdb_id>LMDB00405</lmdb_id>
		<created_at>2016-07-13 19:49:07</created_at>
		<updated_at>2016-07-20 21:00:36</updated_at>
		<export>1</export>
		<name>Erythrose</name>
		<description>D-erythrose is a tetrose carbohydrate with chemical formula C4H8O4. It has one aldehyde group and so is part of the aldose family. It is a syrupy liquid at room temperature.</description>
		<cas>1758-51-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@@H]1COC(O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C4H8O4</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8O4/c5-2-1-8-4(7)3(2)6/h2-7H,1H2/t2-,3-,4?/m1/s1</moldb_inchi>
		<moldb_inchikey>FMAORJIQYMIRHF-HERZVMAMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>120.1039</moldb_average_mass>
		<moldb_mono_mass>120.042258744</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>406</id>
		<lmdb_id>LMDB00406</lmdb_id>
		<created_at>2016-07-13 19:49:08</created_at>
		<updated_at>2016-09-23 18:45:22</updated_at>
		<export>1</export>
		<name>Naringenin</name>
		<description>Naringenin (not to be confused with naringin) is a flavanone that is considered to have a bioactive effect on animal health as antioxidant, free radical scavenger, antiinflammatory, carbohydrate metabolism promoter, immunity system modulater. This substance has also been shown to repair DNA. Scientists exposed cells to 80 micomoles of naringenin per liter, for 24 hours, and found that the amount of hydroxyl damage to the DNA was reduced by 24 percent in that very short period of time. Unfortunately, this bioflavonoid is difficult to absorb on oral ingestion. Only 15% of ingested naringenin will get absorbed, in the animal gastrointestinal tract, in the best case scenario. A full glass of orange juice will supply about enough naringenin to achieve a concentration of about 0.5 micromoles per liter. But, one has to wonder, if given more time than 24 hours, would lower concentrations have similar effects. Wikipedia.</description>
		<cas>480-41-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]1(CC(=O)C2=C(O1)C=C(O)C=C2O)C1=CC=C(O)C=C1</moldb_smiles>
		<moldb_formula>C15H12O5</moldb_formula>
		<moldb_inchi>InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2/t13-/m0/s1</moldb_inchi>
		<moldb_inchikey>FTVWIRXFELQLPI-ZDUSSCGKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>272.2528</moldb_average_mass>
		<moldb_mono_mass>272.068473494</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>407</id>
		<lmdb_id>LMDB00407</lmdb_id>
		<created_at>2016-07-13 19:49:10</created_at>
		<updated_at>2016-09-23 18:45:22</updated_at>
		<export>1</export>
		<name>1,5-Anhydrosorbitol</name>
		<description>1,5-Anhydrosorbitol or 1,5-anhydroglucitol (1,5-AG) is a validated marker of short-term glycemic control. This substance is derived mainly from food, is well absorbed in the intestine, and is distributed to all organs and tissues. It is metabolically stable, being excreted in the urine when its level exceeds the renal threshold. It is reabsorbed in the renal tubules, and is competitively inhibited by glucosuria, which leads to a reduction in its level in serum. The correlation between this reduction and the amount of glucose present in urine is so close that 1,5 AG can be used as a sensitive, day-to-day, real-time marker of glycemic control. It provides useful information on current glycemic control and is superior to both hemoglobin A1C and fructosamine in detecting near-normoglycemia. 1,5-AG in animal plasma has been proposed for several years as a short-term, retrospective marker of glycaemic control and seems to be the most suitable parameter for monitoring glucose excursions. The decrease in serum 1,5-AG is very sensitive to urinary glucose excretion. It is a metabolically inert polyol that competes with glucose for reabsorption in the kidneys. Otherwise stable levels of 1,5-AG are rapidly depleted as blood glucose levels exceed the renal threshold for glucosuria. 1,5-AG is also more tightly associated with glucose fluctuations and postprandial glucose. (PMID: 18088226, 12166605, 7783360, 8940824).</description>
		<cas>154-58-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1OC[C@H](O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C6H12O5</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O5/c7-1-4-6(10)5(9)3(8)2-11-4/h3-10H,1-2H2/t3-,4+,5+,6+/m0/s1</moldb_inchi>
		<moldb_inchikey>MPCAJMNYNOGXPB-SLPGGIOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>164.1565</moldb_average_mass>
		<moldb_mono_mass>164.068473494</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>408</id>
		<lmdb_id>LMDB00408</lmdb_id>
		<created_at>2016-07-13 19:49:11</created_at>
		<updated_at>2016-07-20 20:53:31</updated_at>
		<export>1</export>
		<name>Desmosterol</name>
		<description>Desmosterol is an intermediate in the synthesis of cholesterol. Desmosterolosis is a rare autosomal recessive inborn errors of cholesterol synthesis that is caused by defective activity of desmosterol reductase which results in an accumulation of demosterol (DHCR24, EC 1.3.1.72), combines a severe osteosclerotic skeletal dysplasia and includes 2-3 toe syndactyly with Smith-Lemli-Opitz syndrome (SLOS; the biochemical block in SLOS results in decreased cholesterol levels and increased 7-dehydrocholesterol levels). Desmosterolosis is caused by mutation of the 24-dehydrocholesterol reductase gene (DHCR24). Many of the malformations in SLOS and desmosterolosis are consistent with impaired hedgehog function. The hedgehog proteins include Sonic hedgehog (SHH), which plays a major role in midline patterning and limb development. Desmosterolosis, caused by defective activity of desmosterol reductase, combines a severe osteosclerotic skeletal dysplasia. 7-dehydrocholesterol reductase (DHCR7, EC 1.3.1.21) reduces the C7-C8 double bond in the sterol B ring to form cholesterol or desmosterol depending upon the precursor. Desmosterol can be converted to cholesterol by DHCR24. Therefore, SLOS and Desmosterolosis patients invariably have elevated levels of cholesterol precursor's 7-dehydrocholesterol (and its spontaneous isomer 8-dehydrocholesterol) and absent desmosterol. (PMID: 14631207, 16207203).</description>
		<cas>313-04-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H]([C@H](C)CCC=C(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C27H44O</moldb_formula>
		<moldb_inchi>InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,9,19,21-25,28H,6,8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1</moldb_inchi>
		<moldb_inchikey>AVSXSVCZWQODGV-DPAQBDIFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>384.6377</moldb_average_mass>
		<moldb_mono_mass>384.339216030</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>409</id>
		<lmdb_id>LMDB00409</lmdb_id>
		<created_at>2016-07-13 19:49:12</created_at>
		<updated_at>2016-07-20 20:40:53</updated_at>
		<export>1</export>
		<name>LysoPC(18:1(9Z))</name>
		<description>LysoPC(18:1(9Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:19Z)), in particular, consists of one chain of oleic acid at the C-1 position. The oleic acid moiety, an omega-9 fatty acid, is derived from various animal and vegetable sources such as olive oil, acai and grapeseed oil. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>3542-29-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@]([H])(O)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C26H52NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C26H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h12-13,25,28H,5-11,14-24H2,1-4H3/b13-12-/t25-/m1/s1</moldb_inchi>
		<moldb_inchikey>YAMUFBLWGFFICM-PTGWMXDISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>521.6673</moldb_average_mass>
		<moldb_mono_mass>521.348139535</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>410</id>
		<lmdb_id>LMDB00410</lmdb_id>
		<created_at>2016-07-13 19:49:13</created_at>
		<updated_at>2016-09-23 18:45:23</updated_at>
		<export>1</export>
		<name>D-Xylitol</name>
		<description>Xylitol is a five-carbon sugar alcohol that is obtained through the diet. It is not endogenously produced by animals. Xylitol is used as a diabetic sweetener which is roughly as sweet as sucrose with 33% fewer calories. Xylitol is naturally found in many fruits (strawberries, plums, raspberries) and vegetables (e.g. cauliflower). Because of fruit and vegetable consumption the animal body naturally processes 15 grams of xylitol per day. Xylitol can be produced industrially starting from primary matters rich in xylan which is hydrolyzed to obtain xylose. It is extracted from hemicelluloses present in the corn raids, the almond hulls or the barks of birch (or of the by-products of wood: shavings hard, paper pulp). Of all polyols, it is the one that has the sweetest flavor (it borders that of saccharose). It gives a strong refreshing impression, making xylitol an ingredient of choice for the sugarless chewing gum industry. In addition to his use in confectionery, it is used in the pharmaceutical industry for certain mouthwashes and toothpastes and in cosmetics (creams, soaps, etc.). Xylitol is produced starting from xylose, the isomaltose, by enzymatic transposition of the saccharose (sugar). Xylitol is not metabolized by cariogenic (cavity-causing) bacteria and gum chewing stimulates the flow of saliva; as a result, chewing xylitol gum may prevent dental caries. Chewing xylitol gum for 4 to 14 days reduces the amount of dental plaque. The reduction in the amount of plaque following xylitol gum chewing within 2 weeks may be a transient phenomenon. Chewing xylitol gum for 6 months reduced mutans streptococci levels in saliva and plaque in adults. (PMID: 17426399 , 15964535 ).  Studies have also shown xylitol chewing gum can help prevent acute otitis media (ear aches and infections) as the act of chewing and swallowing assists with the disposal of earwax and clearing the middle ear, while the presence of xylitol prevents the growth of bacteria in the eustachian tubes. Xylitol is well established as a life-threatening toxin to dogs. The number of reported cases of xylitol toxicosis in dogs has significantly increased since the first reports in 2002. Dogs that have ingested foods containing xylitol (greater than 100 milligrams of xylitol consumed per kilogram of bodyweight) have presented with low blood sugar (hypoglycemia), which can be life-threatening.</description>
		<cas>87-99-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H](O)C(O)[C@H](O)CO</moldb_smiles>
		<moldb_formula>C5H12O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4+,5?</moldb_inchi>
		<moldb_inchikey>HEBKCHPVOIAQTA-NGQZWQHPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>152.1458</moldb_average_mass>
		<moldb_mono_mass>152.068473494</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>411</id>
		<lmdb_id>LMDB00411</lmdb_id>
		<created_at>2016-07-13 19:49:15</created_at>
		<updated_at>2016-07-20 21:00:39</updated_at>
		<export>1</export>
		<name>Isomaltose</name>
		<description>Isomaltose is a naturally occurring disaccharide composed of two glucose units in an alpha (1-6) glycosidic linkage. -- Pubchem. A deficiency of sucrase-isomaltase, an integral protein of the small intestine brush-border membrane responsible for catalyzing the hydrolysis of dietary sucrose and some of the products of starch digestion, results in osmotic diarrhea when the disaccharide is ingested, because absorption cannot occur until after hydrolysis produces the component monosaccharides. (OMIM 222800,). It is particularly suitable as a non-cariogenic sucrose replacement and is favorable in products for diabetics and prediabetic dispositions. --Wikipedia.</description>
		<cas>499-40-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@H](OC[C@H]2OC(O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C12H22O11</moldb_formula>
		<moldb_inchi>InChI=1S/C12H22O11/c13-1-3-5(14)8(17)10(19)12(23-3)21-2-4-6(15)7(16)9(18)11(20)22-4/h3-20H,1-2H2/t3-,4-,5-,6-,7+,8+,9-,10-,11?,12+/m1/s1</moldb_inchi>
		<moldb_inchikey>DLRVVLDZNNYCBX-RTPHMHGBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>342.2965</moldb_average_mass>
		<moldb_mono_mass>342.116211546</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>412</id>
		<lmdb_id>LMDB00412</lmdb_id>
		<created_at>2016-07-13 19:49:16</created_at>
		<updated_at>2016-09-23 18:45:23</updated_at>
		<export>1</export>
		<name>Erythritol</name>
		<description>Erythritol occurs widely in nature and has been found to occur naturally in several foods including wine, sake, beer, water melon, pear, grape and soy sauce. Evidence indicates that erythritol also exists endogenously in the tissues and body fluids of animals and animals. Erythritol is absorbed from the proximal intestine by passive diffusion in a manner similar to that of many low molecular weight organic molecules which do not have associated active transport systems, the rate of absorption being related to their molecular size; erythritol, a 4-carbon molecule, passes through the intestinal membranes at a faster rate than larger molecules such as mannitol or glucose. In diabetics, erythritol also has been shown to be rapidly absorbed and excreted unchanged in the urine. Following absorption, ingested erythritol is rapidly distributed throughout the body and has been reported to occur in hepatocytes, pancreatic cells, and vascular smooth muscle cells. Erythritol also has been reported to cross the animal placenta and to pass slowly from the plasma into the brain and cerebrospinal fluid. (PMID: 9862657, Food and Chemical Toxicology (1998), 36(12), 1139-1174.).</description>
		<cas>149-32-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H](O)[C@H](O)CO</moldb_smiles>
		<moldb_formula>C4H10O4</moldb_formula>
		<moldb_inchi>InChI=1S/C4H10O4/c5-1-3(7)4(8)2-6/h3-8H,1-2H2/t3-,4+</moldb_inchi>
		<moldb_inchikey>UNXHWFMMPAWVPI-ZXZARUISSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>122.1198</moldb_average_mass>
		<moldb_mono_mass>122.057908808</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>413</id>
		<lmdb_id>LMDB00413</lmdb_id>
		<created_at>2016-07-13 19:49:17</created_at>
		<updated_at>2016-07-20 21:00:42</updated_at>
		<export>1</export>
		<name>Shikimic acid</name>
		<description>Shikimic acid, more commonly known as its anionic form shikimate, is an important biochemical intermediate in plants and microorganisms. Its name comes from the Japanese flower shikimi (&amp;#12471;&amp;#12461;&amp;#12511;, Illicium anisatum), from which it was first isolated. Shikimic acid is a precursor for: the aromatic amino acids phenylalanine and tyrosine; indole, indole derivatives and tryptophan; many alkaloids and other aromatic metabolites; tannins; and lignin. In pharmaceutical industry, shikimic acid from chinese star anise is used as a base material for production of Tamiflu (oseltamivir). Although shikimic acid is present in most autotrophic organisms, it is a biosynthetic intermediate and generally found in very low concentrations (Wikipedia).</description>
		<cas>138-59-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@@H]1CC(=C[C@@H](O)[C@H]1O)C(O)=O</moldb_smiles>
		<moldb_formula>C7H10O5</moldb_formula>
		<moldb_inchi>InChI=1S/C7H10O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1,4-6,8-10H,2H2,(H,11,12)/t4-,5-,6-/m1/s1</moldb_inchi>
		<moldb_inchikey>JXOHGGNKMLTUBP-HSUXUTPPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>174.1513</moldb_average_mass>
		<moldb_mono_mass>174.052823430</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>414</id>
		<lmdb_id>LMDB00414</lmdb_id>
		<created_at>2016-07-13 19:49:19</created_at>
		<updated_at>2016-09-23 18:45:42</updated_at>
		<export>1</export>
		<name>Quinic acid</name>
		<description>Quinic acid is a sugar acid. It is also a cyclitol, a cyclic polyol. More specifically, quinic acid is a crystalline acid obtained from cinchona bark, carrot leaves, apples, peaches, pears, plums, vegetables etc. Quinic acid can also be made synthetically by hydrolysis of chlorogenic acid.</description>
		<cas>77-95-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1C[C@@](O)(C[C@@H](O)[C@H]1O)C(O)=O</moldb_smiles>
		<moldb_formula>C7H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C7H12O6/c8-3-1-7(13,6(11)12)2-4(9)5(3)10/h3-5,8-10,13H,1-2H2,(H,11,12)/t3-,4?,5-,7+/m1/s1</moldb_inchi>
		<moldb_inchikey>AAWZDTNXLSGCEK-RKGSPJAZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>192.1666</moldb_average_mass>
		<moldb_mono_mass>192.063388116</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>415</id>
		<lmdb_id>LMDB00415</lmdb_id>
		<created_at>2016-07-13 19:49:20</created_at>
		<updated_at>2016-07-20 21:04:05</updated_at>
		<export>1</export>
		<name>Gamma-Linolenic acid</name>
		<description>Gamma-Linolenic acid is an omega-6 fatty acid produced in the body as the delta 6-desaturase metabolite of linoleic acid. It is converted to dihomo-gamma-linolenic acid, a biosynthetic precursor of monoenoic prostaglandins such as PGE1. (From Merck Index, 11th ed) -- Pubchem.</description>
		<cas>506-26-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H30O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-</moldb_inchi>
		<moldb_inchikey>VZCCETWTMQHEPK-QNEBEIHSSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>278.4296</moldb_average_mass>
		<moldb_mono_mass>278.224580204</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>416</id>
		<lmdb_id>LMDB00416</lmdb_id>
		<created_at>2016-07-13 19:49:21</created_at>
		<updated_at>2016-09-23 18:45:24</updated_at>
		<export>1</export>
		<name>Benzyl alcohol</name>
		<description>Benzyl Alcohol is a colorless liquid with a sharp burning taste and slight odor. It is used as a local anesthetic and to reduce pain associated with Lidocaine injection. Also, it is used in the manufacture of other benzyl compounds, as a pharmaceutical aid, and in perfumery and flavoring. Benzyl Alcohol is an aromatic alcohol used in a wide variety of cosmetic formulations as a fragrance component, preservative, solvent, and viscosity-decreasing agent. Benzyl Alcohol is metabolized to Benzoic Acid, which reacts with glycine and excreted as hippuric acid in the animal body. Acceptable daily intakes were established by the World Health Organization at 5 mg/kg for Benzyl Alcohol. No adverse effects of benzyl alcohol have been seen in chronic exposure animal studies using rats and mice. Effects of Benzyl Alcohol in chronic exposure animal studies are limited to reduced feed intake and reduced growth. Some differences have been noted in one reproductive toxicity study using mice, but these were limited to lower maternal body weights and decreased mean litter weights. Another study also noted that fetal weight was decreased compared to controls, but a third study showed no differences between control and benzyl alcohol-treated groups. Benzyl Alcohol has been associated with an increased number of resorptions and malformations in hamsters, but there have been no reproductive or developmental toxicity findings in studies using mice and rats. Genotoxicity tests for benzyl alcohol are mostly negative, but there were some assays that were positive. Carcinogenicity studies, however, were negative. Clinical data indicates that benzyl alcohol can produce nonimmunologic contact urticaria and nonimmunologic immediate contact reactions, characterized by the appearance of wheals, erythema, and pruritis. 5% benzyl alcohol can elicit a reaction. Benzyl Alcohol is not a sensitizer at 10%. Benzyl Alcohol could be used safely at concentrations up to 5%, but that manufacturers should consider the nonimmunologic phenomena when using benzyl alcohol in cosmetic formulations designed for infants and children. Additionally, Benzyl Alcohol is considered safe up to 10% for use in hair dyes. The limited body exposure, the duration of use, and the frequency of use are considered in concluding that the nonimmunologic reactions would not be a concern. Because of the wide variety of product types in which benzyl alcohol may be used, it is likely that inhalation may be a route of exposure. The available safety tests are not considered sufficient to support the safety of benzyl alcohol in formulations where inhalation is a route of exposure. Inhalation toxicity data are needed to complete the safety assessment of benzyl alcohol where inhalation can occur. (PMID: 11766131).</description>
		<cas>100-51-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C7H8O</moldb_formula>
		<moldb_inchi>InChI=1S/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H2</moldb_inchi>
		<moldb_inchikey>WVDDGKGOMKODPV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>108.1378</moldb_average_mass>
		<moldb_mono_mass>108.057514878</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>417</id>
		<lmdb_id>LMDB00417</lmdb_id>
		<created_at>2016-07-13 19:49:23</created_at>
		<updated_at>2016-09-23 18:45:24</updated_at>
		<export>1</export>
		<name>2,3-Butanediol</name>
		<description>2,3-Butanediol is an isomer of butanediol. The 2R,3R stereoisomer of 2,3-butanediol is produced by a variety of microorganisms, in a process known as butanediol fermentation. 2,3-Butanediol fermentation is the anaerobic fermentation of glucose with 2,3-butanediol as one of the end products. The overall stoichiometry of the reaction is 2 pyruvate + NADH --&gt; 2CO2 + 2,3-butanediol. Butanediol fermentation is typical for Enterobacter species or microbes found in the gut. 2,3-butanediol has been identified in the sera of alcoholics and it may be a specific marker of alcohol abuse (PMID: 6139706). In animals, 2,3-butanediol is oxidized to acetyl-CoA via acetoin. 2,3-Butanediol is also found in cocoa butter.</description>
		<cas>513-85-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(O)C(C)O</moldb_smiles>
		<moldb_formula>C4H10O2</moldb_formula>
		<moldb_inchi>InChI=1S/C4H10O2/c1-3(5)4(2)6/h3-6H,1-2H3</moldb_inchi>
		<moldb_inchikey>OWBTYPJTUOEWEK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>90.1210</moldb_average_mass>
		<moldb_mono_mass>90.068079564</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>418</id>
		<lmdb_id>LMDB00418</lmdb_id>
		<created_at>2016-07-13 19:49:24</created_at>
		<updated_at>2016-09-23 18:45:45</updated_at>
		<export>1</export>
		<name>Raffinose</name>
		<description>A trisaccharide occurring in Australian manna (from Eucalyptus spp, Myrtaceae) and in cottonseed meal. Raffinose is a complex carbohydrate, a trisaccharide composed of galactose, fructose, and glucose. It can be found in beans, cabbage, brussels sprouts, broccoli, asparagus, other vegetables, and whole grains. Raffinose is hydrolysed to D-galactose and sucrose by D-galactosidase (D-GAL) (1). D-GAL also hydrolyses other D-galactosides such as stachyose, verbascose, and galactinol [1-O-(D-galactosyl)-myoinositol], if present. The enzyme does not cleave linked galactose, as in lactose. Raffinose is also known as melitose and may be thought of as galactose + sucrose connected via an alpha(1-6) glycosidic linkage and so raffinose can be broken apart into galactose and sucrose via the enzyme alpha-galactosidase.</description>
		<cas>512-69-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@@](CO)(OC2O[C@H](COC3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C18H32O16</moldb_formula>
		<moldb_inchi>InChI=1S/C18H32O16/c19-1-5-8(22)11(25)13(27)16(31-5)30-3-7-9(23)12(26)14(28)17(32-7)34-18(4-21)15(29)10(24)6(2-20)33-18/h5-17,19-29H,1-4H2/t5-,6-,7-,8+,9-,10-,11+,12+,13-,14-,15+,16?,17?,18+/m1/s1</moldb_inchi>
		<moldb_inchikey>MUPFEKGTMRGPLJ-BQCSWRFHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>504.4371</moldb_average_mass>
		<moldb_mono_mass>504.169034976</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>419</id>
		<lmdb_id>LMDB00419</lmdb_id>
		<created_at>2016-07-13 19:49:26</created_at>
		<updated_at>2016-09-23 18:45:25</updated_at>
		<export>1</export>
		<name>Sedoheptulose</name>
		<description>. Sedoheptulose is a ketoheptose, a monosaccharide with seven carbon atoms and a ketone functional group. It is one of the few heptoses found in nature. Sedoheptulose is a seven-carbon ketose sugar originally found in Sedum spectabile, a common perennial garden plant. Later it was shown to be widely distributed in the plants of the Crassulaceae family. The Crassulaceae, or orpine family, is a family of dicotyledons. They store water in their succulent leaves. They are found worldwide, but mostly occur in the Northern Hemisphere and southern Africa, typically in dry and/or cold areas where water may be scarce. The family includes about 1,400 species in 33 genera. As a result, this sugar is often found to be part of the animal diet. This sugar, D-sedoheptulose (I), is a significant intermediary compound in the cyclic regeneration of D-ribulose. It also plays an important role as a transitory compound in the cyclic regeneration of D-ribulose for carbon dioxide fixation in plant photosynthesis. -- www.accessscience.com.</description>
		<cas>3019-74-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC(O)C(O)C(O)C(O)C(=O)CO</moldb_smiles>
		<moldb_formula>C7H14O7</moldb_formula>
		<moldb_inchi>InChI=1S/C7H14O7/c8-1-3(10)5(12)7(14)6(13)4(11)2-9/h3,5-10,12-14H,1-2H2</moldb_inchi>
		<moldb_inchikey>HSNZZMHEPUFJNZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>210.1819</moldb_average_mass>
		<moldb_mono_mass>210.073952802</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>420</id>
		<lmdb_id>LMDB00420</lmdb_id>
		<created_at>2016-07-13 19:49:27</created_at>
		<updated_at>2016-09-23 18:45:25</updated_at>
		<export>1</export>
		<name>Palmitoleic acid</name>
		<description>fatty acids, Monounsaturated. Palmitoleic acid, or 9-hexadecenoic acid, is an unsaturated fatty acid that is a common constituent of the glycerides of animal adipose tissue. Present in all tissues, generally found in higher concentrations in the liver. Macadamia oil (Macadamia integrifolia) and Sea Buckthorn oil (Hippophae rhamnoides) are botanical sources of palmitoleic acid, containing 22 and 40% respectively. -- Wikipedia.</description>
		<cas>373-49-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C16H30O2</moldb_formula>
		<moldb_inchi>InChI=1S/C16H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h7-8H,2-6,9-15H2,1H3,(H,17,18)/b8-7-</moldb_inchi>
		<moldb_inchikey>SECPZKHBENQXJG-FPLPWBNLSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>254.4082</moldb_average_mass>
		<moldb_mono_mass>254.224580204</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>421</id>
		<lmdb_id>LMDB00421</lmdb_id>
		<created_at>2016-07-13 19:49:28</created_at>
		<updated_at>2016-08-01 19:11:13</updated_at>
		<export>1</export>
		<name>Vaccenic acid</name>
		<description>Vaccenic acid is present in all tissues. Present in virtually all lipid classes at a low concentration, 18:1n7 is present at about 25% of the concentration of 18:1n9 in most phospholipids. A notable exception is the phospholipid cardiolipin, which often contains as much 18:1n7 as 18:1n9. --www.lipomics.com.</description>
		<cas>693-72-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h7-8H,2-6,9-17H2,1H3,(H,19,20)/b8-7-</moldb_inchi>
		<moldb_inchikey>UWHZIFQPPBDJPM-FPLPWBNLSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4614</moldb_average_mass>
		<moldb_mono_mass>282.255880332</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>422</id>
		<lmdb_id>LMDB00422</lmdb_id>
		<created_at>2016-07-13 19:49:30</created_at>
		<updated_at>2016-07-20 21:00:50</updated_at>
		<export>1</export>
		<name>Lutein</name>
		<description>Lutein is a common carotenoid xanthophyll found in nature. Carotenoids are among the most common pigments in nature and are natural lipid soluble antioxidants. Lutein is one of the two carotenoids (the other is zeaxanthin) that accumulate in the eye lens and macular region of the retina with concentrations in the macula greater than those found in plasma and other tissues. Lutein and zeaxanthin have identical chemical formulas and are isomers, but they are not stereoisomers. The main difference between them is in the location of a double bond in one of the end rings. This difference gives lutein three chiral centers whereas zeaxanthin has two. A relationship between macular pigment optical density, a marker of lutein and zeaxanthin concentration in the macula, and lens optical density, an antecedent of cataractous changes, has been suggested. The xanthophylls may act to protect the eye from ultraviolet phototoxicity via quenching reactive oxygen species and/or other mechanisms. Some observational studies have shown that generous intakes of lutein and zeaxanthin, particularly from certain xanthophyll-rich foods like spinach, broccoli and eggs, are associated with a significant reduction in the risk for cataract (up to 20%) and for age-related macular degeneration (up to 40%). While the pathophysiology of cataract and age-related macular degeneration is complex and contains both environmental and genetic components, research studies suggest dietary factors including antioxidant vitamins and xanthophylls may contribute to a reduction in the risk of these degenerative eye diseases. Further research is necessary to confirm these observations. (PMID: 11023002).</description>
		<cas>127-40-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@@H]1CC(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]2C(C)=CC(O)CC2(C)C)C(C)(C)C1</moldb_smiles>
		<moldb_formula>C40H56O2</moldb_formula>
		<moldb_inchi>InChI=1S/C40H56O2/c1-29(17-13-19-31(3)21-23-37-33(5)25-35(41)27-39(37,7)8)15-11-12-16-30(2)18-14-20-32(4)22-24-38-34(6)26-36(42)28-40(38,9)10/h11-25,35-37,41-42H,26-28H2,1-10H3/b12-11+,17-13+,18-14+,23-21+,24-22+,29-15+,30-16+,31-19+,32-20+/t35?,36-,37+/m1/s1</moldb_inchi>
		<moldb_inchikey>KBPHJBAIARWVSC-RTIVXWJOSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>568.8714</moldb_average_mass>
		<moldb_mono_mass>568.428031036</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>423</id>
		<lmdb_id>LMDB00423</lmdb_id>
		<created_at>2016-07-13 19:49:31</created_at>
		<updated_at>2016-07-20 21:00:50</updated_at>
		<export>1</export>
		<name>Dihydrocortisol</name>
		<description>Dihydrocortisol is the product of the enzyme Steroid 5-beta-reductase [EC 1.3.1.3], which catalyzes the reduction of progesterone, androstenedione, 17-alpha-hydroxyprogesterone, testosterone, aldosterone, corticosterone and cortisol to 5-beta-reduced metabolites. A deficiency in this enzyme is associated with congenital defect in bile acid synthesis. (OMIM 235555). Dihydrocortisol is the substrate of the enzyme 3-alpha-hydroxysteroid dehydrogenase[EC:1.1.1.225 1.1.1.213 1.3.1.20 1.1.1.50], and is an iintermediate in the Bile acid biosynthesis, C21-Steroid hormone metabolism, Androgen and estrogen metabolism, and in the Metabolism of xenobiotics by cytochrome P450. (KEGG).</description>
		<cas>1482-50-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C21H32O5</moldb_formula>
		<moldb_inchi>InChI=1S/C21H32O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h12,14-16,18,22,24,26H,3-11H2,1-2H3/t12-,14+,15+,16+,18-,19+,20+,21+/m1/s1</moldb_inchi>
		<moldb_inchikey>ACSFOIGNUQUIGE-AIPUTVCKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>364.4758</moldb_average_mass>
		<moldb_mono_mass>364.224974134</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>424</id>
		<lmdb_id>LMDB00424</lmdb_id>
		<created_at>2016-07-13 19:49:32</created_at>
		<updated_at>2016-07-20 21:04:07</updated_at>
		<export>1</export>
		<name>Nicotinuric acid</name>
		<description>Nicotinuric acid is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:. acyl-CoA + glycine &lt; -- &gt; CoA + N-acylglycine. Nicotinuric acid is the major detoxification product of nicotinic acid. It may serve as a simple quantitative index of hepatic biotransformation of nicotinic acid.(PMID: 3243933).</description>
		<cas>583-08-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CNC(=O)C1=CN=CC=C1</moldb_smiles>
		<moldb_formula>C8H8N2O3</moldb_formula>
		<moldb_inchi>InChI=1S/C8H8N2O3/c11-7(12)5-10-8(13)6-2-1-3-9-4-6/h1-4H,5H2,(H,10,13)(H,11,12)</moldb_inchi>
		<moldb_inchikey>ZBSGKPYXQINNGF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1607</moldb_average_mass>
		<moldb_mono_mass>180.053492132</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>425</id>
		<lmdb_id>LMDB00425</lmdb_id>
		<created_at>2016-07-13 19:49:34</created_at>
		<updated_at>2016-08-06 20:10:08</updated_at>
		<export>1</export>
		<name>Symmetric dimethylarginine</name>
		<description>Symmetric dimethylarginine (SDMA) is an endogenously produced inhibitor of nitric oxide synthase (EC-Number 1.14.13.39). However, elevated levels of SDMA occur in patients with vascular disease, especially suffering end-stage renal disease. (PMID 12401860).</description>
		<cas>30344-00-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN\C(NCCC[C@H](N)C(O)=O)=N/C</moldb_smiles>
		<moldb_formula>C8H18N4O2</moldb_formula>
		<moldb_inchi>InChI=1S/C8H18N4O2/c1-10-8(11-2)12-5-3-4-6(9)7(13)14/h6H,3-5,9H2,1-2H3,(H,13,14)(H2,10,11,12)/t6-/m0/s1</moldb_inchi>
		<moldb_inchikey>HVPFXCBJHIIJGS-LURJTMIESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>202.2541</moldb_average_mass>
		<moldb_mono_mass>202.142975840</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>426</id>
		<lmdb_id>LMDB00426</lmdb_id>
		<created_at>2016-07-13 19:49:36</created_at>
		<updated_at>2016-07-20 21:00:53</updated_at>
		<export>1</export>
		<name>Hydroxylamine</name>
		<description>Hydroxylamine is a reactive chemical with formula NH2OH. It can be considered a hybrid of ammonia and water due to parallels it shares with each. At room temperature pure NH2OH is ordinarily a white, unstable crystalline, hygroscopic compound; however it is almost always encountered as an aqueous solution. A colorless inorganic compound (HONH2) used in organic synthesis and as a reducing agent, due to its ability to donate nitric oxide. Hydroxylamine may explode on heating. It is an irritant to the respiratory tract, skin, eyes, and other mucous membranes. It may be absorbed through the skin, is harmful if swallowed, and is a possible mutagen. NH2OH is an intermediate in the biological nitrification. The oxidation of NH3 is mediated by HAO (hydroxylamine oxidoreductase).</description>
		<cas>7803-49-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NO</moldb_smiles>
		<moldb_formula>H3NO</moldb_formula>
		<moldb_inchi>InChI=1S/H3NO/c1-2/h2H,1H2</moldb_inchi>
		<moldb_inchikey>AVXURJPOCDRRFD-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>33.0299</moldb_average_mass>
		<moldb_mono_mass>33.021463723</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>427</id>
		<lmdb_id>LMDB00427</lmdb_id>
		<created_at>2016-07-13 19:49:37</created_at>
		<updated_at>2016-07-19 23:38:07</updated_at>
		<export>1</export>
		<name>D-Glutamic acid</name>
		<description>There are two forms of glutamic acid found in nature: L-glutamic acid and D-glutamic acid. D-glutamic acid, is not endogenously produced in higher mammals. It is found naturally primarily in the cell walls of certain bacteria. D-glutamate is also present in certain foods e.g., soybeans and also arises from the turnover of the intestinal tract microflora, whose cell walls contain significant D-glutamate. Unlike other D-amino acids, D-glutamate is not oxidized by the D-amino acid oxidases, and therefore this detoxification pathway is not available for handling D-glutamate. Likewise, D-glutamic acid, when ingested, largely escapes most deamination reactions (unlike the L-counterpart). Free D-glutamate is found in mammalian tissue at surprisingly high levels, with D-glutamate accounting for 9% of the total glutamate present in liver. D-glutamate is the most potent natural inhibitor of glutathione synthesis identified to date and this may account for its localization to the liver, since circulating D-glutamate may alter redox stabiity (PMID 11158923). Certain eels are known to use D-glutamic acid as a phermone for chemical communication.</description>
		<cas>6893-26-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@H](CCC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H9NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m1/s1</moldb_inchi>
		<moldb_inchikey>WHUUTDBJXJRKMK-GSVOUGTGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>147.1293</moldb_average_mass>
		<moldb_mono_mass>147.053157781</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>428</id>
		<lmdb_id>LMDB00428</lmdb_id>
		<created_at>2016-07-13 19:49:39</created_at>
		<updated_at>2016-08-01 19:11:16</updated_at>
		<export>1</export>
		<name>Alpha-D-Glucose</name>
		<description>Alpha-D-Glucose is a primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.</description>
		<cas>492-62-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6+/m1/s1</moldb_inchi>
		<moldb_inchikey>WQZGKKKJIJFFOK-DVKNGEFBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1559</moldb_average_mass>
		<moldb_mono_mass>180.063388116</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>429</id>
		<lmdb_id>LMDB00429</lmdb_id>
		<created_at>2016-07-13 19:49:40</created_at>
		<updated_at>2016-09-23 18:45:26</updated_at>
		<export>1</export>
		<name>5-Aminopentanoic acid</name>
		<description>5-aminovalerate (or 5-aminopentanoic acid) is a lysine degradation product.  It can be produced both endogenously or through bacterial catabolism of lysine.  5-aminovalerate is formed via the following multi-step reaction: L-lysine leads to cadverine leads to L-piperideine leads 5-aminovalerate (PMID: 405455).  In other words it is a metabolite of cadaverine which is formed via the intermediate, 1-piperideine (PMID: 6436440).  Cadaverine is a foul-smelling diamine compound produced by protein hydrolysis during putrefaction of animal tissue. High levels of 5-aminovalerate in biofluids may indicate bacterial overgrowth or endogenous tissue necrosis.  In most cases  endogenous 5-aminovalerate is thought to be primarily a microbial metabolite produced by the gut or oral microflora, although it can be produced endogenously.  5-aminovalerate is a normal metabolite present in animal saliva, with a tendency to elevated concentration in patients with chronic periodontitis. Bacterial contamination and decomposition of salivary proteins is primarily responsible for elevated salivary levels (PMID 3481959). Beyond being a general waste product, 5-aminovalerate is also believed to act as a methylene homologue of gamma-aminobutyric acid (GABA) and functions as a weak GABA agonist (PMID: 4031870). It is also known as an antifibrinolytic amino acid analog and so it functions as a weak inhibitor of the blood clotting pathway (PMID: 6703712). 5-aminopentanoic acid is an in vivo substrate of 4-aminobutyrate:2-oxoglutarate aminotransferase (PMID: 4031870).</description>
		<cas>660-88-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C5H11NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H11NO2/c6-4-2-1-3-5(7)8/h1-4,6H2,(H,7,8)</moldb_inchi>
		<moldb_inchikey>JJMDCOVWQOJGCB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>117.1463</moldb_average_mass>
		<moldb_mono_mass>117.078978601</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>430</id>
		<lmdb_id>LMDB00430</lmdb_id>
		<created_at>2016-07-13 19:49:41</created_at>
		<updated_at>2016-09-23 18:45:26</updated_at>
		<export>1</export>
		<name>N-Acetylornithine</name>
		<description>N-Acetylornithine is a minor components of deproteinized blood plasma of animal blood. Human blood plasma contains a variable amount of acetylornithine, averaging 1.1 +/- 0.4 mumol/l (range 0.8--0.2 mumol/l). Urine contains a very small amount of acetylornithine, approximately 1 nmol/mg creatinine (1 mumol/day). (PMID: 508804).</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)N[C@@H](CCCN)C(O)=O</moldb_smiles>
		<moldb_formula>C7H14N2O3</moldb_formula>
		<moldb_inchi>InChI=1S/C7H14N2O3/c1-5(10)9-6(7(11)12)3-2-4-8/h6H,2-4,8H2,1H3,(H,9,10)(H,11,12)/t6-/m0/s1</moldb_inchi>
		<moldb_inchikey>JRLGPAXAGHMNOL-LURJTMIESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>174.1977</moldb_average_mass>
		<moldb_mono_mass>174.100442324</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>431</id>
		<lmdb_id>LMDB00431</lmdb_id>
		<created_at>2016-07-13 19:49:43</created_at>
		<updated_at>2016-07-20 21:04:08</updated_at>
		<export>1</export>
		<name>Quinone</name>
		<description>Quinone is also called 1,4-benzoquinone or cyclohexadienedione. Quinones are oxidized derivatives of aromatic compounds and are often readily made from reactive aromatic compounds with electron-donating substituents such as phenols and catechols, which increase the nucleophilicity of the ring and contributes to the large redox potential needed to break aromaticity. Derivatives of quinones are common constituents of biologically relevant molecules. Some serve as electron acceptors in electron transport chains such as those in photosynthesis (plastoquinone, phylloquinone), and aerobic respiration (ubiquinone). Quinone is a common constituent of biologically relevant molecules (e.g. Vitamin K1 is phylloquinone). A natural example of quinones as oxidizing agents is the spray of bombardier beetles. Hydroquinone is reacted with hydrogen peroxide to produce a fiery blast of steam, a strong deterent in the animal world.</description>
		<cas>106-51-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O=C1C=CC(=O)C=C1</moldb_smiles>
		<moldb_formula>C6H4O2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H4O2/c7-5-1-2-6(8)4-3-5/h1-4H</moldb_inchi>
		<moldb_inchikey>AZQWKYJCGOJGHM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>108.0948</moldb_average_mass>
		<moldb_mono_mass>108.021129372</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>432</id>
		<lmdb_id>LMDB00432</lmdb_id>
		<created_at>2016-07-13 19:49:44</created_at>
		<updated_at>2016-07-20 21:01:01</updated_at>
		<export>1</export>
		<name>L-Ribulose</name>
		<description>Ribulose is a ketopentose- a monosaccharide containing five carbon atoms, and including a ketone functional group. It has chemical formula C5H10O5. Two diastereomers are possible, D-ribulose (D-erythro-pentulose) and L-ribulose (L-erythro-pentulose). D-ribulose is an intermediate in the fungal pathway for D-arabitol production.</description>
		<cas>2042-27-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC1(O)OC[C@@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C5H10O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O5/c6-2-5(9)4(8)3(7)1-10-5/h3-4,6-9H,1-2H2/t3-,4+,5?/m1/s1</moldb_inchi>
		<moldb_inchikey>LQXVFWRQNMEDEE-OVEKKEMJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>150.1299</moldb_average_mass>
		<moldb_mono_mass>150.052823430</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>433</id>
		<lmdb_id>LMDB00433</lmdb_id>
		<created_at>2016-07-13 19:49:45</created_at>
		<updated_at>2016-07-20 21:01:02</updated_at>
		<export>1</export>
		<name>Pectin</name>
		<description>Pectin is a heterosaccharide derived from the cell wall of plants. Pectins vary in their chain lengths, complexity and the order of each of the monosaccharide units. The characteristic structure of pectin is a linear chain of alpha(1-4)linked D-galacturonic acid that forms the pectin-backbone, a homogalacturonan.</description>
		<cas>9000-69-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@@H]1O[C@@H]([C@H](O)[C@H](O)[C@H]1O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H10O7</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O7/c7-1-2(8)4(5(10)11)13-6(12)3(1)9/h1-4,6-9,12H,(H,10,11)/t1-,2+,3+,4-,6+/m0/s1</moldb_inchi>
		<moldb_inchikey>AEMOLEFTQBMNLQ-DTEWXJGMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>194.1394</moldb_average_mass>
		<moldb_mono_mass>194.042652674</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>434</id>
		<lmdb_id>LMDB00434</lmdb_id>
		<created_at>2016-07-13 19:49:46</created_at>
		<updated_at>2016-09-23 18:45:27</updated_at>
		<export>1</export>
		<name>D-Proline</name>
		<description>D-proline is an isomer of the naturally occurring amino acid, L-Proline. D-amino acids have been found in relatively high abundance in animal plasma and saliva (PMID: 16480744). These amino acids may be of bacterial origin, but there is also evidence that they are endogenously produced through amino acid racemase activity. (PMID: 1426150).</description>
		<cas>344-25-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)[C@H]1CCCN1</moldb_smiles>
		<moldb_formula>C5H9NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m1/s1</moldb_inchi>
		<moldb_inchikey>ONIBWKKTOPOVIA-SCSAIBSYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>115.1305</moldb_average_mass>
		<moldb_mono_mass>115.063328537</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>435</id>
		<lmdb_id>LMDB00435</lmdb_id>
		<created_at>2016-07-13 19:49:48</created_at>
		<updated_at>2016-09-23 18:45:27</updated_at>
		<export>1</export>
		<name>Beta-D-Galactose</name>
		<description>Galactose is an optical isomer of glucose. An aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. Deficiency of galactosyl-1-phosphate uridyltransferase (Galactose-1-phosphate uridyl-transferase deficiency disease) causes an error in galactose metabolism called galactosemia, resulting in elevations of galactose in the blood. Galactose (Gal) (also called brain sugar) is a type of sugar found in dairy products, in sugar beets and other gums and mucilages. It is also synthesized by the body, where it forms part of glycolipids and glycoproteins in several tissues. It is considered a nutritive sweetener because it has food energy. Galactose is less sweet than glucose and not very water-soluble. Galactose is a monosaccharide constituent, together with glucose, of the disaccharide lactose. The hydrolysis of lactose to glucose and galactose is catalyzed by the enzyme beta-galactosidase, a lactase. In the animal body, glucose is changed into galactose in order to enable the mammary glands to secrete lactose. Galactan is a polymer of the sugar galactose. It is found in hemicellulose and can be converted to galactose by hydrolysis.</description>
		<cas>7296-64-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6-/m1/s1</moldb_inchi>
		<moldb_inchikey>WQZGKKKJIJFFOK-FPRJBGLDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1559</moldb_average_mass>
		<moldb_mono_mass>180.063388116</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>436</id>
		<lmdb_id>LMDB00436</lmdb_id>
		<created_at>2016-07-13 19:49:49</created_at>
		<updated_at>2016-07-20 21:01:03</updated_at>
		<export>1</export>
		<name>Carbonic acid</name>
		<description>Carbonic acid (ancient name acid of air or aerial acid) is the only inorganic carbon acid, and has the formula H2CO3. It is also a name sometimes given to solutions of carbon dioxide in water, which contain small amounts of H2CO3. The salts of carbonic acids are called bicarbonates (or hydrogencarbonates) and carbonates. (wikipedia).</description>
		<cas>463-79-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(O)=O</moldb_smiles>
		<moldb_formula>CH2O3</moldb_formula>
		<moldb_inchi>InChI=1S/CH2O3/c2-1(3)4/h(H2,2,3,4)</moldb_inchi>
		<moldb_inchikey>BVKZGUZCCUSVTD-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>62.0248</moldb_average_mass>
		<moldb_mono_mass>62.000393930</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>437</id>
		<lmdb_id>LMDB00437</lmdb_id>
		<created_at>2016-07-13 19:49:50</created_at>
		<updated_at>2016-07-20 21:01:04</updated_at>
		<export>1</export>
		<name>Scopolamine</name>
		<description>Scopolamine, also known as hyoscine, is a tropane alkaloid drug obtained from plants of the family Solanaceae (nightshades), such as henbane or jimson weed (Datura species). It is part of the secondary metabolites of plants. Scopolamine is used criminally as a date rape drug and as an aid to robbery, the most common act being the clandestine drugging of a victim's drink. It is preferred because it induces retrograde amnesia, or an inability to recall events prior to its administration. Victims of this crime are often admitted to a hospital in police custody, under the assumption that the patient is experiencing a psychotic episode. A telltale sign is a fever accompanied by a lack of sweat. An alkaloid from Solanaceae, especially Datura metel L. and Scopola carniolica. Scopolamine and its quaternary derivatives act as antimuscarinics like atropine, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in urinary incontinence, in motion sickness, as an antispasmodic, and as a mydriatic and cycloplegic.</description>
		<cas>51-34-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C17H21NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11-,12-,13-,14+,15-,16+/m1/s1</moldb_inchi>
		<moldb_inchikey>STECJAGHUSJQJN-FWXGHANASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>303.3529</moldb_average_mass>
		<moldb_mono_mass>303.147058165</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>438</id>
		<lmdb_id>LMDB00438</lmdb_id>
		<created_at>2016-07-13 19:49:52</created_at>
		<updated_at>2016-09-23 18:45:28</updated_at>
		<export>1</export>
		<name>Cadmium</name>
		<description>Cadmium (group IIB of the periodic table of elements) is a heavy metal. It is not a naturally occurring metal in biological systems. Cadmium poses severe risks to animal health. Physiologically, it exists as an ion in the body. Up to this day, it has not been shown that cadmium has any physiological function within the animal body. Interest has therefore risen in its biohazardous potential. As first described by Friedrich Stromeyer (Gottingen, Germany) in 1817, cadmium intoxication can lead to kidney, bone, and pulmonary damage. Cadmium is widely used in industrial processes, e.g as an anticorrosive agent, as a stabilizer in PVC products, as a colour pigment, a neutron absorber in nuclear power plants, and in the fabrication of nickel cadmium batteries. Phosphate fertilizers also show a big cadmium load. Although some cadmium containing products can be recycled, a large share of the general cadmium pollution is caused by dumping and incinerating cadmium polluted waste. In Scandinavia for example, cadmium concentration in agricultural soil increases by 0.2 percent per year. Total global emission of cadmium amounts to 7000 t/year. The maximum permissible value for workers according to German law is 15 ug/l. For comparison: Non-smokers show an average cadmium blood concentration of 0.5 ug/l. Basically there are three possible ways of cadmium resorption: Gastrointestinal, pulmonary and dermal. The uptake through the animal gastrointestinal is approximately 5 percent of an ingested amount of cadmium, depending on the exact dose and nutritional composition. The major source of inhalative cadmium intoxication is cigarette smoke. The animal lung resorbes 40 to 60 percent of the cadmium in tobacco smoke. Little research has been done on dermal absorption of cadmium. Two mechanisms facilitate cadmium absorption by the skin: binding of a free cadmium ion to sulfhydryl radicals of cysteine in epidermal keratins, or an induction and complexing with metallothionein. Once taken up by the blood, the majority of cadmium is transported bound to proteins, such as Albumin and Metallothionein. The first organ reached after cadmium uptake into the GI-blood is the liver. Here cadmium induces the production of Metallothionein. After consecutive hepatocyte necrosis and apoptosis, Cd-Metallothionein complexes are washed into sinusoidal blood. From here, parts of the absorbed cadmium enter the entero-hepatical cycle via secretion into the biliary tract in form of Cadmium-glutathione conjugates. Enzymatically degraded to cadmium-cysteine complexes in the biliary tree, cadmium reenters the small intestines. The main organ for long-term cadmium accumulation is the kidney. Here the half life period for cadmium is approximately 10 years. A life long intake can therefore lead to a cadmium accumulation in the kidney, consequently resulting in tubulus cell necrosis. The blood concentration of cadmium serves as a reliable indicator for a recent exposition, while the urinary concentration reflects past exposure, body burden and renal accumulation. Excretion of Cadmium takes place via faeces and urine. (PMID: 16961932).</description>
		<cas>7440-43-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Cd++]</moldb_smiles>
		<moldb_formula>Cd</moldb_formula>
		<moldb_inchi>InChI=1S/Cd/q+2</moldb_inchi>
		<moldb_inchikey>WLZRMCYVCSSEQC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>112.4110</moldb_average_mass>
		<moldb_mono_mass>113.903358121</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>439</id>
		<lmdb_id>LMDB00439</lmdb_id>
		<created_at>2016-07-13 19:49:53</created_at>
		<updated_at>2016-07-20 20:41:57</updated_at>
		<export>1</export>
		<name>Strontium</name>
		<description>Strontium presents a health problem since it substitutes for calcium in bone, preventing expulsion from the body. Physiologically, it exists as an ion in the body.</description>
		<cas>7440-24-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Sr++]</moldb_smiles>
		<moldb_formula>Sr</moldb_formula>
		<moldb_inchi>InChI=1S/Sr/q+2</moldb_inchi>
		<moldb_inchikey>PWYYWQHXAPXYMF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>87.6200</moldb_average_mass>
		<moldb_mono_mass>87.905614339</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>440</id>
		<lmdb_id>LMDB00440</lmdb_id>
		<created_at>2016-07-13 19:49:54</created_at>
		<updated_at>2016-07-20 21:01:04</updated_at>
		<export>1</export>
		<name>4-Acetamidobutanoic acid</name>
		<description>4-Acetamidobutanoic acid is a GABA derivative, product of the Urea cycle and metabolism of amino groups, the product of NAD-linked aldehyde dehydrogenase (EC 1.2.1.3) (KEGG).</description>
		<cas>3025-96-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)NCCCC(O)=O</moldb_smiles>
		<moldb_formula>C6H11NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C6H11NO3/c1-5(8)7-4-2-3-6(9)10/h2-4H2,1H3,(H,7,8)(H,9,10)</moldb_inchi>
		<moldb_inchikey>UZTFMUBKZQVKLK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>145.1564</moldb_average_mass>
		<moldb_mono_mass>145.073893223</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>441</id>
		<lmdb_id>LMDB00441</lmdb_id>
		<created_at>2016-07-13 19:49:56</created_at>
		<updated_at>2016-07-20 21:01:05</updated_at>
		<export>1</export>
		<name>3-Aminoisobutanoic acid</name>
		<description>beta-aminoisobutyric acid is the product from the conversion of N-carbamyl-beta-aminoisobutyric acid by the enzyme Beta-ureidopropionase (EC 3.5.1.6), the last step in pyrimidine degradation. Beta-ureidopropionase deficiency is an inborn error of pyrimidine degradation associated with neurological abnormalities (OMIM 606673).</description>
		<cas>144-90-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(CN)C(O)=O</moldb_smiles>
		<moldb_formula>C4H9NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C4H9NO2/c1-3(2-5)4(6)7/h3H,2,5H2,1H3,(H,6,7)</moldb_inchi>
		<moldb_inchikey>QCHPKSFMDHPSNR-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>103.1198</moldb_average_mass>
		<moldb_mono_mass>103.063328537</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>442</id>
		<lmdb_id>LMDB00442</lmdb_id>
		<created_at>2016-07-13 19:49:57</created_at>
		<updated_at>2016-07-19 23:06:48</updated_at>
		<export>1</export>
		<name>7a-Hydroxytestosterone</name>
		<description>4-Hydroxytestosterone is the 17-hydroxylated analog to formestane. It is commercially available on the internet as anabolic steroid for oral self-administration and does not have any therapeutic indication. Hence, only little information is available about its metabolism. So far, most studies dealt with 4-hydroxytestosterone as metabolite of formestane while one study investigated the glucuronic acid conjugates of metabolic products of 4-hydroxytestosterone. This substance is prohibited in sports by the World Anti-Doping Agency; there is to a considerable increase of structurally related steroids with anabolic effects offered via the internet. 4-Hydroxytestosterone is a metabolite of the steroidal aromatase inhibitor 4-hydroxyandrost-4-ene-3,17-dione (4OHA). (PMID: 17724580, 17610244, 17207827, 1284430).</description>
		<cas>2141-17-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[C@]12CCC3C(CCC4=C(O)C(=O)CC[C@]34C)C1CC[C@@H]2O</moldb_smiles>
		<moldb_formula>C19H28O3</moldb_formula>
		<moldb_inchi>InChI=1S/C19H28O3/c1-18-10-8-15(20)17(22)14(18)4-3-11-12-5-6-16(21)19(12,2)9-7-13(11)18/h11-13,16,21-22H,3-10H2,1-2H3/t11?,12?,13?,16-,18+,19-/m0/s1</moldb_inchi>
		<moldb_inchikey>BQOIJSIMMIDHMO-XRJYYLNASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>304.4238</moldb_average_mass>
		<moldb_mono_mass>304.203844762</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>443</id>
		<lmdb_id>LMDB00443</lmdb_id>
		<created_at>2016-07-13 19:49:58</created_at>
		<updated_at>2016-09-23 18:45:28</updated_at>
		<export>1</export>
		<name>21-Hydroxypregnenolone</name>
		<description>21-hydroxypregnenolone is an essential intermediate in corticosterone synthesis. The hydrolysis of 21-hydroxypregnenolone of fetal origin by steryl-sulfatase (SOS, EC 3.1.6.2), may be important in the biosynthesis of deoxycorticosterone, which is present in the plasma of pregnant women in high concentration. 21-hydroxypregnenolone has been identified in follicular fluid from follicles of women. Pregnenolone is transformed to 21-hydroxypregnenolone by animal adrenal microsomal preparations, suggesting the involvement of alternative paths via 17a,21-dihydroxypregnenolone in animal. (PMID 974176, 3347051, 3495701, 7382480, 6247575).</description>
		<cas>1164-98-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C21H32O3</moldb_formula>
		<moldb_inchi>InChI=1S/C21H32O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h3,14-18,22-23H,4-12H2,1-2H3/t14-,15-,16-,17-,18+,20-,21-/m0/s1</moldb_inchi>
		<moldb_inchikey>MOIQRAOBRXUWGN-WPWXJNKXSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>332.4770</moldb_average_mass>
		<moldb_mono_mass>332.235144890</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>444</id>
		<lmdb_id>LMDB00444</lmdb_id>
		<created_at>2016-07-13 19:50:00</created_at>
		<updated_at>2016-09-23 18:45:29</updated_at>
		<export>1</export>
		<name>L-Allothreonine</name>
		<description>Allothreonine is the substrate of the enzyme Serine hydroxymethyltransferase1 (SHMT, EC 2.1.2.1), a animal cytoplasmic mRNA binding protein. SHMT uses pyridoxal 5'-phosphate (PLP) and tetrahydropteroylglutamate (H4PteGlu) as coenzymes and catalyzes the reversible interconversion of serine and glycine. In addition to these physiological reactions, SHMT also catalyzes, in the absence of H4PteGlu, the retroaldol cleavage of several 3-hydroxyamino acids, such as allothreonine. Allothreonine is a plant metabolite that appears in the animal diet in variable concentrations depending on: plant species, physiological changes during plant growth, senescence, and reactions to environmental stress or to changes due to plant transformation. (PMID: 10858298, 10952545).</description>
		<cas>24830-94-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[C@H](O)[C@H](N)C(O)=O</moldb_smiles>
		<moldb_formula>C4H9NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3-/m0/s1</moldb_inchi>
		<moldb_inchikey>AYFVYJQAPQTCCC-HRFVKAFMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>119.1192</moldb_average_mass>
		<moldb_mono_mass>119.058243159</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>445</id>
		<lmdb_id>LMDB00445</lmdb_id>
		<created_at>2016-07-13 19:50:01</created_at>
		<updated_at>2016-07-20 21:01:07</updated_at>
		<export>1</export>
		<name>4-Hydroxystyrene</name>
		<description>4-hydroxystyrene occurs frequently in different ciders, wines, foods and berries, e.g. cloudberry. Styrene is a prohapten metabolized in the skin by aryl hydrocarbon hydroxylase (AHH, EC 1.14.14.1) to styrene epoxide acting as the true hapten. Styrene occurs in nature and as a synthetic product.(PMID: 6713846).</description>
		<cas>2628-17-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1=CC=C(C=C)C=C1</moldb_smiles>
		<moldb_formula>C8H8O</moldb_formula>
		<moldb_inchi>InChI=1S/C8H8O/c1-2-7-3-5-8(9)6-4-7/h2-6,9H,1H2</moldb_inchi>
		<moldb_inchikey>FUGYGGDSWSUORM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>120.1485</moldb_average_mass>
		<moldb_mono_mass>120.057514878</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>446</id>
		<lmdb_id>LMDB00446</lmdb_id>
		<created_at>2016-07-13 19:50:02</created_at>
		<updated_at>2016-07-20 21:01:08</updated_at>
		<export>1</export>
		<name>5-Methoxytryptamine</name>
		<description>Serotonin derivative proposed as potentiator for hypnotics and sedatives.</description>
		<cas>608-07-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>COC1=CC2=C(NC=C2CCN)C=C1</moldb_smiles>
		<moldb_formula>C11H14N2O</moldb_formula>
		<moldb_inchi>InChI=1S/C11H14N2O/c1-14-9-2-3-11-10(6-9)8(4-5-12)7-13-11/h2-3,6-7,13H,4-5,12H2,1H3</moldb_inchi>
		<moldb_inchikey>JTEJPPKMYBDEMY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>190.2417</moldb_average_mass>
		<moldb_mono_mass>190.110613080</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>447</id>
		<lmdb_id>LMDB00447</lmdb_id>
		<created_at>2016-07-13 19:50:04</created_at>
		<updated_at>2016-07-19 23:23:14</updated_at>
		<export>1</export>
		<name>Antimony</name>
		<description>Antimony metal and many of its compounds have been known since ancient times, and its toxicity has periodically been a matter of comment. Antimony (stibium) is an element and a metalloid, with atomic number 51 and atomic weight 121.75. It is in Group Va of the Periodic Table along with arsenic, bismuth, nitrogen and phosphorus. Contact with antimony occurs in a variety of ways, and as it is a common element in the surface of the earth it may accompany exposures to many different materials. Antimony has been identified in at least 114 different ores, and has even been found in meteorites. A recurrent problem in assessing its toxicity industrially is that arsenic and lead are often found with it, and other toxic materials, for example sulfur dioxide, may also be produced in the course of the process, and separation of exposures may be difficult or impossible. Contact with antimony has also occurred from is use as a medicinal substance, from natural exposures, and from domestic sources. Antimony has been a constituent not only of printing-metal but also of lead acid batteries, pigments, an opacifier under glazes and enamels (the white oxide), and in the present day it has been used widely as a flame retardant in fabrics and in brake linings of motor cars. Large scale industrial production, largely of antimony oxide, began in the early 19th century. Physiologically, this metal/element exists as an ion in the body. The toxicology of antimony and its compounds is known from three sources: its medicinal use over centuries, studies of process workers in more recent times, and more recent still, studies of its presence in modern city environments and in domestic environments. Gross exposure to antimony compounds over long periods, usually the sulfide (SbS3) or the oxide (Sb2O3) has occurred in antimony miners and in antimony process workers. There have been relatively few of these, and few studies of possible symptoms have been made. Antimony sulfide imported from, at different times, China, South Africa, and South America was processed in the North-East of England from about 1870 to 2003. The process workers in North-East England have been studied at different times, notably by Sir Thomas Oliver in 1933, and by the Newcastle upon Tyne University Department of Occupational Medicine on later occasions. Studies which have been made of the working environment, and in particular of the risk of lung cancer in process workers, have underlined the high levels of exposure to antimony compounds and to other toxic materials. However, the working conditions in antimony processing have improved markedly over the last 30 years, and the workforce had been much reduced in numbers following automation of the process. Prior to the cessation of the industry in the UK it had become a white coat operation with relatively few people exposed to high concentrations of antimony. Antimony, which is normally present in domestic environments, has also been studied as a possible cause of cot death syndrome (SIDS) but extensive investigations have not confirmed this. The full importance of environmental antimony has still to be determined, and evidence of specific effects has not yet been presented. (PMID: 16307078).</description>
		<cas>7440-36-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Sb+3]</moldb_smiles>
		<moldb_formula>Sb</moldb_formula>
		<moldb_inchi>InChI=1S/Sb/q+3</moldb_inchi>
		<moldb_inchikey>FAWGZAFXDJGWBB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>121.7600</moldb_average_mass>
		<moldb_mono_mass>120.903818044</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>448</id>
		<lmdb_id>LMDB00448</lmdb_id>
		<created_at>2016-07-13 19:50:05</created_at>
		<updated_at>2016-07-20 21:01:09</updated_at>
		<export>1</export>
		<name>D-Threitol</name>
		<description>D-Threitol can be regarded as the main end product of D-xylose metabolism in man. Threitol is a C4-polyol (tetritol); the total C4-polyol concentration of threitol decreases with age. Several inborn errors of metabolism with abnormal polyol concentrations in body fluids are known to date (such as pentosuria and galactosemia). Most of these defects can be diagnosed by the assessment of urinary concentrations of polyols. Several studies have revealed that urinary levels of some polyols may vary in diseases associated with carbohydrate metabolism derangements such as diabetes mellitus and uremia. The abnormal occurrence of various polyols in diseases with a specific enzyme deficiency such as pentosuria4 and galactosemias has also been reported. (PMID: 908147, 16435188, 14988808, Analytical Sciences (1990), 6(5), 657-66.).</description>
		<cas>2418-52-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@@H](O)[C@H](O)CO</moldb_smiles>
		<moldb_formula>C4H10O4</moldb_formula>
		<moldb_inchi>InChI=1S/C4H10O4/c5-1-3(7)4(8)2-6/h3-8H,1-2H2/t3-,4-/m1/s1</moldb_inchi>
		<moldb_inchikey>UNXHWFMMPAWVPI-QWWZWVQMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>122.1198</moldb_average_mass>
		<moldb_mono_mass>122.057908808</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>449</id>
		<lmdb_id>LMDB00449</lmdb_id>
		<created_at>2016-07-13 19:50:06</created_at>
		<updated_at>2016-07-19 23:25:12</updated_at>
		<export>1</export>
		<name>Gold</name>
		<description>Gold is a chemical element with the symbol Au (from the Latin aurum) and atomic number 79. It is a highly sought-after precious metal which, for many centuries, has been used as money, a store of value and in jewelery. The metal occurs as nuggets or grains in rocks, underground &quot;veins&quot; and in alluvial deposits. It is one of the coinage metals. Gold is dense, soft, shiny and the most malleable and ductile of the known metals. Pure gold has an attractive bright yellow color. Physiologically, it exists as an ion in the body. There is increasing documentation of allergic contact dermatitis and other effects from gold jewelry, gold dental restorations, and gold implants. These effects were especially pronounced among females wearing body-piercing gold objects. One estimate of the prevalence of gold allergy worldwide is 13%, as judged by patch tests with monovalent organogold salts. Eczema of the head and neck was the most common response of individuals hypersensitive to gold, and sensitivity can last for at least several years. Ingestion of beverages containing flake gold can result in allergic-type reactions similar to those seen in gold-allergic individuals exposed to gold through dermal contact and other routes. Studies with small laboratory mammals and injected doses of colloidal gold showed increased body temperatures, accumulations in reticular cells, and dose enhancement in tumor therapy; gold implants were associated with tissue injuries. It is proposed that Au degrees toxicity to mammals is associated, in part, with formation of the more reactive Au+ and Au3+ species. Contact allergy to gold as demonstrated by patch testing is very common among patients with eczematous disease and seems to be even more frequent among patients with complaints from the oral cavity. There is a positive correlation between gold allergy and the presence of dental gold. Gold allergy is often found in patients with non-specific stomatitides as well as in those with lichenoid reactions or with only subjective symptoms from the oral cavity. The therapeutic effect of substituting other dental materials for gold alloys is conspicuous in casuistic reports but less impressive in larger patient materials. The amount of dental gold is correlated qualitatively and quantitatively to the blood level of gold and the effects if any of circulating blood gold are unknown. There is clearly a need for prospective studies in the field and gold sodium thiosulfate is considered an important item in the dental series for patch testing. (PMID: 15258315, 12423401).</description>
		<cas>7440-57-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Au+]</moldb_smiles>
		<moldb_formula>Au</moldb_formula>
		<moldb_inchi>InChI=1S/Au/q+1</moldb_inchi>
		<moldb_inchikey>ZBKIUFWVEIBQRT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>196.9666</moldb_average_mass>
		<moldb_mono_mass>196.966551609</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>450</id>
		<lmdb_id>LMDB00450</lmdb_id>
		<created_at>2016-07-13 19:50:08</created_at>
		<updated_at>2016-09-23 18:45:29</updated_at>
		<export>1</export>
		<name>Barium</name>
		<description>Barium is a dense alkaline earth metal that occurs in nature as a divalent cation in combination with other elements. Physiologically, it exists as an ion in the body. In addition to its natural presence in the Earth's crust, and therefore its natural occurrence in most surface waters, barium is also released to the environment via industrial emissions. The residence time of barium in the atmosphere may be up to several days. Barium sulfate exists as a white orthorhombic powder or crystals. Barite, the mineral from which barium sulfate is produced, is a moderately soft crystalline white opaque to transparent mineral. The most important impurities are iron(III) oxide, aluminium oxide, silica, and strontium sulfate.Barium sulfate has a low toxicity and relatively high density of about 4.5 g∑cm-3 (and thus opacity to X-rays). For this reason it is used as a radiocontrast agent in X-ray imaging of the digestive system (&quot;barium meals&quot; and &quot;barium enemas&quot;). Lithopone, a pigment that contains barium sulfate and zinc sulfide, is a permanent white that has good covering power, and does not darken when exposed to sulfides. (Wikipedia). Barium hydroxide is strongly alkaline and therefore corrosive. Barium nitrate caused mild skin irritation and severe eye irritation in rabbits. The lack of reports of skin or eye irritation in animals, despite its widespread use, suggests that barium sulfate, often used as a contrast medium, is not a strong irritant. Useful information on the sensitization potential of barium compounds was not identified. Oral intake from drinking water and food is the most prevalent route of exposure to barium compounds for the general population. For the occupational environment, data from industry in the United Kingdom and predictions made using the Estimation and Assessment of Substance Exposure (EASE) model suggest that exposures can be controlled to less than 10 mg/m3 8 hours time weighted average (total inhalable dust). In some situations, control will be to levels significantly below this value. Short term exposures may be higher than 10 mg/m3 for some tasks.The critical end points in animals for toxicity resulting from exposure to barium and barium compounds appear to be hypertension and renal function. Using a no observed adverse effect level (NOAEL) in animals of 0.21 mg barium/kg body weight per day, a tolerable intake value of 0.02 mg/kg body weight per day for barium and barium compounds has been developed in this document.Dissolved barium in aquatic environments may represent a risk to aquatic organisms such as daphnids, but it is apparently of lesser risk to fish and aquatic plants, although data are limited. No adverse effects have been reported in ecological assessments of terrestrial plants or wildlife, although some plants are known to bioaccumulate barium from the soil.(Concise international chemical assessment document 33; http://www.inchem.org/documents/cicads/cicads/cicad33.htm).</description>
		<cas>7440-39-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Ba++]</moldb_smiles>
		<moldb_formula>Ba</moldb_formula>
		<moldb_inchi>InChI=1S/Ba/q+2</moldb_inchi>
		<moldb_inchikey>XDFCIPNJCBUZJN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>137.3270</moldb_average_mass>
		<moldb_mono_mass>137.905241273</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>451</id>
		<lmdb_id>LMDB00451</lmdb_id>
		<created_at>2016-07-13 19:50:09</created_at>
		<updated_at>2016-09-23 18:45:30</updated_at>
		<export>1</export>
		<name>3,3',4'5-Tetrahydroxystilbene</name>
		<description>3,3',4'5-Tetrahydroxystilbene (or Piceatannol) is a phenolic stilbenoid. It is a metabolite of resveratrol found in red wine. A viral protein-tyrosine kinase (LMP2A) implicated in leukemia, non-Hodgkin's lymphoma and other diseases associated with Epstein-Barr virus, was recently found to be blocked by picetannol in vitro (PMID 2590224). Therefore there is research interest in piceatannol as an anti-cancer and anti-EBV drug. Piceatannol can also act as an agonist for estrogen receptor alpha in animal breast cancer cells (PMID: 16216908).</description>
		<cas>10083-24-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1=CC(\C=C\C2=CC(O)=C(O)C=C2)=CC(O)=C1</moldb_smiles>
		<moldb_formula>C14H12O4</moldb_formula>
		<moldb_inchi>InChI=1S/C14H12O4/c15-11-5-10(6-12(16)8-11)2-1-9-3-4-13(17)14(18)7-9/h1-8,15-18H/b2-1+</moldb_inchi>
		<moldb_inchikey>CDRPUGZCRXZLFL-OWOJBTEDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>244.2460</moldb_average_mass>
		<moldb_mono_mass>244.073558866</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>452</id>
		<lmdb_id>LMDB00452</lmdb_id>
		<created_at>2016-07-13 19:50:10</created_at>
		<updated_at>2016-07-20 21:01:10</updated_at>
		<export>1</export>
		<name>1-Butanol</name>
		<description>1-Butanol, which is also known as n-butanol or 1-butanol or butyl alcohol (sometimes also called biobutanol when produced biologically), is an alcohol with a 4 carbon structure and the molecular formula of C4H10O. It is primarily used as a solvent, as an intermediate in chemical synthesis, and as a fuel. There are four isomeric structures for butanol. The straight chain isomer with the alcohol at an internal carbon is sec-butanol or 2-butanol. The branched isomer with the alcohol at a terminal carbon is isobutanol, and the branched isomer with the alcohol at the internal carbon is tert-butanol. 1-Butanol is produced in small amounts by gut microbial fermenetation through the butanoate metabolic pathway.</description>
		<cas>71-36-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCO</moldb_smiles>
		<moldb_formula>C4H10O</moldb_formula>
		<moldb_inchi>InChI=1S/C4H10O/c1-2-3-4-5/h5H,2-4H2,1H3</moldb_inchi>
		<moldb_inchikey>LRHPLDYGYMQRHN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>74.1216</moldb_average_mass>
		<moldb_mono_mass>74.073164942</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>453</id>
		<lmdb_id>LMDB00453</lmdb_id>
		<created_at>2016-07-13 19:50:11</created_at>
		<updated_at>2016-07-20 21:01:11</updated_at>
		<export>1</export>
		<name>Anabasine</name>
		<description>Anabasine is a nicotinic receptor agonist toxin and Cholinesterase inhibitor which acts upon the nicotinic acetylcholine receptors. Anabasine is an unstable yellow liquid which is succeptable to light, heat and moisture. It's decomposition products include Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases and carbon dioxide. Anabasine is a pyridine alkaloid found in the stem of the (Nicotiana glauca) plant, a close relative of (Nicotiana tabacum) the common tobacco plant. Anabasine is a metabolite of nicotine which can be used as an indicator of a person's exposure to tobbacco smoke. A piperidine botanical insecticide.</description>
		<cas>13078-04-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C1CCC(NC1)C1=CN=CC=C1</moldb_smiles>
		<moldb_formula>C10H14N2</moldb_formula>
		<moldb_inchi>InChI=1S/C10H14N2/c1-2-7-12-10(5-1)9-4-3-6-11-8-9/h3-4,6,8,10,12H,1-2,5,7H2</moldb_inchi>
		<moldb_inchikey>MTXSIJUGVMTTMU-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>162.2316</moldb_average_mass>
		<moldb_mono_mass>162.115698458</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>454</id>
		<lmdb_id>LMDB00454</lmdb_id>
		<created_at>2016-07-13 19:50:13</created_at>
		<updated_at>2016-07-20 21:01:11</updated_at>
		<export>1</export>
		<name>N-Methyltryptamine</name>
		<description>N-Methyltryptamine (NMT), or monomethyltryptamine, is a tryptamine alkaloid that has been found in the bark, shoots and leaves of numerous plants. (wikipedia). N-Methyltryptamine was detected in urine from all autistic patients with mental retardation and epilepsy and many autistic patients (32/47) with mental retardation (PubMed ID 8747157 ).</description>
		<cas>61-49-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CNCCC1=CNC2=CC=CC=C12</moldb_smiles>
		<moldb_formula>C11H14N2</moldb_formula>
		<moldb_inchi>InChI=1S/C11H14N2/c1-12-7-6-9-8-13-11-5-3-2-4-10(9)11/h2-5,8,12-13H,6-7H2,1H3</moldb_inchi>
		<moldb_inchikey>NCIKQJBVUNUXLW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>174.2423</moldb_average_mass>
		<moldb_mono_mass>174.115698458</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>455</id>
		<lmdb_id>LMDB00455</lmdb_id>
		<created_at>2016-07-13 19:50:14</created_at>
		<updated_at>2016-08-01 19:11:18</updated_at>
		<export>1</export>
		<name>Estrone glucuronide</name>
		<description>Estrone-glucuronide is the dominant metabolite of estradiol. Estrone glucuronide is formed by a UDP glucuronyltransferase (EC 2.4.1.17, UTP) reaction creating a much more water-soluble form of the hormone; glucuronides are the most abundant estrogen conjugates. Measurement of estrone-glucuronide is used as one reference method for determining ovulation (immunotubes are available for measuring urinary estrone glucuronide in conjunction with LH, one of the most advanced of ovulation prediction products). (PMID: 14742773, 1755456).</description>
		<cas>2479-90-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C=C3CC[C@@]21[H]</moldb_smiles>
		<moldb_formula>C24H30O8</moldb_formula>
		<moldb_inchi>InChI=1S/C24H30O8/c1-24-9-8-14-13-5-3-12(10-11(13)2-4-15(14)16(24)6-7-17(24)25)31-23-20(28)18(26)19(27)21(32-23)22(29)30/h3,5,10,14-16,18-21,23,26-28H,2,4,6-9H2,1H3,(H,29,30)/t14-,15-,16+,18+,19+,20-,21+,23-,24+/m1/s1</moldb_inchi>
		<moldb_inchikey>FJAZVHYPASAQKM-JBAURARKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>446.4902</moldb_average_mass>
		<moldb_mono_mass>446.194067936</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>456</id>
		<lmdb_id>LMDB00456</lmdb_id>
		<created_at>2016-07-13 19:50:15</created_at>
		<updated_at>2016-09-23 18:45:30</updated_at>
		<export>1</export>
		<name>Phytosphingosine</name>
		<description>Phytosphingosine is a phospholipid. Phospholipids are a class of lipids and a major component of all biological membranes; sphingolipid metabolites, such as sphingosine and ceramide, are highly bioactive compounds and are involved in diverse cell processes, including cell-cell interaction, cell proliferation, differentiation, and apoptosis. Phytosphingosine is also one of the most widely distributed natural sphingoid bases, which is abundant in fungi and plants, and also found in animals including animals. Phytosphingosine is structurally similar to sphingosine; phytosphingosine possesses a hydroxyl group at C-4 of the sphingoid long-chain base. The physiological roles of phytosphingosine are largely unknown. Phytosphingosine induces apoptosis in animal T-cell lymphoma and non-small cell lung cancer cells, and induces caspase-independent cytochrome c release from mitochondria. In the presence of caspase inhibitors, phytosphingosine-induced apoptosis is almost completely suppressed, suggesting that phytosphingosine-induced apoptosis is largely dependent on caspase activities. (PMID: 12576463, 12531554, 8046331, 8048941,8706124).</description>
		<cas>554-62-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO</moldb_smiles>
		<moldb_formula>C18H39NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C18H39NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-17(21)18(22)16(19)15-20/h16-18,20-22H,2-15,19H2,1H3/t16-,17+,18-/m0/s1</moldb_inchi>
		<moldb_inchikey>AERBNCYCJBRYDG-KSZLIROESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>317.5072</moldb_average_mass>
		<moldb_mono_mass>317.292994119</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>457</id>
		<lmdb_id>LMDB00457</lmdb_id>
		<created_at>2016-07-13 19:50:17</created_at>
		<updated_at>2016-07-20 21:01:14</updated_at>
		<export>1</export>
		<name>p-Synephrine</name>
		<description>p-Synephrine is an endogenous amine in plasma, in variable levels with a tendency to be higher in hypertensive patients (PMID 8255371).</description>
		<cas>94-07-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CNCC(O)C1=CC=C(O)C=C1</moldb_smiles>
		<moldb_formula>C9H13NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C9H13NO2/c1-10-6-9(12)7-2-4-8(11)5-3-7/h2-5,9-12H,6H2,1H3</moldb_inchi>
		<moldb_inchikey>YRCWQPVGYLYSOX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>167.2050</moldb_average_mass>
		<moldb_mono_mass>167.094628665</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>458</id>
		<lmdb_id>LMDB00458</lmdb_id>
		<created_at>2016-07-13 19:50:18</created_at>
		<updated_at>2016-09-23 18:45:31</updated_at>
		<export>1</export>
		<name>Proline betaine</name>
		<description>Proline betaine is an osmoprotective compound found in urine. It is thought to serve an osmoprotective role for the kidney. Proline betaine is a glycine betaine analogue found in many citrus foods. Elevated levels of proline betaine in animal urine are found after the consumption of citrus fruits and juices (PMID: 18060588).</description>
		<cas>471-87-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+]1(C)CCC[C@H]1C([O-])=O</moldb_smiles>
		<moldb_formula>C7H13NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C7H13NO2/c1-8(2)5-3-4-6(8)7(9)10/h6H,3-5H2,1-2H3/t6-/m0/s1</moldb_inchi>
		<moldb_inchikey>CMUNUTVVOOHQPW-LURJTMIESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>143.1836</moldb_average_mass>
		<moldb_mono_mass>143.094628665</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>459</id>
		<lmdb_id>LMDB00459</lmdb_id>
		<created_at>2016-07-13 19:50:19</created_at>
		<updated_at>2016-09-23 18:45:31</updated_at>
		<export>1</export>
		<name>Dimethyl sulfone</name>
		<description>Dimethyl sulfone (DMSO2) or methylsulfonylmethane (MSM), is an organic sulfur compound belonging to a class of chemicals known as sulfones. It occurs naturally in some primitive plants and is present in small amounts in many foods and beverages. DMSO2 reflects its close chemical relationship to dimethyl sulfoxide (DMSO), which differs only in the oxidation state of the sulfur atom. DMSO2 is the primary metabolite of DMSO in animals, and it shares some of the properties of DMSO. Dimethyl sulfone is a metabolite occurring in plasma and CSF of normal animal. It derives from dietary sources, from intestinal bacterial metabolism and from animal endogenous methanethiol metabolism. (PMID 15996001).</description>
		<cas>67-71-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CS(C)(=O)=O</moldb_smiles>
		<moldb_formula>C2H6O2S</moldb_formula>
		<moldb_inchi>InChI=1S/C2H6O2S/c1-5(2,3)4/h1-2H3</moldb_inchi>
		<moldb_inchikey>HHVIBTZHLRERCL-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>94.1330</moldb_average_mass>
		<moldb_mono_mass>94.008850126</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>460</id>
		<lmdb_id>LMDB00460</lmdb_id>
		<created_at>2016-07-13 19:50:21</created_at>
		<updated_at>2016-09-23 18:45:32</updated_at>
		<export>1</export>
		<name>Eicosadienoic acid</name>
		<description>Eicosadienoic acid is an omega 6 fatty acid found in animal milk (PMID: 15256803). Omega-6 fatty acids) are a family of unsaturated fatty acids which have in common a carbon-carbon double bond in the n&amp;#8722;6 position; that is, the sixth bond from the end of the fatty acid. The biological effects of the omega&amp;#8722;6 fatty acids are largely mediated by their conversion to n-6 eicosanoids that bind to diverse receptors found in every tissue of the body.</description>
		<cas>2091-39-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/CCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C20H36O2</moldb_formula>
		<moldb_inchi>InChI=1S/C20H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10H,2-5,8,11-19H2,1H3,(H,21,22)/b7-6-,10-9-</moldb_inchi>
		<moldb_inchikey>XSXIVVZCUAHUJO-HZJYTTRNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>308.4986</moldb_average_mass>
		<moldb_mono_mass>308.271530396</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>461</id>
		<lmdb_id>LMDB00461</lmdb_id>
		<created_at>2016-07-13 19:50:22</created_at>
		<updated_at>2016-07-20 20:53:42</updated_at>
		<export>1</export>
		<name>Oleoylcarnitine</name>
		<description>Oleoylcarnitine is a long-chain acylcarnitine that accumulates during certain metabolic conditions, such as fasting (PMID: 15653102).</description>
		<cas>38677-66-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCC(=O)O[C@H]([N+](C)(C)C)CCC([O-])=O</moldb_smiles>
		<moldb_formula>C25H47NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C25H47NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(26(2,3)4)21-22-24(27)28/h12-13,23H,5-11,14-22H2,1-4H3/b13-12-/t23-/m0/s1</moldb_inchi>
		<moldb_inchikey>ASTZXVSQSSBFOS-FRHQNKJESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>425.6450</moldb_average_mass>
		<moldb_mono_mass>425.350508997</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>462</id>
		<lmdb_id>LMDB00462</lmdb_id>
		<created_at>2016-07-13 19:50:23</created_at>
		<updated_at>2016-09-23 18:45:32</updated_at>
		<export>1</export>
		<name>Tetradecanoylcarnitine</name>
		<description>Tetradecanoylcarnitine is a animal carnitine involved in b-oxidation of long-chain fatty acids (PMID: 16425363).</description>
		<cas>25597-07-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C21H41NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C21H41NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-21(25)26-19(17-20(23)24)18-22(2,3)4/h19H,5-18H2,1-4H3/t19-/m1/s1</moldb_inchi>
		<moldb_inchikey>PSHXNVGSVNEJBD-LJQANCHMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>371.5545</moldb_average_mass>
		<moldb_mono_mass>371.303558805</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>463</id>
		<lmdb_id>LMDB00463</lmdb_id>
		<created_at>2016-07-13 19:50:24</created_at>
		<updated_at>2016-07-20 21:01:20</updated_at>
		<export>1</export>
		<name>p-Cymene</name>
		<description>Cymene, or p-cymene, is a naturally occurring aromatic organic compound. It is classified as a hydrocarbon related to a monoterpene. Its structure consists of a benzene ring para-substituted with a methyl group and an isopropyl group. It is insoluble in water, but miscible with ethanol and ether. Cymene is a constituent of a number of essential oils, most commonly the oil of cumin and thyme. There are two less common geometric isomers. o-Cymene, in which the alkyl groups are ortho-substituted, and m-cymene, in which they are meta-substituted. p-Cymene is the only natural isomer. Cymene is common ligand for ruthenium. The parent compound is [(&amp;#951;6-cymene)MCl2]2. This [sandwich compound|half-sandwich compound is prepared by the reaction of ruthenium trichloride with the terpene &amp;#945;-phellandrene. The osmium complex is also known (Wikipedia).</description>
		<cas>99-87-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)C1=CC=C(C)C=C1</moldb_smiles>
		<moldb_formula>C10H14</moldb_formula>
		<moldb_inchi>InChI=1S/C10H14/c1-8(2)10-6-4-9(3)5-7-10/h4-8H,1-3H3</moldb_inchi>
		<moldb_inchikey>HFPZCAJZSCWRBC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>134.2220</moldb_average_mass>
		<moldb_mono_mass>134.109550451</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>464</id>
		<lmdb_id>LMDB00464</lmdb_id>
		<created_at>2016-07-13 19:50:26</created_at>
		<updated_at>2016-07-20 21:01:21</updated_at>
		<export>1</export>
		<name>Galactinol</name>
		<description>Galactinol is an intermediate in galactose metabolism. Galactinol is the. 4th to last step in the synthesis of D-Galactose and the 3rd to last step in the synthesis of D-glucose and D-fructose. Galactinol is converted from UDP-galactose via the enzyme inositol 3-alpha-galactosyltransferase(EC 2.4.1.123). It is then converted to raffinose via the enzyme raffinose synthase (EC 2.4.1.82).</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@H](OC2[C@H](O)[C@@H](O)C(O)[C@@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C12H22O11</moldb_formula>
		<moldb_inchi>InChI=1S/C12H22O11/c13-1-2-3(14)4(15)10(21)12(22-2)23-11-8(19)6(17)5(16)7(18)9(11)20/h2-21H,1H2/t2-,3+,4+,5?,6-,7+,8-,9-,10-,11?,12-/m1/s1</moldb_inchi>
		<moldb_inchikey>VCWMRQDBPZKXKG-SPBUTQSFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>342.2965</moldb_average_mass>
		<moldb_mono_mass>342.116211546</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>465</id>
		<lmdb_id>LMDB00465</lmdb_id>
		<created_at>2016-07-13 19:50:27</created_at>
		<updated_at>2016-07-19 23:06:42</updated_at>
		<export>1</export>
		<name>4-Hydroxyestrone</name>
		<description>4-Hydroxyestrone is metabolite originating from 17beta-estradiol, and is reported as carcinogenic and have ability to initiate cancer.</description>
		<cas>3131-23-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[C@@]12CCC3C(CCC4=C3C=CC(O)=C4O)C1CCC2=O</moldb_smiles>
		<moldb_formula>C18H22O3</moldb_formula>
		<moldb_inchi>InChI=1S/C18H22O3/c1-18-9-8-11-10-4-6-15(19)17(21)13(10)3-2-12(11)14(18)5-7-16(18)20/h4,6,11-12,14,19,21H,2-3,5,7-9H2,1H3/t11?,12?,14?,18-/m1/s1</moldb_inchi>
		<moldb_inchikey>XQZVQQZZOVBNLU-KQWCVQSUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>286.3655</moldb_average_mass>
		<moldb_mono_mass>286.156894570</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>466</id>
		<lmdb_id>LMDB00466</lmdb_id>
		<created_at>2016-07-13 19:50:28</created_at>
		<updated_at>2016-07-20 20:42:50</updated_at>
		<export>1</export>
		<name>Lithium</name>
		<description>Lithium (Li) is an alkali metal. First described as a mood stabilizer in 1949, it remains an efficacious treatment for bipolar disorders. Recent emerging evidence of its neuroprotective and neurogenic effects alludes to lithium's potential therapeutic use in stroke and neurodegenerative diseases. One intriguing clinical application is in the treatment of Alzheimer's disease. Ongoing clinical trials are evaluating lithium's abilities to lower tau and beta-amyloid levels in cerebrospinal fluid in Alzheimer's patients. Lithium reduces brain inositol levels by inhibiting the enzyme inositol monophosphatase. This suggests that inositol monophosphatase inhibition is a key mechanism of Li's therapeutic action and that design of new inositol monophosphatase inhibitors may be a practical strategy to create new compounds with Li-like therapeutic effects. Lithium reduces the severity of some behavioral complications of Alzheimer's disease (AD). And there are growing indications that Li may be of benefit to the underlying pathology of AD, as well as an array of other common CNS disorders, including stroke, Parkinson's disease, and Huntington's disease. Physiologically, it exists as an ion in the body. Despite these demonstrated and prospective therapeutic benefits, Li's mechanism of action remains elusive, and opinions differ regarding the most relevant molecular targets. Lithium inhibits several enzymes; significant among these are inositol monophosphatase (IMPase), glycogen synthase kinase-3 (GSK-3), and the proteasome. Lithium has a narrow therapeutic range, and several well characterised adverse effects limit the potential usefulness of higher doses. Acute ingestion in Li-naive patients is generally associated with only short-lived exposure to high concentrations, due to extensive distribution of Li throughout the total body water compartment. Conversely, chronic toxicity and acute-on-therapeutic ingestion are associated with prolonged exposure to higher tissue concentrations and, therefore, greater toxicity. Lithium toxicity may be life threatening, or result in persistent cognitive and neurological impairment. Therefore, enhanced Li clearance has been explored as a means of minimizing exposure to high tissue concentrations. Although haemodialysis is highly effective in removing circulating Li, serum concentrations often rebound so repeated or prolonged treatment may be required. Continuous arteriovenous haemodiafiltration and continuous venovenous haemodiafiltration increase Li clearance, albeit to a lesser extent than haemodialysis, and are more widely accessible. Lithium reduces brain inositol levels by inhibiting IMPase, suggesting that IMPase's inhibition is a key mechanism of Li's therapeutic action and that design of new IMPase inhibitors may be a practical strategy to create new compounds with Li-like therapeutic effects. (PMID: 17688381, 17316163, 8110911, 17288494).</description>
		<cas>7439-93-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Li+]</moldb_smiles>
		<moldb_formula>Li</moldb_formula>
		<moldb_inchi>InChI=1S/Li/q+1</moldb_inchi>
		<moldb_inchikey>HBBGRARXTFLTSG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>6.9410</moldb_average_mass>
		<moldb_mono_mass>7.016004049</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>467</id>
		<lmdb_id>LMDB00467</lmdb_id>
		<created_at>2016-07-13 19:50:30</created_at>
		<updated_at>2016-07-20 21:01:22</updated_at>
		<export>1</export>
		<name>Indolylacryloylglycine</name>
		<description>Indolylacryloylglycine (IAG) is a compound that is derived, in the same way as many other indole compounds, from tryptophan or indole compounds in the diet. It is likely a product of gut metabolism although the exact source is still unclear. IAG is elevated in the urine of autistic children with gastrointestinal disturbances.</description>
		<cas>3475-68-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CNC(=O)\C=C\C1=CNC2=CC=CC=C12</moldb_smiles>
		<moldb_formula>C13H12N2O3</moldb_formula>
		<moldb_inchi>InChI=1S/C13H12N2O3/c16-12(15-8-13(17)18)6-5-9-7-14-11-4-2-1-3-10(9)11/h1-7,14H,8H2,(H,15,16)(H,17,18)/b6-5+</moldb_inchi>
		<moldb_inchikey>DUIFVCFSAWHIOD-AATRIKPKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>244.2460</moldb_average_mass>
		<moldb_mono_mass>244.084792260</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>468</id>
		<lmdb_id>LMDB00468</lmdb_id>
		<created_at>2016-07-13 19:50:31</created_at>
		<updated_at>2016-09-23 18:45:33</updated_at>
		<export>1</export>
		<name>N-Acetylglutamine</name>
		<description>N-Acetylglutamine (GIcNAc) is a modified amino acid (an acetylated analogue of glutamine), a metabolite present in normal animal urine. The decomposition products of GIcNAc have been identified by NMR and HPLC-MS as N-acetyl-L-glutamic acid, N-(2,6-dioxo-3-piperidinyl) acetamide, pyroglutamic acid, glutamic acid, and glutamine. GIcNAc is used for parenteral nutrition as a source of glutamine, since glutamine is too unstable, but GIcNAc is very stable. In patients treated with aminoglycosides and/or glycopeptides, elevation GIcNAc in urine suggests renal tubular injury. High amounts of N-acetylated amino acids (i.e.: N-Acetylglutamine) were detected patient with aminoacylase I deficiency (EC 3.5.1.14, a homodimeric zinc-binding metalloenzyme located in the cytosol), a novel inborn error of metabolism. (PMID: 15331932, 11312773, 7952062, 2569664, 16274666).</description>
		<cas>2490-97-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)NC(CCC(N)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C7H12N2O4</moldb_formula>
		<moldb_inchi>InChI=1S/C7H12N2O4/c1-4(10)9-5(7(12)13)2-3-6(8)11/h5H,2-3H2,1H3,(H2,8,11)(H,9,10)(H,12,13)</moldb_inchi>
		<moldb_inchikey>KSMRODHGGIIXDV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>188.1812</moldb_average_mass>
		<moldb_mono_mass>188.079706882</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>469</id>
		<lmdb_id>LMDB00469</lmdb_id>
		<created_at>2016-07-13 19:50:32</created_at>
		<updated_at>2016-09-23 18:45:34</updated_at>
		<export>1</export>
		<name>Scyllitol</name>
		<description>Scyllitol is an isomer of cyclohexanehexol or inositol. It was first isolated from the kidneys of fish in 1858 by Staedeler and Freierchs. Scyllitol is a naturally occurring plant sugar alcohol found most abundantly in the coconut palm. It appears to accumulate in a number of animal tissues and biofluids through dietary consumption. It has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379). Results reported by Viola et al (PMID: 15340856) suggest that high CSF concentrations of scyllo-inositol can be induced by chronic alcoholism. scyllo-Inositol (also called &quot;scyllitol&quot;) when fed to transgenic mice that exhibit a memory disease very similar to animal Alzheimer's disease, can block the accumulation of soluble amyloid-beta (A&amp;#946;) plaques in the brain. Scyllitol was found to reverse memory deficits in the mice, reduce the amount of A&amp;#946; plaque in the brains of the mice, and reversed other symptoms associated with the presence of A&amp;#946; in the brain (PMID: 16767098).</description>
		<cas>488-59-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H/t1-,2-,3-,4+,5-,6+</moldb_inchi>
		<moldb_inchikey>CDAISMWEOUEBRE-NIPYSYMMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1559</moldb_average_mass>
		<moldb_mono_mass>180.063388116</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>470</id>
		<lmdb_id>LMDB00470</lmdb_id>
		<created_at>2016-07-13 19:50:33</created_at>
		<updated_at>2016-07-19 23:04:19</updated_at>
		<export>1</export>
		<name>Enterolactone</name>
		<description>Enterolactone is a mammalian lignan that have a similar biphenolic structure to lignans from plants. Lignans are compounds with estrogenic properties and are probably the most important source of phytoestrogens in western diets. Mammalian lignans are formed from precursors that are contained mainly in vegetables, whole grain products and berries, via action of intestinal microflora. Enterolactone is produced in the colon by the action of bacteria on secoisolariciresinol, matairesinol and its glycosides. Secoisolariciresinol is converted to enterodiol which is subsequently converted to enterolactone as it passes through the colon. Matairesinol is converted directly to enterolactone. Enterolactone have been shown to possess weakly estrogenic and antiestrogenic activities, and it has been suggested that the high production of this antiestrogenic mammalian lignans in the gut may serve to protect against breast cancer in women and prostate cancer in men; however epidemiological evidence to date is conflicting. (PMID: 16168401, 12270221, 11216511, 12107024).</description>
		<cas>76543-15-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1=CC=CC(CC2COC(=O)C2CC2=CC(O)=CC=C2)=C1</moldb_smiles>
		<moldb_formula>C18H18O4</moldb_formula>
		<moldb_inchi>InChI=1S/C18H18O4/c19-15-5-1-3-12(8-15)7-14-11-22-18(21)17(14)10-13-4-2-6-16(20)9-13/h1-6,8-9,14,17,19-20H,7,10-11H2</moldb_inchi>
		<moldb_inchikey>HVDGDHBAMCBBLR-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>298.3331</moldb_average_mass>
		<moldb_mono_mass>298.120509064</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>471</id>
		<lmdb_id>LMDB00471</lmdb_id>
		<created_at>2016-07-13 19:50:35</created_at>
		<updated_at>2016-07-20 21:01:24</updated_at>
		<export>1</export>
		<name>Phenylacetaldehyde</name>
		<description>Phenylacetaldehyde is one important oxidation-related aldehyde. Exposure to styrene gives phenylacetaldehyde as a secondary metabolite. Styrene has been implicated as reproductive toxicant, neurotoxicant, or carcinogen in vivo or in vitro. Phenylacetaldehyde could be formed by diverse thermal reactions during the cooking process together with C8 compounds is identified as a major aroma- active compound in cooked pine mushroom. Phenylacetaldehyde is readily oxidized to phenylacetic acid. Therefore will eventually be hydrolyzed and oxidized to yield phenylacetic acid that will be excreted primarily in the urine in conjugated form. (PMID: 16910727, 7818768, 15606130).</description>
		<cas>122-78-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O=CCC1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C8H8O</moldb_formula>
		<moldb_inchi>InChI=1S/C8H8O/c9-7-6-8-4-2-1-3-5-8/h1-5,7H,6H2</moldb_inchi>
		<moldb_inchikey>DTUQWGWMVIHBKE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>120.1485</moldb_average_mass>
		<moldb_mono_mass>120.057514878</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>472</id>
		<lmdb_id>LMDB00472</lmdb_id>
		<created_at>2016-07-13 19:50:36</created_at>
		<updated_at>2016-07-20 21:01:25</updated_at>
		<export>1</export>
		<name>25-Hydroxycholesterol</name>
		<description>25-Hydroxycholesterol is steroid derivative that suppresses the cleavage of sterol regulatory element binding proteins (SREBPs). It also induces apoptosis through down-regulation of Bcl-2 expression and activation of caspases. 25-Hydroxycholesterol also enhances Interleukin-1 beta (IL-1beta-induced) IL-8 production.(PMID: 17086498 ). 25-hydroxycholesterol is endogenously produced from cholesterol at early time intervals after cholesterol ingestion. It inhibits HMG-CoA reductase and so it also plays a significant role in the in vivo regulation of cholesterol biosynthesis after an acute dietary cholesterol challenge.</description>
		<cas>2140-46-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]C12CC[C@H]([C@H](C)CCCC(C)(C)O)[C@@]1(C)CCC1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C27H46O2</moldb_formula>
		<moldb_inchi>InChI=1S/C27H46O2/c1-18(7-6-14-25(2,3)29)22-10-11-23-21-9-8-19-17-20(28)12-15-26(19,4)24(21)13-16-27(22,23)5/h8,18,20-24,28-29H,6-7,9-17H2,1-5H3/t18-,20+,21+,22-,23?,24?,26+,27-/m1/s1</moldb_inchi>
		<moldb_inchikey>INBGSXNNRGWLJU-POAVOMIWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>402.6529</moldb_average_mass>
		<moldb_mono_mass>402.349780716</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>473</id>
		<lmdb_id>LMDB00473</lmdb_id>
		<created_at>2016-07-13 19:50:38</created_at>
		<updated_at>2016-09-23 18:45:34</updated_at>
		<export>1</export>
		<name>Alpha-N-Phenylacetyl-L-glutamine</name>
		<description>Phenylacetylglutamine is a product formed by the conjugation of phenylacetate and glutamine. Technically it is the amino acid acetylation product of phenylacetate (or phenylbutyrate after beta-oxidation). Phenylacetylglutamine is a normal constituent of animal urine, but other mammals including the dog, cat, rat, monkey, sheep and horse do not excrete this compound. Phenylacetyl CoA and glutamine react to form phenylacetyl glutamine and Coenzyme A. The enzyme (Glutamine N-acetyl transferase) that catalyzes this reaction has been purified from animal liver mitochondria and shown to be a distinct polypeptide species from glycine-N-acyltransferase. Phenylacetylglutamine is a major nitrogenous metabolite that accumulates in uremia. (PMID: 2791363; PMID: 8972626). It has been shown that over 50% of urine phenylacetylglutamine may be derived from kidney conjugation of free plasma phenylacetic acid and/or from the kidney's preferential filtration of conjugated phenylacetic acid (PMID: 6420430). In enzymology, a glutamine N-phenylacetyltransferase (EC 2.3.1.14) is an enzyme that catalyzes the chemical reaction. phenylacetyl-CoA + L-glutamine CoA + alpha-N-phenylacetyl-L-glutamine. Thus, the two substrates of this enzyme are phenylacetyl-CoA and L-glutamine, whereas its two products are CoA and alpha-N-phenylacetyl-L-glutamine.(Wikipedia).</description>
		<cas>28047-15-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(O)=O</moldb_smiles>
		<moldb_formula>C13H16N2O4</moldb_formula>
		<moldb_inchi>InChI=1S/C13H16N2O4/c14-11(16)7-6-10(13(18)19)15-12(17)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,14,16)(H,15,17)(H,18,19)/t10-/m0/s1</moldb_inchi>
		<moldb_inchikey>JFLIEFSWGNOPJJ-JTQLQIEISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>264.2771</moldb_average_mass>
		<moldb_mono_mass>264.111007010</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>474</id>
		<lmdb_id>LMDB00474</lmdb_id>
		<created_at>2016-07-13 19:50:39</created_at>
		<updated_at>2016-07-20 21:04:10</updated_at>
		<export>1</export>
		<name>Elaidic carnitine</name>
		<description>Elaidic carnitine is an acylcarnitine. Numerous disorders have been described that lead to disturbances in energy production and in intermediary metabolism in the organism which are characterized by the production and excretion of unusual acylcarnitines. A mutation in the gene coding for carnitine-acylcarnitine translocase or the OCTN2 transporter aetiologically causes a carnitine deficiency that results in poor intestinal absorption of dietary L-carnitine, its impaired reabsorption by the kidney and, consequently, in increased urinary loss of L-carnitine. Determination of the qualitative pattern of acylcarnitines can be of diagnostic and therapeutic importance. The betaine structure of carnitine requires special analytical procedures for recording. The ionic nature of L-carnitine causes a high water solubility which decreases with increasing chain length of the ester group in the acylcarnitines. Therefore, the distribution of L-carnitine and acylcarnitines in various organs is defined by their function and their physico-chemical properties as well. High performance liquid chromatography (HPLC) permits screening for free and total carnitine, as well as complete quantitative acylcarnitine determination, including the long-chain acylcarnitine profile. (PMID: 17508264, Monatshefte fuer Chemie (2005), 136(8), 1279-1291., Int J Mass Spectrom. 1999;188:39-52.).</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C\CCCCCCCC(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C25H47NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C25H47NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(21-24(27)28)22-26(2,3)4/h12-13,23H,5-11,14-22H2,1-4H3/b13-12+</moldb_inchi>
		<moldb_inchikey>IPOLTUVFXFHAHI-OUKQBFOZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>425.6450</moldb_average_mass>
		<moldb_mono_mass>425.350508997</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>475</id>
		<lmdb_id>LMDB00475</lmdb_id>
		<created_at>2016-07-13 19:50:40</created_at>
		<updated_at>2016-07-20 21:04:11</updated_at>
		<export>1</export>
		<name>Linoleyl carnitine</name>
		<description>Linoleyl carnitine is a long-chain acyl fatty acid derivative ester of carnitine. Long-chain acyl fatty acid derivatives accumulate in the cytosol and serum of patients suffering of mitochondrial carnitine palmitoyltransferase II (CPT II, EC 2.3.1.12) deficiency, the most common inherited disorder of lipid metabolism in adults. carnitine palmitoyltransferase II deficiency is an autosomal recessive disorder of fatty acid metabolism presenting as two clinical phenotypes: (i) a severe infantile hepatocardiomuscular form and (ii) a milder adult muscular form. Energy production from long-chain fatty acids (LCFAs) requires the transport of LCFAs into the mitochondrial matrix. This transport is carnitine-dependent and involves translocation machinery. mitochondrial fatty acid oxidation disorders cause hypoglycaemia, hepatic dysfunction, myopathy, cardiomyopathy and encephalopathy. Patients with end-stage renal disease (ESRD) undergoing long-term haemodialysis exhibit elevated acylcarnitine concentrations. (PMID: 11999976, 10682306, 15025677, 16168195).</description>
		<cas>36816-10-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/CCCCCCCC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C25H45NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C25H45NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(21-24(27)28)22-26(2,3)4/h9-10,12-13,23H,5-8,11,14-22H2,1-4H3/b10-9-,13-12-/t23-/m1/s1</moldb_inchi>
		<moldb_inchikey>MJLXQSQYKZWZCB-DQFWFXSYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>423.6291</moldb_average_mass>
		<moldb_mono_mass>423.334858933</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>476</id>
		<lmdb_id>LMDB00476</lmdb_id>
		<created_at>2016-07-13 19:50:42</created_at>
		<updated_at>2016-09-23 18:45:35</updated_at>
		<export>1</export>
		<name>Iso-Valeraldehyde</name>
		<description>iso-Valeraldehyde is an oxygenated (aldehyde) volatile organic compounds (VOC), normally found in animals, particularly in the gut. iso-Valeraldehyde is a leucine degradation product that has been found in elevated concentrations in some cases of hepatic encephalopathy, however not significantly. Fermentation of carbohydrates in the gut produces ethanoic, propionic, butanoic, pentanoic, and hexanoic acid acids, particularly by Bacteroides, although it is possible that some of the iso-Valeraldehyde is of dietetic origin. iso-Valeraldehyde has been found to be a normal component of the chemical profile of cheddar cheese, spirits (beer, rum, sake, wine). (PMID: 17314143, 18275147, 18175918, 16899660).</description>
		<cas>590-86-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)CC=O</moldb_smiles>
		<moldb_formula>C5H10O</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O/c1-5(2)3-4-6/h4-5H,3H2,1-2H3</moldb_inchi>
		<moldb_inchikey>YGHRJJRRZDOVPD-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>86.1323</moldb_average_mass>
		<moldb_mono_mass>86.073164942</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>477</id>
		<lmdb_id>LMDB00477</lmdb_id>
		<created_at>2016-07-13 19:50:43</created_at>
		<updated_at>2016-07-20 21:01:29</updated_at>
		<export>1</export>
		<name>LysoSM(d18:1)</name>
		<description>D-erythro-sphingosylphosphorylcholine is an intermediate in Sphingolipid metabolism. D-erythro-sphingosylphosphorylcholine is the 5th to last step in the synthesis of Digalactosylceramidesulfate and is converted from Sphingosine via the enzyme sphingosine cholinephosphotransferase ( EC 2.7.8.10). It is then converted to Sphingomyelin via the enzyme sphingosine N-acyltransferase (EC 2.3.1.24).</description>
		<cas>1670-26-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)COP(=O)(O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C23H50N2O5P</moldb_formula>
		<moldb_inchi>InChI=1S/C23H49N2O5P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(26)22(24)21-30-31(27,28)29-20-19-25(2,3)4/h17-18,22-23,26H,5-16,19-21,24H2,1-4H3/p+1/b18-17+/t22-,23+/m0/s1</moldb_inchi>
		<moldb_inchikey>JLVSPVFPBBFMBE-HXSWCURESA-O</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>465.6273</moldb_average_mass>
		<moldb_mono_mass>465.345734232</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>478</id>
		<lmdb_id>LMDB00478</lmdb_id>
		<created_at>2016-07-13 19:50:44</created_at>
		<updated_at>2016-09-23 18:45:35</updated_at>
		<export>1</export>
		<name>D-Aspartic acid</name>
		<description>D-Aspartic acid is the D-isomer of aspartic acid. Since its discovery in invertebrates, free D-aspartate (D-Asp) has been identified in a variety of organisms, including microorganisms, plants, and lower animals, mammals and animals. D-Asp in mammalian tissues is present in specific cells, indicating the existence of specific molecular components that regulate D-Asp levels and localization in tissues. In the rat adrenal medulla, D-Asp is closely associated with adrenaline-cells (A-cells), which account for approximately 80% of the total number of chromaffin cells in the tissue, and which make and store adrenaline. D-Asp appears to be absent from noradrenaline-cells (NA-cells), which comprise approximately 20% of the total number of chromaffin cells in the adrenal medulla, and which make and store noradrenaline. D-aspartate oxidase (EC 1.4.3.1, D-AspO), which catalyzes oxidative deamination of D-Asp, appears to be present only in NA-cells, suggesting that the lack of D-Asp in these cells is due to D-Asp oxidase-mediated metabolism of D-Asp. In the rat adrenal cortex, the distribution of D-Asp changes during development. It has been suggested that developmental changes in the localization of D-Asp reflects the participation of D-Asp in the development and maturation of steroidogenesis in rat adrenal cortical cells. D-Asp is involved in steroid hormone synthesis and secretion in mammals as well. D-Asp is synthesized intracellularly, most likely by Asp racemase (EC 5.1.1.13). Endogenous D-Asp apparently has two different intracellular localization patterns: cytoplasmic and vesicular. D-Asp release can occur through three distinct pathways: 1) spontaneous, continuous release of cytoplasmic D-Asp, which is not associated with a specific stimulus; 2) release of cytoplasmic D-Asp via a volume-sensitive organic anion channel that connects the cytoplasm and extracellular space; 3) exocytotic discharge of vesicular D-Asp. D-Asp can be released via a mechanism that involves the L-Glu transporter. D-Asp is thus apparently in dynamic flux at the cellular level to carry out its physiological function(s) in mammals. (PMID: 16755369).</description>
		<cas>1783-96-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@H](CC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C4H7NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m1/s1</moldb_inchi>
		<moldb_inchikey>CKLJMWTZIZZHCS-UWTATZPHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>133.1027</moldb_average_mass>
		<moldb_mono_mass>133.037507717</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>479</id>
		<lmdb_id>LMDB00479</lmdb_id>
		<created_at>2016-07-13 19:50:45</created_at>
		<updated_at>2016-07-20 21:04:11</updated_at>
		<export>1</export>
		<name>Docosapentaenoic acid</name>
		<description>Docosapentaenoic acid (also known as clupanodonic acid) is an essential omega-3 fatty acid (EFA) which is prevalent in fish oils. Docosapentaenoic acid, commonly called DPA, is an intermediary between eicosapentaenoic acid (EPA, 20:5 &amp;#969;-3) and docosahexaenoic acid (DHA, 22:6 &amp;#969;-3). Seal oil is a rich source. There are three functions of docosapentaenoic acid. The most important is as part of phospholipids in all animal cellular membranes: a deficiency of docosapentaenoic acid leads to faulty membranes being formed. A second is in the transport and oxidation of cholesterol: clupanodonic acid tends to lower plasma cholesterol. A third function is as a precursor of prostanoids which are only formed from docosapentaenoic acid. Deficiency of this in experimental animals causes lesions mainly attributable to faulty cellular membranes: sudden failure of growth, lesions of skin and kidney and connective tissue, erythrocyte fragility, impaired fertility, uncoupling of oxidation and phosphorylation. In man pure deficiency of docosapentaenoic acid has been studied particularly in persons fed intravenously. A relative deficiency (that is, a low ratio in the body of docosapentaenoic to long-chain saturated fatty acids and isomers of docosapentaenoate) is common on Western diets and plays an important part in the causation of atherosclerosis, coronary thrombosis, multiple sclerosis, the triopathy of diabetes mellitus, hypertension and certain forms of malignant disease. Various factors affect the dietary requirement of docosapentaenoic acid. (PMID: 6469703).</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C22H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C22H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15-</moldb_inchi>
		<moldb_inchikey>YUFFSWGQGVEMMI-JLNKQSITSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>330.5042</moldb_average_mass>
		<moldb_mono_mass>330.255880332</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>480</id>
		<lmdb_id>LMDB00480</lmdb_id>
		<created_at>2016-07-13 19:50:47</created_at>
		<updated_at>2016-09-23 18:45:36</updated_at>
		<export>1</export>
		<name>Stearidonic acid</name>
		<description>Stearidonic acid is found in dietary plant oils which are metabolized to longer-chain, more unsaturated (n-3) PUFA. These oils appear to possess hypotriglyceridemic properties typically associated with fish oils.(PMID: 15173404). Stearidonic acid may be used as a precursor to increase the EPA content of animal lipids and that combinations of gamma-linolenic acid and stearidonic acid eicosapentaenoic acid can be used to manipulate the fatty acid compositions of lipid pools in subtle ways. Such effects may offer new strategies for manipulation of cell composition in order to influence cellular responses and functions in desirable ways. (PMID: 15120716).</description>
		<cas>20290-75-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC\C=C/C\C=C/C\C=C/C\C=C/CCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H28O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10,12-13H,2,5,8,11,14-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-,13-12-</moldb_inchi>
		<moldb_inchikey>JIWBIWFOSCKQMA-LTKCOYKYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>276.4137</moldb_average_mass>
		<moldb_mono_mass>276.208930140</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>481</id>
		<lmdb_id>LMDB00481</lmdb_id>
		<created_at>2016-07-13 19:50:48</created_at>
		<updated_at>2016-09-23 18:45:36</updated_at>
		<export>1</export>
		<name>6'-Sialyllactose</name>
		<description>Sialyllactose is an oligossaccharide found in both animal breast milk and cow's milk. It is the predominant sialylated component in milk. Sialyllactose has recently been shown to inhibit the infection of HIV-1 virus. Sialyllactose is also responsible for the inhibitory activity of milk on cholera toxin.</description>
		<cas>35890-39-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(C)=O)(OC[C@H]1O[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)[C@H](O)[C@@H](O)[C@H]1O)C(O)=O)[C@H](O)[C@H](O)CO</moldb_smiles>
		<moldb_formula>C23H39NO19</moldb_formula>
		<moldb_inchi>InChI=1S/C23H39NO19/c1-7(28)24-13-8(29)2-23(22(38)39,43-20(13)15(34)10(31)4-26)40-6-12-16(35)17(36)18(37)21(41-12)42-19(11(32)5-27)14(33)9(30)3-25/h3,8-21,26-27,29-37H,2,4-6H2,1H3,(H,24,28)(H,38,39)/t8-,9-,10+,11+,12+,13+,14+,15+,16-,17-,18+,19+,20+,21-,23+/m0/s1</moldb_inchi>
		<moldb_inchikey>VMWYCXKMRSTDSP-GIGDJUIZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>633.5511</moldb_average_mass>
		<moldb_mono_mass>633.211628071</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>482</id>
		<lmdb_id>LMDB00482</lmdb_id>
		<created_at>2016-07-13 19:50:49</created_at>
		<updated_at>2016-07-19 23:03:14</updated_at>
		<export>1</export>
		<name>Disialyllactose</name>
		<description>Disialyllactose is a naturally occurring oligosaccharide present in the cell surface and in breast milk. Disialyllactose has been identified as one of the binding sites of the C fragment of the clostridial tetanus toxin, binding with great specificity and high affinity. Clostridial neurotoxins, botulinum and tetanus, gain entry into motor neurons by binding to the sialic or N-acetylneuraminic acid (NeuAc) residues of gangliosides and specific protein receptors attached to the cell's surface. Neurotoxins interact with motor neurons, blocking acetylcholine release and causing muscle paralysis and death. The glycosidic linkage between Neu5Ac and other monosaccharides is susceptible to hydrolysis at low pH, and disialyl lactose is unstable under acidic conditions. (PMID: 16713287, 16104015, 7263800, 7972078).</description>
		<cas>18409-15-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]1(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@]3(C[C@H](O)[C@@H](NC(C)=O)[C@@]([H])(O3)[C@H](O)[C@@H](CO)O[C@@]3(C[C@H](O)[C@@H](NC(C)=O)[C@@]([H])(O3)[C@H](O)[C@H](O)CO)C(O)=O)C(O)=O)[C@H]2O)[C@H](O)[C@@H](O)C(O)O[C@@H]1CO</moldb_smiles>
		<moldb_formula>C34H56N2O27</moldb_formula>
		<moldb_inchi>InChI=1S/C34H56N2O27/c1-9(41)35-17-11(43)3-33(31(53)54,61-26(17)19(46)13(45)5-37)60-15(7-39)21(48)27-18(36-10(2)42)12(44)4-34(62-27,32(55)56)63-28-20(47)14(6-38)58-30(24(28)51)59-25-16(8-40)57-29(52)23(50)22(25)49/h11-30,37-40,43-52H,3-8H2,1-2H3,(H,35,41)(H,36,42)(H,53,54)(H,55,56)/t11-,12-,13+,14+,15+,16+,17+,18+,19+,20-,21+,22+,23+,24+,25+,26+,27+,28-,29?,30-,33+,34-/m0/s1</moldb_inchi>
		<moldb_inchikey>IESOVNOGVZBLMG-MTEFBGAJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>924.8056</moldb_average_mass>
		<moldb_mono_mass>924.307044596</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>483</id>
		<lmdb_id>LMDB00483</lmdb_id>
		<created_at>2016-07-13 19:50:51</created_at>
		<updated_at>2016-07-19 23:06:35</updated_at>
		<export>1</export>
		<name>19-Hydroxytestosterone</name>
		<description>19-Hydroxytestosterone is an intermediate in Androgen and estrogen metabolism. 19-Hydroxytestosterone is the 4th to last step in the synthesis of 16-Glucuronide-estriol. It is generated from Testosterone via the enzyme cytochrome P450 (EC 1.14.14.1) and then converted to 19-Oxotestosterone.</description>
		<cas>2126-37-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]C12CC[C@H](O)[C@@]1(C)CCC1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12CO</moldb_smiles>
		<moldb_formula>C19H28O3</moldb_formula>
		<moldb_inchi>InChI=1S/C19H28O3/c1-18-8-7-16-14(15(18)4-5-17(18)22)3-2-12-10-13(21)6-9-19(12,16)11-20/h10,14-17,20,22H,2-9,11H2,1H3/t14-,15?,16?,17-,18-,19+/m0/s1</moldb_inchi>
		<moldb_inchikey>YLTCTXBDDHSLCS-HRCCTRRKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>304.4238</moldb_average_mass>
		<moldb_mono_mass>304.203844762</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>484</id>
		<lmdb_id>LMDB00484</lmdb_id>
		<created_at>2016-07-13 19:50:52</created_at>
		<updated_at>2016-07-19 23:06:44</updated_at>
		<export>1</export>
		<name>7a-Hydroxyandrost-4-ene-3,17-dione</name>
		<description>7alpha-Hydroxyandrost-4-ene-3,17-dione is an intermediate in androgen and estrogen metabolism. More specifically, it is an intermediate during the conversion of androst-4-ene-3,17-dione to testosterone or vice versa.</description>
		<cas>62-84-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H](O)CC2=CC(=O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C19H26O3</moldb_formula>
		<moldb_inchi>InChI=1S/C19H26O3/c1-18-7-5-12(20)9-11(18)10-15(21)17-13-3-4-16(22)19(13,2)8-6-14(17)18/h9,13-15,17,21H,3-8,10H2,1-2H3/t13-,14-,15+,17-,18-,19-/m0/s1</moldb_inchi>
		<moldb_inchikey>LFWLQMQUJQUZBD-TYHLISGHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>302.4079</moldb_average_mass>
		<moldb_mono_mass>302.188194698</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>485</id>
		<lmdb_id>LMDB00485</lmdb_id>
		<created_at>2016-07-13 19:50:53</created_at>
		<updated_at>2016-07-20 21:01:34</updated_at>
		<export>1</export>
		<name>1-Phosphatidyl-D-myo-inositol</name>
		<description>1-Phosphatidyl-D-myo-inositol is an intermediate in inositol phosphate metabolism (KEGG ID C04637). It is generated from 1-phosphatidyl-1D-myo-inositol-5P via the enzyme 1-phosphatidylinositol-5-phosphate 4-kinase [EC:2.7.1.149] and then converted to 1D-myo-inositol-1,4,5P3 via the enzyme 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase [EC:3.1.4.11].</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1C(O)[C@H](O)C(OP(O)(=O)OCC(COC=O)OC=O)[C@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C11H19O13P</moldb_formula>
		<moldb_inchi>InChI=1S/C11H19O13P/c12-3-21-1-5(22-4-13)2-23-25(19,20)24-11-9(17)7(15)6(14)8(16)10(11)18/h3-11,14-18H,1-2H2,(H,19,20)/t5?,6?,7-,8?,9+,10-,11?/m0/s1</moldb_inchi>
		<moldb_inchikey>GUBXYMKIJFOYOA-WSRCIYAPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>390.2345</moldb_average_mass>
		<moldb_mono_mass>390.056327206</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>486</id>
		<lmdb_id>LMDB00486</lmdb_id>
		<created_at>2016-07-13 19:50:55</created_at>
		<updated_at>2016-08-02 20:39:22</updated_at>
		<export>1</export>
		<name>PC(14:0/18:0)</name>
		<description>PC(14:0/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/18:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of stearic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](COC(=O)CCCCCCCCCCCCC)(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C40H80NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C40H80NO8P/c1-6-8-10-12-14-16-18-19-20-21-23-25-27-29-31-33-40(43)49-38(37-48-50(44,45)47-35-34-41(3,4)5)36-46-39(42)32-30-28-26-24-22-17-15-13-11-9-7-2/h38H,6-37H2,1-5H3/t38-/m1/s1</moldb_inchi>
		<moldb_inchikey>TYAQXZHDAGZOEO-KXQOOQHDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>734.0389</moldb_average_mass>
		<moldb_mono_mass>733.562155053</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>487</id>
		<lmdb_id>LMDB00487</lmdb_id>
		<created_at>2016-07-13 19:50:56</created_at>
		<updated_at>2016-07-20 20:43:18</updated_at>
		<export>1</export>
		<name>PC(14:1(9Z)/14:0)</name>
		<description>PC(14:1(9Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:1(9Z)/14:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of myristic acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)O[C@]([H])(COC(=O)CCCCCCC\C=C/CCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C36H70NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C36H70NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-35(38)42-32-34(33-44-46(40,41)43-31-30-37(3,4)5)45-36(39)29-27-25-23-21-19-17-15-13-11-9-7-2/h12,14,34H,6-11,13,15-33H2,1-5H3/b14-12-/t34-/m1/s1</moldb_inchi>
		<moldb_inchikey>XQPYHFHTTVXZKL-XBEBLRSGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>675.9167</moldb_average_mass>
		<moldb_mono_mass>675.483904733</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>488</id>
		<lmdb_id>LMDB00488</lmdb_id>
		<created_at>2016-07-13 19:50:57</created_at>
		<updated_at>2016-07-20 21:01:35</updated_at>
		<export>1</export>
		<name>PC(14:1(9Z)/18:3(9Z,12Z,15Z))</name>
		<description>PC(14:1(9Z)/18:3(9Z,12Z,15Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:1(9Z)/18:3(9Z,12Z,15Z)), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of a-linolenic acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCC\C=C/CCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC</moldb_smiles>
		<moldb_formula>C40H72NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C40H72NO8P/c1-6-8-10-12-14-16-18-19-20-21-23-25-27-29-31-33-40(43)49-38(37-48-50(44,45)47-35-34-41(3,4)5)36-46-39(42)32-30-28-26-24-22-17-15-13-11-9-7-2/h8,10,13-16,19-20,38H,6-7,9,11-12,17-18,21-37H2,1-5H3/b10-8-,15-13-,16-14-,20-19-/t38-/m1/s1</moldb_inchi>
		<moldb_inchikey>BPBWECRGAITUAO-RPHNJZPISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>725.9753</moldb_average_mass>
		<moldb_mono_mass>725.499554797</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>489</id>
		<lmdb_id>LMDB00489</lmdb_id>
		<created_at>2016-07-13 19:50:59</created_at>
		<updated_at>2016-07-20 20:43:21</updated_at>
		<export>1</export>
		<name>PC(14:1(9Z)/P-18:0)</name>
		<description>PC(14:1(9Z)/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:1(9Z)/P-18:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC\C=C/OC(COC(=O)CCCCCCC\C=C/CCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C40H78NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C40H78NO7P/c1-6-8-10-12-14-16-18-19-20-21-22-24-26-28-30-32-35-45-39(38-48-49(43,44)47-36-34-41(3,4)5)37-46-40(42)33-31-29-27-25-23-17-15-13-11-9-7-2/h13,15,32,35,39H,6-12,14,16-31,33-34,36-38H2,1-5H3/b15-13-,35-32-</moldb_inchi>
		<moldb_inchikey>KSNPZAABSICMCR-CQWYKKOZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>716.0236</moldb_average_mass>
		<moldb_mono_mass>715.551590367</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>490</id>
		<lmdb_id>LMDB00490</lmdb_id>
		<created_at>2016-07-13 19:51:00</created_at>
		<updated_at>2016-07-20 21:01:35</updated_at>
		<export>1</export>
		<name>PC(16:0/18:2(9Z,12Z))</name>
		<description>PC(16:0/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/18:2(9Z,12Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of linoleic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C42H80NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C42H80NO8P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-33-35-42(45)51-40(39-50-52(46,47)49-37-36-43(3,4)5)38-48-41(44)34-32-30-28-26-24-22-19-17-15-13-11-9-7-2/h14,16,20-21,40H,6-13,15,17-19,22-39H2,1-5H3/b16-14-,21-20-/t40-/m1/s1</moldb_inchi>
		<moldb_inchikey>JLPULHDHAOZNQI-ZTIMHPMXSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>758.0603</moldb_average_mass>
		<moldb_mono_mass>757.562155053</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>491</id>
		<lmdb_id>LMDB00491</lmdb_id>
		<created_at>2016-07-13 19:51:02</created_at>
		<updated_at>2016-07-20 21:01:36</updated_at>
		<export>1</export>
		<name>PC(16:0/20:4(5Z,8Z,11Z,14Z))</name>
		<description>PC(16:0/20:4(5Z,8Z,11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/20:4(5Z,8Z,11Z,14Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of arachidonic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the arachidonic acid moiety is derived from animal fats and eggs. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C44H80NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H80NO8P/c1-6-8-10-12-14-16-18-20-21-22-23-25-27-29-31-33-35-37-44(47)53-42(41-52-54(48,49)51-39-38-45(3,4)5)40-50-43(46)36-34-32-30-28-26-24-19-17-15-13-11-9-7-2/h14,16,20-21,23,25,29,31,42H,6-13,15,17-19,22,24,26-28,30,32-41H2,1-5H3/b16-14-,21-20-,25-23-,31-29-/t42-/m1/s1</moldb_inchi>
		<moldb_inchikey>IIZPXYDJLKNOIY-JXPKJXOSSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>782.0817</moldb_average_mass>
		<moldb_mono_mass>781.562155053</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>492</id>
		<lmdb_id>LMDB00492</lmdb_id>
		<created_at>2016-07-13 19:51:04</created_at>
		<updated_at>2016-07-20 21:01:36</updated_at>
		<export>1</export>
		<name>PC(16:0/20:4(8Z,11Z,14Z,17Z))</name>
		<description>PC(16:0/20:4(8Z,11Z,14Z,17Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/20:4(8Z,11Z,14Z,17Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of eicsoatetraenoic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the eicsoatetraenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NULL</moldb_smiles>
		<moldb_formula>NULL</moldb_formula>
		<moldb_inchi>NULL</moldb_inchi>
		<moldb_inchikey>NULL</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>NULL</moldb_average_mass>
		<moldb_mono_mass>NULL</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>493</id>
		<lmdb_id>LMDB00493</lmdb_id>
		<created_at>2016-07-13 19:51:05</created_at>
		<updated_at>2016-07-20 21:01:36</updated_at>
		<export>1</export>
		<name>PC(16:0/22:5(7Z,10Z,13Z,16Z,19Z))</name>
		<description>PC(16:0/22:5(7Z,10Z,13Z,16Z,19Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/22:5(7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of docosapentaenoic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the docosapentaenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC</moldb_smiles>
		<moldb_formula>C46H82NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H82NO8P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-27-29-31-33-35-37-39-46(49)55-44(43-54-56(50,51)53-41-40-47(3,4)5)42-52-45(48)38-36-34-32-30-28-26-19-17-15-13-11-9-7-2/h8,10,14,16,20-21,23-24,27,29,44H,6-7,9,11-13,15,17-19,22,25-26,28,30-43H2,1-5H3/b10-8-,16-14-,21-20-,24-23-,29-27-/t44-/m1/s1</moldb_inchi>
		<moldb_inchikey>ARDJUHDXABDVFH-ZHSIBHBUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>808.1189</moldb_average_mass>
		<moldb_mono_mass>807.577805117</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>494</id>
		<lmdb_id>LMDB00494</lmdb_id>
		<created_at>2016-07-13 19:51:07</created_at>
		<updated_at>2016-07-20 20:43:29</updated_at>
		<export>1</export>
		<name>PC(16:1(9Z)/14:1(9Z))</name>
		<description>PC(16:1(9Z)/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/14:1(9Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCC</moldb_smiles>
		<moldb_formula>C38H72NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C38H72NO8P/c1-6-8-10-12-14-16-18-19-21-22-24-26-28-30-37(40)44-34-36(35-46-48(42,43)45-33-32-39(3,4)5)47-38(41)31-29-27-25-23-20-17-15-13-11-9-7-2/h13,15-16,18,36H,6-12,14,17,19-35H2,1-5H3/b15-13-,18-16-/t36-/m1/s1</moldb_inchi>
		<moldb_inchikey>WEVWHXAKLAWWAP-KQGJYXFZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>701.9539</moldb_average_mass>
		<moldb_mono_mass>701.499554797</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>495</id>
		<lmdb_id>LMDB00495</lmdb_id>
		<created_at>2016-07-13 19:51:08</created_at>
		<updated_at>2016-07-20 21:01:37</updated_at>
		<export>1</export>
		<name>PC(18:0/18:2(9Z,12Z))</name>
		<description>PC(18:0/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/18:2(9Z,12Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of linoleic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C44H84NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H84NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h15,17,21,23,42H,6-14,16,18-20,22,24-41H2,1-5H3/b17-15-,23-21-/t42-/m1/s1</moldb_inchi>
		<moldb_inchikey>FORFDCPQKJHEBF-VPUSDGANSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>786.1134</moldb_average_mass>
		<moldb_mono_mass>785.593455181</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>496</id>
		<lmdb_id>LMDB00496</lmdb_id>
		<created_at>2016-07-13 19:51:09</created_at>
		<updated_at>2016-07-20 21:01:39</updated_at>
		<export>1</export>
		<name>PC(18:0/18:3(6Z,9Z,12Z))</name>
		<description>PC(18:0/18:3(6Z,9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/18:3(6Z,9Z,12Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of g-linolenic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the g-linolenic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C44H82NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H82NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h15,17,21,23,27,29,42H,6-14,16,18-20,22,24-26,28,30-41H2,1-5H3/b17-15-,23-21-,29-27-/t42-/m1/s1</moldb_inchi>
		<moldb_inchikey>KJVJKBRMUDGTKA-NZXQIXPOSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>784.0975</moldb_average_mass>
		<moldb_mono_mass>783.577805117</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>497</id>
		<lmdb_id>LMDB00497</lmdb_id>
		<created_at>2016-07-13 19:51:10</created_at>
		<updated_at>2016-07-20 21:01:39</updated_at>
		<export>1</export>
		<name>PC(18:0/18:4(6Z,9Z,12Z,15Z))</name>
		<description>PC(18:0/18:4(6Z,9Z,12Z,15Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/18:4(6Z,9Z,12Z,15Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of stearidonic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the stearidonic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCC\C=C/C\C=C/C\C=C/C\C=C/CC</moldb_smiles>
		<moldb_formula>C44H80NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H80NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h9,11,15,17,21,23,27,29,42H,6-8,10,12-14,16,18-20,22,24-26,28,30-41H2,1-5H3/b11-9-,17-15-,23-21-,29-27-/t42-/m1/s1</moldb_inchi>
		<moldb_inchikey>MGIFJPVLDQAGPZ-ROBDCESFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>782.0817</moldb_average_mass>
		<moldb_mono_mass>781.562155053</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>498</id>
		<lmdb_id>LMDB00498</lmdb_id>
		<created_at>2016-07-13 19:51:12</created_at>
		<updated_at>2016-07-20 21:01:40</updated_at>
		<export>1</export>
		<name>PC(18:0/20:4(5Z,8Z,11Z,14Z))</name>
		<description>PC(18:0/20:4(5Z,8Z,11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/20:4(5Z,8Z,11Z,14Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of arachidonic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the arachidonic acid moiety is derived from animal fats and eggs. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C46H84NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H84NO8P/c1-6-8-10-12-14-16-18-20-22-23-25-27-29-31-33-35-37-39-46(49)55-44(43-54-56(50,51)53-41-40-47(3,4)5)42-52-45(48)38-36-34-32-30-28-26-24-21-19-17-15-13-11-9-7-2/h14,16,20,22,25,27,31,33,44H,6-13,15,17-19,21,23-24,26,28-30,32,34-43H2,1-5H3/b16-14-,22-20-,27-25-,33-31-/t44-/m1/s1</moldb_inchi>
		<moldb_inchikey>PSVRFUPOQYJOOZ-QNPWAGBNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>810.1348</moldb_average_mass>
		<moldb_mono_mass>809.593455181</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>499</id>
		<lmdb_id>LMDB00499</lmdb_id>
		<created_at>2016-07-13 19:51:13</created_at>
		<updated_at>2016-07-20 21:01:40</updated_at>
		<export>1</export>
		<name>PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))</name>
		<description>PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of docosahexaenoic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the docosahexaenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC</moldb_smiles>
		<moldb_formula>C48H84NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C48H84NO8P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-29-31-33-35-37-39-41-48(51)57-46(45-56-58(52,53)55-43-42-49(3,4)5)44-54-47(50)40-38-36-34-32-30-28-26-21-19-17-15-13-11-9-7-2/h8,10,14,16,20,22,24-25,29,31,35,37,46H,6-7,9,11-13,15,17-19,21,23,26-28,30,32-34,36,38-45H2,1-5H3/b10-8-,16-14-,22-20-,25-24-,31-29-,37-35-/t46-/m1/s1</moldb_inchi>
		<moldb_inchikey>FAUYAENFVCNTAL-PFFNLMTBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>834.1562</moldb_average_mass>
		<moldb_mono_mass>833.593455181</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>500</id>
		<lmdb_id>LMDB00500</lmdb_id>
		<created_at>2016-07-13 19:51:14</created_at>
		<updated_at>2016-07-20 21:01:41</updated_at>
		<export>1</export>
		<name>PC(18:0/P-18:0)</name>
		<description>PC(18:0/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/P-18:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC[N+](C)(C)C)O\C=C/CCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C44H88NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H88NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-39-49-43(42-52-53(47,48)51-40-38-45(3,4)5)41-50-44(46)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h36,39,43H,6-35,37-38,40-42H2,1-5H3/b39-36-</moldb_inchi>
		<moldb_inchikey>LQGHAKFUDWIULA-HYLXNHFUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>774.1458</moldb_average_mass>
		<moldb_mono_mass>773.629840687</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>501</id>
		<lmdb_id>LMDB00501</lmdb_id>
		<created_at>2016-07-13 19:51:16</created_at>
		<updated_at>2016-07-20 20:43:39</updated_at>
		<export>1</export>
		<name>PC(18:1(11Z)/16:0)</name>
		<description>PC(18:1(11Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/16:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)O[C@]([H])(COC(=O)CCCCCCCCC\C=C/CCCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C42H82NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C42H82NO8P/c1-6-8-10-12-14-16-18-20-21-23-24-26-28-30-32-34-41(44)48-38-40(39-50-52(46,47)49-37-36-43(3,4)5)51-42(45)35-33-31-29-27-25-22-19-17-15-13-11-9-7-2/h16,18,40H,6-15,17,19-39H2,1-5H3/b18-16-/t40-/m1/s1</moldb_inchi>
		<moldb_inchikey>WPAONTMCEBPEAF-KWNHIAGJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>760.0761</moldb_average_mass>
		<moldb_mono_mass>759.577805117</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>502</id>
		<lmdb_id>LMDB00502</lmdb_id>
		<created_at>2016-07-13 19:51:17</created_at>
		<updated_at>2016-07-20 21:01:41</updated_at>
		<export>1</export>
		<name>PC(18:2(9Z,12Z)/16:0)</name>
		<description>PC(18:2(9Z,12Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:2(9Z,12Z)/16:0), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The linoleic acid moiety is derived from seed oils, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)O[C@]([H])(COC(=O)CCCCCCC\C=C/C\C=C/CCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C42H80NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C42H80NO8P/c1-6-8-10-12-14-16-18-20-21-23-24-26-28-30-32-34-41(44)48-38-40(39-50-52(46,47)49-37-36-43(3,4)5)51-42(45)35-33-31-29-27-25-22-19-17-15-13-11-9-7-2/h14,16,20-21,40H,6-13,15,17-19,22-39H2,1-5H3/b16-14-,21-20-/t40-/m1/s1</moldb_inchi>
		<moldb_inchikey>FWMYJLDHIVCJCT-ZTIMHPMXSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>758.0603</moldb_average_mass>
		<moldb_mono_mass>757.562155053</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>503</id>
		<lmdb_id>LMDB00503</lmdb_id>
		<created_at>2016-07-13 19:51:18</created_at>
		<updated_at>2016-07-20 21:01:41</updated_at>
		<export>1</export>
		<name>PC(18:2(9Z,12Z)/18:0)</name>
		<description>PC(18:2(9Z,12Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:2(9Z,12Z)/18:0), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of stearic acid at the C-2 position. The linoleic acid moiety is derived from seed oils, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)O[C@]([H])(COC(=O)CCCCCCC\C=C/C\C=C/CCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C44H84NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H84NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h14,16,20,22,42H,6-13,15,17-19,21,23-41H2,1-5H3/b16-14-,22-20-/t42-/m1/s1</moldb_inchi>
		<moldb_inchikey>DZPKSVTWWIZUMS-FPUNCOTOSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>786.1134</moldb_average_mass>
		<moldb_mono_mass>785.593455181</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>504</id>
		<lmdb_id>LMDB00504</lmdb_id>
		<created_at>2016-07-13 19:51:20</created_at>
		<updated_at>2016-07-20 21:01:42</updated_at>
		<export>1</export>
		<name>PC(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))</name>
		<description>PC(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of arachidonic acid at the C-2 position. The linoleic acid moiety is derived from seed oils, while the arachidonic acid moiety is derived from animal fats and eggs. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C46H80NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H80NO8P/c1-6-8-10-12-14-16-18-20-22-23-25-27-29-31-33-35-37-39-46(49)55-44(43-54-56(50,51)53-41-40-47(3,4)5)42-52-45(48)38-36-34-32-30-28-26-24-21-19-17-15-13-11-9-7-2/h14-17,20-22,24-25,27,31,33,44H,6-13,18-19,23,26,28-30,32,34-43H2,1-5H3/b16-14-,17-15-,22-20-,24-21-,27-25-,33-31-/t44-/m1/s1</moldb_inchi>
		<moldb_inchikey>ZZSZQATYGVHNLZ-PUMLCSCDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>806.1031</moldb_average_mass>
		<moldb_mono_mass>805.562155053</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>505</id>
		<lmdb_id>LMDB00505</lmdb_id>
		<created_at>2016-07-13 19:51:21</created_at>
		<updated_at>2016-07-20 21:01:43</updated_at>
		<export>1</export>
		<name>PC(18:3(6Z,9Z,12Z)/20:1(11Z))</name>
		<description>PC(18:3(6Z,9Z,12Z)/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:3(6Z,9Z,12Z)/20:1(11Z)), in particular, consists of one chain of g-linolenic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The g-linolenic acid moiety is derived from animal fats, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCCCC(=O)O[C@]([H])(COC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C46H84NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H84NO8P/c1-6-8-10-12-14-16-18-20-22-23-25-27-29-31-33-35-37-39-46(49)55-44(43-54-56(50,51)53-41-40-47(3,4)5)42-52-45(48)38-36-34-32-30-28-26-24-21-19-17-15-13-11-9-7-2/h15,17,20-22,24,28,30,44H,6-14,16,18-19,23,25-27,29,31-43H2,1-5H3/b17-15-,22-20-,24-21-,30-28-/t44-/m1/s1</moldb_inchi>
		<moldb_inchikey>SVOGSAQWUMDSCM-OJCVPQOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>810.1348</moldb_average_mass>
		<moldb_mono_mass>809.593455181</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>506</id>
		<lmdb_id>LMDB00506</lmdb_id>
		<created_at>2016-07-13 19:51:22</created_at>
		<updated_at>2016-07-20 21:01:44</updated_at>
		<export>1</export>
		<name>PC(18:3(6Z,9Z,12Z)/20:2(11Z,14Z))</name>
		<description>PC(18:3(6Z,9Z,12Z)/20:2(11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:3(6Z,9Z,12Z)/20:2(11Z,14Z)), in particular, consists of one chain of g-linolenic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The g-linolenic acid moiety is derived from animal fats, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/CCCCCCCCCC(=O)O[C@]([H])(COC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C46H82NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H82NO8P/c1-6-8-10-12-14-16-18-20-22-23-25-27-29-31-33-35-37-39-46(49)55-44(43-54-56(50,51)53-41-40-47(3,4)5)42-52-45(48)38-36-34-32-30-28-26-24-21-19-17-15-13-11-9-7-2/h14-17,20-22,24,28,30,44H,6-13,18-19,23,25-27,29,31-43H2,1-5H3/b16-14-,17-15-,22-20-,24-21-,30-28-/t44-/m1/s1</moldb_inchi>
		<moldb_inchikey>JEEMMQUVRFTVSG-AZITXYQXSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>808.1189</moldb_average_mass>
		<moldb_mono_mass>807.577805117</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>507</id>
		<lmdb_id>LMDB00507</lmdb_id>
		<created_at>2016-07-13 19:51:24</created_at>
		<updated_at>2016-07-20 20:43:47</updated_at>
		<export>1</export>
		<name>PC(18:3(9Z,12Z,15Z)/14:0)</name>
		<description>PC(18:3(9Z,12Z,15Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:3(9Z,12Z,15Z)/14:0), in particular, consists of one chain of a-linolenic acid at the C-1 position and one chain of myristic acid at the C-2 position. The a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)O[C@]([H])(COC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C40H74NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C40H74NO8P/c1-6-8-10-12-14-16-18-19-20-21-23-24-26-28-30-32-39(42)46-36-38(37-48-50(44,45)47-35-34-41(3,4)5)49-40(43)33-31-29-27-25-22-17-15-13-11-9-7-2/h8,10,14,16,19-20,38H,6-7,9,11-13,15,17-18,21-37H2,1-5H3/b10-8-,16-14-,20-19-/t38-/m1/s1</moldb_inchi>
		<moldb_inchikey>FJUVFXSFGYBNBR-XPTMXNASSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>727.9912</moldb_average_mass>
		<moldb_mono_mass>727.515204861</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>508</id>
		<lmdb_id>LMDB00508</lmdb_id>
		<created_at>2016-07-13 19:51:25</created_at>
		<updated_at>2016-07-20 21:01:45</updated_at>
		<export>1</export>
		<name>PC(18:4(6Z,9Z,12Z,15Z)/18:1(9Z))</name>
		<description>PC(18:4(6Z,9Z,12Z,15Z)/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:4(6Z,9Z,12Z,15Z)/18:1(9Z)), in particular, consists of one chain of stearidonic acid at the C-1 position and one chain of oleic acid at the C-2 position. The stearidonic acid moiety is derived from seed oils, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCC(=O)O[C@]([H])(COC(=O)CCCC\C=C/C\C=C/C\C=C/C\C=C/CC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C44H78NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H78NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h8,10,14,16,20-23,26,28,42H,6-7,9,11-13,15,17-19,24-25,27,29-41H2,1-5H3/b10-8-,16-14-,22-20-,23-21-,28-26-/t42-/m1/s1</moldb_inchi>
		<moldb_inchikey>SQOJMBITSSDGAU-MAFUUHOFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>780.0658</moldb_average_mass>
		<moldb_mono_mass>779.546504989</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>509</id>
		<lmdb_id>LMDB00509</lmdb_id>
		<created_at>2016-07-13 19:51:26</created_at>
		<updated_at>2016-07-20 21:01:45</updated_at>
		<export>1</export>
		<name>PC(18:4(6Z,9Z,12Z,15Z)/22:1(13Z))</name>
		<description>PC(18:4(6Z,9Z,12Z,15Z)/22:1(13Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:4(6Z,9Z,12Z,15Z)/22:1(13Z)), in particular, consists of one chain of stearidonic acid at the C-1 position and one chain of erucic acid at the C-2 position. The stearidonic acid moiety is derived from seed oils, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCCCCCC(=O)O[C@]([H])(COC(=O)CCCC\C=C/C\C=C/C\C=C/C\C=C/CC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C48H86NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C48H86NO8P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-29-31-33-35-37-39-41-48(51)57-46(45-56-58(52,53)55-43-42-49(3,4)5)44-54-47(50)40-38-36-34-32-30-28-26-21-19-17-15-13-11-9-7-2/h9,11,15,17,20-22,26,30,32,46H,6-8,10,12-14,16,18-19,23-25,27-29,31,33-45H2,1-5H3/b11-9-,17-15-,22-20-,26-21-,32-30-/t46-/m1/s1</moldb_inchi>
		<moldb_inchikey>DJYBHEQPGXRDCL-OAUHGFOMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>836.1721</moldb_average_mass>
		<moldb_mono_mass>835.609105245</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>510</id>
		<lmdb_id>LMDB00510</lmdb_id>
		<created_at>2016-07-13 19:51:28</created_at>
		<updated_at>2016-07-19 23:32:11</updated_at>
		<export>1</export>
		<name>PC(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))</name>
		<description>PC(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of docosahexaenoic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the docosahexaenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC</moldb_smiles>
		<moldb_formula>C50H88NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C50H88NO8P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-41-43-50(53)59-48(47-58-60(54,55)57-45-44-51(3,4)5)46-56-49(52)42-40-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h8,10,14,16,20,22,25,27,31,33,37,39,48H,6-7,9,11-13,15,17-19,21,23-24,26,28-30,32,34-36,38,40-47H2,1-5H3/b10-8-,16-14-,22-20-,27-25-,33-31-,39-37-/t48-/m1/s1</moldb_inchi>
		<moldb_inchikey>WAFWSBFKIPCFOF-ZDAJSWCOSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>862.2094</moldb_average_mass>
		<moldb_mono_mass>861.624755309</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>511</id>
		<lmdb_id>LMDB00511</lmdb_id>
		<created_at>2016-07-13 19:51:29</created_at>
		<updated_at>2016-07-20 20:43:51</updated_at>
		<export>1</export>
		<name>PC(20:1(11Z)/14:1(9Z))</name>
		<description>PC(20:1(11Z)/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:1(11Z)/14:1(9Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCC</moldb_smiles>
		<moldb_formula>C42H80NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C42H80NO8P/c1-6-8-10-12-14-16-18-19-20-21-22-23-25-26-28-30-32-34-41(44)48-38-40(39-50-52(46,47)49-37-36-43(3,4)5)51-42(45)35-33-31-29-27-24-17-15-13-11-9-7-2/h13,15,19-20,40H,6-12,14,16-18,21-39H2,1-5H3/b15-13-,20-19-/t40-/m1/s1</moldb_inchi>
		<moldb_inchikey>FMLFVZOURBVUJL-LYJZGNKWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>758.0603</moldb_average_mass>
		<moldb_mono_mass>757.562155053</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>512</id>
		<lmdb_id>LMDB00512</lmdb_id>
		<created_at>2016-07-13 19:51:30</created_at>
		<updated_at>2016-07-19 23:32:06</updated_at>
		<export>1</export>
		<name>PC(20:4(5Z,8Z,11Z,14Z)/22:0)</name>
		<description>PC(20:4(5Z,8Z,11Z,14Z)/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:4(5Z,8Z,11Z,14Z)/22:0), in particular, consists of one chain of arachidonic acid at the C-1 position and one chain of behenic acid at the C-2 position. The arachidonic acid moiety is derived from animal fats and eggs, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@]([H])(COC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C50H92NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C50H92NO8P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-41-43-50(53)59-48(47-58-60(54,55)57-45-44-51(3,4)5)46-56-49(52)42-40-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h15,17,21,23,28,30,34,36,48H,6-14,16,18-20,22,24-27,29,31-33,35,37-47H2,1-5H3/b17-15-,23-21-,30-28-,36-34-/t48-/m1/s1</moldb_inchi>
		<moldb_inchikey>CVECNRQDBOYLEX-YUDFJFIPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>866.2411</moldb_average_mass>
		<moldb_mono_mass>865.656055437</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>513</id>
		<lmdb_id>LMDB00513</lmdb_id>
		<created_at>2016-07-13 19:51:32</created_at>
		<updated_at>2016-07-20 20:43:51</updated_at>
		<export>1</export>
		<name>PC(20:4(8Z,11Z,14Z,17Z)/14:0)</name>
		<description>PC(20:4(8Z,11Z,14Z,17Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:4(8Z,11Z,14Z,17Z)/14:0), in particular, consists of one chain of eicsoatetraenoic acid at the C-1 position and one chain of myristic acid at the C-2 position. The eicsoatetraenoic acid moiety is derived from fish oils, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)O[C@]([H])(COC(=O)CCCCCC\C=C/C\C=C/C\C=C/C\C=C/CC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C42H76NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C42H76NO8P/c1-6-8-10-12-14-16-18-19-20-21-22-23-25-26-28-30-32-34-41(44)48-38-40(39-50-52(46,47)49-37-36-43(3,4)5)51-42(45)35-33-31-29-27-24-17-15-13-11-9-7-2/h8,10,14,16,19-20,22-23,40H,6-7,9,11-13,15,17-18,21,24-39H2,1-5H3/b10-8-,16-14-,20-19-,23-22-/t40-/m1/s1</moldb_inchi>
		<moldb_inchikey>ZSYMQFVRTIVMFA-JAHIUHDMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>754.0285</moldb_average_mass>
		<moldb_mono_mass>753.530854925</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>514</id>
		<lmdb_id>LMDB00514</lmdb_id>
		<created_at>2016-07-13 19:51:33</created_at>
		<updated_at>2016-07-20 20:43:53</updated_at>
		<export>1</export>
		<name>PC(22:0/20:0)</name>
		<description>PC(22:0/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:0/20:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](COC(=O)CCCCCCCCCCCCCCCCCCCCC)(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C50H100NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C50H100NO8P/c1-6-8-10-12-14-16-18-20-22-24-25-27-28-30-32-34-36-38-40-42-49(52)56-46-48(47-58-60(54,55)57-45-44-51(3,4)5)59-50(53)43-41-39-37-35-33-31-29-26-23-21-19-17-15-13-11-9-7-2/h48H,6-47H2,1-5H3/t48-/m1/s1</moldb_inchi>
		<moldb_inchikey>BBKWJNNMTSKJKD-QSCHNALKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>874.3047</moldb_average_mass>
		<moldb_mono_mass>873.718655693</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>515</id>
		<lmdb_id>LMDB00515</lmdb_id>
		<created_at>2016-07-13 19:51:34</created_at>
		<updated_at>2016-07-20 20:43:54</updated_at>
		<export>1</export>
		<name>PC(22:0/P-16:0)</name>
		<description>PC(22:0/P-16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:0/P-16:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC[N+](C)(C)C)O\C=C/CCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C46H92NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H92NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-26-27-29-31-33-35-37-39-46(48)52-43-45(44-54-55(49,50)53-42-40-47(3,4)5)51-41-38-36-34-32-30-28-21-19-17-15-13-11-9-7-2/h38,41,45H,6-37,39-40,42-44H2,1-5H3/b41-38-</moldb_inchi>
		<moldb_inchikey>VYMPOARESDCNFV-GJARRJKISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>802.1989</moldb_average_mass>
		<moldb_mono_mass>801.661140815</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>516</id>
		<lmdb_id>LMDB00516</lmdb_id>
		<created_at>2016-07-13 19:51:36</created_at>
		<updated_at>2016-07-20 20:43:55</updated_at>
		<export>1</export>
		<name>PC(22:1(13Z)/16:0)</name>
		<description>PC(22:1(13Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:1(13Z)/16:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)O[C@]([H])(COC(=O)CCCCCCCCCCC\C=C/CCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C46H90NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H90NO8P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-27-28-30-32-34-36-38-45(48)52-42-44(43-54-56(50,51)53-41-40-47(3,4)5)55-46(49)39-37-35-33-31-29-26-19-17-15-13-11-9-7-2/h20-21,44H,6-19,22-43H2,1-5H3/b21-20-/t44-/m1/s1</moldb_inchi>
		<moldb_inchikey>QZSYHJOHCCQKPM-UIJSWADASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>816.1825</moldb_average_mass>
		<moldb_mono_mass>815.640405373</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>517</id>
		<lmdb_id>LMDB00517</lmdb_id>
		<created_at>2016-07-13 19:51:37</created_at>
		<updated_at>2016-07-20 20:43:55</updated_at>
		<export>1</export>
		<name>PC(22:4(7Z,10Z,13Z,16Z)/20:1(11Z))</name>
		<description>PC(22:4(7Z,10Z,13Z,16Z)/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:4(7Z,10Z,13Z,16Z)/20:1(11Z)), in particular, consists of one chain of adrenic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The adrenic acid moiety is derived from animal fats, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCCCC(=O)O[C@]([H])(COC(=O)CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C50H90NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C50H90NO8P/c1-6-8-10-12-14-16-18-20-22-24-25-27-28-30-32-34-36-38-40-42-49(52)56-46-48(47-58-60(54,55)57-45-44-51(3,4)5)59-50(53)43-41-39-37-35-33-31-29-26-23-21-19-17-15-13-11-9-7-2/h14,16,20-23,25,27,30,32,48H,6-13,15,17-19,24,26,28-29,31,33-47H2,1-5H3/b16-14-,22-20-,23-21-,27-25-,32-30-/t48-/m1/s1</moldb_inchi>
		<moldb_inchikey>OWLGRGMPPSCQNS-IHOYWFMCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>864.2253</moldb_average_mass>
		<moldb_mono_mass>863.640405373</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>518</id>
		<lmdb_id>LMDB00518</lmdb_id>
		<created_at>2016-07-13 19:51:38</created_at>
		<updated_at>2016-07-20 21:01:46</updated_at>
		<export>1</export>
		<name>PC(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))</name>
		<description>PC(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)), in particular, consists of one chain of adrenic acid at the C-1 position and one chain of mead acid at the C-2 position. The adrenic acid moiety is derived from animal fats, while the mead acid moiety is derived from fish oils, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/C\C=C/C\C=C/CCCC(=O)O[C@]([H])(COC(=O)CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C50H86NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C50H86NO8P/c1-6-8-10-12-14-16-18-20-22-24-25-27-28-30-32-34-36-38-40-42-49(52)56-46-48(47-58-60(54,55)57-45-44-51(3,4)5)59-50(53)43-41-39-37-35-33-31-29-26-23-21-19-17-15-13-11-9-7-2/h14,16,20-23,25,27,29-32,35,37,48H,6-13,15,17-19,24,26,28,33-34,36,38-47H2,1-5H3/b16-14-,22-20-,23-21-,27-25-,31-29-,32-30-,37-35-/t48-/m1/s1</moldb_inchi>
		<moldb_inchikey>TVFZCOGIQILUFS-LNKIIHJVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>860.1935</moldb_average_mass>
		<moldb_mono_mass>859.609105245</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>519</id>
		<lmdb_id>LMDB00519</lmdb_id>
		<created_at>2016-07-13 19:51:40</created_at>
		<updated_at>2016-07-20 20:43:57</updated_at>
		<export>1</export>
		<name>PC(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))</name>
		<description>PC(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z)), in particular, consists of one chain of docosapentaenoic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The docosapentaenoic acid moiety is derived from animal fats and brain, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCC</moldb_smiles>
		<moldb_formula>C44H76NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H76NO8P/c1-6-8-10-12-14-16-18-19-20-21-22-23-24-25-27-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-26-17-15-13-11-9-7-2/h13-16,19-20,22-23,25,27,30,32,42H,6-12,17-18,21,24,26,28-29,31,33-41H2,1-5H3/b15-13-,16-14-,20-19-,23-22-,27-25-,32-30-/t42-/m1/s1</moldb_inchi>
		<moldb_inchikey>XGLZBINKZRQAPD-OTMYLMJASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>778.0499</moldb_average_mass>
		<moldb_mono_mass>777.530854925</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>520</id>
		<lmdb_id>LMDB00520</lmdb_id>
		<created_at>2016-07-13 19:51:41</created_at>
		<updated_at>2016-07-20 20:43:59</updated_at>
		<export>1</export>
		<name>PC(22:5(7Z,10Z,13Z,16Z,19Z)/14:0)</name>
		<description>PC(22:5(7Z,10Z,13Z,16Z,19Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:5(7Z,10Z,13Z,16Z,19Z)/14:0), in particular, consists of one chain of docosapentaenoic acid at the C-1 position and one chain of myristic acid at the C-2 position. The docosapentaenoic acid moiety is derived from fish oils, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)O[C@]([H])(COC(=O)CCCCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C44H78NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H78NO8P/c1-6-8-10-12-14-16-18-19-20-21-22-23-24-25-27-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-26-17-15-13-11-9-7-2/h8,10,14,16,19-20,22-23,25,27,42H,6-7,9,11-13,15,17-18,21,24,26,28-41H2,1-5H3/b10-8-,16-14-,20-19-,23-22-,27-25-/t42-/m1/s1</moldb_inchi>
		<moldb_inchikey>LPZVTJRCWZIDNE-DYPKKMQZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>780.0658</moldb_average_mass>
		<moldb_mono_mass>779.546504989</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>521</id>
		<lmdb_id>LMDB00521</lmdb_id>
		<created_at>2016-07-13 19:51:42</created_at>
		<updated_at>2016-07-20 20:44:01</updated_at>
		<export>1</export>
		<name>PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0)</name>
		<description>PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0), in particular, consists of one chain of docosahexaenoic acid at the C-1 position and one chain of stearic acid at the C-2 position. The docosahexaenoic acid moiety is derived from fish oils, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)O[C@]([H])(COC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C48H84NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C48H84NO8P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-28-30-32-34-36-38-40-47(50)54-44-46(45-56-58(52,53)55-43-42-49(3,4)5)57-48(51)41-39-37-35-33-31-29-26-21-19-17-15-13-11-9-7-2/h8,10,14,16,20,22,24-25,28,30,34,36,46H,6-7,9,11-13,15,17-19,21,23,26-27,29,31-33,35,37-45H2,1-5H3/b10-8-,16-14-,22-20-,25-24-,30-28-,36-34-/t46-/m1/s1</moldb_inchi>
		<moldb_inchikey>AHWXJDWBIIDPKS-TZUVPVEASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>834.1562</moldb_average_mass>
		<moldb_mono_mass>833.593455181</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>522</id>
		<lmdb_id>LMDB00522</lmdb_id>
		<created_at>2016-07-13 19:51:44</created_at>
		<updated_at>2016-07-20 20:44:05</updated_at>
		<export>1</export>
		<name>PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-16:0)</name>
		<description>PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-16:0), in particular, consists of one chain of docosahexaenoic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The docosahexaenoic acid moiety is derived from fish oils, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC\C=C/OC(COC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C46H80NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H80NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-26-27-29-31-33-35-37-39-46(48)52-43-45(44-54-55(49,50)53-42-40-47(3,4)5)51-41-38-36-34-32-30-28-21-19-17-15-13-11-9-7-2/h8,10,14,16,20,22,24-25,27,29,33,35,38,41,45H,6-7,9,11-13,15,17-19,21,23,26,28,30-32,34,36-37,39-40,42-44H2,1-5H3/b10-8-,16-14-,22-20-,25-24-,29-27-,35-33-,41-38-</moldb_inchi>
		<moldb_inchikey>GJRXIEGNAMFGOV-VEOGPPBOSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>790.1037</moldb_average_mass>
		<moldb_mono_mass>789.567240431</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>523</id>
		<lmdb_id>LMDB00523</lmdb_id>
		<created_at>2016-07-13 19:51:45</created_at>
		<updated_at>2016-07-20 20:44:06</updated_at>
		<export>1</export>
		<name>PC(24:1(15Z)/P-18:1(11Z))</name>
		<description>PC(24:1(15Z)/P-18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(24:1(15Z)/P-18:1(11Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The nervonic acid moiety is derived from fish oils, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC[N+](C)(C)C)O\C=C/CCCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C50H96NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C50H96NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-26-27-28-29-31-33-35-37-39-41-43-50(52)56-47-49(48-58-59(53,54)57-46-44-51(3,4)5)55-45-42-40-38-36-34-32-30-23-21-19-17-15-13-11-9-7-2/h17,19-20,22,42,45,49H,6-16,18,21,23-41,43-44,46-48H2,1-5H3/b19-17-,22-20-,45-42-</moldb_inchi>
		<moldb_inchikey>XUCRMKOOPPYQFN-JFKFTMGCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>854.2735</moldb_average_mass>
		<moldb_mono_mass>853.692440943</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>524</id>
		<lmdb_id>LMDB00524</lmdb_id>
		<created_at>2016-07-13 19:51:46</created_at>
		<updated_at>2016-09-23 18:45:37</updated_at>
		<export>1</export>
		<name>SM(d18:1/16:0)</name>
		<description>Sphingomyelin (d18:1/16:0) or SM(d18:1/16:0) is a sphingomyelin. Sphingomyelin (SM or SPH) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. SM(18:1/16:0) consists of oleic acid attached to the C1 position and palmitic acid attached to the C2 position. In animals, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)N[C@@]([H])(COP(O)(=O)OCC[N+](C)(C)C)[C@]([H])(O)\C=C\CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C39H80N2O6P</moldb_formula>
		<moldb_inchi>InChI=1S/C39H79N2O6P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-38(42)37(36-47-48(44,45)46-35-34-41(3,4)5)40-39(43)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h30,32,37-38,42H,6-29,31,33-36H2,1-5H3,(H-,40,43,44,45)/p+1/b32-30+/t37-,38+/m0/s1</moldb_inchi>
		<moldb_inchikey>RWKUXQNLWDTSLO-GWQJGLRPSA-O</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>704.0361</moldb_average_mass>
		<moldb_mono_mass>703.575399814</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>525</id>
		<lmdb_id>LMDB00525</lmdb_id>
		<created_at>2016-07-13 19:51:48</created_at>
		<updated_at>2016-08-02 20:40:30</updated_at>
		<export>1</export>
		<name>LysoPC(14:0)</name>
		<description>LysoPC(14:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(14:0), in particular, consists of one chain of myristic acid at the C-1 position. The myristic acid moiety is derived from nutmeg and butter. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C22H46NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C22H46NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-22(25)28-19-21(24)20-30-31(26,27)29-18-17-23(2,3)4/h21,24H,5-20H2,1-4H3/t21-/m1/s1</moldb_inchi>
		<moldb_inchikey>VXUOFDJKYGDUJI-OAQYLSRUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>467.5769</moldb_average_mass>
		<moldb_mono_mass>467.301189343</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>526</id>
		<lmdb_id>LMDB00526</lmdb_id>
		<created_at>2016-07-13 19:51:49</created_at>
		<updated_at>2016-07-20 21:04:12</updated_at>
		<export>1</export>
		<name>LysoPC(16:0)</name>
		<description>LysoPC(16:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(16:0), in particular, consists of one chain of palmitic acid at the C-1 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CCCCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C24H50NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C24H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-24(27)30-21-23(26)22-32-33(28,29)31-20-19-25(2,3)4/h23,26H,5-22H2,1-4H3/t23-/m1/s1</moldb_inchi>
		<moldb_inchikey>ASWBNKHCZGQVJV-HSZRJFAPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>495.6301</moldb_average_mass>
		<moldb_mono_mass>495.332489471</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>527</id>
		<lmdb_id>LMDB00527</lmdb_id>
		<created_at>2016-07-13 19:51:50</created_at>
		<updated_at>2016-07-20 20:53:52</updated_at>
		<export>1</export>
		<name>LysoPC(16:1(9Z))</name>
		<description>LysoPC(16:1(9Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(16:1(9Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCCCC(=O)OC[C@@]([H])(O)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C24H48NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C24H48NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-24(27)30-21-23(26)22-32-33(28,29)31-20-19-25(2,3)4/h10-11,23,26H,5-9,12-22H2,1-4H3/b11-10-/t23-/m1/s1</moldb_inchi>
		<moldb_inchikey>LFUDDCMNKWEORN-ZXEGGCGDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>493.6142</moldb_average_mass>
		<moldb_mono_mass>493.316839407</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>528</id>
		<lmdb_id>LMDB00528</lmdb_id>
		<created_at>2016-07-13 19:51:52</created_at>
		<updated_at>2016-08-02 20:40:16</updated_at>
		<export>1</export>
		<name>LysoPC(18:0)</name>
		<description>LysoPC(18:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:0), in particular, consists of one chain of stearic acid at the C-1 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CCCCCCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C26H54NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C26H54NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h25,28H,5-24H2,1-4H3/t25-/m1/s1</moldb_inchi>
		<moldb_inchikey>IHNKQIMGVNPMTC-RUZDIDTESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>523.6832</moldb_average_mass>
		<moldb_mono_mass>523.363789599</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>529</id>
		<lmdb_id>LMDB00529</lmdb_id>
		<created_at>2016-07-13 19:51:53</created_at>
		<updated_at>2016-07-20 20:53:53</updated_at>
		<export>1</export>
		<name>LysoPC(18:1(11Z))</name>
		<description>LysoPC(18:1(11Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:1(11Z)), in particular, consists of one chain of vaccenic acid at the C-1 position. The vaccenic acid moiety is derived from butter fat and animal fat. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCCCCCC(=O)OC[C@@]([H])(O)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C26H52NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C26H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h10-11,25,28H,5-9,12-24H2,1-4H3/b11-10-/t25-/m1/s1</moldb_inchi>
		<moldb_inchikey>PZRFVAHZNWPPAC-VBKSFVIKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>521.6673</moldb_average_mass>
		<moldb_mono_mass>521.348139535</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>530</id>
		<lmdb_id>LMDB00530</lmdb_id>
		<created_at>2016-07-13 19:51:54</created_at>
		<updated_at>2016-08-02 20:39:26</updated_at>
		<export>1</export>
		<name>LysoPC(18:2(9Z,12Z))</name>
		<description>LysoPC(18:2(9Z,12Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:2(9Z,12Z)), in particular, consists of one chain of linoleic acid at the C-1 position. The linoleic acid moiety is derived from seed oils. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@]([H])(O)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C26H50NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C26H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h9-10,12-13,25,28H,5-8,11,14-24H2,1-4H3/b10-9-,13-12-/t25-/m1/s1</moldb_inchi>
		<moldb_inchikey>SPJFYYJXNPEZDW-FTJOPAKQSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>519.6515</moldb_average_mass>
		<moldb_mono_mass>519.332489471</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>531</id>
		<lmdb_id>LMDB00531</lmdb_id>
		<created_at>2016-07-13 19:51:55</created_at>
		<updated_at>2016-07-20 21:01:53</updated_at>
		<export>1</export>
		<name>LysoPC(18:3(6Z,9Z,12Z))</name>
		<description>LysoPC(18:3(6Z,9Z,12Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:3(6Z,9Z,12Z)), in particular, consists of one chain of g-linolenic acid at the C-1 position. The g-linolenic acid moiety is derived from animal fats. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/C\C=C/CCCCC(=O)OC[C@](O)([H])COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C26H48NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C26H48NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h9-10,12-13,15-16,25,28H,5-8,11,14,17-24H2,1-4H3/b10-9-,13-12-,16-15-/t25-/m1/s1</moldb_inchi>
		<moldb_inchikey>MRTUWVDDQVMUCR-ACHCNROVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>517.6356</moldb_average_mass>
		<moldb_mono_mass>517.316839407</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>532</id>
		<lmdb_id>LMDB00532</lmdb_id>
		<created_at>2016-07-13 19:51:57</created_at>
		<updated_at>2016-07-20 21:01:53</updated_at>
		<export>1</export>
		<name>LysoPC(20:2(11Z,14Z))</name>
		<description>LysoPC(20:2(11Z,14Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(20:2(11Z,14Z)), in particular, consists of one chain of eicosadienoic acid at the C-1 position. The eicosadienoic acid moiety is derived from fish oils and liver. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/CCCCCCCCCC(=O)OC[C@](O)([H])COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C28H54NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C28H54NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-28(31)34-25-27(30)26-36-37(32,33)35-24-23-29(2,3)4/h9-10,12-13,27,30H,5-8,11,14-26H2,1-4H3/b10-9-,13-12-/t27-/m1/s1</moldb_inchi>
		<moldb_inchikey>YYQVCMMXPIJVHY-ZOIJLGJPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>547.7046</moldb_average_mass>
		<moldb_mono_mass>547.363789599</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>533</id>
		<lmdb_id>LMDB00533</lmdb_id>
		<created_at>2016-07-13 19:51:58</created_at>
		<updated_at>2016-07-20 20:53:54</updated_at>
		<export>1</export>
		<name>LysoPC(20:3(5Z,8Z,11Z))</name>
		<description>LysoPC(20:3(5Z,8Z,11Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(20:3(5Z,8Z,11Z)), in particular, consists of one chain of mead acid at the C-1 position. The mead acid moiety is derived from fish oils, liver and kidney. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/C\C=C/C\C=C/CCCC(=O)OC[C@@]([H])(O)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C28H52NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C28H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-28(31)34-25-27(30)26-36-37(32,33)35-24-23-29(2,3)4/h12-13,15-16,18-19,27,30H,5-11,14,17,20-26H2,1-4H3/b13-12-,16-15-,19-18-/t27-/m1/s1</moldb_inchi>
		<moldb_inchikey>YHGXYYIGHBPDMX-BUTFDPNWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>545.6887</moldb_average_mass>
		<moldb_mono_mass>545.348139535</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>534</id>
		<lmdb_id>LMDB00534</lmdb_id>
		<created_at>2016-07-13 19:51:59</created_at>
		<updated_at>2016-07-20 20:53:55</updated_at>
		<export>1</export>
		<name>LysoPC(20:4(5Z,8Z,11Z,14Z))</name>
		<description>LysoPC(20:4(5Z,8Z,11Z,14Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(20:4(5Z,8Z,11Z,14Z)), in particular, consists of one chain of arachidonic acid at the C-1 position. The arachidonic acid moiety is derived from animal fats and eggs. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC[C@](O)([H])COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C28H50NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C28H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-28(31)34-25-27(30)26-36-37(32,33)35-24-23-29(2,3)4/h9-10,12-13,15-16,18-19,27,30H,5-8,11,14,17,20-26H2,1-4H3/b10-9-,13-12-,16-15-,19-18-/t27-/m1/s1</moldb_inchi>
		<moldb_inchikey>LAXQYRRMGGEGOH-JXRLJXCWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>543.6729</moldb_average_mass>
		<moldb_mono_mass>543.332489471</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>535</id>
		<lmdb_id>LMDB00535</lmdb_id>
		<created_at>2016-07-13 19:52:01</created_at>
		<updated_at>2016-07-20 21:01:54</updated_at>
		<export>1</export>
		<name>LysoPC(20:5(5Z,8Z,11Z,14Z,17Z))</name>
		<description>LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)), in particular, consists of one chain of eicosapentaenoic acid at the C-1 position. The eicosapentaenoic acid moiety is derived from fish oils, liver and kidney. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC[C@](O)([H])COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C28H48NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C28H48NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-28(31)34-25-27(30)26-36-37(32,33)35-24-23-29(2,3)4/h6-7,9-10,12-13,15-16,18-19,27,30H,5,8,11,14,17,20-26H2,1-4H3/b7-6-,10-9-,13-12-,16-15-,19-18-/t27-/m1/s1</moldb_inchi>
		<moldb_inchikey>PDIGSOAOQOXRDU-WJPZTBRDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>541.6570</moldb_average_mass>
		<moldb_mono_mass>541.316839407</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>536</id>
		<lmdb_id>LMDB00536</lmdb_id>
		<created_at>2016-07-13 19:52:02</created_at>
		<updated_at>2016-07-20 21:04:13</updated_at>
		<export>1</export>
		<name>LysoPC(22:4(7Z,10Z,13Z,16Z))</name>
		<description>LysoPC(22:4(7Z,10Z,13Z,16Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(22:4(7Z,10Z,13Z,16Z)), in particular, consists of one chain of adrenic acid at the C-1 position. The adrenic acid moiety is derived from animal fats. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(=O)OC[C@](O)([H])COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C30H54NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C30H54NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-30(33)36-27-29(32)28-38-39(34,35)37-26-25-31(2,3)4/h9-10,12-13,15-16,18-19,29,32H,5-8,11,14,17,20-28H2,1-4H3/b10-9-,13-12-,16-15-,19-18-/t29-/m1/s1</moldb_inchi>
		<moldb_inchikey>ZOJBSSVHFSBHMP-JJJSWPRASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>571.7260</moldb_average_mass>
		<moldb_mono_mass>571.363789599</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>537</id>
		<lmdb_id>LMDB00537</lmdb_id>
		<created_at>2016-07-13 19:52:03</created_at>
		<updated_at>2016-07-20 21:04:13</updated_at>
		<export>1</export>
		<name>LysoPC(22:5(4Z,7Z,10Z,13Z,16Z))</name>
		<description>LysoPC(22:5(4Z,7Z,10Z,13Z,16Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(22:5(4Z,7Z,10Z,13Z,16Z)), in particular, consists of one chain of docosapentaenoic acid at the C-1 position. The docosapentaenoic acid moiety is derived from animal fats and brain. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)OC[C@](O)([H])COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C30H52NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C30H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-30(33)36-27-29(32)28-38-39(34,35)37-26-25-31(2,3)4/h9-10,12-13,15-16,18-19,21-22,29,32H,5-8,11,14,17,20,23-28H2,1-4H3/b10-9-,13-12-,16-15-,19-18-,22-21-/t29-/m1/s1</moldb_inchi>
		<moldb_inchikey>YBUXFQUGNPBZPS-YNBHEIDWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>569.7101</moldb_average_mass>
		<moldb_mono_mass>569.348139535</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>538</id>
		<lmdb_id>LMDB00538</lmdb_id>
		<created_at>2016-07-13 19:52:05</created_at>
		<updated_at>2018-04-30 21:14:53</updated_at>
		<export>1</export>
		<name>LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z))</name>
		<description>LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of docosahexaenoic acid at the C-1 position. The docosahexaenoic acid moiety is derived from fish oils. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C30H50NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C30H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-30(33)36-27-29(32)28-38-39(34,35)37-26-25-31(2,3)4/h6-7,9-10,12-13,15-16,18-19,21-22,29,32H,5,8,11,14,17,20,23-28H2,1-4H3/b7-6-,10-9-,13-12-,16-15-,19-18-,22-21-/t29-/m1/s1</moldb_inchi>
		<moldb_inchikey>LSOWKZULVQWMLY-APPDJCNMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>567.6943</moldb_average_mass>
		<moldb_mono_mass>567.332489471</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>539</id>
		<lmdb_id>LMDB00539</lmdb_id>
		<created_at>2016-07-13 19:52:06</created_at>
		<updated_at>2016-07-20 21:01:54</updated_at>
		<export>1</export>
		<name>Galactosylceramide (d18:1/20:0) </name>
		<description>Galactosylceramides (GalCer) are non-acidic monoglycosphingolipids, i.e. a sphingolipid with one carbohydrate moiety attached to a ceramide unit. They are an intermediate in sphingolipid metabolism and is the second to last step in the synthesis of digalactosylceramidesulfate. GalCer is generated from ceramide via the enzyme UDP-galactose ceramide galactosyltransferase [EC:2.4.1.47]. It can be converted to digalactosylceramide via the enzyme glycosyltransferases [EC 2.4.1.-]. Galactosylceramide is the principal glycosphingolipid in brain tissue, hence the trivial name &quot;cerebroside&quot;, which was first conferred on it in 1874. Galactosylceramides are found in all nervous tissues, but they can amount to 2% of the dry weight of grey matter and 12% of white matter. They are major constituents of oligodendrocytes. Synthesis of galactosylceramide takes place on the lumenal surface of the endoplasmic reticulum, although it has free access to the cytosolic surface by an energy-independent flip-flop process. GalCer sits in the extracellular leaflet of cell membranes in nanometer sized domains or rafts. The local clustering of GalCer within rafts is thought to facilitate the initial adhesion of certain viruses, including HIV-1 and bacteria to cells through multivalent interactions between receptor proteins and GalCer. A defect in the degradation of cerbrosides leads to a disorder called Krabbe disease. Krabbe disease (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare, often fatal degenerative disorder that affects the myelin sheath of the nervous system. Krabbe disease is caused by mutations in the GALC gene, which causes a deficiency of galactosylceramidase. Infants with Krabbe disease are normal at birth. Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures, feeding difficulties, vomiting, and slowing of mental and motor development. There are also juvenile- and adult-onset cases of Krabbe disease, which have similar symptoms but slower progression. In infants, the disease is generally fatal before age 2. Patients with late-onset Krabbe disease tend to have a slower progression of the disease and live significantly longer.Cerebrosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Cerebrosides have a single sugar group linked to ceramide. The most common are galactocerebrosides (containing galactose), the least common are glucocerebrosides (containing glucose). Galactocerebrosides are found predominantly in neuronal cell membranes. In contrast glucocerebrosides are not normally found in membranes. Instead, they are typically intermediates in the synthesis or degradation of more complex glycosphingolipids. Galactocerebrosides are synthesized from ceramide and UDP-galactose. Excess lysosomal accumulation of glucocerebrosides is found in Gaucher disease.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCC(=O)NC(CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)C(O)\C=C/CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C44H85NO8</moldb_formula>
		<moldb_inchi>InChI=1S/C44H85NO8/c1-3-5-7-9-11-13-15-17-18-19-20-22-24-26-28-30-32-34-40(48)45-37(36-52-44-43(51)42(50)41(49)39(35-46)53-44)38(47)33-31-29-27-25-23-21-16-14-12-10-8-6-4-2/h31,33,37-39,41-44,46-47,49-51H,3-30,32,34-36H2,1-2H3,(H,45,48)/b33-31-/t37?,38?,39-,41+,42+,43-,44-/m1/s1</moldb_inchi>
		<moldb_inchikey>DFELABABMXOKTD-RBULGSFCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>756.1476</moldb_average_mass>
		<moldb_mono_mass>755.627518701</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>540</id>
		<lmdb_id>LMDB00540</lmdb_id>
		<created_at>2016-07-13 19:52:07</created_at>
		<updated_at>2016-07-20 21:01:55</updated_at>
		<export>1</export>
		<name>LysoPC(0:0/18:0)</name>
		<description>LysoPC(0:0/18:0) or LPC(0:0/18:0) is a lysophospholipid. The term 'lysophospholipid' (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix 'lyso-' comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. There is also a phospholipase A1, which is able to cleave the sn-1 ester bond. Lysophosphatidylcholine has pro-inflammatory properties in vitro and it is known to be a pathological component of oxidized lipoproteins (LDL) in plasma and of atherosclerotic lesions. Recently, it has been found to have some functions in cell signalling, and specific receptors (coupled to G proteins) have been identified. It activates the specific phospholipase C that releases diacylglycerols and inositol triphosphate with resultant increases in intracellular Ca2+ and activation of protein kinase C. It also activates the mitogen-activated protein kinase in certain cell types.LysoPC(0:0/18:0) has been shown to be protective against lethal sepsis in experimental animals by various mechanisms, including stimulation of neutrophils to eliminate invading pathogens through a peroxide-dependent reaction.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](CO)(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C26H54NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C26H54NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)34-25(23-28)24-33-35(30,31)32-22-21-27(2,3)4/h25,28H,5-24H2,1-4H3/t25-/m1/s1</moldb_inchi>
		<moldb_inchikey>IQGPMZRCLCCXAG-RUZDIDTESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>523.6832</moldb_average_mass>
		<moldb_mono_mass>523.363789599</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>541</id>
		<lmdb_id>LMDB00541</lmdb_id>
		<created_at>2016-07-13 19:52:08</created_at>
		<updated_at>2016-07-20 21:01:55</updated_at>
		<export>1</export>
		<name>LysoPE(0:0/18:0)</name>
		<description>LysoPE(0:0/18:0) or LPE(0:0/18:0) is a lysophospholipid. The term 'lysophospholipid' (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix 'lyso-' comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](CO)(COP(O)(=O)OCCN)OC(=O)CCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C23H48NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C23H48NO7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-23(26)31-22(20-25)21-30-32(27,28)29-19-18-24/h22,25H,2-21,24H2,1H3,(H,27,28)/t22-/m1/s1</moldb_inchi>
		<moldb_inchikey>KIHAGWUUUHJRMS-JOCHJYFZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>481.6035</moldb_average_mass>
		<moldb_mono_mass>481.316839407</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>542</id>
		<lmdb_id>LMDB00542</lmdb_id>
		<created_at>2016-07-13 19:52:10</created_at>
		<updated_at>2016-07-20 20:44:50</updated_at>
		<export>1</export>
		<name>PC(O-16:0/18:2(9Z,12Z))</name>
		<description>PC(O-16:0/18:2(9Z,12Z)) is an ether lipid. Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage.Phosphatidylcholines are a class of phospholipids which incorporate choline as a headgroup. They are a major component of biological membranes and can be isolated from either egg yolk (in Greek lekithos) or soy beans from which they are mechanically extracted or chemically extracted using hexane.Phosphatidylcholines are such a major component of lecithin, that, in some contexts, the terms are sometime used as synonyms. However, lecithin extract consists of a mixture of phosphatidylcholine and other compounds. It is also used along with sodium taurocholate for simulating fed- and fasted-state biorelevant media in dissolution studies of highly-lipophilic drugs. Phosphatidylcholine is a major constituent of cell membranes, and also plays a role in membrane-mediated cell signalling.Phospholipase D catalyzes the hydrolysis of phosphatidylcholine to form phosphatidic acid (PA), releasing the soluble choline headgroup into the cytosol. Some medical researchers are experimenting with using Phosphatidylcholine in a type of injection that will break down fat cells; to be used as an alternative to liposuction known as Injection lipolysis. (Wikipedia)While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>88542-95-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C42H82NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C42H82NO7P/c1-6-8-10-12-14-16-18-20-22-23-25-27-29-31-33-35-42(44)50-41(40-49-51(45,46)48-38-36-43(3,4)5)39-47-37-34-32-30-28-26-24-21-19-17-15-13-11-9-7-2/h14,16,20,22,41H,6-13,15,17-19,21,23-40H2,1-5H3/b16-14-,22-20-/t41-/m1/s1</moldb_inchi>
		<moldb_inchikey>IQACMFWAGALEAQ-WESJWMGVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>744.0767</moldb_average_mass>
		<moldb_mono_mass>743.582890495</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>543</id>
		<lmdb_id>LMDB00543</lmdb_id>
		<created_at>2016-07-13 19:52:11</created_at>
		<updated_at>2016-07-20 20:44:52</updated_at>
		<export>1</export>
		<name>PC(22:1(13Z)/18:1(11Z))</name>
		<description>PC(22:1(13Z)/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:1(13Z)/18:1(11Z)), in particular, consists of one chain of erucic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C48H92NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C48H92NO8P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-28-30-32-34-36-38-40-47(50)54-44-46(45-56-58(52,53)55-43-42-49(3,4)5)57-48(51)41-39-37-35-33-31-29-26-21-19-17-15-13-11-9-7-2/h17,19-20,22,46H,6-16,18,21,23-45H2,1-5H3/b19-17-,22-20-/t46-/m1/s1</moldb_inchi>
		<moldb_inchikey>VMYYPARBVHMEFG-WQZYGQBESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>842.2197</moldb_average_mass>
		<moldb_mono_mass>841.656055437</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>544</id>
		<lmdb_id>LMDB00544</lmdb_id>
		<created_at>2016-07-13 19:52:12</created_at>
		<updated_at>2016-07-20 20:44:54</updated_at>
		<export>1</export>
		<name>PC(P-16:0/14:0)</name>
		<description>PC(P-16:0/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/14:0), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of myristic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC\C=C/OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C38H76NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C38H76NO7P/c1-6-8-10-12-14-16-18-19-20-22-24-26-28-30-33-43-35-37(36-45-47(41,42)44-34-32-39(3,4)5)46-38(40)31-29-27-25-23-21-17-15-13-11-9-7-2/h30,33,37H,6-29,31-32,34-36H2,1-5H3/b33-30-/t37-/m1/s1</moldb_inchi>
		<moldb_inchikey>SOUFUEMRDVBNJD-APMJBGCSSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>689.9863</moldb_average_mass>
		<moldb_mono_mass>689.535940303</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>545</id>
		<lmdb_id>LMDB00545</lmdb_id>
		<created_at>2016-07-13 19:52:14</created_at>
		<updated_at>2016-07-20 20:44:57</updated_at>
		<export>1</export>
		<name>PC(P-16:0/18:3(9Z,12Z,15Z))</name>
		<description>PC(P-16:0/18:3(9Z,12Z,15Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/18:3(9Z,12Z,15Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of a-linolenic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC\C=C/OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC</moldb_smiles>
		<moldb_formula>C42H78NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C42H78NO7P/c1-6-8-10-12-14-16-18-20-22-23-25-27-29-31-33-35-42(44)50-41(40-49-51(45,46)48-38-36-43(3,4)5)39-47-37-34-32-30-28-26-24-21-19-17-15-13-11-9-7-2/h8,10,14,16,20,22,34,37,41H,6-7,9,11-13,15,17-19,21,23-33,35-36,38-40H2,1-5H3/b10-8-,16-14-,22-20-,37-34-/t41-/m1/s1</moldb_inchi>
		<moldb_inchikey>WXQJKOUXCWEMOK-LUPMRSKMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>740.0450</moldb_average_mass>
		<moldb_mono_mass>739.551590367</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>546</id>
		<lmdb_id>LMDB00546</lmdb_id>
		<created_at>2016-07-13 19:52:15</created_at>
		<updated_at>2016-07-20 20:44:58</updated_at>
		<export>1</export>
		<name>PC(P-16:0/20:1(11Z))</name>
		<description>PC(P-16:0/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/20:1(11Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of eicosenoic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC\C=C/OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCC\C=C/CCCCCCCC</moldb_smiles>
		<moldb_formula>C44H86NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H86NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-29-31-33-35-37-44(46)52-43(42-51-53(47,48)50-40-38-45(3,4)5)41-49-39-36-34-32-30-28-26-21-19-17-15-13-11-9-7-2/h20,22,36,39,43H,6-19,21,23-35,37-38,40-42H2,1-5H3/b22-20-,39-36-/t43-/m1/s1</moldb_inchi>
		<moldb_inchikey>WXILBCFZIXHZIG-KOUVQCMKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>772.1299</moldb_average_mass>
		<moldb_mono_mass>771.614190623</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>547</id>
		<lmdb_id>LMDB00547</lmdb_id>
		<created_at>2016-07-13 19:52:16</created_at>
		<updated_at>2016-07-20 21:01:56</updated_at>
		<export>1</export>
		<name>PC(dm16:0/dm16:0)</name>
		<description>PC(dm16:0/dm16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(dm16:0/dm16:0), in particular, consists of two chains of plasmalogen 16:0 at the C-1 and C-2 positions. The plasmalogen 16:0 moieties are derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NULL</moldb_smiles>
		<moldb_formula>NULL</moldb_formula>
		<moldb_inchi>NULL</moldb_inchi>
		<moldb_inchikey>NULL</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>NULL</moldb_average_mass>
		<moldb_mono_mass>NULL</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>548</id>
		<lmdb_id>LMDB00548</lmdb_id>
		<created_at>2016-07-13 19:52:17</created_at>
		<updated_at>2016-07-20 20:45:02</updated_at>
		<export>1</export>
		<name>PC(P-18:0/20:3(8Z,11Z,14Z))</name>
		<description>PC(P-18:0/20:3(8Z,11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/20:3(8Z,11Z,14Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of homo-g-linolenic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the homo-g-linolenic acid moiety is derived from fish oils, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC\C=C/OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCC\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C46H86NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H86NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h14,16,20,22,25,27,38,41,45H,6-13,15,17-19,21,23-24,26,28-37,39-40,42-44H2,1-5H3/b16-14-,22-20-,27-25-,41-38-/t45-/m1/s1</moldb_inchi>
		<moldb_inchikey>LIRPHCPLRLOMHJ-ABWFFGIPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>796.1513</moldb_average_mass>
		<moldb_mono_mass>795.614190623</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>549</id>
		<lmdb_id>LMDB00549</lmdb_id>
		<created_at>2016-07-13 19:52:18</created_at>
		<updated_at>2016-07-20 20:45:05</updated_at>
		<export>1</export>
		<name>PC(P-18:0/22:4(7Z,10Z,13Z,16Z))</name>
		<description>PC(P-18:0/22:4(7Z,10Z,13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/22:4(7Z,10Z,13Z,16Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of adrenic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the adrenic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC\C=C/OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C48H88NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C48H88NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-26-27-29-31-33-35-37-39-41-48(50)56-47(46-55-57(51,52)54-44-42-49(3,4)5)45-53-43-40-38-36-34-32-30-28-23-21-19-17-15-13-11-9-7-2/h14,16,20,22,25-26,29,31,40,43,47H,6-13,15,17-19,21,23-24,27-28,30,32-39,41-42,44-46H2,1-5H3/b16-14-,22-20-,26-25-,31-29-,43-40-/t47-/m1/s1</moldb_inchi>
		<moldb_inchikey>VDLGCGQWZPLRIL-PRDDZFMDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>822.1886</moldb_average_mass>
		<moldb_mono_mass>821.629840687</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>550</id>
		<lmdb_id>LMDB00550</lmdb_id>
		<created_at>2016-07-13 19:52:20</created_at>
		<updated_at>2016-07-20 20:45:09</updated_at>
		<export>1</export>
		<name>PC(P-18:1(11Z)/18:3(9Z,12Z,15Z))</name>
		<description>PC(P-18:1(11Z)/18:3(9Z,12Z,15Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/18:3(9Z,12Z,15Z)), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of a-linolenic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCCCC\C=C/OCC(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC</moldb_smiles>
		<moldb_formula>C44H80NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H80NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-39-49-41-43(42-51-53(47,48)50-40-38-45(3,4)5)52-44(46)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h9,11,15-18,21,23,36,39,43H,6-8,10,12-14,19-20,22,24-35,37-38,40-42H2,1-5H3/b11-9-,17-15-,18-16-,23-21-,39-36-</moldb_inchi>
		<moldb_inchikey>JPNFMUKASUYGCK-ZXWSQSGJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>766.0823</moldb_average_mass>
		<moldb_mono_mass>765.567240431</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>551</id>
		<lmdb_id>LMDB00551</lmdb_id>
		<created_at>2016-07-13 19:52:21</created_at>
		<updated_at>2016-07-20 20:45:12</updated_at>
		<export>1</export>
		<name>PC(P-18:1(11Z)/20:4(5Z,8Z,11Z,14Z))</name>
		<description>PC(P-18:1(11Z)/20:4(5Z,8Z,11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/20:4(5Z,8Z,11Z,14Z)), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of arachidonic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the arachidonic acid moiety is derived from animal fats and eggs. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCCCC\C=C/OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C46H82NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H82NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h14,16-17,19-20,22,25,27,31,33,38,41,45H,6-13,15,18,21,23-24,26,28-30,32,34-37,39-40,42-44H2,1-5H3/b16-14-,19-17-,22-20-,27-25-,33-31-,41-38-/t45-/m1/s1</moldb_inchi>
		<moldb_inchikey>HFQNRECNIUNPMU-PAAZZWMASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>792.1195</moldb_average_mass>
		<moldb_mono_mass>791.582890495</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>552</id>
		<lmdb_id>LMDB00552</lmdb_id>
		<created_at>2016-07-13 19:52:23</created_at>
		<updated_at>2016-07-20 20:45:14</updated_at>
		<export>1</export>
		<name>PC(P-18:1(11Z)/22:2(13Z,16Z))</name>
		<description>PC(P-18:1(11Z)/22:2(13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/22:2(13Z,16Z)), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of docosadienoic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the docosadienoic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCCCC\C=C/OCC(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C48H90NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C48H90NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-26-27-29-31-33-35-37-39-41-48(50)56-47(46-55-57(51,52)54-44-42-49(3,4)5)45-53-43-40-38-36-34-32-30-28-23-21-19-17-15-13-11-9-7-2/h14,16-17,19-20,22,40,43,47H,6-13,15,18,21,23-39,41-42,44-46H2,1-5H3/b16-14-,19-17-,22-20-,43-40-</moldb_inchi>
		<moldb_inchikey>GCJYMGXKZROELS-ARPDTERPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>824.2045</moldb_average_mass>
		<moldb_mono_mass>823.645490751</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>553</id>
		<lmdb_id>LMDB00553</lmdb_id>
		<created_at>2016-07-13 19:52:24</created_at>
		<updated_at>2016-07-19 23:31:58</updated_at>
		<export>1</export>
		<name>PC(P-18:1(11Z)/24:0)</name>
		<description>PC(P-18:1(11Z)/24:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/24:0), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of lignoceric acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@]([H])(CO\C=C/CCCCCCCC\C=C/CCCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C50H98NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C50H98NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-26-27-28-29-31-33-35-37-39-41-43-50(52)58-49(48-57-59(53,54)56-46-44-51(3,4)5)47-55-45-42-40-38-36-34-32-30-23-21-19-17-15-13-11-9-7-2/h17,19,42,45,49H,6-16,18,20-41,43-44,46-48H2,1-5H3/b19-17-,45-42-/t49-/m1/s1</moldb_inchi>
		<moldb_inchikey>FKJFQKGICJZAJQ-XWKRXFSPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>856.2894</moldb_average_mass>
		<moldb_mono_mass>855.708091007</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>554</id>
		<lmdb_id>LMDB00554</lmdb_id>
		<created_at>2016-07-13 19:52:25</created_at>
		<updated_at>2016-07-20 20:45:16</updated_at>
		<export>1</export>
		<name>PC(P-18:1(9Z)/14:1(9Z))</name>
		<description>PC(P-18:1(9Z)/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/14:1(9Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of myristoleic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCC\C=C/OCC(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCC</moldb_smiles>
		<moldb_formula>C40H76NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C40H76NO7P/c1-6-8-10-12-14-16-18-19-20-21-22-24-26-28-30-32-35-45-37-39(38-47-49(43,44)46-36-34-41(3,4)5)48-40(42)33-31-29-27-25-23-17-15-13-11-9-7-2/h13,15,19-20,32,35,39H,6-12,14,16-18,21-31,33-34,36-38H2,1-5H3/b15-13-,20-19-,35-32-</moldb_inchi>
		<moldb_inchikey>HBSHQXCUTWXTCM-WLTDODEOSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>714.0077</moldb_average_mass>
		<moldb_mono_mass>713.535940303</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>555</id>
		<lmdb_id>LMDB00555</lmdb_id>
		<created_at>2016-07-13 19:52:27</created_at>
		<updated_at>2016-07-20 20:45:20</updated_at>
		<export>1</export>
		<name>PC(P-18:1(9Z)/18:2(9Z,12Z))</name>
		<description>PC(P-18:1(9Z)/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/18:2(9Z,12Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of linoleic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCC\C=C/OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C44H82NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H82NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-39-49-41-43(42-51-53(47,48)50-40-38-45(3,4)5)52-44(46)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h15,17,20-23,36,39,43H,6-14,16,18-19,24-35,37-38,40-42H2,1-5H3/b17-15-,22-20-,23-21-,39-36-/t43-/m1/s1</moldb_inchi>
		<moldb_inchikey>GCJSAIGGRCSHDG-UWGOCUKWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>768.0981</moldb_average_mass>
		<moldb_mono_mass>767.582890495</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>556</id>
		<lmdb_id>LMDB00556</lmdb_id>
		<created_at>2016-07-13 19:52:28</created_at>
		<updated_at>2016-07-20 20:45:23</updated_at>
		<export>1</export>
		<name>PC(P-18:1(9Z)/20:3(5Z,8Z,11Z))</name>
		<description>PC(P-18:1(9Z)/20:3(5Z,8Z,11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/20:3(5Z,8Z,11Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of mead acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the mead acid moiety is derived from fish oils, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCC\C=C/OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/CCCCCCCC</moldb_smiles>
		<moldb_formula>C46H84NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H84NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h20-23,25,27,31,33,38,41,45H,6-19,24,26,28-30,32,34-37,39-40,42-44H2,1-5H3/b22-20-,23-21-,27-25-,33-31-,41-38-/t45-/m1/s1</moldb_inchi>
		<moldb_inchikey>CJYQPRLJFDUQJN-XDCBNNJESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>794.1354</moldb_average_mass>
		<moldb_mono_mass>793.598540559</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>557</id>
		<lmdb_id>LMDB00557</lmdb_id>
		<created_at>2016-07-13 19:52:29</created_at>
		<updated_at>2016-08-09 21:33:36</updated_at>
		<export>1</export>
		<name>PC(dm18:1(9Z)/dm18:1(9Z))</name>
		<description>PC(dm18:1(9Z)/dm18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(dm18:1(9Z)/dm18:1(9Z)), in particular, consists of two chains of plasmalogen 18:1n9 at the C-1 and C-2 positions. The plasmalogen 18:1n9 moieties are derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CCOC1=O)NC(=O)C(=O)CCCC</moldb_smiles>
		<moldb_formula>C10H15NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C10H15NO4/c1-2-3-4-8(12)9(13)11-7-5-6-15-10(7)14/h7H,2-6H2,1H3,(H,11,13)/t7-/m0/s1</moldb_inchi>
		<moldb_inchikey>HXDSMMVKIYAMIA-ZETCQYMHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>213.2304</moldb_average_mass>
		<moldb_mono_mass>213.100107973</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>558</id>
		<lmdb_id>LMDB00558</lmdb_id>
		<created_at>2016-07-13 19:52:30</created_at>
		<updated_at>2016-07-20 21:04:14</updated_at>
		<export>1</export>
		<name>LysoPE(18:2(9Z,12Z)/0:0)</name>
		<description>LysoPE(18:2(9Z,12Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term 'lysophospholipid' (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix 'lyso-' comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CCCCCCC\C=C/C\C=C/CCCCC)COP(O)(=O)OCCN</moldb_smiles>
		<moldb_formula>C23H44NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C23H44NO7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-23(26)29-20-22(25)21-31-32(27,28)30-19-18-24/h6-7,9-10,22,25H,2-5,8,11-21,24H2,1H3,(H,27,28)/b7-6-,10-9-/t22-/m1/s1</moldb_inchi>
		<moldb_inchikey>DBHKHNGBVGWQJE-USWSLJGRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>477.5717</moldb_average_mass>
		<moldb_mono_mass>477.285539279</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>559</id>
		<lmdb_id>LMDB00559</lmdb_id>
		<created_at>2016-07-13 19:52:32</created_at>
		<updated_at>2016-07-20 21:04:14</updated_at>
		<export>1</export>
		<name>LysoPE(20:0/0:0)</name>
		<description>LysoPE(20:0/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term 'lysophospholipid' (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix 'lyso-' comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CCCCCCCCCCCCCCCCCCC)COP(O)(=O)OCCN</moldb_smiles>
		<moldb_formula>C25H52NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C25H52NO7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-25(28)31-22-24(27)23-33-34(29,30)32-21-20-26/h24,27H,2-23,26H2,1H3,(H,29,30)/t24-/m1/s1</moldb_inchi>
		<moldb_inchikey>HEQMDGOBDIGJOC-XMMPIXPASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>509.6566</moldb_average_mass>
		<moldb_mono_mass>509.348139535</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>560</id>
		<lmdb_id>LMDB00560</lmdb_id>
		<created_at>2016-07-13 19:52:33</created_at>
		<updated_at>2016-07-20 21:04:15</updated_at>
		<export>1</export>
		<name>LysoPE(20:1(11Z)/0:0)</name>
		<description>LysoPE(20:1(11Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term 'lysophospholipid' (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix 'lyso-' comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CCCCCCCCC\C=C/CCCCCCCC)COP(O)(=O)OCCN</moldb_smiles>
		<moldb_formula>C25H50NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C25H50NO7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-25(28)31-22-24(27)23-33-34(29,30)32-21-20-26/h9-10,24,27H,2-8,11-23,26H2,1H3,(H,29,30)/b10-9-/t24-/m1/s1</moldb_inchi>
		<moldb_inchikey>JEAGLCKGAKACCE-OPSAWKISSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>507.6408</moldb_average_mass>
		<moldb_mono_mass>507.332489471</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>561</id>
		<lmdb_id>LMDB00561</lmdb_id>
		<created_at>2016-07-13 19:52:34</created_at>
		<updated_at>2016-07-20 21:04:15</updated_at>
		<export>1</export>
		<name>LysoPE(20:4(5Z,8Z,11Z,14Z)/0:0)</name>
		<description>LysoPE(20:4(5Z,8Z,11Z,14Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term 'lysophospholipid' (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix 'lyso-' comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC)COP(O)(=O)OCCN</moldb_smiles>
		<moldb_formula>C25H44NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C25H44NO7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-25(28)31-22-24(27)23-33-34(29,30)32-21-20-26/h6-7,9-10,12-13,15-16,24,27H,2-5,8,11,14,17-23,26H2,1H3,(H,29,30)/b7-6-,10-9-,13-12-,16-15-/t24-/m1/s1</moldb_inchi>
		<moldb_inchikey>ROPRRXYVXLDXQO-XSQXPFHXSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>501.5931</moldb_average_mass>
		<moldb_mono_mass>501.285539279</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>562</id>
		<lmdb_id>LMDB00562</lmdb_id>
		<created_at>2016-07-13 19:52:36</created_at>
		<updated_at>2016-07-20 21:04:15</updated_at>
		<export>1</export>
		<name>LysoPE(20:5(5Z,8Z,11Z,14Z,17Z)/0:0)</name>
		<description>LysoPE(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term 'lysophospholipid' (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix 'lyso-' comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC)COP(O)(=O)OCCN</moldb_smiles>
		<moldb_formula>C25H42NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C25H42NO7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-25(28)31-22-24(27)23-33-34(29,30)32-21-20-26/h3-4,6-7,9-10,12-13,15-16,24,27H,2,5,8,11,14,17-23,26H2,1H3,(H,29,30)/b4-3-,7-6-,10-9-,13-12-,16-15-/t24-/m1/s1</moldb_inchi>
		<moldb_inchikey>KCWGBXXAJHVZNN-KOYQJJOGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>499.5772</moldb_average_mass>
		<moldb_mono_mass>499.269889215</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>563</id>
		<lmdb_id>LMDB00563</lmdb_id>
		<created_at>2016-07-13 19:52:37</created_at>
		<updated_at>2016-07-20 21:04:16</updated_at>
		<export>1</export>
		<name>LysoPE(22:4(7Z,10Z,13Z,16Z)/0:0)</name>
		<description>LysoPE(22:4(7Z,10Z,13Z,16Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term 'lysophospholipid' (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix 'lyso-' comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC)COP(O)(=O)OCCN</moldb_smiles>
		<moldb_formula>C27H48NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C27H48NO7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-27(30)33-24-26(29)25-35-36(31,32)34-23-22-28/h6-7,9-10,12-13,15-16,26,29H,2-5,8,11,14,17-25,28H2,1H3,(H,31,32)/b7-6-,10-9-,13-12-,16-15-/t26-/m1/s1</moldb_inchi>
		<moldb_inchikey>NJHKGJJIKOCCMZ-YMIVKDKMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>529.6463</moldb_average_mass>
		<moldb_mono_mass>529.316839407</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>564</id>
		<lmdb_id>LMDB00564</lmdb_id>
		<created_at>2016-07-13 19:52:38</created_at>
		<updated_at>2016-07-20 21:04:16</updated_at>
		<export>1</export>
		<name>LysoPE(22:5(4Z,7Z,10Z,13Z,16Z)/0:0)</name>
		<description>LysoPE(22:5(4Z,7Z,10Z,13Z,16Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term 'lysophospholipid' (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix 'lyso-' comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCC)COP(O)(=O)OCCN</moldb_smiles>
		<moldb_formula>C27H46NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C27H46NO7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-27(30)33-24-26(29)25-35-36(31,32)34-23-22-28/h6-7,9-10,12-13,15-16,18-19,26,29H,2-5,8,11,14,17,20-25,28H2,1H3,(H,31,32)/b7-6-,10-9-,13-12-,16-15-,19-18-/t26-/m1/s1</moldb_inchi>
		<moldb_inchikey>GUWNUQBHHWXHBE-GOGKNFEWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>527.6304</moldb_average_mass>
		<moldb_mono_mass>527.301189343</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>565</id>
		<lmdb_id>LMDB00565</lmdb_id>
		<created_at>2016-07-13 19:52:39</created_at>
		<updated_at>2016-07-20 21:04:16</updated_at>
		<export>1</export>
		<name>LysoPE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)</name>
		<description>LysoPE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term 'lysophospholipid' (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix 'lyso-' comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC)COP(O)(=O)OCCN</moldb_smiles>
		<moldb_formula>C27H44NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C27H44NO7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-27(30)33-24-26(29)25-35-36(31,32)34-23-22-28/h3-4,6-7,9-10,12-13,15-16,18-19,26,29H,2,5,8,11,14,17,20-25,28H2,1H3,(H,31,32)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-/t26-/m1/s1</moldb_inchi>
		<moldb_inchikey>XEVRBOQZSXWGQO-PAUXXPOVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>525.6145</moldb_average_mass>
		<moldb_mono_mass>525.285539279</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>566</id>
		<lmdb_id>LMDB00566</lmdb_id>
		<created_at>2016-07-13 19:52:41</created_at>
		<updated_at>2016-07-20 21:04:17</updated_at>
		<export>1</export>
		<name>p-Cresol sulfate</name>
		<description>p-Cresol sulfate is a microbial metabolite that is found in urine and likely derives from secondary metabolism of p-cresol. It appears to be elevated in the urine of individuals with progressive multiple sclerosis (PMID: 10775436). p-Cresol sulfate is the major component of urinary MBPLM (myelin basic protein-like material). p-Cresol sulfate is a small protein-bound molecule that is poorly cleared with dialysis and is often considered to be a uremic toxin. Uremic toxins include low-molecular-weight compounds such as indoxyl sulfate, p-cresol sulfate, 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and asymmetric dimethylarginine (PMID: 18941347). It has also been linked to cardiovascular disease and oxidative injury.</description>
		<cas>3233-58-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=CC=C(OS(O)(=O)=O)C=C1</moldb_smiles>
		<moldb_formula>C7H8O4S</moldb_formula>
		<moldb_inchi>InChI=1S/C7H8O4S/c1-6-2-4-7(5-3-6)11-12(8,9)10/h2-5H,1H3,(H,8,9,10)</moldb_inchi>
		<moldb_inchikey>WGNAKZGUSRVWRH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>188.2010</moldb_average_mass>
		<moldb_mono_mass>188.014329434</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>567</id>
		<lmdb_id>LMDB00567</lmdb_id>
		<created_at>2016-07-13 19:52:42</created_at>
		<updated_at>2016-07-20 21:04:18</updated_at>
		<export>1</export>
		<name>p-Cresol glucuronide</name>
		<description>p-Cresol glucuronide is a glucuronide derivative a p-Cresol that is typically excreted in the urine. P-Cresol (the precursor of p-cresol sulfate (PCS) and p-cresol glucuronide (PCG)) is mainly generated as an end product of tyrosine biotransformation by anaerobic intestinal bacteria. During passage through the colonic mucosa and liver, sulfatation and glucuronidation generates p-Cresol sulfate (as the most preponderant metabolite) and p-Cresol glucuronide (at markedly lower concentrations) (PMID: 23826225). Cresols are known as methylphenols. Cresols are used to dissolve other chemicals, such as disinfectants and deodorizers. They are also used to make specific chemicals that kill insect pests. Cresol solutions are used as household cleaners and disinfectants such as Lysol. Cresol solutions can also be found in photographic developers. In the past, cresol solutions have been used as antiseptics in surgery, but they have been largely displaced in this role by less toxic compounds. Cresols are found in many foods and in wood and tobacco smoke, crude oil, coal tar, and in brown mixtures such as creosote, cresolene and cresylic acids, which are wood preservatives. Microbes in the soil and water produce cresols when they break down materials in the environment. Most exposures to cresols are at very low levels that are not harmful. When cresols are breathed, ingested, or applied to the skin at very high levels, they can be very harmful. Effects observed in people include irritation and burning of skin, eyes, mouth, and throat; abdominal pain and vomiting. Cresols are also a chemical component found in Sharpie Markers. P-cresol is a major component in pig odor. </description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=CC=C(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)C=C1</moldb_smiles>
		<moldb_formula>C13H16O7</moldb_formula>
		<moldb_inchi>InChI=1S/C13H16O7/c1-6-2-4-7(5-3-6)19-13-10(16)8(14)9(15)11(20-13)12(17)18/h2-5,8-11,13-16H,1H3,(H,17,18)/t8-,9-,10+,11-,13+/m0/s1</moldb_inchi>
		<moldb_inchikey>JPAUCQAJHLSMQW-XPORZQOISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>284.2619</moldb_average_mass>
		<moldb_mono_mass>284.089602866</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>568</id>
		<lmdb_id>LMDB00568</lmdb_id>
		<created_at>2016-07-13 19:52:43</created_at>
		<updated_at>2016-07-20 21:02:01</updated_at>
		<export>1</export>
		<name>2-Keto-L-gluconate</name>
		<description>2-Keto-L-gluconate is a derivative of gluconic acid, which occurs naturally in fruit, honey and wine and is used as a food additive, an acidity regulator. It is also used in cleaning products where it helps cleaning up mineral deposits. It is a strong chelating agent, especially in alkaline solution. It chelates the anions of calcium, iron, aluminium, copper, and other heavy metals.</description>
		<cas>91548-32-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC(O)C(O)C(O)C(=O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H10O7</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-4,7-10H,1H2,(H,12,13)</moldb_inchi>
		<moldb_inchikey>VBUYCZFBVCCYFD-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>194.1394</moldb_average_mass>
		<moldb_mono_mass>194.042652674</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>569</id>
		<lmdb_id>LMDB00569</lmdb_id>
		<created_at>2016-07-13 19:52:45</created_at>
		<updated_at>2016-09-23 18:45:37</updated_at>
		<export>1</export>
		<name>SM(d18:0/18:0)</name>
		<description>Sphingomyelin (d18:0/18:0) or SM(d18:0/18:0) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In animals, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)N[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)[C@H](O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C41H85N2O6P</moldb_formula>
		<moldb_inchi>InChI=1S/C41H85N2O6P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-33-35-41(45)42-39(38-49-50(46,47)48-37-36-43(3,4)5)40(44)34-32-30-28-26-24-22-19-17-15-13-11-9-7-2/h39-40,44H,6-38H2,1-5H3,(H-,42,45,46,47)/t39-,40+/m0/s1</moldb_inchi>
		<moldb_inchikey>JCELSEVNSMXGKA-IOLBBIBUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>733.0972</moldb_average_mass>
		<moldb_mono_mass>732.614524974</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>570</id>
		<lmdb_id>LMDB00570</lmdb_id>
		<created_at>2016-07-13 19:52:46</created_at>
		<updated_at>2016-09-23 18:45:37</updated_at>
		<export>1</export>
		<name>SM(d18:1/24:1(15Z))</name>
		<description>Sphingomyelin (d18:1/24:1(15Z)) or SM(d18:1/24:1(15Z)) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In animals, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](COP([O-])(=O)OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCC\C=C/CCCCCCCC</moldb_smiles>
		<moldb_formula>C47H93N2O6P</moldb_formula>
		<moldb_inchi>InChI=1S/C47H93N2O6P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-26-27-29-31-33-35-37-39-41-47(51)48-45(44-55-56(52,53)54-43-42-49(3,4)5)46(50)40-38-36-34-32-30-28-19-17-15-13-11-9-7-2/h20-21,38,40,45-46,50H,6-19,22-37,39,41-44H2,1-5H3,(H-,48,51,52,53)/b21-20-,40-38+/t45-,46+/m0/s1</moldb_inchi>
		<moldb_inchikey>WKZHECFHXLTOLJ-QYKFWSDSSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>813.2249</moldb_average_mass>
		<moldb_mono_mass>812.677125230</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>571</id>
		<lmdb_id>LMDB00571</lmdb_id>
		<created_at>2016-07-13 19:52:47</created_at>
		<updated_at>2016-07-20 21:02:06</updated_at>
		<export>1</export>
		<name>LysoPC(17:0)</name>
		<description>LysoPC(17:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(17:0), in particular, consists of one chain of margaric acid at the C-1 position. The margaric acid moiety is derived from butter, milk and fat of ruminants. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CCCCCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C25H52NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C25H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-25(28)31-22-24(27)23-33-34(29,30)32-21-20-26(2,3)4/h24,27H,5-23H2,1-4H3/t24-/m1/s1</moldb_inchi>
		<moldb_inchikey>SRRQPVVYXBTRQK-XMMPIXPASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>509.6566</moldb_average_mass>
		<moldb_mono_mass>509.348139535</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>572</id>
		<lmdb_id>LMDB00572</lmdb_id>
		<created_at>2016-07-13 19:52:49</created_at>
		<updated_at>2016-07-20 21:02:06</updated_at>
		<export>1</export>
		<name>Beta-D-ribopyranose</name>
		<description>Beta-D-ribopyranose is the pyranose form of Beta-D-ribose.D-ribose, which can serve as a total source of carbon and energy for E. coli, enters the cell via a high-affinity ABC transport system and hence in unphosphorylated form. The crystal structure of the periplasmic ribose binding protein of the ribose ABC transporter showed it to bind (and thus presumably to facilitate transport of) b-D-ribopyranose.</description>
		<cas>50-69-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@@H]1CO[C@@H](O)[C@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C5H10O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O5/c6-2-1-10-5(9)4(8)3(2)7/h2-9H,1H2/t2-,3-,4-,5-/m1/s1</moldb_inchi>
		<moldb_inchikey>SRBFZHDQGSBBOR-TXICZTDVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>150.1299</moldb_average_mass>
		<moldb_mono_mass>150.052823430</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>573</id>
		<lmdb_id>LMDB00573</lmdb_id>
		<created_at>2016-07-13 19:52:50</created_at>
		<updated_at>2016-09-23 18:45:38</updated_at>
		<export>1</export>
		<name>Phenylethylamine</name>
		<description>Phenethylamine (PEA) is an aromatic amine, which is a colorless liquid at room temperature. It is soluble in water, ethanol, and ether. Similar to other low-molecular-weight amines, it has a fishy odor. Upon exposure to air, it forms a solid carbonate salt with carbon dioxide. Phenethylamine is strongly basic and forms a stable crystalline hydrochloride salt with a melting point of 217 oC. Phenethylamine is also a skin irritant and possible sensitizer. Phenethylamine also has a constitutional isomer (+)-phenylethylamine (1-phenylethylamine), which has two stereoisomers: (R)-(+)-1-phenylethylamine and (S)-(-)-1-phenylethylamine. In the animal brain, 2-phenethylamine is believed to function as a neuromodulator or neurotransmitter (a trace amine). Phenethylamine can be biosynthesized from the amino acid phenylalanine by enzymatic decarboxylation. It is also found in many foods such as chocolate, especially after microbial fermentation. However trace amounts from food are quickly metabolized by the enzyme MAO-B (into phenylacetic acid), preventing significant concentrations from reaching the brain. Phenylethylamine is a precursor to the neurotransmitter phenylethanolamine. High levels of PEA have been found in the urine of schizophrenics but it is not significantly elevated in the serum or CSF of schizophrenics (PMID: 7906896, PMID: 7360842).  Urinary levels of PEA are significantly lower in children with attention deficit hyperactivity disorder (ADHD) (PMID: 12205654).  It has been found that PEA is the primary compound found in carnivore (especially cat) urine that leads to rodent (mouse and rat) avoidance. In other words, phenylethylamine is useful for scaring off rodent pests.  Quantitative HPLC analysis across 38 mammalian species has shown that PEA production in urine is especially enhanced in carnivores, with some producing &gt;3,000-fold more than herbivores (PMID: 21690383).</description>
		<cas>64-04-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCC1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C8H11N</moldb_formula>
		<moldb_inchi>InChI=1S/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H2</moldb_inchi>
		<moldb_inchikey>BHHGXPLMPWCGHP-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>121.1796</moldb_average_mass>
		<moldb_mono_mass>121.089149357</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>574</id>
		<lmdb_id>LMDB00574</lmdb_id>
		<created_at>2016-07-13 19:52:51</created_at>
		<updated_at>2016-07-20 21:02:07</updated_at>
		<export>1</export>
		<name>Arabinofuranose</name>
		<description>Arabinofuranose refers to the furanose form of arabinose, which is an optical isomer of arabinose. For biosynthetic reasons, most saccharides are almost always more abundant in nature as the &quot;D&quot; form, or structurally analogous to D-(+)-glyceraldehyde. However, L-arabinose is in fact more common than D-arabinose in nature and is found in nature as a component of biopolymers such as hemicellulose and pectin.</description>
		<cas>13221-22-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@@H]1OC(O)[C@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C5H10O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O5/c6-1-2-3(7)4(8)5(9)10-2/h2-9H,1H2/t2-,3-,4+,5?/m0/s1</moldb_inchi>
		<moldb_inchikey>HMFHBZSHGGEWLO-HWQSCIPKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>150.1299</moldb_average_mass>
		<moldb_mono_mass>150.052823430</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>575</id>
		<lmdb_id>LMDB00575</lmdb_id>
		<created_at>2016-07-13 19:52:52</created_at>
		<updated_at>2016-07-20 21:02:08</updated_at>
		<export>1</export>
		<name>Palmitelaidic acid</name>
		<description>Palmitelaidic acid is a trans fatty acid (the trans isomer of palmitoleic acid). Trans fatty acids are known to cause changes in plasma lipids and lipoprotein phenotypes, but the mechanisms involved are unknown. The major dietary sources of trans fatty acids are partly hydrogenated vegetable oils, mainly elaidic acid (t-18:1D9). Additional sources are animal and dairy fats [palmitelaidic acid (t-16:1D9) and t-vaccenic acid (t-18:1D11)] and partly hydrogenated fish oils. (very-long-chain trans fatty acids, ie, &gt;C22) (PMID: 9734731). Palmitelaidic acid has been reported as the predominant trans-16:1 isomer in cheeses made with goat and ewe milks (PMID: 11026624).</description>
		<cas>10030-73-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C\CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C16H30O2</moldb_formula>
		<moldb_inchi>InChI=1S/C16H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h7-8H,2-6,9-15H2,1H3,(H,17,18)/b8-7+</moldb_inchi>
		<moldb_inchikey>SECPZKHBENQXJG-BQYQJAHWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>254.4082</moldb_average_mass>
		<moldb_mono_mass>254.224580204</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>576</id>
		<lmdb_id>LMDB00576</lmdb_id>
		<created_at>2016-07-13 19:52:54</created_at>
		<updated_at>2016-07-20 21:02:09</updated_at>
		<export>1</export>
		<name>1-Hexanol</name>
		<description>1-Hexanol is an organic alcohol with a six carbon chain and a condensed structural formula of CH3(CH2)5OH. This colorless liquid is slightly soluble in water, but miscible with ether and ethanol. Two additional straight chain isomers of 1-hexanol exist, 2-hexanol and 3-hexanol, both of which differ by the location of the hydroxyl group. Many isomeric alcohols have the formula C6H13OH. 1-hexanol is believed to be a component of the odour of freshly mown grass. It is used in the perfume industry.</description>
		<cas>111-27-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCO</moldb_smiles>
		<moldb_formula>C6H14O</moldb_formula>
		<moldb_inchi>InChI=1S/C6H14O/c1-2-3-4-5-6-7/h7H,2-6H2,1H3</moldb_inchi>
		<moldb_inchikey>ZSIAUFGUXNUGDI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>102.1748</moldb_average_mass>
		<moldb_mono_mass>102.104465070</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>577</id>
		<lmdb_id>LMDB00577</lmdb_id>
		<created_at>2016-07-13 19:52:55</created_at>
		<updated_at>2016-07-20 21:02:09</updated_at>
		<export>1</export>
		<name>1-Pentanol</name>
		<description>Amyl alcohol is an organic compound with the formula C5H12O. All eight isomers of amyl alcohol are known:; It is a colourless liquid of density 0.8247 g/cm3 (0 oC), boiling at 131.6 oC, slightly soluble in water, easily soluble in organic solvents. It possesses a characteristic strong smell and a sharp burning taste. When pure, it is nontoxic, while the impure product is toxic. On passing its vapour through a red-hot tube, it decomposes with production of acetylene, ethylene, propylene, and other compounds. It is oxidized by chromic acid to isovaleraldehyde, and it forms crystalline addition compounds with calcium chloride and tin(IV) chloride. The other amyl alcohols may be obtained synthetically. Of these, tertiary butyl carbinol has been the most difficult to obtain, its synthesis having first been reported in 1891, by L. Tissier (Comptes Rendus, 1891, 112, p. 1065) by the reduction of a mixture of trimethyl acetic acid and trimethylacetyl chloride with sodium amalgam. It is a solid that melts at 48 to 50 oC and boils at 112.3 oC.</description>
		<cas>71-41-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCO</moldb_smiles>
		<moldb_formula>C5H12O</moldb_formula>
		<moldb_inchi>InChI=1S/C5H12O/c1-2-3-4-5-6/h6H,2-5H2,1H3</moldb_inchi>
		<moldb_inchikey>AMQJEAYHLZJPGS-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>88.1482</moldb_average_mass>
		<moldb_mono_mass>88.088815006</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>578</id>
		<lmdb_id>LMDB00578</lmdb_id>
		<created_at>2016-07-13 19:52:57</created_at>
		<updated_at>2016-07-19 23:25:24</updated_at>
		<export>1</export>
		<name>Hydroxypropionylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+](C)(C)C[C@H](CC([O-])=O)OC(=O)CCO</moldb_smiles>
		<moldb_formula>C10H19NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C10H19NO5/c1-11(2,3)7-8(6-9(13)14)16-10(15)4-5-12/h8,12H,4-7H2,1-3H3/t8-/m0/s1</moldb_inchi>
		<moldb_inchikey>QJGJXKFJFRSERW-QMMMGPOBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>233.2616</moldb_average_mass>
		<moldb_mono_mass>233.126322723</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>579</id>
		<lmdb_id>LMDB00579</lmdb_id>
		<created_at>2016-07-13 19:52:58</created_at>
		<updated_at>2016-07-19 23:23:28</updated_at>
		<export>1</export>
		<name>Butenylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C\C=C\C(=O)O[C@@H](CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C11H19NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C11H19NO4/c1-5-6-11(15)16-9(7-10(13)14)8-12(2,3)4/h5-6,9H,7-8H2,1-4H3/b6-5+/t9-/m0/s1</moldb_inchi>
		<moldb_inchikey>HQDBMDGXEZLSNK-CYNONHLPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>229.2729</moldb_average_mass>
		<moldb_mono_mass>229.131408101</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>580</id>
		<lmdb_id>LMDB00580</lmdb_id>
		<created_at>2016-07-13 19:52:59</created_at>
		<updated_at>2016-07-19 23:25:23</updated_at>
		<export>1</export>
		<name>Hydroxybutyrylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(O)CC(=O)O[C@@H](CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C11H21NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C11H21NO5/c1-8(13)5-11(16)17-9(6-10(14)15)7-12(2,3)4/h8-9,13H,5-7H2,1-4H3/t8?,9-/m0/s1</moldb_inchi>
		<moldb_inchikey>UEFRDQSMQXDWTO-GKAPJAKFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>247.2881</moldb_average_mass>
		<moldb_mono_mass>247.141972787</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>581</id>
		<lmdb_id>LMDB00581</lmdb_id>
		<created_at>2016-07-13 19:53:01</created_at>
		<updated_at>2016-07-20 20:45:51</updated_at>
		<export>1</export>
		<name>Valerylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC(=O)O[C@@H](CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C12H23NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C12H23NO4/c1-5-6-7-12(16)17-10(8-11(14)15)9-13(2,3)4/h10H,5-9H2,1-4H3/t10-/m0/s1</moldb_inchi>
		<moldb_inchikey>VSNFQQXVMPSASB-JTQLQIEISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>245.3153</moldb_average_mass>
		<moldb_mono_mass>245.162708229</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>582</id>
		<lmdb_id>LMDB00582</lmdb_id>
		<created_at>2016-07-13 19:53:02</created_at>
		<updated_at>2016-08-01 19:11:21</updated_at>
		<export>1</export>
		<name>Glutaconylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C\C=C\C(=O)O[C@@H](CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C12H19NO6</moldb_formula>
		<moldb_inchi>InChI=1S/C12H19NO6/c1-13(2,3)8-9(7-11(16)17)19-12(18)6-4-5-10(14)15/h4,6,9H,5,7-8H2,1-3H3,(H-,14,15,16,17)/b6-4+/t9-/m0/s1</moldb_inchi>
		<moldb_inchikey>JXVUHLILXGZLFR-DNQSNQRASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>273.2824</moldb_average_mass>
		<moldb_mono_mass>273.121237345</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>583</id>
		<lmdb_id>LMDB00583</lmdb_id>
		<created_at>2016-07-13 19:53:04</created_at>
		<updated_at>2016-07-20 21:02:10</updated_at>
		<export>1</export>
		<name>Monoethylhexyl phthalic acid</name>
		<description>Monoethylhexyl phthalic acid (MEHP) is an active metabolite of Bis(2-ethylhexyl)phthalate (DEHP). DEHP measured from the blood of pregnant women have been significantly associated with the decreased penis width, shorter anogenital distance, and the incomplete descent of testes of their newborn sons, replicating effects identified in animals(Wikipedia). DEHP hydrolyzes to MEHP via the enzyme Bis(2-ethylhexyl)phthalate acylhydrolase(3.1.1.60)and subsequently to phthalate salts. The released alcohol is susceptible to oxidation to the aldehyde and carboxylic acid.</description>
		<cas>4376-20-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC(CC)COC(=O)C1=CC=CC=C1C(O)=O</moldb_smiles>
		<moldb_formula>C16H22O4</moldb_formula>
		<moldb_inchi>InChI=1S/C16H22O4/c1-3-5-8-12(4-2)11-20-16(19)14-10-7-6-9-13(14)15(17)18/h6-7,9-10,12H,3-5,8,11H2,1-2H3,(H,17,18)</moldb_inchi>
		<moldb_inchikey>DJDSLBVSSOQSLW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>278.3435</moldb_average_mass>
		<moldb_mono_mass>278.151809192</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>584</id>
		<lmdb_id>LMDB00584</lmdb_id>
		<created_at>2016-07-13 19:53:05</created_at>
		<updated_at>2016-07-19 23:28:09</updated_at>
		<export>1</export>
		<name>Pimelylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+](C)(C)[C@H](CCC([O-])=O)OC(=O)CCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C14H25NO6</moldb_formula>
		<moldb_inchi>InChI=1S/C14H25NO6/c1-15(2,3)11(9-10-13(18)19)21-14(20)8-6-4-5-7-12(16)17/h11H,4-10H2,1-3H3,(H-,16,17,18,19)/t11-/m0/s1</moldb_inchi>
		<moldb_inchikey>AUWRHMAICBSXMC-NSHDSACASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>303.3514</moldb_average_mass>
		<moldb_mono_mass>303.168187537</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>585</id>
		<lmdb_id>LMDB00585</lmdb_id>
		<created_at>2016-07-13 19:53:07</created_at>
		<updated_at>2016-07-20 20:45:53</updated_at>
		<export>1</export>
		<name>PC(o-14:0/16:0)</name>
		<description>PC(o-14:0/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-14:0/16:0), in particular, consists of one chain of Myristyl alcohol at the C-1 position and one chain of palmitic acid at the C-2 position. The Myristyl alcohol moiety is derived from butter oil, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](COCCCCCCCCCCCCCC)(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C38H78NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C38H78NO7P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-38(40)46-37(36-45-47(41,42)44-34-32-39(3,4)5)35-43-33-30-28-26-24-22-19-17-15-13-11-9-7-2/h37H,6-36H2,1-5H3/t37-/m1/s1</moldb_inchi>
		<moldb_inchikey>BYMZZQJJOHDZOU-DIPNUNPCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>692.0022</moldb_average_mass>
		<moldb_mono_mass>691.551590367</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>586</id>
		<lmdb_id>LMDB00586</lmdb_id>
		<created_at>2016-07-13 19:53:08</created_at>
		<updated_at>2016-07-20 21:02:10</updated_at>
		<export>1</export>
		<name>PC(o-14:0/16:1(9Z))</name>
		<description>PC(o-14:0/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-14:0/16:1(9Z)), in particular, consists of one chain of Myristyl alcohol at the C-1 position and one chain of palmitoleic acid at the C-2 position. The Myristyl alcohol moiety is derived from butter oil, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C38H76NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C38H76NO7P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-38(40)46-37(36-45-47(41,42)44-34-32-39(3,4)5)35-43-33-30-28-26-24-22-19-17-15-13-11-9-7-2/h16,18,37H,6-15,17,19-36H2,1-5H3/b18-16-/t37-/m1/s1</moldb_inchi>
		<moldb_inchikey>ZCNUNZUDXNSNRZ-WTWBAFHPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>689.9863</moldb_average_mass>
		<moldb_mono_mass>689.535940303</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>587</id>
		<lmdb_id>LMDB00587</lmdb_id>
		<created_at>2016-07-13 19:53:09</created_at>
		<updated_at>2016-07-20 20:45:55</updated_at>
		<export>1</export>
		<name>PC(o-16:0/16:1(9Z))</name>
		<description>PC(o-16:0/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-16:0/16:1(9Z)), in particular, consists of one chain of Palmityl alcohol at the C-1 position and one chain of palmitoleic acid at the C-2 position. The Palmityl alcohol moiety is derived from animal fats and vegetable oils, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C40H80NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C40H80NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-35-45-37-39(38-47-49(43,44)46-36-34-41(3,4)5)48-40(42)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h17,19,39H,6-16,18,20-38H2,1-5H3/b19-17-/t39-/m1/s1</moldb_inchi>
		<moldb_inchikey>HJVQHTGUAIETCQ-VEAYGOGPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>718.0395</moldb_average_mass>
		<moldb_mono_mass>717.567240431</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>588</id>
		<lmdb_id>LMDB00588</lmdb_id>
		<created_at>2016-07-13 19:53:10</created_at>
		<updated_at>2016-07-20 20:45:57</updated_at>
		<export>1</export>
		<name>PC(o-16:0/18:0)</name>
		<description>PC(o-16:0/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-16:0/18:0), in particular, consists of one chain of Palmityl alcohol at the C-1 position and one chain of stearic acid at the C-2 position. The Palmityl alcohol moiety is derived from animal fats and vegetable oils, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](COCCCCCCCCCCCCCCCC)(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C42H86NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C42H86NO7P/c1-6-8-10-12-14-16-18-20-22-23-25-27-29-31-33-35-42(44)50-41(40-49-51(45,46)48-38-36-43(3,4)5)39-47-37-34-32-30-28-26-24-21-19-17-15-13-11-9-7-2/h41H,6-40H2,1-5H3/t41-/m1/s1</moldb_inchi>
		<moldb_inchikey>PXPSGTINXJQLBR-VQJSHJPSSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>748.1085</moldb_average_mass>
		<moldb_mono_mass>747.614190623</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>589</id>
		<lmdb_id>LMDB00589</lmdb_id>
		<created_at>2016-07-13 19:53:12</created_at>
		<updated_at>2016-07-20 20:45:58</updated_at>
		<export>1</export>
		<name>PC(o-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))</name>
		<description>PC(o-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of Palmityl alcohol at the C-1 position and one chain of docosahexaenoic acid at the C-2 position. The Palmityl alcohol moiety is derived from animal fats and vegetable oils, while the docosahexaenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC</moldb_smiles>
		<moldb_formula>C46H82NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H82NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-26-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-21-19-17-15-13-11-9-7-2/h8,10,14,16,20,22,24-25,27,29,33,35,45H,6-7,9,11-13,15,17-19,21,23,26,28,30-32,34,36-44H2,1-5H3/b10-8-,16-14-,22-20-,25-24-,29-27-,35-33-/t45-/m1/s1</moldb_inchi>
		<moldb_inchikey>QQQQNYAHSSIZBU-HIQXTUQZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>792.1195</moldb_average_mass>
		<moldb_mono_mass>791.582890495</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>590</id>
		<lmdb_id>LMDB00590</lmdb_id>
		<created_at>2016-07-13 19:53:13</created_at>
		<updated_at>2016-07-20 20:45:59</updated_at>
		<export>1</export>
		<name>PC(o-16:1(9Z)/14:1(9Z))</name>
		<description>PC(o-16:1(9Z)/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-16:1(9Z)/14:1(9Z)), in particular, consists of one chain of Palmitoleyl alcohol at the C-1 position and one chain of myristoleic acid at the C-2 position. The Palmitoleyl alcohol moiety is derived from whale oil, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCC</moldb_smiles>
		<moldb_formula>C38H74NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C38H74NO7P/c1-6-8-10-12-14-16-18-19-20-22-24-26-28-30-33-43-35-37(36-45-47(41,42)44-34-32-39(3,4)5)46-38(40)31-29-27-25-23-21-17-15-13-11-9-7-2/h13,15-16,18,37H,6-12,14,17,19-36H2,1-5H3/b15-13-,18-16-/t37-/m1/s1</moldb_inchi>
		<moldb_inchikey>SPPSEAUTRSATJZ-LSVLUJLYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>687.9704</moldb_average_mass>
		<moldb_mono_mass>687.520290239</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>591</id>
		<lmdb_id>LMDB00591</lmdb_id>
		<created_at>2016-07-13 19:53:14</created_at>
		<updated_at>2016-07-19 23:32:20</updated_at>
		<export>1</export>
		<name>PC(o-16:1(9Z)/16:1(9Z))</name>
		<description>PC(o-16:1(9Z)/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-16:1(9Z)/16:1(9Z)), in particular, consists of one chain of Palmitoleyl alcohol at the C-1 position and one chain of palmitoleic acid at the C-2 position. The Palmitoleyl alcohol moiety is derived from whale oil, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C40H78NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C40H78NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-35-45-37-39(38-47-49(43,44)46-36-34-41(3,4)5)48-40(42)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h16-19,39H,6-15,20-38H2,1-5H3/b18-16-,19-17-/t39-/m1/s1</moldb_inchi>
		<moldb_inchikey>MZDGVRYVGYDNAO-KETLZHFASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>716.0236</moldb_average_mass>
		<moldb_mono_mass>715.551590367</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>592</id>
		<lmdb_id>LMDB00592</lmdb_id>
		<created_at>2016-07-13 19:53:16</created_at>
		<updated_at>2016-07-19 23:32:29</updated_at>
		<export>1</export>
		<name>PC(o-16:1(9Z)/18:2(9Z,12Z))</name>
		<description>PC(o-16:1(9Z)/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-16:1(9Z)/18:2(9Z,12Z)), in particular, consists of one chain of Palmitoleyl alcohol at the C-1 position and one chain of linoleic acid at the C-2 position. The Palmitoleyl alcohol moiety is derived from whale oil, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C42H80NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C42H80NO7P/c1-6-8-10-12-14-16-18-20-22-23-25-27-29-31-33-35-42(44)50-41(40-49-51(45,46)48-38-36-43(3,4)5)39-47-37-34-32-30-28-26-24-21-19-17-15-13-11-9-7-2/h14,16-17,19-20,22,41H,6-13,15,18,21,23-40H2,1-5H3/b16-14-,19-17-,22-20-/t41-/m1/s1</moldb_inchi>
		<moldb_inchikey>AXCLECQLCBWNLZ-KZZBVOOISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>742.0609</moldb_average_mass>
		<moldb_mono_mass>741.567240431</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>593</id>
		<lmdb_id>LMDB00593</lmdb_id>
		<created_at>2016-07-13 19:53:17</created_at>
		<updated_at>2016-08-02 20:39:27</updated_at>
		<export>1</export>
		<name>PC(o-16:1(9Z)/20:0)</name>
		<description>PC(o-16:1(9Z)/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-16:1(9Z)/20:0), in particular, consists of one chain of Palmitoleyl alcohol at the C-1 position and one chain of arachidic acid at the C-2 position. The Palmitoleyl alcohol moiety is derived from whale oil, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCC(=O)O[C@]([H])(COCCCCCCCC\C=C/CCCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C44H88NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H88NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-29-31-33-35-37-44(46)52-43(42-51-53(47,48)50-40-38-45(3,4)5)41-49-39-36-34-32-30-28-26-21-19-17-15-13-11-9-7-2/h17,19,43H,6-16,18,20-42H2,1-5H3/b19-17-/t43-/m1/s1</moldb_inchi>
		<moldb_inchikey>NEMVGIRAGVGOLH-RPBJOJELSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>774.1458</moldb_average_mass>
		<moldb_mono_mass>773.629840687</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>594</id>
		<lmdb_id>LMDB00594</lmdb_id>
		<created_at>2016-07-13 19:53:19</created_at>
		<updated_at>2016-07-20 20:46:01</updated_at>
		<export>1</export>
		<name>PC(o-16:1(9Z)/20:4(8Z,11Z,14Z,17Z))</name>
		<description>PC(o-16:1(9Z)/20:4(8Z,11Z,14Z,17Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-16:1(9Z)/20:4(8Z,11Z,14Z,17Z)), in particular, consists of one chain of Palmitoleyl alcohol at the C-1 position and one chain of eicosatetraenoic acid at the C-2 position. The Palmitoleyl alcohol moiety is derived from whale oil, while the eicosatetraenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C44H80NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H80NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-29-31-33-35-37-44(46)52-43(42-51-53(47,48)50-40-38-45(3,4)5)41-49-39-36-34-32-30-28-26-21-19-17-15-13-11-9-7-2/h14,16-17,19-20,22,24-25,29,31,43H,6-13,15,18,21,23,26-28,30,32-42H2,1-5H3/b16-14-,19-17-,22-20-,25-24-,31-29-/t43-/m1/s1</moldb_inchi>
		<moldb_inchikey>HOTMLHWJOWGLLX-UZKIFIPLSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>766.0823</moldb_average_mass>
		<moldb_mono_mass>765.567240431</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>595</id>
		<lmdb_id>LMDB00595</lmdb_id>
		<created_at>2016-07-13 19:53:20</created_at>
		<updated_at>2016-07-20 20:46:02</updated_at>
		<export>1</export>
		<name>PC(o-18:0/18:0)</name>
		<description>PC(o-18:0/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:0/18:0), in particular, consists of one chain of Stearyl alcohol at the C-1 position and one chain of stearic acid at the C-2 position. The Stearyl alcohol moiety is derived from beef fat, fish oil, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](COCCCCCCCCCCCCCCCCCC)(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C44H90NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H90NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-39-49-41-43(42-51-53(47,48)50-40-38-45(3,4)5)52-44(46)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h43H,6-42H2,1-5H3/t43-/m1/s1</moldb_inchi>
		<moldb_inchikey>BKEDGKIMIUGHDV-VZUYHUTRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>776.1617</moldb_average_mass>
		<moldb_mono_mass>775.645490751</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>596</id>
		<lmdb_id>LMDB00596</lmdb_id>
		<created_at>2016-07-13 19:53:22</created_at>
		<updated_at>2016-07-20 20:46:03</updated_at>
		<export>1</export>
		<name>PC(o-18:0/18:2(9Z,12Z))</name>
		<description>PC(o-18:0/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:0/18:2(9Z,12Z)), in particular, consists of one chain of Stearyl alcohol at the C-1 position and one chain of linoleic acid at the C-2 position. The Stearyl alcohol moiety is derived from beef fat, fish oil, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C44H86NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H86NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-39-49-41-43(42-51-53(47,48)50-40-38-45(3,4)5)52-44(46)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h15,17,21,23,43H,6-14,16,18-20,22,24-42H2,1-5H3/b17-15-,23-21-/t43-/m1/s1</moldb_inchi>
		<moldb_inchikey>LMGTVCKIUNTOEP-HJTCUGKVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>772.1299</moldb_average_mass>
		<moldb_mono_mass>771.614190623</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>597</id>
		<lmdb_id>LMDB00597</lmdb_id>
		<created_at>2016-07-13 19:53:23</created_at>
		<updated_at>2016-07-20 20:46:04</updated_at>
		<export>1</export>
		<name>PC(o-18:0/20:0)</name>
		<description>PC(o-18:0/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:0/20:0), in particular, consists of one chain of Stearyl alcohol at the C-1 position and one chain of arachidic acid at the C-2 position. The Stearyl alcohol moiety is derived from beef fat, fish oil, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](COCCCCCCCCCCCCCCCCCC)(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C46H94NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H94NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h45H,6-44H2,1-5H3/t45-/m1/s1</moldb_inchi>
		<moldb_inchikey>BVCZSMAYNCVQDT-WBVITSLISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>804.2148</moldb_average_mass>
		<moldb_mono_mass>803.676790879</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>598</id>
		<lmdb_id>LMDB00598</lmdb_id>
		<created_at>2016-07-13 19:53:24</created_at>
		<updated_at>2016-07-20 20:46:05</updated_at>
		<export>1</export>
		<name>PC(o-18:0/20:4(8Z,11Z,14Z,17Z))</name>
		<description>PC(o-18:0/20:4(8Z,11Z,14Z,17Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:0/20:4(8Z,11Z,14Z,17Z)), in particular, consists of one chain of Stearyl alcohol at the C-1 position and one chain of eicosatetraenoic acid at the C-2 position. The Stearyl alcohol moiety is derived from beef fat, fish oil, while the eicosatetraenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C46H86NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H86NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h14,16,20,22,25,27,31,33,45H,6-13,15,17-19,21,23-24,26,28-30,32,34-44H2,1-5H3/b16-14-,22-20-,27-25-,33-31-/t45-/m1/s1</moldb_inchi>
		<moldb_inchikey>GBNPCIWXLWZJGA-IGBSIYCFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>796.1513</moldb_average_mass>
		<moldb_mono_mass>795.614190623</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>599</id>
		<lmdb_id>LMDB00599</lmdb_id>
		<created_at>2016-07-13 19:53:25</created_at>
		<updated_at>2016-07-20 20:46:08</updated_at>
		<export>1</export>
		<name>PC(o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))</name>
		<description>PC(o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of Stearyl alcohol at the C-1 position and one chain of docosahexaenoic acid at the C-2 position. The Stearyl alcohol moiety is derived from beef fat, fish oil, while the docosahexaenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC</moldb_smiles>
		<moldb_formula>C48H86NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C48H86NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-26-27-29-31-33-35-37-39-41-48(50)56-47(46-55-57(51,52)54-44-42-49(3,4)5)45-53-43-40-38-36-34-32-30-28-23-21-19-17-15-13-11-9-7-2/h8,10,14,16,20,22,25-26,29,31,35,37,47H,6-7,9,11-13,15,17-19,21,23-24,27-28,30,32-34,36,38-46H2,1-5H3/b10-8-,16-14-,22-20-,26-25-,31-29-,37-35-/t47-/m1/s1</moldb_inchi>
		<moldb_inchikey>QBZALASVZLFAHF-KYPHJRDXSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>820.1727</moldb_average_mass>
		<moldb_mono_mass>819.614190623</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>600</id>
		<lmdb_id>LMDB00600</lmdb_id>
		<created_at>2016-07-13 19:53:27</created_at>
		<updated_at>2016-07-20 20:46:10</updated_at>
		<export>1</export>
		<name>PC(o-18:1(11Z)/16:0)</name>
		<description>PC(o-18:1(11Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:1(11Z)/16:0), in particular, consists of one chain of Vaccenyl alcohol at the C-1 position and one chain of palmitic acid at the C-2 position. The Vaccenyl alcohol moiety is derived from beef fat, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)O[C@]([H])(COCCCCCCCCCC\C=C/CCCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C42H84NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C42H84NO7P/c1-6-8-10-12-14-16-18-20-21-22-24-26-28-30-32-34-37-47-39-41(40-49-51(45,46)48-38-36-43(3,4)5)50-42(44)35-33-31-29-27-25-23-19-17-15-13-11-9-7-2/h16,18,41H,6-15,17,19-40H2,1-5H3/b18-16-/t41-/m1/s1</moldb_inchi>
		<moldb_inchikey>QCGUXAIDEOWPBV-SNKLRXETSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>746.0926</moldb_average_mass>
		<moldb_mono_mass>745.598540559</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>601</id>
		<lmdb_id>LMDB00601</lmdb_id>
		<created_at>2016-07-13 19:53:28</created_at>
		<updated_at>2016-07-20 20:46:12</updated_at>
		<export>1</export>
		<name>PC(o-18:1(9Z)/18:2(9Z,12Z))</name>
		<description>PC(o-18:1(9Z)/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:1(9Z)/18:2(9Z,12Z)), in particular, consists of one chain of Oleyl alcohol at the C-1 position and one chain of linoleic acid at the C-2 position. The Oleyl alcohol moiety is derived from beef fat, fish oil, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C44H84NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H84NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-39-49-41-43(42-51-53(47,48)50-40-38-45(3,4)5)52-44(46)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h15,17,20-23,43H,6-14,16,18-19,24-42H2,1-5H3/b17-15-,22-20-,23-21-/t43-/m1/s1</moldb_inchi>
		<moldb_inchikey>MFZLAZYUXHHSIA-HVODBARTSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>770.1140</moldb_average_mass>
		<moldb_mono_mass>769.598540559</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>602</id>
		<lmdb_id>LMDB00602</lmdb_id>
		<created_at>2016-07-13 19:53:30</created_at>
		<updated_at>2016-07-19 23:32:48</updated_at>
		<export>1</export>
		<name>PC(o-18:1(9Z)/20:0)</name>
		<description>PC(o-18:1(9Z)/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:1(9Z)/20:0), in particular, consists of one chain of Oleyl alcohol at the C-1 position and one chain of arachidic acid at the C-2 position. The Oleyl alcohol moiety is derived from beef fat, fish oil, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCC(=O)O[C@]([H])(COCCCCCCCC\C=C/CCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C46H92NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H92NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h21,23,45H,6-20,22,24-44H2,1-5H3/b23-21-/t45-/m1/s1</moldb_inchi>
		<moldb_inchikey>XKGBWHAITCMFLI-MWGCQCNTSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>802.1989</moldb_average_mass>
		<moldb_mono_mass>801.661140815</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>603</id>
		<lmdb_id>LMDB00603</lmdb_id>
		<created_at>2016-07-13 19:53:32</created_at>
		<updated_at>2016-07-20 20:46:15</updated_at>
		<export>1</export>
		<name>PC(o-18:1(9Z)/20:4(8Z,11Z,14Z,17Z))</name>
		<description>PC(o-18:1(9Z)/20:4(8Z,11Z,14Z,17Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:1(9Z)/20:4(8Z,11Z,14Z,17Z)), in particular, consists of one chain of Oleyl alcohol at the C-1 position and one chain of eicosatetraenoic acid at the C-2 position. The Oleyl alcohol moiety is derived from beef fat, fish oil, while the eicosatetraenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C46H84NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H84NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h14,16,20-23,25,27,31,33,45H,6-13,15,17-19,24,26,28-30,32,34-44H2,1-5H3/b16-14-,22-20-,23-21-,27-25-,33-31-/t45-/m1/s1</moldb_inchi>
		<moldb_inchikey>VJNPDLZENXBRLB-MQEDXBOASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>794.1354</moldb_average_mass>
		<moldb_mono_mass>793.598540559</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>604</id>
		<lmdb_id>LMDB00604</lmdb_id>
		<created_at>2016-07-13 19:53:33</created_at>
		<updated_at>2016-07-19 23:33:05</updated_at>
		<export>1</export>
		<name>PC(o-18:1(9Z)/22:0)</name>
		<description>PC(o-18:1(9Z)/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:1(9Z)/22:0), in particular, consists of one chain of Oleyl alcohol at the C-1 position and one chain of behenic acid at the C-2 position. The Oleyl alcohol moiety is derived from beef fat, fish oil, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@]([H])(COCCCCCCCC\C=C/CCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C48H96NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C48H96NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-26-27-29-31-33-35-37-39-41-48(50)56-47(46-55-57(51,52)54-44-42-49(3,4)5)45-53-43-40-38-36-34-32-30-28-23-21-19-17-15-13-11-9-7-2/h21,23,47H,6-20,22,24-46H2,1-5H3/b23-21-/t47-/m1/s1</moldb_inchi>
		<moldb_inchikey>VTSFZGCXFALJSV-FYAZAUILSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>830.2521</moldb_average_mass>
		<moldb_mono_mass>829.692440943</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>605</id>
		<lmdb_id>LMDB00605</lmdb_id>
		<created_at>2016-07-13 19:53:35</created_at>
		<updated_at>2016-07-20 20:46:16</updated_at>
		<export>1</export>
		<name>PC(o-18:2(9Z,12Z)/18:2(9Z,12Z))</name>
		<description>PC(o-18:2(9Z,12Z)/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:2(9Z,12Z)/18:2(9Z,12Z)), in particular, consists of one chain of Linoleyl alcohol at the C-1 position and one chain of linoleic acid at the C-2 position. The Linoleyl alcohol moiety is derived from seed oils, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/CCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C44H82NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C44H82NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-39-49-41-43(42-51-53(47,48)50-40-38-45(3,4)5)52-44(46)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h14-17,20-23,43H,6-13,18-19,24-42H2,1-5H3/b16-14-,17-15-,22-20-,23-21-/t43-/m1/s1</moldb_inchi>
		<moldb_inchikey>XCCONPVPHCCYNF-KPFPPAHTSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>768.0981</moldb_average_mass>
		<moldb_mono_mass>767.582890495</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>606</id>
		<lmdb_id>LMDB00606</lmdb_id>
		<created_at>2016-07-13 19:53:36</created_at>
		<updated_at>2016-07-20 20:46:18</updated_at>
		<export>1</export>
		<name>PC(o-18:2(9Z,12Z)/20:0)</name>
		<description>PC(o-18:2(9Z,12Z)/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:2(9Z,12Z)/20:0), in particular, consists of one chain of Linoleyl alcohol at the C-1 position and one chain of arachidic acid at the C-2 position. The Linoleyl alcohol moiety is derived from seed oils, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCC(=O)O[C@]([H])(COCCCCCCCC\C=C/C\C=C/CCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C46H90NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H90NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h15,17,21,23,45H,6-14,16,18-20,22,24-44H2,1-5H3/b17-15-,23-21-/t45-/m1/s1</moldb_inchi>
		<moldb_inchikey>MOCFTDNEKLRJLC-HRGHQQQCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>800.1831</moldb_average_mass>
		<moldb_mono_mass>799.645490751</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>607</id>
		<lmdb_id>LMDB00607</lmdb_id>
		<created_at>2016-07-13 19:53:37</created_at>
		<updated_at>2016-07-20 20:46:19</updated_at>
		<export>1</export>
		<name>PC(o-18:2(9Z,12Z)/22:0)</name>
		<description>PC(o-18:2(9Z,12Z)/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:2(9Z,12Z)/22:0), in particular, consists of one chain of Linoleyl alcohol at the C-1 position and one chain of behenic acid at the C-2 position. The Linoleyl alcohol moiety is derived from seed oils, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@]([H])(COCCCCCCCC\C=C/C\C=C/CCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C48H94NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C48H94NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-26-27-29-31-33-35-37-39-41-48(50)56-47(46-55-57(51,52)54-44-42-49(3,4)5)45-53-43-40-38-36-34-32-30-28-23-21-19-17-15-13-11-9-7-2/h15,17,21,23,47H,6-14,16,18-20,22,24-46H2,1-5H3/b17-15-,23-21-/t47-/m1/s1</moldb_inchi>
		<moldb_inchikey>DMPIMBNFIDOLGO-DTRJYZOJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>828.2362</moldb_average_mass>
		<moldb_mono_mass>827.676790879</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>608</id>
		<lmdb_id>LMDB00608</lmdb_id>
		<created_at>2016-07-13 19:53:39</created_at>
		<updated_at>2016-07-20 20:46:20</updated_at>
		<export>1</export>
		<name>PC(o-18:2(9Z,12Z)/24:0)</name>
		<description>PC(o-18:2(9Z,12Z)/24:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:2(9Z,12Z)/24:0), in particular, consists of one chain of Linoleyl alcohol at the C-1 position and one chain of lignoceric acid at the C-2 position. The Linoleyl alcohol moiety is derived from seed oils, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@]([H])(COCCCCCCCC\C=C/C\C=C/CCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C50H98NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C50H98NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-26-27-28-29-31-33-35-37-39-41-43-50(52)58-49(48-57-59(53,54)56-46-44-51(3,4)5)47-55-45-42-40-38-36-34-32-30-23-21-19-17-15-13-11-9-7-2/h15,17,21,23,49H,6-14,16,18-20,22,24-48H2,1-5H3/b17-15-,23-21-/t49-/m1/s1</moldb_inchi>
		<moldb_inchikey>SJLRNWKFILQPDM-AARZFCJCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>856.2894</moldb_average_mass>
		<moldb_mono_mass>855.708091007</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>609</id>
		<lmdb_id>LMDB00609</lmdb_id>
		<created_at>2016-07-13 19:53:40</created_at>
		<updated_at>2016-07-20 20:46:22</updated_at>
		<export>1</export>
		<name>PC(o-20:0/18:3(6Z,9Z,12Z))</name>
		<description>PC(o-20:0/18:3(6Z,9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-20:0/18:3(6Z,9Z,12Z)), in particular, consists of one chain of Arachidyl alcohol at the C-1 position and one chain of g-linolenic acid at the C-2 position. The Arachidyl alcohol moiety is derived from corn oil, while the g-linolenic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C46H88NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H88NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-26-28-30-32-34-36-38-41-51-43-45(44-53-55(49,50)52-42-40-47(3,4)5)54-46(48)39-37-35-33-31-29-27-25-21-19-17-15-13-11-9-7-2/h15,17,21,25,29,31,45H,6-14,16,18-20,22-24,26-28,30,32-44H2,1-5H3/b17-15-,25-21-,31-29-/t45-/m1/s1</moldb_inchi>
		<moldb_inchikey>XHKFHCCQLHPBPZ-WKDUQDSSSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>798.1672</moldb_average_mass>
		<moldb_mono_mass>797.629840687</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>610</id>
		<lmdb_id>LMDB00610</lmdb_id>
		<created_at>2016-07-13 19:53:41</created_at>
		<updated_at>2016-07-20 21:02:13</updated_at>
		<export>1</export>
		<name>PC(o-20:0/20:0)</name>
		<description>PC(o-20:0/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-20:0/20:0), in particular, consists of one chain of Arachidyl alcohol at the C-1 position and one chain of arachidic acid at the C-2 position. The Arachidyl alcohol moiety is derived from corn oil, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](COCCCCCCCCCCCCCCCCCCCC)(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C48H98NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C48H98NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-40-43-53-45-47(46-55-57(51,52)54-44-42-49(3,4)5)56-48(50)41-39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h47H,6-46H2,1-5H3/t47-/m1/s1</moldb_inchi>
		<moldb_inchikey>OZQMKPUQMDJPII-QZNUWAOFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>832.2680</moldb_average_mass>
		<moldb_mono_mass>831.708091007</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>611</id>
		<lmdb_id>LMDB00611</lmdb_id>
		<created_at>2016-07-13 19:53:43</created_at>
		<updated_at>2016-07-19 23:33:12</updated_at>
		<export>1</export>
		<name>PC(o-20:0/20:4(8Z,11Z,14Z,17Z))</name>
		<description>PC(o-20:0/20:4(8Z,11Z,14Z,17Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-20:0/20:4(8Z,11Z,14Z,17Z)), in particular, consists of one chain of Arachidyl alcohol at the C-1 position and one chain of eicosatetraenoic acid at the C-2 position. The Arachidyl alcohol moiety is derived from corn oil, while the eicosatetraenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C48H90NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C48H90NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-40-43-53-45-47(46-55-57(51,52)54-44-42-49(3,4)5)56-48(50)41-39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h15,17,21,23,27,29,33,35,47H,6-14,16,18-20,22,24-26,28,30-32,34,36-46H2,1-5H3/b17-15-,23-21-,29-27-,35-33-/t47-/m1/s1</moldb_inchi>
		<moldb_inchikey>RDNHPNJCALITSY-MBZSPAKGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>824.2045</moldb_average_mass>
		<moldb_mono_mass>823.645490751</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>612</id>
		<lmdb_id>LMDB00612</lmdb_id>
		<created_at>2016-07-13 19:53:44</created_at>
		<updated_at>2016-07-19 23:08:20</updated_at>
		<export>1</export>
		<name>PC(o-20:0/22:0)</name>
		<description>PC(o-20:0/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-20:0/22:0), in particular, consists of one chain of Arachidyl alcohol at the C-1 position and one chain of behenic acid at the C-2 position. The Arachidyl alcohol moiety is derived from corn oil, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](COCCCCCCCCCCCCCCCCCCCC)(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C50H102NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C50H102NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-27-29-31-33-35-37-39-41-43-50(52)58-49(48-57-59(53,54)56-46-44-51(3,4)5)47-55-45-42-40-38-36-34-32-30-28-25-23-21-19-17-15-13-11-9-7-2/h49H,6-48H2,1-5H3/t49-/m1/s1</moldb_inchi>
		<moldb_inchikey>BJUWREINODTBMO-ANFMRNGASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>860.3211</moldb_average_mass>
		<moldb_mono_mass>859.739391135</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>613</id>
		<lmdb_id>LMDB00613</lmdb_id>
		<created_at>2016-07-13 19:53:45</created_at>
		<updated_at>2016-07-20 20:46:24</updated_at>
		<export>1</export>
		<name>PC(o-20:1(11Z)/20:4(8Z,11Z,14Z,17Z))</name>
		<description>PC(o-20:1(11Z)/20:4(8Z,11Z,14Z,17Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-20:1(11Z)/20:4(8Z,11Z,14Z,17Z)), in particular, consists of one chain of Eicosenyl alcohol at the C-1 position and one chain of eicosatetraenoic acid at the C-2 position. The Eicosenyl alcohol moiety is derived from vegetable oil, while the eicosatetraenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C48H88NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C48H88NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-40-43-53-45-47(46-55-57(51,52)54-44-42-49(3,4)5)56-48(50)41-39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h15,17,20-23,27,29,33,35,47H,6-14,16,18-19,24-26,28,30-32,34,36-46H2,1-5H3/b17-15-,22-20-,23-21-,29-27-,35-33-/t47-/m1/s1</moldb_inchi>
		<moldb_inchikey>UNAQSIZPRIMCTB-QXUJVPJQSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>822.1886</moldb_average_mass>
		<moldb_mono_mass>821.629840687</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>614</id>
		<lmdb_id>LMDB00614</lmdb_id>
		<created_at>2016-07-13 19:53:47</created_at>
		<updated_at>2016-07-20 20:46:26</updated_at>
		<export>1</export>
		<name>PC(o-22:0/18:3(6Z,9Z,12Z))</name>
		<description>PC(o-22:0/18:3(6Z,9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-22:0/18:3(6Z,9Z,12Z)), in particular, consists of one chain of Behenyl alcohol at the C-1 position and one chain of g-linolenic acid at the C-2 position. The Behenyl alcohol moiety is derived from Rice bran, while the g-linolenic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C48H92NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C48H92NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-26-28-30-32-34-36-38-40-43-53-45-47(46-55-57(51,52)54-44-42-49(3,4)5)56-48(50)41-39-37-35-33-31-29-27-21-19-17-15-13-11-9-7-2/h15,17,21,27,31,33,47H,6-14,16,18-20,22-26,28-30,32,34-46H2,1-5H3/b17-15-,27-21-,33-31-/t47-/m1/s1</moldb_inchi>
		<moldb_inchikey>WEFAHDSLMVUAHQ-GEVWEYGMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>826.2203</moldb_average_mass>
		<moldb_mono_mass>825.661140815</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>615</id>
		<lmdb_id>LMDB00615</lmdb_id>
		<created_at>2016-07-13 19:53:48</created_at>
		<updated_at>2016-07-19 23:33:19</updated_at>
		<export>1</export>
		<name>PC(o-22:0/20:1(11Z))</name>
		<description>PC(o-22:0/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-22:0/20:1(11Z)), in particular, consists of one chain of Behenyl alcohol at the C-1 position and one chain of eicosenoic acid at the C-2 position. The Behenyl alcohol moiety is derived from Rice bran, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCC\C=C/CCCCCCCC</moldb_smiles>
		<moldb_formula>C50H100NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C50H100NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-26-28-30-32-34-36-38-40-42-45-55-47-49(48-57-59(53,54)56-46-44-51(3,4)5)58-50(52)43-41-39-37-35-33-31-29-27-23-21-19-17-15-13-11-9-7-2/h21,23,49H,6-20,22,24-48H2,1-5H3/b23-21-/t49-/m1/s1</moldb_inchi>
		<moldb_inchikey>XKPLZICHJPNOFR-WIEGMJJDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>858.3053</moldb_average_mass>
		<moldb_mono_mass>857.723741071</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>616</id>
		<lmdb_id>LMDB00616</lmdb_id>
		<created_at>2016-07-13 19:53:49</created_at>
		<updated_at>2016-07-19 23:33:26</updated_at>
		<export>1</export>
		<name>PC(o-22:0/20:4(8Z,11Z,14Z,17Z))</name>
		<description>PC(o-22:0/20:4(8Z,11Z,14Z,17Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-22:0/20:4(8Z,11Z,14Z,17Z)), in particular, consists of one chain of Behenyl alcohol at the C-1 position and one chain of eicosatetraenoic acid at the C-2 position. The Behenyl alcohol moiety is derived from Rice bran, while the eicosatetraenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C50H94NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C50H94NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-26-28-30-32-34-36-38-40-42-45-55-47-49(48-57-59(53,54)56-46-44-51(3,4)5)58-50(52)43-41-39-37-35-33-31-29-27-23-21-19-17-15-13-11-9-7-2/h15,17,21,23,29,31,35,37,49H,6-14,16,18-20,22,24-28,30,32-34,36,38-48H2,1-5H3/b17-15-,23-21-,31-29-,37-35-/t49-/m1/s1</moldb_inchi>
		<moldb_inchikey>PFSAGEUWPWJOBK-QENZFRSWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>852.2576</moldb_average_mass>
		<moldb_mono_mass>851.676790879</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>617</id>
		<lmdb_id>LMDB00617</lmdb_id>
		<created_at>2016-07-13 19:53:51</created_at>
		<updated_at>2016-07-19 23:33:28</updated_at>
		<export>1</export>
		<name>PC(o-22:0/22:3(10Z,13Z,16Z))</name>
		<description>PC(o-22:0/22:3(10Z,13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-22:0/22:3(10Z,13Z,16Z)), in particular, consists of one chain of Behenyl alcohol at the C-1 position and one chain of (10Z,13Z,16Z-docosatrienoyl) at the C-2 position. The Behenyl alcohol moiety is derived from Rice bran, while the (10Z,13Z,16Z-docosatrienoyl) moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C52H100NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C52H100NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-40-42-44-47-57-49-51(50-59-61(55,56)58-48-46-53(3,4)5)60-52(54)45-43-41-39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h15,17,21,23,27,29,51H,6-14,16,18-20,22,24-26,28,30-50H2,1-5H3/b17-15-,23-21-,29-27-/t51-/m1/s1</moldb_inchi>
		<moldb_inchikey>CQBVYLALIKLMGX-TYGMOWAISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>882.3267</moldb_average_mass>
		<moldb_mono_mass>881.723741071</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>618</id>
		<lmdb_id>LMDB00618</lmdb_id>
		<created_at>2016-07-13 19:53:52</created_at>
		<updated_at>2016-07-19 23:08:23</updated_at>
		<export>1</export>
		<name>PC(o-22:1(13Z)/20:4(8Z,11Z,14Z,17Z))</name>
		<description>PC(o-22:1(13Z)/20:4(8Z,11Z,14Z,17Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-22:1(13Z)/20:4(8Z,11Z,14Z,17Z)), in particular, consists of one chain of Erucyl alcohol at the C-1 position and one chain of eicosatetraenoic acid at the C-2 position. The Erucyl alcohol moiety is derived from Rapeseed oil, while the eicosatetraenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C50H92NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C50H92NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-26-28-30-32-34-36-38-40-42-45-55-47-49(48-57-59(53,54)56-46-44-51(3,4)5)58-50(52)43-41-39-37-35-33-31-29-27-23-21-19-17-15-13-11-9-7-2/h15,17,20-23,29,31,35,37,49H,6-14,16,18-19,24-28,30,32-34,36,38-48H2,1-5H3/b17-15-,22-20-,23-21-,31-29-,37-35-/t49-/m1/s1</moldb_inchi>
		<moldb_inchikey>OQRGDDBNUMCNLP-ABEXPZPBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>850.2417</moldb_average_mass>
		<moldb_mono_mass>849.661140815</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>619</id>
		<lmdb_id>LMDB00619</lmdb_id>
		<created_at>2016-07-13 19:53:53</created_at>
		<updated_at>2016-07-20 20:46:26</updated_at>
		<export>1</export>
		<name>PC(o-22:2(13Z,16Z)/22:3(10Z,13Z,16Z))</name>
		<description>PC(o-22:2(13Z,16Z)/22:3(10Z,13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-22:2(13Z,16Z)/22:3(10Z,13Z,16Z)), in particular, consists of one chain of Docosadienyl alcohol at the C-1 position and one chain of (10Z,13Z,16Z-docosatrienoyl) at the C-2 position. The Docosadienyl alcohol moiety is derived from animal fat, while the (10Z,13Z,16Z-docosatrienoyl) moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/CCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C52H96NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C52H96NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-40-42-44-47-57-49-51(50-59-61(55,56)58-48-46-53(3,4)5)60-52(54)45-43-41-39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h14-17,20-23,27,29,51H,6-13,18-19,24-26,28,30-50H2,1-5H3/b16-14-,17-15-,22-20-,23-21-,29-27-/t51-/m1/s1</moldb_inchi>
		<moldb_inchikey>CEZAZXUWDFPTTE-FHIJIHMSSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>878.2949</moldb_average_mass>
		<moldb_mono_mass>877.692440943</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>620</id>
		<lmdb_id>LMDB00620</lmdb_id>
		<created_at>2016-07-13 19:53:55</created_at>
		<updated_at>2016-07-19 23:33:33</updated_at>
		<export>1</export>
		<name>PC(o-22:3(10Z,13Z,16Z)/22:3(10Z,13Z,16Z))</name>
		<description>PC(o-22:3(10Z,13Z,16Z)/22:3(10Z,13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-22:3(10Z,13Z,16Z)/22:3(10Z,13Z,16Z)), in particular, consists of one chain of 10Z,13Z,16Z-Docosatrienyl alcohol at the C-1 position and one chain of (10Z,13Z,16Z-docosatrienoyl) at the C-2 position. The 10Z,13Z,16Z-Docosatrienyl alcohol moiety is derived from fish oil, while the (10Z,13Z,16Z-docosatrienoyl) moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/C\C=C/CCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C52H94NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C52H94NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-40-42-44-47-57-49-51(50-59-61(55,56)58-48-46-53(3,4)5)60-52(54)45-43-41-39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h14-17,20-23,26-29,51H,6-13,18-19,24-25,30-50H2,1-5H3/b16-14-,17-15-,22-20-,23-21-,28-26-,29-27-/t51-/m1/s1</moldb_inchi>
		<moldb_inchikey>QZMFOSCFDWPISC-KQHSIIGPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>876.2790</moldb_average_mass>
		<moldb_mono_mass>875.676790879</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>621</id>
		<lmdb_id>LMDB00621</lmdb_id>
		<created_at>2016-07-13 19:53:56</created_at>
		<updated_at>2016-07-19 23:33:23</updated_at>
		<export>1</export>
		<name>PC(o-24:0/18:3(6Z,9Z,12Z))</name>
		<description>PC(o-24:0/18:3(6Z,9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-24:0/18:3(6Z,9Z,12Z)), in particular, consists of one chain of Lignoceryl alcohol at the C-1 position and one chain of g-linolenic acid at the C-2 position. The Lignoceryl alcohol moiety is derived from plant waxes and beeswax, while the g-linolenic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C50H96NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C50H96NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-26-27-28-30-32-34-36-38-40-42-45-55-47-49(48-57-59(53,54)56-46-44-51(3,4)5)58-50(52)43-41-39-37-35-33-31-29-21-19-17-15-13-11-9-7-2/h15,17,21,29,33,35,49H,6-14,16,18-20,22-28,30-32,34,36-48H2,1-5H3/b17-15-,29-21-,35-33-/t49-/m1/s1</moldb_inchi>
		<moldb_inchikey>LDFITNYTODJQBW-AQBSXLNYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>854.2735</moldb_average_mass>
		<moldb_mono_mass>853.692440943</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>622</id>
		<lmdb_id>LMDB00622</lmdb_id>
		<created_at>2016-07-13 19:53:58</created_at>
		<updated_at>2016-07-19 23:27:52</updated_at>
		<export>1</export>
		<name>PC(o-24:0/20:4(8Z,11Z,14Z,17Z))</name>
		<description>PC(o-24:0/20:4(8Z,11Z,14Z,17Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-24:0/20:4(8Z,11Z,14Z,17Z)), in particular, consists of one chain of Lignoceryl alcohol at the C-1 position and one chain of eicosatetraenoic acid at the C-2 position. The Lignoceryl alcohol moiety is derived from plant waxes and beeswax, while the eicosatetraenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCCCOC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C52H98NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C52H98NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-26-27-28-30-32-34-36-38-40-42-44-47-57-49-51(50-59-61(55,56)58-48-46-53(3,4)5)60-52(54)45-43-41-39-37-35-33-31-29-23-21-19-17-15-13-11-9-7-2/h15,17,21,23,31,33,37,39,51H,6-14,16,18-20,22,24-30,32,34-36,38,40-50H2,1-5H3/b17-15-,23-21-,33-31-,39-37-/t51-/m1/s1</moldb_inchi>
		<moldb_inchikey>AQJDGYZOTXPNFY-ZFRXABNDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>880.3108</moldb_average_mass>
		<moldb_mono_mass>879.708091007</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>623</id>
		<lmdb_id>LMDB00623</lmdb_id>
		<created_at>2016-07-13 19:53:59</created_at>
		<updated_at>2016-09-23 18:45:38</updated_at>
		<export>1</export>
		<name>SM(d18:0/26:1(17Z))</name>
		<description>Sphingomyelin (d18:0/26:1(17Z)) or SM(d18:0/26:1(17Z)) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. In animals, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](COP([O-])(=O)OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCCCC\C=C/CCCCCCCC</moldb_smiles>
		<moldb_formula>C49H97N2O6P</moldb_formula>
		<moldb_inchi>InChI=1S/C49H97N2O6P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-26-27-28-29-31-33-35-37-39-41-43-49(53)50-47(46-57-58(54,55)56-45-44-51(3,4)5)48(52)42-40-38-36-34-32-30-19-17-15-13-11-9-7-2/h20-21,40,42,47-48,52H,6-19,22-39,41,43-46H2,1-5H3,(H-,50,53,54,55)/b21-20-,42-40+/t47-,48+/m0/s1</moldb_inchi>
		<moldb_inchikey>YXEXWUZHFGYOHJ-UOJCCMJYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>841.2780</moldb_average_mass>
		<moldb_mono_mass>840.708425358</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>624</id>
		<lmdb_id>LMDB00624</lmdb_id>
		<created_at>2016-07-13 19:54:00</created_at>
		<updated_at>2016-09-23 18:45:38</updated_at>
		<export>1</export>
		<name>SM(d18:0/14:1(9Z)(OH))</name>
		<description>Sphingomyelin (d18:0/14:1(9Z)(OH)) or SM(d18:0/14:1(9Z)(OH)) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In animals, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](COP([O-])(=O)OCC[N+](C)(C)C)NC(=O)CC(O)CCCCC\C=C/CCCC</moldb_smiles>
		<moldb_formula>C37H73N2O7P</moldb_formula>
		<moldb_inchi>InChI=1S/C37H73N2O7P/c1-6-8-10-12-14-16-17-18-19-21-23-25-27-29-36(41)35(33-46-47(43,44)45-31-30-39(3,4)5)38-37(42)32-34(40)28-26-24-22-20-15-13-11-9-7-2/h13,15,27,29,34-36,40-41H,6-12,14,16-26,28,30-33H2,1-5H3,(H-,38,42,43,44)/b15-13-,29-27+/t34?,35-,36+/m0/s1</moldb_inchi>
		<moldb_inchikey>ZNHNJXWKKQKMBU-POWUNZFVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>688.9585</moldb_average_mass>
		<moldb_mono_mass>688.515539212</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>625</id>
		<lmdb_id>LMDB00625</lmdb_id>
		<created_at>2016-07-13 19:54:02</created_at>
		<updated_at>2016-09-23 18:45:39</updated_at>
		<export>1</export>
		<name>SM(d18:0/16:1(9Z))</name>
		<description>Sphingomyelin (d18:0/16:1(9Z)) or SM(d18:0/16:1(9Z)) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In animals, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCC[C@@H](O)[C@H](COP([O-])(=O)OCC[N+](C)(C)C)NC(=O)CCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C39H79N2O6P</moldb_formula>
		<moldb_inchi>InChI=1S/C39H79N2O6P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-38(42)37(36-47-48(44,45)46-35-34-41(3,4)5)40-39(43)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h17,19,37-38,42H,6-16,18,20-36H2,1-5H3,(H-,40,43,44,45)/b19-17-/t37-,38+/m0/s1</moldb_inchi>
		<moldb_inchikey>CGVOQSQIYSUXAT-PPLFXBRHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>703.0281</moldb_average_mass>
		<moldb_mono_mass>702.567574782</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>626</id>
		<lmdb_id>LMDB00626</lmdb_id>
		<created_at>2016-07-13 19:54:03</created_at>
		<updated_at>2016-09-23 18:45:39</updated_at>
		<export>1</export>
		<name>SM(d18:0/20:2(11Z,14Z))</name>
		<description>Sphingomyelin (d18:0/20:2(11Z,14Z)) or SM(d18:0/20:2(11Z,14Z)) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In animals, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](COP([O-])(=O)OCC[N+](C)(C)C)NC(=O)CCCCCCCCC\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C43H83N2O6P</moldb_formula>
		<moldb_inchi>InChI=1S/C43H83N2O6P/c1-6-8-10-12-14-16-18-20-21-22-23-25-27-29-31-33-35-37-43(47)44-41(40-51-52(48,49)50-39-38-45(3,4)5)42(46)36-34-32-30-28-26-24-19-17-15-13-11-9-7-2/h14,16,20-21,34,36,41-42,46H,6-13,15,17-19,22-33,35,37-40H2,1-5H3,(H-,44,47,48,49)/b16-14-,21-20-,36-34+/t41-,42+/m0/s1</moldb_inchi>
		<moldb_inchikey>YVTVVJRJLRHYSJ-XJRFMCMQSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>755.1027</moldb_average_mass>
		<moldb_mono_mass>754.598874910</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>627</id>
		<lmdb_id>LMDB00627</lmdb_id>
		<created_at>2016-07-13 19:54:04</created_at>
		<updated_at>2016-09-23 18:45:39</updated_at>
		<export>1</export>
		<name>SM(d18:0/22:1(13Z)(OH))</name>
		<description>Sphingomyelin (d18:0/22:1(13Z)(OH)) or SM(d18:0/22:1(13Z)(OH)) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In animals, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](COP([O-])(=O)OCC[N+](C)(C)C)NC(=O)CC(O)CCCCCCCCC\C=C/CCCCCCCC</moldb_smiles>
		<moldb_formula>C45H89N2O7P</moldb_formula>
		<moldb_inchi>InChI=1S/C45H89N2O7P/c1-6-8-10-12-14-16-18-20-21-22-23-25-26-28-30-32-34-36-42(48)40-45(50)46-43(41-54-55(51,52)53-39-38-47(3,4)5)44(49)37-35-33-31-29-27-24-19-17-15-13-11-9-7-2/h20-21,35,37,42-44,48-49H,6-19,22-34,36,38-41H2,1-5H3,(H-,46,50,51,52)/b21-20-,37-35+/t42?,43-,44+/m0/s1</moldb_inchi>
		<moldb_inchikey>ZUSFLIGNJFDBRL-FYGIKZFGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>801.1711</moldb_average_mass>
		<moldb_mono_mass>800.640739724</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>628</id>
		<lmdb_id>LMDB00628</lmdb_id>
		<created_at>2016-07-13 19:54:06</created_at>
		<updated_at>2016-09-23 18:45:39</updated_at>
		<export>1</export>
		<name>SM(d18:0/22:2(13Z,16Z)(OH))</name>
		<description>Sphingomyelin (d18:0/22:2(13Z,16Z)(OH)) or SM(d18:0/22:2(13Z,16Z)(OH)) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In animals, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](COP([O-])(=O)OCC[N+](C)(C)C)NC(=O)CC(O)CCCCCCCCC\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C45H87N2O7P</moldb_formula>
		<moldb_inchi>InChI=1S/C45H87N2O7P/c1-6-8-10-12-14-16-18-20-21-22-23-25-26-28-30-32-34-36-42(48)40-45(50)46-43(41-54-55(51,52)53-39-38-47(3,4)5)44(49)37-35-33-31-29-27-24-19-17-15-13-11-9-7-2/h14,16,20-21,35,37,42-44,48-49H,6-13,15,17-19,22-34,36,38-41H2,1-5H3,(H-,46,50,51,52)/b16-14-,21-20-,37-35+/t42?,43-,44+/m0/s1</moldb_inchi>
		<moldb_inchikey>DRKCMBAZIYFIGX-ZWLRGCNFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>799.1552</moldb_average_mass>
		<moldb_mono_mass>798.625089660</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>629</id>
		<lmdb_id>LMDB00629</lmdb_id>
		<created_at>2016-07-13 19:54:07</created_at>
		<updated_at>2016-09-23 18:45:40</updated_at>
		<export>1</export>
		<name>SM(d18:0/22:3(10Z,13Z,16Z))</name>
		<description>Sphingomyelin (d18:0/22:3(10Z,13Z,16Z)) or SM (d18:0/22:3(10Z,13Z,16Z)) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In animals, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](COP([O-])(=O)OCC[N+](C)(C)C)NC(=O)CCCCCCCC\C=C/C\C=C/C\C=C/CCCCC</moldb_smiles>
		<moldb_formula>C45H85N2O6P</moldb_formula>
		<moldb_inchi>InChI=1S/C45H85N2O6P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-27-29-31-33-35-37-39-45(49)46-43(42-53-54(50,51)52-41-40-47(3,4)5)44(48)38-36-34-32-30-28-26-19-17-15-13-11-9-7-2/h14,16,20-21,23-24,36,38,43-44,48H,6-13,15,17-19,22,25-35,37,39-42H2,1-5H3,(H-,46,49,50,51)/b16-14-,21-20-,24-23-,38-36+/t43-,44+/m0/s1</moldb_inchi>
		<moldb_inchikey>YTQGMICAWXIKQI-OIMFMVRSSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>781.1400</moldb_average_mass>
		<moldb_mono_mass>780.614524974</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>630</id>
		<lmdb_id>LMDB00630</lmdb_id>
		<created_at>2016-07-13 19:54:08</created_at>
		<updated_at>2016-09-23 18:45:40</updated_at>
		<export>1</export>
		<name>SM(d18:0/24:1(15Z)(OH))</name>
		<description>Sphingomyelin (d18:0/24:1(15Z)(OH))or SM(d18:0/24:1(15Z)(OH)) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In animals, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](COP([O-])(=O)OCC[N+](C)(C)C)NC(=O)CC(O)CCCCCCCCCCC\C=C/CCCCCCCC</moldb_smiles>
		<moldb_formula>C47H93N2O7P</moldb_formula>
		<moldb_inchi>InChI=1S/C47H93N2O7P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-27-28-30-32-34-36-38-44(50)42-47(52)48-45(43-56-57(53,54)55-41-40-49(3,4)5)46(51)39-37-35-33-31-29-26-19-17-15-13-11-9-7-2/h20-21,37,39,44-46,50-51H,6-19,22-36,38,40-43H2,1-5H3,(H-,48,52,53,54)/b21-20-,39-37+/t44?,45-,46+/m0/s1</moldb_inchi>
		<moldb_inchikey>IOOMOQUTKQGEFH-BSZNTFKYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>829.2243</moldb_average_mass>
		<moldb_mono_mass>828.672039852</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>631</id>
		<lmdb_id>LMDB00631</lmdb_id>
		<created_at>2016-07-13 19:54:14</created_at>
		<updated_at>2016-07-19 23:24:13</updated_at>
		<export>1</export>
		<name>LPS with O-antigen</name>
		<description>Lipopolysaccharides (LPS), also known as lipoglycans, are large molecules consisting of a lipid and a polysaccharide joined by a covalent bond; they are found in the outer membrane of Gram-negative bacteria, act as endotoxins and elicit strong immune responses in animals. LPS is the major component of the outer membrane of Gram-negative bacteria, contributing greatly to the structural integrity of the bacteria, and protecting the membrane from certain kinds of chemical attack. LPS also increases the negative charge of the cell membrane and helps stabilize the overall membrane structure. It is of crucial importance to gram negative bacteria, whose death results if it is mutated or removed. LPS is an endotoxin, and induces a strong response from normal animal immune systems. LPS acts as the prototypical endotoxin because it binds the CD14/TLR4/MD2 receptor complex, which promotes the secretion of pro-inflammatory cytokines in many cell types, but especially in macrophages. In Immunology, the term &quot;LPS challenge&quot; refers to the process of exposing a subject to an LPS which may act as a toxin. LPS is also an exogenous pyrogen (external fever-inducing substance). Being of crucial importance to gram negative bacteria, these molecules make candidate targets for new antimicrobial agents. LPS comprises three parts: 1. O antigen (or O polysaccharide). 2. Core polysaccharide. 3. Lipid A. The making of LPS can be modified in order to present a specific sugar structure. Those can be recognised by either other LPS (which enables to inhibit LPS toxins) or glycosyltransferases which use those sugar structure to add more specific sugars. It has recently been shown that a specific enzyme in the intestine (alkaline phosphatase) can detoxify LPS by removing the two phosphate groups found on LPS carbohydrates [6]. This may function as an adaptive mechanism to help the host manage potentially toxic effects of gram-negative bacteria normally found in the small intestine. (from wiki). This card shows the example of LPS in E. coli with one o-antigen unit. </description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)O[C@H](CCCCCCCCCCC)CC(=O)O[C@@H]1[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@H](OC[C@H]2O[C@H](OP(O)(O)=O)[C@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H]2O)O[C@H](CO[C@@]2(C[C@@H](O[C@@]3(C[C@@H](O[C@@]4(C[C@@H](OP(O)(=O)OCCN)[C@H](O)[C@H](O4)[C@@H](O)CO)C(O)=O)[C@H](O)[C@H](O3)[C@@H](O)CO)C(O)=O)[C@H](OC3O[C@H]([C@@H](O)CO)[C@@H](OP(O)(=O)OP(O)(=O)OCCN)[C@H](OC4O[C@H]([C@@H](O)COC5O[C@H]([C@@H](O)CO)[C@@H](OP(O)(O)=O)[C@H](O)[C@@H]5O)[C@@H](O)[C@H](OC5O[C@H](CO[C@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H](O[C@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6OC6O[C@H](CO)[C@@H](O)[C@H](O[C@@H]7O[C@H](CO[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8NC(C)=O)[C@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@H](O)[C@H](O[C@H]9O[C@H](CO[C@H]%10O[C@H](CO)[C@H](O)[C@H](O)[C@H]%10O)[C@H](O)[C@H](O)[C@H]9O)[C@H]8NC(C)=O)[C@H]7NC(C)=O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6NC(C)=O)[C@H]5O)[C@@H]4O)[C@@H]3O)[C@H](O2)[C@@H](O)CO)C(O)=O)[C@H]1OP(O)(O)=O</moldb_smiles>
		<moldb_formula>C211H376N8O126P6</moldb_formula>
		<moldb_inchi>InChI=1S/C211H376N8O126P6/c1-11-17-23-29-35-41-42-48-54-60-66-72-134(247)308-109(70-64-58-52-46-39-33-27-21-15-5)80-136(249)322-182-142(219-132(245)79-108(69-63-57-51-45-38-32-26-20-14-4)307-133(246)71-65-59-53-47-40-34-28-22-16-6)192(301-99-128-153(260)179(321-135(248)78-107(237)68-62-56-50-44-37-31-25-19-13-3)141(196(317-128)344-348(290,291)292)218-131(244)77-106(236)67-61-55-49-43-36-30-24-18-12-2)320-130(178(182)341-346(284,285)286)101-304-209(206(278)279)83-118(336-210(207(280)281)81-116(149(256)172(337-210)110(238)84-220)335-211(208(282)283)82-117(340-349(293,294)305-75-73-212)150(257)173(338-211)111(239)85-221)177(176(339-209)114(242)88-224)326-203-170(277)186(189(175(325-203)113(241)87-223)343-351(297,298)345-350(295,296)306-76-74-213)332-202-169(276)184(167(274)171(323-202)115(243)96-299-199-166(273)162(269)187(342-347(287,288)289)174(324-199)112(240)86-222)329-201-168(275)183(155(262)129(319-201)100-303-198-164(271)159(266)146(253)122(92-228)313-198)330-204-188(161(268)147(254)123(93-229)314-204)333-205-190(334-193-138(215-103(8)233)157(264)144(251)120(90-226)310-193)185(152(259)125(95-231)315-205)331-195-140(217-105(10)235)181(154(261)127(316-195)98-300-191-137(214-102(7)232)156(263)143(250)119(89-225)309-191)327-194-139(216-104(9)234)180(151(258)124(94-230)311-194)328-200-165(272)160(267)148(255)126(318-200)97-302-197-163(270)158(265)145(252)121(91-227)312-197/h106-130,137-205,220-231,236-243,250-277H,11-101,212-213H2,1-10H3,(H,214,232)(H,215,233)(H,216,234)(H,217,235)(H,218,244)(H,219,245)(H,278,279)(H,280,281)(H,282,283)(H,293,294)(H,295,296)(H,297,298)(H2,284,285,286)(H2,287,288,289)(H2,290,291,292)/t106-,107-,108-,109-,110+,111+,112+,113+,114+,115+,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,137-,138-,139-,140-,141-,142-,143-,144-,145+,146+,147+,148+,149+,150+,151+,152-,153-,154+,155-,156-,157-,158+,159+,160+,161+,162-,163-,164-,165-,166+,167-,168-,169+,170+,171-,172-,173-,174-,175-,176-,177+,178-,179-,180-,181-,182-,183+,184+,185+,186-,187+,188-,189-,190-,191-,192-,193+,194+,195+,196-,197+,198+,199?,200-,201?,202?,203?,204-,205?,209-,210-,211-/m1/s1</moldb_inchi>
		<moldb_inchikey>BFVQTKQTUCQRPI-YYEZTRBPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>5227.0637</moldb_average_mass>
		<moldb_mono_mass>5224.168615516</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>632</id>
		<lmdb_id>LMDB00632</lmdb_id>
		<created_at>2016-07-13 19:54:15</created_at>
		<updated_at>2016-07-20 21:02:18</updated_at>
		<export>1</export>
		<name>4b-Hydroxycholesterol</name>
		<description>4[beta]-Hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4[C@@H](O)[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C</moldb_smiles>
		<moldb_formula>C27H46O2</moldb_formula>
		<moldb_inchi>InChI=1S/C27H46O2/c1-17(2)7-6-8-18(3)20-11-12-21-19-9-10-23-25(29)24(28)14-16-27(23,5)22(19)13-15-26(20,21)4/h10,17-22,24-25,28-29H,6-9,11-16H2,1-5H3/t18-,19+,20-,21+,22+,24+,25-,26-,27-/m1/s1</moldb_inchi>
		<moldb_inchikey>CZDKQKOAHAICSF-JSAMMMMSSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>402.6529</moldb_average_mass>
		<moldb_mono_mass>402.349780716</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>633</id>
		<lmdb_id>LMDB00633</lmdb_id>
		<created_at>2016-07-13 19:54:16</created_at>
		<updated_at>2016-07-19 23:29:39</updated_at>
		<export>1</export>
		<name>Yttrium</name>
		<description>An element of the rare earth family of metals. It has the atomic symbol Y, atomic number 39, and atomic weight 88.91. In conjunction with other rare earths, yttrium is used as a phosphor in television receivers and is a component of the yttrium-aluminum garnet (YAG) lasers.</description>
		<cas>7440-65-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Y]</moldb_smiles>
		<moldb_formula>Y</moldb_formula>
		<moldb_inchi>InChI=1S/Y</moldb_inchi>
		<moldb_inchikey>VWQVUPCCIRVNHF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>88.9059</moldb_average_mass>
		<moldb_mono_mass>88.905847902</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>634</id>
		<lmdb_id>LMDB00634</lmdb_id>
		<created_at>2016-07-13 19:54:18</created_at>
		<updated_at>2016-07-19 23:23:58</updated_at>
		<export>1</export>
		<name>Cesium</name>
		<description>Cesium (Caesium) is a soft, silvery-gold alkali metal with a melting point of 28 ∞C (82 ∞F). Cesium is used in various industries, from the oil industry as cesium formate in drilling fluid, atomic clocks, centrifugation fluids, and cesium vapor thermionic generators, which convert heat energy to electrical energy.</description>
		<cas>7440-46-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Cs]</moldb_smiles>
		<moldb_formula>Cs</moldb_formula>
		<moldb_inchi>InChI=1S/Cs</moldb_inchi>
		<moldb_inchikey>TVFDJXOCXUVLDH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>132.9055</moldb_average_mass>
		<moldb_mono_mass>132.905446870</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>635</id>
		<lmdb_id>LMDB00635</lmdb_id>
		<created_at>2016-07-13 19:54:19</created_at>
		<updated_at>2016-07-19 23:26:44</updated_at>
		<export>1</export>
		<name>Palladium</name>
		<description>Palladium is a rare and lustrous silvery-white metal. Palladium has the lowest melting point and is the least dense of platinum group metals. The primary use for palladium is in catalytic converters for the automotive industry. </description>
		<cas>7440-05-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Pd]</moldb_smiles>
		<moldb_formula>Pd</moldb_formula>
		<moldb_inchi>InChI=1S/Pd</moldb_inchi>
		<moldb_inchikey>KDLHZDBZIXYQEI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>106.4200</moldb_average_mass>
		<moldb_mono_mass>105.903483087</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>636</id>
		<lmdb_id>LMDB00636</lmdb_id>
		<created_at>2016-07-13 19:54:20</created_at>
		<updated_at>2016-07-19 23:23:58</updated_at>
		<export>1</export>
		<name>Cerium</name>
		<description>An element of the rare earth family of metals. It has the atomic symbol Ce, atomic number 58, and atomic weight 140.12. Cerium is a malleable metal used in many industrial applications including catalysts, additives to fuel to reduce emissions, and to glass and enamels to change their color.</description>
		<cas>7440-45-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Ce]</moldb_smiles>
		<moldb_formula>Ce</moldb_formula>
		<moldb_inchi>InChI=1S/Ce</moldb_inchi>
		<moldb_inchikey>GWXLDORMOJMVQZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>140.1160</moldb_average_mass>
		<moldb_mono_mass>139.905434035</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>637</id>
		<lmdb_id>LMDB00637</lmdb_id>
		<created_at>2016-07-13 19:54:22</created_at>
		<updated_at>2018-04-30 21:14:57</updated_at>
		<export>1</export>
		<name>1,2,3-Trihydroxybenzene</name>
		<description>Pyrogallol or benzene-1,2,3-triol is a benzenetriol. It is a white crystalline powder and a powerful reducing agent. It was first prepared by Scheele 1786 by heating gallic acid. An alternate preparation is heating para-chlorophenoldisulphonic acid with potassium hydroxide.</description>
		<cas>87-66-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]OC1=CC=CC(O[H])=C1O[H]</moldb_smiles>
		<moldb_formula>C6H6O3</moldb_formula>
		<moldb_inchi>InChI=1S/C6H6O3/c7-4-2-1-3-5(8)6(4)9/h1-3,7-9H</moldb_inchi>
		<moldb_inchikey>WQGWDDDVZFFDIG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>126.1100</moldb_average_mass>
		<moldb_mono_mass>126.031694058</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>638</id>
		<lmdb_id>LMDB00638</lmdb_id>
		<created_at>2016-07-13 19:54:23</created_at>
		<updated_at>2018-04-30 21:14:57</updated_at>
		<export>1</export>
		<name>Lanthanum</name>
		<description>Lanthanum is a chemical element with the symbol La and atomic number 57. Lanthanum is a silvery white metallic element that belongs to group 3 of the periodic table and is the first element of the lanthanide series. It is found in some rare-earth minerals, usually in combination with cerium and other rare earth elements. Lanthanum is a malleable, ductile, and soft metal that oxidizes rapidly when exposed to air. It is produced from the minerals monazite and bastnasite using a complex multistage extraction process. Lanthanum compounds have numerous applications as catalysts, additives in glass, carbon lighting for studio lighting and projection, ignition elements in lighters and torches, electron cathodes, scintillators, and others. Lanthanum carbonate (La2(CO3)3) was approved as a medication against renal failure. Lanthanum is a soft, malleable, silvery white metal which has hexagonal crystal structure at room temperature. At 310 ∞C, lanthanum changes to a face-centered cubic structure, and at 865 ∞C into a body-centered cubic structure. Lanthanum easily is oxidized (a centimeter-sized sample will completely oxidize within a year) and is therefore used as in elemental form only for research purposes. For example, single La atoms have been isolated by implanting them into fullerene molecules. If carbon nanotubes are filled with those lanthanum-encapsulated fullerenes and annealed, metallic nanochains of lanthanum are produced inside carbon nanotubes. Lanthanum is most commonly obtained from monazite and bastnasite. The mineral mixtures are crushed and ground. Monazite, because of its magnetic properties, can be separated by repeated electromagnetic separation. After separation, it is treated with hot concentrated sulfuric acid to produce water-soluble sulfates of rare earths. The acidic filtrates are partially neutralized with sodium hydroxide to pH 3-4. Thorium precipitates out of solution as hydroxide and is removed. After that, the solution is treated with ammonium oxalate to convert rare earths to their insoluble oxalates. The oxalates are converted to oxides by annealing. The oxides are dissolved in nitric acid that excludes one of the main components, cerium, whose oxide is insoluble in HNO3. Lanthanum is separated as a double salt with ammonium nitrate by crystallization. This salt is relatively less soluble than other rare earth double salts and therefore stays in the residue. While lanthanum has pharmacological effects on several receptors and ion channels, its specificity for the GABA receptor is unique among divalent cations. Lanthanum acts at the same modulatory site on the GABA receptor as zinc- a known negative allosteric modulator. The Lanthanum cation La3+ is a positive allosteric modulator at native and recombinant GABA receptors, increasing open channel time and decreasing desensitization in a subunit configuration dependent manner.</description>
		<cas>7439-91-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O.[La+3].[La+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O</moldb_smiles>
		<moldb_formula>(H2O)nC3La2O9</moldb_formula>
		<moldb_inchi>InChI=1S/3CH2O3.2La.H2O/c3*2-1(3)4;;;/h3*(H2,2,3,4);;;1H2/q;;;2*+3;/p-6</moldb_inchi>
		<moldb_inchikey>AFCUGQOTNCVYSW-UHFFFAOYSA-H</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>NULL</moldb_average_mass>
		<moldb_mono_mass>NULL</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>639</id>
		<lmdb_id>LMDB00639</lmdb_id>
		<created_at>2016-07-13 19:54:24</created_at>
		<updated_at>2016-07-20 21:02:20</updated_at>
		<export>1</export>
		<name>Norvaline</name>
		<description>Norvaline is a non-proteinogenic branched-chain amino acid. It has previously been reported to be a natural component of an antifungal peptide of Bacillus subtilis. Norvaline and other modified branched chain amino acids have received attention in recent studies, as they appear to be incorporated in some recombinant proteins found in E. coli. Norvaline is an amino acid with the chemical formula C5H11NO2, isomeric with valine. This amino acid is often made synthetically.</description>
		<cas>760-78-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC[C@@H](N)C(O)=O</moldb_smiles>
		<moldb_formula>C5H11NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H11NO2/c1-2-3-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m1/s1</moldb_inchi>
		<moldb_inchikey>SNDPXSYFESPGGJ-SCSAIBSYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>117.1463</moldb_average_mass>
		<moldb_mono_mass>117.078978601</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>640</id>
		<lmdb_id>LMDB00640</lmdb_id>
		<created_at>2016-07-13 19:54:26</created_at>
		<updated_at>2016-07-19 23:28:32</updated_at>
		<export>1</export>
		<name>Rhenium</name>
		<description>Its usual commercial form is a powder, but this element can be consolidated by pressing and sintering in a vacuum or hydrogen atmosphere. This procedure yields a compact solid having a density above 90% of the density of the metal. When annealed this metal is very ductile and can be bent, coiled, or rolled. Rhenium-molybdenum alloys are superconductive at 10 K; tungsten-rhenium alloys are also superconductive around 4-8 K, depending on the alloy. Rhenium metal superconducts at 2.4 K. Methylrhenium trioxide (&quot;MTO&quot;), CH3ReO3 is a volatile, colourless solid has been used as a catalyst in some laboratory experiments. It can be prepared by many routes, a typical method is the reaction of Re2O7 and tetramethyltin:; Rhenium is a chemical element with the symbol Re and atomic number 75. It is a silvery-white, heavy, third-row transition metal in group 7 of the periodic table. With an average concentration of 1 part per billion (ppb), rhenium is one of the rarest elements in the Earth's crust. The free element has the third-highest melting point and highest boiling point of any element. Rhenium resembles manganese chemically and is obtained as a by-product of molybdenum and copper refinement. Rhenium shows in its compounds a wide variety of oxidation states ranging from 1 to +7. Rhenium diboride (ReB2) is a hard compound having the hardness similar to that of tungsten carbide, silicon carbide, titanium diboride or zirconium diboride. Rhenium has a stable isotope, rhenium-185, which nevertheless occurs in minority abundance, a situation found only in one other element (indium). Naturally occurring rhenium is 37.4% 185Re, which is stable, and 62.6% 187Re, which is unstable but has a very long half-life (~1010 years). This lifetime is affected by the charge state of rhenium atom. The beta decay of 187Re is used for rhenium-osmium dating of ores. The available energy for this beta decay (2.6 keV) is one of the lowest known among all radionuclides. There are twenty-six other recognized radioactive isotopes of rhenium. Rhenium in the form of rhenium-platinum alloy is used as catalyst for catalytic reforming, which is a chemical process to convert petroleum refinery naphthas with low octane ratings into high-octane liquid products. Worldwide, 30% of catalysts used for this process contain rhenium. The olefin metathesis is the other reaction for which rhenium is used as catalyst. Normally Re2O7 on alumina is used for this process. Rhenium catalysts are very resistant to chemical poisoning from nitrogen, sulfur and phosphorus, and so are used in certain kinds of hydrogenation reactions. Rhenium is a silvery-white metal with one of the highest melting points of all elements, exceeded by only tungsten and carbon. It is also one of the densest, exceeded only by platinum, iridium and osmium. Rhenium has a hexagonal close-packed crystal structure, with lattice parameters a = 276.1 pm and c = 445.6 pm. Rhenium is one of the rarest elements in Earth's crust with an average concentration of 1 ppb; other sources quote the number of 0.5 ppb making it the 77th most abundant element in Earth's crust. Rhenium is probably not found free in nature (its possible natural occurrence is uncertain), but occurs in amounts up to 0.2% in the mineral molybdenite (which is primarily molybdenum disulfide), the major commercial source, although single molybdenite samples with up to 1.88% have been found. Chile has the world's largest rhenium reserves, part of the copper ore deposits, and was the leading producer as of 2005. It was only recently that the first rhenium mineral was found and described (in 1994), a rhenium sulfide mineral (ReS2) condensing from a fumarole on Russia's Kudriavy volcano, Iturup island, in the Kurile Islands. Kudryavy discharges up to 20-60 kg rhenium per year mostly in the form of rhenium disulfide. Named rheniite, this rare mineral commands high prices among collectors.</description>
		<cas>7440-15-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Re]</moldb_smiles>
		<moldb_formula>Re</moldb_formula>
		<moldb_inchi>InChI=1S/Re</moldb_inchi>
		<moldb_inchikey>WUAPFZMCVAUBPE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>186.2070</moldb_average_mass>
		<moldb_mono_mass>186.955750787</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>641</id>
		<lmdb_id>LMDB00641</lmdb_id>
		<created_at>2016-07-13 19:54:27</created_at>
		<updated_at>2018-04-30 21:14:58</updated_at>
		<export>1</export>
		<name>Thallium</name>
		<description>A mercury-thallium alloy, which forms a eutectic at 8.5% thallium, is reported to freeze at -60 C, some 20 ∞C below the freezing point of mercury. This alloy is used in thermometers and low-temperature switches. In organic synthesis thallium(III) salts, as thallium trinitrate or triacetate, are useful reagents performing different transformations in aromatics, ketones, olefins, among others. Thallium is a constituent of the alloy in the anode plates in magnesium seawater batteries. Soluble thallium salts are added to gold plating baths to increase the speed of plating and to reduce grain size within the gold layer. A thallium stress test is a form of scintigraphy, where the amount of thallium in tissues correlates with tissue blood supply. Viable cardiac cells have normal Na+/K+ ion exchange pumps. The Tl+ cation binds the K+ pumps and is transported into the cells. Exercise or dipyridamole induces widening (vasodilation) of normal coronary arteries. This produces coronary steal from areas where arteries are maximally dilated. Areas of infarct or ischemic tissue will remain &quot;cold&quot;. Pre- and post-stress thallium may indicate areas which will benefit from myocardial revascularization. Redistribution indicates the existence of coronary steal and the presence of ischemic coronary artery disease. Although thallium is a modestly abundant element in the Earth's crust, with a concentration estimated to be about 0.7 mg/kg, mostly in association with potassium-based minerals in clays, soils, and granites, thallium is not generally economically recoverable from these sources. The major source of thallium for practical purposes is the trace amount that is found in copper, lead, zinc, and other heavy-metal-sulfide ores. One of the main methods of removing thallium (both radioactive and normal) from animals is to use Prussian blue, which is a material which absorbs thallium. Up to 20 g per day of Prussian blue is fed by mouth to the person, and it passes through their digestive system and comes out in the stool. Hemodialysis and hemoperfusion are also used to remove thallium from the blood serum. At later stage of the treatment additional potassium is used to mobilize thallium from the tissue. Thallium is a chemical element with the symbol Tl and atomic number 81. This soft gray poor metal resembles tin but discolors when exposed to air. Chemists William Crookes and Claude-Auguste Lamy discovered thallium independently in 1861 by the newly developed method of flame spectroscopy. Each discovered the new element in residues of sulfuric acid production. Thallium and its compounds are extremely toxic, and should be handled with great care. There are numerous recorded cases of fatal thallium poisoning. Contact with skin is dangerous, and adequate ventilation should be provided when melting this metal. Thallium(I) compounds have a high aqueous solubility and are readily absorbed through the skin. Exposure to them should not exceed 0.1 mg per m2 of skin in an 8-hour time-weighted average (40-hour work week). Thallium is a suspected animal carcinogen. For a long time thallium compounds were easily available as rat poison. This fact and that it is water soluble and nearly tasteless led to frequent intoxications caused by accident or criminal intent. Thallium can also be obtained from the smelting of lead and zinc ores. Manganese nodules found on the ocean floor also contain some thallium, but the collection of these nodules has been and continues to be prohibitively expensive. There is also the potential for damaging the environment of the oceans. In addition, several other thallium minerals, containing 16% to 60% thallium, occur in nature as complexes of sulfides or selenides that primarily contain antimony, arsenic, copper, lead, and/or silver. However, these minerals are rare, and they have had no commercial importance as sources of thallium. The Allchar deposit in southern Macedonia was the only area where thallium was ever actively mined. This deposit still contains a loosely estimated 500 tonnes of thallium, and it is a source for several rare thallium minerals, for example lorandite. The compounds with oxidation state +3 resemble the corresponding aluminium(III) compounds. They are moderately strong oxidizing agents, as illustrated by the reduction potential of +0.72 volts for Tl3+. The thallium(III) oxide is a black solid which decomposes above 800 ∞C, forming the thallium(I) oxide and oxygen. The saturated solution of equal parts of thallium(I) formate (Tl(CHO2)) and thallium(I) malonate (Tl(C3H3O4)) in water is known as Clerici solution. It is a mobile odorless liquid whose color changes from yellowish to clear upon reducing the concentration of the thallium salts. With the density of 4.25 g/cm3 at 20 ∞C, Clerici solution is one of the heaviest aqueous solutions known. It was used in the 20th century for measuring density of minerals by the flotation method, but the use is discontinued due to the high toxicity and corrosiveness of the solution. The two main oxidation states of thallium are +1 and +3. In the oxidation state +1 most compounds closely resemble the corresponding potassium or silver compounds (the ionic radius of thallium(I) is 1.47 while that of potassium is 1.33 and that of silver is 1.26),[citation needed] which was the reason why thallium was sometimes considered to be an alkali metal in Europe (but not in England) in the years immediately following its discovery.:126 For example, the water-soluble and very basic thallium(I) hydroxide reacts with carbon dioxide forming water-soluble thallium carbonate This carbonate is the only water soluble heavy metal carbonate.[citation needed] The similarity with silver compounds is observed with the halide, oxide, and sulfide compounds. Thallium(I) bromide is a photosensitive yellow compound very similar to the silver bromide, while the black thallium(I) oxide and thallium(I) sulfide are very similar to the silver oxide and silver sulfide.[citation needed]</description>
		<cas>7440-28-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>Cl[Tl]</moldb_smiles>
		<moldb_formula>ClTl</moldb_formula>
		<moldb_inchi>InChI=1S/ClH.Tl/h1H;/q;+1/p-1</moldb_inchi>
		<moldb_inchikey>GBECUEIQVRDUKB-UHFFFAOYSA-M</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>239.8300</moldb_average_mass>
		<moldb_mono_mass>239.943281000</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>642</id>
		<lmdb_id>LMDB00642</lmdb_id>
		<created_at>2016-07-13 19:54:28</created_at>
		<updated_at>2016-07-20 21:02:21</updated_at>
		<export>1</export>
		<name>2-Hydroxypyridine</name>
		<description>(NMR-spectroscopy is a slow method, high resolution IR-spectroscopy in solvent is difficult, the broad absorption in UV-spectroscopy makes it hard to discriminate 3 and more very similar molecules). 2-Pyridone is an organic compound with the formula C5H4NH(O). This colourless crystalline solid is used in peptide synthesis. It is well known to form hydrogen bonded structures somewhat related to the base-pairing mechanism found in RNA and DNA. It is also a classic case of a molecule that exists as tautomers. Some publications only focus one of the two possible patterns, and neglect the influence of the other. For example, to calculation of the energy difference of the two tautomers in a non-polar solution will lead to a wrong result if a large quantity of the substance is on the side of the dimer in an equilibrium. The direct tautomerisation is not energetically favoured, but a dimerisation followed by a double proton transfer and dissociation of the dimer is a self catalytic path from one tautomer to the other. Protic solvents also mediate the proton transfer during the tautomerisation.</description>
		<cas>142-08-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1=CC=CC=N1</moldb_smiles>
		<moldb_formula>C5H5NO</moldb_formula>
		<moldb_inchi>InChI=1S/C5H5NO/c7-5-3-1-2-4-6-5/h1-4H,(H,6,7)</moldb_inchi>
		<moldb_inchikey>UBQKCCHYAOITMY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>95.0993</moldb_average_mass>
		<moldb_mono_mass>95.037113787</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>643</id>
		<lmdb_id>LMDB00643</lmdb_id>
		<created_at>2016-07-13 19:54:29</created_at>
		<updated_at>2016-09-23 18:45:40</updated_at>
		<export>1</export>
		<name>Vitamin C</name>
		<description>A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in animal diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant. [PubChem]</description>
		<cas>50-81-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO</moldb_smiles>
		<moldb_formula>C6H8O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1</moldb_inchi>
		<moldb_inchikey>CIWBSHSKHKDKBQ-JLAZNSOCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>176.1241</moldb_average_mass>
		<moldb_mono_mass>176.032087988</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>644</id>
		<lmdb_id>LMDB00644</lmdb_id>
		<created_at>2016-07-13 19:54:31</created_at>
		<updated_at>2016-07-20 21:02:22</updated_at>
		<export>1</export>
		<name>Phosphatidylserine</name>
		<description>Phosphatidylserine (PS) is a phospholipid nutrient found in fish, green leafy vegetables, soybeans and rice, and is essential for the normal functioning of neuronal cell membranes and activates Protein kinase C (PKC) which has been shown to be involved in memory function. In apoptosis, phosphatidylserine is transferred to the outer leaflet of the plasma membrane. This is part of the process by which the cell is targeted for phagocytosis. PS has been shown to slow cognitive decline in animal models. PS has been investigated in a small number of double-blind placebo trials and has been shown to increase memory performance in the elderly. Because of the potentail cognitive benefits of phosphatidylserine, the substance is sold as a dietary supplement to people who believe they can benefit from an increased intake. The dietary supplement was originally processed from bovine sources however Prion disease scares in the 1990s outlawed this process, and a soy-based alternative was adopted.</description>
		<cas>8002-43-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCC(=O)O[C@H](COC(=O)CC)COP(O)(=O)OC[C@H](N)C(O)=O</moldb_smiles>
		<moldb_formula>C13H24NO10P</moldb_formula>
		<moldb_inchi>InChI=1S/C13H24NO10P/c1-3-5-12(16)24-9(6-21-11(15)4-2)7-22-25(19,20)23-8-10(14)13(17)18/h9-10H,3-8,14H2,1-2H3,(H,17,18)(H,19,20)/t9-,10+/m1/s1</moldb_inchi>
		<moldb_inchikey>UNJJBGNPUUVVFQ-ZJUUUORDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>385.3041</moldb_average_mass>
		<moldb_mono_mass>385.113782505</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>645</id>
		<lmdb_id>LMDB00645</lmdb_id>
		<created_at>2016-07-13 19:54:32</created_at>
		<updated_at>2016-07-20 21:02:22</updated_at>
		<export>1</export>
		<name>Cycloserine</name>
		<description>Cycloserine is only found in individuals that have used or taken this drug. It is an antibiotic substance produced by Streptomyces garyphalus. [PubChem]Cycloserine is an analog of the amino acid D-alanine. It interferes with an early step in bacterial cell wall synthesis in the cytoplasm by competitive inhibition of two enzymes, L-alanine racemase, which forms D-alanine from L-alanine, and D-alanylalanine synthetase, which incorporates D-alanine into the pentapeptide necessary for peptidoglycan formation and bacterial cell wall synthesis.</description>
		<cas>68-41-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H]1CONC1=O</moldb_smiles>
		<moldb_formula>C3H6N2O2</moldb_formula>
		<moldb_inchi>InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m1/s1</moldb_inchi>
		<moldb_inchikey>DYDCUQKUCUHJBH-UWTATZPHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>102.0919</moldb_average_mass>
		<moldb_mono_mass>102.042927446</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>646</id>
		<lmdb_id>LMDB00646</lmdb_id>
		<created_at>2016-07-13 19:54:33</created_at>
		<updated_at>2016-07-20 21:02:23</updated_at>
		<export>1</export>
		<name>Spironolactone</name>
		<description>A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)</description>
		<cas>52-01-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O</moldb_smiles>
		<moldb_formula>C24H32O4S</moldb_formula>
		<moldb_inchi>InChI=1S/C24H32O4S/c1-14(25)29-19-13-15-12-16(26)4-8-22(15,2)17-5-9-23(3)18(21(17)19)6-10-24(23)11-7-20(27)28-24/h12,17-19,21H,4-11,13H2,1-3H3/t17-,18-,19+,21+,22-,23-,24+/m0/s1</moldb_inchi>
		<moldb_inchikey>LXMSZDCAJNLERA-ZHYRCANASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>416.5730</moldb_average_mass>
		<moldb_mono_mass>416.202130202</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>647</id>
		<lmdb_id>LMDB00647</lmdb_id>
		<created_at>2016-07-13 19:54:35</created_at>
		<updated_at>2016-07-20 21:02:23</updated_at>
		<export>1</export>
		<name>Fosfomycin</name>
		<description>Fosfomycin is only found in individuals that have used or taken this drug. It is an antibiotic produced by Streptomyces fradiae. [PubChem]Fosfomycin is a phosphoenolpyruvate analogue produced by Streptomyces that irreversibly inhibits enolpyruvate transferase (MurA), which prevents the formation of N-acetylmuramic acid, an essential element of the peptidoglycan cell wall.</description>
		<cas>23155-02-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[C@@H]1O[C@@H]1P(O)(O)=O</moldb_smiles>
		<moldb_formula>C3H7O4P</moldb_formula>
		<moldb_inchi>InChI=1S/C3H7O4P/c1-2-3(7-2)8(4,5)6/h2-3H,1H3,(H2,4,5,6)/t2-,3+/m0/s1</moldb_inchi>
		<moldb_inchikey>YMDXZJFXQJVXBF-STHAYSLISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>138.0590</moldb_average_mass>
		<moldb_mono_mass>138.008195224</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>648</id>
		<lmdb_id>LMDB00648</lmdb_id>
		<created_at>2016-07-13 19:54:36</created_at>
		<updated_at>2016-07-20 21:02:24</updated_at>
		<export>1</export>
		<name>Hydroxyurea</name>
		<description>Hydroxyurea is only found in individuals that have used or taken this drug. It is an antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. [PubChem]Hydroxyurea is converted to a free radical nitroxide (NO) in vivo, and transported by diffusion into cells where it quenches the tyrosyl free radical at the active site of the M2 protein subunit of ribonucleotide reductase, inactivating the enzyme. The entire replicase complex, including ribonucleotide reductase, is inactivated and DNA synthesis is selectively inhibited, producing cell death in S phase and synchronization of the fraction of cells that survive. Repair of DNA damaged by chemicals or irradiation is also inhibited by hydroxyurea, offering potential synergy between hydroxyurea and radiation or alkylating agents. Hydroxyurea also increases the level of fetal hemoglobin, leading to a reduction in the incidence of vasoocclusive crises in sickle cell anemia. Levels of fetal hemoglobin increase in response to activation of soluble guanylyl cyclase (sGC) by hydroxyurea-derived NO.</description>
		<cas>127-07-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC(=O)NO</moldb_smiles>
		<moldb_formula>CH4N2O2</moldb_formula>
		<moldb_inchi>InChI=1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4)</moldb_inchi>
		<moldb_inchikey>VSNHCAURESNICA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>76.0547</moldb_average_mass>
		<moldb_mono_mass>76.027277382</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>649</id>
		<lmdb_id>LMDB00649</lmdb_id>
		<created_at>2016-07-13 19:54:37</created_at>
		<updated_at>2016-07-20 21:02:24</updated_at>
		<export>1</export>
		<name>Aminophylline</name>
		<description>Aminophylline is only found in individuals that have used or taken this drug. It is a drug combination that contains theophylline and ethylenediamine in 2:1 ratio. [Wikipedia]Theophylline is structurally related to theobromine and caffeine. The precise mechanism of action of theophylline is not known, however, it is thought to be a phosphodiesterase inhibitor which may give a bronchodilatory effect. It also binds adenosine receptors.</description>
		<cas>317-34-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O</moldb_smiles>
		<moldb_formula>C16H24N10O4</moldb_formula>
		<moldb_inchi>InChI=1S/2C7H8N4O2.C2H8N2/c2*1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;3-1-2-4/h2*3H,1-2H3,(H,8,9);1-4H2</moldb_inchi>
		<moldb_inchikey>FQPFAHBPWDRTLU-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>420.4264</moldb_average_mass>
		<moldb_mono_mass>420.198199306</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>650</id>
		<lmdb_id>LMDB00650</lmdb_id>
		<created_at>2016-07-13 19:54:38</created_at>
		<updated_at>2016-07-20 21:02:24</updated_at>
		<export>1</export>
		<name>Gamma Hydroxybutyric Acid</name>
		<description>Gamma Hydroxybutyric Acid, commonly abbreviated GHB, is a therapeutic drug which is illegal in multiple countries. It is currently regulated in the US and sold by Jazz Pharmaceuticals under the name Xyrem. However, it is important to note that GHB is a designated Orphan drug (in 1985). Today Xyrem is a Schedule III drug. However, GHB remains a Schedule I drug and the illicit use of Xyrem falls under penalties of Schedule I. GHB is a naturally occurring substance found in the central nervous system, wine, beef, small citrus fruits and almost all other living creatures in small amounts. It is used illegally under the street names Juice, Liquid Ecstasy or simply G, either as an intoxicant, or as a date rape drug. Xyrem is a central nervous system depressant that reduces excessive daytime sleepiness and cataplexy in patients with narcolepsy. </description>
		<cas>591-81-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCCCC([O-])=O</moldb_smiles>
		<moldb_formula>C4H7O3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8O3/c5-3-1-2-4(6)7/h5H,1-3H2,(H,6,7)/p-1</moldb_inchi>
		<moldb_inchikey>SJZRECIVHVDYJC-UHFFFAOYSA-M</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>103.0966</moldb_average_mass>
		<moldb_mono_mass>103.039519090</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>651</id>
		<lmdb_id>LMDB00651</lmdb_id>
		<created_at>2016-07-13 19:54:40</created_at>
		<updated_at>2016-07-19 23:36:19</updated_at>
		<export>1</export>
		<name>Iron</name>
		<description>A metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia. </description>
		<cas>7439-89-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Fe]</moldb_smiles>
		<moldb_formula>Fe</moldb_formula>
		<moldb_inchi>InChI=1S/Fe</moldb_inchi>
		<moldb_inchikey>XEEYBQQBJWHFJM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>55.8450</moldb_average_mass>
		<moldb_mono_mass>55.934942133</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>652</id>
		<lmdb_id>LMDB00652</lmdb_id>
		<created_at>2016-07-13 19:54:41</created_at>
		<updated_at>2016-07-20 20:47:00</updated_at>
		<export>1</export>
		<name>Zinc</name>
		<description>A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with anemia, short stature, hypogonadism, impaired wound healing, and geophagia. It is known by the symbol Zn.</description>
		<cas>7440-66-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Zn]</moldb_smiles>
		<moldb_formula>Zn</moldb_formula>
		<moldb_inchi>InChI=1S/Zn</moldb_inchi>
		<moldb_inchikey>HCHKCACWOHOZIP-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>65.4090</moldb_average_mass>
		<moldb_mono_mass>63.929146578</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>653</id>
		<lmdb_id>LMDB00653</lmdb_id>
		<created_at>2016-07-13 19:54:43</created_at>
		<updated_at>2016-07-19 23:26:07</updated_at>
		<export>1</export>
		<name>lysoPC(26:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CCCCCCCCCCCCCCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C34H70NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C34H70NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27-28-34(37)40-31-33(36)32-42-43(38,39)41-30-29-35(2,3)4/h33,36H,5-32H2,1-4H3/t33-/m1/s1</moldb_inchi>
		<moldb_inchikey>WSDKRPCAPHRNNZ-MGBGTMOVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>635.8959</moldb_average_mass>
		<moldb_mono_mass>635.488990111</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>654</id>
		<lmdb_id>LMDB00654</lmdb_id>
		<created_at>2016-07-13 19:54:44</created_at>
		<updated_at>2016-08-02 20:40:33</updated_at>
		<export>1</export>
		<name>lysoPC(28:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C36H74NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C36H74NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27-28-29-30-36(39)42-33-35(38)34-44-45(40,41)43-32-31-37(2,3)4/h35,38H,5-34H2,1-4H3/t35-/m1/s1</moldb_inchi>
		<moldb_inchikey>VPAMUPUPKCTFGJ-PGUFJCEWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>663.9490</moldb_average_mass>
		<moldb_mono_mass>663.520290239</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>655</id>
		<lmdb_id>LMDB00655</lmdb_id>
		<created_at>2016-07-13 19:54:45</created_at>
		<updated_at>2016-08-02 20:40:35</updated_at>
		<export>1</export>
		<name>lysoPC(6:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C14H30NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C14H30NO7P/c1-5-6-7-8-14(17)20-11-13(16)12-22-23(18,19)21-10-9-15(2,3)4/h13,16H,5-12H2,1-4H3/t13-/m1/s1</moldb_inchi>
		<moldb_inchikey>WDNDPXJAUNUOFK-CYBMUJFWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>355.3643</moldb_average_mass>
		<moldb_mono_mass>355.175988831</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>656</id>
		<lmdb_id>LMDB00656</lmdb_id>
		<created_at>2016-07-13 19:54:46</created_at>
		<updated_at>2016-07-20 20:47:03</updated_at>
		<export>1</export>
		<name>SM C16:1</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCC\C=C\CCCCCCC[C@@H](O)[C@H](COP(O)(=O)OCC[N+](C)(C)C)NC(=O)CCCCCCC\C=C\CCCCCC</moldb_smiles>
		<moldb_formula>C40H80N2O6P</moldb_formula>
		<moldb_inchi>InChI=1S/C40H79N2O6P/c1-6-8-10-12-14-16-18-20-22-23-25-27-29-31-33-39(43)38(37-48-49(45,46)47-36-35-42(3,4)5)41-40(44)34-32-30-28-26-24-21-19-17-15-13-11-9-7-2/h17-20,38-39,43H,6-16,21-37H2,1-5H3,(H-,41,44,45,46)/p+1/b19-17+,20-18+/t38-,39+/m0/s1</moldb_inchi>
		<moldb_inchikey>ZKIVREDSEABFBU-NDBDZNEVSA-O</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>716.0468</moldb_average_mass>
		<moldb_mono_mass>715.575399814</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>657</id>
		<lmdb_id>LMDB00657</lmdb_id>
		<created_at>2016-07-13 19:54:48</created_at>
		<updated_at>2016-07-20 21:02:26</updated_at>
		<export>1</export>
		<name>lysoPC(28:1(5Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCC\C=C\CCCC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C36H72NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C36H72NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27-28-29-30-36(39)42-33-35(38)34-44-45(40,41)43-32-31-37(2,3)4/h26-27,35,38H,5-25,28-34H2,1-4H3/b27-26+/t35-/m1/s1</moldb_inchi>
		<moldb_inchikey>VCXKVGMRVJRCIV-XRKADIMJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>661.9331</moldb_average_mass>
		<moldb_mono_mass>661.504640175</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>658</id>
		<lmdb_id>LMDB00658</lmdb_id>
		<created_at>2016-07-13 19:54:49</created_at>
		<updated_at>2016-07-20 21:02:26</updated_at>
		<export>1</export>
		<name>Glutaral</name>
		<description>Glutaral is used as an antimicrobial agent in sugar mills and as a fixing agent in the immobilisation of glucose isomerase enzyme preparations for use in the manufacture of high fructose corn syrup A polymerized isomer of glutaraldehyde known as polycycloglutaracetal is a fertilizer for aquatic plants. It is claimed that it provides a bioavailable source of carbon for higher plants that is not available to algae. Though not marketed as such due to federal regulations, the biocidal effect of glutaraldehyde kills most algae at concentrations of 0.5 - 5.0 ppm. These levels are not harmful to most aquatic fauna and flora. Adverse reactions have been observed by some aquarists at these concentrations in some aquatic mosses, liverworts, and vascular plants. Glutaraldehyde is a colorless liquid with a pungent odor used to disinfect medical and dental equipment. It is also used for industrial water treatment and as a chemical preservative. Glutaraldehyde is an oily liquid at room temperature (density 1.06 g/mL), and miscible with water, alcohol, and benzene. It is used as a tissue fixative in electron microscopy. It is employed as an embalming fluid, is a component of leather tanning solutions, and occurs as an intermediate in the production of certain industrial chemicals. Glutaraldehyde is frequently used in biochemistry applications as an amine-reactive homobifunctional crosslinker. The oligomeric state of proteins can be examined through this application. However, it is toxic, causing severe eye, nose, throat and lung irritation, along with headaches, drowsiness and dizziness. It is a main source of occupational asthma among health care providers. Glutaral has been shown to exhibit antibiotic function (PMID 9396023). Glutaral belongs to the family of Aldehydes. These are organic compounds containing the aldehyde functional group.</description>
		<cas>111-30-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O=CCCCC=O</moldb_smiles>
		<moldb_formula>C5H8O2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H8O2/c6-4-2-1-3-5-7/h4-5H,1-3H2</moldb_inchi>
		<moldb_inchikey>SXRSQZLOMIGNAQ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>100.1158</moldb_average_mass>
		<moldb_mono_mass>100.052429500</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>659</id>
		<lmdb_id>LMDB00659</lmdb_id>
		<created_at>2016-07-13 19:54:50</created_at>
		<updated_at>2016-07-20 21:02:27</updated_at>
		<export>1</export>
		<name>Tricetin</name>
		<description>Tricetin is found in cereals and cereal products. Tricetin is a constituent of the seed coat of lentil (Lens culinaris). Tricetin has been shown to exhibit antibiotic and anti-inflammatory functions (PMID 20120106, 19292976). Tricetin belongs to the family of Flavonols. These are compounds that has the 3-hydroxyflavone backbone.</description>
		<cas>520-31-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1=CC2=C(C(O)=C1)C(=O)C=C(O2)C1=CC(O)=C(O)C(O)=C1</moldb_smiles>
		<moldb_formula>C15H10O7</moldb_formula>
		<moldb_inchi>InChI=1S/C15H10O7/c16-7-3-8(17)14-9(18)5-12(22-13(14)4-7)6-1-10(19)15(21)11(20)2-6/h1-5,16-17,19-21H</moldb_inchi>
		<moldb_inchikey>ARSRJFRKVXALTF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>302.2357</moldb_average_mass>
		<moldb_mono_mass>302.042652674</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>660</id>
		<lmdb_id>LMDB00660</lmdb_id>
		<created_at>2016-07-13 19:54:52</created_at>
		<updated_at>2016-07-20 21:02:27</updated_at>
		<export>1</export>
		<name>Saccharin</name>
		<description>Saccharin, ammonium salt is used as a food additive [EAFUS] (&quot;EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]&quot;). Saccharin belongs to the family of Aromatic Homomonocyclic Compounds. These are aromatic compounds containig only one ring, which is homocyclic.</description>
		<cas>81-07-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O=C1NS(=O)(=O)C2=C1C=CC=C2</moldb_smiles>
		<moldb_formula>C7H5NO3S</moldb_formula>
		<moldb_inchi>InChI=1S/C7H5NO3S/c9-7-5-3-1-2-4-6(5)12(10,11)8-7/h1-4H,(H,8,9)</moldb_inchi>
		<moldb_inchikey>CVHZOJJKTDOEJC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>183.1850</moldb_average_mass>
		<moldb_mono_mass>182.999013721</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>661</id>
		<lmdb_id>LMDB00661</lmdb_id>
		<created_at>2016-07-13 19:54:53</created_at>
		<updated_at>2016-07-20 21:02:28</updated_at>
		<export>1</export>
		<name>1H-Indole-3-carboxaldehyde</name>
		<description>1H-Indole-3-carboxaldehyde is found in barley. 1H-Indole-3-carboxaldehyde is found in barley and tomato seedlings and cotton. 1H-Indole-3-carboxaldehyde belongs to the family of Indoles. These are compounds containing an indole moiety, which consists of pyrrole ring fused to benzene to form 2,3-benzopyrrole.</description>
		<cas>487-89-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O=CC1=CNC2=C1C=CC=C2</moldb_smiles>
		<moldb_formula>C9H7NO</moldb_formula>
		<moldb_inchi>InChI=1S/C9H7NO/c11-6-7-5-10-9-4-2-1-3-8(7)9/h1-6,10H</moldb_inchi>
		<moldb_inchikey>OLNJUISKUQQNIM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>145.1580</moldb_average_mass>
		<moldb_mono_mass>145.052763851</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>662</id>
		<lmdb_id>LMDB00662</lmdb_id>
		<created_at>2016-07-13 19:54:55</created_at>
		<updated_at>2016-07-20 21:02:28</updated_at>
		<export>1</export>
		<name>D-Arabino-hexos-2-ulose</name>
		<description>D-Arabino-hexos-2-ulose is formed during sterilisation of foods by irradiation. D-Arabino-hexos-2-ulose belongs to the family of Mixed Pentose/Hexose Tetrasaccharides. These are tetrasaccharides containing both an hexose and a pentose.</description>
		<cas>26345-59-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](O)(CO)[C@]([H])(O)[C@@]([H])(O)C(=O)C=O</moldb_smiles>
		<moldb_formula>C6H10O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1,4-6,8,10-12H,2H2/t4-,5-,6-/m0/s1</moldb_inchi>
		<moldb_inchikey>DCNMIDLYWOTSGK-ZLUOBGJFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>178.1400</moldb_average_mass>
		<moldb_mono_mass>178.047738042</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>663</id>
		<lmdb_id>LMDB00663</lmdb_id>
		<created_at>2016-07-13 19:54:56</created_at>
		<updated_at>2016-07-20 21:04:19</updated_at>
		<export>1</export>
		<name>Arabinose</name>
		<description>D-Arabinose is found in sweet basil. Arabinose is an aldopentose a monosaccharide containing five carbon atoms, and including an aldehyde (CHO) functional group. (Wikipedia)  Arabinose belongs to the family of Pentoses. These are monosaccharides in which the carbohydrate moiety contains five carbon atoms.</description>
		<cas>147-81-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@@H](O)[C@@H](O)[C@H](O)C=O</moldb_smiles>
		<moldb_formula>C5H10O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4-,5+/m1/s1</moldb_inchi>
		<moldb_inchikey>PYMYPHUHKUWMLA-WDCZJNDASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>150.1299</moldb_average_mass>
		<moldb_mono_mass>150.052823430</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>664</id>
		<lmdb_id>LMDB00664</lmdb_id>
		<created_at>2016-07-13 19:54:58</created_at>
		<updated_at>2016-07-20 21:04:19</updated_at>
		<export>1</export>
		<name>Ethyl beta-D-glucopyranoside</name>
		<description>Ethyl alpha-D-galactopyranoside is found in pulses. Ethyl alpha-D-galactopyranoside is a constituent of Glycine max (soybean).</description>
		<cas>3198-49-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCOC1OC(CO)C(O)C(O)C1O</moldb_smiles>
		<moldb_formula>C8H16O6</moldb_formula>
		<moldb_inchi>InChI=1S/C8H16O6/c1-2-13-8-7(12)6(11)5(10)4(3-9)14-8/h4-12H,2-3H2,1H3</moldb_inchi>
		<moldb_inchikey>WYUFTYLVLQZQNH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>208.2090</moldb_average_mass>
		<moldb_mono_mass>208.094688244</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>665</id>
		<lmdb_id>LMDB00665</lmdb_id>
		<created_at>2016-07-13 19:54:59</created_at>
		<updated_at>2016-07-20 21:02:30</updated_at>
		<export>1</export>
		<name>(S)-14-Methylhexadecanoic acid</name>
		<description>(S)-14-Methylhexadecanoic acid is found in fats and oils. (S)-14-Methylhexadecanoic acid occurs in several animal fats. (S)-14-Methylhexadecanoic acid belongs to the family of Branched Fatty Acids. These are fatty acids containing a branched chain.</description>
		<cas>5746-59-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC(C)CCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C17H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C17H34O2/c1-3-16(2)14-12-10-8-6-4-5-7-9-11-13-15-17(18)19/h16H,3-15H2,1-2H3,(H,18,19)</moldb_inchi>
		<moldb_inchikey>FXUKWLSZZHVEJD-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>270.4507</moldb_average_mass>
		<moldb_mono_mass>270.255880332</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>666</id>
		<lmdb_id>LMDB00666</lmdb_id>
		<created_at>2016-07-13 19:55:00</created_at>
		<updated_at>2016-07-20 21:02:30</updated_at>
		<export>1</export>
		<name>Isopalmitic acid</name>
		<description>Isopalmitic acid is found in milk and milk products. Isopalmitic acid occurs in butterfat. Isopalmitic acid belongs to the family of Branched Fatty Acids. These are fatty acids containing a branched chain.</description>
		<cas>4669-02-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)CCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C16H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C16H32O2/c1-15(2)13-11-9-7-5-3-4-6-8-10-12-14-16(17)18/h15H,3-14H2,1-2H3,(H,17,18)</moldb_inchi>
		<moldb_inchikey>ZONJATNKKGGVSU-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>256.4241</moldb_average_mass>
		<moldb_mono_mass>256.240230268</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>667</id>
		<lmdb_id>LMDB00667</lmdb_id>
		<created_at>2016-07-13 19:55:02</created_at>
		<updated_at>2016-07-20 21:02:31</updated_at>
		<export>1</export>
		<name>12-Methyltridecanoic acid</name>
		<description>12-Methyltridecanoic acid is found in fishes. 12-Methyltridecanoic acid occurs in Baltic salmon and sperm whale. 12-Methyltridecanoic acid belongs to the family of Branched Fatty Acids. These are fatty acids containing a branched chain.</description>
		<cas>2724-57-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)CCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C14H28O2</moldb_formula>
		<moldb_inchi>InChI=1S/C14H28O2/c1-13(2)11-9-7-5-3-4-6-8-10-12-14(15)16/h13H,3-12H2,1-2H3,(H,15,16)</moldb_inchi>
		<moldb_inchikey>YYVJAABUJYRQJO-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>228.3709</moldb_average_mass>
		<moldb_mono_mass>228.208930140</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>668</id>
		<lmdb_id>LMDB00668</lmdb_id>
		<created_at>2016-07-13 19:55:03</created_at>
		<updated_at>2016-07-20 21:02:32</updated_at>
		<export>1</export>
		<name>Glycerol 1-hexadecanoate</name>
		<description>Glycerol 1-hexadecanoate is found in fats and oils. Glycerol 1-hexadecanoate is a minor component of olive oil and other vegetable oils. Glycerol 1-hexadecanoate belongs to the family of Monoacylglycerols. These are glycerides consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage.</description>
		<cas>542-44-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(O)CO</moldb_smiles>
		<moldb_formula>C19H38O4</moldb_formula>
		<moldb_inchi>InChI=1S/C19H38O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(22)23-17-18(21)16-20/h18,20-21H,2-17H2,1H3</moldb_inchi>
		<moldb_inchikey>QHZLMUACJMDIAE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>330.5026</moldb_average_mass>
		<moldb_mono_mass>330.277009704</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>669</id>
		<lmdb_id>LMDB00669</lmdb_id>
		<created_at>2016-07-13 19:55:04</created_at>
		<updated_at>2016-07-20 21:02:32</updated_at>
		<export>1</export>
		<name>Glycerol 1-octadecanoate</name>
		<description>Glyceryl monostearate is used as a food additive [EAFUS] (&quot;EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]&quot;). Glycerol 1-octadecanoate belongs to the family of Monoacylglycerols. These are glycerides consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage.</description>
		<cas>123-94-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO</moldb_smiles>
		<moldb_formula>C21H42O4</moldb_formula>
		<moldb_inchi>InChI=1S/C21H42O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-19-20(23)18-22/h20,22-23H,2-19H2,1H3</moldb_inchi>
		<moldb_inchikey>VBICKXHEKHSIBG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>358.5558</moldb_average_mass>
		<moldb_mono_mass>358.308309832</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>670</id>
		<lmdb_id>LMDB00670</lmdb_id>
		<created_at>2016-07-13 19:55:06</created_at>
		<updated_at>2016-07-20 21:02:33</updated_at>
		<export>1</export>
		<name>Pentanal</name>
		<description>Pentanal is found in alcoholic beverages. Pentanal is found in olive oil and several essential oils. Also present in Bantu beer, plum brandy, cardamom, coriander leaf, rice, Bourbon vanilla, clary sage, cooked shrimps, scallops, apple, banana, sweet cherry, blackcurrant and other foods. Pentanal belongs to the family of Aldehydes. These are organic compounds containing the aldehyde functional group.</description>
		<cas>110-62-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC=O</moldb_smiles>
		<moldb_formula>C5H10O</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O/c1-2-3-4-5-6/h5H,2-4H2,1H3</moldb_inchi>
		<moldb_inchikey>HGBOYTHUEUWSSQ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>86.1323</moldb_average_mass>
		<moldb_mono_mass>86.073164942</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>671</id>
		<lmdb_id>LMDB00671</lmdb_id>
		<created_at>2016-07-13 19:55:07</created_at>
		<updated_at>2016-09-23 18:45:45</updated_at>
		<export>1</export>
		<name>2-Nonanone</name>
		<description>2-Nonanone is present in banana, ginger, Brazil nut, attar of rose, clove oil, coconut oil, passionflower, sorghum, tomato, corn, cheese, blackcurrant buds, melon, and strawberry jam. 2-Nonanone is a flavor and fragrance agent. It is a clear slightly yellow liquid. Ketones, such as 2-Nonanone, are reactive with many acids and bases liberating heat and flammable gases (e.g., H2). The amount of heat may be sufficient to start a fire in the unreacted portion of the ketone. Ketones react with reducing agents such as hydrides, alkali metals, and nitrides to produce flammable gas (H2) and heat. Ketones are incompatible with isocyanates, aldehydes, cyanides, peroxides, and anhydrides. They react violently with aldehydes, HNO3, HNO3 + H2O2, and HClO4.</description>
		<cas>821-55-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC(C)=O</moldb_smiles>
		<moldb_formula>C9H18O</moldb_formula>
		<moldb_inchi>InChI=1S/C9H18O/c1-3-4-5-6-7-8-9(2)10/h3-8H2,1-2H3</moldb_inchi>
		<moldb_inchikey>VKCYHJWLYTUGCC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>142.2386</moldb_average_mass>
		<moldb_mono_mass>142.135765198</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>672</id>
		<lmdb_id>LMDB00672</lmdb_id>
		<created_at>2016-07-13 19:55:08</created_at>
		<updated_at>2016-07-20 21:02:34</updated_at>
		<export>1</export>
		<name>1,3-Butanediol</name>
		<description>1,3-Butanediol is found in pepper (c. annuum). 1,3-Butanediol is a solvent for flavouring agents 1,3-Butanediol is an organic chemical, an alcohol. It is commonly used as a solvent for food flavouring agents and is a co-monomer used in certain polyurethane and polyester resins. It is one of four stable isomers of butanediol. In biology, 1,3-butanediol is used as a hypoglycaemic agent. 1,3-Butanediol belongs to the family of Secondary Alcohols. These are compounds containing a secondary alcohol functional group, with the general structure HOC(R)(R') (R,R'=alkyl, aryl).</description>
		<cas>107-88-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(O)CCO</moldb_smiles>
		<moldb_formula>C4H10O2</moldb_formula>
		<moldb_inchi>InChI=1S/C4H10O2/c1-4(6)2-3-5/h4-6H,2-3H2,1H3</moldb_inchi>
		<moldb_inchikey>PUPZLCDOIYMWBV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>90.1210</moldb_average_mass>
		<moldb_mono_mass>90.068079564</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>673</id>
		<lmdb_id>LMDB00673</lmdb_id>
		<created_at>2016-07-13 19:55:10</created_at>
		<updated_at>2016-07-20 21:02:34</updated_at>
		<export>1</export>
		<name>Cyclamic acid</name>
		<description>Cyclamic acid is an artificial sweetening agent, usually employed as Na or Ca salt (cyclamate). Use suspended in some countries, including USA, because of possible weak carcinogenic activity (disputed). Cyclamic acid is a permitted in EU at levels of 250-1600 ppm in food products.Cyclamic acid is a compound with formula C6H11NHSO2OH. Cyclamic acid belongs to the family of Organic Sulfuric Acid Amides. These are organic compounds containing the sulfuric acid amid functional group.</description>
		<cas>100-88-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OS(=O)(=O)NC1CCCCC1</moldb_smiles>
		<moldb_formula>C6H13NO3S</moldb_formula>
		<moldb_inchi>InChI=1S/C6H13NO3S/c8-11(9,10)7-6-4-2-1-3-5-6/h6-7H,1-5H2,(H,8,9,10)</moldb_inchi>
		<moldb_inchikey>HCAJEUSONLESMK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>179.2370</moldb_average_mass>
		<moldb_mono_mass>179.061613977</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>674</id>
		<lmdb_id>LMDB00674</lmdb_id>
		<created_at>2016-07-13 19:55:11</created_at>
		<updated_at>2016-09-23 18:45:41</updated_at>
		<export>1</export>
		<name>N-Nitrosodimethylamine</name>
		<description>N-Nitrosodimethylamine is found in pepper (&lt;i&gt;Capsicum annuum&lt;/i&gt;). N-Nitrosodimethylamine is a food contaminant especially in cured meat products. N-Nitrosodimethylamine (NDMA), also known as dimethylnitrosamine (DMN), is a semi-volatile organic chemical that is highly toxic and is a suspected animal carcinogen. The US Environmental Protection Agency has determined that the maximum admissible concentration of NDMA in drinking water is 7 ng L 1. The EPA has not yet set a regulatory maximum contaminant level (MCL) for drinking water. At high doses, it is a &quot;potent hepatotoxin that can cause fibrosis of the liver&quot; in rats. The induction of liver tumors in rats after chronic exposure to low doses is well-documented. Its toxic effects on animals are inferred from animal experiments but not well-established experimentally. NDMA is an industrial by-product or waste product of several industrial processes. It first came to attention as a groundwater contaminant in California in 1998 and 1999 at several sites that produced rocket fuel. Manufacturing of unsymmetrical dimethylhydrazine (UDMH), which is a component of rocket fuel that requires NDMA for its synthesis, proved to be the culprit in these cases. Of more general concern, water treatment via chlorination or chloramination of organic nitrogen-containing wastewater can lead to the production of NDMA at potentially harmful levels. Further, NDMA can form or be leached during treatment of water by anion exchange resins. Finally, NDMA is found at low levels in numerous items of animal consumption including cured meat, fish, beer, and tobacco smoke It is, however, unlikely to bioaccumulate. N-nitrosodimethylamine belongs to the family of Nitrosamines. These are compounds containing the nitrosamine functional group, with the structure R2NNO.</description>
		<cas>62-75-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN(C)N=O</moldb_smiles>
		<moldb_formula>C2H6N2O</moldb_formula>
		<moldb_inchi>InChI=1S/C2H6N2O/c1-4(2)3-5/h1-2H3</moldb_inchi>
		<moldb_inchikey>UMFJAHHVKNCGLG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>74.0818</moldb_average_mass>
		<moldb_mono_mass>74.048012824</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>675</id>
		<lmdb_id>LMDB00675</lmdb_id>
		<created_at>2016-07-13 19:55:12</created_at>
		<updated_at>2016-07-20 21:02:35</updated_at>
		<export>1</export>
		<name>N-Dodecane</name>
		<description>N-Dodecane is found in black walnut. Dodecane is a liquid alkane hydrocarbon with the chemical formula CH3(CH2)10CH3. It is an oily liquid of the paraffin series and has 355 isomers. (Wikipedia) N-Dodecane belongs to the family of Acyclic Alkanes. These are acyclic hydrocarbons consisting only of n carbon atoms and m hydrogen atoms where m=2*n + 2.</description>
		<cas>112-40-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C12H26</moldb_formula>
		<moldb_inchi>InChI=1S/C12H26/c1-3-5-7-9-11-12-10-8-6-4-2/h3-12H2,1-2H3</moldb_inchi>
		<moldb_inchikey>SNRUBQQJIBEYMU-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>170.3348</moldb_average_mass>
		<moldb_mono_mass>170.203450832</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>676</id>
		<lmdb_id>LMDB00676</lmdb_id>
		<created_at>2016-07-13 19:55:13</created_at>
		<updated_at>2016-07-20 21:02:35</updated_at>
		<export>1</export>
		<name>N-Heptane</name>
		<description>N-Heptane is found in cardamom. Heptane is an alkane hydrocarbon with the chemical formula CH3(CH2)8CH3. Heptane has 9 isomers, or 11 if enantiomers are counted. (Wikipedia) N-Heptane belongs to the family of Acyclic Alkanes. These are acyclic hydrocarbons consisting only of n carbon atoms and m hydrogen atoms where m=2*n + 2.</description>
		<cas>142-82-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCC</moldb_smiles>
		<moldb_formula>C7H16</moldb_formula>
		<moldb_inchi>InChI=1S/C7H16/c1-3-5-7-6-4-2/h3-7H2,1-2H3</moldb_inchi>
		<moldb_inchikey>IMNFDUFMRHMDMM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>100.2019</moldb_average_mass>
		<moldb_mono_mass>100.125200512</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>677</id>
		<lmdb_id>LMDB00677</lmdb_id>
		<created_at>2016-07-13 19:55:15</created_at>
		<updated_at>2016-07-20 21:02:37</updated_at>
		<export>1</export>
		<name>N-Decane</name>
		<description>N-Decane is found in common oregano. Decane is an alkane hydrocarbon with the chemical formula CH3(CH2)8CH3. 75 isomers of decane exist, all of which are flammable liquids. (Wikipedia)  N-Decane belongs to the family of Acyclic Alkanes. These are acyclic hydrocarbons consisting only of n carbon atoms and m hydrogen atoms where m=2*n + 2.</description>
		<cas>124-18-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCC</moldb_smiles>
		<moldb_formula>C10H22</moldb_formula>
		<moldb_inchi>InChI=1S/C10H22/c1-3-5-7-9-10-8-6-4-2/h3-10H2,1-2H3</moldb_inchi>
		<moldb_inchikey>DIOQZVSQGTUSAI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>142.2817</moldb_average_mass>
		<moldb_mono_mass>142.172150704</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>678</id>
		<lmdb_id>LMDB00678</lmdb_id>
		<created_at>2016-07-13 19:55:16</created_at>
		<updated_at>2016-07-20 21:02:37</updated_at>
		<export>1</export>
		<name>Heptanal</name>
		<description>Heptanal is found in allspice. Heptanal is found in essential oils of ylang-ylang, clary sage, California orange, bitter orange and others. Heptanal is a flavouring agent Heptanal or heptanaldehyde is an alkyl aldehyde with a strong fruity odor which is used as an ingredient in cosmetics, perfumes, and flavors. It can be obtained from castor oil by distillation under reduced pressure. Industrially, it is used in the manufacture of 1-heptanol and ethyl heptanoate. Heptanal belongs to the family of Medium-chain Aldehydes. These are An aldehyde with a chain length containing between 6 and 12 carbon atoms.</description>
		<cas>111-71-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCC=O</moldb_smiles>
		<moldb_formula>C7H14O</moldb_formula>
		<moldb_inchi>InChI=1S/C7H14O/c1-2-3-4-5-6-7-8/h7H,2-6H2,1H3</moldb_inchi>
		<moldb_inchikey>FXHGMKSSBGDXIY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>114.1855</moldb_average_mass>
		<moldb_mono_mass>114.104465070</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>679</id>
		<lmdb_id>LMDB00679</lmdb_id>
		<created_at>2016-07-13 19:55:17</created_at>
		<updated_at>2016-07-20 21:02:38</updated_at>
		<export>1</export>
		<name>(S)-2-Methyl-1-butanol</name>
		<description>(S)-2-Methyl-1-butanol is found in fruits. (S)-2-Methyl-1-butanol is isolated from grapes, apples, tomatoes etc. (S)-2-Methyl-1-butanol belongs to the family of Primary Alcohols. These are compounds comprising the primary alcohol functional group, with the general strucuture RCOH (R=alkyl, aryl).</description>
		<cas>1565-80-6</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC(C)CO</moldb_smiles>
		<moldb_formula>C5H12O</moldb_formula>
		<moldb_inchi>InChI=1S/C5H12O/c1-3-5(2)4-6/h5-6H,3-4H2,1-2H3</moldb_inchi>
		<moldb_inchikey>QPRQEDXDYOZYLA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>88.1482</moldb_average_mass>
		<moldb_mono_mass>88.088815006</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>680</id>
		<lmdb_id>LMDB00680</lmdb_id>
		<created_at>2016-07-13 19:55:19</created_at>
		<updated_at>2016-07-20 21:02:40</updated_at>
		<export>1</export>
		<name>Acrylic acid</name>
		<description>Polyacrylic acid, sodium salt is used as a food additive [EAFUS] (&quot;EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]&quot;). Acrylic acid belongs to the family of Enones. These are compounds containing the enone functional group, with the structure RC(=O)CR'.</description>
		<cas>79-10-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C=C</moldb_smiles>
		<moldb_formula>C3H4O2</moldb_formula>
		<moldb_inchi>InChI=1S/C3H4O2/c1-2-3(4)5/h2H,1H2,(H,4,5)</moldb_inchi>
		<moldb_inchikey>NIXOWILDQLNWCW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>72.0627</moldb_average_mass>
		<moldb_mono_mass>72.021129372</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>681</id>
		<lmdb_id>LMDB00681</lmdb_id>
		<created_at>2016-07-13 19:55:20</created_at>
		<updated_at>2016-09-23 18:45:44</updated_at>
		<export>1</export>
		<name>Trimethylpyrazine</name>
		<description>Trimethylpyrazine is found in cereals and cereal products. Trimethylpyrazine is found in many foodstuffs e.g. baked potato, wheat, Swiss cheese, roasted filbert and peanut, soybean etc. Trimethylpyrazine is a flavouring ingredient. Trimethylpyrazine belongs to the family of Pyrazines. These are compounds containing a pyrazine ring, which is a six-member aromatic heterocycle, that consists of two nitrogen atoms (at positions 1 and 4) and four carbon atoms.</description>
		<cas>14667-55-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=NC(C)=C(C)N=C1</moldb_smiles>
		<moldb_formula>C7H10N2</moldb_formula>
		<moldb_inchi>InChI=1S/C7H10N2/c1-5-4-8-6(2)7(3)9-5/h4H,1-3H3</moldb_inchi>
		<moldb_inchikey>IAEGWXHKWJGQAZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>122.1677</moldb_average_mass>
		<moldb_mono_mass>122.084398330</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>682</id>
		<lmdb_id>LMDB00682</lmdb_id>
		<created_at>2016-07-13 19:55:21</created_at>
		<updated_at>2016-07-20 21:02:40</updated_at>
		<export>1</export>
		<name>Benzoin</name>
		<description>(±)-Benzoin is a flavouring ingredient.Benzoin is an organic compound with the formula PhCH(OH)C(O)Ph. It is a hydroxy ketone attached to two phenyl groups. It appears as off-white crystals, with a light camphor-like odor. Benzoin is synthesized from benzaldehyde in the benzoin condensation. It is chiral and it exists as a pair of enantiomers: (R)-benzoin and (S)-benzoin. (Wikipedia) Benzoin belongs to the family of Benzoins. These are organic compounds containing a 1,2-hydroxy ketone attached to two phenyl groups.</description>
		<cas>119-53-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(C(=O)C1=CC=CC=C1)C1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C14H12O2</moldb_formula>
		<moldb_inchi>InChI=1S/C14H12O2/c15-13(11-7-3-1-4-8-11)14(16)12-9-5-2-6-10-12/h1-10,13,15H</moldb_inchi>
		<moldb_inchikey>ISAOCJYIOMOJEB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>212.2439</moldb_average_mass>
		<moldb_mono_mass>212.083729628</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>683</id>
		<lmdb_id>LMDB00683</lmdb_id>
		<created_at>2016-07-13 19:55:22</created_at>
		<updated_at>2016-07-20 21:02:42</updated_at>
		<export>1</export>
		<name>11-Dodecenoic acid</name>
		<description>11-Dodecenoic acid is used as a food additive [EAFUS] (&quot;EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]&quot;). 11-Dodecenoic acid belongs to the family of Unsaturated Fatty Acids. These are fatty acids whose chain contains at least one CC double bond.</description>
		<cas>65423-25-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CCCCCCCCCC=C</moldb_smiles>
		<moldb_formula>C12H22O2</moldb_formula>
		<moldb_inchi>InChI=1S/C12H22O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2H,1,3-11H2,(H,13,14)</moldb_inchi>
		<moldb_inchikey>GZZPOFFXKUVNSW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>198.3019</moldb_average_mass>
		<moldb_mono_mass>198.161979948</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>684</id>
		<lmdb_id>LMDB00684</lmdb_id>
		<created_at>2016-07-13 19:55:24</created_at>
		<updated_at>2016-07-20 21:02:43</updated_at>
		<export>1</export>
		<name>1-Octene</name>
		<description>1-Octene is used as a food additive [EAFUS] (&quot;EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]&quot;). 1-Octene belongs to the family of Acyclic Alkenes. These are acyclic unsaturated compounds containing at least one carbon-carbon double bond.</description>
		<cas>111-66-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCC=C</moldb_smiles>
		<moldb_formula>C8H16</moldb_formula>
		<moldb_inchi>InChI=1S/C8H16/c1-3-5-7-8-6-4-2/h3H,1,4-8H2,2H3</moldb_inchi>
		<moldb_inchikey>KWKAKUADMBZCLK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>112.2126</moldb_average_mass>
		<moldb_mono_mass>112.125200512</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>685</id>
		<lmdb_id>LMDB00685</lmdb_id>
		<created_at>2016-07-13 19:55:25</created_at>
		<updated_at>2016-07-20 21:02:43</updated_at>
		<export>1</export>
		<name>Succinic anhydride</name>
		<description>Succinic anhydride, also called dihydro-2,5-furandione, is an organic compound with the molecular formula C4H4O3. It is the acid anhydride of succinic acid. Succinic anhydride has been shown to exhibit antibiotic function (PMID 4840443). Succinic anhydride belongs to the family of Oxolanes. These are organic compounds containing an oxolane (tetrahydrofuran) ring, which is a saturated aliphatic five-member ring containing one oxygen and five carbon atoms.</description>
		<cas>108-30-5</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O=C1CCC(=O)O1</moldb_smiles>
		<moldb_formula>C4H4O3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H4O3/c5-3-1-2-4(6)7-3/h1-2H2</moldb_inchi>
		<moldb_inchikey>RINCXYDBBGOEEQ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>100.0728</moldb_average_mass>
		<moldb_mono_mass>100.016043994</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>686</id>
		<lmdb_id>LMDB00686</lmdb_id>
		<created_at>2016-07-13 19:55:26</created_at>
		<updated_at>2016-07-20 21:02:44</updated_at>
		<export>1</export>
		<name>1-Phenylethanol</name>
		<description>(±)-1-Phenylethanol is a flavouring agent. 1-Phenylethanol belongs to the family of Benzyl Alcohols and Derivatives. These are organic compounds containing the phenylmethanol substructure.</description>
		<cas>98-85-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(O)C1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C8H10O</moldb_formula>
		<moldb_inchi>InChI=1S/C8H10O/c1-7(9)8-5-3-2-4-6-8/h2-7,9H,1H3</moldb_inchi>
		<moldb_inchikey>WAPNOHKVXSQRPX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>122.1644</moldb_average_mass>
		<moldb_mono_mass>122.073164942</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>687</id>
		<lmdb_id>LMDB00687</lmdb_id>
		<created_at>2016-07-13 19:55:28</created_at>
		<updated_at>2016-09-23 18:45:42</updated_at>
		<export>1</export>
		<name>2-Furanmethanethiol</name>
		<description>2-Furanmethanethiol is found in animal feed. 2-Furanmethanethiol is a flavour ingredient. Formed by thermal treatment of cysteine/ribose mixtures. 2-Furanmethanethiol is present in cooked meats.</description>
		<cas>98-02-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>SCC1=CC=CO1</moldb_smiles>
		<moldb_formula>C5H6OS</moldb_formula>
		<moldb_inchi>InChI=1S/C5H6OS/c7-4-5-2-1-3-6-5/h1-3,7H,4H2</moldb_inchi>
		<moldb_inchikey>ZFFTZDQKIXPDAF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>114.1660</moldb_average_mass>
		<moldb_mono_mass>114.013935504</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>688</id>
		<lmdb_id>LMDB00688</lmdb_id>
		<created_at>2016-07-13 19:55:29</created_at>
		<updated_at>2016-07-20 21:02:45</updated_at>
		<export>1</export>
		<name>5-(2-Hydroxyethyl)-4-methylthiazole</name>
		<description>5-(2-Hydroxyethyl)-4-methylthiazole is found in alcoholic beverages. 5-(2-Hydroxyethyl)-4-methylthiazole is a flavour ingredient. 5-(2-Hydroxyethyl)-4-methylthiazole is present in cooked beef, beer, spirits, cocoa, roast peanut, porcini (Boletus edulis) and malt.</description>
		<cas>137-00-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=C(CCO)SC=N1</moldb_smiles>
		<moldb_formula>C6H9NOS</moldb_formula>
		<moldb_inchi>InChI=1S/C6H9NOS/c1-5-6(2-3-8)9-4-7-5/h4,8H,2-3H2,1H3</moldb_inchi>
		<moldb_inchikey>BKAWJIRCKVUVED-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>143.2070</moldb_average_mass>
		<moldb_mono_mass>143.040484605</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>689</id>
		<lmdb_id>LMDB00689</lmdb_id>
		<created_at>2016-07-13 19:55:30</created_at>
		<updated_at>2016-09-23 18:45:42</updated_at>
		<export>1</export>
		<name>2-Methylthiophene</name>
		<description>2-Methylthiophene is found in animal feed. 2-Methylthiophene is a maillard product; present in roast beef.</description>
		<cas>554-14-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=CC=CS1</moldb_smiles>
		<moldb_formula>C5H6S</moldb_formula>
		<moldb_inchi>InChI=1S/C5H6S/c1-5-3-2-4-6-5/h2-4H,1H3</moldb_inchi>
		<moldb_inchikey>XQQBUAPQHNYYRS-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>98.1660</moldb_average_mass>
		<moldb_mono_mass>98.019020882</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>690</id>
		<lmdb_id>LMDB00690</lmdb_id>
		<created_at>2016-07-13 19:55:32</created_at>
		<updated_at>2016-07-20 21:02:45</updated_at>
		<export>1</export>
		<name>Benzylamine</name>
		<description>Benzylamine is found in apple. Benzylamine is an alkaloid from Moringa oleifera (horseradish tree) Benzylamine is the chemical compound with the formula C6H5CH2NH2. It consists of a benzyl group, C6H5CH2, attached to an amine functional group. This colorless liquid is a common precursor in organic synthesis. Benzylamine has been shown to exhibit lipolytic, antibiotic and anti-mycotic functions (PMID 18457006, 6445750, 8340915).</description>
		<cas>100-46-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCC1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C7H9N</moldb_formula>
		<moldb_inchi>InChI=1S/C7H9N/c8-6-7-4-2-1-3-5-7/h1-5H,6,8H2</moldb_inchi>
		<moldb_inchikey>WGQKYBSKWIADBV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>107.1531</moldb_average_mass>
		<moldb_mono_mass>107.073499293</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>691</id>
		<lmdb_id>LMDB00691</lmdb_id>
		<created_at>2016-07-13 19:55:33</created_at>
		<updated_at>2016-07-20 21:02:46</updated_at>
		<export>1</export>
		<name>2-Hydroxybenzaldehyde</name>
		<description>2-Hydroxybenzaldehyde is found in common buckwheat. 2-Hydroxybenzaldehyde is present in cinnamon (Cinnamomum versum). 2-Hydroxybenzaldehyde is a flavouring ingredient.</description>
		<cas>90-02-8</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1=CC=CC=C1C=O</moldb_smiles>
		<moldb_formula>C7H6O2</moldb_formula>
		<moldb_inchi>InChI=1S/C7H6O2/c8-5-6-3-1-2-4-7(6)9/h1-5,9H</moldb_inchi>
		<moldb_inchikey>SMQUZDBALVYZAC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>122.1213</moldb_average_mass>
		<moldb_mono_mass>122.036779436</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>692</id>
		<lmdb_id>LMDB00692</lmdb_id>
		<created_at>2016-07-13 19:55:34</created_at>
		<updated_at>2016-07-19 23:07:10</updated_at>
		<export>1</export>
		<name>3-Mercapto-2-pentanone</name>
		<description>3-Mercapto-2-pentanone is found in animal foods. 3-Mercapto-2-pentanone is a maillard product from reaction of cysteine and ribose. Aroma/flavour component of cookes meats. 3-Mercapto-2-pentanone is a flavouring agent. 3-Mercapto-2-pentanone belongs to the family of Ketones. These are organic compounds in which a carbonyl group is bonded to two carbon atoms R2C=O (neither R may be H) [1]. (Reference: [1] IUPAC. Compendium of Chemical Terminology, 2nd ed. (the &quot;Gold Book&quot;). Compiled by A. D. McNaught and A. Wilkinson. Blackwell Scientific Publications, Oxford (1997). XML on-line corrected version: http://goldbook.iupac.org (2006-) created by M. Nic, J. Jirat, B. Kosata; updates compiled by A. Jenkins. ISBN 0-9678550-9-8. doi:10.1351/goldbook. (PAC, 1995, 67, 1307 (Glossary of class names of organic compounds and reactivity intermediates based on structure (IUPAC Recommendations 1995)) on page 1346)).</description>
		<cas>67633-97-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC(S)C(C)=O</moldb_smiles>
		<moldb_formula>C5H10OS</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10OS/c1-3-5(7)4(2)6/h5,7H,3H2,1-2H3</moldb_inchi>
		<moldb_inchikey>SZECUQRKLXRGSJ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>118.1970</moldb_average_mass>
		<moldb_mono_mass>118.045235632</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>693</id>
		<lmdb_id>LMDB00693</lmdb_id>
		<created_at>2016-07-13 19:55:35</created_at>
		<updated_at>2016-09-23 18:45:45</updated_at>
		<export>1</export>
		<name>2,5-Dimethylpyrazine</name>
		<description>2,5-Dimethylpyrazine is found in cereals and cereal products. 2,5-Dimethylpyrazine is used as flavour additive and odorant in foods. 2,5-Dimethylpyrazine is present in wheat bread, crispbread, Swiss cheeses, soya and malt.</description>
		<cas>123-32-0</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=CN=C(C)C=N1</moldb_smiles>
		<moldb_formula>C6H8N2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H8N2/c1-5-3-8-6(2)4-7-5/h3-4H,1-2H3</moldb_inchi>
		<moldb_inchikey>LCZUOKDVTBMCMX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>108.1411</moldb_average_mass>
		<moldb_mono_mass>108.068748266</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>694</id>
		<lmdb_id>LMDB00694</lmdb_id>
		<created_at>2016-07-13 19:55:37</created_at>
		<updated_at>2018-04-30 22:15:42</updated_at>
		<export>1</export>
		<name>(-)-Dihydrocarveol</name>
		<description>p-Menth-8-en-2-ol is found in herbs and spices. p-Menth-8-en-2-ol occurs in Mentha species, Piper longum (long pepper), Heracleum candicans and other essential oils. Stereoisomeric mixture used as flavour ingredient. (-)-Dihydrocarveol belongs to the family of Monoterpenes. These are compounds contaning a chain of two isoprene units.</description>
		<cas>20549-47-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[C@@H]1CC[C@H](CC1O)C(C)=C</moldb_smiles>
		<moldb_formula>C10H18O</moldb_formula>
		<moldb_inchi>InChI=1S/C10H18O/c1-7(2)9-5-4-8(3)10(11)6-9/h8-11H,1,4-6H2,2-3H3/t8-,9-,10?/m1/s1</moldb_inchi>
		<moldb_inchikey>KRCZYMFUWVJCLI-MGRQHWMJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>154.2493</moldb_average_mass>
		<moldb_mono_mass>154.135765198</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>695</id>
		<lmdb_id>LMDB00695</lmdb_id>
		<created_at>2016-07-13 19:55:39</created_at>
		<updated_at>2016-07-19 23:07:07</updated_at>
		<export>1</export>
		<name>Pyrrole</name>
		<description>Pyrrole is found in corn. Pyrrole is a flavouring ingredient Pyrrole has very low basicity compared to conventional amines and some other aromatic compounds like pyridine. This decreased basicity is attributed to the delocalization of the lone pair of electrons of the nitrogen atom in the aromatic ring. Pyrrole is a very weak base with a pKaH of about 4. Protonation results in loss of aromaticity, and is, therefore, unfavorable. Pyrrole is a heterocyclic aromatic organic compound, a five-membered ring with the formula C4H4NH. Substituted derivatives are also called pyrroles. For example, C4H4NCH3 is N-methylpyrrole. Porphobilinogen is a trisubstituted pyrrole, which is the biosynthetic precursor to many natural products. The starting materials in the Piloty-Robinson pyrrole synthesis are 2 equivalents of an aldehyde and hydrazine. The product is a pyrrole with specific substituents in the 3 and 4 positions. The aldehyde reacts with the diamine to an intermediate di-imine (R C=N N=C R), which, with added hydrochloric acid, gives ring-closure and loss of ammonia to the pyrrole. Pyrrole has been shown to exhibit anti-fungal, anti-microbial, anti-tumor, anti-hypertensive and anti-inflammatory functions (PMID 4007154, 17000033, 10425104, 19487166, 18200590). Pyrrole belongs to the family of Pyrroles. These are compounds containing a pyrrole ring, which is a five-member aromatic heterocycle with one nitrogen atom and four carbon atoms.</description>
		<cas>109-97-7</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N1C=CC=C1</moldb_smiles>
		<moldb_formula>C4H5N</moldb_formula>
		<moldb_inchi>InChI=1S/C4H5N/c1-2-4-5-3-1/h1-5H</moldb_inchi>
		<moldb_inchikey>KAESVJOAVNADME-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>67.0892</moldb_average_mass>
		<moldb_mono_mass>67.042199165</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>696</id>
		<lmdb_id>LMDB00696</lmdb_id>
		<created_at>2016-07-13 19:55:40</created_at>
		<updated_at>2016-07-19 23:07:08</updated_at>
		<export>1</export>
		<name>2-Methyl-3-furanthiol</name>
		<description>2-Methyl-3-furanthiol is found in animal foods. 2-Methyl-3-furanthiol occurs in chicken, beef and tunafish. 2-Methyl-3-furanthiol is formed by thermal treatment of cysteine-ribose mixtures. 2-Methyl-3-furanthiol is organoleptic compound with beef broth aroma.</description>
		<cas>28588-74-1</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=C(S)C=CO1</moldb_smiles>
		<moldb_formula>C5H6OS</moldb_formula>
		<moldb_inchi>InChI=1S/C5H6OS/c1-4-5(7)2-3-6-4/h2-3,7H,1H3</moldb_inchi>
		<moldb_inchikey>RUYNUXHHUVUINQ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>114.1660</moldb_average_mass>
		<moldb_mono_mass>114.013935504</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>697</id>
		<lmdb_id>LMDB00697</lmdb_id>
		<created_at>2016-07-13 19:55:41</created_at>
		<updated_at>2016-07-20 21:02:48</updated_at>
		<export>1</export>
		<name>2,4-Dimethyldodecane</name>
		<description>2,4-Dimethyldodecane is found in green vegetables. 2,4-Dimethyldodecane is a constituent of the flowers of Viola odorata (sweet violet).</description>
		<cas>6117-99-3</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCC(C)CC(C)C</moldb_smiles>
		<moldb_formula>C14H30</moldb_formula>
		<moldb_inchi>InChI=1S/C14H30/c1-5-6-7-8-9-10-11-14(4)12-13(2)3/h13-14H,5-12H2,1-4H3</moldb_inchi>
		<moldb_inchikey>AFELDWXNIFIYOC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>198.3880</moldb_average_mass>
		<moldb_mono_mass>198.234750960</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>698</id>
		<lmdb_id>LMDB00698</lmdb_id>
		<created_at>2016-07-13 19:55:43</created_at>
		<updated_at>2016-07-20 21:02:49</updated_at>
		<export>1</export>
		<name>Lactitol</name>
		<description>Lactitol is found in herbs and spices. Artificial sweetener used in foods. Sweetness 0.4 x sucrose.Lactitol is a sugar alcohol used as a replacement bulk sweetener for low calorie foods with approximately 40% of the sweetness of sugar. Lactitol is produced by two manufacturers, Danisco and Purac Biochem. Lactitol has been shown to exhibit antibiotic, laxative and prebiotic functions (PMID 8913707, 2792176, 19351047).</description>
		<cas>585-86-4</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC(O)C(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)CO</moldb_smiles>
		<moldb_formula>C12H24O11</moldb_formula>
		<moldb_inchi>InChI=1S/C12H24O11/c13-1-4(16)7(18)11(5(17)2-14)23-12-10(21)9(20)8(19)6(3-15)22-12/h4-21H,1-3H2</moldb_inchi>
		<moldb_inchikey>VQHSOMBJVWLPSR-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>344.3124</moldb_average_mass>
		<moldb_mono_mass>344.131861610</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>699</id>
		<lmdb_id>LMDB00699</lmdb_id>
		<created_at>2016-07-13 19:55:44</created_at>
		<updated_at>2018-04-30 21:15:00</updated_at>
		<export>1</export>
		<name>Propylpyrazine</name>
		<description>Propylpyrazine is used in feed flavouring.</description>
		<cas>18138-03-9</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCC1=CN=CC=N1</moldb_smiles>
		<moldb_formula>C7H10N2</moldb_formula>
		<moldb_inchi>InChI=1S/C7H10N2/c1-2-3-7-6-8-4-5-9-7/h4-6H,2-3H2,1H3</moldb_inchi>
		<moldb_inchikey>DJLLTFRHLPVCEL-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>122.1710</moldb_average_mass>
		<moldb_mono_mass>122.084398330</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>700</id>
		<lmdb_id>LMDB00700</lmdb_id>
		<created_at>2016-07-13 19:55:45</created_at>
		<updated_at>2016-07-19 23:05:06</updated_at>
		<export>1</export>
		<name>Phosphocreatinine</name>
		<description>Phosphocreatinine is found in milk.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN1CC(=O)NC1=NP(O)(O)=O</moldb_smiles>
		<moldb_formula>C4H8N3O4P</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8N3O4P/c1-7-2-3(8)5-4(7)6-12(9,10)11/h2H2,1H3,(H3,5,6,8,9,10,11)</moldb_inchi>
		<moldb_inchikey>HIPLEPXPNLWKCQ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>193.0978</moldb_average_mass>
		<moldb_mono_mass>193.025242271</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>701</id>
		<lmdb_id>LMDB00701</lmdb_id>
		<created_at>2016-07-13 19:55:47</created_at>
		<updated_at>2016-07-19 23:04:54</updated_at>
		<export>1</export>
		<name>beta-Lactose</name>
		<description>Beta-Lactose is the beta-pyranose form of the compound lactose [CCD].</description>
		<cas>5965-66-2</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C12H22O11</moldb_formula>
		<moldb_inchi>InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5+,6+,7-,8-,9-,10-,11-,12+/m1/s1</moldb_inchi>
		<moldb_inchikey>GUBGYTABKSRVRQ-DCSYEGIMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>342.2965</moldb_average_mass>
		<moldb_mono_mass>342.116211546</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>702</id>
		<lmdb_id>LMDB00702</lmdb_id>
		<created_at>2016-07-13 19:55:48</created_at>
		<updated_at>2016-09-23 18:45:41</updated_at>
		<export>1</export>
		<name>2-Hydroxyglutarate</name>
		<description>2-Hydroxyglutarate exists in 2 isomers: L-2-hydroxyglutarate acid and D-2-hydroxyglutarate. Both the D and the L stereoisomers of hydroxyglutaric acid (EC 1.1.99.2) are found in body fluids. In animals it is part of butanoate metabolic pathway and can be produced by phosphoglycerate dehydrogenase (PHGDH). More specifically, the enzyme PHGDH catalyzes the NADH-dependent reduction of ?-ketoglutarate (AKG) to D-2-hydroxyglutarate (D-2HG). 2-hydroxyglutarate is also the product of gain-of-function mutations in the cytosolic and mitochondrial isoforms of isocitrate dehydrogenase (IDH). Additionally, 2-hydroxyglutarate can be converted to ?-ketoglutaric acid through the action of 2-hydroxyglutarate dehydrogenase (HGDH). Humans have to variants of this enzyme: D-2-hydroxyglutarate dehydrogenase (D2HGDH) and L-2-hydroxyglutarate dehydrogenase (L2HGDH). A deficiency in either of these two enzymes can lead to a disease known as 2-hydroxyglutaric aciduria. L-2-hydroxyglutaric aciduria (caused by loss of L2HGDH) is chronic, with early symptoms such as hypotonia, tremors, and epilepsy declining into spongiform leukoencephalopathy, muscular choreodystonia, mental retardation, and psychomotor regression. D-2-hydroxyglutaric aciduria (caused by loss of D2HGDH or gain of function of IDH) is rare, with symptoms including cancer, macrocephaly, cardiomyopathy, mental retardation, hypotonia, and cortical blindness. 2-hydroxyglutarate was the first oncometabolite (or cancer-causing metabolite) to be formally named or identified. In cancer it is either produced by overexpression of phosphoglycerate dehydrogenase (PHGDH) or is produced in excess by gain-of-function mutations in the cytosolic and mitochondrial isoforms of isocitrate dehydrogenase (IDH). IDH is part of TCA cycle and is generated in high abundance when IDH is mutated. 2-hydroxyglutarate is sufficiently similar in structure to 2-oxogluratate (2OG) that it is able to inhibit a range of 2OG-dependent dioxygenases, including histone lysine demethylases (KDMs) and members of the ten-eleven translocation (TET) family of 5-methylcytosine (5mC) hydroxylases. This inhibitory effect leads to alterations in the hypoxia induced factor (HIF)-mediated hypoxic response and alterations in gene expression through global epigenetic remodeling. The net effect is that 2-hydroxyglutarate causes a cascading effect that leads genetic perturbations and malignant transformation.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(CCC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H8O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H8O5/c6-3(5(9)10)1-2-4(7)8/h3,6H,1-2H2,(H,7,8)(H,9,10)</moldb_inchi>
		<moldb_inchikey>HWXBTNAVRSUOJR-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>148.1140</moldb_average_mass>
		<moldb_mono_mass>148.037173366</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>703</id>
		<lmdb_id>LMDB00703</lmdb_id>
		<created_at>2016-07-13 19:55:49</created_at>
		<updated_at>2016-08-01 19:11:32</updated_at>
		<export>1</export>
		<name>Nonanal</name>
		<description>Nonanal belongs to the family of Medium-chain Aldehydes. These are An aldehyde with a chain length containing between 6 and 12 carbon atoms</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCC=O</moldb_smiles>
		<moldb_formula>C9H18O</moldb_formula>
		<moldb_inchi>InChI=1S/C9H18O/c1-2-3-4-5-6-7-8-9-10/h9H,2-8H2,1H3</moldb_inchi>
		<moldb_inchikey>GYHFUZHODSMOHU-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>142.2386</moldb_average_mass>
		<moldb_mono_mass>142.135765198</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>704</id>
		<lmdb_id>LMDB00704</lmdb_id>
		<created_at>2016-07-13 19:55:51</created_at>
		<updated_at>2016-07-20 21:02:50</updated_at>
		<export>1</export>
		<name>Pentadecane</name>
		<description>Pentadecane belongs to the family of Acyclic Alkanes. These are acyclic hydrocarbons consisting only of n carbon atoms and m hydrogen atoms where m=2*n + 2</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C15H32</moldb_formula>
		<moldb_inchi>InChI=1S/C15H32/c1-3-5-7-9-11-13-15-14-12-10-8-6-4-2/h3-15H2,1-2H3</moldb_inchi>
		<moldb_inchikey>YCOZIPAWZNQLMR-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>212.4146</moldb_average_mass>
		<moldb_mono_mass>212.250401024</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>705</id>
		<lmdb_id>LMDB00705</lmdb_id>
		<created_at>2016-07-13 19:55:52</created_at>
		<updated_at>2016-09-23 18:45:41</updated_at>
		<export>1</export>
		<name>11,14,17-Eicosatrienoic acid</name>
		<description>11,14,17-Eicosatrienoic acid, or Eicosatrienoic Acid (20:3w-3), is a rare polyunsaturated fatty acid of the omega-3 series. In normal animals, it represents less than 0.25% of serum phospholipid fatty acids. However, it is one of the most active essential fatty acids when assayed for the inhibition of fatty acid elongation/desaturation reactions which convert dietary C-18 fatty acids to C-20 eicosanoid precursors. (http://www.caymanchem.com)</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC\C=C/C\C=C/C\C=C/CCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C20H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h3-4,6-7,9-10H,2,5,8,11-19H2,1H3,(H,21,22)/b4-3-,7-6-,10-9-</moldb_inchi>
		<moldb_inchikey>AHANXAKGNAKFSK-PDBXOOCHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>306.4828</moldb_average_mass>
		<moldb_mono_mass>306.255880332</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>706</id>
		<lmdb_id>LMDB00706</lmdb_id>
		<created_at>2016-07-13 19:55:53</created_at>
		<updated_at>2016-07-20 21:02:53</updated_at>
		<export>1</export>
		<name>L-Xylonate</name>
		<description>This compound belongs to the family of Sugar Acids and Derivatives. These are compounds containing a saccharide unit which bears a carboxylic acid group.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H](O)[C@@H](O)[C@H](O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H10O6</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O6/c6-1-2(7)3(8)4(9)5(10)11/h2-4,6-9H,1H2,(H,10,11)/t2-,3+,4-/m0/s1</moldb_inchi>
		<moldb_inchikey>QXKAIJAYHKCRRA-NUNKFHFFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>166.1293</moldb_average_mass>
		<moldb_mono_mass>166.047738052</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>707</id>
		<lmdb_id>LMDB00707</lmdb_id>
		<created_at>2016-07-13 19:55:55</created_at>
		<updated_at>2016-07-20 21:02:54</updated_at>
		<export>1</export>
		<name>Phosphatidylethanolamine</name>
		<description>Phosphatidylethanolamine (cephalin, sometimes abbreviated PE) is a lipid found in biological membranes. It is synthesized by the addition of CDP-ethanolamine to diglyceride, releasing CMP. S-adenosyl methionine can subsequently methylate the amine of phosphatidyl ethanolamine to yield phosphatidyl choline. Cephalin is a phospholipid, which is a lipid derivative. It is not to be confused with the molecule of the same name that is an alkaloid constituent of Ipecac. (Wikipedia)</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](CO[P@](O)(=O)OCCN)OC(=O)CCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C41H82NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C41H82NO8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-40(43)47-37-39(38-49-51(45,46)48-36-35-42)50-41(44)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h39H,3-38,42H2,1-2H3,(H,45,46)/t39-/m0/s1</moldb_inchi>
		<moldb_inchikey>LVNGJLRDBYCPGB-KDXMTYKHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>748.0654</moldb_average_mass>
		<moldb_mono_mass>747.577805117</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>708</id>
		<lmdb_id>LMDB00708</lmdb_id>
		<created_at>2016-07-13 19:55:57</created_at>
		<updated_at>2016-07-20 21:02:55</updated_at>
		<export>1</export>
		<name>1,2-diacylglycerol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](CO)(COC=O)OC(C)=O</moldb_smiles>
		<moldb_formula>C6H10O5</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O5/c1-5(9)11-6(2-7)3-10-4-8/h4,6-7H,2-3H2,1H3/t6-/m0/s1</moldb_inchi>
		<moldb_inchikey>OTBZCXAQBQMYNZ-LURJTMIESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>162.1410</moldb_average_mass>
		<moldb_mono_mass>162.052823422</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>709</id>
		<lmdb_id>LMDB00709</lmdb_id>
		<created_at>2016-07-13 19:55:58</created_at>
		<updated_at>2016-07-20 21:02:55</updated_at>
		<export>1</export>
		<name>13-Methylmyristic acid</name>
		<description>13-Methylmyristic acid (CAS# 2485-71-4), also known as 13-methyltetradecanoic acid, iso-pentadecanoic acid, 13-methyltetradecanoic acid, 13-MTD, or 13-MTDA, is an iso-fatty acid. It is used to study the induction of mitochondrial-mediated apoptosis via the AKT and MAPK pathways. 13-MTDA is used for the biosynthesis of methyl-branched polyhydroxyalkanoates.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)CCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C15H30O2</moldb_formula>
		<moldb_inchi>InChI=1S/C15H30O2/c1-14(2)12-10-8-6-4-3-5-7-9-11-13-15(16)17/h14H,3-13H2,1-2H3,(H,16,17)</moldb_inchi>
		<moldb_inchikey>ZOCYQVNGROEVLU-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>242.3975</moldb_average_mass>
		<moldb_mono_mass>242.224580204</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>710</id>
		<lmdb_id>LMDB00710</lmdb_id>
		<created_at>2016-07-13 19:55:59</created_at>
		<updated_at>2018-04-30 22:34:24</updated_at>
		<export>1</export>
		<name>Dihydroxyphenylalanine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O</moldb_smiles>
		<moldb_formula>C9H11NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1</moldb_inchi>
		<moldb_inchikey>WTDRDQBEARUVNC-LURJTMIESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>197.1879</moldb_average_mass>
		<moldb_mono_mass>197.068807845</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>711</id>
		<lmdb_id>LMDB00711</lmdb_id>
		<created_at>2016-07-13 19:56:00</created_at>
		<updated_at>2016-07-20 21:04:20</updated_at>
		<export>1</export>
		<name>Caproate (6:0)</name>
		<description>Caproate (6:0) belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC([O-])=O</moldb_smiles>
		<moldb_formula>C6H11O2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O2/c1-2-3-4-5-6(7)8/h2-5H2,1H3,(H,7,8)/p-1</moldb_inchi>
		<moldb_inchikey>FUZZWVXGSFPDMH-UHFFFAOYSA-M</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>115.1503</moldb_average_mass>
		<moldb_mono_mass>115.075904596</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>712</id>
		<lmdb_id>LMDB00712</lmdb_id>
		<created_at>2016-07-13 19:56:01</created_at>
		<updated_at>2016-07-20 21:02:56</updated_at>
		<export>1</export>
		<name>beta-D-Galactofuranose</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]OC([H])([H])[C@@]([H])(O[H])[C@]1([H])O[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])O[H]</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2-11H,1H2/t2-,3-,4-,5+,6-/m1/s1</moldb_inchi>
		<moldb_inchikey>AVVWPBAENSWJCB-DGPNFKTASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1559</moldb_average_mass>
		<moldb_mono_mass>180.063388116</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>713</id>
		<lmdb_id>LMDB00713</lmdb_id>
		<created_at>2016-07-13 19:56:03</created_at>
		<updated_at>2016-07-20 21:04:20</updated_at>
		<export>1</export>
		<name>Dimethyl sulfate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>COS(=O)(=O)OC</moldb_smiles>
		<moldb_formula>C2H6O4S</moldb_formula>
		<moldb_inchi>InChI=1S/C2H6O4S/c1-5-7(3,4)6-2/h1-2H3</moldb_inchi>
		<moldb_inchikey>VAYGXNSJCAHWJZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>126.1300</moldb_average_mass>
		<moldb_mono_mass>125.998679847</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>714</id>
		<lmdb_id>LMDB00714</lmdb_id>
		<created_at>2016-07-13 19:56:04</created_at>
		<updated_at>2016-07-20 21:02:57</updated_at>
		<export>1</export>
		<name>D-Glucopyranoside</name>
		<description>D-Glucopyranoside belongs to the class of organic compounds known as monosaccharides. These are compounds containing one carbohydrate unit not glycosidically linked to another such unit, and no set of two or more glycosidically linked carbohydrate units. Monosaccharides have the general formula CnH2nOn.</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC1OC(O)C(O)C(O)C1O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2</moldb_inchi>
		<moldb_inchikey>WQZGKKKJIJFFOK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1559</moldb_average_mass>
		<moldb_mono_mass>180.063388116</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>715</id>
		<lmdb_id>LMDB00715</lmdb_id>
		<created_at>2016-07-30 17:28:28</created_at>
		<updated_at>2016-08-02 20:15:34</updated_at>
		<export>1</export>
		<name>10Z-Heptadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C17H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C17H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17(18)19/h7-8H,2-6,9-16H2,1H3,(H,18,19)/b8-7-</moldb_inchi>
		<moldb_inchikey>GDTXICBNEOEPAZ-FPLPWBNLSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>268.4348</moldb_average_mass>
		<moldb_mono_mass>268.240230268</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>716</id>
		<lmdb_id>LMDB00716</lmdb_id>
		<created_at>2016-07-30 17:31:07</created_at>
		<updated_at>2016-08-01 19:16:44</updated_at>
		<export>1</export>
		<name>12-HETE</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/CC(O)\C=C/C=C\C\C=C\CCCC(O)=O</moldb_smiles>
		<moldb_formula>C20H32O3</moldb_formula>
		<moldb_inchi>InChI=1S/C20H32O3/c1-2-3-4-5-10-13-16-19(21)17-14-11-8-6-7-9-12-15-18-20(22)23/h7-11,13-14,17,19,21H,2-6,12,15-16,18H2,1H3,(H,22,23)/b9-7+,11-8-,13-10-,17-14-</moldb_inchi>
		<moldb_inchikey>ZNHVWPKMFKADKW-FYMOKONMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>320.4663</moldb_average_mass>
		<moldb_mono_mass>320.235144890</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>719</id>
		<lmdb_id>LMDB00719</lmdb_id>
		<created_at>2016-07-30 17:45:17</created_at>
		<updated_at>2018-04-30 20:45:34</updated_at>
		<export>1</export>
		<name>TG(14:0/14:0/14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C45H86O6</moldb_formula>
		<moldb_inchi>InChI=1S/C45H86O6/c1-4-7-10-13-16-19-22-25-28-31-34-37-43(46)49-40-42(51-45(48)39-36-33-30-27-24-21-18-15-12-9-6-3)41-50-44(47)38-35-32-29-26-23-20-17-14-11-8-5-2/h42H,4-41H2,1-3H3</moldb_inchi>
		<moldb_inchikey>DUXYWXYOBMKGIN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>723.1607</moldb_average_mass>
		<moldb_mono_mass>722.642440484</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>720</id>
		<lmdb_id>LMDB00720</lmdb_id>
		<created_at>2016-07-30 17:45:19</created_at>
		<updated_at>2018-04-30 22:16:39</updated_at>
		<export>1</export>
		<name>TG(14:0/16:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C49H94O6</moldb_formula>
		<moldb_inchi>InChI=1S/C49H94O6/c1-4-7-10-13-16-19-22-24-27-30-33-36-39-42-48(51)54-45-46(44-53-47(50)41-38-35-32-29-26-21-18-15-12-9-6-3)55-49(52)43-40-37-34-31-28-25-23-20-17-14-11-8-5-2/h46H,4-45H2,1-3H3/t46-/m0/s1</moldb_inchi>
		<moldb_inchikey>JWVXCFSNEOMSHH-DXQCBLCSSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>779.2850</moldb_average_mass>
		<moldb_mono_mass>778.705040747</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>721</id>
		<lmdb_id>LMDB00721</lmdb_id>
		<created_at>2016-07-30 17:45:20</created_at>
		<updated_at>2018-04-30 22:20:37</updated_at>
		<export>1</export>
		<name>TG(14:0/16:0/16:1(9Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>0</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCC)(COC(=O)CCCCCCC\C=C/CCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C49H92O6</moldb_formula>
		<moldb_inchi>InChI=1S/C49H92O6/c1-4-7-10-13-16-19-22-24-27-30-33-36-39-42-48(51)54-45-46(44-53-47(50)41-38-35-32-29-26-21-18-15-12-9-6-3)55-49(52)43-40-37-34-31-28-25-23-20-17-14-11-8-5-2/h19,22,46H,4-18,20-21,23-45H2,1-3H3/b22-19-/t46-/m0/s1</moldb_inchi>
		<moldb_inchikey>JYICXCHHKWVGEI-FIZKWYBOSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>777.2690</moldb_average_mass>
		<moldb_mono_mass>776.689390682</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>722</id>
		<lmdb_id>LMDB00722</lmdb_id>
		<created_at>2016-07-30 17:45:22</created_at>
		<updated_at>2018-04-30 22:19:04</updated_at>
		<export>1</export>
		<name>TG(14:0/16:0/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C51H98O6</moldb_formula>
		<moldb_inchi>InChI=1S/C51H98O6/c1-4-7-10-13-16-19-22-24-25-27-29-32-35-38-41-44-50(53)56-47-48(46-55-49(52)43-40-37-34-31-28-21-18-15-12-9-6-3)57-51(54)45-42-39-36-33-30-26-23-20-17-14-11-8-5-2/h48H,4-47H2,1-3H3/t48-/m0/s1</moldb_inchi>
		<moldb_inchikey>JTDPHURHZMZJHD-DYVQZXGMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>807.3390</moldb_average_mass>
		<moldb_mono_mass>806.736340876</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>723</id>
		<lmdb_id>LMDB00723</lmdb_id>
		<created_at>2016-07-30 17:45:23</created_at>
		<updated_at>2018-04-30 22:23:34</updated_at>
		<export>1</export>
		<name>TG(14:0/16:0/18:1(11Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCC)(COC(=O)CCCCCCCCC\C=C/CCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C51H96O6</moldb_formula>
		<moldb_inchi>InChI=1S/C51H96O6/c1-4-7-10-13-16-19-22-24-25-27-29-32-35-38-41-44-50(53)56-47-48(46-55-49(52)43-40-37-34-31-28-21-18-15-12-9-6-3)57-51(54)45-42-39-36-33-30-26-23-20-17-14-11-8-5-2/h19,22,48H,4-18,20-21,23-47H2,1-3H3/b22-19-/t48-/m0/s1</moldb_inchi>
		<moldb_inchikey>UPTISBGEYYYCRS-DLOIZKPKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>805.3230</moldb_average_mass>
		<moldb_mono_mass>804.720690811</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>724</id>
		<lmdb_id>LMDB00724</lmdb_id>
		<created_at>2016-07-30 17:45:25</created_at>
		<updated_at>2018-04-30 22:26:14</updated_at>
		<export>1</export>
		<name>TG(14:0/16:0/18:2(9Z,12Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCC)(COC(=O)CCCCCCC\C=C/C\C=C/CCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C51H94O6</moldb_formula>
		<moldb_inchi>InChI=1S/C51H94O6/c1-4-7-10-13-16-19-22-24-25-27-29-32-35-38-41-44-50(53)56-47-48(46-55-49(52)43-40-37-34-31-28-21-18-15-12-9-6-3)57-51(54)45-42-39-36-33-30-26-23-20-17-14-11-8-5-2/h16,19,24-25,48H,4-15,17-18,20-23,26-47H2,1-3H3/b19-16-,25-24-/t48-/m0/s1</moldb_inchi>
		<moldb_inchikey>YUIIXXZIUIOJQY-RGFFXGESSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>803.3070</moldb_average_mass>
		<moldb_mono_mass>802.705040747</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>725</id>
		<lmdb_id>LMDB00725</lmdb_id>
		<created_at>2016-07-30 17:45:27</created_at>
		<updated_at>2018-04-30 22:27:30</updated_at>
		<export>1</export>
		<name>TG(14:0/16:1(9Z)/18:1(9Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCC)(COC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C51H94O6</moldb_formula>
		<moldb_inchi>InChI=1S/C51H94O6/c1-4-7-10-13-16-19-22-24-25-27-29-32-35-38-41-44-50(53)56-47-48(46-55-49(52)43-40-37-34-31-28-21-18-15-12-9-6-3)57-51(54)45-42-39-36-33-30-26-23-20-17-14-11-8-5-2/h20,23-25,48H,4-19,21-22,26-47H2,1-3H3/b23-20-,25-24-/t48-/m0/s1</moldb_inchi>
		<moldb_inchikey>QABWZGMVIDDGGI-SWKFLNMBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>803.3070</moldb_average_mass>
		<moldb_mono_mass>802.705040747</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>726</id>
		<lmdb_id>LMDB00726</lmdb_id>
		<created_at>2016-07-30 17:45:29</created_at>
		<updated_at>2018-04-30 22:26:53</updated_at>
		<export>1</export>
		<name>TG(14:0/18:0/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C53H102O6</moldb_formula>
		<moldb_inchi>InChI=1S/C53H102O6/c1-4-7-10-13-16-19-22-24-26-28-31-34-37-40-43-46-52(55)58-49-50(48-57-51(54)45-42-39-36-33-30-21-18-15-12-9-6-3)59-53(56)47-44-41-38-35-32-29-27-25-23-20-17-14-11-8-5-2/h50H,4-49H2,1-3H3/t50-/m0/s1</moldb_inchi>
		<moldb_inchikey>RDVFJKJMACSAJD-DPDRHGIRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>835.3930</moldb_average_mass>
		<moldb_mono_mass>834.767641004</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>727</id>
		<lmdb_id>LMDB00727</lmdb_id>
		<created_at>2016-07-30 17:45:30</created_at>
		<updated_at>2018-04-30 22:28:09</updated_at>
		<export>1</export>
		<name>TG(14:0/18:1(11Z)/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C53H100O6</moldb_formula>
		<moldb_inchi>InChI=1S/C53H100O6/c1-4-7-10-13-16-19-22-24-26-28-31-34-37-40-43-46-52(55)58-49-50(48-57-51(54)45-42-39-36-33-30-21-18-15-12-9-6-3)59-53(56)47-44-41-38-35-32-29-27-25-23-20-17-14-11-8-5-2/h20,23,50H,4-19,21-22,24-49H2,1-3H3/b23-20-/t50-/m0/s1</moldb_inchi>
		<moldb_inchikey>XOOWHGZNMQLAPI-YVMYVILJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>833.3770</moldb_average_mass>
		<moldb_mono_mass>832.751990940</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>728</id>
		<lmdb_id>LMDB00728</lmdb_id>
		<created_at>2016-07-30 17:45:32</created_at>
		<updated_at>2018-04-30 22:28:43</updated_at>
		<export>1</export>
		<name>TG(14:0/18:1(11Z)/18:1(11Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCC)(COC(=O)CCCCCCCCC\C=C/CCCCCC)OC(=O)CCCCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C53H98O6</moldb_formula>
		<moldb_inchi>InChI=1S/C53H98O6/c1-4-7-10-13-16-19-22-24-26-28-31-34-37-40-43-46-52(55)58-49-50(48-57-51(54)45-42-39-36-33-30-21-18-15-12-9-6-3)59-53(56)47-44-41-38-35-32-29-27-25-23-20-17-14-11-8-5-2/h19-20,22-23,50H,4-18,21,24-49H2,1-3H3/b22-19-,23-20-/t50-/m0/s1</moldb_inchi>
		<moldb_inchikey>JSXDYDGETRNNDY-ZRBMIEAUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>831.3610</moldb_average_mass>
		<moldb_mono_mass>830.736340876</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>729</id>
		<lmdb_id>LMDB00729</lmdb_id>
		<created_at>2016-07-30 17:45:34</created_at>
		<updated_at>2018-04-30 22:29:07</updated_at>
		<export>1</export>
		<name>TG(15:0/16:0/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C52H100O6</moldb_formula>
		<moldb_inchi>InChI=1S/C52H100O6/c1-4-7-10-13-16-19-22-25-26-28-30-33-36-39-42-45-51(54)57-48-49(47-56-50(53)44-41-38-35-32-29-24-21-18-15-12-9-6-3)58-52(55)46-43-40-37-34-31-27-23-20-17-14-11-8-5-2/h49H,4-48H2,1-3H3/t49-/m0/s1</moldb_inchi>
		<moldb_inchikey>BABSZGMYWGFHOB-GGCSAXROSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>821.3660</moldb_average_mass>
		<moldb_mono_mass>820.751990940</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>730</id>
		<lmdb_id>LMDB00730</lmdb_id>
		<created_at>2016-07-30 17:45:35</created_at>
		<updated_at>2018-04-30 22:29:56</updated_at>
		<export>1</export>
		<name>TG(16:0/15:0/16:1(9Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCCCC)(COC(=O)CCCCCCC\C=C/CCCCCC)OC(=O)CCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C50H94O6</moldb_formula>
		<moldb_inchi>InChI=1S/C50H94O6/c1-4-7-10-13-16-19-22-25-28-30-33-36-39-42-48(51)54-45-47(56-50(53)44-41-38-35-32-27-24-21-18-15-12-9-6-3)46-55-49(52)43-40-37-34-31-29-26-23-20-17-14-11-8-5-2/h19,22,47H,4-18,20-21,23-46H2,1-3H3/b22-19-/t47-/m1/s1</moldb_inchi>
		<moldb_inchikey>PMHPAVPAGLAMOD-AHIIZLPLSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>791.2960</moldb_average_mass>
		<moldb_mono_mass>790.705040747</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>731</id>
		<lmdb_id>LMDB00731</lmdb_id>
		<created_at>2016-07-30 17:45:37</created_at>
		<updated_at>2018-04-30 22:29:34</updated_at>
		<export>1</export>
		<name>TG(16:0/14:0/18:1(11Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCC\C=C/CCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C51H96O6</moldb_formula>
		<moldb_inchi>InChI=1S/C51H96O6/c1-4-7-10-13-16-19-22-24-25-27-30-32-35-38-41-44-50(53)56-47-48(57-51(54)45-42-39-36-33-28-21-18-15-12-9-6-3)46-55-49(52)43-40-37-34-31-29-26-23-20-17-14-11-8-5-2/h19,22,48H,4-18,20-21,23-47H2,1-3H3/b22-19-/t48-/m0/s1</moldb_inchi>
		<moldb_inchikey>TVYRIOFXPORHMG-DLOIZKPKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>805.3230</moldb_average_mass>
		<moldb_mono_mass>804.720690811</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>732</id>
		<lmdb_id>LMDB00732</lmdb_id>
		<created_at>2016-07-30 17:45:39</created_at>
		<updated_at>2018-04-30 22:30:18</updated_at>
		<export>1</export>
		<name>TG(16:0/14:1(9Z)/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC\C=C/CCCC</moldb_smiles>
		<moldb_formula>C51H96O6</moldb_formula>
		<moldb_inchi>InChI=1S/C51H96O6/c1-4-7-10-13-16-19-22-24-25-27-30-32-35-38-41-44-50(53)56-47-48(57-51(54)45-42-39-36-33-28-21-18-15-12-9-6-3)46-55-49(52)43-40-37-34-31-29-26-23-20-17-14-11-8-5-2/h15,18,48H,4-14,16-17,19-47H2,1-3H3/b18-15-/t48-/m0/s1</moldb_inchi>
		<moldb_inchikey>FTSVKEQEERVOIA-CVGXBFGDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>805.3230</moldb_average_mass>
		<moldb_mono_mass>804.720690811</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>733</id>
		<lmdb_id>LMDB00733</lmdb_id>
		<created_at>2016-07-30 17:45:40</created_at>
		<updated_at>2018-04-30 21:03:42</updated_at>
		<export>1</export>
		<name>TG(16:0/16:0/18:0)[iso3]</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C53H102O6</moldb_formula>
		<moldb_inchi>InChI=1S/C53H102O6/c1-4-7-10-13-16-19-22-25-26-29-31-34-37-40-43-46-52(55)58-49-50(59-53(56)47-44-41-38-35-32-28-24-21-18-15-12-9-6-3)48-57-51(54)45-42-39-36-33-30-27-23-20-17-14-11-8-5-2/h50H,4-49H2,1-3H3/t50-/m1/s1</moldb_inchi>
		<moldb_inchikey>DQKMNCLZNGAXNX-VCZQVZGSSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>835.3734</moldb_average_mass>
		<moldb_mono_mass>834.767640996</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>734</id>
		<lmdb_id>LMDB00734</lmdb_id>
		<created_at>2016-07-30 17:45:42</created_at>
		<updated_at>2018-04-30 21:03:42</updated_at>
		<export>1</export>
		<name>TG(16:0/16:0/18:1(9Z))[iso3]</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C53H100O6</moldb_formula>
		<moldb_inchi>InChI=1S/C53H100O6/c1-4-7-10-13-16-19-22-25-26-29-31-34-37-40-43-46-52(55)58-49-50(59-53(56)47-44-41-38-35-32-28-24-21-18-15-12-9-6-3)48-57-51(54)45-42-39-36-33-30-27-23-20-17-14-11-8-5-2/h25-26,50H,4-24,27-49H2,1-3H3/b26-25-/t50-/m1/s1</moldb_inchi>
		<moldb_inchikey>YHMDGPZOSGBQRH-YYSBDVFPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>833.3575</moldb_average_mass>
		<moldb_mono_mass>832.751990932</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>735</id>
		<lmdb_id>LMDB00735</lmdb_id>
		<created_at>2016-07-30 17:45:44</created_at>
		<updated_at>2018-04-30 21:03:42</updated_at>
		<export>1</export>
		<name>TG(16:0/16:0/18:2(9Z,12Z))[iso3]</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCC\C=C/C\C=C/CCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C53H98O6</moldb_formula>
		<moldb_inchi>InChI=1S/C53H98O6/c1-4-7-10-13-16-19-22-25-26-29-31-34-37-40-43-46-52(55)58-49-50(59-53(56)47-44-41-38-35-32-28-24-21-18-15-12-9-6-3)48-57-51(54)45-42-39-36-33-30-27-23-20-17-14-11-8-5-2/h16,19,25-26,50H,4-15,17-18,20-24,27-49H2,1-3H3/b19-16-,26-25-/t50-/m1/s1</moldb_inchi>
		<moldb_inchikey>MTWYSKGJIDFSRC-IICCMCGVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>831.3416</moldb_average_mass>
		<moldb_mono_mass>830.736340868</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>736</id>
		<lmdb_id>LMDB00736</lmdb_id>
		<created_at>2016-07-30 17:45:46</created_at>
		<updated_at>2018-04-30 21:03:43</updated_at>
		<export>1</export>
		<name>TG(16:0/16:1(9Z)/18:1(9Z))[iso6]</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C53H98O6</moldb_formula>
		<moldb_inchi>InChI=1S/C53H98O6/c1-4-7-10-13-16-19-22-25-26-29-31-34-37-40-43-46-52(55)58-49-50(59-53(56)47-44-41-38-35-32-28-24-21-18-15-12-9-6-3)48-57-51(54)45-42-39-36-33-30-27-23-20-17-14-11-8-5-2/h21,24-26,50H,4-20,22-23,27-49H2,1-3H3/b24-21-,26-25-/t50-/m1/s1</moldb_inchi>
		<moldb_inchikey>TWJCMQZMAPGUSG-JMFJKIOKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>831.3416</moldb_average_mass>
		<moldb_mono_mass>830.736340868</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>737</id>
		<lmdb_id>LMDB00737</lmdb_id>
		<created_at>2016-07-30 17:45:47</created_at>
		<updated_at>2018-04-30 22:30:41</updated_at>
		<export>1</export>
		<name>TG(16:0/18:1(11Z)/18:2(9Z,12Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCCCC)(COC(=O)CCCCCCC\C=C/C\C=C/CCCCC)OC(=O)CCCCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C55H100O6</moldb_formula>
		<moldb_inchi>InChI=1S/C55H100O6/c1-4-7-10-13-16-19-22-25-27-30-33-36-39-42-45-48-54(57)60-51-52(50-59-53(56)47-44-41-38-35-32-29-24-21-18-15-12-9-6-3)61-55(58)49-46-43-40-37-34-31-28-26-23-20-17-14-11-8-5-2/h16,19-20,23,25,27,52H,4-15,17-18,21-22,24,26,28-51H2,1-3H3/b19-16-,23-20-,27-25-/t52-/m0/s1</moldb_inchi>
		<moldb_inchikey>UOSXDBUYARIRPO-XFAWJRLMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>857.3990</moldb_average_mass>
		<moldb_mono_mass>856.751990940</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>738</id>
		<lmdb_id>LMDB00738</lmdb_id>
		<created_at>2016-07-30 17:45:49</created_at>
		<updated_at>2018-04-30 22:31:11</updated_at>
		<export>1</export>
		<name>TG(16:0/18:1(11Z)/18:3(6Z,9Z,12Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCCCC)(COC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC)OC(=O)CCCCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C55H98O6</moldb_formula>
		<moldb_inchi>InChI=1S/C55H98O6/c1-4-7-10-13-16-19-22-25-27-30-33-36-39-42-45-48-54(57)60-51-52(50-59-53(56)47-44-41-38-35-32-29-24-21-18-15-12-9-6-3)61-55(58)49-46-43-40-37-34-31-28-26-23-20-17-14-11-8-5-2/h16,19-20,23,25,27,33,36,52H,4-15,17-18,21-22,24,26,28-32,34-35,37-51H2,1-3H3/b19-16-,23-20-,27-25-,36-33-/t52-/m0/s1</moldb_inchi>
		<moldb_inchikey>AGZKWUAHBZQQNY-KYTQBJKTSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>855.3830</moldb_average_mass>
		<moldb_mono_mass>854.736340876</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>739</id>
		<lmdb_id>LMDB00739</lmdb_id>
		<created_at>2016-07-30 17:45:51</created_at>
		<updated_at>2018-04-30 22:32:37</updated_at>
		<export>1</export>
		<name>TG(16:1(9Z)/18:1(11Z)/18:1(11Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](COC(=O)CCCCCCCCC\C=C/CCCCCC)(COC(=O)CCCCCCC\C=C/CCCCCC)OC(=O)CCCCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C55H100O6</moldb_formula>
		<moldb_inchi>InChI=1S/C55H100O6/c1-4-7-10-13-16-19-22-25-27-30-33-36-39-42-45-48-54(57)60-51-52(50-59-53(56)47-44-41-38-35-32-29-24-21-18-15-12-9-6-3)61-55(58)49-46-43-40-37-34-31-28-26-23-20-17-14-11-8-5-2/h19-24,52H,4-18,25-51H2,1-3H3/b22-19-,23-20-,24-21-/t52-/m0/s1</moldb_inchi>
		<moldb_inchikey>FVASQEUWMANRGF-KACSEKLOSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>857.3990</moldb_average_mass>
		<moldb_mono_mass>856.751990940</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>740</id>
		<lmdb_id>LMDB00740</lmdb_id>
		<created_at>2016-07-30 17:45:53</created_at>
		<updated_at>2018-04-30 22:31:45</updated_at>
		<export>1</export>
		<name>TG(18:0/16:0/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]C(COC(=O)CCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C55H106O6</moldb_formula>
		<moldb_inchi>InChI=1S/C55H106O6/c1-4-7-10-13-16-19-22-25-27-30-32-35-38-41-44-47-53(56)59-50-52(61-55(58)49-46-43-40-37-34-29-24-21-18-15-12-9-6-3)51-60-54(57)48-45-42-39-36-33-31-28-26-23-20-17-14-11-8-5-2/h52H,4-51H2,1-3H3</moldb_inchi>
		<moldb_inchikey>ZGVGTPFSVCXVNJ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>863.4265</moldb_average_mass>
		<moldb_mono_mass>862.798941124</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>741</id>
		<lmdb_id>LMDB00741</lmdb_id>
		<created_at>2016-07-30 17:45:54</created_at>
		<updated_at>2018-04-30 22:32:12</updated_at>
		<export>1</export>
		<name>TG(18:0/16:0/18:1(9Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C55H104O6</moldb_formula>
		<moldb_inchi>InChI=1S/C55H104O6/c1-4-7-10-13-16-19-22-25-27-30-32-35-38-41-44-47-53(56)59-50-52(61-55(58)49-46-43-40-37-34-29-24-21-18-15-12-9-6-3)51-60-54(57)48-45-42-39-36-33-31-28-26-23-20-17-14-11-8-5-2/h25,27,52H,4-24,26,28-51H2,1-3H3/b27-25-/t52-/m1/s1</moldb_inchi>
		<moldb_inchikey>WRXCJQWYSUUELD-FQUZZJBASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>861.4310</moldb_average_mass>
		<moldb_mono_mass>860.783291069</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>742</id>
		<lmdb_id>LMDB00742</lmdb_id>
		<created_at>2016-07-30 17:45:56</created_at>
		<updated_at>2018-04-30 22:13:30</updated_at>
		<export>1</export>
		<name>TG(18:0/18:0/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]C(COC(=O)CCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C57H110O6</moldb_formula>
		<moldb_inchi>InChI=1S/C57H110O6/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-46-49-55(58)61-52-54(63-57(60)51-48-45-42-39-36-33-30-27-24-21-18-15-12-9-6-3)53-62-56(59)50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2/h54H,4-53H2,1-3H3</moldb_inchi>
		<moldb_inchikey>DCXXMTOCNZCJGO-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>891.4797</moldb_average_mass>
		<moldb_mono_mass>890.830241252</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>743</id>
		<lmdb_id>LMDB00743</lmdb_id>
		<created_at>2016-07-30 17:45:58</created_at>
		<updated_at>2018-04-30 21:03:45</updated_at>
		<export>1</export>
		<name>TG(18:0/18:0/18:1(9Z))[iso3]</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C57H108O6</moldb_formula>
		<moldb_inchi>InChI=1S/C57H108O6/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-46-49-55(58)61-52-54(63-57(60)51-48-45-42-39-36-33-30-27-24-21-18-15-12-9-6-3)53-62-56(59)50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2/h25,28,54H,4-24,26-27,29-53H2,1-3H3/b28-25-/t54-/m0/s1</moldb_inchi>
		<moldb_inchikey>YFFIQXNTTVSKJC-NZEOUKRFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>889.4638</moldb_average_mass>
		<moldb_mono_mass>888.814591188</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>744</id>
		<lmdb_id>LMDB00744</lmdb_id>
		<created_at>2016-07-30 17:54:18</created_at>
		<updated_at>2018-04-30 21:03:45</updated_at>
		<export>1</export>
		<name>cis-13-Octadecenoic acid </name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC=CCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h5-6H,2-4,7-17H2,1H3,(H,19,20)</moldb_inchi>
		<moldb_inchikey>BDLLSHRIFPDGQB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4680</moldb_average_mass>
		<moldb_mono_mass>282.255880335</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>745</id>
		<lmdb_id>LMDB00745</lmdb_id>
		<created_at>2016-07-30 18:15:55</created_at>
		<updated_at>2016-08-01 19:17:01</updated_at>
		<export>1</export>
		<name>TG(18:1(11Z)/15:0/o-18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCC\C=C/CCCCCC)OC(=O)CCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C54H104O5</moldb_formula>
		<moldb_inchi>InChI=1S/C54H104O5/c1-4-7-10-13-16-19-22-25-27-29-31-34-37-40-43-46-49-57-50-52(59-54(56)48-45-42-39-36-32-24-21-18-15-12-9-6-3)51-58-53(55)47-44-41-38-35-33-30-28-26-23-20-17-14-11-8-5-2/h20,23,52H,4-19,21-22,24-51H2,1-3H3/b23-20-</moldb_inchi>
		<moldb_inchikey>MPYBOTIYCVLPJN-ATJXCDBQSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>833.4006</moldb_average_mass>
		<moldb_mono_mass>832.788376438</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>746</id>
		<lmdb_id>LMDB00746</lmdb_id>
		<created_at>2016-07-30 18:15:57</created_at>
		<updated_at>2018-04-30 21:15:02</updated_at>
		<export>1</export>
		<name>TG(18:1(9Z)/16:0/18:1(9Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]C(COC(=O)CCCCCCC\C=C/CCCCCCCC)(COC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C55H102O6</moldb_formula>
		<moldb_inchi>InChI=1S/C55H102O6/c1-4-7-10-13-16-19-22-25-27-30-32-35-38-41-44-47-53(56)59-50-52(61-55(58)49-46-43-40-37-34-29-24-21-18-15-12-9-6-3)51-60-54(57)48-45-42-39-36-33-31-28-26-23-20-17-14-11-8-5-2/h25-28,52H,4-24,29-51H2,1-3H3/b27-25-,28-26-</moldb_inchi>
		<moldb_inchikey>PPTGNVIVNZLPPS-LBXGSASVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>859.3948</moldb_average_mass>
		<moldb_mono_mass>858.767640996</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>747</id>
		<lmdb_id>LMDB00747</lmdb_id>
		<created_at>2016-07-30 18:15:58</created_at>
		<updated_at>2016-08-01 19:17:03</updated_at>
		<export>1</export>
		<name>TG(18:1(11Z)/18:1(11Z)/o-18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCC\C=C/CCCCCC)OC(=O)CCCCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C57H108O5</moldb_formula>
		<moldb_inchi>InChI=1S/C57H108O5/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-46-49-52-60-53-55(62-57(59)51-48-45-42-39-36-33-30-27-24-21-18-15-12-9-6-3)54-61-56(58)50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2/h20-21,23-24,55H,4-19,22,25-54H2,1-3H3/b23-20-,24-21-</moldb_inchi>
		<moldb_inchikey>CLCQSBVFBLSNEE-XFUYORNGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>873.4644</moldb_average_mass>
		<moldb_mono_mass>872.819676566</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>748</id>
		<lmdb_id>LMDB00748</lmdb_id>
		<created_at>2016-07-30 18:16:00</created_at>
		<updated_at>2018-04-30 21:15:02</updated_at>
		<export>1</export>
		<name>TG(18:1(11Z)/18:1(11Z)/18:1(11Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]C(COC(=O)CCCCCCCCC\C=C/CCCCCC)(COC(=O)CCCCCCCCC\C=C/CCCCCC)OC(=O)CCCCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C57H104O6</moldb_formula>
		<moldb_inchi>InChI=1S/C57H104O6/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-46-49-55(58)61-52-54(63-57(60)51-48-45-42-39-36-33-30-27-24-21-18-15-12-9-6-3)53-62-56(59)50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2/h19-24,54H,4-18,25-53H2,1-3H3/b22-19-,23-20-,24-21-</moldb_inchi>
		<moldb_inchikey>JSSROPRCXOAGCW-BUTYCLJRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>885.4321</moldb_average_mass>
		<moldb_mono_mass>884.783291060</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>749</id>
		<lmdb_id>LMDB00749</lmdb_id>
		<created_at>2016-07-30 18:16:01</created_at>
		<updated_at>2016-08-01 19:17:03</updated_at>
		<export>1</export>
		<name>TG(18:2(9Z,12Z)/18:1(11Z)/o-18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC\C=C/C\C=C/CCCCCC)OC(=O)CCCCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C58H108O5</moldb_formula>
		<moldb_inchi>InChI=1S/C58H108O5/c1-4-7-10-13-16-19-22-25-28-31-33-36-39-42-45-48-51-57(59)62-55-56(54-61-53-50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2)63-58(60)52-49-46-43-40-37-34-30-27-24-21-18-15-12-9-6-3/h19,21-22,24,28,31,56H,4-18,20,23,25-27,29-30,32-55H2,1-3H3/b22-19-,24-21-,31-28-</moldb_inchi>
		<moldb_inchikey>FNANQTJLDDUKQM-MSCNUBGFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>885.4751</moldb_average_mass>
		<moldb_mono_mass>884.819676566</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>750</id>
		<lmdb_id>LMDB00750</lmdb_id>
		<created_at>2016-07-30 18:16:03</created_at>
		<updated_at>2016-08-02 20:15:35</updated_at>
		<export>1</export>
		<name>3-Hydroxy-4-methoxymandelate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>COC1=C(O)C=C(C=C1)[C@@H](O)C(O)=O</moldb_smiles>
		<moldb_formula>C9H10O5</moldb_formula>
		<moldb_inchi>InChI=1S/C9H10O5/c1-14-7-3-2-5(4-6(7)10)8(11)9(12)13/h2-4,8,10-11H,1H3,(H,12,13)/t8-/m1/s1</moldb_inchi>
		<moldb_inchikey>PXMUSCHKJYFZFD-MRVPVSSYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>198.1727</moldb_average_mass>
		<moldb_mono_mass>198.052823430</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>751</id>
		<lmdb_id>LMDB00751</lmdb_id>
		<created_at>2016-07-30 18:16:05</created_at>
		<updated_at>2016-08-01 19:17:05</updated_at>
		<export>1</export>
		<name>Isopentanol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)CCO</moldb_smiles>
		<moldb_formula>C5H12O</moldb_formula>
		<moldb_inchi>InChI=1S/C5H12O/c1-5(2)3-4-6/h5-6H,3-4H2,1-2H3</moldb_inchi>
		<moldb_inchikey>PHTQWCKDNZKARW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>88.1482</moldb_average_mass>
		<moldb_mono_mass>88.088815006</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>752</id>
		<lmdb_id>LMDB00752</lmdb_id>
		<created_at>2016-07-30 18:16:11</created_at>
		<updated_at>2016-08-01 19:17:06</updated_at>
		<export>1</export>
		<name>Tranexamic Acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC[C@H]1CC[C@@H](CC1)C(O)=O</moldb_smiles>
		<moldb_formula>C8H15NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)/t6-,7-</moldb_inchi>
		<moldb_inchikey>GYDJEQRTZSCIOI-LJGSYFOKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>157.2102</moldb_average_mass>
		<moldb_mono_mass>157.110278729</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>753</id>
		<lmdb_id>LMDB00753</lmdb_id>
		<created_at>2016-07-30 18:16:13</created_at>
		<updated_at>2016-08-01 19:17:07</updated_at>
		<export>1</export>
		<name>4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)C1=C(C)C(=C(C(=C1C)N(=O)=O)C(C)(C)C)N(=O)=O</moldb_smiles>
		<moldb_formula>C14H18N2O5</moldb_formula>
		<moldb_inchi>InChI=1S/C14H18N2O5/c1-7-10(9(3)17)8(2)13(16(20)21)11(14(4,5)6)12(7)15(18)19/h1-6H3</moldb_inchi>
		<moldb_inchikey>WXCMHFPAUCOJIG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>294.3031</moldb_average_mass>
		<moldb_mono_mass>294.121571696</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>754</id>
		<lmdb_id>LMDB00754</lmdb_id>
		<created_at>2016-07-30 18:16:18</created_at>
		<updated_at>2016-08-01 19:17:07</updated_at>
		<export>1</export>
		<name>Deoxyadenosine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](CO)O1</moldb_smiles>
		<moldb_formula>C10H13N5O3</moldb_formula>
		<moldb_inchi>InChI=1S/C10H13N5O3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7/h3-7,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,7+/m0/s1</moldb_inchi>
		<moldb_inchikey>OLXZPDWKRNYJJZ-RRKCRQDMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>251.2419</moldb_average_mass>
		<moldb_mono_mass>251.101839307</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>755</id>
		<lmdb_id>LMDB00755</lmdb_id>
		<created_at>2016-07-30 18:16:24</created_at>
		<updated_at>2016-08-01 19:17:09</updated_at>
		<export>1</export>
		<name>Alpha-D-Glucopyranoside</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@@H]1O[C@@H](O)[C@@H](O)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4-,5-,6+/m0/s1</moldb_inchi>
		<moldb_inchikey>WQZGKKKJIJFFOK-GKFJPSPNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1559</moldb_average_mass>
		<moldb_mono_mass>180.063388116</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>756</id>
		<lmdb_id>LMDB00756</lmdb_id>
		<created_at>2016-07-30 18:16:26</created_at>
		<updated_at>2016-08-02 20:15:35</updated_at>
		<export>1</export>
		<name>(S)-b-aminoisobutyric acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[C@@H](CN)C(O)=O</moldb_smiles>
		<moldb_formula>C4H9NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C4H9NO2/c1-3(2-5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1</moldb_inchi>
		<moldb_inchikey>QCHPKSFMDHPSNR-VKHMYHEASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>103.1198</moldb_average_mass>
		<moldb_mono_mass>103.063328537</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>757</id>
		<lmdb_id>LMDB00757</lmdb_id>
		<created_at>2016-07-30 18:17:05</created_at>
		<updated_at>2016-08-07 02:11:10</updated_at>
		<export>1</export>
		<name>9,12-Hexadecadienoylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC\C=C/C\C=C/CCCCCCCC(=O)O[C@H]([N+](C)(C)C)CCC([O-])=O</moldb_smiles>
		<moldb_formula>C23H41NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C23H41NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(27)28-21(24(2,3)4)19-20-22(25)26/h7-8,10-11,21H,5-6,9,12-20H2,1-4H3/b8-7-,11-10-/t21-/m0/s1</moldb_inchi>
		<moldb_inchikey>AHZCIODFJPNPKS-XBDLETADSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>395.5759</moldb_average_mass>
		<moldb_mono_mass>395.303558805</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>758</id>
		<lmdb_id>LMDB00758</lmdb_id>
		<created_at>2016-07-30 18:17:06</created_at>
		<updated_at>2016-08-02 20:15:13</updated_at>
		<export>1</export>
		<name>(Z)-9-Heptadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCC\C=C\CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C17H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C17H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17(18)19/h8-9H,2-7,10-16H2,1H3,(H,18,19)/b9-8+</moldb_inchi>
		<moldb_inchikey>QSBYPNXLFMSGKH-CMDGGOBGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>268.4348</moldb_average_mass>
		<moldb_mono_mass>268.240230268</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>759</id>
		<lmdb_id>LMDB00759</lmdb_id>
		<created_at>2016-07-30 18:17:07</created_at>
		<updated_at>2016-08-01 19:17:15</updated_at>
		<export>1</export>
		<name>10E,12Z-Octadecadienoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/C=C/CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h7-10H,2-6,11-17H2,1H3,(H,19,20)/b8-7-,10-9+</moldb_inchi>
		<moldb_inchikey>JBYXPOFIGCOSSB-UQGDGPGGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>280.4455</moldb_average_mass>
		<moldb_mono_mass>280.240230268</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>760</id>
		<lmdb_id>LMDB00760</lmdb_id>
		<created_at>2016-07-30 18:17:24</created_at>
		<updated_at>2016-08-02 20:15:16</updated_at>
		<export>1</export>
		<name>Bovinic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C\C=C/CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h7-10H,2-6,11-17H2,1H3,(H,19,20)/b8-7+,10-9-</moldb_inchi>
		<moldb_inchikey>JBYXPOFIGCOSSB-GOJKSUSPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>280.4455</moldb_average_mass>
		<moldb_mono_mass>280.240230268</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>761</id>
		<lmdb_id>LMDB00761</lmdb_id>
		<created_at>2016-07-30 18:17:26</created_at>
		<updated_at>2016-08-09 20:16:30</updated_at>
		<export>1</export>
		<name>Malonyl-L-carnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+](C)(C)C[C@H](CC([O-])=O)OC(=O)CC(O)=O</moldb_smiles>
		<moldb_formula>C10H17NO6</moldb_formula>
		<moldb_inchi>InChI=1S/C10H17NO6/c1-11(2,3)6-7(4-8(12)13)17-10(16)5-9(14)15/h7H,4-6H2,1-3H3,(H-,12,13,14,15)/t7-/m0/s1</moldb_inchi>
		<moldb_inchikey>ZGNBLKBZJBJFDG-ZETCQYMHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>247.2451</moldb_average_mass>
		<moldb_mono_mass>247.105587281</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>762</id>
		<lmdb_id>LMDB00762</lmdb_id>
		<created_at>2016-07-30 18:17:28</created_at>
		<updated_at>2016-08-01 19:17:16</updated_at>
		<export>1</export>
		<name>Propenoylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+](C)(C)C[C@H](CC([O-])=O)OC(=O)C=C</moldb_smiles>
		<moldb_formula>C10H17NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C10H17NO4/c1-5-10(14)15-8(6-9(12)13)7-11(2,3)4/h5,8H,1,6-7H2,2-4H3/t8-/m0/s1</moldb_inchi>
		<moldb_inchikey>YUCNWOKTRWJLGY-QMMMGPOBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>215.2463</moldb_average_mass>
		<moldb_mono_mass>215.115758037</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>763</id>
		<lmdb_id>LMDB00763</lmdb_id>
		<created_at>2016-07-30 18:17:30</created_at>
		<updated_at>2016-07-30 18:17:30</updated_at>
		<export>1</export>
		<name>TG(14:0/14:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>0</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C47H90O6</moldb_formula>
		<moldb_inchi>InChI=1S/C47H90O6/c1-4-7-10-13-16-19-22-23-26-28-31-34-37-40-46(49)52-43-44(53-47(50)41-38-35-32-29-25-21-18-15-12-9-6-3)42-51-45(48)39-36-33-30-27-24-20-17-14-11-8-5-2/h44H,4-43H2,1-3H3</moldb_inchi>
		<moldb_inchikey>AMXRERGJDVUTMF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>751.2139</moldb_average_mass>
		<moldb_mono_mass>750.673740612</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>764</id>
		<lmdb_id>LMDB00764</lmdb_id>
		<created_at>2016-07-30 18:17:31</created_at>
		<updated_at>2016-08-01 19:17:17</updated_at>
		<export>1</export>
		<name>TG(14:0/14:0/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C49H94O6</moldb_formula>
		<moldb_inchi>InChI=1S/C49H94O6/c1-4-7-10-13-16-19-22-23-24-25-28-30-33-36-39-42-48(51)54-45-46(55-49(52)43-40-37-34-31-27-21-18-15-12-9-6-3)44-53-47(50)41-38-35-32-29-26-20-17-14-11-8-5-2/h46H,4-45H2,1-3H3</moldb_inchi>
		<moldb_inchikey>YQLXPOXDXQWEKE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>779.2671</moldb_average_mass>
		<moldb_mono_mass>778.705040740</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>765</id>
		<lmdb_id>LMDB00765</lmdb_id>
		<created_at>2016-07-30 18:17:33</created_at>
		<updated_at>2016-08-01 19:17:17</updated_at>
		<export>1</export>
		<name>TG(14:0/14:0/20:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C51H98O6</moldb_formula>
		<moldb_inchi>InChI=1S/C51H98O6/c1-4-7-10-13-16-19-22-23-24-25-26-27-30-32-35-38-41-44-50(53)56-47-48(57-51(54)45-42-39-36-33-29-21-18-15-12-9-6-3)46-55-49(52)43-40-37-34-31-28-20-17-14-11-8-5-2/h48H,4-47H2,1-3H3</moldb_inchi>
		<moldb_inchikey>ZARHKOGIOAZUIC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>807.3202</moldb_average_mass>
		<moldb_mono_mass>806.736340868</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>766</id>
		<lmdb_id>LMDB00766</lmdb_id>
		<created_at>2016-07-30 18:17:35</created_at>
		<updated_at>2016-08-01 19:17:18</updated_at>
		<export>1</export>
		<name>Glutarylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+](C)(C)C[C@H](CC([O-])=O)OC(=O)CCCC(O)=O</moldb_smiles>
		<moldb_formula>C12H21NO6</moldb_formula>
		<moldb_inchi>InChI=1S/C12H21NO6/c1-13(2,3)8-9(7-11(16)17)19-12(18)6-4-5-10(14)15/h9H,4-8H2,1-3H3,(H-,14,15,16,17)/t9-/m0/s1</moldb_inchi>
		<moldb_inchikey>NXJAXUYOQLTISD-VIFPVBQESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>275.2982</moldb_average_mass>
		<moldb_mono_mass>275.136887409</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>767</id>
		<lmdb_id>LMDB00767</lmdb_id>
		<created_at>2016-07-30 18:17:36</created_at>
		<updated_at>2016-07-30 18:17:37</updated_at>
		<export>1</export>
		<name>TG(14:0/14:0/22:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>0</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C53H102O6</moldb_formula>
		<moldb_inchi>InChI=1S/C53H102O6/c1-4-7-10-13-16-19-22-23-24-25-26-27-28-29-32-34-37-40-43-46-52(55)58-49-50(59-53(56)47-44-41-38-35-31-21-18-15-12-9-6-3)48-57-51(54)45-42-39-36-33-30-20-17-14-11-8-5-2/h50H,4-49H2,1-3H3</moldb_inchi>
		<moldb_inchikey>VBHCISIMDOKKHO-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>835.3734</moldb_average_mass>
		<moldb_mono_mass>834.767640996</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>768</id>
		<lmdb_id>LMDB00768</lmdb_id>
		<created_at>2016-07-30 18:17:38</created_at>
		<updated_at>2016-07-30 18:17:38</updated_at>
		<export>1</export>
		<name>TG(14:0/14:0/24:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>0</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C55H106O6</moldb_formula>
		<moldb_inchi>InChI=1S/C55H106O6/c1-4-7-10-13-16-19-22-23-24-25-26-27-28-29-30-31-34-36-39-42-45-48-54(57)60-51-52(61-55(58)49-46-43-40-37-33-21-18-15-12-9-6-3)50-59-53(56)47-44-41-38-35-32-20-17-14-11-8-5-2/h52H,4-51H2,1-3H3</moldb_inchi>
		<moldb_inchikey>FCBDBDGGHRJXBL-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>863.4265</moldb_average_mass>
		<moldb_mono_mass>862.798941124</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>769</id>
		<lmdb_id>LMDB00769</lmdb_id>
		<created_at>2016-07-30 18:17:39</created_at>
		<updated_at>2016-08-01 19:17:19</updated_at>
		<export>1</export>
		<name>Hexanoylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C13H25NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C13H25NO4/c1-5-6-7-8-13(17)18-11(9-12(15)16)10-14(2,3)4/h11H,5-10H2,1-4H3</moldb_inchi>
		<moldb_inchikey>VVPRQWTYSNDTEA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>259.3419</moldb_average_mass>
		<moldb_mono_mass>259.178358293</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>770</id>
		<lmdb_id>LMDB00770</lmdb_id>
		<created_at>2016-07-30 18:17:41</created_at>
		<updated_at>2016-08-01 19:17:19</updated_at>
		<export>1</export>
		<name>4-Hydroxycinnamic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)\C=C\C1=CC=C(O)C=C1</moldb_smiles>
		<moldb_formula>C9H8O3</moldb_formula>
		<moldb_inchi>InChI=1S/C9H8O3/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-6,10H,(H,11,12)/b6-3+</moldb_inchi>
		<moldb_inchikey>NGSWKAQJJWESNS-ZZXKWVIFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>164.1580</moldb_average_mass>
		<moldb_mono_mass>164.047344122</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>771</id>
		<lmdb_id>LMDB00771</lmdb_id>
		<created_at>2016-07-30 18:17:42</created_at>
		<updated_at>2016-08-02 20:15:36</updated_at>
		<export>1</export>
		<name>Cytidine monophosphate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C9H14N3O8P</moldb_formula>
		<moldb_inchi>InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1</moldb_inchi>
		<moldb_inchikey>IERHLVCPSMICTF-XVFCMESISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>323.1965</moldb_average_mass>
		<moldb_mono_mass>323.051850951</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>772</id>
		<lmdb_id>LMDB00772</lmdb_id>
		<created_at>2016-07-30 18:17:44</created_at>
		<updated_at>2016-08-06 20:09:54</updated_at>
		<export>1</export>
		<name>3-Decenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CC(O)=O</moldb_smiles>
		<moldb_formula>C10H18O2</moldb_formula>
		<moldb_inchi>InChI=1S/C10H18O2/c1-2-3-4-5-6-7-8-9-10(11)12/h7-8H,2-6,9H2,1H3,(H,11,12)/b8-7-</moldb_inchi>
		<moldb_inchikey>CPVUNKGURQKKKX-FPLPWBNLSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>170.2487</moldb_average_mass>
		<moldb_mono_mass>170.130679820</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>773</id>
		<lmdb_id>LMDB00773</lmdb_id>
		<created_at>2016-07-30 18:17:46</created_at>
		<updated_at>2016-08-06 20:10:56</updated_at>
		<export>1</export>
		<name>Dehydroepiandrosterone sulfate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@H](CC[C@]12C)OS(O)(=O)=O</moldb_smiles>
		<moldb_formula>C19H28O5S</moldb_formula>
		<moldb_inchi>InChI=1S/C19H28O5S/c1-18-9-7-13(24-25(21,22)23)11-12(18)3-4-14-15-5-6-17(20)19(15,2)10-8-16(14)18/h3,13-16H,4-11H2,1-2H3,(H,21,22,23)/t13-,14-,15-,16-,18-,19-/m0/s1</moldb_inchi>
		<moldb_inchikey>CZWCKYRVOZZJNM-USOAJAOKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>368.4880</moldb_average_mass>
		<moldb_mono_mass>368.165744696</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>774</id>
		<lmdb_id>LMDB00774</lmdb_id>
		<created_at>2016-07-30 18:17:52</created_at>
		<updated_at>2016-08-02 20:40:53</updated_at>
		<export>1</export>
		<name>24,25-Dihydrolanosterol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](C)(CCCC(C)C)[C@@]1([H])CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@]1([H])CC3</moldb_smiles>
		<moldb_formula>C30H52O</moldb_formula>
		<moldb_inchi>InChI=1S/C30H52O/c1-20(2)10-9-11-21(3)22-14-18-30(8)24-12-13-25-27(4,5)26(31)16-17-28(25,6)23(24)15-19-29(22,30)7/h20-22,25-26,31H,9-19H2,1-8H3/t21-,22-,25+,26+,28-,29-,30+/m1/s1</moldb_inchi>
		<moldb_inchikey>MBZYKEVPFYHDOH-BQNIITSRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>428.7333</moldb_average_mass>
		<moldb_mono_mass>428.401816286</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>775</id>
		<lmdb_id>LMDB00775</lmdb_id>
		<created_at>2016-07-30 18:17:54</created_at>
		<updated_at>2016-08-01 19:17:22</updated_at>
		<export>1</export>
		<name>17alpha-Estradiol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3</moldb_smiles>
		<moldb_formula>C18H24O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17-,18+/m1/s1</moldb_inchi>
		<moldb_inchikey>VOXZDWNPVJITMN-SFFUCWETSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>272.3820</moldb_average_mass>
		<moldb_mono_mass>272.177630012</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>776</id>
		<lmdb_id>LMDB00776</lmdb_id>
		<created_at>2016-07-30 18:17:56</created_at>
		<updated_at>2016-08-01 19:17:23</updated_at>
		<export>1</export>
		<name>Estrone sulfate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(OS(O)(=O)=O)=C4)[C@@H]1CCC2=O</moldb_smiles>
		<moldb_formula>C18H22O5S</moldb_formula>
		<moldb_inchi>InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1</moldb_inchi>
		<moldb_inchikey>JKKFKPJIXZFSSB-CBZIJGRNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>350.4290</moldb_average_mass>
		<moldb_mono_mass>350.118794504</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>777</id>
		<lmdb_id>LMDB00777</lmdb_id>
		<created_at>2016-07-30 18:17:57</created_at>
		<updated_at>2016-08-01 19:17:23</updated_at>
		<export>1</export>
		<name>Etiocholanolone glucuronide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@@H](CC[C@]12C)O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O</moldb_smiles>
		<moldb_formula>C25H38O8</moldb_formula>
		<moldb_inchi>InChI=1S/C25H38O8/c1-24-9-7-13(32-23-20(29)18(27)19(28)21(33-23)22(30)31)11-12(24)3-4-14-15-5-6-17(26)25(15,2)10-8-16(14)24/h12-16,18-21,23,27-29H,3-11H2,1-2H3,(H,30,31)/t12-,13-,14+,15+,16+,18+,19+,20-,21+,23-,24+,25+/m1/s1</moldb_inchi>
		<moldb_inchikey>VFUIRAVTUVCQTF-SDHZCXLISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>466.5644</moldb_average_mass>
		<moldb_mono_mass>466.256668192</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>778</id>
		<lmdb_id>LMDB00778</lmdb_id>
		<created_at>2016-07-30 18:17:59</created_at>
		<updated_at>2016-08-01 19:17:24</updated_at>
		<export>1</export>
		<name>N-Acetylgalactosamine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C8H15NO6</moldb_formula>
		<moldb_inchi>InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6+,7-,8+/m1/s1</moldb_inchi>
		<moldb_inchikey>OVRNDRQMDRJTHS-CBQIKETKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>221.2078</moldb_average_mass>
		<moldb_mono_mass>221.089937217</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>779</id>
		<lmdb_id>LMDB00779</lmdb_id>
		<created_at>2016-07-30 18:18:00</created_at>
		<updated_at>2016-08-02 20:15:18</updated_at>
		<export>1</export>
		<name>Beta-Glycerophosphoric acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC(CO)OP(O)(O)=O</moldb_smiles>
		<moldb_formula>C3H9O6P</moldb_formula>
		<moldb_inchi>InChI=1S/C3H9O6P/c4-1-3(2-5)9-10(6,7)8/h3-5H,1-2H2,(H2,6,7,8)</moldb_inchi>
		<moldb_inchikey>DHCLVCXQIBBOPH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>172.0737</moldb_average_mass>
		<moldb_mono_mass>172.013674532</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>780</id>
		<lmdb_id>LMDB00780</lmdb_id>
		<created_at>2016-07-30 18:18:01</created_at>
		<updated_at>2016-08-02 20:40:38</updated_at>
		<export>1</export>
		<name>SM(d18:0/16:1(9Z)(OH))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](COP([O-])(=O)OCC[N+](C)(C)C)NC(=O)CC(O)CCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C39H77N2O7P</moldb_formula>
		<moldb_inchi>InChI=1S/C39H77N2O7P/c1-6-8-10-12-14-16-18-19-21-23-25-27-29-31-38(43)37(35-48-49(45,46)47-33-32-41(3,4)5)40-39(44)34-36(42)30-28-26-24-22-20-17-15-13-11-9-7-2/h17,20,29,31,36-38,42-43H,6-16,18-19,21-28,30,32-35H2,1-5H3,(H-,40,44,45,46)/b20-17-,31-29+/t36?,37-,38+/m0/s1</moldb_inchi>
		<moldb_inchikey>LPHMSPONPQCKTL-FKUNDBCPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>717.0116</moldb_average_mass>
		<moldb_mono_mass>716.546839340</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>781</id>
		<lmdb_id>LMDB00781</lmdb_id>
		<created_at>2016-07-30 18:18:49</created_at>
		<updated_at>2016-08-02 20:15:37</updated_at>
		<export>1</export>
		<name>Hyodeoxycholic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](O)C2C[C@H](O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C24H40O4</moldb_formula>
		<moldb_inchi>InChI=1S/C24H40O4/c1-14(4-7-22(27)28)17-5-6-18-16-13-21(26)20-12-15(25)8-10-24(20,3)19(16)9-11-23(17,18)2/h14-21,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15-,16+,17-,18+,19+,20?,21+,23-,24-/m1/s1</moldb_inchi>
		<moldb_inchikey>DGABKXLVXPYZII-CDONHWFASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>392.5720</moldb_average_mass>
		<moldb_mono_mass>392.292659768</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>782</id>
		<lmdb_id>LMDB00782</lmdb_id>
		<created_at>2016-07-30 18:18:51</created_at>
		<updated_at>2016-08-01 19:17:27</updated_at>
		<export>1</export>
		<name>Inosinic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O</moldb_smiles>
		<moldb_formula>C10H13N4O8P</moldb_formula>
		<moldb_inchi>InChI=1S/C10H13N4O8P/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1</moldb_inchi>
		<moldb_inchikey>GRSZFWQUAKGDAV-KQYNXXCUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>348.2060</moldb_average_mass>
		<moldb_mono_mass>348.047099924</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>783</id>
		<lmdb_id>LMDB00783</lmdb_id>
		<created_at>2016-07-30 18:18:53</created_at>
		<updated_at>2016-08-01 19:17:27</updated_at>
		<export>1</export>
		<name>LysoPC(P-18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC\C=C/OC[C@](O)([H])COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C26H54NO6P</moldb_formula>
		<moldb_inchi>InChI=1S/C26H54NO6P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-22-31-24-26(28)25-33-34(29,30)32-23-21-27(2,3)4/h20,22,26,28H,5-19,21,23-25H2,1-4H3/b22-20-/t26-/m1/s1</moldb_inchi>
		<moldb_inchikey>WBOMIOWRFSPZMC-AYICAFKVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>507.6838</moldb_average_mass>
		<moldb_mono_mass>507.368874977</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>784</id>
		<lmdb_id>LMDB00784</lmdb_id>
		<created_at>2016-07-30 18:18:55</created_at>
		<updated_at>2016-08-01 19:17:28</updated_at>
		<export>1</export>
		<name>N-Acetylmannosamine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(O)O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1NC(C)=O</moldb_smiles>
		<moldb_formula>C8H15NO6</moldb_formula>
		<moldb_inchi>InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5+,6-,7-,8-/m1/s1</moldb_inchi>
		<moldb_inchikey>OVRNDRQMDRJTHS-OZRXBMAMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>221.2078</moldb_average_mass>
		<moldb_mono_mass>221.089937217</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>785</id>
		<lmdb_id>LMDB00785</lmdb_id>
		<created_at>2016-07-30 18:19:37</created_at>
		<updated_at>2016-08-08 18:36:27</updated_at>
		<export>1</export>
		<name>11Z-Octadecenylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCCCCCC(=O)O[C@H]([N+](C)(C)C)CCC([O-])=O</moldb_smiles>
		<moldb_formula>C25H47NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C25H47NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(26(2,3)4)21-22-24(27)28/h10-11,23H,5-9,12-22H2,1-4H3/b11-10-/t23-/m0/s1</moldb_inchi>
		<moldb_inchikey>HITOYGLMAFIRNI-JCKUYFFHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>425.6450</moldb_average_mass>
		<moldb_mono_mass>425.350508997</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>786</id>
		<lmdb_id>LMDB00786</lmdb_id>
		<created_at>2016-07-30 18:19:38</created_at>
		<updated_at>2016-08-02 20:15:37</updated_at>
		<export>1</export>
		<name>2-Oxovaleric acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCC(=O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H8O3</moldb_formula>
		<moldb_inchi>InChI=1S/C5H8O3/c1-2-3-4(6)5(7)8/h2-3H2,1H3,(H,7,8)</moldb_inchi>
		<moldb_inchikey>KDVFRMMRZOCFLS-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>116.1152</moldb_average_mass>
		<moldb_mono_mass>116.047344122</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>787</id>
		<lmdb_id>LMDB00787</lmdb_id>
		<created_at>2016-07-30 18:19:40</created_at>
		<updated_at>2016-08-01 19:17:28</updated_at>
		<export>1</export>
		<name>PC(14:0/16:1(9Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C38H74NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C38H74NO8P/c1-6-8-10-12-14-16-18-19-21-23-25-27-29-31-38(41)47-36(35-46-48(42,43)45-33-32-39(3,4)5)34-44-37(40)30-28-26-24-22-20-17-15-13-11-9-7-2/h16,18,36H,6-15,17,19-35H2,1-5H3/b18-16-/t36-/m1/s1</moldb_inchi>
		<moldb_inchikey>XGGMHQYOVYWRLV-IZNHTBNISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>703.9698</moldb_average_mass>
		<moldb_mono_mass>703.515204861</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>788</id>
		<lmdb_id>LMDB00788</lmdb_id>
		<created_at>2016-07-30 18:19:41</created_at>
		<updated_at>2016-08-01 19:17:29</updated_at>
		<export>1</export>
		<name>PC(14:0/20:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](COC(=O)CCCCCCCCCCCCC)(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C42H84NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C42H84NO8P/c1-6-8-10-12-14-16-18-19-20-21-22-23-25-27-29-31-33-35-42(45)51-40(39-50-52(46,47)49-37-36-43(3,4)5)38-48-41(44)34-32-30-28-26-24-17-15-13-11-9-7-2/h40H,6-39H2,1-5H3/t40-/m1/s1</moldb_inchi>
		<moldb_inchikey>VELOKQJUJJVGMB-RRHRGVEJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>762.0920</moldb_average_mass>
		<moldb_mono_mass>761.593455181</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>789</id>
		<lmdb_id>LMDB00789</lmdb_id>
		<created_at>2016-07-30 18:19:43</created_at>
		<updated_at>2016-08-01 19:17:29</updated_at>
		<export>1</export>
		<name>PC(14:1(9Z)/24:1(15Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCC\C=C/CCCCCCCCCCCCCC(=O)O[C@]([H])(COC(=O)CCCCCCC\C=C/CCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C46H88NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C46H88NO8P/c1-6-8-10-12-14-16-18-19-20-21-22-23-24-25-26-27-29-31-33-35-37-39-46(49)55-44(43-54-56(50,51)53-41-40-47(3,4)5)42-52-45(48)38-36-34-32-30-28-17-15-13-11-9-7-2/h13,15,19-20,44H,6-12,14,16-18,21-43H2,1-5H3/b15-13-,20-19-/t44-/m1/s1</moldb_inchi>
		<moldb_inchikey>ODKRDLFMXDISEG-BERHWORVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>814.1666</moldb_average_mass>
		<moldb_mono_mass>813.624755309</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>790</id>
		<lmdb_id>LMDB00790</lmdb_id>
		<created_at>2016-07-30 18:19:44</created_at>
		<updated_at>2016-08-01 19:17:31</updated_at>
		<export>1</export>
		<name>2,3,4,5-Tetrahydroxypentanoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC(O)C(O)C(O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H10O6</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O6/c6-1-2(7)3(8)4(9)5(10)11/h2-4,6-9H,1H2,(H,10,11)</moldb_inchi>
		<moldb_inchikey>QXKAIJAYHKCRRA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>166.1293</moldb_average_mass>
		<moldb_mono_mass>166.047738052</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>791</id>
		<lmdb_id>LMDB00791</lmdb_id>
		<created_at>2016-07-30 18:19:46</created_at>
		<updated_at>2018-04-30 21:15:04</updated_at>
		<export>1</export>
		<name>All-trans-retinoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O</moldb_smiles>
		<moldb_formula>C20H28O2</moldb_formula>
		<moldb_inchi>InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+</moldb_inchi>
		<moldb_inchikey>SHGAZHPCJJPHSC-YCNIQYBTSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>300.4420</moldb_average_mass>
		<moldb_mono_mass>300.208930142</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>792</id>
		<lmdb_id>LMDB00792</lmdb_id>
		<created_at>2016-07-30 18:19:47</created_at>
		<updated_at>2016-08-02 20:15:38</updated_at>
		<export>1</export>
		<name>D-Ribose 5-phosphate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C5H11O8P</moldb_formula>
		<moldb_inchi>InChI=1S/C5H11O8P/c6-3-2(1-12-14(9,10)11)13-5(8)4(3)7/h2-8H,1H2,(H2,9,10,11)/t2-,3-,4-,5?/m1/s1</moldb_inchi>
		<moldb_inchikey>KTVPXOYAKDPRHY-SOOFDHNKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>230.1098</moldb_average_mass>
		<moldb_mono_mass>230.019153840</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>793</id>
		<lmdb_id>LMDB00793</lmdb_id>
		<created_at>2016-07-30 18:19:49</created_at>
		<updated_at>2016-08-02 20:40:39</updated_at>
		<export>1</export>
		<name>SM(d18:1/24:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@]([H])(COP(O)(=O)OCC[N+](C)(C)C)[C@]([H])(O)\C=C\CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C47H96N2O6P</moldb_formula>
		<moldb_inchi>InChI=1S/C47H95N2O6P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-26-27-29-31-33-35-37-39-41-47(51)48-45(44-55-56(52,53)54-43-42-49(3,4)5)46(50)40-38-36-34-32-30-28-19-17-15-13-11-9-7-2/h38,40,45-46,50H,6-37,39,41-44H2,1-5H3,(H-,48,51,52,53)/p+1/b40-38+/t45-,46+/m0/s1</moldb_inchi>
		<moldb_inchikey>QEDPUVGSSDPBMD-XTAIVQBESA-O</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>816.2487</moldb_average_mass>
		<moldb_mono_mass>815.700600326</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>794</id>
		<lmdb_id>LMDB00794</lmdb_id>
		<created_at>2016-07-30 18:19:51</created_at>
		<updated_at>2016-08-01 19:17:33</updated_at>
		<export>1</export>
		<name>SM(d18:1/26:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@]([H])(COP(O)(=O)OCC[N+](C)(C)C)[C@]([H])(O)\C=C\CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C49H100N2O6P</moldb_formula>
		<moldb_inchi>InChI=1S/C49H99N2O6P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-26-27-28-29-31-33-35-37-39-41-43-49(53)50-47(46-57-58(54,55)56-45-44-51(3,4)5)48(52)42-40-38-36-34-32-30-19-17-15-13-11-9-7-2/h40,42,47-48,52H,6-39,41,43-46H2,1-5H3,(H-,50,53,54,55)/p+1/b42-40+/t47-,48+/m0/s1</moldb_inchi>
		<moldb_inchikey>VRAWSAPVSSLIRI-MVUJCARGSA-O</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>844.3019</moldb_average_mass>
		<moldb_mono_mass>843.731900454</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>795</id>
		<lmdb_id>LMDB00795</lmdb_id>
		<created_at>2016-07-30 18:19:52</created_at>
		<updated_at>2016-08-01 19:17:34</updated_at>
		<export>1</export>
		<name>Testosterone glucuronide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H](O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C25H36O8</moldb_formula>
		<moldb_inchi>InChI=1S/C25H36O8/c1-24-9-7-13(26)11-12(24)3-4-14-15-5-6-17(25(15,2)10-8-16(14)24)32-23-20(29)18(27)19(28)21(33-23)22(30)31/h11,14-21,23,27-29H,3-10H2,1-2H3,(H,30,31)/t14-,15-,16-,17-,18-,19-,20+,21-,23+,24-,25-/m0/s1</moldb_inchi>
		<moldb_inchikey>NIKZPECGCSUSBV-HMAFJQTKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>464.5485</moldb_average_mass>
		<moldb_mono_mass>464.241018128</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>796</id>
		<lmdb_id>LMDB00796</lmdb_id>
		<created_at>2016-07-30 18:20:00</created_at>
		<updated_at>2016-08-01 19:17:34</updated_at>
		<export>1</export>
		<name>Testosterone sulfate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H](OS(O)(=O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C19H28O5S</moldb_formula>
		<moldb_inchi>InChI=1S/C19H28O5S/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(24-25(21,22)23)19(15,2)10-8-16(14)18/h11,14-17H,3-10H2,1-2H3,(H,21,22,23)/t14-,15-,16-,17-,18-,19-/m0/s1</moldb_inchi>
		<moldb_inchikey>WAQBISPOEAOCOG-DYKIIFRCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>368.4880</moldb_average_mass>
		<moldb_mono_mass>368.165744696</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>797</id>
		<lmdb_id>LMDB00797</lmdb_id>
		<created_at>2016-07-30 18:20:01</created_at>
		<updated_at>2016-07-30 18:20:02</updated_at>
		<export>1</export>
		<name>trans-Tetra-dec-2-enoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>0</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCC\C=C\C(O)=O</moldb_smiles>
		<moldb_formula>C14H26O2</moldb_formula>
		<moldb_inchi>InChI=1S/C14H26O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h12-13H,2-11H2,1H3,(H,15,16)/b13-12+</moldb_inchi>
		<moldb_inchikey>IBYFOBGPNPINBU-OUKQBFOZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>226.3550</moldb_average_mass>
		<moldb_mono_mass>226.193280076</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>813</id>
		<lmdb_id>LMDB00813</lmdb_id>
		<created_at>2016-07-30 18:50:33</created_at>
		<updated_at>2016-08-01 19:17:35</updated_at>
		<export>1</export>
		<name>TG(14:0/15:0/18:1(11Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCC\C=C/CCCCCC</moldb_smiles>
		<moldb_formula>C50H94O6</moldb_formula>
		<moldb_inchi>InChI=1S/C50H94O6/c1-4-7-10-13-16-19-22-24-25-26-29-31-34-37-40-43-49(52)55-46-47(45-54-48(51)42-39-36-33-30-27-21-18-15-12-9-6-3)56-50(53)44-41-38-35-32-28-23-20-17-14-11-8-5-2/h19,22,47H,4-18,20-21,23-46H2,1-3H3/b22-19-</moldb_inchi>
		<moldb_inchikey>ZRADZZUWHHIFJP-QOCHGBHMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>791.2778</moldb_average_mass>
		<moldb_mono_mass>790.705040740</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>814</id>
		<lmdb_id>LMDB00814</lmdb_id>
		<created_at>2016-07-30 18:50:35</created_at>
		<updated_at>2016-08-01 19:17:36</updated_at>
		<export>1</export>
		<name>TG(14:0/16:0/20:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C53H102O6</moldb_formula>
		<moldb_inchi>InChI=1S/C53H102O6/c1-4-7-10-13-16-19-22-24-25-26-27-29-31-34-37-40-43-46-52(55)58-49-50(48-57-51(54)45-42-39-36-33-30-21-18-15-12-9-6-3)59-53(56)47-44-41-38-35-32-28-23-20-17-14-11-8-5-2/h50H,4-49H2,1-3H3</moldb_inchi>
		<moldb_inchikey>VGEMNMJCWPDGJU-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>835.3734</moldb_average_mass>
		<moldb_mono_mass>834.767640996</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>815</id>
		<lmdb_id>LMDB00815</lmdb_id>
		<created_at>2016-07-30 18:55:44</created_at>
		<updated_at>2016-08-01 19:17:36</updated_at>
		<export>1</export>
		<name>(+)-12-Methyltetradecanoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC(C)CCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C15H30O2</moldb_formula>
		<moldb_inchi>InChI=1S/C15H30O2/c1-3-14(2)12-10-8-6-4-5-7-9-11-13-15(16)17/h14H,3-13H2,1-2H3,(H,16,17)</moldb_inchi>
		<moldb_inchikey>XKLJLHAPJBUBNL-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>242.4030</moldb_average_mass>
		<moldb_mono_mass>242.224580206</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>816</id>
		<lmdb_id>LMDB00816</lmdb_id>
		<created_at>2016-07-30 18:55:46</created_at>
		<updated_at>2016-08-01 19:17:37</updated_at>
		<export>1</export>
		<name>(+)-Eudesmin</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]12CO[C@]([H])(C3=CC(OC)=C(OC)C=C3)[C@@]1([H])CO[C@]2([H])C1=CC(OC)=C(OC)C=C1</moldb_smiles>
		<moldb_formula>C22H26O6</moldb_formula>
		<moldb_inchi>InChI=1S/C22H26O6/c1-23-17-7-5-13(9-19(17)25-3)21-15-11-28-22(16(15)12-27-21)14-6-8-18(24-2)20(10-14)26-4/h5-10,15-16,21-22H,11-12H2,1-4H3/t15-,16-,21+,22+/m0/s1</moldb_inchi>
		<moldb_inchikey>PEUUVVGQIVMSAW-RZTYQLBFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>386.4440</moldb_average_mass>
		<moldb_mono_mass>386.172938557</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>817</id>
		<lmdb_id>LMDB00817</lmdb_id>
		<created_at>2016-07-30 18:55:48</created_at>
		<updated_at>2016-08-01 19:17:38</updated_at>
		<export>1</export>
		<name>(E)-2-Nonen-1-ol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C\CO</moldb_smiles>
		<moldb_formula>C9H18O</moldb_formula>
		<moldb_inchi>InChI=1S/C9H18O/c1-2-3-4-5-6-7-8-9-10/h7-8,10H,2-6,9H2,1H3/b8-7+</moldb_inchi>
		<moldb_inchikey>NSSALFVIQPAIQK-BQYQJAHWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>142.2386</moldb_average_mass>
		<moldb_mono_mass>142.135765198</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>818</id>
		<lmdb_id>LMDB00818</lmdb_id>
		<created_at>2016-07-30 18:57:09</created_at>
		<updated_at>2016-08-01 19:17:39</updated_at>
		<export>1</export>
		<name>(E)-4-Octene</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCC)=C(\[H])CCC</moldb_smiles>
		<moldb_formula>C8H16</moldb_formula>
		<moldb_inchi>InChI=1S/C8H16/c1-3-5-7-8-6-4-2/h7-8H,3-6H2,1-2H3/b8-7+</moldb_inchi>
		<moldb_inchikey>IRUCBBFNLDIMIK-BQYQJAHWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>112.2160</moldb_average_mass>
		<moldb_mono_mass>112.125200515</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>819</id>
		<lmdb_id>LMDB00819</lmdb_id>
		<created_at>2016-07-30 18:57:11</created_at>
		<updated_at>2016-08-02 20:15:39</updated_at>
		<export>1</export>
		<name>1,2-Dipalmitoylglycerol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C35H68O5</moldb_formula>
		<moldb_inchi>InChI=1S/C35H68O5/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-34(37)39-32-33(31-36)40-35(38)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h33,36H,3-32H2,1-2H3</moldb_inchi>
		<moldb_inchikey>JEJLGIQLPYYGEE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>568.9114</moldb_average_mass>
		<moldb_mono_mass>568.506675286</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>820</id>
		<lmdb_id>LMDB00820</lmdb_id>
		<created_at>2016-07-30 18:57:12</created_at>
		<updated_at>2016-08-01 19:17:40</updated_at>
		<export>1</export>
		<name>1,2,3-Trihydroxybutane</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(O)C(O)CO</moldb_smiles>
		<moldb_formula>C4H10O3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H10O3/c1-3(6)4(7)2-5/h3-7H,2H2,1H3</moldb_inchi>
		<moldb_inchikey>YAXKTBLXMTYWDQ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>106.1204</moldb_average_mass>
		<moldb_mono_mass>106.062994186</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>821</id>
		<lmdb_id>LMDB00821</lmdb_id>
		<created_at>2016-07-30 18:57:13</created_at>
		<updated_at>2016-08-01 19:17:40</updated_at>
		<export>1</export>
		<name>1,2,4-Benzenetriol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1=CC(O)=C(O)C=C1</moldb_smiles>
		<moldb_formula>C6H6O3</moldb_formula>
		<moldb_inchi>InChI=1S/C6H6O3/c7-4-1-2-5(8)6(9)3-4/h1-3,7-9H</moldb_inchi>
		<moldb_inchikey>GGNQRNBDZQJCCN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>126.1100</moldb_average_mass>
		<moldb_mono_mass>126.031694058</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>822</id>
		<lmdb_id>LMDB00822</lmdb_id>
		<created_at>2016-07-30 18:57:15</created_at>
		<updated_at>2016-08-01 19:17:41</updated_at>
		<export>1</export>
		<name>10-Deacetyl-2-debenzoylbaccatin III</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12C[C@]([H])(O)[C@@]3(C)C(=O)[C@]([H])(O)C4=C(C)[C@@]([H])(O)C[C@@](O)([C@@]([H])(O)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C</moldb_smiles>
		<moldb_formula>C22H32O9</moldb_formula>
		<moldb_inchi>InChI=1S/C22H32O9/c1-9-11(24)7-22(29)18(28)16-20(5,17(27)15(26)14(9)19(22,3)4)12(25)6-13-21(16,8-30-13)31-10(2)23/h11-13,15-16,18,24-26,28-29H,6-8H2,1-5H3/t11-,12-,13+,15+,16-,18-,20+,21-,22+/m0/s1</moldb_inchi>
		<moldb_inchikey>LHXBWTCSJBQSGI-QOBCYHTASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>440.4890</moldb_average_mass>
		<moldb_mono_mass>440.204632610</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>823</id>
		<lmdb_id>LMDB00823</lmdb_id>
		<created_at>2016-07-30 18:57:17</created_at>
		<updated_at>2016-08-01 19:17:41</updated_at>
		<export>1</export>
		<name>10-Hydroxydecanoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C10H20O3</moldb_formula>
		<moldb_inchi>InChI=1S/C10H20O3/c11-9-7-5-3-1-2-4-6-8-10(12)13/h11H,1-9H2,(H,12,13)</moldb_inchi>
		<moldb_inchikey>YJCJVMMDTBEITC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>188.2670</moldb_average_mass>
		<moldb_mono_mass>188.141244504</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>824</id>
		<lmdb_id>LMDB00824</lmdb_id>
		<created_at>2016-07-30 18:57:19</created_at>
		<updated_at>2016-08-01 19:17:42</updated_at>
		<export>1</export>
		<name>11-Methyldodecanoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)CCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C13H26O2</moldb_formula>
		<moldb_inchi>InChI=1S/C13H26O2/c1-12(2)10-8-6-4-3-5-7-9-11-13(14)15/h12H,3-11H2,1-2H3,(H,14,15)</moldb_inchi>
		<moldb_inchikey>SIOLDWZBFABPJU-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>214.3490</moldb_average_mass>
		<moldb_mono_mass>214.193280077</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>825</id>
		<lmdb_id>LMDB00825</lmdb_id>
		<created_at>2016-07-30 18:57:21</created_at>
		<updated_at>2016-08-01 19:17:43</updated_at>
		<export>1</export>
		<name>15-Methylhexadecanoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)CCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C17H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C17H34O2/c1-16(2)14-12-10-8-6-4-3-5-7-9-11-13-15-17(18)19/h16H,3-15H2,1-2H3,(H,18,19)</moldb_inchi>
		<moldb_inchikey>IIUXHTGBZYEGHI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>270.4570</moldb_average_mass>
		<moldb_mono_mass>270.255880335</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>826</id>
		<lmdb_id>LMDB00826</lmdb_id>
		<created_at>2016-07-30 18:57:22</created_at>
		<updated_at>2016-08-01 19:17:43</updated_at>
		<export>1</export>
		<name>17alpha-Estradiol 3-sulphate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OS(O)(=O)=O)=CC=C4[C@@]3([H])CC[C@]12C</moldb_smiles>
		<moldb_formula>C18H24O5S</moldb_formula>
		<moldb_inchi>InChI=1S/C18H24O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-17,19H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,17+,18+/m1/s1</moldb_inchi>
		<moldb_inchikey>QZIGLSSUDXBTLJ-ZBRFXRBCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>352.4500</moldb_average_mass>
		<moldb_mono_mass>352.134445047</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>827</id>
		<lmdb_id>LMDB00827</lmdb_id>
		<created_at>2016-07-30 18:57:24</created_at>
		<updated_at>2016-08-01 19:17:44</updated_at>
		<export>1</export>
		<name>2-Butyl-thiophene</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC1=CC=CS1</moldb_smiles>
		<moldb_formula>C8H12S</moldb_formula>
		<moldb_inchi>InChI=1S/C8H12S/c1-2-3-5-8-6-4-7-9-8/h4,6-7H,2-3,5H2,1H3</moldb_inchi>
		<moldb_inchikey>MNDZHERKKXUTOE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>140.2400</moldb_average_mass>
		<moldb_mono_mass>140.065971560</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>828</id>
		<lmdb_id>LMDB00828</lmdb_id>
		<created_at>2016-07-30 18:57:26</created_at>
		<updated_at>2016-08-01 19:17:45</updated_at>
		<export>1</export>
		<name>2-Ethyl-1-Hexanol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC(CC)CO</moldb_smiles>
		<moldb_formula>C8H18O</moldb_formula>
		<moldb_inchi>InChI=1S/C8H18O/c1-3-5-6-8(4-2)7-9/h8-9H,3-7H2,1-2H3</moldb_inchi>
		<moldb_inchikey>YIWUKEYIRIRTPP-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>130.2279</moldb_average_mass>
		<moldb_mono_mass>130.135765198</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>829</id>
		<lmdb_id>LMDB00829</lmdb_id>
		<created_at>2016-07-30 18:57:28</created_at>
		<updated_at>2016-08-01 19:17:46</updated_at>
		<export>1</export>
		<name>2-Ethyl-N-(2-ethylhexyl)-N-methyl-1-hexanamine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC(CC)CN(C)CC(CC)CCCC</moldb_smiles>
		<moldb_formula>C17H37N</moldb_formula>
		<moldb_inchi>InChI=1S/C17H37N/c1-6-10-12-16(8-3)14-18(5)15-17(9-4)13-11-7-2/h16-17H,6-15H2,1-5H3</moldb_inchi>
		<moldb_inchikey>VPCAZZICACQNKZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>255.4900</moldb_average_mass>
		<moldb_mono_mass>255.292600195</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>830</id>
		<lmdb_id>LMDB00830</lmdb_id>
		<created_at>2016-07-30 18:57:33</created_at>
		<updated_at>2016-08-01 19:17:47</updated_at>
		<export>1</export>
		<name>2-Imino-4(5H)-thiazolone</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N</moldb_smiles>
		<moldb_formula>C17H19N5</moldb_formula>
		<moldb_inchi>InChI=1S/C17H19N5/c1-16(2,9-18)14-5-13(8-22-12-20-11-21-22)6-15(7-14)17(3,4)10-19/h5-7,11-12H,8H2,1-4H3</moldb_inchi>
		<moldb_inchikey>YBBLVLTVTVSKRW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>293.3663</moldb_average_mass>
		<moldb_mono_mass>293.164045633</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>831</id>
		<lmdb_id>LMDB00831</lmdb_id>
		<created_at>2016-07-30 18:57:36</created_at>
		<updated_at>2016-08-01 19:17:47</updated_at>
		<export>1</export>
		<name>2-Keto-D-gluconic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)C(=O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H10O7</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-4,7-10H,1H2,(H,12,13)/t2-,3-,4+/m1/s1</moldb_inchi>
		<moldb_inchikey>VBUYCZFBVCCYFD-JJYYJPOSSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>194.1394</moldb_average_mass>
		<moldb_mono_mass>194.042652674</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>832</id>
		<lmdb_id>LMDB00832</lmdb_id>
		<created_at>2016-07-30 18:57:38</created_at>
		<updated_at>2016-08-01 19:17:48</updated_at>
		<export>1</export>
		<name>2-Methoxyestradiol-17beta 3-sulfate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OS(O)(=O)=O)=C(OC)C=C4[C@@]3([H])CC[C@]12C</moldb_smiles>
		<moldb_formula>C19H26O6S</moldb_formula>
		<moldb_inchi>InChI=1S/C19H26O6S/c1-19-8-7-12-13(15(19)5-6-18(19)20)4-3-11-9-17(25-26(21,22)23)16(24-2)10-14(11)12/h9-10,12-13,15,18,20H,3-8H2,1-2H3,(H,21,22,23)/t12-,13+,15-,18-,19-/m0/s1</moldb_inchi>
		<moldb_inchikey>HKVMUVAMCRTTDB-SSTWWWIQSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>382.4700</moldb_average_mass>
		<moldb_mono_mass>382.145009731</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>833</id>
		<lmdb_id>LMDB00833</lmdb_id>
		<created_at>2016-07-30 18:57:40</created_at>
		<updated_at>2016-08-01 19:17:49</updated_at>
		<export>1</export>
		<name>2-Methyl-1(2H)-isoquinolinone</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN1C=CC2=CC=CC=C2C1=O</moldb_smiles>
		<moldb_formula>C10H9NO</moldb_formula>
		<moldb_inchi>InChI=1S/C10H9NO/c1-11-7-6-8-4-2-3-5-9(8)10(11)12/h2-7H,1H3</moldb_inchi>
		<moldb_inchikey>YJRMHIKEMDTYDR-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>159.1880</moldb_average_mass>
		<moldb_mono_mass>159.068413914</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>834</id>
		<lmdb_id>LMDB00834</lmdb_id>
		<created_at>2016-07-30 18:57:41</created_at>
		<updated_at>2016-08-01 19:17:50</updated_at>
		<export>1</export>
		<name>2-Methyl-2-butenedioic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C\C(=C\C(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C5H6O4</moldb_formula>
		<moldb_inchi>InChI=1S/C5H6O4/c1-3(5(8)9)2-4(6)7/h2H,1H3,(H,6,7)(H,8,9)/b3-2-</moldb_inchi>
		<moldb_inchikey>HNEGQIOMVPPMNR-IHWYPQMZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>130.0987</moldb_average_mass>
		<moldb_mono_mass>130.026608680</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>835</id>
		<lmdb_id>LMDB00835</lmdb_id>
		<created_at>2016-07-30 18:57:43</created_at>
		<updated_at>2016-08-02 20:15:39</updated_at>
		<export>1</export>
		<name>2-Methylbutyrate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC(C)C([O-])=O</moldb_smiles>
		<moldb_formula>C5H9O2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O2/c1-3-4(2)5(6)7/h4H,3H2,1-2H3,(H,6,7)/p-1</moldb_inchi>
		<moldb_inchikey>WLAMNBDJUVNPJU-UHFFFAOYSA-M</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>101.1260</moldb_average_mass>
		<moldb_mono_mass>101.060803110</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>836</id>
		<lmdb_id>LMDB00836</lmdb_id>
		<created_at>2016-07-30 18:57:44</created_at>
		<updated_at>2016-08-01 19:17:51</updated_at>
		<export>1</export>
		<name>2-Monoolein</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]C(CO)(CO)OC(=O)CCCCCCC\C=C/CCCCCCCC</moldb_smiles>
		<moldb_formula>C21H40O4</moldb_formula>
		<moldb_inchi>InChI=1S/C21H40O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-20(18-22)19-23/h9-10,20,22-23H,2-8,11-19H2,1H3/b10-9-</moldb_inchi>
		<moldb_inchikey>UPWGQKDVAURUGE-KTKRTIGZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>356.5399</moldb_average_mass>
		<moldb_mono_mass>356.292659768</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>837</id>
		<lmdb_id>LMDB00837</lmdb_id>
		<created_at>2016-07-30 18:57:52</created_at>
		<updated_at>2016-08-01 19:17:52</updated_at>
		<export>1</export>
		<name>2-Undecyne</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCC#CC</moldb_smiles>
		<moldb_formula>C11H20</moldb_formula>
		<moldb_inchi>InChI=1S/C11H20/c1-3-5-7-9-11-10-8-6-4-2/h3,5,7-11H2,1-2H3</moldb_inchi>
		<moldb_inchikey>XZSXEDPHMIFYOS-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>152.2810</moldb_average_mass>
		<moldb_mono_mass>152.156500644</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>838</id>
		<lmdb_id>LMDB00838</lmdb_id>
		<created_at>2016-07-30 18:57:53</created_at>
		<updated_at>2016-08-01 19:17:52</updated_at>
		<export>1</export>
		<name>2,2-bis(Hydroxymethyl)propionic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(CO)(CO)C(O)=O</moldb_smiles>
		<moldb_formula>C5H10O4</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O4/c1-5(2-6,3-7)4(8)9/h6-7H,2-3H2,1H3,(H,8,9)</moldb_inchi>
		<moldb_inchikey>PTBDIHRZYDMNKB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>134.1310</moldb_average_mass>
		<moldb_mono_mass>134.057908802</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>839</id>
		<lmdb_id>LMDB00839</lmdb_id>
		<created_at>2016-07-30 18:57:55</created_at>
		<updated_at>2016-08-01 19:17:53</updated_at>
		<export>1</export>
		<name>2,2,2-Trifluoro-N-methylacetamide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN=C(O)C(F)(F)F</moldb_smiles>
		<moldb_formula>C3H4F3NO</moldb_formula>
		<moldb_inchi>InChI=1S/C3H4F3NO/c1-7-2(8)3(4,5)6/h1H3,(H,7,8)</moldb_inchi>
		<moldb_inchikey>IQNHBUQSOSYAJU-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>127.0660</moldb_average_mass>
		<moldb_mono_mass>127.024498242</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>840</id>
		<lmdb_id>LMDB00840</lmdb_id>
		<created_at>2016-07-30 18:57:57</created_at>
		<updated_at>2016-08-01 19:17:54</updated_at>
		<export>1</export>
		<name>2,3-Dihydroxyindole</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1=C(O)C2=CC=CC=C2N1</moldb_smiles>
		<moldb_formula>C8H7NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C8H7NO2/c10-7-5-3-1-2-4-6(5)9-8(7)11/h1-4,9-11H</moldb_inchi>
		<moldb_inchikey>PGNRLPTYNKQQDY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>149.1490</moldb_average_mass>
		<moldb_mono_mass>149.047678469</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>841</id>
		<lmdb_id>LMDB00841</lmdb_id>
		<created_at>2016-07-30 18:57:59</created_at>
		<updated_at>2016-08-01 19:17:55</updated_at>
		<export>1</export>
		<name>2,5-Dihydroxypyrazine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1=CNC(=O)C=N1</moldb_smiles>
		<moldb_formula>C4H4N2O2</moldb_formula>
		<moldb_inchi>InChI=1S/C4H4N2O2/c7-3-1-5-4(8)2-6-3/h1-2H,(H,5,8)(H,6,7)</moldb_inchi>
		<moldb_inchikey>USHRADXTTYICIJ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>112.0880</moldb_average_mass>
		<moldb_mono_mass>112.027277377</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>842</id>
		<lmdb_id>LMDB00842</lmdb_id>
		<created_at>2016-07-30 18:58:00</created_at>
		<updated_at>2016-08-01 19:17:56</updated_at>
		<export>1</export>
		<name>3-4-Diethylamino-1-methylbutylamino]-1-methoxynaphthalene</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCC1=CNC=N1</moldb_smiles>
		<moldb_formula>C5H9N3</moldb_formula>
		<moldb_inchi>InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)</moldb_inchi>
		<moldb_inchikey>NTYJJOPFIAHURM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>111.1451</moldb_average_mass>
		<moldb_mono_mass>111.079647303</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>843</id>
		<lmdb_id>LMDB00843</lmdb_id>
		<created_at>2016-07-30 18:58:03</created_at>
		<updated_at>2016-08-02 20:40:40</updated_at>
		<export>1</export>
		<name>3-Hydroxyoleoylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCCCCC)=C(/[H])CCCCCC(O)CC(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C25H47NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C25H47NO5/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-22(27)19-25(30)31-23(20-24(28)29)21-26(2,3)4/h12-13,22-23,27H,5-11,14-21H2,1-4H3/b13-12-</moldb_inchi>
		<moldb_inchikey>YBCVTTMMURGSEY-SEYXRHQNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>441.6530</moldb_average_mass>
		<moldb_mono_mass>441.345423617</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>844</id>
		<lmdb_id>LMDB00844</lmdb_id>
		<created_at>2016-07-30 18:58:04</created_at>
		<updated_at>2016-08-01 19:17:58</updated_at>
		<export>1</export>
		<name>3,4,5-Trimethoxy-trans-cinnamic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>COC1=CC(\C=C\C(O)=O)=CC(OC)=C1OC</moldb_smiles>
		<moldb_formula>C12H14O5</moldb_formula>
		<moldb_inchi>InChI=1S/C12H14O5/c1-15-9-6-8(4-5-11(13)14)7-10(16-2)12(9)17-3/h4-7H,1-3H3,(H,13,14)/b5-4+</moldb_inchi>
		<moldb_inchikey>YTFVRYKNXDADBI-SNAWJCMRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>238.2366</moldb_average_mass>
		<moldb_mono_mass>238.084123558</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>845</id>
		<lmdb_id>LMDB00845</lmdb_id>
		<created_at>2016-07-30 18:58:06</created_at>
		<updated_at>2016-08-02 20:15:40</updated_at>
		<export>1</export>
		<name>3beta-Hydroxychol-4-en-24-oic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])CCC4=C[C@@]([H])(O)CC[C@]4(C)[C@@]3([H])CC[C@]12C</moldb_smiles>
		<moldb_formula>C24H38O3</moldb_formula>
		<moldb_inchi>InChI=1S/C24H38O3/c1-15(4-9-22(26)27)19-7-8-20-18-6-5-16-14-17(25)10-12-23(16,2)21(18)11-13-24(19,20)3/h14-15,17-21,25H,4-13H2,1-3H3,(H,26,27)/t15-,17+,18+,19-,20+,21+,23+,24-/m1/s1</moldb_inchi>
		<moldb_inchikey>PBEOKCZYNAQOKE-QIZZZRFXSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>374.5650</moldb_average_mass>
		<moldb_mono_mass>374.282095084</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>846</id>
		<lmdb_id>LMDB00846</lmdb_id>
		<created_at>2016-07-30 18:58:07</created_at>
		<updated_at>2016-08-01 19:17:58</updated_at>
		<export>1</export>
		<name>4-(Methylamino)benzoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CNC1=CC=C(C=C1)C(O)=O</moldb_smiles>
		<moldb_formula>C8H9NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C8H9NO2/c1-9-7-4-2-6(3-5-7)8(10)11/h2-5,9H,1H3,(H,10,11)</moldb_inchi>
		<moldb_inchikey>ZVIDMSBTYRSMAR-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>151.1626</moldb_average_mass>
		<moldb_mono_mass>151.063328537</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>847</id>
		<lmdb_id>LMDB00847</lmdb_id>
		<created_at>2016-07-30 18:58:09</created_at>
		<updated_at>2016-08-01 19:17:59</updated_at>
		<export>1</export>
		<name>4-Hydroxyphenyl-beta-glucopyranoside</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]1(CO)O[C@@]([H])(OC2=CC=C(O)C=C2)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O</moldb_smiles>
		<moldb_formula>C12H16O7</moldb_formula>
		<moldb_inchi>InChI=1S/C12H16O7/c13-5-8-9(15)10(16)11(17)12(19-8)18-7-3-1-6(14)2-4-7/h1-4,8-17H,5H2/t8-,9-,10+,11-,12-/m1/s1</moldb_inchi>
		<moldb_inchikey>BJRNKVDFDLYUGJ-RMPHRYRLSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>272.2512</moldb_average_mass>
		<moldb_mono_mass>272.089602866</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>848</id>
		<lmdb_id>LMDB00848</lmdb_id>
		<created_at>2016-07-30 18:58:11</created_at>
		<updated_at>2016-08-01 19:18:00</updated_at>
		<export>1</export>
		<name>4-Methyldodecane</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCC(C)CCC</moldb_smiles>
		<moldb_formula>C13H28</moldb_formula>
		<moldb_inchi>InChI=1S/C13H28/c1-4-6-7-8-9-10-12-13(3)11-5-2/h13H,4-12H2,1-3H3</moldb_inchi>
		<moldb_inchikey>UZTXSMATBUWDDZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>184.3670</moldb_average_mass>
		<moldb_mono_mass>184.219100902</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>849</id>
		<lmdb_id>LMDB00849</lmdb_id>
		<created_at>2016-07-30 18:58:13</created_at>
		<updated_at>2016-08-01 19:18:00</updated_at>
		<export>1</export>
		<name>4-Pyrimidinamine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1=CC=NC=N1</moldb_smiles>
		<moldb_formula>C4H5N3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H5N3/c5-4-1-2-6-3-7-4/h1-3H,(H2,5,6,7)</moldb_inchi>
		<moldb_inchikey>OYRRZWATULMEPF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>95.1050</moldb_average_mass>
		<moldb_mono_mass>95.048347173</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>850</id>
		<lmdb_id>LMDB00850</lmdb_id>
		<created_at>2016-07-30 18:58:14</created_at>
		<updated_at>2016-08-01 19:18:01</updated_at>
		<export>1</export>
		<name>4-Sulfobenzyl alcohol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC1=CC=C(C=C1)S(O)(=O)=O</moldb_smiles>
		<moldb_formula>C7H8O4S</moldb_formula>
		<moldb_inchi>InChI=1S/C7H8O4S/c8-5-6-1-3-7(4-2-6)12(9,10)11/h1-4,8H,5H2,(H,9,10,11)</moldb_inchi>
		<moldb_inchikey>VVQVMHASNBSOOC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>188.2000</moldb_average_mass>
		<moldb_mono_mass>188.014329912</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>851</id>
		<lmdb_id>LMDB00851</lmdb_id>
		<created_at>2016-07-30 18:58:16</created_at>
		<updated_at>2016-08-02 20:15:40</updated_at>
		<export>1</export>
		<name>4,8,12,15,19,21-Tetracosahexaenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CC\C([H])=C(/[H])CCC(O)=O)=C(\[H])CC\C([H])=C(/[H])C\C([H])=C(/[H])CC\C([H])=C(/[H])\C(\[H])=C(/[H])CC</moldb_smiles>
		<moldb_formula>C24H36O2</moldb_formula>
		<moldb_inchi>InChI=1S/C24H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26/h3-6,9-10,12-13,16-17,20-21H,2,7-8,11,14-15,18-19,22-23H2,1H3,(H,25,26)/b4-3+,6-5+,10-9+,13-12+,17-16+,21-20+</moldb_inchi>
		<moldb_inchikey>VIEVDWQLJOPJTP-FWMXRSOJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>356.5500</moldb_average_mass>
		<moldb_mono_mass>356.271530399</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>852</id>
		<lmdb_id>LMDB00852</lmdb_id>
		<created_at>2016-07-30 18:58:18</created_at>
		<updated_at>2016-08-01 19:18:01</updated_at>
		<export>1</export>
		<name>5-Hydroxynorvaline</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CCCO)C(O)=O</moldb_smiles>
		<moldb_formula>C5H11NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C5H11NO3/c6-4(5(8)9)2-1-3-7/h4,7H,1-3,6H2,(H,8,9)/t4-/m0/s1</moldb_inchi>
		<moldb_inchikey>CZWARROQQFCFJB-BYPYZUCNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>133.1457</moldb_average_mass>
		<moldb_mono_mass>133.073893223</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>853</id>
		<lmdb_id>LMDB00853</lmdb_id>
		<created_at>2016-07-30 18:58:20</created_at>
		<updated_at>2016-08-01 19:18:03</updated_at>
		<export>1</export>
		<name>5-Isopropyl-1H-indole-2,3-dione</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)C1=CC2=C(NC(=O)C2=O)C=C1</moldb_smiles>
		<moldb_formula>C11H11NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C11H11NO2/c1-6(2)7-3-4-9-8(5-7)10(13)11(14)12-9/h3-6H,1-2H3,(H,12,13,14)</moldb_inchi>
		<moldb_inchikey>LFNQRSQKXQFHDB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>189.2140</moldb_average_mass>
		<moldb_mono_mass>189.078978598</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>854</id>
		<lmdb_id>LMDB00854</lmdb_id>
		<created_at>2016-07-30 18:58:22</created_at>
		<updated_at>2016-08-01 19:18:04</updated_at>
		<export>1</export>
		<name>5-Isopropylidene-3,3-dimethyl-dihydrofuran-2-one</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)=C1CC(C)(C)C(=O)O1</moldb_smiles>
		<moldb_formula>C9H14O2</moldb_formula>
		<moldb_inchi>InChI=1S/C9H14O2/c1-6(2)7-5-9(3,4)8(10)11-7/h5H2,1-4H3</moldb_inchi>
		<moldb_inchikey>MQEYXTPGBZSYJM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>154.2090</moldb_average_mass>
		<moldb_mono_mass>154.099379691</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>855</id>
		<lmdb_id>LMDB00855</lmdb_id>
		<created_at>2016-07-30 18:58:24</created_at>
		<updated_at>2016-08-02 20:15:40</updated_at>
		<export>1</export>
		<name>5-Octadecylenic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCCCCCCCCC)=C(\[H])CCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h13-14H,2-12,15-17H2,1H3,(H,19,20)/b14-13+</moldb_inchi>
		<moldb_inchikey>AQWHMKSIVLSRNY-BUHFOSPRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4680</moldb_average_mass>
		<moldb_mono_mass>282.255880335</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>856</id>
		<lmdb_id>LMDB00856</lmdb_id>
		<created_at>2016-07-30 18:58:30</created_at>
		<updated_at>2016-08-01 19:18:08</updated_at>
		<export>1</export>
		<name>8-Quinolinecarboxanilide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=NC1=CC=CC=C1)C1=CC=CC2=C1N=CC=C2</moldb_smiles>
		<moldb_formula>C16H12N2O</moldb_formula>
		<moldb_inchi>InChI=1S/C16H12N2O/c19-16(18-13-8-2-1-3-9-13)14-10-4-6-12-7-5-11-17-15(12)14/h1-11H,(H,18,19)</moldb_inchi>
		<moldb_inchikey>QQYWGNSDNZBBJZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>248.2850</moldb_average_mass>
		<moldb_mono_mass>248.094963014</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>857</id>
		<lmdb_id>LMDB00857</lmdb_id>
		<created_at>2016-07-30 18:58:31</created_at>
		<updated_at>2016-08-01 19:18:09</updated_at>
		<export>1</export>
		<name>Acetylene</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C#C</moldb_smiles>
		<moldb_formula>C2H2</moldb_formula>
		<moldb_inchi>InChI=1S/C2H2/c1-2/h1-2H</moldb_inchi>
		<moldb_inchikey>HSFWRNGVRCDJHI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>26.0373</moldb_average_mass>
		<moldb_mono_mass>26.015650064</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>858</id>
		<lmdb_id>LMDB00858</lmdb_id>
		<created_at>2016-07-30 18:58:33</created_at>
		<updated_at>2016-08-01 19:18:10</updated_at>
		<export>1</export>
		<name>Adipamide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=N)CCCCC(O)=N</moldb_smiles>
		<moldb_formula>C6H12N2O2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12N2O2/c7-5(9)3-1-2-4-6(8)10/h1-4H2,(H2,7,9)(H2,8,10)</moldb_inchi>
		<moldb_inchikey>GVNWZKBFMFUVNX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>144.1717</moldb_average_mass>
		<moldb_mono_mass>144.089877638</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>859</id>
		<lmdb_id>LMDB00859</lmdb_id>
		<created_at>2016-07-30 18:58:36</created_at>
		<updated_at>2018-04-30 21:03:46</updated_at>
		<export>1</export>
		<name>alpha-D-Galactofuranose</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NULL</moldb_smiles>
		<moldb_formula>NULL</moldb_formula>
		<moldb_inchi>NULL</moldb_inchi>
		<moldb_inchikey>NULL</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>NULL</moldb_average_mass>
		<moldb_mono_mass>NULL</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>860</id>
		<lmdb_id>LMDB00860</lmdb_id>
		<created_at>2016-07-30 18:58:39</created_at>
		<updated_at>2016-08-01 19:18:12</updated_at>
		<export>1</export>
		<name>alpha-L-Galactofuranose</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](O)(CO)[C@@]1([H])O[C@@]([H])(O)[C@@]([H])(O)[C@]1([H])O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2-11H,1H2/t2-,3-,4-,5+,6+/m0/s1</moldb_inchi>
		<moldb_inchikey>AVVWPBAENSWJCB-FQJSGBEDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1560</moldb_average_mass>
		<moldb_mono_mass>180.063388106</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>861</id>
		<lmdb_id>LMDB00861</lmdb_id>
		<created_at>2016-07-30 18:58:40</created_at>
		<updated_at>2016-08-01 19:18:12</updated_at>
		<export>1</export>
		<name>Aminooxyacetic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NOCC(O)=O</moldb_smiles>
		<moldb_formula>C2H5NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C2H5NO3/c3-6-1-2(4)5/h1,3H2,(H,4,5)</moldb_inchi>
		<moldb_inchikey>NQRKYASMKDDGHT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>91.0660</moldb_average_mass>
		<moldb_mono_mass>91.026943031</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>862</id>
		<lmdb_id>LMDB00862</lmdb_id>
		<created_at>2016-07-30 18:58:42</created_at>
		<updated_at>2016-08-01 19:18:13</updated_at>
		<export>1</export>
		<name>beta-D-Fructofuranosyl-(2,1)-beta-D-Fructofuranose</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(O)[C@@]([H])(CO)O[C@](O)(CO[C@@]2(CO)O[C@]([H])(CO)[C@@]([H])(O)[C@]2([H])O)[C@@]1([H])O</moldb_smiles>
		<moldb_formula>C12H22O11</moldb_formula>
		<moldb_inchi>InChI=1S/C12H22O11/c13-1-5-7(16)9(18)11(20,22-5)4-21-12(3-15)10(19)8(17)6(2-14)23-12/h5-10,13-20H,1-4H2/t5-,6-,7-,8-,9+,10+,11-,12+/m1/s1</moldb_inchi>
		<moldb_inchikey>WOHYVFWWTVNXTP-IYDDCBTQSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>342.2965</moldb_average_mass>
		<moldb_mono_mass>342.116211546</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>863</id>
		<lmdb_id>LMDB00863</lmdb_id>
		<created_at>2016-07-30 18:58:44</created_at>
		<updated_at>2016-08-01 19:18:14</updated_at>
		<export>1</export>
		<name>beta-L-Mannofuranose</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](O)(CO)[C@]1([H])O[C@]([H])(O)[C@]([H])(O)[C@]1([H])O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2-11H,1H2/t2-,3-,4+,5-,6-/m0/s1</moldb_inchi>
		<moldb_inchikey>AVVWPBAENSWJCB-QYESYBIKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1560</moldb_average_mass>
		<moldb_mono_mass>180.063388106</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>865</id>
		<lmdb_id>LMDB00864</lmdb_id>
		<created_at>2016-08-01 07:24:00</created_at>
		<updated_at>2016-08-06 20:10:53</updated_at>
		<export>1</export>
		<name>D-Altrose</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]C1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@@]([H])(O)[C@]1([H])O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4-,5+,6?/m1/s1</moldb_inchi>
		<moldb_inchikey>WQZGKKKJIJFFOK-RSVSWTKNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1559</moldb_average_mass>
		<moldb_mono_mass>180.063388116</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>866</id>
		<lmdb_id>LMDB00865</lmdb_id>
		<created_at>2016-08-01 07:24:00</created_at>
		<updated_at>2016-08-01 19:18:15</updated_at>
		<export>1</export>
		<name>D-Ribofuranose</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC[C@H]1OC(O)[C@H](O)[C@@H]1O</moldb_smiles>
		<moldb_formula>C5H10O5</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O5/c6-1-2-3(7)4(8)5(9)10-2/h2-9H,1H2/t2-,3-,4-,5?/m1/s1</moldb_inchi>
		<moldb_inchikey>HMFHBZSHGGEWLO-SOOFDHNKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>150.1299</moldb_average_mass>
		<moldb_mono_mass>150.052823430</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>867</id>
		<lmdb_id>LMDB00866</lmdb_id>
		<created_at>2016-08-01 08:03:07</created_at>
		<updated_at>2016-08-09 21:08:09</updated_at>
		<export>1</export>
		<name>cis-11-Octadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h7-8H,2-6,9-17H2,1H3,(H,19,20)/b8-7-</moldb_inchi>
		<moldb_inchikey>UWHZIFQPPBDJPM-FPLPWBNLSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4614</moldb_average_mass>
		<moldb_mono_mass>282.255880332</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>868</id>
		<lmdb_id>LMDB00867</lmdb_id>
		<created_at>2016-08-01 08:03:09</created_at>
		<updated_at>2016-08-01 19:18:17</updated_at>
		<export>1</export>
		<name>cis-12-Octadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCC)=C(/[H])CCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7H,2-5,8-17H2,1H3,(H,19,20)/b7-6-</moldb_inchi>
		<moldb_inchikey>OXEDXHIBHVMDST-SREVYHEPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4680</moldb_average_mass>
		<moldb_mono_mass>282.255880335</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>870</id>
		<lmdb_id>LMDB00868</lmdb_id>
		<created_at>2016-08-01 08:03:12</created_at>
		<updated_at>2016-08-09 21:34:20</updated_at>
		<export>1</export>
		<name>cis-14-Octadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>0</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCC)=C(\[H])CCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h4-5H,2-3,6-17H2,1H3,(H,19,20)/b5-4+</moldb_inchi>
		<moldb_inchikey>JQBJOWDLTJOBRO-SNAWJCMRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4680</moldb_average_mass>
		<moldb_mono_mass>282.255880335</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>871</id>
		<lmdb_id>LMDB00869</lmdb_id>
		<created_at>2016-08-01 08:03:14</created_at>
		<updated_at>2016-08-01 19:18:19</updated_at>
		<export>1</export>
		<name>cis-15-Octadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC=CCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4H,2,5-17H2,1H3,(H,19,20)</moldb_inchi>
		<moldb_inchikey>KSIKGJKZYDOVFA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4680</moldb_average_mass>
		<moldb_mono_mass>282.255880335</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>872</id>
		<lmdb_id>LMDB00870</lmdb_id>
		<created_at>2016-08-01 08:03:16</created_at>
		<updated_at>2016-08-01 19:18:20</updated_at>
		<export>1</export>
		<name>Conduritol b epoxide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]12O[C@@]1([H])[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O</moldb_smiles>
		<moldb_formula>C6H10O5</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O5/c7-1-2(8)4(10)6-5(11-6)3(1)9/h1-10H/t1-,2-,3+,4+,5-,6+/m0/s1</moldb_inchi>
		<moldb_inchikey>ZHMWOVGZCINIHW-FTYOSCRSSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>162.1410</moldb_average_mass>
		<moldb_mono_mass>162.052823422</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>873</id>
		<lmdb_id>LMDB00871</lmdb_id>
		<created_at>2016-08-01 08:03:27</created_at>
		<updated_at>2016-08-06 20:10:55</updated_at>
		<export>1</export>
		<name>D-Xylofuranose</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NULL</moldb_smiles>
		<moldb_formula>NULL</moldb_formula>
		<moldb_inchi>NULL</moldb_inchi>
		<moldb_inchikey>NULL</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>NULL</moldb_average_mass>
		<moldb_mono_mass>NULL</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>874</id>
		<lmdb_id>LMDB00872</lmdb_id>
		<created_at>2016-08-01 08:03:29</created_at>
		<updated_at>2016-08-01 19:18:21</updated_at>
		<export>1</export>
		<name>Diethylene glycol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCCOCCO</moldb_smiles>
		<moldb_formula>C4H10O3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H10O3/c5-1-3-7-4-2-6/h5-6H,1-4H2</moldb_inchi>
		<moldb_inchikey>MTHSVFCYNBDYFN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>106.1204</moldb_average_mass>
		<moldb_mono_mass>106.062994186</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>875</id>
		<lmdb_id>LMDB00873</lmdb_id>
		<created_at>2016-08-01 08:03:30</created_at>
		<updated_at>2016-08-02 20:15:41</updated_at>
		<export>1</export>
		<name>Dihomo-alpha-linolenate (20:3(n-3))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC\C=C/C\C=C/C\C=C/CCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C20H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h3-4,6-7,9-10H,2,5,8,11-19H2,1H3,(H,21,22)/b4-3-,7-6-,10-9-</moldb_inchi>
		<moldb_inchikey>AHANXAKGNAKFSK-PDBXOOCHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>306.4828</moldb_average_mass>
		<moldb_mono_mass>306.255880332</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>876</id>
		<lmdb_id>LMDB00874</lmdb_id>
		<created_at>2016-08-01 08:03:32</created_at>
		<updated_at>2016-08-01 19:18:21</updated_at>
		<export>1</export>
		<name>Erucamide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCCCCC)=C(/[H])CCCCCCCCCCCC(O)=N</moldb_smiles>
		<moldb_formula>C22H43NO</moldb_formula>
		<moldb_inchi>InChI=1S/C22H43NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h9-10H,2-8,11-21H2,1H3,(H2,23,24)/b10-9-</moldb_inchi>
		<moldb_inchikey>UAUDZVJPLUQNMU-KTKRTIGZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>337.5829</moldb_average_mass>
		<moldb_mono_mass>337.334465003</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>877</id>
		<lmdb_id>LMDB00875</lmdb_id>
		<created_at>2016-08-01 08:03:39</created_at>
		<updated_at>2016-08-01 19:18:22</updated_at>
		<export>1</export>
		<name>Estradiol 17-glucuronide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O)C=C3</moldb_smiles>
		<moldb_formula>C24H32O8</moldb_formula>
		<moldb_inchi>InChI=1S/C24H32O8/c1-24-9-8-14-13-5-3-12(10-11(13)2-4-15(14)16(24)6-7-17(24)25)31-23-20(28)18(26)19(27)21(32-23)22(29)30/h3,5,10,14-21,23,25-28H,2,4,6-9H2,1H3,(H,29,30)/t14-,15-,16+,17+,18+,19+,20-,21+,23?,24+/m1/s1</moldb_inchi>
		<moldb_inchikey>MUOHJTRCBBDUOW-BFXFFQJBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>448.5061</moldb_average_mass>
		<moldb_mono_mass>448.209718000</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>878</id>
		<lmdb_id>LMDB00876</lmdb_id>
		<created_at>2016-08-01 08:03:41</created_at>
		<updated_at>2016-08-01 19:18:23</updated_at>
		<export>1</export>
		<name>Estradiol 3-glucuronide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C=C3CC[C@@]21[H]</moldb_smiles>
		<moldb_formula>C24H32O8</moldb_formula>
		<moldb_inchi>InChI=1S/C24H32O8/c1-24-9-8-14-13-5-3-12(10-11(13)2-4-15(14)16(24)6-7-17(24)25)31-23-20(28)18(26)19(27)21(32-23)22(29)30/h3,5,10,14-21,23,25-28H,2,4,6-9H2,1H3,(H,29,30)/t14-,15-,16+,17+,18+,19+,20-,21+,23-,24+/m1/s1</moldb_inchi>
		<moldb_inchikey>MUOHJTRCBBDUOW-QXYWQCSFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>448.5061</moldb_average_mass>
		<moldb_mono_mass>448.209718000</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>879</id>
		<lmdb_id>LMDB00877</lmdb_id>
		<created_at>2016-08-01 08:03:43</created_at>
		<updated_at>2016-08-01 19:18:23</updated_at>
		<export>1</export>
		<name>Estradiol 3-sulphate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OS(O)(=O)=O)=CC=C4[C@@]3([H])CC[C@]12C</moldb_smiles>
		<moldb_formula>C18H24O5S</moldb_formula>
		<moldb_inchi>InChI=1S/C18H24O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-17,19H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,17+,18+/m1/s1</moldb_inchi>
		<moldb_inchikey>QZIGLSSUDXBTLJ-ZBRFXRBCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>352.4500</moldb_average_mass>
		<moldb_mono_mass>352.134445047</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>880</id>
		<lmdb_id>LMDB00878</lmdb_id>
		<created_at>2016-08-01 08:03:45</created_at>
		<updated_at>2016-08-01 19:18:24</updated_at>
		<export>1</export>
		<name>Estriol 3-glucuronide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(O)C[C@@]2([H])[C@]3([H])CCC4=CC(O[C@]5([H])O[C@]([H])(C(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]5([H])O)=CC=C4[C@@]3([H])CC[C@]2(C)[C@@]1([H])O</moldb_smiles>
		<moldb_formula>C24H32O9</moldb_formula>
		<moldb_inchi>InChI=1S/C24H32O9/c1-24-7-6-13-12-5-3-11(32-23-19(28)17(26)18(27)20(33-23)22(30)31)8-10(12)2-4-14(13)15(24)9-16(25)21(24)29/h3,5,8,13-21,23,25-29H,2,4,6-7,9H2,1H3,(H,30,31)/t13-,14-,15+,16-,17+,18+,19-,20+,21+,23-,24+/m1/s1</moldb_inchi>
		<moldb_inchikey>UZKIAJMSMKLBQE-JRSYHJKYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>464.5055</moldb_average_mass>
		<moldb_mono_mass>464.204632622</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>881</id>
		<lmdb_id>LMDB00879</lmdb_id>
		<created_at>2016-08-01 08:03:46</created_at>
		<updated_at>2016-08-01 19:18:25</updated_at>
		<export>1</export>
		<name>Ethanolaminephosphate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NCCOP(O)(O)=O</moldb_smiles>
		<moldb_formula>C2H8NO4P</moldb_formula>
		<moldb_inchi>InChI=1S/C2H8NO4P/c3-1-2-7-8(4,5)6/h1-3H2,(H2,4,5,6)</moldb_inchi>
		<moldb_inchikey>SUHOOTKUPISOBE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>141.0630</moldb_average_mass>
		<moldb_mono_mass>141.019094261</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>882</id>
		<lmdb_id>LMDB00880</lmdb_id>
		<created_at>2016-08-01 08:03:48</created_at>
		<updated_at>2016-08-01 19:18:26</updated_at>
		<export>1</export>
		<name>Ethyl pipecolinate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCOC(=O)C1CCCCN1</moldb_smiles>
		<moldb_formula>C8H15NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C8H15NO2/c1-2-11-8(10)7-5-3-4-6-9-7/h7,9H,2-6H2,1H3</moldb_inchi>
		<moldb_inchikey>SZIKRGHFZTYTIT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>157.2130</moldb_average_mass>
		<moldb_mono_mass>157.110278727</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>883</id>
		<lmdb_id>LMDB00881</lmdb_id>
		<created_at>2016-08-01 08:03:50</created_at>
		<updated_at>2016-08-01 19:18:26</updated_at>
		<export>1</export>
		<name>Ethylenediaminetetraacetic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O</moldb_smiles>
		<moldb_formula>C10H16N2O8</moldb_formula>
		<moldb_inchi>InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)</moldb_inchi>
		<moldb_inchikey>KCXVZYZYPLLWCC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>292.2426</moldb_average_mass>
		<moldb_mono_mass>292.090665498</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>884</id>
		<lmdb_id>LMDB00882</lmdb_id>
		<created_at>2016-08-01 08:03:52</created_at>
		<updated_at>2016-08-01 19:18:27</updated_at>
		<export>1</export>
		<name>Fluorometholone Acetate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)C[C@]([H])(O)[C@@]1(F)[C@@]2([H])C[C@]([H])(C)C2=CC(=O)C=C[C@]12C</moldb_smiles>
		<moldb_formula>C24H31FO5</moldb_formula>
		<moldb_inchi>InChI=1S/C24H31FO5/c1-13-10-19-17-7-9-23(14(2)26,30-15(3)27)22(17,5)12-20(29)24(19,25)21(4)8-6-16(28)11-18(13)21/h6,8,11,13,17,19-20,29H,7,9-10,12H2,1-5H3/t13-,17-,19-,20-,21-,22-,23-,24-/m0/s1</moldb_inchi>
		<moldb_inchikey>YRFXGQHBPBMFHW-SBTZIJSASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>418.5050</moldb_average_mass>
		<moldb_mono_mass>418.215552261</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>885</id>
		<lmdb_id>LMDB00883</lmdb_id>
		<created_at>2016-08-01 08:03:54</created_at>
		<updated_at>2016-08-01 19:18:28</updated_at>
		<export>1</export>
		<name>Glucose oxime</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(=N/O)[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CO</moldb_smiles>
		<moldb_formula>C6H13NO6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H13NO6/c8-2-4(10)6(12)5(11)3(9)1-7-13/h1,3-6,8-13H,2H2/b7-1+/t3-,4+,5+,6+/m0/s1</moldb_inchi>
		<moldb_inchikey>FQDOAQMGAIINEJ-LJVFLWCUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>195.1710</moldb_average_mass>
		<moldb_mono_mass>195.074287143</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>886</id>
		<lmdb_id>LMDB00884</lmdb_id>
		<created_at>2016-08-01 08:03:55</created_at>
		<updated_at>2016-08-02 20:15:42</updated_at>
		<export>1</export>
		<name>Glycohyocholic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](C)(CCC(O)=NCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)[C@]([H])(O)[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])CC[C@]12C</moldb_smiles>
		<moldb_formula>C26H43NO6</moldb_formula>
		<moldb_inchi>InChI=1S/C26H43NO6/c1-14(4-7-20(29)27-13-21(30)31)16-5-6-17-22-18(9-11-25(16,17)2)26(3)10-8-15(28)12-19(26)23(32)24(22)33/h14-19,22-24,28,32-33H,4-13H2,1-3H3,(H,27,29)(H,30,31)/t14-,15-,16-,17+,18+,19+,22+,23-,24+,25-,26-/m1/s1</moldb_inchi>
		<moldb_inchikey>ZQYUKJFJPJDMMR-ZDWCHQGWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>465.6310</moldb_average_mass>
		<moldb_mono_mass>465.309038109</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>887</id>
		<lmdb_id>LMDB00885</lmdb_id>
		<created_at>2016-08-01 08:03:58</created_at>
		<updated_at>2016-08-01 19:18:28</updated_at>
		<export>1</export>
		<name>Hexadecasphinganine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](N)(CO)[C@]([H])(O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C16H35NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C16H35NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-16(19)15(17)14-18/h15-16,18-19H,2-14,17H2,1H3/t15-,16+/m0/s1</moldb_inchi>
		<moldb_inchikey>ZKLREJQHRKUJHD-JKSUJKDBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>273.4610</moldb_average_mass>
		<moldb_mono_mass>273.266779371</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>888</id>
		<lmdb_id>LMDB00886</lmdb_id>
		<created_at>2016-08-01 08:04:00</created_at>
		<updated_at>2016-08-01 19:18:29</updated_at>
		<export>1</export>
		<name>Hydrogen cyanamide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC#N</moldb_smiles>
		<moldb_formula>CH2N2</moldb_formula>
		<moldb_inchi>InChI=1S/CH2N2/c2-1-3/h2H2</moldb_inchi>
		<moldb_inchikey>XZMCDFZZKTWFGF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>42.0400</moldb_average_mass>
		<moldb_mono_mass>42.021798074</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>889</id>
		<lmdb_id>LMDB00887</lmdb_id>
		<created_at>2016-08-01 08:04:01</created_at>
		<updated_at>2016-08-02 20:15:42</updated_at>
		<export>1</export>
		<name>Isobutyrylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](CC(O)=O)(C[N+](C)(C)C)OC(=O)C(C)C</moldb_smiles>
		<moldb_formula>C11H22NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C11H21NO4/c1-8(2)11(15)16-9(6-10(13)14)7-12(3,4)5/h8-9H,6-7H2,1-5H3/p+1/t9-/m1/s1</moldb_inchi>
		<moldb_inchikey>LRCNOZRCYBNMEP-SECBINFHSA-O</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>232.2990</moldb_average_mass>
		<moldb_mono_mass>232.154334613</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>890</id>
		<lmdb_id>LMDB00888</lmdb_id>
		<created_at>2016-08-01 08:04:03</created_at>
		<updated_at>2016-08-01 19:18:31</updated_at>
		<export>1</export>
		<name>L-Altrose</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]C1(O)O[C@@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]1([H])O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4-,5+,6?/m0/s1</moldb_inchi>
		<moldb_inchikey>WQZGKKKJIJFFOK-VSOAQEOCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1560</moldb_average_mass>
		<moldb_mono_mass>180.063388106</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>891</id>
		<lmdb_id>LMDB00889</lmdb_id>
		<created_at>2016-08-01 08:04:05</created_at>
		<updated_at>2016-08-01 19:18:31</updated_at>
		<export>1</export>
		<name>lactobionic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(CO)[C@@]([H])(O[C@]1([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]1([H])O)[C@]([H])(O)[C@@]([H])(O)C(O)=O</moldb_smiles>
		<moldb_formula>C12H22O12</moldb_formula>
		<moldb_inchi>InChI=1S/C12H22O12/c13-1-3(15)10(7(18)8(19)11(21)22)24-12-9(20)6(17)5(16)4(2-14)23-12/h3-10,12-20H,1-2H2,(H,21,22)/t3-,4-,5+,6+,7-,8-,9-,10-,12+/m1/s1</moldb_inchi>
		<moldb_inchikey>JYTUSYBCFIZPBE-AMTLMPIISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>358.2959</moldb_average_mass>
		<moldb_mono_mass>358.111126168</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>892</id>
		<lmdb_id>LMDB00890</lmdb_id>
		<created_at>2016-08-01 08:04:07</created_at>
		<updated_at>2016-08-02 20:15:42</updated_at>
		<export>1</export>
		<name>Maleic anhydride</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>O=C1OC(=O)C=C1</moldb_smiles>
		<moldb_formula>C4H2O3</moldb_formula>
		<moldb_inchi>InChI=1S/C4H2O3/c5-3-1-2-4(6)7-3/h1-2H</moldb_inchi>
		<moldb_inchikey>FPYJFEHAWHCUMM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>98.0570</moldb_average_mass>
		<moldb_mono_mass>98.000393924</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>893</id>
		<lmdb_id>LMDB00891</lmdb_id>
		<created_at>2016-08-01 08:04:09</created_at>
		<updated_at>2016-08-06 20:11:03</updated_at>
		<export>1</export>
		<name>Malonamide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=N)CC(O)=N</moldb_smiles>
		<moldb_formula>C3H6N2O2</moldb_formula>
		<moldb_inchi>InChI=1S/C3H6N2O2/c4-2(6)1-3(5)7/h1H2,(H2,4,6)(H2,5,7)</moldb_inchi>
		<moldb_inchikey>WRIRWRKPLXCTFD-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>102.0919</moldb_average_mass>
		<moldb_mono_mass>102.042927446</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>894</id>
		<lmdb_id>LMDB00892</lmdb_id>
		<created_at>2016-08-01 08:04:10</created_at>
		<updated_at>2016-08-01 19:18:33</updated_at>
		<export>1</export>
		<name>Methoxymethyl cyclopropane</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>COCC1CC1</moldb_smiles>
		<moldb_formula>C5H10O</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O/c1-6-4-5-2-3-5/h5H,2-4H2,1H3</moldb_inchi>
		<moldb_inchikey>XZUHEKNCBBQEBT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>86.1323</moldb_average_mass>
		<moldb_mono_mass>86.073164942</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>895</id>
		<lmdb_id>LMDB00893</lmdb_id>
		<created_at>2016-08-01 08:04:12</created_at>
		<updated_at>2016-08-01 19:18:33</updated_at>
		<export>1</export>
		<name>Methyl alpha-D-glucopyranoside</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]OC([H])([H])[C@@]1([H])O[C@]([H])(OC([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H]</moldb_smiles>
		<moldb_formula>C7H14O6</moldb_formula>
		<moldb_inchi>InChI=1S/C7H14O6/c1-12-7-6(11)5(10)4(9)3(2-8)13-7/h3-11H,2H2,1H3/t3-,4-,5+,6-,7+/m1/s1</moldb_inchi>
		<moldb_inchikey>HOVAGTYPODGVJG-ZFYZTMLRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>194.1825</moldb_average_mass>
		<moldb_mono_mass>194.079038180</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>896</id>
		<lmdb_id>LMDB00894</lmdb_id>
		<created_at>2016-08-01 08:04:14</created_at>
		<updated_at>2016-08-01 08:04:15</updated_at>
		<export>1</export>
		<name>Monoolein</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>0</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCCCCC)=C(/[H])CCCCCCCC(=O)OCC(O)CO</moldb_smiles>
		<moldb_formula>C21H40O4</moldb_formula>
		<moldb_inchi>InChI=1S/C21H40O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-19-20(23)18-22/h9-10,20,22-23H,2-8,11-19H2,1H3/b10-9-</moldb_inchi>
		<moldb_inchikey>RZRNAYUHWVFMIP-KTKRTIGZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>356.5399</moldb_average_mass>
		<moldb_mono_mass>356.292659768</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>897</id>
		<lmdb_id>LMDB00895</lmdb_id>
		<created_at>2016-08-01 08:04:16</created_at>
		<updated_at>2016-08-02 20:15:43</updated_at>
		<export>1</export>
		<name>Myristoyl L-alpha-lysophosphatidylcholine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(COC(=O)CCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C22H46NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C22H46NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-22(25)28-19-21(24)20-30-31(26,27)29-18-17-23(2,3)4/h21,24H,5-20H2,1-4H3/t21-/m1/s1</moldb_inchi>
		<moldb_inchikey>VXUOFDJKYGDUJI-OAQYLSRUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>467.5769</moldb_average_mass>
		<moldb_mono_mass>467.301189343</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>898</id>
		<lmdb_id>LMDB00896</lmdb_id>
		<created_at>2016-08-01 08:04:23</created_at>
		<updated_at>2016-08-06 20:10:59</updated_at>
		<export>1</export>
		<name>N-(Cyclohex-1-en-1-ylcarbonyl)glycine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CNC(=O)C1=CCCCC1</moldb_smiles>
		<moldb_formula>C9H13NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C9H13NO3/c11-8(12)6-10-9(13)7-4-2-1-3-5-7/h4H,1-3,5-6H2,(H,10,13)(H,11,12)</moldb_inchi>
		<moldb_inchikey>OSUSJBWSQBKORT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>183.2044</moldb_average_mass>
		<moldb_mono_mass>183.089543287</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>899</id>
		<lmdb_id>LMDB00897</lmdb_id>
		<created_at>2016-08-01 08:04:24</created_at>
		<updated_at>2016-08-06 20:10:59</updated_at>
		<export>1</export>
		<name>N-acetyl-Muramic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](C)(O[C@@]1([H])[C@]([H])(O)[C@@]([H])(CO)OC([H])(O)[C@]1([H])N=C(C)O)C(O)=O</moldb_smiles>
		<moldb_formula>C11H19NO8</moldb_formula>
		<moldb_inchi>InChI=1S/C11H19NO8/c1-4(10(16)17)19-9-7(12-5(2)14)11(18)20-6(3-13)8(9)15/h4,6-9,11,13,15,18H,3H2,1-2H3,(H,12,14)(H,16,17)/t4-,6-,7-,8-,9-,11?/m1/s1</moldb_inchi>
		<moldb_inchikey>MNLRQHMNZILYPY-MKFCKLDKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>293.2705</moldb_average_mass>
		<moldb_mono_mass>293.111066589</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>900</id>
		<lmdb_id>LMDB00898</lmdb_id>
		<created_at>2016-08-01 08:04:26</created_at>
		<updated_at>2016-08-01 19:18:34</updated_at>
		<export>1</export>
		<name>N-benzenesulfonyloxy-2,2-bis(trifluoromethyl)aziridine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>FC(F)(F)C1(CN1OS(=O)(=O)C1=CC=CC=C1)C(F)(F)F</moldb_smiles>
		<moldb_formula>C10H7F6NO3S</moldb_formula>
		<moldb_inchi>InChI=1S/C10H7F6NO3S/c11-9(12,13)8(10(14,15)16)6-17(8)20-21(18,19)7-4-2-1-3-5-7/h1-5H,6H2</moldb_inchi>
		<moldb_inchikey>CKWMYBMYJVUCMK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>335.2200</moldb_average_mass>
		<moldb_mono_mass>335.005083241</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>901</id>
		<lmdb_id>LMDB00899</lmdb_id>
		<created_at>2016-08-01 08:04:28</created_at>
		<updated_at>2016-08-01 19:18:35</updated_at>
		<export>1</export>
		<name>n-Heptanol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCO</moldb_smiles>
		<moldb_formula>C7H16O</moldb_formula>
		<moldb_inchi>InChI=1S/C7H16O/c1-2-3-4-5-6-7-8/h8H,2-7H2,1H3</moldb_inchi>
		<moldb_inchikey>BBMCTIGTTCKYKF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>116.2013</moldb_average_mass>
		<moldb_mono_mass>116.120115134</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>902</id>
		<lmdb_id>LMDB00900</lmdb_id>
		<created_at>2016-08-01 08:04:30</created_at>
		<updated_at>2018-04-30 21:15:07</updated_at>
		<export>1</export>
		<name>N-Methyl-L-glutamic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN[C@@H](CCC(O)=O)C(O)=O</moldb_smiles>
		<moldb_formula>C6H11NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C6H11NO4/c1-7-4(6(10)11)2-3-5(8)9/h4,7H,2-3H2,1H3,(H,8,9)(H,10,11)/t4-/m0/s1</moldb_inchi>
		<moldb_inchikey>XLBVNMSMFQMKEY-BYPYZUCNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>161.1558</moldb_average_mass>
		<moldb_mono_mass>161.068807845</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>903</id>
		<lmdb_id>LMDB00901</lmdb_id>
		<created_at>2016-08-01 08:04:32</created_at>
		<updated_at>2016-08-01 19:18:37</updated_at>
		<export>1</export>
		<name>N,N-di(2-hydroxyethyl)-methanamine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN(CCO)CCO</moldb_smiles>
		<moldb_formula>C5H13NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C5H13NO2/c1-6(2-4-7)3-5-8/h7-8H,2-5H2,1H3</moldb_inchi>
		<moldb_inchikey>CRVGTESFCCXCTH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>119.1640</moldb_average_mass>
		<moldb_mono_mass>119.094628663</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>904</id>
		<lmdb_id>LMDB00902</lmdb_id>
		<created_at>2016-08-01 08:04:34</created_at>
		<updated_at>2016-08-01 19:18:37</updated_at>
		<export>1</export>
		<name>N,N-diethyldodecanamide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCC(=O)N(CC)CC</moldb_smiles>
		<moldb_formula>C16H33NO</moldb_formula>
		<moldb_inchi>InChI=1S/C16H33NO/c1-4-7-8-9-10-11-12-13-14-15-16(18)17(5-2)6-3/h4-15H2,1-3H3</moldb_inchi>
		<moldb_inchikey>CWNSVVHTTQBGQB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>255.4460</moldb_average_mass>
		<moldb_mono_mass>255.256214687</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>905</id>
		<lmdb_id>LMDB00903</lmdb_id>
		<created_at>2016-08-01 08:04:35</created_at>
		<updated_at>2016-08-01 19:18:38</updated_at>
		<export>1</export>
		<name>Orcinol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=CC(O)=CC(O)=C1</moldb_smiles>
		<moldb_formula>C7H8O2</moldb_formula>
		<moldb_inchi>InChI=1S/C7H8O2/c1-5-2-6(8)4-7(9)3-5/h2-4,8-9H,1H3</moldb_inchi>
		<moldb_inchikey>OIPPWFOQEKKFEE-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>124.1390</moldb_average_mass>
		<moldb_mono_mass>124.052429498</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>906</id>
		<lmdb_id>LMDB00904</lmdb_id>
		<created_at>2016-08-01 08:04:37</created_at>
		<updated_at>2016-08-02 20:15:43</updated_at>
		<export>1</export>
		<name>p-Hydroxyphenylpyruvate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1=CC=C(CC(=O)C([O-])=O)C=C1</moldb_smiles>
		<moldb_formula>C9H7O4</moldb_formula>
		<moldb_inchi>InChI=1S/C9H8O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,10H,5H2,(H,12,13)/p-1</moldb_inchi>
		<moldb_inchikey>KKADPXVIOXHVKN-UHFFFAOYSA-M</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>179.1495</moldb_average_mass>
		<moldb_mono_mass>179.034433712</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>907</id>
		<lmdb_id>LMDB00905</lmdb_id>
		<created_at>2016-08-01 08:04:39</created_at>
		<updated_at>2016-08-01 19:18:39</updated_at>
		<export>1</export>
		<name>Rumenic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C\C=C/CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h7-10H,2-6,11-17H2,1H3,(H,19,20)/b8-7+,10-9-</moldb_inchi>
		<moldb_inchikey>JBYXPOFIGCOSSB-GOJKSUSPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>280.4455</moldb_average_mass>
		<moldb_mono_mass>280.240230268</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>908</id>
		<lmdb_id>LMDB00906</lmdb_id>
		<created_at>2016-08-01 08:04:40</created_at>
		<updated_at>2016-08-06 20:10:59</updated_at>
		<export>1</export>
		<name>Sophorose</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O[C@]1([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O</moldb_smiles>
		<moldb_formula>C12H22O11</moldb_formula>
		<moldb_inchi>InChI=1S/C12H22O11/c13-1-3-6(16)8(18)10(11(20)21-3)23-12-9(19)7(17)5(15)4(2-14)22-12/h3-20H,1-2H2/t3-,4-,5-,6-,7+,8+,9-,10-,11+,12+/m1/s1</moldb_inchi>
		<moldb_inchikey>HIWPGCMGAMJNRG-NCFXGAEVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>342.2970</moldb_average_mass>
		<moldb_mono_mass>342.116211528</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>909</id>
		<lmdb_id>LMDB00907</lmdb_id>
		<created_at>2016-08-01 08:04:42</created_at>
		<updated_at>2016-08-01 19:18:39</updated_at>
		<export>1</export>
		<name>Thiazolidine-4-carboxylic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)C1CSCN1</moldb_smiles>
		<moldb_formula>C4H7NO2S</moldb_formula>
		<moldb_inchi>InChI=1S/C4H7NO2S/c6-4(7)3-1-8-2-5-3/h3,5H,1-2H2,(H,6,7)</moldb_inchi>
		<moldb_inchikey>DZLNHFMRPBPULJ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>133.1700</moldb_average_mass>
		<moldb_mono_mass>133.019749643</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>910</id>
		<lmdb_id>LMDB00908</lmdb_id>
		<created_at>2016-08-01 08:04:49</created_at>
		<updated_at>2016-08-09 21:08:09</updated_at>
		<export>1</export>
		<name>trans-10 Octadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCC\C=C\CCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h8-9H,2-7,10-17H2,1H3,(H,19,20)/b9-8+</moldb_inchi>
		<moldb_inchikey>QXJSBBXBKPUZAA-CMDGGOBGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4614</moldb_average_mass>
		<moldb_mono_mass>282.255880332</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>911</id>
		<lmdb_id>LMDB00909</lmdb_id>
		<created_at>2016-08-01 08:04:50</created_at>
		<updated_at>2016-08-01 19:18:43</updated_at>
		<export>1</export>
		<name>trans-12-Octadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C\CCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7H,2-5,8-17H2,1H3,(H,19,20)/b7-6+</moldb_inchi>
		<moldb_inchikey>OXEDXHIBHVMDST-VOTSOKGWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4680</moldb_average_mass>
		<moldb_mono_mass>282.255880335</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>912</id>
		<lmdb_id>LMDB00910</lmdb_id>
		<created_at>2016-08-01 08:04:52</created_at>
		<updated_at>2016-08-09 21:08:10</updated_at>
		<export>1</export>
		<name>trans-13-Octadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCC\C=C\CCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h5-6H,2-4,7-17H2,1H3,(H,19,20)/b6-5+</moldb_inchi>
		<moldb_inchikey>BDLLSHRIFPDGQB-AATRIKPKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4614</moldb_average_mass>
		<moldb_mono_mass>282.255880332</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>913</id>
		<lmdb_id>LMDB00911</lmdb_id>
		<created_at>2016-08-01 08:04:54</created_at>
		<updated_at>2016-08-01 19:18:44</updated_at>
		<export>1</export>
		<name>trans-14-Octadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCC)=C(\[H])CCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h4-5H,2-3,6-17H2,1H3,(H,19,20)/b5-4+</moldb_inchi>
		<moldb_inchikey>JQBJOWDLTJOBRO-SNAWJCMRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4680</moldb_average_mass>
		<moldb_mono_mass>282.255880335</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>914</id>
		<lmdb_id>LMDB00912</lmdb_id>
		<created_at>2016-08-01 08:04:56</created_at>
		<updated_at>2016-08-09 21:08:08</updated_at>
		<export>1</export>
		<name>trans-15-Octadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CC)=C(\[H])CCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4H,2,5-17H2,1H3,(H,19,20)/b4-3+</moldb_inchi>
		<moldb_inchikey>KSIKGJKZYDOVFA-ONEGZZNKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4680</moldb_average_mass>
		<moldb_mono_mass>282.255880335</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>915</id>
		<lmdb_id>LMDB00913</lmdb_id>
		<created_at>2016-08-01 08:04:58</created_at>
		<updated_at>2016-08-01 19:18:47</updated_at>
		<export>1</export>
		<name>trans-16-Octadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(C)=C(\[H])CCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-3H,4-17H2,1H3,(H,19,20)/b3-2+</moldb_inchi>
		<moldb_inchikey>DPUHOWDIWWPPIP-NSCUHMNNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4680</moldb_average_mass>
		<moldb_mono_mass>282.255880335</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>916</id>
		<lmdb_id>LMDB00914</lmdb_id>
		<created_at>2016-08-01 08:05:00</created_at>
		<updated_at>2016-08-01 19:18:48</updated_at>
		<export>1</export>
		<name>trans-4-Octadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCCCCCCCCCC)=C(\[H])CCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h14-15H,2-13,16-17H2,1H3,(H,19,20)/b15-14+</moldb_inchi>
		<moldb_inchikey>OBNDIDKDLXSSCB-CCEZHUSRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4680</moldb_average_mass>
		<moldb_mono_mass>282.255880335</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>917</id>
		<lmdb_id>LMDB00915</lmdb_id>
		<created_at>2016-08-01 08:05:01</created_at>
		<updated_at>2016-08-01 19:18:49</updated_at>
		<export>1</export>
		<name>trans-5-Octadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCCCCCCCCC)=C(\[H])CCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h13-14H,2-12,15-17H2,1H3,(H,19,20)/b14-13+</moldb_inchi>
		<moldb_inchikey>AQWHMKSIVLSRNY-BUHFOSPRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4680</moldb_average_mass>
		<moldb_mono_mass>282.255880335</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>918</id>
		<lmdb_id>LMDB00916</lmdb_id>
		<created_at>2016-08-01 08:05:03</created_at>
		<updated_at>2016-08-01 19:18:49</updated_at>
		<export>1</export>
		<name>trans-6-Octadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCC\C=C\CCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h12-13H,2-11,14-17H2,1H3,(H,19,20)/b13-12+</moldb_inchi>
		<moldb_inchikey>CNVZJPUDSLNTQU-OUKQBFOZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4614</moldb_average_mass>
		<moldb_mono_mass>282.255880332</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>919</id>
		<lmdb_id>LMDB00917</lmdb_id>
		<created_at>2016-08-01 08:05:04</created_at>
		<updated_at>2016-08-01 19:18:50</updated_at>
		<export>1</export>
		<name>trans-7-Octadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCC\C=C\CCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h11-12H,2-10,13-17H2,1H3,(H,19,20)/b12-11+</moldb_inchi>
		<moldb_inchikey>RVUCYJXFCAVHNC-VAWYXSNFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4614</moldb_average_mass>
		<moldb_mono_mass>282.255880332</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>920</id>
		<lmdb_id>LMDB00918</lmdb_id>
		<created_at>2016-08-01 08:05:06</created_at>
		<updated_at>2016-08-01 19:18:51</updated_at>
		<export>1</export>
		<name>trans-8-Octadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCCCCCC)=C(\[H])CCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H34O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h10-11H,2-9,12-17H2,1H3,(H,19,20)/b11-10+</moldb_inchi>
		<moldb_inchikey>WRIDQFICGBMAFQ-ZHACJKMWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>282.4680</moldb_average_mass>
		<moldb_mono_mass>282.255880335</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>921</id>
		<lmdb_id>LMDB00919</lmdb_id>
		<created_at>2016-08-01 08:05:08</created_at>
		<updated_at>2018-04-30 21:15:08</updated_at>
		<export>1</export>
		<name>trans-Coniferylaldehyde</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(C=O)=C(\[H])C1=CC(OC)=C(O)C=C1</moldb_smiles>
		<moldb_formula>C10H10O3</moldb_formula>
		<moldb_inchi>InChI=1S/C10H10O3/c1-13-10-7-8(3-2-6-11)4-5-9(10)12/h2-7,12H,1H3/b3-2+</moldb_inchi>
		<moldb_inchikey>DKZBBWMURDFHNE-NSCUHMNNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>178.1846</moldb_average_mass>
		<moldb_mono_mass>178.062994186</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>922</id>
		<lmdb_id>LMDB00920</lmdb_id>
		<created_at>2016-08-01 08:05:10</created_at>
		<updated_at>2016-08-01 19:18:52</updated_at>
		<export>1</export>
		<name>Tricosylic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C23H46O2</moldb_formula>
		<moldb_inchi>InChI=1S/C23H46O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23(24)25/h2-22H2,1H3,(H,24,25)</moldb_inchi>
		<moldb_inchikey>XEZVDURJDFGERA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>354.6101</moldb_average_mass>
		<moldb_mono_mass>354.349780716</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>923</id>
		<lmdb_id>LMDB00921</lmdb_id>
		<created_at>2016-08-01 08:05:14</created_at>
		<updated_at>2016-08-01 19:18:53</updated_at>
		<export>1</export>
		<name>Trimethyl phosphate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>COP(=O)(OC)OC</moldb_smiles>
		<moldb_formula>C3H9O4P</moldb_formula>
		<moldb_inchi>InChI=1S/C3H9O4P/c1-5-8(4,6-2)7-3/h1-3H3</moldb_inchi>
		<moldb_inchikey>WVLBCYQITXONBZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>140.0749</moldb_average_mass>
		<moldb_mono_mass>140.023845288</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>924</id>
		<lmdb_id>LMDB00922</lmdb_id>
		<created_at>2016-08-01 08:05:16</created_at>
		<updated_at>2016-08-06 20:11:04</updated_at>
		<export>1</export>
		<name>Tropic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC(C(O)=O)C1=CC=CC=C1</moldb_smiles>
		<moldb_formula>C9H10O3</moldb_formula>
		<moldb_inchi>InChI=1S/C9H10O3/c10-6-8(9(11)12)7-4-2-1-3-5-7/h1-5,8,10H,6H2,(H,11,12)</moldb_inchi>
		<moldb_inchikey>JACRWUWPXAESPB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>166.1739</moldb_average_mass>
		<moldb_mono_mass>166.062994186</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>925</id>
		<lmdb_id>LMDB00923</lmdb_id>
		<created_at>2016-08-01 08:05:18</created_at>
		<updated_at>2016-08-01 19:18:54</updated_at>
		<export>1</export>
		<name>Vinylbital</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCC(C)C1(C=C)C(O)=NC(=O)N=C1O</moldb_smiles>
		<moldb_formula>C11H16N2O3</moldb_formula>
		<moldb_inchi>InChI=1S/C11H16N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h5,7H,2,4,6H2,1,3H3,(H2,12,13,14,15,16)</moldb_inchi>
		<moldb_inchikey>KGKJZEKQJQQOTD-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>224.2600</moldb_average_mass>
		<moldb_mono_mass>224.116092383</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>926</id>
		<lmdb_id>LMDB00924</lmdb_id>
		<created_at>2016-08-01 08:05:20</created_at>
		<updated_at>2016-08-01 19:18:55</updated_at>
		<export>1</export>
		<name>Xylitol (5TMS)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[Si](C)(C)OCC(O[Si](C)(C)C)C(O[Si](C)(C)C)C(CO[Si](C)(C)C)O[Si](C)(C)C</moldb_smiles>
		<moldb_formula>C20H52O5Si5</moldb_formula>
		<moldb_inchi>InChI=1S/C20H52O5Si5/c1-26(2,3)21-16-18(23-28(7,8)9)20(25-30(13,14)15)19(24-29(10,11)12)17-22-27(4,5)6/h18-20H,16-17H2,1-15H3</moldb_inchi>
		<moldb_inchikey>SUZLPERYXSOGNY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>513.0560</moldb_average_mass>
		<moldb_mono_mass>512.266107449</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>927</id>
		<lmdb_id>LMDB00925</lmdb_id>
		<created_at>2016-08-01 08:05:27</created_at>
		<updated_at>2016-08-06 20:11:03</updated_at>
		<export>1</export>
		<name>Loganin</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]1(O)C[C@]2([H])C(=CO[C@@]([H])(O[C@]3([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]2([H])[C@@]1([H])C)C(=O)OC</moldb_smiles>
		<moldb_formula>C17H26O10</moldb_formula>
		<moldb_inchi>InChI=1S/C17H26O10/c1-6-9(19)3-7-8(15(23)24-2)5-25-16(11(6)7)27-17-14(22)13(21)12(20)10(4-18)26-17/h5-7,9-14,16-22H,3-4H2,1-2H3/t6-,7+,9-,10+,11+,12+,13-,14+,16-,17-/m0/s1</moldb_inchi>
		<moldb_inchikey>AMBQHHVBBHTQBF-UOUCRYGSSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>390.3823</moldb_average_mass>
		<moldb_mono_mass>390.152597052</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>928</id>
		<lmdb_id>LMDB00926</lmdb_id>
		<created_at>2016-08-01 08:05:28</created_at>
		<updated_at>2016-08-01 19:18:55</updated_at>
		<export>1</export>
		<name>Talose</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]C1(O)O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@]1([H])O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5+,6?/m1/s1</moldb_inchi>
		<moldb_inchikey>WQZGKKKJIJFFOK-WHZQZERISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1560</moldb_average_mass>
		<moldb_mono_mass>180.063388106</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>951</id>
		<lmdb_id>LMDB00927</lmdb_id>
		<created_at>2016-08-01 22:02:17</created_at>
		<updated_at>2018-04-30 21:15:09</updated_at>
		<export>1</export>
		<name>3-Methylglutarylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(CC(O)=O)CC(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C13H23NO6</moldb_formula>
		<moldb_inchi>InChI=1S/C13H23NO6/c1-9(5-11(15)16)6-13(19)20-10(7-12(17)18)8-14(2,3)4/h9-10H,5-8H2,1-4H3,(H-,15,16,17,18)</moldb_inchi>
		<moldb_inchikey>HFCPFJNSBPQJDP-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>289.3248</moldb_average_mass>
		<moldb_mono_mass>289.152537473</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>952</id>
		<lmdb_id>LMDB00928</lmdb_id>
		<created_at>2016-08-01 22:02:19</created_at>
		<updated_at>2016-08-02 20:40:54</updated_at>
		<export>1</export>
		<name>CE(16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)CCCCCCCCCCCCCCC)[C@H](C)CCCC(C)C</moldb_smiles>
		<moldb_formula>C43H76O2</moldb_formula>
		<moldb_inchi>InChI=1S/C43H76O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-23-41(44)45-36-28-30-42(5)35(32-36)24-25-37-39-27-26-38(34(4)22-20-21-33(2)3)43(39,6)31-29-40(37)42/h24,33-34,36-40H,7-23,25-32H2,1-6H3/t34-,36+,37+,38-,39+,40+,42+,43-/m1/s1</moldb_inchi>
		<moldb_inchikey>BBJQPKLGPMQWBU-JADYGXMDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>625.0623</moldb_average_mass>
		<moldb_mono_mass>624.584531676</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>953</id>
		<lmdb_id>LMDB00929</lmdb_id>
		<created_at>2016-08-01 22:02:21</created_at>
		<updated_at>2016-08-02 20:40:54</updated_at>
		<export>1</export>
		<name>CE(12:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)CCCCCCCCCCC)[C@H](C)CCCC(C)C</moldb_smiles>
		<moldb_formula>C39H68O2</moldb_formula>
		<moldb_inchi>InChI=1S/C39H68O2/c1-7-8-9-10-11-12-13-14-15-19-37(40)41-32-24-26-38(5)31(28-32)20-21-33-35-23-22-34(30(4)18-16-17-29(2)3)39(35,6)27-25-36(33)38/h20,29-30,32-36H,7-19,21-28H2,1-6H3/t30-,32+,33+,34-,35+,36+,38+,39-/m1/s1</moldb_inchi>
		<moldb_inchikey>RMLFYKFCGMSLTB-ZBDFTZOCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>568.9560</moldb_average_mass>
		<moldb_mono_mass>568.521931420</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>954</id>
		<lmdb_id>LMDB00930</lmdb_id>
		<created_at>2016-08-01 22:02:23</created_at>
		<updated_at>2018-04-30 21:15:09</updated_at>
		<export>1</export>
		<name>TG(16:0/16:0/16:0)[iso]</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]C(COC(=O)CCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C51H98O6</moldb_formula>
		<moldb_inchi>InChI=1S/C51H98O6/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-49(52)55-46-48(57-51(54)45-42-39-36-33-30-27-24-21-18-15-12-9-6-3)47-56-50(53)44-41-38-35-32-29-26-23-20-17-14-11-8-5-2/h48H,4-47H2,1-3H3</moldb_inchi>
		<moldb_inchikey>PVNIQBQSYATKKL-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>807.3202</moldb_average_mass>
		<moldb_mono_mass>806.736340868</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>955</id>
		<lmdb_id>LMDB00931</lmdb_id>
		<created_at>2016-08-01 22:02:31</created_at>
		<updated_at>2016-08-02 20:40:54</updated_at>
		<export>1</export>
		<name>CE(14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)CCCCCCCCCCCCC)[C@H](C)CCCC(C)C</moldb_smiles>
		<moldb_formula>C41H72O2</moldb_formula>
		<moldb_inchi>InChI=1S/C41H72O2/c1-7-8-9-10-11-12-13-14-15-16-17-21-39(42)43-34-26-28-40(5)33(30-34)22-23-35-37-25-24-36(32(4)20-18-19-31(2)3)41(37,6)29-27-38(35)40/h22,31-32,34-38H,7-21,23-30H2,1-6H3/t32-,34+,35+,36-,37+,38+,40+,41-/m1/s1</moldb_inchi>
		<moldb_inchikey>SJDMTGSQPOFVLR-ZPQCIJQQSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>597.0092</moldb_average_mass>
		<moldb_mono_mass>596.553231548</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>956</id>
		<lmdb_id>LMDB00932</lmdb_id>
		<created_at>2016-08-01 22:02:33</created_at>
		<updated_at>2016-08-02 20:40:55</updated_at>
		<export>1</export>
		<name>CE(22:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@]2(C)C3CC[C@]4(C)C(CCC4C3CC=C2C1)[C@H](C)CCCC(C)C</moldb_smiles>
		<moldb_formula>C49H88O2</moldb_formula>
		<moldb_inchi>InChI=1S/C49H88O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-29-47(50)51-42-34-36-48(5)41(38-42)30-31-43-45-33-32-44(40(4)28-26-27-39(2)3)49(45,6)37-35-46(43)48/h30,39-40,42-46H,7-29,31-38H2,1-6H3/t40-,42+,43?,44?,45?,46?,48+,49-/m1/s1</moldb_inchi>
		<moldb_inchikey>WBOQXYUYHINMOC-KNEWWSHNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>709.2218</moldb_average_mass>
		<moldb_mono_mass>708.678432060</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>957</id>
		<lmdb_id>LMDB00933</lmdb_id>
		<created_at>2016-08-01 22:02:34</created_at>
		<updated_at>2016-08-02 20:40:55</updated_at>
		<export>1</export>
		<name>CE(20:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@]2(C)C3CC[C@]4(C)C(CCC4C3CC=C2C1)[C@H](C)CCCC(C)C</moldb_smiles>
		<moldb_formula>C47H84O2</moldb_formula>
		<moldb_inchi>InChI=1S/C47H84O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-27-45(48)49-40-32-34-46(5)39(36-40)28-29-41-43-31-30-42(38(4)26-24-25-37(2)3)47(43,6)35-33-44(41)46/h28,37-38,40-44H,7-27,29-36H2,1-6H3/t38-,40+,41?,42?,43?,44?,46+,47-/m1/s1</moldb_inchi>
		<moldb_inchikey>SUOVMGLZSOAHJY-YEYBIBAWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>681.1687</moldb_average_mass>
		<moldb_mono_mass>680.647131932</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>958</id>
		<lmdb_id>LMDB00934</lmdb_id>
		<created_at>2016-08-01 22:02:36</created_at>
		<updated_at>2016-08-02 20:40:56</updated_at>
		<export>1</export>
		<name>CE(18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@]2(C)C3CC[C@]4(C)C(CCC4C3CC=C2C1)[C@H](C)CCCC(C)C</moldb_smiles>
		<moldb_formula>C45H80O2</moldb_formula>
		<moldb_inchi>InChI=1S/C45H80O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-43(46)47-38-30-32-44(5)37(34-38)26-27-39-41-29-28-40(36(4)24-22-23-35(2)3)45(41,6)33-31-42(39)44/h26,35-36,38-42H,7-25,27-34H2,1-6H3/t36-,38+,39?,40?,41?,42?,44+,45-/m1/s1</moldb_inchi>
		<moldb_inchikey>XHRPOTDGOASDJS-GHOVPUJYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>653.1155</moldb_average_mass>
		<moldb_mono_mass>652.615831804</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>959</id>
		<lmdb_id>LMDB00935</lmdb_id>
		<created_at>2016-08-01 22:02:38</created_at>
		<updated_at>2016-08-02 20:40:56</updated_at>
		<export>1</export>
		<name>CE(24:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@]2(C)C3CC[C@]4(C)C(CCC4C3CC=C2C1)[C@H](C)CCCC(C)C</moldb_smiles>
		<moldb_formula>C51H92O2</moldb_formula>
		<moldb_inchi>InChI=1S/C51H92O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27-31-49(52)53-44-36-38-50(5)43(40-44)32-33-45-47-35-34-46(42(4)30-28-29-41(2)3)51(47,6)39-37-48(45)50/h32,41-42,44-48H,7-31,33-40H2,1-6H3/t42-,44+,45?,46?,47?,48?,50+,51-/m1/s1</moldb_inchi>
		<moldb_inchikey>AMUHTLRUMQYZJF-HVZUPDIGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>737.2750</moldb_average_mass>
		<moldb_mono_mass>736.709732188</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>960</id>
		<lmdb_id>LMDB00936</lmdb_id>
		<created_at>2016-08-01 22:02:39</created_at>
		<updated_at>2016-08-01 22:02:40</updated_at>
		<export>1</export>
		<name>LysoPC(20:4(8Z,11Z,14Z,17Z))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>0</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC\C=C/C\C=C/C\C=C/C\C=C/CCCCCCC(=O)OC[C@](O)([H])COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C28H50NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C28H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-28(31)34-25-27(30)26-36-37(32,33)35-24-23-29(2,3)4/h6-7,9-10,12-13,15-16,27,30H,5,8,11,14,17-26H2,1-4H3/b7-6-,10-9-,13-12-,16-15-/t27-/m1/s1</moldb_inchi>
		<moldb_inchikey>GOMVPVRDBLLHQC-VEJNOCSESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>543.6729</moldb_average_mass>
		<moldb_mono_mass>543.332489471</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>961</id>
		<lmdb_id>LMDB00937</lmdb_id>
		<created_at>2016-08-01 22:02:41</created_at>
		<updated_at>2016-08-02 20:40:41</updated_at>
		<export>1</export>
		<name>TG(16:0/14:0/18:0)[iso6]</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](COC(=O)CCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C51H98O6</moldb_formula>
		<moldb_inchi>InChI=1S/C51H98O6/c1-4-7-10-13-16-19-22-24-25-27-30-32-35-38-41-44-50(53)56-47-48(57-51(54)45-42-39-36-33-28-21-18-15-12-9-6-3)46-55-49(52)43-40-37-34-31-29-26-23-20-17-14-11-8-5-2/h48H,4-47H2,1-3H3/t48-/m1/s1</moldb_inchi>
		<moldb_inchikey>HVGKTEKOBPKGTR-QSCHNALKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>807.3202</moldb_average_mass>
		<moldb_mono_mass>806.736340868</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>962</id>
		<lmdb_id>LMDB00938</lmdb_id>
		<created_at>2016-08-01 22:02:43</created_at>
		<updated_at>2016-08-02 20:40:42</updated_at>
		<export>1</export>
		<name>TG(18:0/14:0/18:1(11Z))[iso6]</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](COC(=O)CCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCC\C=C/CCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C53H100O6</moldb_formula>
		<moldb_inchi>InChI=1S/C53H100O6/c1-4-7-10-13-16-19-22-24-26-28-31-33-36-39-42-45-51(54)57-48-50(59-53(56)47-44-41-38-35-30-21-18-15-12-9-6-3)49-58-52(55)46-43-40-37-34-32-29-27-25-23-20-17-14-11-8-5-2/h19,22,50H,4-18,20-21,23-49H2,1-3H3/b22-19-/t50-/m0/s1</moldb_inchi>
		<moldb_inchikey>MITUBFKADCJAMS-ZMSSUMMHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>833.3575</moldb_average_mass>
		<moldb_mono_mass>832.751990932</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>963</id>
		<lmdb_id>LMDB00939</lmdb_id>
		<created_at>2016-08-01 22:02:45</created_at>
		<updated_at>2016-08-02 20:40:56</updated_at>
		<export>1</export>
		<name>12-Hydroxy-12-octadecanoylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCC(O)CCCCCCCCCCC(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C25H49NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C25H49NO5/c1-5-6-7-14-17-22(27)18-15-12-10-8-9-11-13-16-19-25(30)31-23(20-24(28)29)21-26(2,3)4/h22-23,27H,5-21H2,1-4H3</moldb_inchi>
		<moldb_inchikey>QAIWREXEZLJMTC-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>443.6603</moldb_average_mass>
		<moldb_mono_mass>443.361073683</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>964</id>
		<lmdb_id>LMDB00940</lmdb_id>
		<created_at>2016-08-01 22:02:47</created_at>
		<updated_at>2016-08-02 20:40:57</updated_at>
		<export>1</export>
		<name>2-Hexenoylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC\C=C\C(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C13H23NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C13H23NO4/c1-5-6-7-8-13(17)18-11(9-12(15)16)10-14(2,3)4/h7-8,11H,5-6,9-10H2,1-4H3/b8-7+</moldb_inchi>
		<moldb_inchikey>JUAQYRSUSCWTQK-BQYQJAHWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>257.3260</moldb_average_mass>
		<moldb_mono_mass>257.162708229</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>965</id>
		<lmdb_id>LMDB00941</lmdb_id>
		<created_at>2016-08-01 22:02:48</created_at>
		<updated_at>2016-08-02 20:40:57</updated_at>
		<export>1</export>
		<name>3-Hydroxyhexadecanoylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(O)CC(=O)O[C@@H](CCC([O-])=O)[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C23H45NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C23H45NO5/c1-5-6-7-8-9-10-11-12-13-14-15-16-20(25)19-23(28)29-21(24(2,3)4)17-18-22(26)27/h20-21,25H,5-19H2,1-4H3/t20?,21-/m0/s1</moldb_inchi>
		<moldb_inchikey>MHJOYNGEDDXLLU-LBAQZLPGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>415.6071</moldb_average_mass>
		<moldb_mono_mass>415.329773555</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>966</id>
		<lmdb_id>LMDB00942</lmdb_id>
		<created_at>2016-08-01 22:02:51</created_at>
		<updated_at>2016-08-02 20:40:57</updated_at>
		<export>1</export>
		<name>CE(15:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](C)(CCCC(C)C)C1([H])CC[C@]2([H])[C@@]3([H])CC=C4C[C@@]([H])(CC[C@@]4(C)[C@]3([H])CC[C@@]12C)OC(=O)CCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C42H74O2</moldb_formula>
		<moldb_inchi>InChI=1S/C42H74O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-22-40(43)44-35-27-29-41(5)34(31-35)23-24-36-38-26-25-37(33(4)21-19-20-32(2)3)42(38,6)30-28-39(36)41/h23,32-33,35-39H,7-22,24-31H2,1-6H3/t33-,35+,36+,37?,38+,39+,41+,42-/m0/s1</moldb_inchi>
		<moldb_inchikey>BDBPUUADYAQHAV-SEPWIHNRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>611.0520</moldb_average_mass>
		<moldb_mono_mass>610.568881623</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>967</id>
		<lmdb_id>LMDB00943</lmdb_id>
		<created_at>2016-08-01 23:24:13</created_at>
		<updated_at>2016-08-02 20:40:42</updated_at>
		<export>1</export>
		<name>3'-Sialyllactosamine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)N[C@@H]1[C@@H](O)C[C@@](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](N)C=O)[C@@H]2O)(OC1[C@H](O)[C@H](O)CO)C(O)=O</moldb_smiles>
		<moldb_formula>C23H40N2O18</moldb_formula>
		<moldb_inchi>InChI=1S/C23H40N2O18/c1-7(30)25-13-9(31)2-23(22(38)39,42-19(13)15(35)10(32)4-27)43-20-16(36)12(6-29)40-21(17(20)37)41-18(11(33)5-28)14(34)8(24)3-26/h3,8-21,27-29,31-37H,2,4-6,24H2,1H3,(H,25,30)(H,38,39)/t8-,9-,10+,11+,12+,13+,14+,15+,16-,17+,18+,19?,20-,21-,23-/m0/s1</moldb_inchi>
		<moldb_inchikey>MKNNYTWMAUAKMA-FRLIKFETSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>632.5663</moldb_average_mass>
		<moldb_mono_mass>632.227612486</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>968</id>
		<lmdb_id>LMDB00944</lmdb_id>
		<created_at>2016-08-01 23:24:15</created_at>
		<updated_at>2016-08-02 20:40:43</updated_at>
		<export>1</export>
		<name>Indoxyl</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC1=CNC2=CC=CC=C12</moldb_smiles>
		<moldb_formula>C8H7NO</moldb_formula>
		<moldb_inchi>InChI=1S/C8H7NO/c10-8-5-9-7-4-2-1-3-6(7)8/h1-5,9-10H</moldb_inchi>
		<moldb_inchikey>PCKPVGOLPKLUHR-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>133.1473</moldb_average_mass>
		<moldb_mono_mass>133.052763851</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>969</id>
		<lmdb_id>LMDB00945</lmdb_id>
		<created_at>2016-08-01 23:24:17</created_at>
		<updated_at>2016-08-02 20:40:44</updated_at>
		<export>1</export>
		<name>19-Hydroxyandrostendione</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CCC[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2([H])C=CC(=O)C(=O)[C@]12CO</moldb_smiles>
		<moldb_formula>C19H26O3</moldb_formula>
		<moldb_inchi>InChI=1S/C19H26O3/c1-18-9-2-3-14(18)13-6-4-12-5-7-16(21)17(22)19(12,11-20)15(13)8-10-18/h5,7,12-15,20H,2-4,6,8-11H2,1H3/t12?,13-,14-,15-,18-,19-/m0/s1</moldb_inchi>
		<moldb_inchikey>MMFXYRUVLDPUFI-YQQVEUKQSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>302.4140</moldb_average_mass>
		<moldb_mono_mass>302.188194697</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>970</id>
		<lmdb_id>LMDB00946</lmdb_id>
		<created_at>2016-08-01 23:24:19</created_at>
		<updated_at>2016-08-02 20:40:45</updated_at>
		<export>1</export>
		<name>2-Methoxyestrone</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(OC)=C3</moldb_smiles>
		<moldb_formula>C19H24O3</moldb_formula>
		<moldb_inchi>InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,20H,3-8H2,1-2H3/t12-,13+,15-,19-/m0/s1</moldb_inchi>
		<moldb_inchikey>WHEUWNKSCXYKBU-QPWUGHHJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>300.3921</moldb_average_mass>
		<moldb_mono_mass>300.172544634</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>971</id>
		<lmdb_id>LMDB00947</lmdb_id>
		<created_at>2016-08-01 23:24:21</created_at>
		<updated_at>2016-08-02 20:40:47</updated_at>
		<export>1</export>
		<name>Triiodothyronine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O</moldb_smiles>
		<moldb_formula>C15H12I3NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1</moldb_inchi>
		<moldb_inchikey>AUYYCJSJGJYCDS-LBPRGKRZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>650.9735</moldb_average_mass>
		<moldb_mono_mass>650.790038137</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>972</id>
		<lmdb_id>LMDB00948</lmdb_id>
		<created_at>2016-08-01 23:24:22</created_at>
		<updated_at>2016-08-02 20:40:47</updated_at>
		<export>1</export>
		<name>2-(Furan-2-ylmethyldisulfanylmethyl)furan</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C(SSCC1=CC=CO1)C1=CC=CO1</moldb_smiles>
		<moldb_formula>C10H10O2S2</moldb_formula>
		<moldb_inchi>InChI=1S/C10H10O2S2/c1-3-9(11-5-1)7-13-14-8-10-4-2-6-12-10/h1-6H,7-8H2</moldb_inchi>
		<moldb_inchikey>CBJPZHSWLMJQRI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>226.3150</moldb_average_mass>
		<moldb_mono_mass>226.012220944</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>973</id>
		<lmdb_id>LMDB00949</lmdb_id>
		<created_at>2016-08-01 23:24:26</created_at>
		<updated_at>2016-08-02 20:40:48</updated_at>
		<export>1</export>
		<name>Suberylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](CC(O)=O)(C[N+](C)(C)C)OC(=O)CCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C15H28NO6</moldb_formula>
		<moldb_inchi>InChI=1S/C15H27NO6/c1-16(2,3)11-12(10-14(19)20)22-15(21)9-7-5-4-6-8-13(17)18/h12H,4-11H2,1-3H3,(H-,17,18,19,20)/p+1/t12-/m1/s1</moldb_inchi>
		<moldb_inchikey>YVWVEIPYMGBQPE-GFCCVEGCSA-O</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>318.3890</moldb_average_mass>
		<moldb_mono_mass>318.191114046</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>974</id>
		<lmdb_id>LMDB00950</lmdb_id>
		<created_at>2016-08-01 23:24:28</created_at>
		<updated_at>2016-08-02 20:40:58</updated_at>
		<export>1</export>
		<name>Sodium Chloride</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[Na+].[Cl-]</moldb_smiles>
		<moldb_formula>ClNa</moldb_formula>
		<moldb_inchi>InChI=1S/ClH.Na/h1H;/q;+1/p-1</moldb_inchi>
		<moldb_inchikey>FAPWRFPIFSIZLT-UHFFFAOYSA-M</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>58.4430</moldb_average_mass>
		<moldb_mono_mass>57.958622382</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>975</id>
		<lmdb_id>LMDB00951</lmdb_id>
		<created_at>2016-08-04 21:12:55</created_at>
		<updated_at>2016-08-04 22:06:18</updated_at>
		<export>1</export>
		<name>1-Furan-2-ylpropan-2-one</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(=O)CC1=CC=CO1</moldb_smiles>
		<moldb_formula>C7H8O2</moldb_formula>
		<moldb_inchi>InChI=1S/C7H8O2/c1-6(8)5-7-3-2-4-9-7/h2-4H,5H2,1H3</moldb_inchi>
		<moldb_inchikey>IQOJTGSBENZIOL-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>124.1372</moldb_average_mass>
		<moldb_mono_mass>124.052429500</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>977</id>
		<lmdb_id>LMDB00953</lmdb_id>
		<created_at>2016-08-04 21:13:02</created_at>
		<updated_at>2016-08-04 22:06:18</updated_at>
		<export>1</export>
		<name>4-methoxyestrone</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])C3=C(CC[C@]21[H])C(OC)=C(O)C=C3</moldb_smiles>
		<moldb_formula>C19H24O3</moldb_formula>
		<moldb_inchi>InChI=1S/C19H24O3/c1-19-10-9-12-11-5-7-16(20)18(22-2)14(11)4-3-13(12)15(19)6-8-17(19)21/h5,7,12-13,15,20H,3-4,6,8-10H2,1-2H3/t12-,13-,15+,19-/m0/s1</moldb_inchi>
		<moldb_inchikey>PUEXVLNGOBYUEW-AEVLCDIHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>300.3980</moldb_average_mass>
		<moldb_mono_mass>300.172544633</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>978</id>
		<lmdb_id>LMDB00954</lmdb_id>
		<created_at>2016-08-04 21:13:03</created_at>
		<updated_at>2016-08-04 22:06:19</updated_at>
		<export>1</export>
		<name>9(Z),12(Z)-Hexadecadienoylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC\C=C/C\C=C/CCCCCCCC(=O)O[C@H]([N+](C)(C)C)CCC([O-])=O</moldb_smiles>
		<moldb_formula>C23H41NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C23H41NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(27)28-21(24(2,3)4)19-20-22(25)26/h7-8,10-11,21H,5-6,9,12-20H2,1-4H3/b8-7-,11-10-/t21-/m0/s1</moldb_inchi>
		<moldb_inchikey>AHZCIODFJPNPKS-XBDLETADSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>395.5759</moldb_average_mass>
		<moldb_mono_mass>395.303558805</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>979</id>
		<lmdb_id>LMDB00955</lmdb_id>
		<created_at>2016-08-04 21:13:08</created_at>
		<updated_at>2016-08-04 22:06:18</updated_at>
		<export>1</export>
		<name>CE(18:2(9,11))</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCCC)=C(\[H])/C(/[H])=C(/[H])CCCCCCCC(=O)O[C@@]1([H])CC[C@@]2(C)C(C1)=CC[C@@]1([H])[C@]3([H])CC[C@]([H])([C@]([H])(C)CCCC(C)C)[C@@]3(C)CC[C@]21[H]</moldb_smiles>
		<moldb_formula>C45H76O2</moldb_formula>
		<moldb_inchi>InChI=1S/C45H76O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-43(46)47-38-30-32-44(5)37(34-38)26-27-39-41-29-28-40(36(4)24-22-23-35(2)3)45(41,6)33-31-42(39)44/h12-15,26,35-36,38-42H,7-11,16-25,27-34H2,1-6H3/b13-12+,15-14-/t36-,38+,39+,40-,41+,42+,44+,45-/m1/s1</moldb_inchi>
		<moldb_inchikey>QSYLQVWJIMNXAX-HIAMTALESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>649.1010</moldb_average_mass>
		<moldb_mono_mass>648.584531687</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>980</id>
		<lmdb_id>LMDB00956</lmdb_id>
		<created_at>2016-08-04 21:13:15</created_at>
		<updated_at>2016-08-04 22:06:15</updated_at>
		<export>1</export>
		<name>Disialoganglioside Ib</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]C(CCCCCCCCCCCCC)=C([H])C([H])(O)C([H])(CO[C@]1([H])O[C@]([H])(CO)[C@@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@]([H])(O[C@]3([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O[C@]4([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]4([H])O)[C@@]3([H])N=C(C)O)[C@]([H])(O[C@@]3(C[C@]([H])(O)[C@@]([H])(N=C(C)O)[C@@]([H])(O3)[C@]([H])(O)[C@@]([H])(CO)O[C@@]3(C[C@]([H])(O)[C@@]([H])(N=C(O)CO)[C@@]([H])(O3)[C@]([H])(O)[C@]([H])(O)CO)C(O)=O)C(O)=O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O)N=C(O)CCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C84H148N4O40</moldb_formula>
		<moldb_inchi>InChI=1S/C84H148N4O40/c1-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-57(102)87-47(48(98)33-31-29-27-25-23-21-18-16-14-12-10-8-6-2)44-117-78-69(111)67(109)71(55(41-93)120-78)122-80-70(112)76(72(56(42-94)121-80)123-77-61(86-46(4)97)73(64(106)53(39-91)118-77)124-79-68(110)66(108)63(105)52(38-90)119-79)128-84(82(115)116)36-49(99)59(85-45(3)96)75(127-84)65(107)54(40-92)125-83(81(113)114)35-50(100)60(88-58(103)43-95)74(126-83)62(104)51(101)37-89/h31,33,47-56,59-80,89-95,98-101,104-112H,5-30,32,34-44H2,1-4H3,(H,85,96)(H,86,97)(H,87,102)(H,88,103)(H,113,114)(H,115,116)/b33-31+/t47?,48?,49-,50-,51+,52+,53+,54+,55+,56+,59+,60+,61+,62+,63-,64-,65+,66-,67+,68+,69+,70+,71+,72-,73+,74+,75+,76+,77-,78+,79-,80-,83+,84-/m0/s1</moldb_inchi>
		<moldb_inchikey>VPUOVUBYFYUBRY-INNWTUFDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>1854.0960</moldb_average_mass>
		<moldb_mono_mass>1852.966985582</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>981</id>
		<lmdb_id>LMDB00957</lmdb_id>
		<created_at>2016-08-04 21:13:21</created_at>
		<updated_at>2016-08-04 22:06:15</updated_at>
		<export>1</export>
		<name>Monosialoganglioside GM1</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCCCCCCCCCC)=C(\[H])C([H])(O)C([H])(CO[C@]1([H])O[C@]([H])(CO)[C@@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@]([H])(O[C@]3([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O[C@]4([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]4([H])O)[C@@]3([H])N=C(C)O)[C@]([H])(O[C@@]3(C[C@]([H])(O)[C@@]([H])(N=C(C)O)[C@]([H])(O3)C([H])(O)C([H])(O)CO)C(O)=O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O)N=C(O)CCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C73H131N3O31</moldb_formula>
		<moldb_inchi>InChI=1S/C73H131N3O31/c1-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-52(87)76-44(45(84)33-31-29-27-25-23-21-18-16-14-12-10-8-6-2)41-98-69-61(94)59(92)63(50(39-80)101-69)103-71-62(95)67(107-73(72(96)97)35-46(85)53(74-42(3)82)66(106-73)55(88)47(86)36-77)64(51(40-81)102-71)104-68-54(75-43(4)83)65(57(90)49(38-79)99-68)105-70-60(93)58(91)56(89)48(37-78)100-70/h31,33,44-51,53-71,77-81,84-86,88-95H,5-30,32,34-41H2,1-4H3,(H,74,82)(H,75,83)(H,76,87)(H,96,97)/b33-31+/t44?,45?,46-,47?,48+,49+,50+,51+,53+,54+,55?,56-,57-,58-,59+,60+,61+,62+,63+,64-,65+,66-,67+,68-,69+,70-,71-,73-/m0/s1</moldb_inchi>
		<moldb_inchikey>QPJBWNIQKHGLAU-BVLUPYCXSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>1546.8410</moldb_average_mass>
		<moldb_mono_mass>1545.876654450</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>982</id>
		<lmdb_id>LMDB00958</lmdb_id>
		<created_at>2016-08-04 21:13:27</created_at>
		<updated_at>2016-08-04 22:06:16</updated_at>
		<export>1</export>
		<name>Monosialoganglioside GM2</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCCCCCCCCCC)=C(\[H])[C@]([H])(O)[C@@]([H])(CO[C@]1([H])O[C@@]([H])(CO)[C@]([H])(O[C@@]2([H])O[C@@]([H])(CO)[C@@]([H])(O[C@@]3([H])O[C@@]([H])(CO)[C@@]([H])(O)[C@@]([H])(O)[C@]3([H])N=C(C)O)[C@@]([H])(OC[C@]3(C[C@@]([H])(O)[C@]([H])(N=C(C)O)[C@]([H])(O3)[C@@]([H])(O)[C@@]([H])(O)CO)C(O)=O)[C@]2([H])O)[C@@]([H])(O)[C@]1([H])O)N=C(O)CCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C68H123N3O26</moldb_formula>
		<moldb_inchi>InChI=1S/C68H123N3O26/c1-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-51(81)71-44(45(78)33-31-29-27-25-23-21-18-16-14-12-10-8-6-2)40-90-65-58(86)57(85)60(49(38-74)93-65)95-66-59(87)63(61(50(39-75)94-66)96-64-53(70-43(4)77)56(84)55(83)48(37-73)92-64)91-41-68(67(88)89)35-46(79)52(69-42(3)76)62(97-68)54(82)47(80)36-72/h31,33,44-50,52-66,72-75,78-80,82-87H,5-30,32,34-41H2,1-4H3,(H,69,76)(H,70,77)(H,71,81)(H,88,89)/b33-31+/t44-,45+,46-,47+,48+,49+,50+,52+,53+,54+,55-,56+,57+,58+,59+,60+,61-,62+,63+,64-,65-,66-,68-/m1/s1</moldb_inchi>
		<moldb_inchikey>USMMPBVNWHAJBE-YMEOXFOQSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>1398.7270</moldb_average_mass>
		<moldb_mono_mass>1397.839481093</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>983</id>
		<lmdb_id>LMDB00959</lmdb_id>
		<created_at>2016-08-04 21:13:33</created_at>
		<updated_at>2016-08-04 22:06:16</updated_at>
		<export>1</export>
		<name>Monosialoganglioside GM3</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCCCCC)=C(/[H])CCCCCCCCCCCCCC(O)=N[C@@]([H])(CO[C@]1([H])O[C@]([H])(CO)[C@@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O[C@@]3(C[C@]([H])(O)[C@@]([H])(N=C(C)O)[C@@]([H])(O3)[C@]([H])(O)[C@]([H])(O)CO)C(O)=O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O)[C@]([H])(O)C(\[H])=C(/[H])CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C65H118N2O21</moldb_formula>
		<moldb_inchi>InChI=1S/C65H118N2O21/c1-4-6-8-10-12-14-16-18-19-20-21-22-23-24-25-27-29-31-33-35-37-39-52(75)67-46(47(72)38-36-34-32-30-28-26-17-15-13-11-9-7-5-2)44-83-62-57(79)56(78)59(51(43-70)85-62)86-63-58(80)61(55(77)50(42-69)84-63)88-65(64(81)82)40-48(73)53(66-45(3)71)60(87-65)54(76)49(74)41-68/h18-19,36,38,46-51,53-63,68-70,72-74,76-80H,4-17,20-35,37,39-44H2,1-3H3,(H,66,71)(H,67,75)(H,81,82)/b19-18-,38-36+/t46-,47+,48-,49+,50+,51+,53+,54+,55-,56+,57+,58+,59+,60+,61-,62+,63-,65-/m0/s1</moldb_inchi>
		<moldb_inchikey>PFJKOHUKELZMLE-VEUXDRLPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>1263.6520</moldb_average_mass>
		<moldb_mono_mass>1262.822708828</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>984</id>
		<lmdb_id>LMDB00960</lmdb_id>
		<created_at>2016-08-04 21:13:40</created_at>
		<updated_at>2016-08-04 22:06:05</updated_at>
		<export>1</export>
		<name>TG(14:0/14:0/4:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C35H66O6</moldb_formula>
		<moldb_inchi>InChI=1S/C35H66O6/c1-4-7-9-11-13-15-17-19-21-23-25-28-34(37)40-31-32(30-39-33(36)27-6-3)41-35(38)29-26-24-22-20-18-16-14-12-10-8-5-2/h32H,4-31H2,1-3H3</moldb_inchi>
		<moldb_inchikey>CPUBTQNPGNMTLT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>582.9070</moldb_average_mass>
		<moldb_mono_mass>582.485939845</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>985</id>
		<lmdb_id>LMDB00961</lmdb_id>
		<created_at>2016-08-04 21:13:45</created_at>
		<updated_at>2016-08-04 22:06:06</updated_at>
		<export>1</export>
		<name>TG(14:0/14:0/6:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C37H70O6</moldb_formula>
		<moldb_inchi>InChI=1S/C37H70O6/c1-4-7-10-12-14-16-18-20-22-24-27-30-36(39)42-33-34(32-41-35(38)29-26-9-6-3)43-37(40)31-28-25-23-21-19-17-15-13-11-8-5-2/h34H,4-33H2,1-3H3</moldb_inchi>
		<moldb_inchikey>RLJXXZJSIPCFFV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>610.9610</moldb_average_mass>
		<moldb_mono_mass>610.517239974</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>986</id>
		<lmdb_id>LMDB00962</lmdb_id>
		<created_at>2016-08-04 21:13:51</created_at>
		<updated_at>2016-08-04 22:06:06</updated_at>
		<export>1</export>
		<name>TG(14:0/16:0/4:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC)COC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C37H70O6</moldb_formula>
		<moldb_inchi>InChI=1S/C37H70O6/c1-4-7-9-11-13-15-17-18-20-22-24-26-28-31-37(40)43-34(32-41-35(38)29-6-3)33-42-36(39)30-27-25-23-21-19-16-14-12-10-8-5-2/h34H,4-33H2,1-3H3</moldb_inchi>
		<moldb_inchikey>SQKOCYHMNMIISZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>610.9610</moldb_average_mass>
		<moldb_mono_mass>610.517239974</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>987</id>
		<lmdb_id>LMDB00963</lmdb_id>
		<created_at>2016-08-04 21:13:56</created_at>
		<updated_at>2016-08-04 22:06:06</updated_at>
		<export>1</export>
		<name>TG(14:0/16:0/6:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC)COC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C39H74O6</moldb_formula>
		<moldb_inchi>InChI=1S/C39H74O6/c1-4-7-10-12-14-16-18-19-21-23-25-27-30-33-39(42)45-36(34-43-37(40)31-28-9-6-3)35-44-38(41)32-29-26-24-22-20-17-15-13-11-8-5-2/h36H,4-35H2,1-3H3</moldb_inchi>
		<moldb_inchikey>DWIUNYGOSZKHPJ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>639.0150</moldb_average_mass>
		<moldb_mono_mass>638.548540103</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>988</id>
		<lmdb_id>LMDB00964</lmdb_id>
		<created_at>2016-08-04 21:14:01</created_at>
		<updated_at>2016-08-04 22:06:07</updated_at>
		<export>1</export>
		<name>TG(16:0/10:0/4:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCC</moldb_smiles>
		<moldb_formula>C33H62O6</moldb_formula>
		<moldb_inchi>InChI=1S/C33H62O6/c1-4-7-9-11-13-14-15-16-17-18-20-21-23-26-32(35)38-29-30(28-37-31(34)25-6-3)39-33(36)27-24-22-19-12-10-8-5-2/h30H,4-29H2,1-3H3</moldb_inchi>
		<moldb_inchikey>NMPTUNQSGSBSHZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>554.8530</moldb_average_mass>
		<moldb_mono_mass>554.454639716</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>989</id>
		<lmdb_id>LMDB00965</lmdb_id>
		<created_at>2016-08-04 21:14:07</created_at>
		<updated_at>2016-08-04 22:06:07</updated_at>
		<export>1</export>
		<name>TG(16:0/10:0/6:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCC</moldb_smiles>
		<moldb_formula>C35H66O6</moldb_formula>
		<moldb_inchi>InChI=1S/C35H66O6/c1-4-7-10-12-14-15-16-17-18-19-21-22-25-28-34(37)40-31-32(30-39-33(36)27-24-9-6-3)41-35(38)29-26-23-20-13-11-8-5-2/h32H,4-31H2,1-3H3</moldb_inchi>
		<moldb_inchikey>QKLBUEWDUVXZCS-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>582.9070</moldb_average_mass>
		<moldb_mono_mass>582.485939845</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>990</id>
		<lmdb_id>LMDB00966</lmdb_id>
		<created_at>2016-08-04 21:14:12</created_at>
		<updated_at>2016-08-04 22:06:08</updated_at>
		<export>1</export>
		<name>TG(16:0/12:0/4:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C35H66O6</moldb_formula>
		<moldb_inchi>InChI=1S/C35H66O6/c1-4-7-9-11-13-15-16-17-18-20-21-23-25-28-34(37)40-31-32(30-39-33(36)27-6-3)41-35(38)29-26-24-22-19-14-12-10-8-5-2/h32H,4-31H2,1-3H3</moldb_inchi>
		<moldb_inchikey>DNRWLLOQTTWJKS-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>582.9070</moldb_average_mass>
		<moldb_mono_mass>582.485939845</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>991</id>
		<lmdb_id>LMDB00967</lmdb_id>
		<created_at>2016-08-04 21:14:18</created_at>
		<updated_at>2016-08-04 22:06:08</updated_at>
		<export>1</export>
		<name>TG(16:0/12:0/6:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C37H70O6</moldb_formula>
		<moldb_inchi>InChI=1S/C37H70O6/c1-4-7-10-12-14-16-17-18-19-21-22-24-27-30-36(39)42-33-34(32-41-35(38)29-26-9-6-3)43-37(40)31-28-25-23-20-15-13-11-8-5-2/h34H,4-33H2,1-3H3</moldb_inchi>
		<moldb_inchikey>OGVRYRODVYXWHK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>610.9610</moldb_average_mass>
		<moldb_mono_mass>610.517239974</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>992</id>
		<lmdb_id>LMDB00968</lmdb_id>
		<created_at>2016-08-04 21:14:23</created_at>
		<updated_at>2016-08-04 22:06:09</updated_at>
		<export>1</export>
		<name>TG(16:0/14:0/10:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C43H82O6</moldb_formula>
		<moldb_inchi>InChI=1S/C43H82O6/c1-4-7-10-13-16-18-20-21-23-24-27-30-33-36-42(45)48-39-40(38-47-41(44)35-32-29-26-15-12-9-6-3)49-43(46)37-34-31-28-25-22-19-17-14-11-8-5-2/h40H,4-39H2,1-3H3</moldb_inchi>
		<moldb_inchikey>SMIGULGEODNQEX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>695.1230</moldb_average_mass>
		<moldb_mono_mass>694.611140360</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>993</id>
		<lmdb_id>LMDB00969</lmdb_id>
		<created_at>2016-08-04 21:14:24</created_at>
		<updated_at>2016-08-04 22:06:09</updated_at>
		<export>1</export>
		<name>TG(16:0/14:0/14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C47H90O6</moldb_formula>
		<moldb_inchi>InChI=1S/C47H90O6/c1-4-7-10-13-16-19-22-23-26-28-31-34-37-40-46(49)52-43-44(53-47(50)41-38-35-32-29-25-21-18-15-12-9-6-3)42-51-45(48)39-36-33-30-27-24-20-17-14-11-8-5-2/h44H,4-43H2,1-3H3</moldb_inchi>
		<moldb_inchikey>AMXRERGJDVUTMF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>751.2139</moldb_average_mass>
		<moldb_mono_mass>750.673740612</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>994</id>
		<lmdb_id>LMDB00970</lmdb_id>
		<created_at>2016-08-04 21:14:26</created_at>
		<updated_at>2016-08-04 22:06:09</updated_at>
		<export>1</export>
		<name>TG(16:0/14:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]C(COC(=O)CCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C49H94O6</moldb_formula>
		<moldb_inchi>InChI=1S/C49H94O6/c1-4-7-10-13-16-19-22-24-27-29-32-35-38-41-47(50)53-44-46(55-49(52)43-40-37-34-31-26-21-18-15-12-9-6-3)45-54-48(51)42-39-36-33-30-28-25-23-20-17-14-11-8-5-2/h46H,4-45H2,1-3H3</moldb_inchi>
		<moldb_inchikey>NSQZMMPMMBEIIA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>779.2671</moldb_average_mass>
		<moldb_mono_mass>778.705040740</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>995</id>
		<lmdb_id>LMDB00971</lmdb_id>
		<created_at>2016-08-04 21:14:31</created_at>
		<updated_at>2016-08-04 22:06:10</updated_at>
		<export>1</export>
		<name>TG(16:0/14:0/4:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C37H70O6</moldb_formula>
		<moldb_inchi>InChI=1S/C37H70O6/c1-4-7-9-11-13-15-17-18-20-21-23-25-27-30-36(39)42-33-34(32-41-35(38)29-6-3)43-37(40)31-28-26-24-22-19-16-14-12-10-8-5-2/h34H,4-33H2,1-3H3</moldb_inchi>
		<moldb_inchikey>ZRSCOWDQAGAMTK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>610.9610</moldb_average_mass>
		<moldb_mono_mass>610.517239974</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>996</id>
		<lmdb_id>LMDB00972</lmdb_id>
		<created_at>2016-08-04 21:14:36</created_at>
		<updated_at>2016-08-04 22:06:10</updated_at>
		<export>1</export>
		<name>TG(16:0/14:0/6:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C39H74O6</moldb_formula>
		<moldb_inchi>InChI=1S/C39H74O6/c1-4-7-10-12-14-16-18-19-21-22-24-26-29-32-38(41)44-35-36(34-43-37(40)31-28-9-6-3)45-39(42)33-30-27-25-23-20-17-15-13-11-8-5-2/h36H,4-35H2,1-3H3</moldb_inchi>
		<moldb_inchikey>CRYHRFJZXLSNCF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>639.0150</moldb_average_mass>
		<moldb_mono_mass>638.548540103</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>997</id>
		<lmdb_id>LMDB00973</lmdb_id>
		<created_at>2016-08-04 21:14:41</created_at>
		<updated_at>2016-08-04 22:06:11</updated_at>
		<export>1</export>
		<name>TG(16:0/16:0/10:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C45H86O6</moldb_formula>
		<moldb_inchi>InChI=1S/C45H86O6/c1-4-7-10-13-16-18-20-22-24-26-29-32-35-38-44(47)50-41-42(40-49-43(46)37-34-31-28-15-12-9-6-3)51-45(48)39-36-33-30-27-25-23-21-19-17-14-11-8-5-2/h42H,4-41H2,1-3H3</moldb_inchi>
		<moldb_inchikey>WBURFJXMBPWRIG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>723.1770</moldb_average_mass>
		<moldb_mono_mass>722.642440489</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>998</id>
		<lmdb_id>LMDB00974</lmdb_id>
		<created_at>2016-08-04 21:14:47</created_at>
		<updated_at>2016-08-04 22:06:11</updated_at>
		<export>1</export>
		<name>TG(16:0/16:0/12:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C47H90O6</moldb_formula>
		<moldb_inchi>InChI=1S/C47H90O6/c1-4-7-10-13-16-19-21-23-25-28-31-34-37-40-46(49)52-43-44(42-51-45(48)39-36-33-30-27-18-15-12-9-6-3)53-47(50)41-38-35-32-29-26-24-22-20-17-14-11-8-5-2/h44H,4-43H2,1-3H3</moldb_inchi>
		<moldb_inchikey>ZCHDZACIKMGEJU-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>751.2310</moldb_average_mass>
		<moldb_mono_mass>750.673740618</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>999</id>
		<lmdb_id>LMDB00975</lmdb_id>
		<created_at>2016-08-04 21:14:48</created_at>
		<updated_at>2016-08-04 22:06:11</updated_at>
		<export>1</export>
		<name>TG(16:0/16:0/14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C49H94O6</moldb_formula>
		<moldb_inchi>InChI=1S/C49H94O6/c1-4-7-10-13-16-19-22-24-27-30-33-36-39-42-48(51)54-45-46(44-53-47(50)41-38-35-32-29-26-21-18-15-12-9-6-3)55-49(52)43-40-37-34-31-28-25-23-20-17-14-11-8-5-2/h46H,4-45H2,1-3H3</moldb_inchi>
		<moldb_inchikey>JWVXCFSNEOMSHH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>779.2671</moldb_average_mass>
		<moldb_mono_mass>778.705040740</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1000</id>
		<lmdb_id>LMDB00976</lmdb_id>
		<created_at>2016-08-04 21:14:53</created_at>
		<updated_at>2016-08-04 22:06:12</updated_at>
		<export>1</export>
		<name>TG(16:0/16:0/4:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C39H74O6</moldb_formula>
		<moldb_inchi>InChI=1S/C39H74O6/c1-4-7-9-11-13-15-17-19-21-23-25-27-29-32-38(41)44-35-36(34-43-37(40)31-6-3)45-39(42)33-30-28-26-24-22-20-18-16-14-12-10-8-5-2/h36H,4-35H2,1-3H3</moldb_inchi>
		<moldb_inchikey>SPNPZKFZBBJGJK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>639.0150</moldb_average_mass>
		<moldb_mono_mass>638.548540103</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1001</id>
		<lmdb_id>LMDB00977</lmdb_id>
		<created_at>2016-08-04 21:14:59</created_at>
		<updated_at>2016-08-04 22:06:12</updated_at>
		<export>1</export>
		<name>TG(16:0/16:0/6:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C41H78O6</moldb_formula>
		<moldb_inchi>InChI=1S/C41H78O6/c1-4-7-10-12-14-16-18-20-22-24-26-28-31-34-40(43)46-37-38(36-45-39(42)33-30-9-6-3)47-41(44)35-32-29-27-25-23-21-19-17-15-13-11-8-5-2/h38H,4-37H2,1-3H3</moldb_inchi>
		<moldb_inchikey>SAYUNMDZOOEJHF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>667.0690</moldb_average_mass>
		<moldb_mono_mass>666.579840232</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1002</id>
		<lmdb_id>LMDB00978</lmdb_id>
		<created_at>2016-08-04 21:15:04</created_at>
		<updated_at>2016-08-04 22:06:13</updated_at>
		<export>1</export>
		<name>TG(16:0/16:0/8:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C43H82O6</moldb_formula>
		<moldb_inchi>InChI=1S/C43H82O6/c1-4-7-10-13-15-17-19-21-23-25-27-30-33-36-42(45)48-39-40(38-47-41(44)35-32-29-12-9-6-3)49-43(46)37-34-31-28-26-24-22-20-18-16-14-11-8-5-2/h40H,4-39H2,1-3H3</moldb_inchi>
		<moldb_inchikey>RFWJYKONNDGWCW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>695.1230</moldb_average_mass>
		<moldb_mono_mass>694.611140360</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1003</id>
		<lmdb_id>LMDB00979</lmdb_id>
		<created_at>2016-08-04 21:15:09</created_at>
		<updated_at>2016-08-04 22:06:13</updated_at>
		<export>1</export>
		<name>TG(16:0/18:0/4:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC)COC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C41H78O6</moldb_formula>
		<moldb_inchi>InChI=1S/C41H78O6/c1-4-7-9-11-13-15-17-19-20-22-24-26-28-30-32-35-41(44)47-38(36-45-39(42)33-6-3)37-46-40(43)34-31-29-27-25-23-21-18-16-14-12-10-8-5-2/h38H,4-37H2,1-3H3</moldb_inchi>
		<moldb_inchikey>QDICJGWYEVKHJA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>667.0690</moldb_average_mass>
		<moldb_mono_mass>666.579840232</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1004</id>
		<lmdb_id>LMDB00980</lmdb_id>
		<created_at>2016-08-04 21:15:15</created_at>
		<updated_at>2016-08-04 22:06:13</updated_at>
		<export>1</export>
		<name>TG(18:0/14:0/4:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C39H74O6</moldb_formula>
		<moldb_inchi>InChI=1S/C39H74O6/c1-4-7-9-11-13-15-17-18-19-20-22-23-25-27-29-32-38(41)44-35-36(34-43-37(40)31-6-3)45-39(42)33-30-28-26-24-21-16-14-12-10-8-5-2/h36H,4-35H2,1-3H3</moldb_inchi>
		<moldb_inchikey>GNPZHHYWFFYGOF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>639.0150</moldb_average_mass>
		<moldb_mono_mass>638.548540103</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1005</id>
		<lmdb_id>LMDB00981</lmdb_id>
		<created_at>2016-08-04 21:15:21</created_at>
		<updated_at>2016-08-04 22:06:14</updated_at>
		<export>1</export>
		<name>TG(18:0/14:0/6:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C41H78O6</moldb_formula>
		<moldb_inchi>InChI=1S/C41H78O6/c1-4-7-10-12-14-16-18-19-20-21-23-24-26-28-31-34-40(43)46-37-38(36-45-39(42)33-30-9-6-3)47-41(44)35-32-29-27-25-22-17-15-13-11-8-5-2/h38H,4-37H2,1-3H3</moldb_inchi>
		<moldb_inchikey>BYIJSVHOFIDXCL-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>667.0690</moldb_average_mass>
		<moldb_mono_mass>666.579840232</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1006</id>
		<lmdb_id>LMDB00982</lmdb_id>
		<created_at>2016-08-04 21:15:26</created_at>
		<updated_at>2016-08-04 22:06:14</updated_at>
		<export>1</export>
		<name>TG(18:0/16:0/4:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C41H78O6</moldb_formula>
		<moldb_inchi>InChI=1S/C41H78O6/c1-4-7-9-11-13-15-17-19-20-22-23-25-27-29-31-34-40(43)46-37-38(36-45-39(42)33-6-3)47-41(44)35-32-30-28-26-24-21-18-16-14-12-10-8-5-2/h38H,4-37H2,1-3H3</moldb_inchi>
		<moldb_inchikey>MSBNBDZZIPTJCP-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>667.0690</moldb_average_mass>
		<moldb_mono_mass>666.579840232</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1007</id>
		<lmdb_id>LMDB00983</lmdb_id>
		<created_at>2016-08-04 21:15:31</created_at>
		<updated_at>2016-08-04 22:06:15</updated_at>
		<export>1</export>
		<name>TG(18:0/16:0/6:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>2</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C43H82O6</moldb_formula>
		<moldb_inchi>InChI=1S/C43H82O6/c1-4-7-10-12-14-16-18-20-21-23-24-26-28-30-33-36-42(45)48-39-40(38-47-41(44)35-32-9-6-3)49-43(46)37-34-31-29-27-25-22-19-17-15-13-11-8-5-2/h40H,4-39H2,1-3H3</moldb_inchi>
		<moldb_inchikey>NJJSVYBVDBGZKT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>695.1230</moldb_average_mass>
		<moldb_mono_mass>694.611140360</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1008</id>
		<lmdb_id>LMDB00984</lmdb_id>
		<created_at>2016-08-06 05:37:46</created_at>
		<updated_at>2016-08-06 05:37:47</updated_at>
		<export>1</export>
		<name>5-tert-Butyl-2-thiophenecarboxylic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>0</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C)(C)C1=CC=C(S1)C(O)=O</moldb_smiles>
		<moldb_formula>C9H12O2S</moldb_formula>
		<moldb_inchi>InChI=1S/C9H12O2S/c1-9(2,3)7-5-4-6(12-7)8(10)11/h4-5H,1-3H3,(H,10,11)</moldb_inchi>
		<moldb_inchikey>BJDXNKJQTLSJPM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>184.2500</moldb_average_mass>
		<moldb_mono_mass>184.055800800</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1009</id>
		<lmdb_id>LMDB00985</lmdb_id>
		<created_at>2016-08-06 05:37:54</created_at>
		<updated_at>2016-08-06 20:10:14</updated_at>
		<export>1</export>
		<name>1,3-bis(Ethynylbenzene)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C#CC1=CC(=CC=C1)C#C</moldb_smiles>
		<moldb_formula>C10H6</moldb_formula>
		<moldb_inchi>InChI=1S/C10H6/c1-3-9-6-5-7-10(4-2)8-9/h1-2,5-8H</moldb_inchi>
		<moldb_inchikey>PNXLPYYXCOXPBM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>126.1580</moldb_average_mass>
		<moldb_mono_mass>126.046950193</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1010</id>
		<lmdb_id>LMDB00986</lmdb_id>
		<created_at>2016-08-06 05:37:59</created_at>
		<updated_at>2016-08-06 20:10:25</updated_at>
		<export>1</export>
		<name>2,3-Dimethylquinoline-1-oxide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=CC2=CC=CC=C2N(=O)=C1C</moldb_smiles>
		<moldb_formula>C11H11NO</moldb_formula>
		<moldb_inchi>InChI=1S/C11H11NO/c1-8-7-10-5-3-4-6-11(10)12(13)9(8)2/h3-7H,1-2H3</moldb_inchi>
		<moldb_inchikey>WBLLAYDCFPAIPX-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>173.2150</moldb_average_mass>
		<moldb_mono_mass>173.084063978</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1011</id>
		<lmdb_id>LMDB00987</lmdb_id>
		<created_at>2016-08-06 05:38:00</created_at>
		<updated_at>2016-08-06 20:10:52</updated_at>
		<export>1</export>
		<name>Butenoylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C\C=C\C(=O)O[C@@H](CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C11H19NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C11H19NO4/c1-5-6-11(15)16-9(7-10(13)14)8-12(2,3)4/h5-6,9H,7-8H2,1-4H3/b6-5+/t9-/m0/s1</moldb_inchi>
		<moldb_inchikey>HQDBMDGXEZLSNK-CYNONHLPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>229.2729</moldb_average_mass>
		<moldb_mono_mass>229.131408101</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1012</id>
		<lmdb_id>LMDB00988</lmdb_id>
		<created_at>2016-08-06 05:38:02</created_at>
		<updated_at>2016-08-06 20:10:58</updated_at>
		<export>1</export>
		<name>Indole-3-acetylglycine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CNC(=O)CC1=CNC2=C1C=CC=C2</moldb_smiles>
		<moldb_formula>C12H12N2O3</moldb_formula>
		<moldb_inchi>InChI=1S/C12H12N2O3/c15-11(14-7-12(16)17)5-8-6-13-10-4-2-1-3-9(8)10/h1-4,6,13H,5,7H2,(H,14,15)(H,16,17)</moldb_inchi>
		<moldb_inchikey>YDXXLJMIHMIOIF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>232.2353</moldb_average_mass>
		<moldb_mono_mass>232.084792260</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1013</id>
		<lmdb_id>LMDB00989</lmdb_id>
		<created_at>2016-08-06 05:38:03</created_at>
		<updated_at>2016-08-06 20:10:13</updated_at>
		<export>1</export>
		<name>(+)-10-Methyldodecanoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC(C)CCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C13H26O2</moldb_formula>
		<moldb_inchi>InChI=1S/C13H26O2/c1-3-12(2)10-8-6-4-5-7-9-11-13(14)15/h12H,3-11H2,1-2H3,(H,14,15)</moldb_inchi>
		<moldb_inchikey>YETWOCQNUTWSQA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>214.3490</moldb_average_mass>
		<moldb_mono_mass>214.193280077</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1014</id>
		<lmdb_id>LMDB00990</lmdb_id>
		<created_at>2016-08-06 05:38:09</created_at>
		<updated_at>2016-08-06 20:10:49</updated_at>
		<export>1</export>
		<name>cis-9,cis-12-Hexadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCC)=C(/[H])C\C([H])=C(\[H])CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C16H28O2</moldb_formula>
		<moldb_inchi>InChI=1S/C16H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h4-5,7-8H,2-3,6,9-15H2,1H3,(H,17,18)/b5-4-,8-7-</moldb_inchi>
		<moldb_inchikey>RVEKLXYYCHAMDF-UTOQUPLUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>252.3980</moldb_average_mass>
		<moldb_mono_mass>252.208930142</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1015</id>
		<lmdb_id>LMDB00991</lmdb_id>
		<created_at>2016-08-06 05:38:14</created_at>
		<updated_at>2016-08-06 20:10:49</updated_at>
		<export>1</export>
		<name>trans-12-Hexadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCC)=C(\[H])CCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C16H30O2</moldb_formula>
		<moldb_inchi>InChI=1S/C16H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h4-5H,2-3,6-15H2,1H3,(H,17,18)/b5-4+</moldb_inchi>
		<moldb_inchikey>MAJQLUHZSRVCAT-SNAWJCMRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>254.4140</moldb_average_mass>
		<moldb_mono_mass>254.224580206</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1016</id>
		<lmdb_id>LMDB00992</lmdb_id>
		<created_at>2016-08-06 05:38:15</created_at>
		<updated_at>2016-08-06 20:10:48</updated_at>
		<export>1</export>
		<name>trans-11-Hexadecenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCC\C=C\CCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C16H30O2</moldb_formula>
		<moldb_inchi>InChI=1S/C16H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h5-6H,2-4,7-15H2,1H3,(H,17,18)/b6-5+</moldb_inchi>
		<moldb_inchikey>JGMYDQCXGIMHLL-AATRIKPKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>254.4082</moldb_average_mass>
		<moldb_mono_mass>254.224580204</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1017</id>
		<lmdb_id>LMDB00993</lmdb_id>
		<created_at>2016-08-06 05:38:17</created_at>
		<updated_at>2016-08-06 05:38:18</updated_at>
		<export>1</export>
		<name>Decenoylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>0</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[N+](C)(C)CC(CC([O-])=O)OC(=O)CCCCCCCC=C</moldb_smiles>
		<moldb_formula>C17H31NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C17H31NO4/c1-5-6-7-8-9-10-11-12-17(21)22-15(13-16(19)20)14-18(2,3)4/h5,15H,1,6-14H2,2-4H3</moldb_inchi>
		<moldb_inchikey>GOOOCIIXFLVRAG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>313.4323</moldb_average_mass>
		<moldb_mono_mass>313.225308485</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1018</id>
		<lmdb_id>LMDB00994</lmdb_id>
		<created_at>2016-08-06 05:38:22</created_at>
		<updated_at>2016-08-06 20:10:51</updated_at>
		<export>1</export>
		<name>trans-11,cis-15-Octadecadienoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CC)=C(/[H])CC\C([H])=C(/[H])CCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,7-8H,2,5-6,9-17H2,1H3,(H,19,20)/b4-3-,8-7+</moldb_inchi>
		<moldb_inchikey>HHELYEVVXBEXIZ-ODYTWBPASA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>280.4520</moldb_average_mass>
		<moldb_mono_mass>280.240230270</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1019</id>
		<lmdb_id>LMDB00995</lmdb_id>
		<created_at>2016-08-06 05:38:28</created_at>
		<updated_at>2016-08-06 20:10:51</updated_at>
		<export>1</export>
		<name>11Z,15E-Octadecadienoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CC)=C(\[H])CC\C([H])=C(\[H])CCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,7-8H,2,5-6,9-17H2,1H3,(H,19,20)/b4-3+,8-7-</moldb_inchi>
		<moldb_inchikey>HHELYEVVXBEXIZ-UTUPVWNLSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>280.4520</moldb_average_mass>
		<moldb_mono_mass>280.240230270</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1020</id>
		<lmdb_id>LMDB00996</lmdb_id>
		<created_at>2016-08-06 05:38:33</created_at>
		<updated_at>2016-08-06 20:10:51</updated_at>
		<export>1</export>
		<name>10E,15Z-Octadecadienoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CC)=C(/[H])CCC\C([H])=C(/[H])CCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,8-9H,2,5-7,10-17H2,1H3,(H,19,20)/b4-3-,9-8+</moldb_inchi>
		<moldb_inchikey>KGFMVFJMZIGUCV-VHPFQHCPSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>280.4520</moldb_average_mass>
		<moldb_mono_mass>280.240230270</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1021</id>
		<lmdb_id>LMDB00997</lmdb_id>
		<created_at>2016-08-06 05:38:39</created_at>
		<updated_at>2016-08-06 20:10:18</updated_at>
		<export>1</export>
		<name>12E, 14E-Octadecadienoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCC)=C(\[H])/C(/[H])=C(\[H])CCCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h4-7H,2-3,8-17H2,1H3,(H,19,20)/b5-4+,7-6+</moldb_inchi>
		<moldb_inchikey>NLGIQISOWDWGRJ-YTXTXJHMSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>280.4520</moldb_average_mass>
		<moldb_mono_mass>280.240230270</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1022</id>
		<lmdb_id>LMDB00998</lmdb_id>
		<created_at>2016-08-06 05:38:44</created_at>
		<updated_at>2016-08-06 20:10:17</updated_at>
		<export>1</export>
		<name>11E, 13E-Octadecadienoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCC)=C(\[H])/C(/[H])=C(\[H])CCCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h5-8H,2-4,9-17H2,1H3,(H,19,20)/b6-5+,8-7+</moldb_inchi>
		<moldb_inchikey>JGFMXQLVWUGIPI-BSWSSELBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>280.4520</moldb_average_mass>
		<moldb_mono_mass>280.240230270</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1023</id>
		<lmdb_id>LMDB00999</lmdb_id>
		<created_at>2016-08-06 05:38:50</created_at>
		<updated_at>2016-08-06 20:10:15</updated_at>
		<export>1</export>
		<name>10E, 12E-Octadecadienoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCC)=C(\[H])/C(/[H])=C(\[H])CCCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-9H,2-5,10-17H2,1H3,(H,19,20)/b7-6+,9-8+</moldb_inchi>
		<moldb_inchikey>GKJZMAHZJGSBKD-BLHCBFLLSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>280.4520</moldb_average_mass>
		<moldb_mono_mass>280.240230270</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1024</id>
		<lmdb_id>LMDB01000</lmdb_id>
		<created_at>2016-08-06 05:38:51</created_at>
		<updated_at>2016-08-06 20:10:46</updated_at>
		<export>1</export>
		<name>9E, 11E-Octadecadienoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C\C=C\CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h7-10H,2-6,11-17H2,1H3,(H,19,20)/b8-7+,10-9+</moldb_inchi>
		<moldb_inchikey>JBYXPOFIGCOSSB-XBLVEGMJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>280.4455</moldb_average_mass>
		<moldb_mono_mass>280.240230268</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1025</id>
		<lmdb_id>LMDB01001</lmdb_id>
		<created_at>2016-08-06 05:38:57</created_at>
		<updated_at>2016-08-06 20:10:43</updated_at>
		<export>1</export>
		<name>8E, 10E-Octadecadienoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCCCC)=C(\[H])/C(/[H])=C(\[H])CCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h8-11H,2-7,12-17H2,1H3,(H,19,20)/b9-8+,11-10+</moldb_inchi>
		<moldb_inchikey>QJKCKUNKNNYJNS-BNFZFUHLSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>280.4520</moldb_average_mass>
		<moldb_mono_mass>280.240230270</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1026</id>
		<lmdb_id>LMDB01002</lmdb_id>
		<created_at>2016-08-06 05:39:02</created_at>
		<updated_at>2016-08-06 20:10:42</updated_at>
		<export>1</export>
		<name>7E, 9E-Octadecadienoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCCCCC)=C(\[H])/C(/[H])=C(\[H])CCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C18H32O2</moldb_formula>
		<moldb_inchi>InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-12H,2-8,13-17H2,1H3,(H,19,20)/b10-9+,12-11+</moldb_inchi>
		<moldb_inchikey>HACBQSMIIGXKGA-HULFFUFUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>280.4520</moldb_average_mass>
		<moldb_mono_mass>280.240230270</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1029</id>
		<lmdb_id>LMDB01005</lmdb_id>
		<created_at>2016-08-06 05:39:11</created_at>
		<updated_at>2016-08-06 20:10:47</updated_at>
		<export>1</export>
		<name>Boldenone 17-sulphate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)C=C[C@]4(C)[C@@]3([H])CC[C@]12C)OS(O)(=O)=O</moldb_smiles>
		<moldb_formula>C19H26O5S</moldb_formula>
		<moldb_inchi>InChI=1S/C19H26O5S/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(24-25(21,22)23)19(15,2)10-8-16(14)18/h7,9,11,14-17H,3-6,8,10H2,1-2H3,(H,21,22,23)/t14-,15-,16-,17+,18-,19-/m0/s1</moldb_inchi>
		<moldb_inchikey>GSLOLTKGVZFNKZ-KZYORJDKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>366.4700</moldb_average_mass>
		<moldb_mono_mass>366.150095111</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1030</id>
		<lmdb_id>LMDB01006</lmdb_id>
		<created_at>2016-08-06 05:39:12</created_at>
		<updated_at>2016-08-06 20:11:00</updated_at>
		<export>1</export>
		<name>alpha-Testosterone 17-sulphate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H](OS(O)(=O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C19H28O5S</moldb_formula>
		<moldb_inchi>InChI=1S/C19H28O5S/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(24-25(21,22)23)19(15,2)10-8-16(14)18/h11,14-17H,3-10H2,1-2H3,(H,21,22,23)/t14-,15-,16-,17-,18-,19-/m0/s1</moldb_inchi>
		<moldb_inchikey>WAQBISPOEAOCOG-DYKIIFRCSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>368.4880</moldb_average_mass>
		<moldb_mono_mass>368.165744696</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1031</id>
		<lmdb_id>LMDB01007</lmdb_id>
		<created_at>2016-08-06 05:39:13</created_at>
		<updated_at>2016-08-06 20:10:46</updated_at>
		<export>1</export>
		<name>Androsterone 3-sulphate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](CC[C@]12C)OS(O)(=O)=O</moldb_smiles>
		<moldb_formula>C19H30O5S</moldb_formula>
		<moldb_inchi>InChI=1S/C19H30O5S/c1-18-9-7-13(24-25(21,22)23)11-12(18)3-4-14-15-5-6-17(20)19(15,2)10-8-16(14)18/h12-16H,3-11H2,1-2H3,(H,21,22,23)/t12-,13+,14-,15-,16-,18-,19-/m0/s1</moldb_inchi>
		<moldb_inchikey>ZMITXKRGXGRMKS-HLUDHZFRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>370.5040</moldb_average_mass>
		<moldb_mono_mass>370.181394760</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1032</id>
		<lmdb_id>LMDB01008</lmdb_id>
		<created_at>2016-08-06 05:39:15</created_at>
		<updated_at>2016-08-06 05:39:15</updated_at>
		<export>1</export>
		<name>Dodecenoylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>0</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCC=CC(=O)O[C@@H](CCC([O-])=O)[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C19H35NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C19H35NO4/c1-5-6-7-8-9-10-11-12-13-14-19(23)24-17(20(2,3)4)15-16-18(21)22/h13-14,17H,5-12,15-16H2,1-4H3/t17-/m0/s1</moldb_inchi>
		<moldb_inchikey>JEOZLTJHDSKQIT-KRWDZBQOSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>341.4855</moldb_average_mass>
		<moldb_mono_mass>341.256608613</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1033</id>
		<lmdb_id>LMDB01009</lmdb_id>
		<created_at>2016-08-06 05:39:20</created_at>
		<updated_at>2016-08-06 20:10:52</updated_at>
		<export>1</export>
		<name>Gadoleic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCCCCCCC)=C(\[H])CCCCCCCC(O)=O</moldb_smiles>
		<moldb_formula>C20H38O2</moldb_formula>
		<moldb_inchi>InChI=1S/C20H38O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h11-12H,2-10,13-19H2,1H3,(H,21,22)/b12-11+</moldb_inchi>
		<moldb_inchikey>LQJBNNIYVWPHFW-VAWYXSNFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>310.5220</moldb_average_mass>
		<moldb_mono_mass>310.287180464</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1034</id>
		<lmdb_id>LMDB01010</lmdb_id>
		<created_at>2016-08-06 05:39:25</created_at>
		<updated_at>2016-08-06 20:10:47</updated_at>
		<export>1</export>
		<name>5Z,8E-3-hydroxytetradecadienoylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCC)=C(/[H])CC([H])=C([H])CC(O)CC(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C21H37NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C21H37NO5/c1-5-6-7-8-9-10-11-12-13-14-18(23)15-21(26)27-19(16-20(24)25)17-22(2,3)4/h9-10,12-13,18-19,23H,5-8,11,14-17H2,1-4H3/b10-9-,13-12-</moldb_inchi>
		<moldb_inchikey>LVNITLZCNUEXQK-UTJQPWESSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>383.5290</moldb_average_mass>
		<moldb_mono_mass>383.267173295</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1035</id>
		<lmdb_id>LMDB01011</lmdb_id>
		<created_at>2016-08-06 05:39:27</created_at>
		<updated_at>2016-08-06 05:39:27</updated_at>
		<export>1</export>
		<name>Tetradecenoylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>0</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCC=CCCCC(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C21H39NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C21H39NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-21(25)26-19(17-20(23)24)18-22(2,3)4/h12-13,19H,5-11,14-18H2,1-4H3</moldb_inchi>
		<moldb_inchikey>NNCBVXBBLABOCB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>369.5387</moldb_average_mass>
		<moldb_mono_mass>369.287908741</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1036</id>
		<lmdb_id>LMDB01012</lmdb_id>
		<created_at>2016-08-06 05:39:29</created_at>
		<updated_at>2016-08-06 20:10:48</updated_at>
		<export>1</export>
		<name>Hydroxyhexadecenoylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCC\C=C/CCCCCC(O)CC(=O)O[C@H]([N+](C)(C)C)CCC([O-])=O</moldb_smiles>
		<moldb_formula>C23H43NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C23H43NO5/c1-5-6-7-8-9-10-11-12-13-14-15-16-20(25)19-23(28)29-21(24(2,3)4)17-18-22(26)27/h10-11,20-21,25H,5-9,12-19H2,1-4H3/b11-10-/t20?,21-/m0/s1</moldb_inchi>
		<moldb_inchikey>WAGYLURELCUJPG-RPZXQYRRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>413.5912</moldb_average_mass>
		<moldb_mono_mass>413.314123491</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1037</id>
		<lmdb_id>LMDB01013</lmdb_id>
		<created_at>2016-08-06 05:39:34</created_at>
		<updated_at>2016-08-06 20:10:45</updated_at>
		<export>1</export>
		<name>9-Fluoro-16a,17-(isopropylidenedioxy)corticosterone</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@]([H])(O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO</moldb_smiles>
		<moldb_formula>C24H33FO6</moldb_formula>
		<moldb_inchi>InChI=1S/C24H33FO6/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,25)17(28)11-22(16,4)24(19,31-20)18(29)12-26/h9,15-17,19,26,28H,5-8,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1</moldb_inchi>
		<moldb_inchikey>TZFZVQNBXVBQDC-JNQJZLCISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>436.5200</moldb_average_mass>
		<moldb_mono_mass>436.226116946</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1038</id>
		<lmdb_id>LMDB01014</lmdb_id>
		<created_at>2016-08-06 05:39:40</created_at>
		<updated_at>2016-08-06 20:10:21</updated_at>
		<export>1</export>
		<name>12beta-Hydroxy-3-oxo-5-beta-cholan-24-oic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])CC[C@]4([H])CC(=O)CC[C@]4(C)[C@@]3([H])C[C@@]([H])(O)[C@]12C</moldb_smiles>
		<moldb_formula>C24H38O4</moldb_formula>
		<moldb_inchi>InChI=1S/C24H38O4/c1-14(4-9-22(27)28)18-7-8-19-17-6-5-15-12-16(25)10-11-23(15,2)20(17)13-21(26)24(18,19)3/h14-15,17-21,26H,4-13H2,1-3H3,(H,27,28)/t14-,15-,17+,18-,19+,20+,21-,23+,24-/m1/s1</moldb_inchi>
		<moldb_inchikey>WMUMZOAFCDOTRW-RXTDITKTSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>390.5640</moldb_average_mass>
		<moldb_mono_mass>390.277009704</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1039</id>
		<lmdb_id>LMDB01015</lmdb_id>
		<created_at>2016-08-06 05:39:41</created_at>
		<updated_at>2016-08-06 20:10:56</updated_at>
		<export>1</export>
		<name>Epitestosterone 17-glucuronide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CC[C@H](O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C</moldb_smiles>
		<moldb_formula>C25H36O8</moldb_formula>
		<moldb_inchi>InChI=1S/C25H36O8/c1-24-9-7-13(26)11-12(24)3-4-14-15-5-6-17(25(15,2)10-8-16(14)24)32-23-20(29)18(27)19(28)21(33-23)22(30)31/h11,14-21,23,27-29H,3-10H2,1-2H3,(H,30,31)/t14-,15-,16-,17-,18-,19-,20+,21-,23+,24-,25-/m0/s1</moldb_inchi>
		<moldb_inchikey>NIKZPECGCSUSBV-HMAFJQTKSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>464.5485</moldb_average_mass>
		<moldb_mono_mass>464.241018128</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1040</id>
		<lmdb_id>LMDB01016</lmdb_id>
		<created_at>2016-08-06 05:39:42</created_at>
		<updated_at>2016-08-06 20:10:55</updated_at>
		<export>1</export>
		<name>Dehydroepiandrosterone 3-glucuronide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@H](CC[C@]12C)O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O</moldb_smiles>
		<moldb_formula>C25H36O8</moldb_formula>
		<moldb_inchi>InChI=1S/C25H36O8/c1-24-9-7-13(32-23-20(29)18(27)19(28)21(33-23)22(30)31)11-12(24)3-4-14-15-5-6-17(26)25(15,2)10-8-16(14)24/h3,13-16,18-21,23,27-29H,4-11H2,1-2H3,(H,30,31)/t13-,14-,15-,16-,18-,19-,20+,21-,23+,24-,25-/m0/s1</moldb_inchi>
		<moldb_inchikey>GLONBVCUAVPJFV-PCDHEYSGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>464.5485</moldb_average_mass>
		<moldb_mono_mass>464.241018128</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1041</id>
		<lmdb_id>LMDB01017</lmdb_id>
		<created_at>2016-08-06 05:39:48</created_at>
		<updated_at>2016-08-06 20:10:22</updated_at>
		<export>1</export>
		<name>1alpha,25-Dihydroxy-24-oxocholecalciferol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(\C(\[H])=C1/CCC[C@@]2(C)[C@@]1([H])CC[C@]2([H])[C@]([H])(C)CCC(=O)C(C)(C)O)=C1/C[C@@]([H])(O)C[C@]([H])(O)C1=C</moldb_smiles>
		<moldb_formula>C27H42O4</moldb_formula>
		<moldb_inchi>InChI=1S/C27H42O4/c1-17(8-13-25(30)26(3,4)31)22-11-12-23-19(7-6-14-27(22,23)5)9-10-20-15-21(28)16-24(29)18(20)2/h9-10,17,21-24,28-29,31H,2,6-8,11-16H2,1,3-5H3/b19-9+,20-10-/t17-,21-,22-,23+,24+,27-/m1/s1</moldb_inchi>
		<moldb_inchikey>BWFQMABKLLTETH-YGQRWWDYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>430.6290</moldb_average_mass>
		<moldb_mono_mass>430.308309832</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1042</id>
		<lmdb_id>LMDB01018</lmdb_id>
		<created_at>2016-08-06 05:39:49</created_at>
		<updated_at>2016-08-06 20:10:47</updated_at>
		<export>1</export>
		<name>Arachidonyl lysolecithin</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC[C@](O)([H])COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C28H50NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C28H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-28(31)34-25-27(30)26-36-37(32,33)35-24-23-29(2,3)4/h9-10,12-13,15-16,18-19,27,30H,5-8,11,14,17,20-26H2,1-4H3/b10-9-,13-12-,16-15-,19-18-/t27-/m1/s1</moldb_inchi>
		<moldb_inchikey>LAXQYRRMGGEGOH-JXRLJXCWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>543.6729</moldb_average_mass>
		<moldb_mono_mass>543.332489471</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1043</id>
		<lmdb_id>LMDB01019</lmdb_id>
		<created_at>2016-08-06 05:39:55</created_at>
		<updated_at>2016-08-06 20:10:37</updated_at>
		<export>1</export>
		<name>TG(6:0/8:0/14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCC</moldb_smiles>
		<moldb_formula>C31H58O6</moldb_formula>
		<moldb_inchi>InChI=1S/C31H58O6/c1-4-7-10-12-13-14-15-16-17-19-21-24-30(33)36-27-28(26-35-29(32)23-20-9-6-3)37-31(34)25-22-18-11-8-5-2/h28H,4-27H2,1-3H3</moldb_inchi>
		<moldb_inchikey>HMYXRAROFDYZSY-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>526.7990</moldb_average_mass>
		<moldb_mono_mass>526.423339588</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1044</id>
		<lmdb_id>LMDB01020</lmdb_id>
		<created_at>2016-08-06 05:40:00</created_at>
		<updated_at>2016-08-06 20:10:36</updated_at>
		<export>1</export>
		<name>TG(4:0/8:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCC</moldb_smiles>
		<moldb_formula>C31H58O6</moldb_formula>
		<moldb_inchi>InChI=1S/C31H58O6/c1-4-7-9-11-12-13-14-15-16-17-18-20-21-24-30(33)36-27-28(26-35-29(32)23-6-3)37-31(34)25-22-19-10-8-5-2/h28H,4-27H2,1-3H3</moldb_inchi>
		<moldb_inchikey>DQSUYNONXLJKFQ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>526.7990</moldb_average_mass>
		<moldb_mono_mass>526.423339588</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1045</id>
		<lmdb_id>LMDB01021</lmdb_id>
		<created_at>2016-08-06 05:40:06</created_at>
		<updated_at>2016-08-06 20:10:31</updated_at>
		<export>1</export>
		<name>TG(4:0/10:0/14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCC</moldb_smiles>
		<moldb_formula>C31H58O6</moldb_formula>
		<moldb_inchi>InChI=1S/C31H58O6/c1-4-7-9-11-13-14-15-16-18-19-21-24-30(33)36-27-28(26-35-29(32)23-6-3)37-31(34)25-22-20-17-12-10-8-5-2/h28H,4-27H2,1-3H3</moldb_inchi>
		<moldb_inchikey>CZNCEKYZOLXFEW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>526.7990</moldb_average_mass>
		<moldb_mono_mass>526.423339588</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1046</id>
		<lmdb_id>LMDB01022</lmdb_id>
		<created_at>2016-08-06 05:40:11</created_at>
		<updated_at>2016-08-06 20:10:38</updated_at>
		<export>1</export>
		<name>TG(6:0/10:0/14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCC</moldb_smiles>
		<moldb_formula>C33H62O6</moldb_formula>
		<moldb_inchi>InChI=1S/C33H62O6/c1-4-7-10-12-14-15-16-17-19-20-23-26-32(35)38-29-30(28-37-31(34)25-22-9-6-3)39-33(36)27-24-21-18-13-11-8-5-2/h30H,4-29H2,1-3H3</moldb_inchi>
		<moldb_inchikey>CTUNPMWDIDEHLG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>554.8530</moldb_average_mass>
		<moldb_mono_mass>554.454639716</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1047</id>
		<lmdb_id>LMDB01023</lmdb_id>
		<created_at>2016-08-06 05:40:13</created_at>
		<updated_at>2018-04-30 21:15:12</updated_at>
		<export>1</export>
		<name>TG(10:0/10:0/10:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]C(COC(=O)CCCCCCCCC)(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC</moldb_smiles>
		<moldb_formula>C33H62O6</moldb_formula>
		<moldb_inchi>InChI=1S/C33H62O6/c1-4-7-10-13-16-19-22-25-31(34)37-28-30(39-33(36)27-24-21-18-15-12-9-6-3)29-38-32(35)26-23-20-17-14-11-8-5-2/h30H,4-29H2,1-3H3</moldb_inchi>
		<moldb_inchikey>LADGBHLMCUINGV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>554.8530</moldb_average_mass>
		<moldb_mono_mass>554.454639716</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1048</id>
		<lmdb_id>LMDB01024</lmdb_id>
		<created_at>2016-08-06 05:40:14</created_at>
		<updated_at>2016-08-06 20:10:31</updated_at>
		<export>1</export>
		<name>TG(4:0/10:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCC</moldb_smiles>
		<moldb_formula>C33H62O6</moldb_formula>
		<moldb_inchi>InChI=1S/C33H62O6/c1-4-7-9-11-13-14-15-16-17-18-20-21-23-26-32(35)38-29-30(28-37-31(34)25-6-3)39-33(36)27-24-22-19-12-10-8-5-2/h30H,4-29H2,1-3H3</moldb_inchi>
		<moldb_inchikey>NMPTUNQSGSBSHZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>554.8530</moldb_average_mass>
		<moldb_mono_mass>554.454639716</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1049</id>
		<lmdb_id>LMDB01025</lmdb_id>
		<created_at>2016-08-06 05:40:19</created_at>
		<updated_at>2016-08-06 20:10:32</updated_at>
		<export>1</export>
		<name>TG(4:0/12:0/14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C33H62O6</moldb_formula>
		<moldb_inchi>InChI=1S/C33H62O6/c1-4-7-9-11-13-15-16-18-19-21-23-26-32(35)38-29-30(28-37-31(34)25-6-3)39-33(36)27-24-22-20-17-14-12-10-8-5-2/h30H,4-29H2,1-3H3</moldb_inchi>
		<moldb_inchikey>SPIIOGCAPPVNDU-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>554.8530</moldb_average_mass>
		<moldb_mono_mass>554.454639716</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1050</id>
		<lmdb_id>LMDB01026</lmdb_id>
		<created_at>2016-08-06 05:40:25</created_at>
		<updated_at>2016-08-06 20:10:17</updated_at>
		<export>1</export>
		<name>TG(10:0/16:0/6:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC)COC(=O)CCCCCCCCC</moldb_smiles>
		<moldb_formula>C35H66O6</moldb_formula>
		<moldb_inchi>InChI=1S/C35H66O6/c1-4-7-10-12-14-15-16-17-18-19-21-23-26-29-35(38)41-32(30-39-33(36)27-24-9-6-3)31-40-34(37)28-25-22-20-13-11-8-5-2/h32H,4-31H2,1-3H3</moldb_inchi>
		<moldb_inchikey>CBCAPZYHHAJWQD-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>582.9070</moldb_average_mass>
		<moldb_mono_mass>582.485939845</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1051</id>
		<lmdb_id>LMDB01027</lmdb_id>
		<created_at>2016-08-06 05:40:31</created_at>
		<updated_at>2016-08-06 20:10:37</updated_at>
		<export>1</export>
		<name>TG(6:0/12:0/14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C35H66O6</moldb_formula>
		<moldb_inchi>InChI=1S/C35H66O6/c1-4-7-10-12-14-16-17-19-20-22-25-28-34(37)40-31-32(30-39-33(36)27-24-9-6-3)41-35(38)29-26-23-21-18-15-13-11-8-5-2/h32H,4-31H2,1-3H3</moldb_inchi>
		<moldb_inchikey>XTWZFTFRQTXTLI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>582.9070</moldb_average_mass>
		<moldb_mono_mass>582.485939845</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1052</id>
		<lmdb_id>LMDB01028</lmdb_id>
		<created_at>2016-08-06 05:40:32</created_at>
		<updated_at>2016-08-06 20:10:32</updated_at>
		<export>1</export>
		<name>TG(4:0/12:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C35H66O6</moldb_formula>
		<moldb_inchi>InChI=1S/C35H66O6/c1-4-7-9-11-13-15-16-17-18-20-21-23-25-28-34(37)40-31-32(30-39-33(36)27-6-3)41-35(38)29-26-24-22-19-14-12-10-8-5-2/h32H,4-31H2,1-3H3</moldb_inchi>
		<moldb_inchikey>DNRWLLOQTTWJKS-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>582.9070</moldb_average_mass>
		<moldb_mono_mass>582.485939845</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1053</id>
		<lmdb_id>LMDB01029</lmdb_id>
		<created_at>2016-08-06 05:40:33</created_at>
		<updated_at>2016-08-06 20:10:33</updated_at>
		<export>1</export>
		<name>TG(4:0/14:0/14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C35H66O6</moldb_formula>
		<moldb_inchi>InChI=1S/C35H66O6/c1-4-7-9-11-13-15-17-19-21-23-25-28-34(37)40-31-32(30-39-33(36)27-6-3)41-35(38)29-26-24-22-20-18-16-14-12-10-8-5-2/h32H,4-31H2,1-3H3</moldb_inchi>
		<moldb_inchikey>CPUBTQNPGNMTLT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>582.9070</moldb_average_mass>
		<moldb_mono_mass>582.485939845</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1054</id>
		<lmdb_id>LMDB01030</lmdb_id>
		<created_at>2016-08-06 05:40:39</created_at>
		<updated_at>2016-08-06 20:10:33</updated_at>
		<export>1</export>
		<name>TG(4:0/14:0/15:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C36H68O6</moldb_formula>
		<moldb_inchi>InChI=1S/C36H68O6/c1-4-7-9-11-13-15-17-19-20-22-24-26-29-35(38)41-32-33(31-40-34(37)28-6-3)42-36(39)30-27-25-23-21-18-16-14-12-10-8-5-2/h33H,4-32H2,1-3H3</moldb_inchi>
		<moldb_inchikey>JMGKZUFRLWPSBP-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>596.9340</moldb_average_mass>
		<moldb_mono_mass>596.501589910</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1055</id>
		<lmdb_id>LMDB01031</lmdb_id>
		<created_at>2016-08-06 05:40:40</created_at>
		<updated_at>2016-08-06 20:10:38</updated_at>
		<export>1</export>
		<name>TG(6:0/12:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C37H70O6</moldb_formula>
		<moldb_inchi>InChI=1S/C37H70O6/c1-4-7-10-12-14-16-17-18-19-21-22-24-27-30-36(39)42-33-34(32-41-35(38)29-26-9-6-3)43-37(40)31-28-25-23-20-15-13-11-8-5-2/h34H,4-33H2,1-3H3</moldb_inchi>
		<moldb_inchikey>OGVRYRODVYXWHK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>610.9610</moldb_average_mass>
		<moldb_mono_mass>610.517239974</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1056</id>
		<lmdb_id>LMDB01032</lmdb_id>
		<created_at>2016-08-06 05:40:42</created_at>
		<updated_at>2016-08-06 20:10:39</updated_at>
		<export>1</export>
		<name>TG(6:0/14:0/14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C37H70O6</moldb_formula>
		<moldb_inchi>InChI=1S/C37H70O6/c1-4-7-10-12-14-16-18-20-22-24-27-30-36(39)42-33-34(32-41-35(38)29-26-9-6-3)43-37(40)31-28-25-23-21-19-17-15-13-11-8-5-2/h34H,4-33H2,1-3H3</moldb_inchi>
		<moldb_inchikey>RLJXXZJSIPCFFV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>610.9610</moldb_average_mass>
		<moldb_mono_mass>610.517239974</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1057</id>
		<lmdb_id>LMDB01033</lmdb_id>
		<created_at>2016-08-06 05:40:47</created_at>
		<updated_at>2016-08-06 20:10:43</updated_at>
		<export>1</export>
		<name>TG(8:0/12:0/14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C37H70O6</moldb_formula>
		<moldb_inchi>InChI=1S/C37H70O6/c1-4-7-10-13-15-17-18-20-21-24-27-30-36(39)42-33-34(32-41-35(38)29-26-23-12-9-6-3)43-37(40)31-28-25-22-19-16-14-11-8-5-2/h34H,4-33H2,1-3H3</moldb_inchi>
		<moldb_inchikey>RJHHICMBDSUIHF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>610.9610</moldb_average_mass>
		<moldb_mono_mass>610.517239974</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1058</id>
		<lmdb_id>LMDB01034</lmdb_id>
		<created_at>2016-08-06 05:40:48</created_at>
		<updated_at>2016-08-06 20:10:33</updated_at>
		<export>1</export>
		<name>TG(4:0/14:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C37H70O6</moldb_formula>
		<moldb_inchi>InChI=1S/C37H70O6/c1-4-7-9-11-13-15-17-18-20-21-23-25-27-30-36(39)42-33-34(32-41-35(38)29-6-3)43-37(40)31-28-26-24-22-19-16-14-12-10-8-5-2/h34H,4-33H2,1-3H3</moldb_inchi>
		<moldb_inchikey>ZRSCOWDQAGAMTK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>610.9610</moldb_average_mass>
		<moldb_mono_mass>610.517239974</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1059</id>
		<lmdb_id>LMDB01035</lmdb_id>
		<created_at>2016-08-06 05:40:54</created_at>
		<updated_at>2016-08-06 20:10:34</updated_at>
		<export>1</export>
		<name>TG(4:0/15:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C38H72O6</moldb_formula>
		<moldb_inchi>InChI=1S/C38H72O6/c1-4-7-9-11-13-15-17-19-21-22-24-26-28-31-37(40)43-34-35(33-42-36(39)30-6-3)44-38(41)32-29-27-25-23-20-18-16-14-12-10-8-5-2/h35H,4-34H2,1-3H3</moldb_inchi>
		<moldb_inchikey>PCDSPVRPORJHDW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>624.9880</moldb_average_mass>
		<moldb_mono_mass>624.532890038</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1060</id>
		<lmdb_id>LMDB01036</lmdb_id>
		<created_at>2016-08-06 05:40:55</created_at>
		<updated_at>2016-08-06 20:10:39</updated_at>
		<export>1</export>
		<name>TG(6:0/14:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C39H74O6</moldb_formula>
		<moldb_inchi>InChI=1S/C39H74O6/c1-4-7-10-12-14-16-18-19-21-22-24-26-29-32-38(41)44-35-36(34-43-37(40)31-28-9-6-3)45-39(42)33-30-27-25-23-20-17-15-13-11-8-5-2/h36H,4-35H2,1-3H3</moldb_inchi>
		<moldb_inchikey>CRYHRFJZXLSNCF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>639.0150</moldb_average_mass>
		<moldb_mono_mass>638.548540103</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1061</id>
		<lmdb_id>LMDB01037</lmdb_id>
		<created_at>2016-08-06 05:40:56</created_at>
		<updated_at>2016-08-06 20:10:34</updated_at>
		<export>1</export>
		<name>TG(4:0/14:0/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C39H74O6</moldb_formula>
		<moldb_inchi>InChI=1S/C39H74O6/c1-4-7-9-11-13-15-17-18-19-20-22-23-25-27-29-32-38(41)44-35-36(34-43-37(40)31-6-3)45-39(42)33-30-28-26-24-21-16-14-12-10-8-5-2/h36H,4-35H2,1-3H3</moldb_inchi>
		<moldb_inchikey>GNPZHHYWFFYGOF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>639.0150</moldb_average_mass>
		<moldb_mono_mass>638.548540103</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1062</id>
		<lmdb_id>LMDB01038</lmdb_id>
		<created_at>2016-08-06 05:41:02</created_at>
		<updated_at>2016-08-06 20:10:31</updated_at>
		<export>1</export>
		<name>TG(4:0/17:0/15:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC)COC(=O)CCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C39H74O6</moldb_formula>
		<moldb_inchi>InChI=1S/C39H74O6/c1-4-7-9-11-13-15-17-19-20-22-24-26-28-30-33-39(42)45-36(34-43-37(40)31-6-3)35-44-38(41)32-29-27-25-23-21-18-16-14-12-10-8-5-2/h36H,4-35H2,1-3H3</moldb_inchi>
		<moldb_inchikey>CYIZPZFVFXXNAW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>639.0150</moldb_average_mass>
		<moldb_mono_mass>638.548540103</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1063</id>
		<lmdb_id>LMDB01039</lmdb_id>
		<created_at>2016-08-06 05:41:03</created_at>
		<updated_at>2016-08-06 20:10:35</updated_at>
		<export>1</export>
		<name>TG(4:0/16:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C39H74O6</moldb_formula>
		<moldb_inchi>InChI=1S/C39H74O6/c1-4-7-9-11-13-15-17-19-21-23-25-27-29-32-38(41)44-35-36(34-43-37(40)31-6-3)45-39(42)33-30-28-26-24-22-20-18-16-14-12-10-8-5-2/h36H,4-35H2,1-3H3</moldb_inchi>
		<moldb_inchikey>SPNPZKFZBBJGJK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>639.0150</moldb_average_mass>
		<moldb_mono_mass>638.548540103</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1064</id>
		<lmdb_id>LMDB01040</lmdb_id>
		<created_at>2016-08-06 05:41:09</created_at>
		<updated_at>2016-08-06 20:10:23</updated_at>
		<export>1</export>
		<name>2,3-Hydroxy acrylic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(O)=C(\[H])C(O)=O</moldb_smiles>
		<moldb_formula>C3H4O3</moldb_formula>
		<moldb_inchi>InChI=1S/C3H4O3/c4-2-1-3(5)6/h1-2,4H,(H,5,6)/b2-1+</moldb_inchi>
		<moldb_inchikey>ZJKIBABOSPFBNO-OWOJBTEDSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>88.0620</moldb_average_mass>
		<moldb_mono_mass>88.016043989</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1065</id>
		<lmdb_id>LMDB01041</lmdb_id>
		<created_at>2016-08-06 05:41:10</created_at>
		<updated_at>2016-08-06 20:10:22</updated_at>
		<export>1</export>
		<name>2,3-Bishydroxypropanoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCC(O)C(O)=O</moldb_smiles>
		<moldb_formula>C3H6O4</moldb_formula>
		<moldb_inchi>InChI=1S/C3H6O4/c4-1-2(5)3(6)7/h2,4-5H,1H2,(H,6,7)</moldb_inchi>
		<moldb_inchikey>RBNPOMFGQQGHHO-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>106.0773</moldb_average_mass>
		<moldb_mono_mass>106.026608680</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1066</id>
		<lmdb_id>LMDB01042</lmdb_id>
		<created_at>2016-08-06 05:41:15</created_at>
		<updated_at>2016-08-06 20:10:30</updated_at>
		<export>1</export>
		<name>TG(4:0/15:0/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C40H76O6</moldb_formula>
		<moldb_inchi>InChI=1S/C40H76O6/c1-4-7-9-11-13-15-17-19-20-21-23-24-26-28-30-33-39(42)45-36-37(35-44-38(41)32-6-3)46-40(43)34-31-29-27-25-22-18-16-14-12-10-8-5-2/h37H,4-36H2,1-3H3</moldb_inchi>
		<moldb_inchikey>SORNCPQAUOVNGB-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>653.0420</moldb_average_mass>
		<moldb_mono_mass>652.564190167</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1067</id>
		<lmdb_id>LMDB01043</lmdb_id>
		<created_at>2016-08-06 05:41:21</created_at>
		<updated_at>2016-08-06 20:10:30</updated_at>
		<export>1</export>
		<name>TG(4:0/16:0/17:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C40H76O6</moldb_formula>
		<moldb_inchi>InChI=1S/C40H76O6/c1-4-7-9-11-13-15-17-19-21-22-24-26-28-30-33-39(42)45-36-37(35-44-38(41)32-6-3)46-40(43)34-31-29-27-25-23-20-18-16-14-12-10-8-5-2/h37H,4-36H2,1-3H3</moldb_inchi>
		<moldb_inchikey>VJWVCPAYJXNGCJ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>653.0420</moldb_average_mass>
		<moldb_mono_mass>652.564190167</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1068</id>
		<lmdb_id>LMDB01044</lmdb_id>
		<created_at>2016-08-06 05:41:22</created_at>
		<updated_at>2016-08-06 20:10:39</updated_at>
		<export>1</export>
		<name>TG(6:0/16:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C41H78O6</moldb_formula>
		<moldb_inchi>InChI=1S/C41H78O6/c1-4-7-10-12-14-16-18-20-22-24-26-28-31-34-40(43)46-37-38(36-45-39(42)33-30-9-6-3)47-41(44)35-32-29-27-25-23-21-19-17-15-13-11-8-5-2/h38H,4-37H2,1-3H3</moldb_inchi>
		<moldb_inchikey>SAYUNMDZOOEJHF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>667.0690</moldb_average_mass>
		<moldb_mono_mass>666.579840232</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1069</id>
		<lmdb_id>LMDB01045</lmdb_id>
		<created_at>2016-08-06 05:41:27</created_at>
		<updated_at>2016-08-06 20:10:44</updated_at>
		<export>1</export>
		<name>TG(8:0/14:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C41H78O6</moldb_formula>
		<moldb_inchi>InChI=1S/C41H78O6/c1-4-7-10-13-15-17-19-20-22-23-25-28-31-34-40(43)46-37-38(36-45-39(42)33-30-27-12-9-6-3)47-41(44)35-32-29-26-24-21-18-16-14-11-8-5-2/h38H,4-37H2,1-3H3</moldb_inchi>
		<moldb_inchikey>LONDUFXOLIQUKZ-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>667.0690</moldb_average_mass>
		<moldb_mono_mass>666.579840232</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1070</id>
		<lmdb_id>LMDB01046</lmdb_id>
		<created_at>2016-08-06 05:41:33</created_at>
		<updated_at>2016-08-06 20:10:15</updated_at>
		<export>1</export>
		<name>TG(10:0/14:0/14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C41H78O6</moldb_formula>
		<moldb_inchi>InChI=1S/C41H78O6/c1-4-7-10-13-16-18-20-22-25-28-31-34-40(43)46-37-38(36-45-39(42)33-30-27-24-15-12-9-6-3)47-41(44)35-32-29-26-23-21-19-17-14-11-8-5-2/h38H,4-37H2,1-3H3</moldb_inchi>
		<moldb_inchikey>OECYYRPLQTZAGN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>667.0690</moldb_average_mass>
		<moldb_mono_mass>666.579840232</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1071</id>
		<lmdb_id>LMDB01047</lmdb_id>
		<created_at>2016-08-06 05:41:35</created_at>
		<updated_at>2016-08-06 20:10:19</updated_at>
		<export>1</export>
		<name>TG(12:0/12:0/14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C41H78O6</moldb_formula>
		<moldb_inchi>InChI=1S/C41H78O6/c1-4-7-10-13-16-19-20-23-25-28-31-34-40(43)46-37-38(47-41(44)35-32-29-26-22-18-15-12-9-6-3)36-45-39(42)33-30-27-24-21-17-14-11-8-5-2/h38H,4-37H2,1-3H3/t38-/m0/s1</moldb_inchi>
		<moldb_inchikey>SMUUMIRCIBXLGI-LHEWISCISA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>667.0690</moldb_average_mass>
		<moldb_mono_mass>666.579840232</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1072</id>
		<lmdb_id>LMDB01048</lmdb_id>
		<created_at>2016-08-06 05:41:36</created_at>
		<updated_at>2016-08-06 20:10:35</updated_at>
		<export>1</export>
		<name>TG(4:0/16:0/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C41H78O6</moldb_formula>
		<moldb_inchi>InChI=1S/C41H78O6/c1-4-7-9-11-13-15-17-19-20-22-23-25-27-29-31-34-40(43)46-37-38(36-45-39(42)33-6-3)47-41(44)35-32-30-28-26-24-21-18-16-14-12-10-8-5-2/h38H,4-37H2,1-3H3</moldb_inchi>
		<moldb_inchikey>MSBNBDZZIPTJCP-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>667.0690</moldb_average_mass>
		<moldb_mono_mass>666.579840232</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1073</id>
		<lmdb_id>LMDB01049</lmdb_id>
		<created_at>2016-08-06 05:41:38</created_at>
		<updated_at>2016-08-06 20:10:40</updated_at>
		<export>1</export>
		<name>TG(6:0/16:0/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C43H82O6</moldb_formula>
		<moldb_inchi>InChI=1S/C43H82O6/c1-4-7-10-12-14-16-18-20-21-23-24-26-28-30-33-36-42(45)48-39-40(38-47-41(44)35-32-9-6-3)49-43(46)37-34-31-29-27-25-22-19-17-15-13-11-8-5-2/h40H,4-39H2,1-3H3</moldb_inchi>
		<moldb_inchikey>NJJSVYBVDBGZKT-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>695.1230</moldb_average_mass>
		<moldb_mono_mass>694.611140360</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1074</id>
		<lmdb_id>LMDB01050</lmdb_id>
		<created_at>2016-08-06 05:41:39</created_at>
		<updated_at>2016-08-06 20:10:44</updated_at>
		<export>1</export>
		<name>TG(8:0/16:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C43H82O6</moldb_formula>
		<moldb_inchi>InChI=1S/C43H82O6/c1-4-7-10-13-15-17-19-21-23-25-27-30-33-36-42(45)48-39-40(38-47-41(44)35-32-29-12-9-6-3)49-43(46)37-34-31-28-26-24-22-20-18-16-14-11-8-5-2/h40H,4-39H2,1-3H3</moldb_inchi>
		<moldb_inchikey>RFWJYKONNDGWCW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>695.1230</moldb_average_mass>
		<moldb_mono_mass>694.611140360</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1075</id>
		<lmdb_id>LMDB01051</lmdb_id>
		<created_at>2016-08-06 05:41:45</created_at>
		<updated_at>2016-08-06 20:10:16</updated_at>
		<export>1</export>
		<name>TG(10:0/16:0/14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCC)COC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C43H82O6</moldb_formula>
		<moldb_inchi>InChI=1S/C43H82O6/c1-4-7-10-13-16-18-20-21-23-25-28-31-34-37-43(46)49-40(38-47-41(44)35-32-29-26-15-12-9-6-3)39-48-42(45)36-33-30-27-24-22-19-17-14-11-8-5-2/h40H,4-39H2,1-3H3</moldb_inchi>
		<moldb_inchikey>ZBYLOVWUEAWMBM-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>695.1230</moldb_average_mass>
		<moldb_mono_mass>694.611140360</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1076</id>
		<lmdb_id>LMDB01052</lmdb_id>
		<created_at>2016-08-06 05:41:47</created_at>
		<updated_at>2016-08-06 20:10:19</updated_at>
		<export>1</export>
		<name>TG(12:0/14:0/14:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C43H82O6</moldb_formula>
		<moldb_inchi>InChI=1S/C43H82O6/c1-4-7-10-13-16-19-21-24-27-30-33-36-42(45)48-39-40(38-47-41(44)35-32-29-26-23-18-15-12-9-6-3)49-43(46)37-34-31-28-25-22-20-17-14-11-8-5-2/h40H,4-39H2,1-3H3/t40-/m0/s1</moldb_inchi>
		<moldb_inchikey>UGBCBXMLXHJYBS-FAIXQHPJSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>695.1230</moldb_average_mass>
		<moldb_mono_mass>694.611140360</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1077</id>
		<lmdb_id>LMDB01053</lmdb_id>
		<created_at>2016-08-06 05:41:53</created_at>
		<updated_at>2016-08-06 20:10:35</updated_at>
		<export>1</export>
		<name>TG(4:0/18:0/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C43H82O6</moldb_formula>
		<moldb_inchi>InChI=1S/C43H82O6/c1-4-7-9-11-13-15-17-19-21-23-25-27-29-31-33-36-42(45)48-39-40(38-47-41(44)35-6-3)49-43(46)37-34-32-30-28-26-24-22-20-18-16-14-12-10-8-5-2/h40H,4-39H2,1-3H3</moldb_inchi>
		<moldb_inchikey>XFFRLQGZYVVLQI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>695.1230</moldb_average_mass>
		<moldb_mono_mass>694.611140360</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1078</id>
		<lmdb_id>LMDB01054</lmdb_id>
		<created_at>2016-08-06 05:41:58</created_at>
		<updated_at>2016-08-06 20:10:41</updated_at>
		<export>1</export>
		<name>TG(6:0/16:0/20:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C45H86O6</moldb_formula>
		<moldb_inchi>InChI=1S/C45H86O6/c1-4-7-10-12-14-16-18-20-21-22-23-25-26-28-30-32-35-38-44(47)50-41-42(40-49-43(46)37-34-9-6-3)51-45(48)39-36-33-31-29-27-24-19-17-15-13-11-8-5-2/h42H,4-41H2,1-3H3</moldb_inchi>
		<moldb_inchikey>DFKKDPLHBBTFFO-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>723.1770</moldb_average_mass>
		<moldb_mono_mass>722.642440489</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1079</id>
		<lmdb_id>LMDB01055</lmdb_id>
		<created_at>2016-08-06 05:42:04</created_at>
		<updated_at>2016-08-06 20:10:41</updated_at>
		<export>1</export>
		<name>TG(6:0/18:0/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC)OC(=O)CCCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C45H86O6</moldb_formula>
		<moldb_inchi>InChI=1S/C45H86O6/c1-4-7-10-12-14-16-18-20-22-24-26-28-30-32-35-38-44(47)50-41-42(40-49-43(46)37-34-9-6-3)51-45(48)39-36-33-31-29-27-25-23-21-19-17-15-13-11-8-5-2/h42H,4-41H2,1-3H3</moldb_inchi>
		<moldb_inchikey>WZPUIXJVKWWFBH-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>723.1770</moldb_average_mass>
		<moldb_mono_mass>722.642440489</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1080</id>
		<lmdb_id>LMDB01056</lmdb_id>
		<created_at>2016-08-06 05:42:09</created_at>
		<updated_at>2016-08-06 20:10:44</updated_at>
		<export>1</export>
		<name>TG(8:0/16:0/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C45H86O6</moldb_formula>
		<moldb_inchi>InChI=1S/C45H86O6/c1-4-7-10-13-15-17-19-21-22-24-25-27-29-32-35-38-44(47)50-41-42(40-49-43(46)37-34-31-12-9-6-3)51-45(48)39-36-33-30-28-26-23-20-18-16-14-11-8-5-2/h42H,4-41H2,1-3H3</moldb_inchi>
		<moldb_inchikey>SXRIIQRGPQMOSV-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>723.1770</moldb_average_mass>
		<moldb_mono_mass>722.642440489</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1081</id>
		<lmdb_id>LMDB01057</lmdb_id>
		<created_at>2016-08-06 05:42:10</created_at>
		<updated_at>2016-08-06 20:10:16</updated_at>
		<export>1</export>
		<name>TG(10:0/16:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C45H86O6</moldb_formula>
		<moldb_inchi>InChI=1S/C45H86O6/c1-4-7-10-13-16-18-20-22-24-26-29-32-35-38-44(47)50-41-42(40-49-43(46)37-34-31-28-15-12-9-6-3)51-45(48)39-36-33-30-27-25-23-21-19-17-14-11-8-5-2/h42H,4-41H2,1-3H3</moldb_inchi>
		<moldb_inchikey>WBURFJXMBPWRIG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>723.1770</moldb_average_mass>
		<moldb_mono_mass>722.642440489</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1082</id>
		<lmdb_id>LMDB01058</lmdb_id>
		<created_at>2016-08-06 05:42:12</created_at>
		<updated_at>2016-08-06 20:10:20</updated_at>
		<export>1</export>
		<name>TG(12:0/14:0/16:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](COC(=O)CCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C45H86O6</moldb_formula>
		<moldb_inchi>InChI=1S/C45H86O6/c1-4-7-10-13-16-19-21-22-24-26-29-32-35-38-44(47)50-41-42(40-49-43(46)37-34-31-28-25-18-15-12-9-6-3)51-45(48)39-36-33-30-27-23-20-17-14-11-8-5-2/h42H,4-41H2,1-3H3/t42-/m0/s1</moldb_inchi>
		<moldb_inchikey>PGZSAELMQZLYOA-WBCKFURZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>723.1770</moldb_average_mass>
		<moldb_mono_mass>722.642440489</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1083</id>
		<lmdb_id>LMDB01059</lmdb_id>
		<created_at>2016-08-06 05:42:17</created_at>
		<updated_at>2016-08-06 20:10:20</updated_at>
		<export>1</export>
		<name>TG(12:0/14:0/20:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C49H94O6</moldb_formula>
		<moldb_inchi>InChI=1S/C49H94O6/c1-4-7-10-13-16-19-21-22-23-24-25-26-28-30-33-36-39-42-48(51)54-45-46(44-53-47(50)41-38-35-32-29-18-15-12-9-6-3)55-49(52)43-40-37-34-31-27-20-17-14-11-8-5-2/h46H,4-45H2,1-3H3</moldb_inchi>
		<moldb_inchikey>FNKDFKYDCKFOPA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>779.2850</moldb_average_mass>
		<moldb_mono_mass>778.705040747</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1084</id>
		<lmdb_id>LMDB01060</lmdb_id>
		<created_at>2016-08-06 05:42:23</created_at>
		<updated_at>2016-08-06 20:10:20</updated_at>
		<export>1</export>
		<name>TG(12:0/16:0/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](COC(=O)CCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C49H94O6</moldb_formula>
		<moldb_inchi>InChI=1S/C49H94O6/c1-4-7-10-13-16-19-21-23-24-26-27-30-33-36-39-42-48(51)54-45-46(44-53-47(50)41-38-35-32-29-18-15-12-9-6-3)55-49(52)43-40-37-34-31-28-25-22-20-17-14-11-8-5-2/h46H,4-45H2,1-3H3/t46-/m1/s1</moldb_inchi>
		<moldb_inchikey>HBNALZRPCNRSPZ-YACUFSJGSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>779.2850</moldb_average_mass>
		<moldb_mono_mass>778.705040747</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1085</id>
		<lmdb_id>LMDB01061</lmdb_id>
		<created_at>2016-08-06 05:42:24</created_at>
		<updated_at>2016-08-06 20:10:29</updated_at>
		<export>1</export>
		<name>2-Hydroxy-4-pyrimidinamine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>NC1=CC=NC(=O)N1</moldb_smiles>
		<moldb_formula>C4H5N3O</moldb_formula>
		<moldb_inchi>InChI=1S/C4H5N3O/c5-3-1-2-6-4(8)7-3/h1-2H,(H3,5,6,7,8)</moldb_inchi>
		<moldb_inchikey>OPTASPLRGRRNAP-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>111.1020</moldb_average_mass>
		<moldb_mono_mass>111.043261797</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1086</id>
		<lmdb_id>LMDB01062</lmdb_id>
		<created_at>2016-08-06 05:42:25</created_at>
		<updated_at>2016-08-06 20:10:25</updated_at>
		<export>1</export>
		<name>2,4-Dihydroxybutanoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OCCC(O)C(O)=O</moldb_smiles>
		<moldb_formula>C4H8O4</moldb_formula>
		<moldb_inchi>InChI=1S/C4H8O4/c5-2-1-3(6)4(7)8/h3,5-6H,1-2H2,(H,7,8)</moldb_inchi>
		<moldb_inchikey>UFYGCFHQAXXBCF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>120.1039</moldb_average_mass>
		<moldb_mono_mass>120.042258744</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1087</id>
		<lmdb_id>LMDB01063</lmdb_id>
		<created_at>2016-08-06 05:42:30</created_at>
		<updated_at>2016-08-06 20:10:21</updated_at>
		<export>1</export>
		<name>TG(14:0/17:0/18:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC</moldb_smiles>
		<moldb_formula>C52H100O6</moldb_formula>
		<moldb_inchi>InChI=1S/C52H100O6/c1-4-7-10-13-16-19-22-24-26-28-30-33-36-39-42-45-51(54)57-48-49(47-56-50(53)44-41-38-35-32-29-21-18-15-12-9-6-3)58-52(55)46-43-40-37-34-31-27-25-23-20-17-14-11-8-5-2/h49H,4-48H2,1-3H3</moldb_inchi>
		<moldb_inchikey>DIMXBKATFQGNNF-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>821.3660</moldb_average_mass>
		<moldb_mono_mass>820.751990940</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1088</id>
		<lmdb_id>LMDB01064</lmdb_id>
		<created_at>2016-08-06 05:42:36</created_at>
		<updated_at>2016-08-06 20:10:24</updated_at>
		<export>1</export>
		<name>2,3-Dimethyl-5-methylamino-1,3,4-thiadiazole</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CN=C1N[N+](C)=C(C)S1</moldb_smiles>
		<moldb_formula>C5H10N3S</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10N3S/c1-4-8(3)7-5(6-2)9-4/h1-3H3,(H,6,7)/q+1</moldb_inchi>
		<moldb_inchikey>MLNVPMGBXVXELR-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>144.2200</moldb_average_mass>
		<moldb_mono_mass>144.058994928</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1089</id>
		<lmdb_id>LMDB01065</lmdb_id>
		<created_at>2016-08-06 05:42:37</created_at>
		<updated_at>2016-08-06 20:10:30</updated_at>
		<export>1</export>
		<name>4-Hydroxypentenoic acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(O)CCC(O)=O</moldb_smiles>
		<moldb_formula>C5H10O3</moldb_formula>
		<moldb_inchi>InChI=1S/C5H10O3/c1-4(6)2-3-5(7)8/h4,6H,2-3H2,1H3,(H,7,8)</moldb_inchi>
		<moldb_inchikey>FMHKPLXYWVCLME-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>118.1320</moldb_average_mass>
		<moldb_mono_mass>118.062994182</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1090</id>
		<lmdb_id>LMDB01066</lmdb_id>
		<created_at>2016-08-06 05:42:43</created_at>
		<updated_at>2016-08-06 20:10:58</updated_at>
		<export>1</export>
		<name>alpha-D-glucofuranose</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(CO)[C@@]1([H])O[C@]([H])(O)[C@]([H])(O)[C@@]1([H])O</moldb_smiles>
		<moldb_formula>C6H12O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H12O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2-11H,1H2/t2-,3-,4-,5-,6+/m1/s1</moldb_inchi>
		<moldb_inchikey>AVVWPBAENSWJCB-UKFBFLRUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>180.1560</moldb_average_mass>
		<moldb_mono_mass>180.063388106</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1091</id>
		<lmdb_id>LMDB01067</lmdb_id>
		<created_at>2016-08-06 05:42:44</created_at>
		<updated_at>2016-08-06 20:10:57</updated_at>
		<export>1</export>
		<name>Glucaric acid-1,4-lactone</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](O)(C(O)=O)[C@@]1([H])OC(=O)[C@]([H])(O)[C@@]1([H])O</moldb_smiles>
		<moldb_formula>C6H8O7</moldb_formula>
		<moldb_inchi>InChI=1S/C6H8O7/c7-1-2(8)6(12)13-4(1)3(9)5(10)11/h1-4,7-9H,(H,10,11)/t1-,2-,3+,4+/m1/s1</moldb_inchi>
		<moldb_inchikey>XECPAIJNBXCOBO-MMPJQOAZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>192.1235</moldb_average_mass>
		<moldb_mono_mass>192.027002610</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1092</id>
		<lmdb_id>LMDB01068</lmdb_id>
		<created_at>2016-08-06 05:42:49</created_at>
		<updated_at>2016-08-06 20:11:02</updated_at>
		<export>1</export>
		<name>Crotonyl glycine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(C)=C(\[H])C(O)=NCC(O)=O</moldb_smiles>
		<moldb_formula>C6H9NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C6H9NO3/c1-2-3-5(8)7-4-6(9)10/h2-3H,4H2,1H3,(H,7,8)(H,9,10)/b3-2+</moldb_inchi>
		<moldb_inchikey>WWJXRJJBIVSSNF-NSCUHMNNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>143.1420</moldb_average_mass>
		<moldb_mono_mass>143.058243154</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1093</id>
		<lmdb_id>LMDB01069</lmdb_id>
		<created_at>2016-08-06 05:42:51</created_at>
		<updated_at>2016-08-06 20:10:57</updated_at>
		<export>1</export>
		<name>Methyl beta-D-glucopyranoside</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O</moldb_smiles>
		<moldb_formula>C7H14O6</moldb_formula>
		<moldb_inchi>InChI=1S/C7H14O6/c1-12-7-6(11)5(10)4(9)3(2-8)13-7/h3-11H,2H2,1H3/t3-,4+,5+,6-,7-/m1/s1</moldb_inchi>
		<moldb_inchikey>HOVAGTYPODGVJG-VOQCIKJUSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>194.1825</moldb_average_mass>
		<moldb_mono_mass>194.079038180</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1094</id>
		<lmdb_id>LMDB01070</lmdb_id>
		<created_at>2016-08-06 05:42:56</created_at>
		<updated_at>2016-08-06 20:11:01</updated_at>
		<export>1</export>
		<name>beta-D-methylfructofuranoside</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(O)[C@@]([H])(CO)O[C@@](CO)(OC)[C@@]1([H])O</moldb_smiles>
		<moldb_formula>C7H14O6</moldb_formula>
		<moldb_inchi>InChI=1S/C7H14O6/c1-12-7(3-9)6(11)5(10)4(2-8)13-7/h4-6,8-11H,2-3H2,1H3/t4-,5-,6+,7-/m1/s1</moldb_inchi>
		<moldb_inchikey>JPHVNZOOBXUCDJ-MVIOUDGNSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>194.1830</moldb_average_mass>
		<moldb_mono_mass>194.079038171</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1095</id>
		<lmdb_id>LMDB01071</lmdb_id>
		<created_at>2016-08-06 05:42:58</created_at>
		<updated_at>2016-08-06 20:10:27</updated_at>
		<export>1</export>
		<name>2,6-bis(1,1-dimethyl) Phenol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC1=CC=CC(C)=C1O</moldb_smiles>
		<moldb_formula>C8H10O</moldb_formula>
		<moldb_inchi>InChI=1S/C8H10O/c1-6-4-3-5-7(2)8(6)9/h3-5,9H,1-2H3</moldb_inchi>
		<moldb_inchikey>NXXYKOUNUYWIHA-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>122.1644</moldb_average_mass>
		<moldb_mono_mass>122.073164942</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1096</id>
		<lmdb_id>LMDB01072</lmdb_id>
		<created_at>2016-08-06 05:43:00</created_at>
		<updated_at>2016-08-06 20:10:37</updated_at>
		<export>1</export>
		<name>Isopropyl beta-D-1-thiogalactopyranoside</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@]1(CO)O[C@@]([H])(SC(C)C)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O</moldb_smiles>
		<moldb_formula>C9H18O5S</moldb_formula>
		<moldb_inchi>InChI=1S/C9H18O5S/c1-4(2)15-9-8(13)7(12)6(11)5(3-10)14-9/h4-13H,3H2,1-2H3/t5-,6+,7+,8-,9+/m1/s1</moldb_inchi>
		<moldb_inchikey>BPHPUYQFMNQIOC-NXRLNHOXSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>238.3010</moldb_average_mass>
		<moldb_mono_mass>238.087494376</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1097</id>
		<lmdb_id>LMDB01073</lmdb_id>
		<created_at>2016-08-06 05:43:05</created_at>
		<updated_at>2016-08-06 20:10:28</updated_at>
		<export>1</export>
		<name>2-Butyl-2-ethyloxazolidine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC1(CC)NCCO1</moldb_smiles>
		<moldb_formula>C9H19NO</moldb_formula>
		<moldb_inchi>InChI=1S/C9H19NO/c1-3-5-6-9(4-2)10-7-8-11-9/h10H,3-8H2,1-2H3</moldb_inchi>
		<moldb_inchikey>HPUBLNNVQPMSKK-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>157.2570</moldb_average_mass>
		<moldb_mono_mass>157.146664236</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1098</id>
		<lmdb_id>LMDB01074</lmdb_id>
		<created_at>2016-08-06 17:30:07</created_at>
		<updated_at>2016-08-06 20:11:03</updated_at>
		<export>1</export>
		<name>Methyl jasmonate</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CC)=C(/[H])C[C@]1([H])C(=O)CC[C@@]1([H])CC(=O)OC</moldb_smiles>
		<moldb_formula>C13H20O3</moldb_formula>
		<moldb_inchi>InChI=1S/C13H20O3/c1-3-4-5-6-11-10(7-8-12(11)14)9-13(15)16-2/h4-5,10-11H,3,6-9H2,1-2H3/b5-4-/t10-,11-/m0/s1</moldb_inchi>
		<moldb_inchikey>GEWDNTWNSAZUDX-XXJOZFEBSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>224.3000</moldb_average_mass>
		<moldb_mono_mass>224.141244504</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1099</id>
		<lmdb_id>LMDB01075</lmdb_id>
		<created_at>2016-08-06 17:30:13</created_at>
		<updated_at>2016-08-06 20:10:22</updated_at>
		<export>1</export>
		<name>19-Norandrosterone 3-glucuronide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@@]([H])(CC[C@]12[H])O[C@]1([H])OC([H])(C(O)=O)[C@@]([H])(O)C([H])(O)C1([H])O</moldb_smiles>
		<moldb_formula>C24H36O8</moldb_formula>
		<moldb_inchi>InChI=1S/C24H36O8/c1-24-9-8-14-13-5-3-12(10-11(13)2-4-15(14)16(24)6-7-17(24)25)31-23-20(28)18(26)19(27)21(32-23)22(29)30/h11-16,18-21,23,26-28H,2-10H2,1H3,(H,29,30)/t11-,12-,13+,14-,15-,16+,18?,19+,20?,21?,23-,24+/m1/s1</moldb_inchi>
		<moldb_inchikey>JGNAYBFRYHOLMC-QJOJGNLZSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>452.5440</moldb_average_mass>
		<moldb_mono_mass>452.241018119</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1103</id>
		<lmdb_id>LMDB01079</lmdb_id>
		<created_at>2016-08-08 18:11:22</created_at>
		<updated_at>2016-08-08 18:36:28</updated_at>
		<export>1</export>
		<name>Hydroxyhexanoylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCCCC(O)CC(=O)OC(CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C14H27NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C14H27NO5/c1-5-6-7-11(16)8-14(19)20-12(9-13(17)18)10-15(2,3)4/h11-12,16H,5-10H2,1-4H3</moldb_inchi>
		<moldb_inchikey>YWSDGPGKVSDFES-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>289.3679</moldb_average_mass>
		<moldb_mono_mass>289.188922979</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1104</id>
		<lmdb_id>LMDB01080</lmdb_id>
		<created_at>2016-08-08 18:11:24</created_at>
		<updated_at>2016-08-08 18:36:28</updated_at>
		<export>1</export>
		<name>Hydroxyvalerylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC(O)CC(O)O[C@@H](CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C12H25NO5</moldb_formula>
		<moldb_inchi>InChI=1S/C12H25NO5/c1-5-9(14)6-12(17)18-10(7-11(15)16)8-13(2,3)4/h9-10,12,14,17H,5-8H2,1-4H3/t9?,10-,12?/m0/s1</moldb_inchi>
		<moldb_inchikey>PSRQDLCMEPQOQH-YZRBJQDESA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>263.3306</moldb_average_mass>
		<moldb_mono_mass>263.173272915</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1105</id>
		<lmdb_id>LMDB01081</lmdb_id>
		<created_at>2016-08-08 18:11:25</created_at>
		<updated_at>2016-08-08 18:36:28</updated_at>
		<export>1</export>
		<name>Methylmalonylcarnitine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CC(C(O)=O)C(=O)O[C@@H](CC([O-])=O)C[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C11H19NO6</moldb_formula>
		<moldb_inchi>InChI=1S/C11H19NO6/c1-7(10(15)16)11(17)18-8(5-9(13)14)6-12(2,3)4/h7-8H,5-6H2,1-4H3,(H-,13,14,15,16)/t7?,8-/m0/s1</moldb_inchi>
		<moldb_inchikey>XROYFEWIXXCPAW-MQWKRIRWSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>261.2717</moldb_average_mass>
		<moldb_mono_mass>261.121237345</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1106</id>
		<lmdb_id>LMDB01082</lmdb_id>
		<created_at>2016-08-09 17:40:00</created_at>
		<updated_at>2016-08-09 21:33:37</updated_at>
		<export>1</export>
		<name>N-(2-Oxohexanoyl)homoserine lactone</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CCOC1=O)NC(=O)C(=O)CCCC</moldb_smiles>
		<moldb_formula>C10H15NO4</moldb_formula>
		<moldb_inchi>InChI=1S/C10H15NO4/c1-2-3-4-8(12)9(13)11-7-5-6-15-10(7)14/h7H,2-6H2,1H3,(H,11,13)/t7-/m0/s1</moldb_inchi>
		<moldb_inchikey>HXDSMMVKIYAMIA-ZETCQYMHSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>213.2304</moldb_average_mass>
		<moldb_mono_mass>213.100107973</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1108</id>
		<lmdb_id>LMDB01084</lmdb_id>
		<created_at>2016-08-09 17:40:05</created_at>
		<updated_at>2016-08-09 21:33:41</updated_at>
		<export>1</export>
		<name>PC(4:0/4:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](COC(=O)CCC)(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC</moldb_smiles>
		<moldb_formula>C16H32NO8P</moldb_formula>
		<moldb_inchi>InChI=1S/C16H32NO8P/c1-6-8-15(18)22-12-14(25-16(19)9-7-2)13-24-26(20,21)23-11-10-17(3,4)5/h14H,6-13H2,1-5H3/t14-/m1/s1</moldb_inchi>
		<moldb_inchikey>QIJYAMAPPUXBSC-CQSZACIVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>397.4050</moldb_average_mass>
		<moldb_mono_mass>397.186553992</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1109</id>
		<lmdb_id>LMDB01085</lmdb_id>
		<created_at>2016-08-09 17:40:06</created_at>
		<updated_at>2016-08-09 21:33:46</updated_at>
		<export>1</export>
		<name>Boldenone 17-O-b-D-glucuronide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@]1(CCC2([H])C3([H])CCC4=CC(=O)C=C[C@]4(C)C3([H])CC[C@]12C)OC1([H])OC([H])(C(O)=O)C([H])(O)C([H])(O)C1([H])O</moldb_smiles>
		<moldb_formula>C25H34O8</moldb_formula>
		<moldb_inchi>InChI=1S/C25H34O8/c1-24-9-7-13(26)11-12(24)3-4-14-15-5-6-17(25(15,2)10-8-16(14)24)32-23-20(29)18(27)19(28)21(33-23)22(30)31/h7,9,11,14-21,23,27-29H,3-6,8,10H2,1-2H3,(H,30,31)/t14?,15?,16?,17-,18?,19?,20?,21?,23?,24-,25-/m0/s1</moldb_inchi>
		<moldb_inchikey>WTOYIEKXMIILRQ-QQUUXXDRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>462.5390</moldb_average_mass>
		<moldb_mono_mass>462.225368055</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1110</id>
		<lmdb_id>LMDB01086</lmdb_id>
		<created_at>2016-08-09 17:40:08</created_at>
		<updated_at>2016-08-09 21:33:50</updated_at>
		<export>1</export>
		<name>PC(18:2(2E,4E)/0:0)</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H]\C(CCCCCCCCCCCCC)=C(\[H])/C(/[H])=C(\[H])C(=O)OC[C@@]([H])(O)COP([O-])(=O)OCC[N+](C)(C)C</moldb_smiles>
		<moldb_formula>C26H50NO7P</moldb_formula>
		<moldb_inchi>InChI=1S/C26H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h17-20,25,28H,5-16,21-24H2,1-4H3/b18-17+,20-19+/t25-/m1/s1</moldb_inchi>
		<moldb_inchikey>CLDXAAPENVNFAW-JRMAHNDFSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>519.6600</moldb_average_mass>
		<moldb_mono_mass>519.332489952</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1111</id>
		<lmdb_id>LMDB01087</lmdb_id>
		<created_at>2016-08-09 17:40:09</created_at>
		<updated_at>2016-08-09 21:33:51</updated_at>
		<export>1</export>
		<name>24-Dihydrolanosterol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@@](C)(CCCC(C)C)[C@@]1([H])CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@]1([H])CC3</moldb_smiles>
		<moldb_formula>C30H52O</moldb_formula>
		<moldb_inchi>InChI=1S/C30H52O/c1-20(2)10-9-11-21(3)22-14-18-30(8)24-12-13-25-27(4,5)26(31)16-17-28(25,6)23(24)15-19-29(22,30)7/h20-22,25-26,31H,9-19H2,1-8H3/t21-,22-,25+,26+,28-,29-,30+/m1/s1</moldb_inchi>
		<moldb_inchikey>MBZYKEVPFYHDOH-BQNIITSRSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>428.7333</moldb_average_mass>
		<moldb_mono_mass>428.401816286</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1113</id>
		<lmdb_id>LMDB01089</lmdb_id>
		<created_at>2016-08-09 17:40:11</created_at>
		<updated_at>2016-08-09 21:33:56</updated_at>
		<export>1</export>
		<name>2,2,2-Trifluoro-N-(1-methylpropyl)acetamide</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCC(C)N=C(O)C(F)(F)F</moldb_smiles>
		<moldb_formula>C6H10F3NO</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10F3NO/c1-3-4(2)10-5(11)6(7,8)9/h4H,3H2,1-2H3,(H,10,11)</moldb_inchi>
		<moldb_inchikey>MOAMIZJDECJMPD-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>169.1470</moldb_average_mass>
		<moldb_mono_mass>169.071448435</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1114</id>
		<lmdb_id>LMDB01090</lmdb_id>
		<created_at>2016-08-09 17:40:13</created_at>
		<updated_at>2016-08-09 21:34:00</updated_at>
		<export>1</export>
		<name>D-Gluco-hexodialdose</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](O)(C=O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)C=O</moldb_smiles>
		<moldb_formula>C6H10O6</moldb_formula>
		<moldb_inchi>InChI=1S/C6H10O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1-6,9-12H/t3-,4+,5-,6-/m1/s1</moldb_inchi>
		<moldb_inchikey>VYPPEYAOCURAAE-JGWLITMVSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>178.1400</moldb_average_mass>
		<moldb_mono_mass>178.047738042</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1115</id>
		<lmdb_id>LMDB01091</lmdb_id>
		<created_at>2016-08-09 17:40:15</created_at>
		<updated_at>2016-08-09 21:34:09</updated_at>
		<export>1</export>
		<name>3-Deoxyglucitol</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>[H][C@](O)(CO)C[C@]([H])(O)[C@]([H])(O)CO</moldb_smiles>
		<moldb_formula>C6H14O5</moldb_formula>
		<moldb_inchi>InChI=1S/C6H14O5/c7-2-4(9)1-5(10)6(11)3-8/h4-11H,1-3H2/t4-,5+,6-/m1/s1</moldb_inchi>
		<moldb_inchikey>RUIACMUVCHMOMF-NGJCXOISSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>166.1730</moldb_average_mass>
		<moldb_mono_mass>166.084123551</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1116</id>
		<lmdb_id>LMDB01092</lmdb_id>
		<created_at>2016-08-09 17:40:17</created_at>
		<updated_at>2016-08-09 21:34:14</updated_at>
		<export>1</export>
		<name>3,8-Dioxa-2,9-disiladecane</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>C[SiH2]OCCCCO[SiH2]C</moldb_smiles>
		<moldb_formula>C6H18O2Si2</moldb_formula>
		<moldb_inchi>InChI=1S/C6H18O2Si2/c1-9-7-5-3-4-6-8-10-2/h3-6,9-10H2,1-2H3</moldb_inchi>
		<moldb_inchikey>VLUDBXXJIWNNBI-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>178.3780</moldb_average_mass>
		<moldb_mono_mass>178.084532890</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1117</id>
		<lmdb_id>LMDB01093</lmdb_id>
		<created_at>2016-08-09 17:40:19</created_at>
		<updated_at>2016-08-09 21:34:18</updated_at>
		<export>1</export>
		<name>N,N-Diethyl-N'-methyl-1,2-ethanediamine</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>CCN(CC)CCNC</moldb_smiles>
		<moldb_formula>C7H18N2</moldb_formula>
		<moldb_inchi>InChI=1S/C7H18N2/c1-4-9(5-2)7-6-8-3/h8H,4-7H2,1-3H3</moldb_inchi>
		<moldb_inchikey>MKDYQLJYEBWUIG-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>130.2350</moldb_average_mass>
		<moldb_mono_mass>130.146998588</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1118</id>
		<lmdb_id>LMDB01094</lmdb_id>
		<created_at>2016-08-09 17:40:21</created_at>
		<updated_at>2016-08-09 21:34:19</updated_at>
		<export>1</export>
		<name>Methyl-1-methyl-1,2,5,6-tetrahydro-3-pyridincarboxylat</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>COC(=O)C1=CCCN(C)C1</moldb_smiles>
		<moldb_formula>C8H13NO2</moldb_formula>
		<moldb_inchi>InChI=1S/C8H13NO2/c1-9-5-3-4-7(6-9)8(10)11-2/h4H,3,5-6H2,1-2H3</moldb_inchi>
		<moldb_inchikey>HJJPJSXJAXAIPN-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>155.1943</moldb_average_mass>
		<moldb_mono_mass>155.094628665</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	<row>
		<id>1119</id>
		<lmdb_id>LMDB01095</lmdb_id>
		<created_at>2016-08-09 17:40:22</created_at>
		<updated_at>2016-08-09 21:34:19</updated_at>
		<export>1</export>
		<name>Hexahydrohippuric Acid</name>
		<description>NULL</description>
		<cas>NULL</cas>
		<synthesis_reference>NULL</synthesis_reference>
		<state>NULL</state>
		<status>1</status>
		<comment>NULL</comment>
		<quantified>0</quantified>
		<detected>0</detected>
		<msds_file_name>NULL</msds_file_name>
		<msds_content_type>NULL</msds_content_type>
		<msds_file_size>NULL</msds_file_size>
		<msds_updated_at>NULL</msds_updated_at>
		<moldb_id>NULL</moldb_id>
		<moldb_smiles>OC(=O)CNC(=O)C1CCCCC1</moldb_smiles>
		<moldb_formula>C9H15NO3</moldb_formula>
		<moldb_inchi>InChI=1S/C9H15NO3/c11-8(12)6-10-9(13)7-4-2-1-3-5-7/h7H,1-6H2,(H,10,13)(H,11,12)</moldb_inchi>
		<moldb_inchikey>ROXXNENGCGLRSW-UHFFFAOYSA-N</moldb_inchikey>
		<moldb_iupac>NULL</moldb_iupac>
		<moldb_logp>NULL</moldb_logp>
		<moldb_pka>NULL</moldb_pka>
		<moldb_average_mass>185.2230</moldb_average_mass>
		<moldb_mono_mass>185.105193347</moldb_mono_mass>
		<moldb_alogps_solubility>NULL</moldb_alogps_solubility>
		<moldb_alogps_logp>NULL</moldb_alogps_logp>
		<moldb_alogps_logs>NULL</moldb_alogps_logs>
		<moldb_acceptor_count>NULL</moldb_acceptor_count>
		<moldb_donor_count>NULL</moldb_donor_count>
		<moldb_rotatable_bond_count>NULL</moldb_rotatable_bond_count>
		<moldb_polar_surface_area>NULL</moldb_polar_surface_area>
		<moldb_refractivity>NULL</moldb_refractivity>
		<moldb_polarizability>NULL</moldb_polarizability>
		<moldb_traditional_iupac>NULL</moldb_traditional_iupac>
		<moldb_formal_charge>NULL</moldb_formal_charge>
		<moldb_physiological_charge>NULL</moldb_physiological_charge>
		<moldb_pka_strongest_acidic>NULL</moldb_pka_strongest_acidic>
		<moldb_pka_strongest_basic>NULL</moldb_pka_strongest_basic>
		<hml_compound>0</hml_compound>
	</row>

	</custom>

</lmdb>
